Citrus Sinensis ID: 014307
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 427 | 2.2.26 [Sep-21-2011] | |||||||
| O64816 | 432 | Casein kinase II subunit | yes | no | 0.735 | 0.726 | 0.866 | 1e-151 | |
| P28523 | 332 | Casein kinase II subunit | N/A | no | 0.629 | 0.810 | 0.918 | 1e-136 | |
| Q08467 | 409 | Casein kinase II subunit | no | no | 0.667 | 0.696 | 0.860 | 1e-135 | |
| Q08466 | 403 | Casein kinase II subunit | no | no | 0.658 | 0.697 | 0.860 | 1e-135 | |
| O64817 | 333 | Probable casein kinase II | no | no | 0.634 | 0.813 | 0.870 | 1e-130 | |
| P40231 | 332 | Casein kinase II subunit | yes | no | 0.639 | 0.822 | 0.730 | 1e-118 | |
| O76484 | 353 | Casein kinase II subunit | N/A | no | 0.637 | 0.770 | 0.775 | 1e-116 | |
| Q60737 | 391 | Casein kinase II subunit | yes | no | 0.632 | 0.690 | 0.774 | 1e-116 | |
| P19139 | 391 | Casein kinase II subunit | yes | no | 0.632 | 0.690 | 0.774 | 1e-116 | |
| P21868 | 391 | Casein kinase II subunit | yes | no | 0.632 | 0.690 | 0.774 | 1e-116 |
| >sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 535 bits (1379), Expect = e-151, Method: Compositional matrix adjust.
Identities = 278/321 (86%), Positives = 297/321 (92%), Gaps = 7/321 (2%)
Query: 59 TLRGLASSASL--SHARHQHQRLR-----QLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
LR ASSASL H R+Q Q+ + ++ +TLAQKIGKS+RR+GAPSKARVY+D
Sbjct: 48 NLRRFASSASLYRQHLRNQQQQHQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYAD 107
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVK
Sbjct: 108 VNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVK 167
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVR
Sbjct: 168 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVR 227
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
YYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 228 YYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 287
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL
Sbjct: 288 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 347
Query: 352 NAYLNKYHIELDPHLAALVGR 372
NAYLNKY IELDP+L +LVGR
Sbjct: 348 NAYLNKYRIELDPNLTSLVGR 368
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 484 bits (1247), Expect = e-136, Method: Compositional matrix adjust.
Identities = 247/269 (91%), Positives = 260/269 (96%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++ +NEKCI
Sbjct: 2 SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61
Query: 164 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGR 372
KVLGTD LN YLNKY IELDP L ALVGR
Sbjct: 242 KVLGTDGLNVYLNKYRIELDPQLEALVGR 270
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 482 bits (1241), Expect = e-135, Method: Compositional matrix adjust.
Identities = 247/287 (86%), Positives = 267/287 (93%), Gaps = 2/287 (0%)
Query: 86 PDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRG 145
PD L + I S ++ A SKARVY+++NV+RP++YWDYESL VQWGEQDDYEVVRKVGRG
Sbjct: 62 PDFLVE-ISDS-NQTRAMSKARVYTEVNVIRPKDYWDYESLIVQWGEQDDYEVVRKVGRG 119
Query: 146 KYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205
KYSEVFEG++ EKCIIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQ SKT
Sbjct: 120 KYSEVFEGINVNSKEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKT 179
Query: 206 PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
PSLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHE
Sbjct: 180 PSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHEL 239
Query: 266 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 325
RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFR
Sbjct: 240 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFR 299
Query: 326 KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
KEPFFYGHDN DQLVKIAKVLGTDELNAYLNKY +ELDP L ALVGR
Sbjct: 300 KEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDPQLEALVGR 346
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 482 bits (1240), Expect = e-135, Method: Compositional matrix adjust.
Identities = 246/286 (86%), Positives = 266/286 (93%), Gaps = 5/286 (1%)
Query: 87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
D+LA+ + S SKARVY+D+NV+RP++YWDYESL VQWGEQDDYEVVRKVGRGK
Sbjct: 60 DSLAK-----ISLSTVMSKARVYTDVNVIRPKDYWDYESLNVQWGEQDDYEVVRKVGRGK 114
Query: 147 YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206
YSEVFEG++ +NEKCIIKILKPVKKKKI+REIKILQNLCGGPNIVKLLD+VRDQ SKTP
Sbjct: 115 YSEVFEGINMNNNEKCIIKILKPVKKKKIRREIKILQNLCGGPNIVKLLDVVRDQHSKTP 174
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
SLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDHE R
Sbjct: 175 SLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHELR 234
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRK
Sbjct: 235 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRK 294
Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
EPFFYGHDN DQLVKIAKVLGTDELNAYLNKY +ELD L ALVGR
Sbjct: 295 EPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDTQLEALVGR 340
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 236/271 (87%), Positives = 255/271 (94%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
SKARVY+D+NVVRP+EYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG + NE+C+
Sbjct: 2 SKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCV 61
Query: 164 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
IKILKPVKKKKIKREIKILQNLCGGPNIVKL DIVRD+ SKTPSL+FE VN+ DFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRLV 374
KVLGT+EL+ YLNKY ++LDP L ALVGR V
Sbjct: 242 KVLGTNELDHYLNKYQLDLDPQLEALVGRHV 272
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P40231|CSK2A_SCHPO Casein kinase II subunit alpha OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cka1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 424 bits (1091), Expect = e-118, Method: Compositional matrix adjust.
Identities = 201/275 (73%), Positives = 233/275 (84%), Gaps = 2/275 (0%)
Query: 100 SGAP--SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCT 157
AP S +RVY+ +N PREYWDYE++ +G QD+YE++RKVGRGKYSEVFEG++
Sbjct: 5 EAAPVVSVSRVYAHVNEEMPREYWDYENMQEVFGYQDNYEIIRKVGRGKYSEVFEGLNVL 64
Query: 158 DNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217
+N KCIIK+LKPVK KKIKREIKILQNL GGPNI+ LLDIVRD +SKTPSLIFE V+N D
Sbjct: 65 NNSKCIIKVLKPVKYKKIKREIKILQNLAGGPNIISLLDIVRDPESKTPSLIFEFVDNID 124
Query: 218 FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277
F+ LYPTLSDYD+RYY YELLKALD+CHS+GIMHRDVKPHNVMIDH++RKLRLIDWGLAE
Sbjct: 125 FRTLYPTLSDYDIRYYSYELLKALDFCHSRGIMHRDVKPHNVMIDHKKRKLRLIDWGLAE 184
Query: 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
FYH G EYNVRVASRYFKGPELLVD ++YDYSLD+WS G MFA +IF+K+ FF G DNYD
Sbjct: 185 FYHAGMEYNVRVASRYFKGPELLVDFREYDYSLDIWSFGVMFAALIFKKDTFFRGRDNYD 244
Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
QLVKIAKVLGTDEL AY+ KY I LD ++G+
Sbjct: 245 QLVKIAKVLGTDELFAYVQKYQIVLDRQYDNILGQ 279
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Plays a role in the translation of cell polarity into polarized growth. The alpha and alpha' chains contain the catalytic site. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O76484|CSK2A_SPOFR Casein kinase II subunit alpha OS=Spodoptera frugiperda PE=2 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1080), Expect = e-116, Method: Compositional matrix adjust.
Identities = 211/272 (77%), Positives = 241/272 (88%)
Query: 101 GAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNE 160
PS+ARVY+D+N RPREYWDYES V WG Q+DY++VRK+GRGKYSEVFE ++ T+NE
Sbjct: 4 AVPSRARVYADVNSQRPREYWDYESYVVDWGNQEDYQLVRKLGRGKYSEVFEAINITNNE 63
Query: 161 KCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220
KC++KILKPVKKKKIKREIKIL+NL GG NI+ L +V+D S+TP+LIFEHVNNTDFK
Sbjct: 64 KCVVKILKPVKKKKIKREIKILENLRGGTNIITLQAVVKDPVSRTPALIFEHVNNTDFKQ 123
Query: 221 LYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280
LY TLSDYD+RYY+YELLKALDYCHS GIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYH
Sbjct: 124 LYQTLSDYDIRYYLYELLKALDYCHSMGIMHRDVKPHNVMIDHDHRKLRLIDWGLAEFYH 183
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
PG++YNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV
Sbjct: 184 PGQDYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 243
Query: 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
+IAKVLGT+EL YL+KYHIELDP ++GR
Sbjct: 244 RIAKVLGTEELFEYLDKYHIELDPRFNDILGR 275
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May participate in Wnt signaling. Spodoptera frugiperda (taxid: 7108) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q60737|CSK21_MOUSE Casein kinase II subunit alpha OS=Mus musculus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 420 bits (1079), Expect = e-116, Method: Compositional matrix adjust.
Identities = 209/270 (77%), Positives = 243/270 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 245
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGR 372
AKVLGT++L Y++KY+IELDP ++GR
Sbjct: 246 AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P19139|CSK21_RAT Casein kinase II subunit alpha OS=Rattus norvegicus GN=Csnk2a1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 419 bits (1078), Expect = e-116, Method: Compositional matrix adjust.
Identities = 209/270 (77%), Positives = 243/270 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 245
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGR 372
AKVLGT++L Y++KY+IELDP ++GR
Sbjct: 246 AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P21868|CSK21_CHICK Casein kinase II subunit alpha OS=Gallus gallus GN=CSNK2A1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1077), Expect = e-116, Method: Compositional matrix adjust.
Identities = 209/270 (77%), Positives = 243/270 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 6 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 65
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 66 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 125
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 126 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 185
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 186 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 245
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGR 372
AKVLGT++L Y++KY+IELDP ++GR
Sbjct: 246 AKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 427 | ||||||
| 224071301 | 448 | predicted protein [Populus trichocarpa] | 0.854 | 0.814 | 0.778 | 1e-156 | |
| 225438980 | 424 | PREDICTED: casein kinase II subunit alph | 0.728 | 0.733 | 0.890 | 1e-154 | |
| 255568569 | 489 | casein kinase II, alpha chain, putative | 0.763 | 0.666 | 0.817 | 1e-154 | |
| 147841853 | 392 | hypothetical protein VITISV_034030 [Viti | 0.693 | 0.755 | 0.942 | 1e-153 | |
| 297825193 | 432 | hypothetical protein ARALYDRAFT_481178 [ | 0.845 | 0.835 | 0.773 | 1e-150 | |
| 17977868 | 414 | casein kinase II alpha subunit [Sinapis | 0.812 | 0.838 | 0.754 | 1e-149 | |
| 15227778 | 432 | casein kinase 2, alpha polypeptide [Arab | 0.735 | 0.726 | 0.866 | 1e-149 | |
| 224081845 | 361 | predicted protein [Populus trichocarpa] | 0.693 | 0.819 | 0.922 | 1e-149 | |
| 449519104 | 441 | PREDICTED: casein kinase II subunit alph | 0.669 | 0.648 | 0.933 | 1e-149 | |
| 449448236 | 423 | PREDICTED: casein kinase II subunit alph | 0.826 | 0.834 | 0.751 | 1e-147 |
| >gi|224071301|ref|XP_002303393.1| predicted protein [Populus trichocarpa] gi|222840825|gb|EEE78372.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1436), Expect = e-156, Method: Compositional matrix adjust.
Identities = 306/393 (77%), Positives = 324/393 (82%), Gaps = 28/393 (7%)
Query: 1 MAIRPFQF-----TI------HRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSP-LS 48
MAIRPF TI + N N TLFSS I R + + +P L
Sbjct: 1 MAIRPFLLQQKLTTILNRQRQKKKNNINKTLFSSLLFI-------RNNNNNNNNNNPFLF 53
Query: 49 QSSRIFTPFGTLRGLASSAS-LSHARHQHQ--------RLRQLATPPDTLAQKIGKSVRR 99
S + + LR ASS + SH + Q R R L PPDTLAQKIGKS+RR
Sbjct: 54 SSPQSSSISTLLRQFASSTTAFSHQKQGQQEIQHRLPHRFRSLVPPPDTLAQKIGKSIRR 113
Query: 100 SGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDN 159
GAPSKARVY+DINV+RP++YWDYESLTVQWGEQDDYEVV+KVGRGKYSEVFEGVHCTDN
Sbjct: 114 PGAPSKARVYADINVIRPKDYWDYESLTVQWGEQDDYEVVKKVGRGKYSEVFEGVHCTDN 173
Query: 160 EKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 219
EKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE+VNNTDFK
Sbjct: 174 EKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEYVNNTDFK 233
Query: 220 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279
VLYPTLSD+D+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY
Sbjct: 234 VLYPTLSDFDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 293
Query: 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL
Sbjct: 294 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 353
Query: 340 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
VKIAKVLGTDELNAYLN+Y IELD HLAALVGR
Sbjct: 354 VKIAKVLGTDELNAYLNRYRIELDLHLAALVGR 386
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438980|ref|XP_002284333.1| PREDICTED: casein kinase II subunit alpha isoform 1 [Vitis vinifera] gi|296087330|emb|CBI33704.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1419), Expect = e-154, Method: Compositional matrix adjust.
Identities = 286/321 (89%), Positives = 298/321 (92%), Gaps = 10/321 (3%)
Query: 61 RGLASSASLSHARHQ---------HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
R +S A LSH + H R L++ P+TLAQ+IGKSVRR GAPSKARVY+D
Sbjct: 42 RLASSPAPLSHPQKSPPPPPPPPSHHRF-ALSSLPETLAQRIGKSVRRPGAPSKARVYAD 100
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
INV+RP+EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK
Sbjct: 101 INVIRPKEYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 160
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+R
Sbjct: 161 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIR 220
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 221 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 280
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL
Sbjct: 281 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 340
Query: 352 NAYLNKYHIELDPHLAALVGR 372
NAYLNKY +ELDPHLAALVGR
Sbjct: 341 NAYLNKYRLELDPHLAALVGR 361
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255568569|ref|XP_002525258.1| casein kinase II, alpha chain, putative [Ricinus communis] gi|223535416|gb|EEF37086.1| casein kinase II, alpha chain, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1416), Expect = e-154, Method: Compositional matrix adjust.
Identities = 286/350 (81%), Positives = 302/350 (86%), Gaps = 24/350 (6%)
Query: 47 LSQSSRIFTPFGTLRGLASSASLSHARHQH-----------------------QRLRQ-L 82
L S +F+P + + AS S R QH RL+ +
Sbjct: 78 LPSPSPLFSPQSPITSVLRLASTSSHRKQHLPPPPPPPPPPPPLQPIAEAIRLHRLKNSV 137
Query: 83 ATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKV 142
A +TLAQKIGKS+RR GAPSKARVY+D+NV+RP++YWDYESLTVQWGEQDDYEVVRKV
Sbjct: 138 ALSSETLAQKIGKSIRRPGAPSKARVYADVNVIRPKDYWDYESLTVQWGEQDDYEVVRKV 197
Query: 143 GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202
GRGKYSEVFEGVHC DNEKC+IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ
Sbjct: 198 GRGKYSEVFEGVHCADNEKCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 257
Query: 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262
SKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMID
Sbjct: 258 SKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 317
Query: 263 HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM 322
HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM
Sbjct: 318 HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM 377
Query: 323 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY IELDPHLAALVGR
Sbjct: 378 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRIELDPHLAALVGR 427
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147841853|emb|CAN71837.1| hypothetical protein VITISV_034030 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1412), Expect = e-153, Method: Compositional matrix adjust.
Identities = 280/297 (94%), Positives = 290/297 (97%), Gaps = 1/297 (0%)
Query: 76 HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD 135
H R L++ P+TLAQ+IGKSVRR GAPSKARVY+DINV+RP+EYWDYESLTVQWGEQDD
Sbjct: 34 HHRF-ALSSLPETLAQRIGKSVRRPGAPSKARVYADINVIRPKEYWDYESLTVQWGEQDD 92
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL
Sbjct: 93 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 152
Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
DIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMHRDVK
Sbjct: 153 DIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMHRDVK 212
Query: 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL 315
PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL
Sbjct: 213 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSL 272
Query: 316 GCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
GCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY +ELDPHLAALVGR
Sbjct: 273 GCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRLELDPHLAALVGR 329
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297825193|ref|XP_002880479.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata] gi|297326318|gb|EFH56738.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1383), Expect = e-150, Method: Compositional matrix adjust.
Identities = 293/379 (77%), Positives = 322/379 (84%), Gaps = 18/379 (4%)
Query: 1 MAIRPFQ-FTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGT 59
MA+RP FTI ++ +N + + + SSS + + +LFS L
Sbjct: 1 MALRPCTGFTI--SSLRNASAANDNLFSLLSFSSSSSPAKRNLLFSSLRDH--------- 49
Query: 60 LRGLASSASL--SHARHQHQRLR----QLATPPDTLAQKIGKSVRRSGAPSKARVYSDIN 113
LR ASSASL H R+Q Q+ + ++ +TLAQKIGKS+RR+GAPSKARVY+D+N
Sbjct: 50 LRRFASSASLYRQHLRNQQQQQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYADVN 109
Query: 114 VVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK 173
VVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKK
Sbjct: 110 VVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKK 169
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYY 233
KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYY
Sbjct: 170 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYY 229
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
I+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY
Sbjct: 230 IFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 289
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA
Sbjct: 290 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 349
Query: 354 YLNKYHIELDPHLAALVGR 372
YLNKY IELDP+L +LVGR
Sbjct: 350 YLNKYRIELDPNLTSLVGR 368
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|17977868|emb|CAD12663.1| casein kinase II alpha subunit [Sinapis alba] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1379), Expect = e-149, Method: Compositional matrix adjust.
Identities = 282/374 (75%), Positives = 308/374 (82%), Gaps = 27/374 (7%)
Query: 1 MAIRPFQFTIH--RNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFG 58
MA RP +TI R L SF +I S+ + + +S
Sbjct: 1 MAFRPIGYTISSLRKASAANDLRFSFLSIYSSFPAKKNLLLS------------------ 42
Query: 59 TLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPR 118
LRG +S H+ Q+ + +TLAQKIGKS+RR+GAPSKARVY+D+NV++P+
Sbjct: 43 FLRGFSSL-------HRRQQQQSRVNKSETLAQKIGKSIRRAGAPSKARVYADVNVIKPK 95
Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKRE 178
+YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKKKIKRE
Sbjct: 96 DYWDYESLAVQWGAQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKRE 155
Query: 179 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYYIYELL
Sbjct: 156 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIYELL 215
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
KALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE
Sbjct: 216 KALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 275
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
LLVDL DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN YLN+Y
Sbjct: 276 LLVDLMDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNTYLNRY 335
Query: 359 HIELDPHLAALVGR 372
IELDP+LA+LVGR
Sbjct: 336 RIELDPNLASLVGR 349
|
Source: Sinapis alba Species: Sinapis alba Genus: Sinapis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15227778|ref|NP_179889.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana] gi|75318502|sp|O64816.1|CSK2P_ARATH RecName: Full=Casein kinase II subunit alpha, chloroplastic; Flags: Precursor gi|3169180|gb|AAC17823.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|17065110|gb|AAL32709.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|20148299|gb|AAM10040.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|330252310|gb|AEC07404.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 535 bits (1379), Expect = e-149, Method: Compositional matrix adjust.
Identities = 278/321 (86%), Positives = 297/321 (92%), Gaps = 7/321 (2%)
Query: 59 TLRGLASSASL--SHARHQHQRLR-----QLATPPDTLAQKIGKSVRRSGAPSKARVYSD 111
LR ASSASL H R+Q Q+ + ++ +TLAQKIGKS+RR+GAPSKARVY+D
Sbjct: 48 NLRRFASSASLYRQHLRNQQQQHQQQQQSRVKEKSETLAQKIGKSIRRAGAPSKARVYAD 107
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK 171
+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVK
Sbjct: 108 VNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVK 167
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR 231
KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVR
Sbjct: 168 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVR 227
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
YYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS
Sbjct: 228 YYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 287
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL
Sbjct: 288 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 347
Query: 352 NAYLNKYHIELDPHLAALVGR 372
NAYLNKY IELDP+L +LVGR
Sbjct: 348 NAYLNKYRIELDPNLTSLVGR 368
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081845|ref|XP_002306501.1| predicted protein [Populus trichocarpa] gi|222855950|gb|EEE93497.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 534 bits (1376), Expect = e-149, Method: Compositional matrix adjust.
Identities = 273/296 (92%), Positives = 282/296 (95%)
Query: 77 QRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDY 136
R R PDTLAQKIGKS RR GAPSKARVY+D NV+RP++YWDYESLTVQWGEQDDY
Sbjct: 6 HRFRSSVPLPDTLAQKIGKSFRRPGAPSKARVYADANVIRPKDYWDYESLTVQWGEQDDY 65
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 196
VV+KVGRGKYSEVFEG+HCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD
Sbjct: 66 MVVKKVGRGKYSEVFEGMHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 125
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
IVRDQQSKTPSLIFE+V NTDFKVLYPTLSD+D RYYIYELLKALDYCHSQGIMHRDVKP
Sbjct: 126 IVRDQQSKTPSLIFEYVKNTDFKVLYPTLSDFDTRYYIYELLKALDYCHSQGIMHRDVKP 185
Query: 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG
Sbjct: 186 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 245
Query: 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD+LNAYLNKY IELDPHLAALVGR
Sbjct: 246 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDDLNAYLNKYRIELDPHLAALVGR 301
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519104|ref|XP_004166575.1| PREDICTED: casein kinase II subunit alpha, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1374), Expect = e-149, Method: Compositional matrix adjust.
Identities = 267/286 (93%), Positives = 281/286 (98%)
Query: 87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
+TLAQKIGKS+RR GAPSKARVY+D+NV+RP++YWDYESLTVQWG+QD+YEVVRKVGRGK
Sbjct: 93 ETLAQKIGKSIRRPGAPSKARVYADVNVIRPKDYWDYESLTVQWGDQDNYEVVRKVGRGK 152
Query: 147 YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206
YSEVFEGVHCTDNEKC+IKILKPVKKKKIKREIKILQNLCGG NIVKLLDIVRDQQSKTP
Sbjct: 153 YSEVFEGVHCTDNEKCVIKILKPVKKKKIKREIKILQNLCGGINIVKLLDIVRDQQSKTP 212
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
SLIFEHVNN DFKVLYPTLSD+D+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR
Sbjct: 213 SLIFEHVNNIDFKVLYPTLSDFDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 272
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK
Sbjct: 273 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 332
Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
EPFFYGHDNYDQLVKIAKVLGTDELN YL+KY IELDPHL+ALVGR
Sbjct: 333 EPFFYGHDNYDQLVKIAKVLGTDELNTYLSKYRIELDPHLSALVGR 378
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448236|ref|XP_004141872.1| PREDICTED: casein kinase II subunit alpha, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 529 bits (1362), Expect = e-147, Method: Compositional matrix adjust.
Identities = 285/379 (75%), Positives = 308/379 (81%), Gaps = 26/379 (6%)
Query: 1 MAIRPFQFTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTL 60
MAIRP F + N + T ++ S S+ F L
Sbjct: 1 MAIRPLNFKVSSNFH--TLSSILSSPSLFLSAQSPPPSI-----------------FFFL 41
Query: 61 RGLASSAS-------LSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDIN 113
R +ASS + H + +P +TLAQKIGKS+RR GAPSKARVY+D+N
Sbjct: 42 RRIASSTASLSPSHHHHHPPPPPPPRLRSPSPQETLAQKIGKSIRRPGAPSKARVYADVN 101
Query: 114 VVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK 173
V+RP++YWDYESLTVQWG+QD+YEVVRKVGRGKYSEVFEGVHCTDNEKC+IKILKPVKKK
Sbjct: 102 VIRPKDYWDYESLTVQWGDQDNYEVVRKVGRGKYSEVFEGVHCTDNEKCVIKILKPVKKK 161
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYY 233
KIKREIKILQNLCGG NIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSD+D+RYY
Sbjct: 162 KIKREIKILQNLCGGINIVKLLDIVRDQQSKTPSLIFEHVNNIDFKVLYPTLSDFDIRYY 221
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY
Sbjct: 222 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 281
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN
Sbjct: 282 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNT 341
Query: 354 YLNKYHIELDPHLAALVGR 372
YL+KY IELDPHL+ALVGR
Sbjct: 342 YLSKYRIELDPHLSALVGR 360
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 427 | ||||||
| TAIR|locus:2045339 | 432 | AT2G23070 [Arabidopsis thalian | 0.669 | 0.662 | 0.860 | 2.9e-135 | |
| UNIPROTKB|Q9AR27 | 333 | OSCKA2 "Casein kinase II alpha | 0.629 | 0.807 | 0.843 | 4.3e-125 | |
| TAIR|locus:2045349 | 333 | CKA3 "casein kinase II, alpha | 0.634 | 0.813 | 0.800 | 6e-119 | |
| UNIPROTKB|P21868 | 391 | CSNK2A1 "Casein kinase II subu | 0.639 | 0.698 | 0.704 | 1.3e-107 | |
| UNIPROTKB|P68399 | 391 | CSNK2A1 "Casein kinase II subu | 0.639 | 0.698 | 0.704 | 1.3e-107 | |
| UNIPROTKB|E2RHZ1 | 391 | CSNK2A1 "Uncharacterized prote | 0.639 | 0.698 | 0.704 | 1.3e-107 | |
| UNIPROTKB|E7EU96 | 385 | CSNK2A1 "Casein kinase II subu | 0.639 | 0.709 | 0.704 | 1.3e-107 | |
| UNIPROTKB|P68400 | 391 | CSNK2A1 "Casein kinase II subu | 0.639 | 0.698 | 0.704 | 1.3e-107 | |
| UNIPROTKB|F2Z5I5 | 391 | CSNK2A1 "Uncharacterized prote | 0.639 | 0.698 | 0.704 | 1.3e-107 | |
| MGI|MGI:88543 | 391 | Csnk2a1 "casein kinase 2, alph | 0.639 | 0.698 | 0.704 | 1.3e-107 |
| TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1325 (471.5 bits), Expect = 2.9e-135, P = 2.9e-135
Identities = 246/286 (86%), Positives = 259/286 (90%)
Query: 87 DTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGK 146
+TLAQKIGKS+RR+GAPSKARVY+D+NVVRP++YWDYESL VQWG QDDYEVVRKVGRGK
Sbjct: 83 ETLAQKIGKSIRRAGAPSKARVYADVNVVRPKDYWDYESLAVQWGVQDDYEVVRKVGRGK 142
Query: 147 YSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTP 206
YSEVFEG+H TDNE LQNLCGGPNIVKLLDIVRDQQSKTP
Sbjct: 143 YSEVFEGIHATDNEKCVIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 202
Query: 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
SLIFEHVNN DFKVLYPTLSDYDVRYYI+ELLKALD+CHS+GIMHRDVKPHNVMIDHEQR
Sbjct: 203 SLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLKALDFCHSRGIMHRDVKPHNVMIDHEQR 262
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK
Sbjct: 263 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 322
Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY IELDP+L +LVGR
Sbjct: 323 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRIELDPNLTSLVGR 368
|
|
| UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)] | Back alignment and assigned GO terms |
|---|
Score = 1229 (437.7 bits), Expect = 4.3e-125, P = 4.3e-125
Identities = 227/269 (84%), Positives = 241/269 (89%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
SKARVY+D+NV+RP+EYWDYE+LTVQWGEQDDYEVVRKVGRGKYSEVFEG++ +NE
Sbjct: 2 SKARVYADVNVLRPKEYWDYEALTVQWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCI 61
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
LQNLCGGPNIVKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGR 372
KVLGT+ LNAYLNKYHIELDP L ALVGR
Sbjct: 242 KVLGTEALNAYLNKYHIELDPQLEALVGR 270
|
|
| TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1171 (417.3 bits), Expect = 6.0e-119, P = 6.0e-119
Identities = 217/271 (80%), Positives = 234/271 (86%)
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXX 163
SKARVY+D+NVVRP+EYWDYESL VQWG QDDYEVVRKVGRGKYSEVFEG + NE
Sbjct: 2 SKARVYTDVNVVRPKEYWDYESLVVQWGHQDDYEVVRKVGRGKYSEVFEGKNVNTNERCV 61
Query: 164 XXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP 223
LQNLCGGPNIVKL DIVRD+ SKTPSL+FE VN+ DFKVLYP
Sbjct: 62 IKILKPVKKKKIKREIKILQNLCGGPNIVKLYDIVRDEHSKTPSLVFEFVNSVDFKVLYP 121
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+DYD+RYYIYELLKALD+CHSQGIMHRDVKPHNVMIDH+ RKLRLIDWGLAEFYHPGK
Sbjct: 122 TLTDYDIRYYIYELLKALDFCHSQGIMHRDVKPHNVMIDHQLRKLRLIDWGLAEFYHPGK 181
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
EYNVRVASRYFKGPELLVDLQDYDYSLD+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIA
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 344 KVLGTDELNAYLNKYHIELDPHLAALVGRLV 374
KVLGT+EL+ YLNKY ++LDP L ALVGR V
Sbjct: 242 KVLGTNELDHYLNKYQLDLDPQLEALVGRHV 272
|
|
| UNIPROTKB|P21868 CSNK2A1 "Casein kinase II subunit alpha" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 193/274 (70%), Positives = 225/274 (82%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
LV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
|
| UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 193/274 (70%), Positives = 225/274 (82%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
LV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
|
| UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 193/274 (70%), Positives = 225/274 (82%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
LV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
|
| UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 193/274 (70%), Positives = 225/274 (82%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
LV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
|
| UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 193/274 (70%), Positives = 225/274 (82%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
LV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
|
| UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 193/274 (70%), Positives = 225/274 (82%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
LV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
|
| MGI|MGI:88543 Csnk2a1 "casein kinase 2, alpha 1 polypeptide" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1064 (379.6 bits), Expect = 1.3e-107, P = 1.3e-107
Identities = 193/274 (70%), Positives = 225/274 (82%)
Query: 100 SG-APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTD 158
SG PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+
Sbjct: 2 SGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITN 61
Query: 159 NEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
NE L+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDF
Sbjct: 62 NEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 121
Query: 219 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
K LY TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEF
Sbjct: 122 KQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 181
Query: 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
YHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQ
Sbjct: 182 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 339 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 372
LV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 242 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P19454 | CSK22_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6312 | 0.6440 | 0.8112 | yes | no |
| P21868 | CSK21_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7740 | 0.6323 | 0.6905 | yes | no |
| Q8TG13 | CSK2A_NEUCR | 2, ., 7, ., 1, 1, ., 1 | 0.7649 | 0.6276 | 0.7976 | N/A | no |
| P68399 | CSK21_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7740 | 0.6323 | 0.6905 | yes | no |
| P28523 | CSK2A_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.9182 | 0.6299 | 0.8102 | N/A | no |
| O64816 | CSK2P_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8660 | 0.7353 | 0.7268 | yes | no |
| P18334 | CSK2A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7518 | 0.6323 | 0.75 | yes | no |
| P08181 | CSK2A_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7629 | 0.6323 | 0.8035 | yes | no |
| P19139 | CSK21_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.7740 | 0.6323 | 0.6905 | yes | no |
| O76484 | CSK2A_SPOFR | 2, ., 7, ., 1, 1, ., 1 | 0.7757 | 0.6370 | 0.7705 | N/A | no |
| P28547 | CSK2A_THEPA | 2, ., 7, ., 1, 1, ., 1 | 0.7169 | 0.6206 | 0.7614 | yes | no |
| P68400 | CSK21_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7740 | 0.6323 | 0.6905 | yes | no |
| Q8SRU0 | CSK2A_ENCCU | 2, ., 7, ., 1, 1, ., 1 | 0.52 | 0.6323 | 0.8463 | yes | no |
| P40231 | CSK2A_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7309 | 0.6393 | 0.8222 | yes | no |
| Q02720 | CSK2A_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7286 | 0.6299 | 0.7982 | yes | no |
| P33674 | CSK21_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.7703 | 0.6323 | 0.6905 | yes | no |
| P28020 | CSK21_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7703 | 0.6323 | 0.6887 | N/A | no |
| Q60737 | CSK21_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7740 | 0.6323 | 0.6905 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 427 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-60 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-59 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-50 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-47 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-45 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-44 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-44 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-42 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-42 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-37 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 9e-37 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-36 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-36 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-36 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-36 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-35 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-35 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-35 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-34 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-34 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-34 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-33 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-33 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-33 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-33 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-32 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-32 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-31 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-30 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-30 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-30 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-29 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-28 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-28 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-28 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-28 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-28 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-28 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-27 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-27 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-27 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-27 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-26 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-24 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-23 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-23 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-23 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-22 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 9e-20 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-19 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-19 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-17 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-17 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-13 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-09 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 6e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-05 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 7e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-05 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 8e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 8e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.001 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 0.001 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 0.002 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.002 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.003 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-60
Identities = 70/223 (31%), Positives = 115/223 (51%), Gaps = 14/223 (6%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGGPN 190
YE++RK+G G + V++ H + +KILK +K K REI+IL+ L PN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYIYELLKALDYCHSQ 247
IV+L+D D L+ E+ D LS+ + + ++L+ L+Y HS
Sbjct: 60 IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI+HRD+KP N+++D +++ D+GLA+ V + ++ PE+L+ Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 349
+D+WSLG + ++ K P F G + DQL I ++LG
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP-FSGENILDQLQLIRRILGPP 218
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 193 bits (494), Expect = 2e-59
Identities = 79/245 (32%), Positives = 130/245 (53%), Gaps = 18/245 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNI 191
YE++ K+G G + +V+ + IK++K K KK I REIKIL+ L PNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 248
V+L D+ D+ L+ E+ D F +L LS+ + R+Y+ ++L AL+Y HS+G
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
I+HRD+KP N+++D E ++L D+GLA PG++ V + + PE+L+ + Y
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 368
++D+WSLG + ++ K P F G D +L K + ++ P
Sbjct: 176 AVDIWSLGVILYELLTGK-PPFPGDDQLLELFKKIG-----KPKPPFPPPEWDISPEAKD 229
Query: 369 LVGRL 373
L+ +L
Sbjct: 230 LIRKL 234
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 1e-50
Identities = 80/223 (35%), Positives = 128/223 (57%), Gaps = 16/223 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQNLCGGPN 190
YE + K+G G Y V++ E +K ++ +++ I REI +L+ L PN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
IVKLLD++ ++ L+FE+ + D K LS ++ +Y+LL+ L YCHS
Sbjct: 60 IVKLLDVIHTERKLY--LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 305
I+HRD+KP N++I+ + L+L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 117 HRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+WS+GC+FA MI +P F G DQL KI ++LGT
Sbjct: 176 YSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGT 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 7e-47
Identities = 82/223 (36%), Positives = 129/223 (57%), Gaps = 16/223 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
Y+ + K+G G Y V++ E IK +K K REIK+L+ L PN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
I+KLLD+ R + L+FE ++ +K++ L + ++ Y+Y+LL+ L +CHS
Sbjct: 60 IIKLLDVFRHKGDL--YLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 305
GI+HRD+KP N++I+ + L+L D+GLA F P + Y V +R+++ PELL+ +
Sbjct: 117 HGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y +D+WS+GC+FA ++ R+ P F G DQL KI + LGT
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGT 217
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-45
Identities = 71/228 (31%), Positives = 127/228 (55%), Gaps = 23/228 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 190
YE + ++G G Y +V++ + E +K ++ +K+ REIK+LQ L PN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEHV--------NNTDFKVLYPTLSDYDVRYYIYELLKALD 242
IV+L +IV + + ++FE++ ++ + K ++ ++ Y+ +LL+ L
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FTESQIKCYMKQLLEGLQ 114
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 300
Y HS GI+HRD+K N++I+++ L+L D+GLA Y +Y RV + +++ PELL
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y +D+WS+GC+ A + F +P F G +QL KI ++ G+
Sbjct: 174 LGATRYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFELCGS 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 83/234 (35%), Positives = 127/234 (54%), Gaps = 31/234 (13%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 190
YE+++ +G G Y V V K IK I K+I REIK+L++L N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLKAL 241
I+ LLDI+R + F V TD KV+ L+D ++Y++Y++L+ L
Sbjct: 61 IIGLLDILRPPSPED----FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYF 294
Y HS ++HRD+KP N++++ L++ D+GLA + G EY V +R++
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWY 172
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ PELL+ Y ++D+WS+GC+FA ++ RK P F G D DQL I +VLGT
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEVLGT 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-44
Identities = 74/225 (32%), Positives = 122/225 (54%), Gaps = 17/225 (7%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCGGP 189
Y+++ ++G G + VF+ E +K + + I REIK LQ C P
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCH 245
+VKLLD+ L+ E++ + +VL P L + V+ Y+ LLK + Y H
Sbjct: 60 YVVKLLDVFPHGSGF--VLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 303
+ GIMHRD+KP N++I L++ D+GLA + + Y+ +VA+R+++ PELL
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ YD +DLW++GC+FA ++ P F G ++ +QL + + LGT
Sbjct: 176 RKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGT 219
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 7e-44
Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 12/190 (6%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 197
+G G + V+ +K IKI+K + REI+IL+ L PNIVKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 198 VRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
D+ L+ E+ K L LS+ ++ + ++L+ L+Y HS GI+HRD
Sbjct: 60 FEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 312
+KP N+++D + K++L D+GL++ V + + PE+L+ Y D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 313 WSLGCMFAGM 322
WSLG + +
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 88/247 (35%), Positives = 126/247 (51%), Gaps = 24/247 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
YEV+ VG G Y V + + E IK K KK RE+K+L+ L N
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHSQ 247
IV L + R + L+FE+V T ++L P D VR YI++LL+A+ YCHS
Sbjct: 62 IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 305
I+HRD+KP N+++ E L+L D+G A P VA+R+++ PELLV +
Sbjct: 120 NIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL--- 362
Y +D+W++GC+ A ++ EP F G + DQL I K LG L H EL
Sbjct: 179 YGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKCLGP------LPPSHQELFSS 231
Query: 363 DPHLAAL 369
+P A +
Sbjct: 232 NPRFAGV 238
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-42
Identities = 79/226 (34%), Positives = 128/226 (56%), Gaps = 19/226 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
YE +K+G G Y+ V++ IK +K ++K+ K REIK+LQ L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDY 243
PNI+ LLD+ + + +L+FE + TD + + L+ D++ Y+ L+ L+Y
Sbjct: 61 HPNIIGLLDVFGHKSNI--NLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
HS I+HRD+KP+N++I L+L D+GLA + P ++ +V +R+++ PELL
Sbjct: 118 LHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y +D+WS+GC+FA ++ R PF G + DQL KI + LGT
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGT 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 81/232 (34%), Positives = 125/232 (53%), Gaps = 33/232 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 182
Y+ V K+G G Y V++ E V KKI+ REI +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-----VRYYIYEL 237
+ L PNIV+LLD+V ++K L+FE ++ D K + ++ Y+Y+L
Sbjct: 53 KEL-NHPNIVRLLDVVH-SENKL-YLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKG 296
L+ + YCHS ++HRD+KP N++ID E L+L D+GLA F P + Y V + +++
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
PE+L+ + Y +D+WS+GC+FA M+ R+ P F G DQL +I + LGT
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGT 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 9e-37
Identities = 77/238 (32%), Positives = 130/238 (54%), Gaps = 31/238 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------REIKIL 182
D YE + K+G G Y +V++ + L +KK +++ REI +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54
Query: 183 QNLCGGPNIVKLLDIVR-DQQSKTPSL--IFEHVNNTDFKVLYPT--------LSDYDVR 231
Q L IV+LLD+ ++++ PSL +FE+++ +D K + L ++
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVA 290
++Y+LLK + +CH G+MHRD+KP N+++D ++ L++ D GL F P K Y +
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ +++ PE+L+ Y +D+WS+GC+FA M RK+P F G QL+ I K+LGT
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGT 230
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 1e-36
Identities = 68/225 (30%), Positives = 117/225 (52%), Gaps = 20/225 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
Y+V++++G G + V+ + E IK +K KK RE+K L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDY 243
PNIVKL ++ R+ + +FE++ ++++ S+ +R IY++L+ L +
Sbjct: 57 HPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
H G HRD+KP N+++ +++ D+GLA Y V++R+++ PE+L+
Sbjct: 115 IHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y +D+W+LGC+ A + + P F G DQL KI VLGT
Sbjct: 174 TSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGT 217
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 73/239 (30%), Positives = 134/239 (56%), Gaps = 15/239 (6%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
Y+++ K+G G +SEV + + KC+ K K +++ REI+ L+ L PNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHSQ 247
++L++++ D+++ +L+FE ++ ++++ P L + V+ Y+Y+LLK+LD+ H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRN 119
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
GI HRD+KP N++I L+L D+G + Y +++R+++ PE L+ Y
Sbjct: 120 GIFHRDIKPENILIK--DDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--DELNAYLNKY-HIELD 363
+D+W++GC+F ++ P F G + DQ+ KI VLGT E+ K H+ +
Sbjct: 178 PKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYN 235
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 79/227 (34%), Positives = 129/227 (56%), Gaps = 18/227 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
D YE V K+G G Y V++ NE +K ++ V I REI +L+ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELLKALD 242
G NIV+L D+V + K L+FE+++ D K + D+ ++ Y+Y++L+ +
Sbjct: 61 G-NIVRLQDVVHSE--KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
YCHS ++HRD+KP N++ID L+L D+GLA F P + + V + +++ PE+L+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y +D+WS+GC+FA M+ +K P F G D+L KI ++LGT
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRILGT 222
|
Length = 294 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 5e-36
Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGPNI 191
+E++ K+G+G + EV++ H ++ IK++K K+K I EI+IL+ C PNI
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
VK + ++ E + D K TL++ + Y ELLK L+Y HS
Sbjct: 60 VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
GI+HRD+K N+++ + +++LID+GL+ K N V + Y+ PE++ + YD
Sbjct: 118 GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFY 331
Y D+WSLG + K P+
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 79/223 (35%), Positives = 123/223 (55%), Gaps = 16/223 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 189
YE + VG G Y V + H + IK K VKK + REI++L+ L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHS 246
N+V L+++ R + K L+FE V++T L YP D VR Y++++L+ +++CHS
Sbjct: 61 NLVNLIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 305
I+HRD+KP N+++ + ++L D+G A PG+ Y VA+R+++ PELLV
Sbjct: 119 HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+W++GC+ M EP F G + DQL I K LG
Sbjct: 178 YGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIKCLGN 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 135 bits (339), Expect = 9e-36
Identities = 77/256 (30%), Positives = 124/256 (48%), Gaps = 28/256 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGG 188
Y ++RK+G G + EV+ D + +K+L + K REI+IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
PNIVKL D +D+ S L+ E+V+ + L LS+ + + + ++L AL+
Sbjct: 58 PNIVKLYDFFQDEGSLY--LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 295
Y HS+GI+HRD+KP N+++D + R ++LID+GLA+ + V + +
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 296 GPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPF--FYGHDNYDQLVKIAKVLGTDEL 351
PE+L+ L S D+WSLG ++ PF Q +KI L T L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 352 NAYLNKYHIELDPHLA 367
+ L+ + EL A
Sbjct: 236 ASPLSPSNPELISKAA 251
|
Length = 384 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 75/230 (32%), Positives = 127/230 (55%), Gaps = 20/230 (8%)
Query: 136 YEVVRKVGRGKYSEVFEG--VHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGG 188
YE+++++G+G Y V ++ E IK + V KKI RE+K+L++ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 189 PNIVKL--LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDY 243
NI L +DIV L +E + D + + L+D + +IY++L L Y
Sbjct: 62 KNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPE 298
HS ++HRD+KP N++++ + +L++ D+GLA + N VA+R+++ PE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+++ Q Y ++D+WS+GC+ A ++ RK P F G D DQL +I +VLGT
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGT 228
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 78/227 (34%), Positives = 131/227 (57%), Gaps = 22/227 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQNL 185
+ YE + K+G G Y VF+ C + E I +K PV KK REI++L+ L
Sbjct: 1 EKYEKLSKIGEGSYGVVFK---CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 242
PN+V L+++ R + + L+FE+ ++T L P + ++ ++ I++ L+A++
Sbjct: 58 -KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 301
+CH +HRDVKP N++I + + ++L D+G A PG +Y VA+R+++ PELLV
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173
Query: 302 -DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
D Q Y +D+W++GC+FA ++ +P + G + DQL I K LG
Sbjct: 174 GDTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 8e-35
Identities = 80/233 (34%), Positives = 125/233 (53%), Gaps = 32/233 (13%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------KREIKIL 182
YE+++K+G+G Y V++ + E V KKI REI L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKA 240
Q L PNIVKLL++++ + K L+FE++ TD + L D RY +Y+LLKA
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------VASRYF 294
L Y HS ++HRD+KP N++++ + R ++L D+GLA +E VA+R++
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
+ PE+L+ Y +D+WS+GC+ M+ K P F G +QL KI +V+G
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIG 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 73/240 (30%), Positives = 122/240 (50%), Gaps = 43/240 (17%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 182
YE + ++G G Y V++ + V KK++ REI +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52
Query: 183 QNL--CGGPNIVKLLDI---VRDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYY 233
+ L PNIV+LLD+ R + +L+FEHV+ + K P L ++
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----V 289
+ +LL+ +D+ HS I+HRD+KP N+++ + + +++ D+GLA Y + + V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167
Query: 290 ASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ +++ PE+L LQ Y +D+WS+GC+FA + FR+ P F G DQL KI V+G
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGL 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 75/247 (30%), Positives = 126/247 (51%), Gaps = 39/247 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCG 187
DYE++ K+G G + EV++ +K IL +K REIKIL+ L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65
Query: 188 GPNIVKLLDIV---RDQQSKTPSLIF------EH-----VNNTDFKVLYPTLSDYDVRYY 233
PN+V L+D+ D+ + ++ +H + N K L++ ++ Y
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTESQIKCY 120
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY--------HPG--- 282
+ +LL+ ++Y H I+HRD+K N++ID+ Q L++ D+GLA Y G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
++Y V +R+++ PELL+ + Y ++D+W +GC+FA M R+ P G + DQL
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHL 238
Query: 342 IAKVLGT 348
I K+ GT
Sbjct: 239 IFKLCGT 245
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-34
Identities = 75/226 (33%), Positives = 127/226 (56%), Gaps = 21/226 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCG 187
YE + K+G G Y VF+ + +E I LK V+ REI +L+ L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALDY 243
NIV+L D++ + T L+FE+ + D K + + + V+ ++++LLK L +
Sbjct: 58 HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 302
CHS ++HRD+KP N++I+ + +L+L D+GLA + P + Y+ V + +++ P++L
Sbjct: 115 CHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y S+D+WS GC+FA + P F G+D DQL +I ++LGT
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-33
Identities = 81/237 (34%), Positives = 133/237 (56%), Gaps = 32/237 (13%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------R 177
+G+ + Y+ + K+G G Y+ V++G + V K+I+ R
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTG--------QLVALKEIRLEHEEGAPFTAIR 52
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPT-LSDYDVRYY 233
E +L++L NIV L DI+ + KT +L+FE+++ TD K LS ++VR +
Sbjct: 53 EASLLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLF 108
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASR 292
+++LL+ L YCH + ++HRD+KP N++I E+ +L+L D+GLA P K Y+ V +
Sbjct: 109 LFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTL 167
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DNYDQLVKIAKVLGT 348
+++ P++L+ +Y SLD+W +GC+F M P F G D DQL KI +VLGT
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRVLGT 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 73/224 (32%), Positives = 126/224 (56%), Gaps = 17/224 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
++ V K+G G Y V++ + E +K ++ V I REI +L+ L P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 245
NIVKLLD++ + L+FE ++ K + + + ++ Y+++LL+ L +CH
Sbjct: 60 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 304
S ++HRD+KP N++I+ + ++L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+WSLGC+FA M+ R+ F G DQL +I + LGT
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRTLGT 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-33
Identities = 76/230 (33%), Positives = 127/230 (55%), Gaps = 21/230 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----KIKREIKILQNLCGGP 189
Y+ + +G G Y V H K IK + P + + + REIKIL+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63
Query: 190 NIVKLLDIVR--DQQSKTPSLIFEHVNNTD-FKVLYP-TLSDYDVRYYIYELLKALDYCH 245
NI+ +LDI+R +S I + + TD +K++ LS+ ++Y++Y++L+ L Y H
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 298
S ++HRD+KP N++++ L++ D+GLA E H G EY VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
++++ + Y ++D+WS+GC+ A M+ + P F G D QL I VLGT
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGVLGT 228
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 72/243 (29%), Positives = 132/243 (54%), Gaps = 35/243 (14%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
W D Y+ + VG G Y +V T + I K+ +P + K+ RE+++L++
Sbjct: 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKH 70
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYP-------------TLSDYDV 230
+ N++ LLD+ TP+ + + D ++ LSD +
Sbjct: 71 MDH-ENVIGLLDVF------TPA---SSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290
++ +Y++L+ L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E VA
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVA 177
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-- 348
+R+++ PE++++ Y+ ++D+WS+GC+ A ++ K F G D+ DQL +I ++GT
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTPD 236
Query: 349 DEL 351
+EL
Sbjct: 237 EEL 239
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-33
Identities = 78/234 (33%), Positives = 127/234 (54%), Gaps = 34/234 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKI 181
DY + K+G G Y V++G + + V KKI+ REI +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIY 235
L+ L PNIV L D++ Q+S+ LIFE ++ D K +L V+ Y+Y
Sbjct: 53 LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 294
++L+ + +CHS+ ++HRD+KP N++ID + ++L D+GLA F P + Y V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWY 167
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ PE+L+ Y +D+WS+G +FA M +K P F+G DQL +I ++LGT
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRILGT 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-33
Identities = 68/239 (28%), Positives = 134/239 (56%), Gaps = 23/239 (9%)
Query: 130 WGEQ--DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKIL 182
WG++ D ++++ ++G G Y +V++ E +K ++ +K+ REIKIL
Sbjct: 1 WGKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKIL 60
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTP--------SLIFEHVNNTDFKVLYPTLSDYD---VR 231
+ L NIV L +IV D+Q L+FE++++ +L L + ++
Sbjct: 61 RQL-NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYNVRV 289
++ +LL+ L+YCH + +HRD+K N++++++ +++L D+GLA Y+ + Y +V
Sbjct: 120 SFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKV 178
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ +++ PELL+ + Y ++D+WS GC+ G +F K+P F + QL I+++ G+
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCIL-GELFTKKPIFQANQELAQLELISRLCGS 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 73/227 (32%), Positives = 126/227 (55%), Gaps = 23/227 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLCGG 188
++ + K+G G Y+ V++G + T E I LK + REI +++ L
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALD 242
NIV+L D++ + L+FE+++ D K T L V+ + Y+LLK +
Sbjct: 58 ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 301
+CH ++HRD+KP N++I+ L+L D+GLA F P ++ V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y S+D+WS+GC+ A MI + P F G +N DQL+KI +++GT
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRIMGT 219
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 72/232 (31%), Positives = 128/232 (55%), Gaps = 23/232 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGG 188
Y+ + +G G Y V + +K IK + P K+ RE+KIL++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63
Query: 189 PNIVKLLDIVRDQQS--KTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYC 244
NI+ + DI+R + K ++ + + + +++ L++ +RY++Y+LL+ L Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 296
HS ++HRD+KP N++++ E +LR+ D+G+A H EY VA+R+++
Sbjct: 124 HSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
PELL+ L +Y ++D+WS+GC+FA M+ R++ F G + QL I VLG+
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLKLILSVLGS 230
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 78/247 (31%), Positives = 134/247 (54%), Gaps = 31/247 (12%)
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KK 174
Y+ E W D Y +++VG G Y V + K IK L +P + K+
Sbjct: 1 YYRQEVNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKR 60
Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----------- 223
RE+++L+++ N++ LLD+ TP L + + DF ++ P
Sbjct: 61 AYRELRLLKHM-KHENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMK 111
Query: 224 --TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
LS+ +++ +Y++LK L Y H+ GI+HRD+KP N+ ++ E +L+++D+GLA
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--QT 168
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
E V +R+++ PE++++ Y ++D+WS+GC+ A M+ K P F GHD+ DQL++
Sbjct: 169 DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLME 227
Query: 342 IAKVLGT 348
I KV GT
Sbjct: 228 IMKVTGT 234
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 70/228 (30%), Positives = 111/228 (48%), Gaps = 38/228 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
DD++ + +G G +S V N++ IKIL +K+KK +K E ++L L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF--EHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 242
P I+KL +D+++ L F E+ N + Y +L + R+Y E+L AL+
Sbjct: 61 HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------------EYNV 287
Y HS+GI+HRD+KP N+++D + +++ D+G A+ P
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 288 RVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
R F G PELL + + S DLW+LGC+ M+ K PF
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 75/225 (33%), Positives = 124/225 (55%), Gaps = 14/225 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IK--REIKILQNLCGG 188
D+YE + ++ G Y V+ E +K LK K+K+ I REI IL L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QH 63
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALDYC 244
PNIV + ++V ++ E+V + D K L T+ +V+ + +LL + +
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
H I+HRD+K N+++++ L++ D+GLA E+ P K Y V + +++ PELL+
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
++Y ++D+WS+GC+FA ++ K+P F G DQL KI K+LGT
Sbjct: 182 KEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLLGT 225
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-30
Identities = 74/232 (31%), Positives = 127/232 (54%), Gaps = 22/232 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
YE V ++G G Y +VF+ + + + LK V+ + + RE+ +L++L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 188 --GPNIVKLLDIV---RDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYYIYELL 238
PN+V+L D+ R + +L+FEHV+ T + KV P + ++ +++LL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
+ LD+ HS ++HRD+KP N+++ +++L D+GLA Y V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
+L+ Y +DLWS+GC+FA M FR++P F G + DQL KI V+G
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPG 229
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 80/224 (35%), Positives = 119/224 (53%), Gaps = 16/224 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 188
+ +EV+ VG G Y V + H E IK K + K+ RE+K+L+ L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCH 245
NIV+L + R + L+FE+V ++L P + VR YIY+L+KA+ +CH
Sbjct: 60 ENIVELKEAFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 303
I+HRD+KP N++I H L+L D+G A G Y VA+R+++ PELL+
Sbjct: 118 KNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
Y ++D+WS+GC+ G + +P F G DQL I KVLG
Sbjct: 176 APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQLFTIQKVLG 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 59/221 (26%), Positives = 107/221 (48%), Gaps = 14/221 (6%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKK---IKREIKILQNLCGGP 189
++ +GRG + V+ + E +K L +++ ++REI+IL +L P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
NIV+ RD++ T ++ E+V+ + + L + +R Y ++L+ L Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 303
GI+HRD+K N+++D + ++L D+G A G+ + Y+ PE++
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
++Y + D+WSLGC M K P+ + L KI
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 70/225 (31%), Positives = 127/225 (56%), Gaps = 10/225 (4%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNL 185
+G Y + K+G G Y+ V++G+ + + +K++ ++ + RE +L+ L
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYC 244
NIV L DI+ +++ T + H + + + +P L Y+VR ++++LL+ L Y
Sbjct: 61 -KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDL 303
H Q I+HRD+KP N++I + +L+L D+GLA P + Y+ V + +++ P++L+
Sbjct: 120 HGQHILHRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLG 347
DY +LD+W GC+F M + +P F G + ++QL KI VLG
Sbjct: 179 TDYSSALDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTVLG 222
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-28
Identities = 75/235 (31%), Positives = 129/235 (54%), Gaps = 27/235 (11%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQN 184
W + Y+ + VG G Y V +K +K L +P + ++ RE+++L++
Sbjct: 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKH 70
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDFK--VLYPTLSDYDVRYY 233
+ N++ LLD+ TP+ E+ N D V LSD V++
Sbjct: 71 M-KHENVIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFL 123
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
IY+LL+ L Y HS GI+HRD+KP NV ++ E +LR++D+GLA E VA+R+
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADDEMTGYVATRW 180
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
++ PE++++ Y+ ++D+WS+GC+ A ++ + + F G+D DQL +I +V+GT
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGT 234
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-28
Identities = 76/226 (33%), Positives = 124/226 (54%), Gaps = 17/226 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIVKL 194
Y++ +G G + V+E + +EK IK +L+ + K RE+ I++NL NI+ L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL-NHINIIFL 124
Query: 195 LD------IVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 242
D +++++ +++ E + T K + L + V+ Y Y+L +AL
Sbjct: 125 KDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
Y HS+ I HRD+KP N++ID L+L D+G A+ G+ + SR+++ PEL++
Sbjct: 185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG 244
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+Y +DLWSLGC+ A MI P F G + DQLV+I +VLGT
Sbjct: 245 ATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGT 289
|
Length = 440 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 76/234 (32%), Positives = 126/234 (53%), Gaps = 34/234 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 190
Y ++ +GRG Y V + NEK IK + + K+ REIK+L++L N
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVN------NTDFKVLY---PTLSDYDVRYYIYELLKAL 241
++ + DI+ + F V +TD + TLSD +Y++Y+LL+ L
Sbjct: 66 VIAIKDIMPPPHREA----FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EFYHPGKEYNVRVASRYF 294
Y HS ++HRD+KP N++++ L++ D+GLA +F EY V +R++
Sbjct: 122 KYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFM---TEY---VVTRWY 174
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ PELL++ +Y ++D+WS+GC+FA ++ RK P F G D QL I ++LG+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITELLGS 227
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 74/233 (31%), Positives = 127/233 (54%), Gaps = 26/233 (11%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KKIKREIKILQN 184
W + Y +++VG G Y V + EK IK L +P + K+ RE+ +L++
Sbjct: 11 WELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH 70
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDF-KVLYPTLSDYDVRYYI 234
+ N++ LLD+ T ++ + + TD K++ LS+ V+Y +
Sbjct: 71 M-QHENVIGLLDV------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLV 123
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
Y++L L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E V +R++
Sbjct: 124 YQMLCGLKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWY 180
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
+ PE++++ Y+ ++D+WS+GC+ A M+ K F G D DQL +I KV G
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTG 232
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 76/235 (32%), Positives = 136/235 (57%), Gaps = 29/235 (12%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
+G+ + Y + K+G G Y+ V++G TDN + LK ++ + + RE+ +
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDN----LVALKEIRLEHEEGAPCTAIREVSL 57
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD-------YDVRYYI 234
L++L NIV L DI+ ++S T L+FE+++ K L L D ++V+ ++
Sbjct: 58 LKDL-KHANIVTLHDIIHTEKSLT--LVFEYLD----KDLKQYLDDCGNSINMHNVKLFL 110
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRY 293
++LL+ L+YCH + ++HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLW 169
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
++ P++L+ DY +D+W +GC+F M + P F G +QL I ++LGT
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGT 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 76/221 (34%), Positives = 120/221 (54%), Gaps = 16/221 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPN 190
Y ++ VG G + V T I KI+KP V K+ RE+K+L++L N
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70
Query: 191 IVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 247
I+ L DI S + F + TD L + L ++Y++Y++L+ L Y HS
Sbjct: 71 IISLSDIF---ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
G++HRD+KP N++I+ E L++ D+GLA P + V++RY++ PE+++ Q YD
Sbjct: 128 GVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+D+WS GC+FA M +P F G D+ +Q I +LGT
Sbjct: 185 VEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDLLGT 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 75/232 (32%), Positives = 134/232 (57%), Gaps = 23/232 (9%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
+G+ + Y + K+G G Y+ VF+G T+N + LK ++ + + RE+ +
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSL 57
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYEL 237
L++L NIV L DIV +S T L+FE+++ D K +S ++V+ ++Y++
Sbjct: 58 LKDL-KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQI 113
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
L+ L YCH + ++HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +++
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 172
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L+ +Y +D+W +GC+F M + P F G D+L I ++LGT
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIFRLLGT 223
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 70/237 (29%), Positives = 126/237 (53%), Gaps = 27/237 (11%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQN 184
W + Y+ + VG G Y V + +K L +P + K+ RE+++L++
Sbjct: 13 WEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 72
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDFK--VLYPTLSDYDVRYY 233
+ N++ LLD+ TP+ E N+ D V L+D V++
Sbjct: 73 M-KHENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 125
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
IY++L+ L Y HS I+HRD+KP N+ ++ E +L+++D+GLA H E VA+R+
Sbjct: 126 IYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRW 182
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++GT
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPG 238
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 72/227 (31%), Positives = 129/227 (56%), Gaps = 12/227 (5%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNL 185
+G+ D YE + K+G G Y+ V++G + + +K+++ +++ RE +L+ L
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 242
NIV L DI+ +++ T L+FE+V+ + + +P L +V+ ++++LL+ L
Sbjct: 61 -KHANIVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 301
Y H + I+HRD+KP N++I + +L+L D+GLA P Y+ V + +++ P++L+
Sbjct: 118 YIHQRYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+Y LD+W +GC+F MI F D DQL +I VLGT
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT 223
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 9e-27
Identities = 74/231 (32%), Positives = 124/231 (53%), Gaps = 27/231 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNL-- 185
YE V ++G G Y V++ D LK V+ + + RE+ +L+ L
Sbjct: 2 YEPVAEIGVGAYGTVYKA---RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA 58
Query: 186 CGGPNIVKLLDIV----RDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYE 236
PNIV+L+D+ D+++K +L+FEHV+ D KV P L ++ + +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
L+ LD+ H+ I+HRD+KP N+++ +++L D+GLA Y V + +++
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
PE+L+ Y +D+WS+GC+FA M FR++P F G+ DQL KI ++G
Sbjct: 176 PEVLLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIG 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-26
Identities = 73/232 (31%), Positives = 134/232 (57%), Gaps = 23/232 (9%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKI 181
+G+ + Y + K+G G Y+ VF+G T+N + LK ++ + + RE+ +
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSL 56
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYEL 237
L+NL NIV L DI+ ++ T L+FE++++ D K +S ++V+ ++++L
Sbjct: 57 LKNL-KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQL 112
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
L+ L YCH + I+HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +++
Sbjct: 113 LRGLSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRP 171
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L+ +Y +D+W +GC+ M + P F G ++L I ++LGT
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLGT 222
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 65/226 (28%), Positives = 113/226 (50%), Gaps = 18/226 (7%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLC 186
++E + ++G G Y V+ T E I LK V+ + REI +L N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDY 243
PNIV+L ++V + + L+ E+ +L S+ V+ + +LL+ L Y
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
H I+HRD+K N+++ + L++ D+GLA Y P K +V + +++ PELL+
Sbjct: 124 LHENFIIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+W++GC+ A + +P G +QL I ++LGT
Sbjct: 183 CTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLIIQLLGT 227
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 23/223 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 189
YE+++++G+G + +V+ +D + ++K + +++ E+KIL+ L P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIF-EHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 241
NI+K + + K I E+ + D K + + + +L AL
Sbjct: 60 NIIKYYE---SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 300
Y HS+ I+HRD+KP N+ + ++L D+G+++ + V + Y+ PEL
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KI 342
+ + Y+Y D+WSLGC+ + K PF +N +L KI
Sbjct: 176 QN-KPYNYKSDIWSLGCVLYELCTLKHPF--EGENLLELALKI 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/229 (28%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIV 192
Y +R +G G VF V +++ +K + + +K REIKI++ L NIV
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65
Query: 193 KLLDIVRDQQSKTPSLIFE--HVN---------NTDFKVL--YPTLSDYDVRYYIYELLK 239
K+ +++ S + +N TD + LS+ R ++Y+LL+
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 295
L Y HS ++HRD+KP NV I+ E L++ D+GLA P + + + +++++
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
P LL+ +Y ++D+W+ GC+FA M+ K P F G +Q+ I +
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILE 233
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-23
Identities = 52/199 (26%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGGPNIVK 193
+G G + V+EG++ D + +K + K++++EI +L L PNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 250
L R+ + E V L Y + + +R Y ++L L+Y H + +
Sbjct: 67 YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
HRD+K N+++D ++L D+G+A+ S Y+ PE++ Y +
Sbjct: 125 HRDIKGANILVDTNG-VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 311 DLWSLGCMFAGMIFRKEPF 329
D+WSLGC M K P+
Sbjct: 184 DIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 76/241 (31%), Positives = 122/241 (50%), Gaps = 32/241 (13%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLC 186
E YE + K+G+G + EVF+ H + +K +L +K+ REIKILQ L
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL- 68
Query: 187 GGPNIVKLLDIVRDQQSK------TPSLIFE---H-----VNNTDFKVLYPTLSDYDVRY 232
N+V L++I R + + + L+FE H ++N + K TLS+ ++
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKF---TLSE--IKK 123
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNV 287
+ LL L Y H I+HRD+K N++I + L+L D+GLA + K Y
Sbjct: 124 VMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
RV + +++ PELL+ +DY +D+W GC+ A M R P G+ QL I+++ G
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCG 241
Query: 348 T 348
+
Sbjct: 242 S 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 8e-23
Identities = 77/265 (29%), Positives = 131/265 (49%), Gaps = 30/265 (11%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGP 189
D E R +G G + V+ D ++ +K + V K++ RE+K+L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59
Query: 190 NIVKLLDIVRDQQSKTPSL-IFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLK 239
N++ LDI+ + P + FE + +D K++ LS V+ ++Y++L+
Sbjct: 60 NVLSALDIL-----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGP 297
L Y HS GI+HRD+KP N++++ L++ D+GLA P K V ++Y++ P
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN- 356
E+L+ + Y ++D+WS+GC+FA ++ R+ F QL I +LGT L A +
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232
Query: 357 ----KYHIELDPHLAALVGRLVILS 377
+ HI PH + L LS
Sbjct: 233 CEGARAHILRGPHKPPSLPVLYTLS 257
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 9e-23
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG 188
D++++ +VG+G Y +VF E +K +K + + + E IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCH 245
+VKLL +D + L E+V DF+ L LS+ R+Y+ E+ +A+D H
Sbjct: 61 EWLVKLLYAFQDDEYLY--LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 304
G +HRD+KP N +ID ++L D+GL++ Y N V S + PE+L +
Sbjct: 119 ELGYIHRDLKPENFLIDASGH-IKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
YD+++D WSLGCM + PF
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 64/244 (26%), Positives = 128/244 (52%), Gaps = 33/244 (13%)
Query: 136 YEVVRKVGRGKYSEVFEGV--HCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 187
YE+ +GRG Y V++ + D ++ IK K K++ REI +L+ L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKA 240
N+V L+++ + K+ L+F++ + ++++ ++ V+ ++++L
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRY 293
+ Y HS ++HRD+KP N+++ E+ +++ D GLA ++ P + + V + +
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAK 344
++ PELL+ + Y ++D+W++GC+FA ++ EP F G + DQL +I +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLERIFE 239
Query: 345 VLGT 348
VLGT
Sbjct: 240 VLGT 243
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-22
Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 23/203 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 191
+E+V +G G Y +V++ H + IKI+ ++ +++IK E IL+ PNI
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 192 VKL--LDIVRDQQSKTPSLIF-----------EHVNNTDFKVLYPTLSDYDVRYYIYELL 238
I ++ L + V + L + + Y + E L
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGKRLKEEWIAYILRETL 123
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 297
+ L Y H ++HRD+K N+++ ++L+D+G+ A+ N + + Y+ P
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 298 E-LLVDLQD---YDYSLDLWSLG 316
E + D Q YD D+WSLG
Sbjct: 183 EVIACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 22/227 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKPVKKK---KIKREIKILQNLC 186
++++ +K+G+G++S V++ + C + + + ++I + + K +EI +L+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAI-CLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL- 59
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLK 239
PN++K L + ++ E + D FK + + + Y +L
Sbjct: 60 DHPNVIKYLASFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 298
AL++ HS+ IMHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAK 344
+ + Y++ D+WSLGC+ M + PF+ N Y KI K
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 4e-22
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 192
+G+G + +V + +K+LK KKKI + E IL + P IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCHSQGI 249
KL + ++ L+ E+ + F L S+ R+Y E++ AL+Y HS GI
Sbjct: 57 KLHYAFQTEEKL--YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
++RD+KP N+++D ++L D+GLA E G N + + PE+L + Y
Sbjct: 115 IYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LGKGYGK 172
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDN 335
++D WSLG + M+ K P FY D
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP-FYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 56/209 (26%), Positives = 105/209 (50%), Gaps = 20/209 (9%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGP 189
+Y++ +GRG + V++G++ + IK + K K+ I +EI +L+NL P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIYELLKALDY 243
NIVK + + S +I E+ N L + + V Y+Y++L+ L Y
Sbjct: 60 NIVKYIGSIETSDSL--YIILEYAENGS---LRQIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 302
H QG++HRD+K N++ + ++L D+G+A + K+ V + Y+ PE +++
Sbjct: 115 LHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIE 172
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
+ + D+WSLGC ++ P++
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYYD 201
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 16/197 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVK 193
Y+ + K+G G EV++ ++ IK L+ K+ I EI I+++ C PNIV
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD-CKHPNIVD 79
Query: 194 LLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQ 247
D ++ E+++ TD ++ +++ + Y E+L+ L+Y HSQ
Sbjct: 80 YYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
++HRD+K N+++ + ++L D+G A+ + N V + Y+ PE++ +DY
Sbjct: 136 NVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193
Query: 307 DYSLDLWSLGCMFAGMI 323
+D+WSLG M M
Sbjct: 194 GPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-20
Identities = 59/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIK---REIKILQNLCGG 188
+E++R +G+G + +V + K + K K V+K ++ E +ILQ L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQEL-NH 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDY 243
P +V L +D+++ L+ + + D + Y S+ V+++I E++ AL+Y
Sbjct: 60 PFLVNLWYSFQDEENMY--LVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
HS+GI+HRD+KP N+++D EQ + + D+ +A P + + PE+L
Sbjct: 116 LHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR- 173
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
Q Y ++D WSLG + K P + GH
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP-YRGHSR 204
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 60/200 (30%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 157 TDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQS----KTPSL 208
T I K+ +P + K+ RE+ +++ L NI+ LL++ Q+S + L
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYL 98
Query: 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268
+ E ++ +V+ L + Y +Y++L + + HS GI+HRD+KP N+++ + L
Sbjct: 99 VMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TL 157
Query: 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328
+++D+GLA V +RY++ PE+++ + Y ++D+WS+GC+ MI R
Sbjct: 158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMI-RGTV 215
Query: 329 FFYGHDNYDQLVKIAKVLGT 348
F G D+ DQ KI + LGT
Sbjct: 216 LFPGTDHIDQWNKIIEQLGT 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 69/228 (30%), Positives = 121/228 (53%), Gaps = 18/228 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPN 190
Y++ +G+G Y V + EK IK + V +I REIK+L+ L P+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR-LLRHPD 60
Query: 191 IVKLLDIV---RDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCH 245
IV++ I+ ++ K ++FE + + +V+ L+ ++++Y+LL+AL Y H
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
+ + HRD+KP N++ + + KL++ D+GLA + VA+R+++ PEL
Sbjct: 121 TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 302 DL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+WS+GC+FA ++ K P F G + QL I +LGT
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGT 226
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 59/230 (25%), Positives = 120/230 (52%), Gaps = 23/230 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEK------CIIKILKPVKK----KKIKREIKILQNL 185
Y+ ++ +G G +G+ C + + K+ +P + K+ RE+ +L+ +
Sbjct: 23 YQQLKPIGSGA-----QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 77
Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LL++ Q+S + L+ E ++ +V++ L + Y +Y++L +
Sbjct: 78 -NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
+ Y ++D+WS+GC+ ++ + F G D+ DQ K+ + LGT
Sbjct: 196 GMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGTPSA 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 63/227 (27%), Positives = 117/227 (51%), Gaps = 23/227 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 185
Y+ ++ +G G +G+ C D I K+ +P + K+ RE+ +L
Sbjct: 19 YQNLKPIGSGA-----QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 72
Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LL++ Q+S + L+ E ++ +V+ L + Y +Y++L +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y ++D+WS+GC+ M+ R + F G D DQ K+ + LGT
Sbjct: 192 GM-GYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGT 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 52/193 (26%), Positives = 106/193 (54%), Gaps = 17/193 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPN 190
++ ++++ K+G G Y V++ +H + IK++ PV++ ++I +EI IL+ C P
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59
Query: 191 IVKLLDIVRDQQSKTPSLIFEH-----VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
IVK ++ ++ E+ V++ K+ TL++ ++ +Y+ LK L+Y H
Sbjct: 60 IVKYYGSY--FKNTDLWIVMEYCGAGSVSDI-MKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 246 SQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
S +HRD+K N++++ E Q K L D+G++ + + N + + ++ PE++ +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAK--LADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE- 173
Query: 304 QDYDYSLDLWSLG 316
Y+ D+WSLG
Sbjct: 174 IGYNNKADIWSLG 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 7e-19
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLCGGPNIVK 193
+ +G Y VF + + IK++K K I++ E IL P +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 250
L Q K L+ E++ D L +L + R YI E++ AL+Y HS GI+
Sbjct: 58 LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 301
HRD+KP N++ID L+L D+GL++ ++ N+ + + PE+++
Sbjct: 116 HRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
Q + ++D WSLGC+ + PF
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPFH 202
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 61/227 (26%), Positives = 116/227 (51%), Gaps = 23/227 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 185
Y+ ++ +G G +G+ C + I K+ +P + K+ RE+ +L
Sbjct: 26 YQNLKPIGSGA-----QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 79
Query: 186 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LL++ Q+S + ++ E ++ +V+ L + Y +Y++L +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y ++D+WS+GC+ MI F G D+ DQ K+ + LGT
Sbjct: 199 GM-GYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGT 243
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKC------IIKILKPVKKKKIKREIKILQNLCGG 188
++++ +K+GRG++SEV+ D + I +++ ++ +EI +L+ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61
Query: 189 PNIVKLLD-IVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
PN++K LD + D + +++ E + D FK + + V Y +L A
Sbjct: 62 PNVIKYLDSFIEDNEL---NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPEL 299
+++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 VEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + Y++ D+WSLGC+ M + PF+
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 66/247 (26%), Positives = 104/247 (42%), Gaps = 66/247 (26%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-----------KREIKIL 182
DD+EV++ +GRG + EV+ D + + +K ++K + +R+I
Sbjct: 1 DDFEVIKVIGRGAFGEVWL---VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYE 236
+ P IVKL +D++ L+ E++ D L L DV R+YI E
Sbjct: 58 AD---SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNL---LIRKDVFPEETARFYIAE 109
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLA----------------- 276
L+ ALD H G +HRD+KP N++ID H ++L D+GL
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 277 ---------EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
K+ VR V + + PE+L Y D WSLG + M+
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEML 224
Query: 324 FRKEPFF 330
+ PF+
Sbjct: 225 YGFPPFY 231
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 28/256 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGP 189
DYEV+ +G+G + V + +D + + K + +K+++ E+ IL+ L P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIY----ELLKALD 242
NIV+ D + D+ ++T ++ E+ D L Y +I+ +LL AL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 243 YCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKG 296
CH ++HRD+KP N+ +D ++L D+GLA+ + V + Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF-YGHDNYDQLVKIAKVLG-----TDE 350
PE L YD D+WSLGC+ + PF +K K + E
Sbjct: 179 PEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237
Query: 351 LNAYLNKYHIELDPHL 366
LN + K + +DP
Sbjct: 238 LNEVI-KSMLNVDPDK 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 53/254 (20%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------------REIKILQN 184
+G G Y +V + + IK +K ++ RE+KI+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 185 LCGGPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIY 235
+ NI+ L+D +V D + + D K+ L++ V+ +
Sbjct: 77 I-KHENIMGLVDVYVEGDFINLVMDIMASDLKKVV------DRKIR---LTESQVKCILL 126
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---------------EFYH 280
++L L+ H MHRD+ P N+ I+ + ++ D+GLA E
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+E +V + +++ PELL+ + Y +++D+WS+GC+FA ++ K P F G + DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLG 244
Query: 341 KIAKVLGTDELNAY 354
+I ++LGT + +
Sbjct: 245 RIFELLGTPNEDNW 258
|
Length = 335 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNI 191
D +E++ +G+G Y +V++ + D +KIL P+ ++I+ E ILQ+L PN+
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81
Query: 192 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 241
VK + L+ E N L L + + Y +Y L L
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
+ H+ I+HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 301 VDLQDYDYSL----DLWSLG 316
Q YDYS D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCGGPNIV 192
++ + +G + V+ + + IK+LK + K ++ K E I+ P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 193 KLLDIVRDQQSKTP-SLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQG 248
KL QSK L+ E++N D L T L + + YI E++ ++ H +G
Sbjct: 61 KLYYSF---QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
I+HRD+KP N++ID + L+L D+GL+ K++ V + + PE ++ + D D
Sbjct: 118 IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DK 172
Query: 309 SLDLWSLGCMFAGMIFRKEPF 329
D WSLGC+ +F PF
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPF 193
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 43/217 (19%)
Query: 140 RKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKK--KKIKREIKILQNLCGGPNIVK 193
K+G G + +V+ V+ E K I+I K K+I E+K+L+ L PN+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVK-EIRIQDNDPKTIKEIADEMKVLELL-KHPNLVK 63
Query: 194 L--LDIVRDQ--------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
+++ R++ T + EH D V +R Y +LL+ L Y
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---------IRVYTLQLLEGLAY 114
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------- 296
HS GI+HRD+KP N+ +DH ++L D+G A +
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNT----TTMGEEVQSLAGTPAY 169
Query: 297 --PELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE++ + + + D+WSLGC+ M K P+
Sbjct: 170 MAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 59/238 (24%), Positives = 117/238 (49%), Gaps = 34/238 (14%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 196
KVGRG Y V++ D + LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKR-KDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQK 65
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCH 245
+ + L+F++ + + ++ L V+ +Y++L + Y H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 298
+ ++HRD+KP N+++ E+ ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAKVLG 347
LL+ + Y ++D+W++GC+FA ++ EP F+ ++DQL +I V+G
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-17
Identities = 59/238 (24%), Positives = 117/238 (49%), Gaps = 34/238 (14%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 196
KVGRG Y V++ D + LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKR-KDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQK 65
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCH 245
+ + L+F++ + + ++ L V+ +Y++L + Y H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 246 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 298
+ ++HRD+KP N+++ E+ ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAKVLG 347
LL+ + Y ++D+W++GC+FA ++ EP F+ ++DQL +I V+G
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 242
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 192
+G+G + EV K + K + KK++K+ E KIL+ IV
Sbjct: 1 LGKGGFGEVC-ACQVKATGK--MYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIV 56
Query: 193 KLLDIVRDQQSKTP-SLIFEHVNNTDFK-----VLYPTLSDYDVRYYIYELLKALDYCHS 246
L ++K L+ +N D K V P + +Y +++ L++ H
Sbjct: 57 SL---AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+ I++RD+KP NV++D + +R+ D GLA GK+ R + + PE+L + Y
Sbjct: 114 RRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVY 171
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
D+S+D ++LGC MI + PF
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 191
D +E++ +G+G Y +VF+ ++ + K +KIL P+ ++I+ E IL+ L PN+
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 192 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 241
VK + + K L+ E N L + + + Y ++E L L
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
+ H +HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 301 VDLQD----YDYSLDLWSLG 316
Q YD D+WSLG
Sbjct: 197 ACEQQLDSTYDARCDVWSLG 216
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 7e-16
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG--PNIVK-- 193
+GRG Y V+ G H +KI+ I+RE+ +L L PNI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 194 --LLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 247
L K P L I E+ + L +++ + I E+L AL Y H
Sbjct: 69 GSYL--------KGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
G++HRD+K N+++ + ++L D+G+ A + + V + Y+ PE++ + + Y
Sbjct: 121 GVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
D D+WSLG M P+
Sbjct: 180 DTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 51/214 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
DDYE++ +G G + V+ + +NEK IK + ++++E++ + + C P
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59
Query: 190 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 227
N+VK LLDI++ S P +
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPG---- 282
+ + E+LK L+Y HS G +HRD+K N+++ E +++ D+G+ A G
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
K V + + PE++ + YD+ D+WS G
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG 194
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 52/185 (28%), Positives = 104/185 (56%), Gaps = 12/185 (6%)
Query: 161 KCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD- 217
KC+ K I++ +++ I E +IL+ C P IVKL +D++ ++ E+ +
Sbjct: 24 KCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLYRTFKDKKYIY--MLMEYCLGGEL 80
Query: 218 FKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
+ +L +Y R+YI ++ A +Y H++GI++RD+KP N+++D ++L+D+G
Sbjct: 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY-VKLVDFGF 139
Query: 276 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
A+ G++ + + PE++++ + YD+S+D WSLG + ++ + PF G D+
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPF--GEDD 196
Query: 336 YDQLV 340
D +
Sbjct: 197 EDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCGG 188
++ + +K+GRG++SEV+ D +K ++ + +EI +L+ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61
Query: 189 PNIVKL-LDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
PN++K + D + +++ E + D FK + + V Y +L A
Sbjct: 62 PNVIKYYASFIEDNEL---NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPEL 299
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 LEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
+ + Y++ D+WSLGC+ M + PF+ N L K
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 31/226 (13%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 189
+G G + V+ G++ + E +K + +K+ + REI +L+ L
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
NIV+ L D + E+V L Y + VR ++ ++LK L+Y H+
Sbjct: 67 NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 299
+GI+HRD+K N+++D++ +++ D+G+++ +R ++ PE
Sbjct: 125 RGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+V Y D+WSLGC+ M+ K PF + QL I K+
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFKI 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKK---IKREIKILQNLCG 187
DD+E ++ +G G + V H + +KIL K VK K+ + E +ILQ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYC 244
P +V L +D + L+ E+V + F L + R+Y +++ AL+Y
Sbjct: 61 -PFLVNLYGSFQDDSNL--YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 296
HS I++RD+KP N+++D +++ D+G A RV R +
Sbjct: 118 HSLDIVYRDLKPENLLLDS-DGYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE+++ + Y ++D W+LG + M+ PFF
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 24/199 (12%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGP 189
Q+DYE+++++G G Y +V++ E IK++K + I++EI +L+ C P
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60
Query: 190 NIVKLL-DIVRDQQ-------SKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYIYELLKA 240
NIV +R + SL D ++V LS+ + Y E LK
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSL-------QDIYQVTRGPLSELQIAYVCRETLKG 113
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPEL 299
L Y H G +HRD+K N+++ E ++L D+G+ A+ + + + Y+ PE+
Sbjct: 114 LAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 300 LVDLQ--DYDYSLDLWSLG 316
+ YD D+W+LG
Sbjct: 173 AAVERKGGYDGKCDIWALG 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (184), Expect = 2e-14
Identities = 65/260 (25%), Positives = 124/260 (47%), Gaps = 44/260 (16%)
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCI-IKILKPVK 171
P +Y D ES ++YEV++K+G G++ EVF H E K I + LK +
Sbjct: 2 PGKYDDGES------RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKERE 55
Query: 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPT 224
K ++ E+ +++ L NIV+ +D ++ ++ ++ E + D ++
Sbjct: 56 KSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114
Query: 225 LSDYDVRYYIYELLKALDYCHS-------QGIMHRDVKPHNVMIDHEQRKL--------- 268
+ ++ + +LL AL YCH+ + ++HRD+KP N+ + R +
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 269 -------RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDLWSLGCMFA 320
++ D+GL++ + V + Y+ PELL+ + + YD D+W+LGC+
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 321 GMIFRKEPFFYGHDNYDQLV 340
+ K P F+ +N+ QL+
Sbjct: 235 ELCSGKTP-FHKANNFSQLI 253
|
Length = 1021 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 190
R +GRG Y++V V N++ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
+V L Q + L+ E+VN D L + R+Y E+ AL++ H +
Sbjct: 58 LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI++RD+K NV++D + ++L D+G+ E PG + + + PE+L ++Y
Sbjct: 116 GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
+S+D W+LG + M+ + PF DN D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
DD E + ++G G V + +H + K I + +K+I RE+ IL C P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLKALDYCH 245
IV + S+ E+++ + + + +LK L Y H
Sbjct: 60 YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 246 SQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 300
+ I+HRDVKP N++++ + +++L D+G++ G+ N V + + PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 301 VDLQDYDYSLDLWSLGCMF 319
DY D+WSLG
Sbjct: 172 QGN-DYSVKSDIWSLGLSL 189
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 48/193 (24%), Positives = 95/193 (49%), Gaps = 16/193 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 189
+ + ++ +G+G + EV++ + N+ IK++ + + I++EI+ L C P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59
Query: 190 NIVKLLDIVRDQQSKTPSL--IFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCH 245
I K K L I E+ + +L P L + + + + E+L L+Y H
Sbjct: 60 YITKYYGSF----LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
+G +HRD+K N+++ E+ ++L D+G++ + + N V + ++ PE++
Sbjct: 116 EEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-S 173
Query: 305 DYDYSLDLWSLGC 317
YD D+WSLG
Sbjct: 174 GYDEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 20/195 (10%)
Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD----- 229
+++EI+++ L P+I+++L + +L E + L LS Y
Sbjct: 50 LRKEIRLMARL-NHPHIIRMLGAT--CEDSHFNLFVEWMAGGSVSHL---LSKYGAFKEA 103
Query: 230 -VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK 283
+ Y +LL+ L Y H I+HRDVK N++ID ++LR+ D+G A + G+
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF-FYGHDNYDQLV-K 341
+ + F PE+L + Y S D+WS+GC+ M K P+ H N+ L+ K
Sbjct: 164 FQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222
Query: 342 IAKVLGTDELNAYLN 356
IA + +L+
Sbjct: 223 IASATTAPSIPEHLS 237
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--------VKKKKIKREIKILQNL 185
D++V VGRG + EV + +K++K V + +R+I + N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-------VRYYIYELL 238
P I +L +D L+ E+ D L L+ Y+ ++Y+ EL+
Sbjct: 60 --SPWIPQLQYAFQD--KDNLYLVMEYQPGGD---LLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKG 296
A+ H G +HRD+KP NV+ID ++L D+G A K N + V + +
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 297 PELLVDLQD-----YDYSLDLWSLGCMFAGMIFRKEPF 329
PE+L + Y D WSLG + MI+ + PF
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 7e-14
Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 140 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 191
+K+G G + EV++G + +K LK ++ RE +I++ L PN+
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
VKLL + +++ ++ E++ D Y P LS D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ +HRD+ N ++ E +++ D+GL+ + Y R
Sbjct: 121 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKR 161
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 8e-14
Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 191
YE+++K+G G + +++ +D+E C+IK + PVK+K+ ++ IL PNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFK--------VLYPTLSDYDVRYYIYELLKALDY 243
V Q++ ++ E+ + D VL+ S+ + + ++ L +
Sbjct: 62 VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 302
H + I+HRD+K N+ + +L D+G+A + E V + Y+ PE+ +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+ Y+ D+WSLGC+ + K PF +N QLV
Sbjct: 177 -RPYNNKTDIWSLGCVLYELCTLKHPF--EGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
+DYEVV+ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
P +V+L +D + ++ E++ D L +S+YDV R+Y E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
D HS G +HRDVKP N+++D + L+L D+G KE VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212
Query: 298 ELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 47/207 (22%), Positives = 93/207 (44%), Gaps = 41/207 (19%)
Query: 140 RKVGRGKYSEVFEG-VHCTDNEKCI--IKILK----PVKKKKIKREIKILQNLCGGPNIV 192
+K+G G + EV++G + D + +K LK ++K +E ++++ L G PN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFK------------VLYPTLSDYDVRYYIYELLKA 240
+LL + +++ L+ E++ D TLS D+ + ++ K
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
++Y S+ +HRD+ N ++ E +++ D+GL+ + Y + G
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171
Query: 297 ----PELLVDLQDYDYSL--DLWSLGC 317
PE L+D ++ D+WS G
Sbjct: 172 RWMAPES---LKDGIFTSKSDVWSFGV 195
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 15/198 (7%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKL 194
+ K+G+G + EVF+G+ + IKI+ + + I++EI +L C P + K
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67
Query: 195 L-DIVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMH 251
++D + +I E++ + +L P L + + + E+LK LDY HS+ +H
Sbjct: 68 YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
RD+K NV++ E +++L D+G+A + + N V + ++ PE ++ YD
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182
Query: 311 DLWSLGCMFAGMIFRKEP 328
D+WSLG + A + + EP
Sbjct: 183 DIWSLG-ITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 52/183 (28%), Positives = 94/183 (51%), Gaps = 12/183 (6%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 196
++G+G + EV++G+ E IKI+ + + I++EI +L C P I +
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69
Query: 197 IVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
+ +I E++ + +L P L + + + E+LK LDY HS+ +HRD+
Sbjct: 70 SY--LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 255 KPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
K NV++ EQ ++L D+G+A + + N V + ++ PE ++ YD+ D+W
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKADIW 185
Query: 314 SLG 316
SLG
Sbjct: 186 SLG 188
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 190
R +GRG Y++V V E+ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
+V L Q + E+VN D L + R+Y E+ AL+Y H +
Sbjct: 58 LVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L +DY
Sbjct: 116 GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF--FYGHDNYDQ 338
+S+D W+LG + M+ + PF DN DQ
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 51/205 (24%), Positives = 100/205 (48%), Gaps = 14/205 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
D E V+ +G+G V++ H + +K + +K++ RE+K L++ C P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
+VK + S++ E+++ D + + + Y ++LK LDY H+
Sbjct: 60 YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 247 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 304
+ I+HRD+KP N++I+ + ++++ D+G+++ + N V + + PE + +
Sbjct: 118 KRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
Y Y+ D+WSLG K PF
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPF 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 4e-13
Identities = 53/200 (26%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVK 193
+E+V VG G Y +V++G H + IK++ ++++IK+EI +L+ NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 194 LLDIVRDQQSKTPS-------LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKAL 241
K P L+ E L TL + + Y E+L+ L
Sbjct: 68 YYGAF---IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 300
+ H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+ PE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 301 VDLQD----YDYSLDLWSLG 316
++ YD+ DLWSLG
Sbjct: 184 ACDENPDATYDFKSDLWSLG 203
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 5e-13
Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 139 VRKVGRGKYSEVFEGVH--CTDN--EKCIIKILK----PVKKKKIKREIKILQNLCGGPN 190
++++G G + +V + DN E+ +K L + +REI+IL+ L N
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR----YYIYELLKALDYCHS 246
IVK + ++ LI E++ + + D + ++ K +DY S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 302
Q +HRD+ N++++ E +++ D+GLA+ K+Y + ++ PE L
Sbjct: 128 QRYIHRDLAARNILVESEDL-VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
+ S D+WS G + F YG + + +++G
Sbjct: 187 SKFSSAS-DVWSFGVTLYEL------FTYGDPSQSPPAEFLRMIG 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
+DY+VV+ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
P +V+L +D K ++ E++ D L +S+YDV ++Y E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 299
D HS G++HRDVKP N+++D + L+L D+G + G + V + + PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 300 LVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 330
L Y D WS+G M+ PF+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 32/206 (15%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------------KKIKREIKILQNLCGG 188
+G+G Y V+ ++ T E +K ++ K ++ EI+ L++L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 245
NIV+ L + + S+ E+V T ++ VR++ ++L+ L Y H
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 301
S+GI+HRD+K N+++D ++ D+G+ + Y + +++ S ++ PE ++
Sbjct: 126 SKGILHRDLKADNLLVDA-DGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182
Query: 302 DLQDYDYS--LDLWSLGC----MFAG 321
YS +D+WSLGC MFAG
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 7e-13
Identities = 39/162 (24%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 140 RKVGRGKYSEVFEGV--HCTDN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 191
+K+G G + EV++G D + +K LK ++ RE +I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFK-VL----YPTLSDYDVRYYIYELLKALDYCHS 246
VKLL + +++ ++ E++ D L LS D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ +HRD+ N ++ E +++ D+GL+ + Y V+
Sbjct: 122 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVK 162
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKK----IKREIKILQNLCGGPNIVK 193
R +GRG Y++V +K++K V + ++ E + + P +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 194 LLDIVRDQQSKTPSLIF---EHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 247
L +T S +F E V+ D L + R+Y E+ AL++ H +
Sbjct: 61 LHSCF-----QTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L +DY
Sbjct: 116 GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
+S+D W+LG + M+ + PF
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201
+GRG + EV+ G D K + +K + KK+IK +K + L I +L +V
Sbjct: 2 IGRGGFGEVY-GCRKADTGK--MYAMKCLDKKRIK--MKQGETLALNERI--MLSLVSTG 54
Query: 202 QS----------KTP---SLIFEHVNNTDFKV---LYPTLSDYDVRYYIYELLKALDYCH 245
TP S I + +N D + S+ ++R+Y E++ L++ H
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
++ +++RD+KP N+++D E +R+ D GLA + K + V + + PE+L
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
YD S D +SLGCM ++ P F H D+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPN 190
R +G+G + EV C + K ++KK+IK+ E +IL+ + N
Sbjct: 6 RVLGKGGFGEV---CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV----N 58
Query: 191 IVKLLDIVRDQQSKTP-SLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDYC 244
++++ ++K L+ +N D K +Y P + +Y E+L L+
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
H + ++RD+KP N+++D + +R+ D GLA G+ RV + + PE+L + Q
Sbjct: 119 HRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-Q 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
Y S D W LGC+ MI + PF
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 59/224 (26%), Positives = 108/224 (48%), Gaps = 17/224 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G VF + ++ IK + K KK+ I EI +++ L PNIV
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIV 79
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
LD +V D+ ++ E++ V + + + E L+AL++ H+
Sbjct: 80 NFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
++HRD+K NV++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 136 VIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
+D+WSLG M M+ + P+ ++N + + + GT EL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 31/204 (15%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVK 193
+E+V VG G Y +V++G H + IK++ + +++IK EI +L+ NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 194 LLDIVRDQQSKTPS-------LIFEH---------VNNTDFKVLYPTLSDYDVRYYIYEL 237
K+P L+ E V NT L + + Y E+
Sbjct: 78 YYGAF---IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN----ALKEDWIAYICREI 130
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 296
L+ L + H+ ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+
Sbjct: 131 LRGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 189
Query: 297 PELLVDLQD----YDYSLDLWSLG 316
PE++ ++ YDY D+WSLG
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKR---------EIKILQNLCGG 188
R +G+G + EV C + K+ K ++KK+IK+ E +IL+ +
Sbjct: 6 RVLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NS 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDY 243
+V L + + L+ +N D K +Y P + +Y E+ L+
Sbjct: 60 RFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
H + I++RD+KP N+++D + +R+ D GLA G+ RV + + PE +V
Sbjct: 118 LHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE-VVKN 175
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y +S D W LGC+ MI K PF
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGP 189
YE +R VGRG + V D + IIK + PV ++ + E ++L+ L P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLL-SHP 59
Query: 190 NIV---------KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
NI+ K L IV + + E++ K L + + ++ ++L A
Sbjct: 60 NIIEYYENFLEDKALMIV--MEYAPGGTLAEYIQ----KRCNSLLDEDTILHFFVQILLA 113
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
L + H++ I+HRD+K N+++D + +++ D+G++ K Y V V + + PE
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCYISPE- 171
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
L + + Y+ D+W+LGC+ + K F
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
EI++L+NL IV+ +RD +T S+ EH+ K Y L++ R Y
Sbjct: 54 EIQLLKNLLH-ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT 112
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 290
++L+ + Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y+ PE ++ + Y D+WS+GC M+ K P+
Sbjct: 172 TPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 42/118 (35%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYN 286
DV++Y+ EL ALD+ HS GI++RD+KP N+++D E+ ++L D+GL++ H K Y+
Sbjct: 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Y PE +V+ + + S D WS G + M+ P F G D + + I K
Sbjct: 158 FCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 8e-12
Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 2/100 (2%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
V +Y ++ + + HS I++RD+KP NV++D +Q RL D GLA GK R
Sbjct: 97 VIHYSAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA 155
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + PE+L + + Y Y +D +++GC M+ + PF
Sbjct: 156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-12
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLC 186
D+E++ K+G+G + VF+ V D + +K + K+ R E ++L L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKR---VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKA 240
I++ + D+ +++ E+ N D L P D R++I LL
Sbjct: 57 DSSYIIRYYESFLDKGKL--NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 299
L + HS+ I+HRD+K N+ +D +++ D G+A+ + N V + Y+ PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
D + Y+ D+W+LG + K PF
Sbjct: 173 CED-KPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 37/234 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILK----PVKKKKIKREIKILQNL 185
++D + R +G G++ +V++GV+ + + I +K K P ++K +E I++
Sbjct: 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF 64
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLI------------FEHVNNTDFKVLYPTLSDYDVRYY 233
P+IVKL+ ++ + P I + VN + L Y
Sbjct: 65 -DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL-------Y 112
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
Y+L AL Y S+ +HRD+ NV++ ++L D+GL+ + Y
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 294 FK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
K PE ++ + + + D+W G CM+ ++ +PF G N D + +I
Sbjct: 172 IKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN 223
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 192
+R++G G + V+ ++E IK + K+ I +E++ LQ L PN +
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78
Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 79 QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
+HRDVK N+++ E ++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192
Query: 308 YSLDLWSLGCMFAGMIFRKEPFF 330
+D+WSLG + RK P F
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 34/105 (32%), Positives = 61/105 (58%), Gaps = 2/105 (1%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
S+ ++R+Y E++ L++ H++ +++RD+KP N+++D E +R+ D GLA + K
Sbjct: 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP 152
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ V + + PE+L YD S D +SLGCM ++ PF
Sbjct: 153 H-ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIK-----ILQNLCGGPNIVKL 194
+G+G + +V +D +K+L K + KKK + I +L+NL P +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGL 61
Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMH 251
Q ++ + ++VN + + R+Y E+ A+ Y HS I++
Sbjct: 62 H--YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 310
RD+KP N+++D Q + L D+GL E P + + + + PE+L + YD ++
Sbjct: 120 RDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTV 177
Query: 311 DLWSLGCMFAGMIFRKEPFF 330
D W LG + M++ PF+
Sbjct: 178 DWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 37/119 (31%), Positives = 65/119 (54%), Gaps = 5/119 (4%)
Query: 212 HVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271
H+ N D + P + +Y +++ L++ H + I++RD+KP NV++D++ +R+
Sbjct: 83 HIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRIS 139
Query: 272 DWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
D GLA G+ A + F PELL ++YD+S+D ++LG MI + PF
Sbjct: 140 DLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 50/183 (27%), Positives = 90/183 (49%), Gaps = 12/183 (6%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 196
++G+G + EVF+G+ + IKI+ + + I++EI +L C P + K
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
+ +I E++ L ++ + + E+LK LDY HS+ +HRD+
Sbjct: 70 SY--LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 255 KPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
K NV++ EQ ++L D+G+A + + N V + ++ PE ++ YD D+W
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADIW 185
Query: 314 SLG 316
SLG
Sbjct: 186 SLG 188
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 52/203 (25%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------KIKREIKILQNLCGGPNIV 192
+ ++G G + V+ + NE +K + K+ I +E+K LQ L PN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84
Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 85 EYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYD 198
Query: 308 YSLDLWSLGCMFAGMIFRKEPFF 330
+D+WSLG + RK P F
Sbjct: 199 GKVDVWSLGITCIELAERKPPLF 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 45/201 (22%), Positives = 87/201 (43%), Gaps = 38/201 (18%)
Query: 140 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNI 191
+K+G G + EV++G K +K LK ++++ E I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
V+LL + + ++ E++ D + L+ D+ ++ K ++Y S
Sbjct: 64 VRLLGVCTQGEP--LYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---------VASRYFKGP 297
+ +HRD+ N ++ E +++ D+GL+ + Y R +A P
Sbjct: 121 KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA------P 173
Query: 298 ELLVDLQDYDYSL--DLWSLG 316
E L+D ++ D+WS G
Sbjct: 174 ES---LKDGKFTSKSDVWSFG 191
|
Length = 258 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 190
Q+D+E+++++G G Y +V++ + E IK++K P + + ++ I+ C N
Sbjct: 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 191 IVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCH 245
IV + RD+ + E + +Y LS+ + Y E L+ L Y H
Sbjct: 68 IVAYFGSYLRRDKLW----ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S+G MHRD+K N+++ + ++L D+G+ A+ + + + Y+ PE+ +
Sbjct: 124 SKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 305 D--YDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
Y+ D+W++G + + P F H
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-11
Identities = 49/175 (28%), Positives = 83/175 (47%), Gaps = 14/175 (8%)
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
EI++L+NL IV+ +RD+ KT ++ E++ K Y L++ R Y
Sbjct: 54 EIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 290
++L+ + Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+ Y+ PE ++ + Y D+WSLGC M+ K P+ Y+ + I K+
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 3e-11
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 192
+R++G G + V+ NE IK + K+ I +E+K LQ + PN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88
Query: 193 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 89 EYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 307
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202
Query: 308 YSLDLWSLGCMFAGMIFRKEPFF 330
+D+WSLG + RK P F
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 60/212 (28%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 135 DYEVVRKVGRGKYSEVF----EGVHCTDNEKCIIKILKP---VKKKKI----KREIKILQ 183
++E++R +G G Y +VF G H + +K+LK V+K K + E ++L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKA 240
+ P +V L Q LI ++VN + F LY ++ +VR YI E++ A
Sbjct: 60 AVRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA 117
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPE 298
LD+ H GI++RD+K N+++D E + L D+GL++ + +E + + PE
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 299 LLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 329
++ +D ++D WSLG + ++ PF
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 186
+D++V++ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 241
IV+L +D K ++ E++ D L +S+YD+ R+Y E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 297
D HS G +HRDVKP N+++D + L+L D+G VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212
Query: 298 ELLVDLQ---DYDYSLDLWSLGCMFAGMIFRKEPFF 330
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 61/235 (25%), Positives = 112/235 (47%), Gaps = 19/235 (8%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR----- 177
YE + + +E++ ++G G + +V++ + E + K ++ K +
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYM 57
Query: 178 -EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYI 234
EI+IL C P IVKLL + F D +L L++ ++
Sbjct: 58 VEIEILAT-CNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRY 293
++L+AL Y HS I+HRD+K NV++ + ++L D+G+ A+ + + + + Y
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPY 175
Query: 294 FKGPELLV--DLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ PE+++ ++D YDY D+WSLG M + EP + + L+KIAK
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 229
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 5e-11
Identities = 57/224 (25%), Positives = 107/224 (47%), Gaps = 17/224 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G V+ + ++ IK + + KK+ I EI +++ PNIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE-NKNPNIV 79
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
LD +V D+ ++ E++ V + + + E L+ALD+ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 136 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
+D+WSLG M M+ + P+ ++N + + + GT EL
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G V+ + ++ IK + + KK+ I EI +++ PNIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIV 79
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
LD +V D+ ++ E++ TD V + + + E L+AL++ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQ 304
++HRD+K N+++ + ++L D+G P E + R V + Y+ PE +V +
Sbjct: 135 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE-VVTRK 190
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFF 330
Y +D+WSLG M M+ + P+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKK----IKREIKILQNLCGGPNIVKLL 195
+G+G + +V H D + +K+L K + KKK I E +L P +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTL------SDYDVRYYIYELLKALDYCHSQGI 249
Q + + ++VN + L+ L + R+Y E+ AL Y HS I
Sbjct: 63 --YSFQTADKLYFVLDYVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
++RD+KP N+++D Q + L D+GL E K + + + PE+L Q YD
Sbjct: 118 IYRDLKPENILLDS-QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDR 175
Query: 309 SLDLWSLGCMFAGMIFRKEPFF 330
++D W LG + M++ PF+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 38/211 (18%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 199
+G+G + +V H + + +K+L K + KKK ++ I +N+ LL V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV--------LLKNV- 53
Query: 200 DQQSKTPSLIFEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLKA 240
K P L+ H + LY L DY R+Y E+ A
Sbjct: 54 ----KHPFLVGLHFSFQTADKLYFVL-DYINGGELFYHLQRERCFLEPRARFYAAEIASA 108
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
L Y HS I++RD+KP N+++D Q + L D+GL E + + + PE+
Sbjct: 109 LGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
L Q YD ++D W LG + M++ PF+
Sbjct: 168 L-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
+Y E+ L+ H + I++RD+KP N+++D + +R+ D GLA G+ RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGT 164
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ PE +V + Y +S D W+LGC+ MI + PF
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 59/225 (26%), Positives = 110/225 (48%), Gaps = 19/225 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLC 186
++ +E++ ++G G + +V++ + E ++ K + K + EI IL + C
Sbjct: 4 EEFWEIIGELGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS-C 59
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYC 244
PNIVKLLD + + + F D +L L++ +R + L+AL+Y
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV-- 301
H I+HRD+K N++ + ++L D+G+ A+ + + + + Y+ PE+++
Sbjct: 120 HENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 302 --DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ YDY D+WSLG M + EP + + L+KIAK
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 45/142 (31%), Positives = 75/142 (52%), Gaps = 14/142 (9%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRY 293
+LKAL H+QG++HRD+K ++++ H+ R ++L D+G KE R V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
+ PEL+ L Y +D+WSLG M M+ + P+F + +K K++ D L
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYF-----NEPPLKAMKMI-RDNLPP 234
Query: 354 YLNKYHIELDPHLAALVGRLVI 375
L H ++ P L + RL++
Sbjct: 235 KLKNLH-KVSPSLKGFLDRLLV 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKK---IKREIKILQNLCG 187
DD E ++ VG G + V +K++ ++ K+ + E ++L+ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 244
P I++L DQ+ ++ E+V + F L S+ +Y E++ AL+Y
Sbjct: 60 HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
HS+ I++RD+KP N+++D E ++L D+G A+ + + + Y PE++ +
Sbjct: 118 HSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFF 330
++ ++D W+LG + M+ PFF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-----EIKILQNLCGGP 189
D++V++K+G+G Y V++ +DN+ +K + + +R EI+IL ++ P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHP 59
Query: 190 NIVK----LLDIVR----DQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
NI+ LD + + + L + L P R +I +LL+ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE--QEIWRIFI-QLLRGL 116
Query: 242 DYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
H Q I+HRD+K N+++ ++ K+ D G+++ + + ++ PE+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAPEVW 173
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y Y D+WSLGC+ M PF
Sbjct: 174 KG-RPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLCGG 188
D+E+ +G G + V H E IK LK + K+K+ E IL L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDV-RYYIYELLKAL 241
P IV ++ +D+ + E V + F L +P DV ++Y EL+ A
Sbjct: 78 PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 298
+Y HS+ I++RD+KP N+++D + +++ D+G A+ +V R F PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLD-NKGHVKVTDFGFAK----------KVPDRTFTLCGTPE 180
Query: 299 LL----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
L + + + ++D W++G + I PFF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216
|
Length = 329 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 47/194 (24%), Positives = 100/194 (51%), Gaps = 14/194 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---EIKILQNLCGGPN 190
D +E++ ++G G + +V++ H KI++ +++++ EI IL C PN
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63
Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
IV L + + + F +++ ++ L++ +RY ++L+AL++ HS
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSH 122
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV----D 302
++HRD+K N+++ + ++L D+G+ A+ ++ + + + Y+ PE++
Sbjct: 123 KVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFK 181
Query: 303 LQDYDYSLDLWSLG 316
YDY D+WSLG
Sbjct: 182 DNPYDYKADIWSLG 195
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 139 VRKVGRGKYSEVF--EGVHCTDNEKCIIKILKPVKKKKIKREIK----------ILQNLC 186
++ +G+G Y +VF V D K I +K +KK I R K IL+ +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGK--IFAMKVLKKATIVRNQKDTAHTKAERNILEAV- 57
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYELLKA 240
P IV L I Q LI E+++ + L+ L + +Y+ E+ A
Sbjct: 58 KHPFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLA 112
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 299
L++ H QGI++RD+KP N+++D Q ++L D+GL E H G + + + PE+
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
L+ + ++D WSLG + M+ PF
Sbjct: 172 LMR-SGHGKAVDWWSLGALMYDMLTGAPPF 200
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGP 189
Q DYE++++VG G Y +V++ + E +KI+K I++EI +++ C
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHS 246
NIV ++ + E+ + +Y LS+ + Y E L+ L Y HS
Sbjct: 67 NIVAYFGSYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+G MHRD+K N+++ + ++L D+G+ A+ + + + Y+ PE+ ++
Sbjct: 125 KGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 306 --YDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
Y+ D+W++G + + P F H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201
+G+G + +V++ V D + I +K + KK+I + ++ + G NI +VR
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRR--IYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51
Query: 202 QSKTPSLI---FEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLK 239
++P ++ F ++D LY ++DY ++YI EL+
Sbjct: 52 LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 298
AL++ H I++RD+KP N+++D + L D+GL++ K N + + PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+L+D + Y +D WSLG + M PF+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPN 190
R +G+G + EV C + K ++KK+IK+ E +IL+ + N
Sbjct: 6 RVLGKGGFGEV---CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV----N 58
Query: 191 IVKLLDIVRDQQSKTP-SLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDYC 244
++ + ++K L+ +N D K +Y P + +Y EL L+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
+ I++RD+KP N+++D ++ +R+ D GLA G+ RV + + PE++ + +
Sbjct: 119 QRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-E 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
Y +S D W LGC+ MI + PF
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 56/224 (25%), Positives = 107/224 (47%), Gaps = 17/224 (7%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 192
Y K+G+G V+ + ++ I+ + + KK+ I EI +++ PNIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80
Query: 193 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
LD +V D+ ++ E++ V + + + E L+AL++ HS
Sbjct: 81 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 307
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 137 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 194
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 351
+D+WSLG M MI + P+ ++N + + + GT EL
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPEL 236
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 55/235 (23%), Positives = 106/235 (45%), Gaps = 27/235 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 190
Y +R +G+G + E D+ + K L +++ EI IL L PN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN 60
Query: 191 IVKLLDIVRDQQSKTPSL-------IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
I+ + D + + +++ + ++ + V +Y+++++ A+ Y
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF----EEEMVLWYLFQIVSAVSY 116
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELL 300
H GI+HRD+K N+ + ++L D+G+++ G EY++ V + Y+ PE L
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGL-IKLGDFGISKIL--GSEYSMAETVVGTPYYMSPE-L 172
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAY 354
Y++ D+W+LGC+ ++ K F N LV KI + T ++ Y
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPVVSVY 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 32/95 (33%), Positives = 56/95 (58%), Gaps = 3/95 (3%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 295
+L+AL Y H+QG++HRD+K ++++ + R ++L D+G A+ + V + Y+
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE++ L Y +D+WSLG M MI + P+F
Sbjct: 186 APEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYF 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 186
DD+E+++ +GRG + EV V E+ ++LK + + E +L N
Sbjct: 1 DDFEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-- 57
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY---DV-RYYIYELLKALD 242
G + L Q L+ ++ D L D D+ R+YI E++ A+
Sbjct: 58 GDCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 300
H +HRD+KP NV++D +RL D+G L + +V V + + PE+L
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 301 VDLQD----YDYSLDLWSLG-CMFAGMIFRKEPFF 330
++D Y D WSLG CM+ M++ + PF+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 35/131 (26%), Positives = 70/131 (53%), Gaps = 7/131 (5%)
Query: 208 LIFEHVNNTDFKVLYPTLSDYDV---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
+ E++N D + +D+ +Y E++ L + HS+GI++RD+K N+++D +
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132
Query: 265 QRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 323
+++ D+G+ + G + + + PE+L+ Q Y+ S+D WS G + M+
Sbjct: 133 GH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190
Query: 324 FRKEPFFYGHD 334
+ P F+GHD
Sbjct: 191 IGQSP-FHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-10
Identities = 33/96 (34%), Positives = 55/96 (57%), Gaps = 7/96 (7%)
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYF 294
LKAL + H+QG++HRD+K ++++ + R ++L D+G KE R V + Y+
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYW 181
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE++ L Y +D+WSLG M M+ + P+F
Sbjct: 182 MAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYF 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 18/210 (8%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEK---CIIKILKP---VKKKKI----KREIKILQN 184
++E+++ +G G Y +VF T ++ +K+L+ V+K K + E +L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 241
+ P +V L Q LI ++V+ + F LY S+ +VR+Y E++ AL
Sbjct: 61 VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 299
++ H GI++RD+K N+++D E + L D+GL+ EF KE + + PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + ++D WSLG + ++ PF
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 186
+D+E+++ +GRG + EV V + +K ++LK + + E +L N
Sbjct: 1 EDFEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-- 57
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALD 242
G + L Q L+ ++ D L D R+Y+ E++ A+D
Sbjct: 58 GDNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 300
H +HRD+KP N+++D +RL D+G L + +V V + + PE+L
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 301 VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
++D Y D WSLG M++ + PF+
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 28/198 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGPN 190
+ E V ++G G V++ +H +K++ + +++I REI+IL+++ PN
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 246
+VK D+ + ++ E ++ + + L+D ++L + Y H
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 301
+ I+HRD+KP N++I+ + +++ D+G LA+ P N V + + PE +
Sbjct: 187 RHIVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242
Query: 302 DLQD--YD-YSLDLWSLG 316
DL YD Y+ D+WSLG
Sbjct: 243 DLNHGAYDGYAGDIWSLG 260
|
Length = 353 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYD 229
++ EI++L+NL IV+ +RD + T S+ E++ K Y L++
Sbjct: 49 NALECEIQLLKNL-QHERIVQYYGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETV 105
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEY 285
R Y ++L+ ++Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 106 TRKYTRQILEGVEYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGM 164
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+ Y+ PE ++ + Y D+WS+GC M+ K P+ ++ + I K+
Sbjct: 165 KSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKPPW----AEFEAMAAIFKI 219
Query: 346 LGTDELNAYLNKYHIELDPHLAALVGR 372
T N L + P + R
Sbjct: 220 -ATQPTNPQLP---SHVSPDARNFLRR 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 38/107 (35%), Positives = 61/107 (57%), Gaps = 9/107 (8%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVR 288
R+Y+ E++ A+D H G +HRD+KP NV++D + +RL D+G L + NV
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVA 163
Query: 289 VASRYFKGPELLVDLQD----YDYSLDLWSLG-CMFAGMIFRKEPFF 330
V + + PE+L ++D Y D WSLG CM+ M++ + PF+
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 204 KTPSLIF---EHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPH 257
+TP +F E VN D +D R+Y E+ AL + H +GI++RD+K
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125
Query: 258 NVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
NV++DHE +L D+G+ E GK + + + PE+L ++ Y S+D W++G
Sbjct: 126 NVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183
Query: 317 CMFAGMIFRKEPF 329
+ M+ PF
Sbjct: 184 VLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 27/198 (13%)
Query: 139 VRKVGRGKYSEVF------EGVHCTDN--EKCIIKILKPVKKKK----IKREIKILQNLC 186
+R +G G + +V EG DN E+ +K LKP +K+EI+IL+NL
Sbjct: 9 IRDLGEGHFGKVELCRYDPEG----DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALD 242
NIVK I + LI E + + K P ++ Y ++ K +D
Sbjct: 65 H-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMD 123
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPE 298
Y S+ +HRD+ NV+++ E + +++ D+GL + KEY + ++ PE
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 299 LLVDLQDYDYSLDLWSLG 316
L+ + Y S D+WS G
Sbjct: 183 CLIQSKFYIAS-DVWSFG 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 21/160 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKRE----IKILQNLCG-- 187
DD+E ++ +GRG + EV +K L+ K + +++E ++ +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58
Query: 188 -GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 243
P +VKL +D LI E++ D L T ++ + R+YI E + A+D
Sbjct: 59 DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 244 CHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYH 280
H G +HRD+KP N+++D H ++L D+GL
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH----IKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 14/175 (8%)
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 234
EI++L+NL IV+ +RD + K S+ E++ K Y L++ R Y
Sbjct: 54 EIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT 112
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE----FYHPGKEYNVRVA 290
++L+ + Y HS I+HRD+K N++ D ++L D+G ++ G
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+ Y+ PE ++ + Y D+WS+ C M+ K P+ Y+ + I K+
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKPPW----AEYEAMAAIFKI 221
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 76/361 (21%), Positives = 149/361 (41%), Gaps = 60/361 (16%)
Query: 26 AISSNTSSSRTTSVSKILFSPLSQSSRIFTPFGTLRGLASSASLSHARHQHQRLRQLATP 85
+++ + +S + S S+S+ G+ R ++ S R + + A
Sbjct: 23 PVNALSGNSPKANNSASTGQTTSRSTNSARRSGSKRDRETATSTDSGRTKSH---EGAAT 79
Query: 86 PDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD-----YEVVR 140
+V + P K +V P + + V GE D ++++
Sbjct: 80 TKQATTTPTTNVEVAPPPKKKKV----TYALPNQSREEGHFYVVLGEDIDVSTQRFKILS 135
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQN--LCGGPNIVKLLD 196
+G G + +V E E C +KI++ V K + K EI+ ++ + L+
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195
Query: 197 IVRDQQSKT-----------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 245
I R Q++T P L+ D+ + + S + I++ ALDY H
Sbjct: 196 IQRYFQNETGHMCIVMPKYGPCLL-------DWIMKHGPFSHRHLAQIIFQTGVALDYFH 248
Query: 246 SQ-GIMHRDVKPHNVMIDHEQR---------------KLRLIDWGLAEFYHPGKEYNVR- 288
++ +MH D+KP N++++ ++R+ D G E + R
Sbjct: 249 TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-----CDERHSRT 303
Query: 289 --VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
V++R+++ PE+++ L + YS D+WS+GC+ + + + + HDN + L + K L
Sbjct: 304 AIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL-YTGKLLYDTHDNLEHLHLMEKTL 361
Query: 347 G 347
G
Sbjct: 362 G 362
|
Length = 467 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 22/208 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGP 189
+ +R++G G + V+ NE IK + K+ I +E++ LQ P
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75
Query: 190 NIVKLLDI-VRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCH 245
N ++ +R+ T L+ E+ + +D +V L + ++ + L+ L Y H
Sbjct: 76 NTIEYKGCYLREH---TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 246 SQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVD 302
S +HRD+K N+++ + KL D+G A P + V + Y+ PE L +D
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPANSF---VGTPYWMAPEVILAMD 187
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
YD +D+WSLG + RK P F
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 23/227 (10%)
Query: 139 VRKVGRGKYSEVFEGVHCTD------NEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
+R +G G + +V ++C D E +K LK K+EI IL+ L
Sbjct: 9 IRVLGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YH 65
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS 246
NIVK +Q K LI E+V + P L+ + + ++ + + Y HS
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLV 301
Q +HRD+ NV++D++ R +++ D+GLA+ G EY RV ++ E L
Sbjct: 126 QHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLK 183
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ + Y+ D+WS G ++ + +++++ + T
Sbjct: 184 ENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 197
+G+G Y V+ + + IK + P + + + EI + L NIV+ L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72
Query: 198 VRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYD--VRYYIYELLKALDYCHSQGIMH 251
D ++ + E V L + L D + + +Y ++L+ L Y H I+H
Sbjct: 73 -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 252 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 304
RD+K NV+++ +++ D+G ++ + + + F G PE++ +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPF 329
Y D+WSLGC M K PF
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 209 IFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
+ E+VN D +D R+Y E+ AL + H G+++RD+K N+++D E
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG 133
Query: 266 RKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF 324
+L D+G+ E G + + PE+L + +Y S+D W+LG + M+
Sbjct: 134 H-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMA 191
Query: 325 RKEPFFYGHDNYDQL 339
+ PF DN D L
Sbjct: 192 GQPPF--EADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 32/101 (31%), Positives = 57/101 (56%), Gaps = 3/101 (2%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
R+Y E++ AL+Y HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFC 156
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
R+Y E+ AL Y HS I++RD+KP N+++D Q + L D+GL E
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY--GHDNYDQLV 340
+ + PE++ Q YD ++D W LG + M++ PF+ + YD ++
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 13/156 (8%)
Query: 169 PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
P +K+I RE++I ++ C P IVK D+ S + + E+ +Y +
Sbjct: 40 PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 229 DVRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYH 280
R L LK L Y HS+ I+HRD+KP N+++ + +++L D+G++ E +
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVN 157
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
+ ++ PE + + Y + D+WSLG
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLG 190
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 190
Y VR VG+G Y EV H TD ++ +IK L ++K ++E ++L L PN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--------DVRYYIYELLKALD 242
IV R+ L++ + + LY L + V + ++ AL
Sbjct: 61 IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 301
Y H + I+HRD+K NV + +++ D G+A + + + + Y+ PEL
Sbjct: 117 YLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + Y+Y D+W+LGC M K F
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 5/119 (4%)
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYN 286
Y +Y E++ L + HS+GI++RD+K NVM+D + +++ D+G+ E +
Sbjct: 96 YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRAS 154
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+ + PE+L L+ Y +S+D WS G + M+ + P F+G D+ D+L + +V
Sbjct: 155 TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 17/107 (15%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-- 288
R+Y E++ L + H +GI++RD+K NV++D E +++ D+G+ KE +
Sbjct: 99 RFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMC------KE-GILGG 150
Query: 289 VASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
V + F G PE+L Q Y ++D W+LG + M+ + PF
Sbjct: 151 VTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 19/41 (46%), Positives = 26/41 (63%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
++L ALD HS GI+HRDVKP N++ ++ID G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 54/220 (24%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 190
Y V+K+G G + + D ++ +IK + P ++++ ++E+ +L N+ PN
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60
Query: 191 IVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
IV+ L IV D +++ +N VL+P + + + ++ AL
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGD--LYKKINAQR-GVLFP---EDQILDWFVQICLAL 114
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 300
+ H + I+HRD+K N+ + + ++L D+G+A + E + + Y+ PE +
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-I 172
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+ + Y+ D+W+LGC+ M K F G N LV
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 3/104 (2%)
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286
R+Y ELL AL+ H +++RD+KP N+++D+ Q + L D+GL + + N
Sbjct: 93 SRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTN 151
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PELL+ Y ++D W+LG + M+ PF+
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 55/207 (26%), Positives = 82/207 (39%), Gaps = 24/207 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
Y ++ + G EVF CT +K I+K + K REI IL+ +
Sbjct: 94 YNILSSLTPGSEGEVFV---CTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRA 147
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 248
I+ L+ R + T ++ F + L LL+AL Y H +G
Sbjct: 148 IINLIHAYRWKS--TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG 205
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDL 303
I+HRDVK N+ +D + + L D+G A P + Y + PELL L
Sbjct: 206 IIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA-L 261
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFF 330
Y D+WS G + M + F
Sbjct: 262 DPYCAKTDIWSAGLVLFEMSVKNVTLF 288
|
Length = 392 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 31/95 (32%), Positives = 55/95 (57%), Gaps = 3/95 (3%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 295
+L+AL Y HSQG++HRD+K ++++ + R ++L D+G A+ + V + Y+
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWM 184
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE ++ Y +D+WSLG M M+ + P+F
Sbjct: 185 APE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 50/241 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
DD+E ++ +GRG + EV +KIL+ ++K++ I+ E IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 244
G +VK+ +D+++ LI E + D L TLS+ ++YI E + A+D
Sbjct: 60 GAWVVKMFYSFQDKRNLY--LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFY-----HPGKEYNVR-- 288
H G +HRD+KP N+++D + ++L D+GL EFY +P +++ +
Sbjct: 118 HQLGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 289 --------------------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328
V + + PE+ + Y+ D WSLG + M+ P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 329 F 329
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 7/116 (6%)
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA--EFYHPGK 283
+ R+Y E++ L + H +GI++RD+K NV++D + +++ D+G+ GK
Sbjct: 94 DEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGK 152
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
+ + + PE+L Q Y+ S+D WS G + M+ + P F+G D D+L
Sbjct: 153 A-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSP-FHGEDE-DEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 33/108 (30%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
S+ R+Y E++ AL Y HS +++RD+K N+M+D + +++ D+GL E G
Sbjct: 91 VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDG 149
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 174 KIKREIKILQNLCGGPNIVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT 224
I E+ I++ PNIV+ L IV D P + EH N+ K
Sbjct: 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109
Query: 225 LSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
++ + +++ AL Y H + I+HRD+ P+N+M+ E K+ + D+GLA+ P
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ V + + PE++ + Y D+W+ GC+ M + PF+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 3/107 (2%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK 283
S+ R+Y E++ ALDY HS I++RD+K N+M+D + +++ D+GL E
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAA 150
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 151 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 22/193 (11%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIK----ILKPVKKKKIKREIKILQNLCGGPNIVKLLD 196
++GRG + EVF G DN +K L P K K +E +IL+ PNIV+L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60
Query: 197 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCHSQGI 249
+ Q + ++ E V DF L R + EL++ ++Y S+
Sbjct: 61 VC--TQKQPIYIVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 306
+HRD+ N ++ E+ L++ D+G++ G ++ + PE L + Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173
Query: 307 DYSLDLWSLGCMF 319
D+WS G +
Sbjct: 174 SSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 17/155 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKP---VKKKKIKR---EIKILQNLC 186
++ ++ +G+G VF V + +K+L +K+ K+KR E +IL L
Sbjct: 1 KHFKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL- 58
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKAL 241
P + L Q L+ ++ + L LS+ R+Y E+L AL
Sbjct: 59 DHPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+Y H GI++RD+KP N+++ HE + L D+ L+
Sbjct: 117 EYLHLLGIVYRDLKPENILL-HESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 282
S+ R+Y E++ ALDY HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDG 150
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 151 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 55/215 (25%), Positives = 108/215 (50%), Gaps = 27/215 (12%)
Query: 135 DYEVVRKVGRGKYSEVF--EGVHCTDNEKC-IIKILKP---VKKKKI----KREIKILQN 184
++E+++ +G G Y +VF V D+ K +K+LK V+K K + E ++L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS------DYDVRYYIYELL 238
+ P +V L Q LI +++N + L+ LS + +V+ Y E++
Sbjct: 61 IRQSPFLVTLHYAF--QTDTKLHLILDYINGGE---LFTHLSQRERFKEQEVQIYSGEIV 115
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFK 295
AL++ H GI++RD+K N+++D + L D+GL++ +H + Y+ Y
Sbjct: 116 LALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYM- 173
Query: 296 GPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 329
P+++ +D ++D WS+G + ++ PF
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 15/112 (13%)
Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPT---L 225
+ +RE + L PNIV LLD + P +FE+V + + L
Sbjct: 23 ARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLFAVFEYVPGRTLREVLAADGAL 76
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGL 275
+ + ++L AL H+QGI+HRD+KP N+M+ + +++D+G+
Sbjct: 77 PAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQN---LCGG 188
+++ +V+ + RG + +V+ G +++ +K++K K + +++ ++ L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 245
P IV L + Q + L+ E++ D K L +D YI E+ ALDY H
Sbjct: 64 PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
GI+HRD+KP N++I +E ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGH-IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIK--REIKILQNLCGGPNI 191
Y V+R VG G + H ++K +K ++ P ++ R+ +L PNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDF--KV------LYPTLSDYDVRYYIYELLKALDY 243
V + + ++ E+ + D K+ L+P D +++++ ++ + +
Sbjct: 61 VAFKESF--EADGHLYIVMEYCDGGDLMQKIKLQRGKLFP--EDTILQWFV-QMCLGVQH 115
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 302
H + ++HRD+K N+ + + K++L D+G A PG V + Y+ PE+ +
Sbjct: 116 IHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y+ D+WSLGC+ + K PF
Sbjct: 175 MP-YNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KK-----IKREIKILQN 184
+D+ V+ +G+G + EV V D K I +K + K KK +K E +L
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGK--IYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 241
P +V L +D Q LI E + D + Y T S+ R+Y+ E + A+
Sbjct: 58 -SDSPWVVSLYYSFQDAQYLY--LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280
+ H G +HRD+KP N++ID ++L D+GL+ +H
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFH 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 187
+ DD+E + ++G G VF+ H K I +KP + +I RE+++L C
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--------KVLYPTLSDYDVRYYIYELLK 239
P IV S+ EH++ ++ L + ++K
Sbjct: 62 SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIK 114
Query: 240 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
L Y + IMHRDVKP N++++ + +++L D+G++ N V +R + PE
Sbjct: 115 GLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE 172
Query: 299 LLVDLQDYDYSL--DLWSLGCMFAGMIFRKEP 328
LQ YS+ D+WS+G M + P
Sbjct: 173 ---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E GK
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCG 163
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + PE ++ Q Y S+D W+ G + M+ + PF
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 46/143 (32%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFYHP 281
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL +++Y
Sbjct: 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQK 162
Query: 282 G-------------------------KEYNVR----------VASRYFKGPELLVDLQDY 306
G + R V + + PE+L+ Y
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGY 221
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
D WS+G + M+ + PF
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 53/211 (25%), Positives = 84/211 (39%), Gaps = 54/211 (25%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 189
DD+E + ++G G V + +H K I +KP + +I RE+K+L C P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59
Query: 190 NIVKL---------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
IV LD V + + P I ++
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105
Query: 229 DVRYYIYELLKALDYC---HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+L+ L Y H IMHRDVKP N++++ + +++L D+G++
Sbjct: 106 ------IAVLRGLTYLREKHK--IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA- 155
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
N V +R + PE L Y D+WSLG
Sbjct: 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 30/112 (26%), Positives = 60/112 (53%), Gaps = 5/112 (4%)
Query: 237 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
++KAL+Y HS+ ++HRDVKP NV+I+ +++L D+G++ + + + +
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170
Query: 296 GPELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE + ++ + YD D+WSLG + + P+ + QL ++ +
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE 222
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 187
Y + +++G+G + V+ + +K+LK + ++ +E ++L L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALD 242
P IVK ++ + + + D K+ TLS+ V + +LL +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 301
Y H + I+HRD+K N+ + + L++ D+G++ + + Y+ PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 302 DLQDYDYSLDLWSLGCMFAGM 322
Q YD D+WSLGC+ M
Sbjct: 179 H-QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 46/237 (19%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
Y V++ + G VF + ++KI +K E +LQN+ P+++++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123
Query: 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI-------YELLKALDYCHSQG 248
D + ++ H ++ LY L+ I ++L+ L Y H+Q
Sbjct: 124 DTL--VSGAITCMVLPHYSSD----LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 299
I+HRDVK N+ I+ ++ + D G A+F V + F G PE+
Sbjct: 178 IIHRDVKTENIFINDVD-QVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEV 227
Query: 300 LVDLQDYDYSLDLWSLGCMFAGM------IFRKEPFF---YGHDNYDQLVKIAKVLG 347
L Y+ D+WS G + M IF P Y + L+KI L
Sbjct: 228 LAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283
|
Length = 357 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-VA 290
+Y E+ L + H +GI++RD+K NVM+D E +++ D+G+ KE+ V V
Sbjct: 105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KEHMVDGVT 157
Query: 291 SRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+R F G PE++ Q Y S+D W+ G + M+ + PF
Sbjct: 158 TRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 28/100 (28%), Positives = 50/100 (50%), Gaps = 3/100 (3%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 289
+Y ++ L Y H I++RD+K N+++D E +++ D+GL E G +
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFC 162
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ F PE+L + Y ++D W LG + M+ + PF
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 26/121 (21%)
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE---------FYH 280
R Y E + AL+Y H+ GI+HRD+KP N++I ++L D+GL++ Y
Sbjct: 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY- 160
Query: 281 PGKEYNVRVASRYFK-----------GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
E ++ +R F PE+++ Q Y +D W++G + + PF
Sbjct: 161 ---EGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPF 216
Query: 330 F 330
F
Sbjct: 217 F 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 52/228 (22%), Positives = 108/228 (47%), Gaps = 29/228 (12%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
++ ++V+K+G G++ EV+ G + ++ K +K LKP + + E +++ L
Sbjct: 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDK 62
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNN---TDF-------KVLYPTLSDYDVRYYIYELLKA 240
+V+L +V + + +I E++ DF KVL P L D+ ++ +
Sbjct: 63 LVRLYAVV--TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA-----QIAEG 115
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 297
+ Y + +HRD++ NV++ E ++ D+GLA EY R +++ + P
Sbjct: 116 MAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFPIKWTAP 173
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAK 344
E ++ + D+WS G + ++ + K P + G N D + + +
Sbjct: 174 E-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 235 YELLKALDYC-HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
++KAL Y G++HRDVKP N+++D ++L D+G++ K
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 294 FKGPELLVDLQD----YDYSLDLWSLG 316
+ PE + D D YD D+WSLG
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLG 205
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 187
+D+E ++ +GRG + EV +KIL+ ++K++ I+ E IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 244
+VK+ +D+ + LI E + D L TL++ + ++YI E + A+D
Sbjct: 60 SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275
H G +HRD+KP N+++D + ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLD-SKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+Y+V Y+++ ALD HS+ +MHRD+K N+ + ++L D+G ++ Y +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 287 VRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
V + + Y+ PEL + + Y D+WSLG + ++ PF
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 35/212 (16%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKKKKIK----REIKILQNLCGGPNIVK 193
K+G G + V G T K I +K LK K I +E I+ +L N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60
Query: 194 LLDIVRDQQSKTPSLIFE-----------HVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
L +V ++ E + L TL DY V ++ +
Sbjct: 61 LYGVVLTHPLM---MVTELAPLGSLLDRLRKDALGH-FLISTLCDYAV-----QIANGMR 111
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPE 298
Y S+ +HRD+ N+++ K+++ D+GL +++ V PE
Sbjct: 112 YLESKRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPF 329
L + ++ D+W G ++ + +EP+
Sbjct: 171 SLRTRT-FSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 290
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E G
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCG 163
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + PE++ Q Y S+D W+ G + M+ + PF
Sbjct: 164 TPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 35/111 (31%), Positives = 55/111 (49%), Gaps = 30/111 (27%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV------------------MIDHEQR 266
+S+ + Y + +LKALDY H G +HR VK ++ MI+H QR
Sbjct: 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG 316
LR++ H +Y+V+V + PE+L +LQ YD D++S+G
Sbjct: 158 -LRVV--------HDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVG 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 187
+ DD+E + ++G G V + H K I +KP + +I RE+++L C
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLYPT--LSDYDVRYYIYELLKALDYC 244
P IV S+ EH++ +VL + + + +L+ L Y
Sbjct: 62 SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 245 HSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
+ IMHRDVKP N++++ + +++L D+G++ N V +R + PE L
Sbjct: 120 REKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE---RL 174
Query: 304 QDYDYSL--DLWSLGCMFAGMIFRKEP 328
Q YS+ D+WS+G + + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 51/216 (23%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEK-CI---IKILK----PVKKKKIKREIKILQNLCGG 188
E ++ +G G + V++GV + EK I IK+L+ P K+I E ++ +
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68
Query: 189 PNIVKLLDIVRDQQSKTPSLI---------FEHV-NNTDFKVLYPTLSDYDVRYYIYELL 238
P++V+LL I S LI ++V N+ D + + + ++
Sbjct: 69 PHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 294
K + Y + ++HRD+ NV++ + +++ D+GLA+ KEY+ +V ++
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 295 KGPELLVDLQDYDYSLDLWSLGC-MFAGMIFRKEPF 329
E ++ + Y + D+WS G ++ M F +P+
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 45/191 (23%), Positives = 73/191 (38%), Gaps = 56/191 (29%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFYHP 281
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL +++Y
Sbjct: 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQK 162
Query: 282 GKEY---------------NVRVASRY------------------------FKGPELLVD 302
G N R R + PE+L+
Sbjct: 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
+ Y D WS+G + M+ + PF QL KV+ + N ++L
Sbjct: 223 -KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL----KVINWE--NTLHIPPQVKL 275
Query: 363 DPHLAALVGRL 373
P L+ +L
Sbjct: 276 SPEAVDLITKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 50/227 (22%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 142 VGRGKYSEVFEGV------HCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 191
+G G + EV+EG + + +K L+ +KK+ +E ++ N PNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDF----------KVLYPTLSDYDVRYYIYELLKAL 241
VKLL + + + +I E + D + P L+ ++ ++ K
Sbjct: 62 VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 293
Y +HRD+ N ++ + R +++ D+GLA + Y + R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 294 FKGPELLVDLQDYDYSLDLWSLGC-MFAGMIFRKEPFFYGHDNYDQL 339
PE L+D + S D+WS G M+ + ++P + +N + L
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVKK----KKIKREIKILQNLCGGPNIV 192
R +G+G + V+ G + + C +K L + ++ +E I+++ PN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHS 246
LL I + +P ++ ++ + D + PT+ D + + ++ K ++Y S
Sbjct: 60 SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 300
+ +HRD+ N M+D E +++ D+GLA E+Y ++ ++ L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171
Query: 301 VDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
LQ ++ D+WS G + ++ R P + D++D V + +
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 4/58 (6%)
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEY 285
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL + H K Y
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYY 160
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 51/226 (22%), Positives = 99/226 (43%), Gaps = 24/226 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 189
+D E + +G G V + H +K + K +K+I RE++I+ C P
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CRSP 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD--FKVLYPTLSDYDVRYYIYELLKALDYCHS- 246
IV ++ + + F + D +K P + + +++ L Y ++
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLYNV 122
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLVD 302
IMHRD+KP N++++ + +++L D+G++ G+ N V + + PE
Sbjct: 123 HRIMHRDIKPSNILVN-SRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE---R 173
Query: 303 LQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
+Q Y++ D+WSLG + K PF + + + D +L
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL 219
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 38/170 (22%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
Y+++R +G+G EV+ + + +K ++ P+ KK+ RE KI +L P
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62
Query: 190 NIVKLLDIVRDQQS---------------------KTPSLIFEHVNNTDFKVLYPTLSDY 228
IV + I D + SL E T
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF--- 119
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
+++ ++Y HS+G++HRD+KP N+++ + ++DWG A F
Sbjct: 120 ------HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIF 162
|
Length = 932 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 31/182 (17%)
Query: 156 CTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
C DN+ C ++K ++ E IL+ + P+I++L +K LI
Sbjct: 111 CIDNKTCEHVVIKAGQRGGTATEAHILRAI-NHPSIIQLKGTF--TYNKFTCLILPRYK- 166
Query: 216 TDFKVLYPTLSDY------DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269
TD LY L+ D+ +L+A+ Y H I+HRD+K N+ I+H +
Sbjct: 167 TD---LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVC 222
Query: 270 LIDWGLAEFYHPGKEYNVRV-ASRYF--------KGPELLVDLQDYDYSLDLWSLGCMFA 320
L D+G A + V + A++Y+ PELL Y ++D+WS G +
Sbjct: 223 LGDFGAA-------CFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLF 274
Query: 321 GM 322
M
Sbjct: 275 EM 276
|
Length = 391 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 48/195 (24%), Positives = 83/195 (42%), Gaps = 31/195 (15%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKI------LKPVKKKKIKREIKILQNLCGGPNIVK 193
K+G+G + +V++GV + + L P K+K +E +IL+ PNIVK
Sbjct: 1 EKIGKGNFGDVYKGVL---KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVK 56
Query: 194 LLDIVRDQQSKTPSLI-FEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCH 245
L+ + +Q P I E V + R + +LL+ ++Y
Sbjct: 57 LIGVCVQKQ---PIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLE 110
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLV 301
S+ +HRD+ N ++ E L++ D+G++ G Y V + + PE L
Sbjct: 111 SKNCIHRDLAARNCLVG-ENNVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL- 167
Query: 302 DLQDYDYSLDLWSLG 316
+ Y D+WS G
Sbjct: 168 NYGRYTSESDVWSYG 182
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 15/89 (16%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF--------YHPGKEYNV 287
+LL A+DY H +GI+HRD+K NV+++ + + L D+G A F +H G V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLG 316
PE+L Y S+D+WS G
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAG 349
|
Length = 461 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 48/203 (23%), Positives = 86/203 (42%), Gaps = 17/203 (8%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKI-LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD 200
+G+G Y V+ G+ + ++ L ++E + LQ +K ++IV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 201 ----QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
T S+ E V + + L + Y ++L + Y H+ ++HRD
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRD 127
Query: 254 VKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQDY 306
+K +NVM+ ++LID+G LA G N+ + Y+ PE++ + Y
Sbjct: 128 IKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGY 185
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
D+WS+GC M K P
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 1/44 (2%)
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279
++L L+Y H GI H D+KP N+M+D R +ID+G+A +
Sbjct: 134 DMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 10/129 (7%)
Query: 157 TDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
T +E ++KI K +RE+ ILQ L V + + + L+ E +
Sbjct: 19 TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77
Query: 216 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLID 272
+S+ + +L + L H + H D+ P N+++D + + L +ID
Sbjct: 78 ET----LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIID 132
Query: 273 WGLAEFYHP 281
W A + P
Sbjct: 133 WEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---------EKCIIKILKPVKKKKIKREIKILQN 184
+D+ +R +G G + V + ++ EK KI+K + + E KIL N
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--DVR-YYIYELLKAL 241
P V L +D+ L+ E V +F + DV +Y +++
Sbjct: 87 YINHPFCVNLYGSFKDESYLY--LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
+Y S I++RD+KP N+++D + +++ D+G A+ + Y + Y PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
++ + + D W+LG ++ PF+
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 27/90 (30%), Positives = 49/90 (54%), Gaps = 11/90 (12%)
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVR 288
Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA ++Y K N R
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYK--KTTNGR 200
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
+ ++ PE L D + Y + D+WS G +
Sbjct: 201 LPVKWM-APEALFD-RVYTHQSDVWSFGVL 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 281
LS D+ Y++ + ++Y S+ +HRD+ NV++ E +++ D+GLA H
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 195
Query: 282 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 196 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 40/214 (18%), Positives = 85/214 (39%), Gaps = 40/214 (18%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGV--HCTDNE---KCIIKILKPV----KKKKIKREIKILQ 183
++ ++R++G+G + V+EG+ E + IK + ++ + E +++
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMK 64
Query: 184 NL-CGGPNIVKLLDIVRDQQSKTPSLIF--------------EHVNNTDFKVLYPTLSDY 228
C ++V+LL +V Q P+L+ + +
Sbjct: 65 EFNC--HHVVRLLGVVSTGQ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPG 282
E+ + Y ++ +HRD+ N M+ E +++ D+G+ ++Y G
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV-AEDLTVKIGDFGMTRDIYETDYYRKG 178
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
+ + V R+ PE L D + D+WS G
Sbjct: 179 GKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 7e-05
Identities = 18/83 (21%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 197 IVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255
++ D + +++ E++ D K VL + ++ + + H GI+H D+
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455
Query: 256 PHNVMIDHEQRKLRLIDWGLAEF 278
N ++ + +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 43/194 (22%), Positives = 83/194 (42%), Gaps = 26/194 (13%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192
+++G G + V +GV+ + K +K LK KK+ RE ++ L P IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59
Query: 193 KLLDIVRDQQSKTPS--LIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+L+ + K L+ E + + D++ +++ + Y S+
Sbjct: 60 RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 248 GIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVD 302
+HRD+ NV++ + Q K+ D+G++ G + Y A R+ + PE ++
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKIS--DFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CIN 171
Query: 303 LQDYDYSLDLWSLG 316
+ D+WS G
Sbjct: 172 YGKFSSKSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 13/48 (27%), Positives = 22/48 (45%)
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
+ L AL ++H D+ P N+++D R +ID+ A P
Sbjct: 152 LLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 47/216 (21%), Positives = 93/216 (43%), Gaps = 35/216 (16%)
Query: 132 EQDDYEVVRKVGRGKYSEVFE----GVHCTDNE-KCIIKILKPVKKKK----IKREIKIL 182
+D + + +G G + +V + G+ + +K+LK +K + E++++
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMM 69
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFE---HVNNTDF----------------KVLYP 223
+ + NI+ LL + Q ++ E H N DF +
Sbjct: 70 KMIGKHKNIINLLGVC--TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
TL+ D+ + Y++ + +++ S+ +HRD+ NV++ E +++ D+GLA H
Sbjct: 128 TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARDIHHID 186
Query: 284 EYNVRVASRY---FKGPELLVDLQDYDYSLDLWSLG 316
Y R + PE L D + Y + D+WS G
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-- 281
L+ D+ Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA H
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFGLARDVHNID 188
Query: 282 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 319
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLL 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 4/110 (3%)
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
LS+ +V+ I +L++AL+ H I+H D+K NV+ D + ++ L D+GL +
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC 165
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
Y+ + YF PE + +YD S D W++G + ++ K PF D
Sbjct: 166 YDGTLD--YFS-PEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
|
Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 7/108 (6%)
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVASRYF 294
++K L Y S I+HRDVKP N++++ + +++L D+G++ K Y V + +
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTY---VGTNAY 159
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
PE + Q Y D+WSLG F + + P+ N L+ +
Sbjct: 160 MAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL 206
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
L + +R ++ P F+ + ++ + D+ Y++ + ++Y S+ +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFK-----DLVSCAYQVARGMEYLESRRCIHRD 159
Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 309
+ NV++ E +++ D+GLA H K N R+ ++ PE L D + Y +
Sbjct: 160 LAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216
Query: 310 LDLWSLGCM 318
D+WS G +
Sbjct: 217 SDVWSFGIL 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 27/225 (12%)
Query: 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILKPVKKKKIKREIKILQNLC----GGPNIVK 193
+ +G G++ V EG D+ K +K +K + + E + + +C PN+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 194 LLDI----VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRY-------YIYELLKA 240
L+ + V + +P +I + + D +LY L D ++ ++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK--GP 297
++Y S+ +HRD+ N M++ E + + D+GL++ + G Y R+A K
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN---YDQL 339
E L D + Y D+WS G + R + + G +N YD L
Sbjct: 184 ESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 47/226 (20%), Positives = 102/226 (45%), Gaps = 26/226 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
++ ++++K+G G++ EV+ G N K +K LKP + + E +I++ L
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDK 62
Query: 191 IVKLLDIVRDQ--------QSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKAL 241
+V+L +V ++ SK L F + + + + L P L D ++ +
Sbjct: 63 LVQLYAVVSEEPIYIVTEYMSKGSLLDF--LKDGEGRALKLPNLVDMAA-----QVAAGM 115
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPE 298
Y +HRD++ N+++ + ++ D+GLA EY R +++ + PE
Sbjct: 116 AYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPE 173
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + D+WS G + ++ + + G +N + L ++ +
Sbjct: 174 AAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 40/199 (20%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 189
E+ D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + P
Sbjct: 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62
Query: 190 NIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
N+V+LL + + + T + +++ + + + + + Y ++ A++
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAME 118
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPEL 299
Y + +HRD+ N ++ E +++ D+GL+ G Y +++ + PE
Sbjct: 119 YLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 176
Query: 300 LVDLQDYDYSLDLWSLGCM 318
L + D+W+ G +
Sbjct: 177 LA-YNKFSIKSDVWAFGVL 194
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 11/81 (13%)
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY------DVRYYIYELLKALD 242
PN+V L + + S +F + + + L+ +S + V+ + E++ ALD
Sbjct: 45 PNMVCLHKYIVSEDS-----VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALD 99
Query: 243 YCHSQGIMHRDVKPHNVMIDH 263
H +GI+ RD+ P+N+++D
Sbjct: 100 ALHREGIVCRDLNPNNILLDD 120
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 48/186 (25%), Positives = 78/186 (41%), Gaps = 37/186 (19%)
Query: 161 KCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215
KC I K VK +++ EI L L NI+K+ +I+R + + +
Sbjct: 191 KCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMITQK 244
Query: 216 TDFKVLYPTLSDYDV-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264
DF LY + D R + +LL A++Y H + ++HRD+K N+ ++ +
Sbjct: 245 YDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303
Query: 265 QRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDLWSLGC 317
K+ L D+G A + R A Y PE+L Y D+WS G
Sbjct: 304 G-KIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGL 356
Query: 318 MFAGMI 323
+ M+
Sbjct: 357 ILLDML 362
|
Length = 501 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 45/213 (21%), Positives = 83/213 (38%), Gaps = 44/213 (20%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--REIKILQNLCGGPNIVKLLDIVR 199
+G+G++ +V G + +K +K LK E ++ L PN+V+LL +V
Sbjct: 14 IGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVL 70
Query: 200 DQQSKTPSLIFEHVNNTDFKVLYPTLSDY------------DVRYYIYELLKALDYCHSQ 247
++ E++ +L DY + ++ + ++Y +
Sbjct: 71 QGNPLY--IVTEYMAKG-------SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF----KGPELLVDL 303
+HRD+ NV++ E ++ D+GLA KE + S PE L
Sbjct: 122 NFVHRDLAARNVLVS-EDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEAL-RE 173
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
+ + D+WS G I E + +G Y
Sbjct: 174 KKFSTKSDVWSFG------ILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 9e-04
Identities = 39/154 (25%), Positives = 76/154 (49%), Gaps = 21/154 (13%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNI 191
++ + RK+G G + EV+EG+ + + IKILK +K++ ++E++ L+ L ++
Sbjct: 7 EFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHL 64
Query: 192 VKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALD 242
+ L I+ + K L F + + + +VL P S D+ + E +
Sbjct: 65 ISLFAVCSVGEPVYIITELMEKGSLLAF--LRSPEGQVL-PVASLIDMACQVAE---GMA 118
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y Q +HRD+ N+++ E ++ D+GLA
Sbjct: 119 YLEEQNSIHRDLAARNILVG-EDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 164 IKILKPVKKKKI---KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220
+K L+ + + +REI+IL++L NIVK + + L+ E++
Sbjct: 38 VKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVMEYLP------ 90
Query: 221 LYPTLSDYDVRY-----------YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269
Y +L DY ++ Y ++ K ++Y S+ +HRD+ N++++ E R ++
Sbjct: 91 -YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-VK 148
Query: 270 LIDWGLAEFYHPGKE-YNVRVASR---YFKGPELLVDLQDYDYSLDLWSLG 316
+ D+GL + KE Y VR ++ PE L + + + D+WS G
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFG 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 46/201 (22%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQ 183
+++ + +G G + +V E K +K+LKP +++ + E+KI+
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYELL 238
+L NIV LL +I E+ D + L+ D+ + Y++
Sbjct: 94 HLGNHENIVNLLGAC--TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FK 295
K + + S+ +HRD+ NV++ H + +++ D+GLA Y V+ +R +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 296 GPELLVDLQDYDYSLDLWSLG 316
PE + + Y + D+WS G
Sbjct: 211 APESIFNCV-YTFESDVWSYG 230
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.001
Identities = 44/207 (21%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPN 190
++ ++V+K+G G++ EV+ G + + K IK LK + + E +++ L P
Sbjct: 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPR 62
Query: 191 IVKLLDIVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYYIYELLK 239
+V+L +V ++ P I E++ N DF K+ L D ++ +
Sbjct: 63 LVRLYAVV----TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA-----QIAE 113
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKG 296
+ + + +HRD++ N+++ ++ D+GLA EY R +++ +
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKFPIKWTA 171
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMI 323
PE ++ + D+WS G + ++
Sbjct: 172 PE-AINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 25/199 (12%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 189
++ +++RK+G G++ EV+EG+ + +K LKP + K E +I++ L P
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHP 61
Query: 190 NIVKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKA 240
+++L + ++ K SL+ E++ + L P L D ++
Sbjct: 62 KLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA-----QVASG 115
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGP 297
+ Y +Q +HRD+ NV++ E ++ D+GLA Y R +++ + P
Sbjct: 116 MAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKE-DIYEAREGAKFPIKWTAP 173
Query: 298 ELLVDLQDYDYSLDLWSLG 316
E + D+WS G
Sbjct: 174 E-AALYNRFSIKSDVWSFG 191
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (92), Expect = 0.002
Identities = 40/168 (23%), Positives = 77/168 (45%), Gaps = 25/168 (14%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLD 196
RK+G G++ EV+ G K +K LKP + + +E +I++ L +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYA 68
Query: 197 IVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYYIYELLKALDYCH 245
+ +++ P I E+++ DF K+ P L D ++ + + Y
Sbjct: 69 VCSEEE---PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA-----QIAEGMAYLE 120
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
S+ +HRD+ N+++ E ++ D+GLA EY R +++
Sbjct: 121 SRNYIHRDLAARNILVG-ENLVCKIADFGLARLIED-DEYTAREGAKF 166
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 235 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVAS 291
+KAL+Y + I+HRDVKP N+++D R ++L D+G++
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 292 RYFKGPELLV--DLQDYDYSLDLWSLG 316
R + PE + YD D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.003
Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 32/175 (18%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLD 196
KV +G+ + E + T IK LK P +++ ++E +++ +L PNIV LL
Sbjct: 20 KVYKGELTGPNERLSAT---SVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLG 75
Query: 197 IVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDY----------------DVRYYIYEL 237
+ + + ++FE++ + D F V SD D + ++
Sbjct: 76 VC--TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++Y S +HRD+ N ++ E +++ D+GL+ + Y RV S+
Sbjct: 134 AAGMEYLSSHHFVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYY--RVQSK 185
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 427 | |||
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.5 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.2 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.95 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.83 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.78 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.76 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.73 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.54 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.39 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.35 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.35 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.26 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.1 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.09 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.08 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.95 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.92 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.87 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.79 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.69 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.67 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.65 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.49 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.48 | |
| PLN02236 | 344 | choline kinase | 97.2 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.11 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.97 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.91 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.9 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.73 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.72 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.55 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.39 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.17 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.16 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.11 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.05 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.02 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.86 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.83 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.51 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 95.45 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.14 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-60 Score=412.04 Aligned_cols=320 Identities=73% Similarity=1.166 Sum_probs=302.9
Q ss_pred CCCCCcccccCCCcCCCCCcccccccccccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHH
Q 014307 101 GAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIK 180 (427)
Q Consensus 101 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~ 180 (427)
..++.++++.+++..+++++|+|+...+.|+.+++|++++++|+|.+++||.|....++++++||++++.+.+.+.+|+.
T Consensus 5 ~v~s~ARvya~vn~~rp~eYWdYE~~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREik 84 (338)
T KOG0668|consen 5 VVPSVARVYADVNEERPREYWDYESLVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIK 84 (338)
T ss_pred ccchhhhhhhhccccCchhhcchhheeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHH
Confidence 35677889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceE
Q 014307 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260 (427)
Q Consensus 181 il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 260 (427)
||+.|++||||++++++..++......||+||+++.++..+.+.++..+++.++.|+++||+|||++||+|||+||.|++
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm 164 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM 164 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EcCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014307 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340 (427)
Q Consensus 261 l~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~ 340 (427)
||.....++|+|+|+|.++.++.+++.++.+.+|..||.+.+++.|+.+.|+|||||++..|+..+.||+.|.++.+|+.
T Consensus 165 Idh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV 244 (338)
T KOG0668|consen 165 IDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 244 (338)
T ss_pred echhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence 99998899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhcccc
Q 014307 341 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCG 420 (427)
Q Consensus 341 ~i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~ 420 (427)
+|++.+|++++..++.++.+.+||....++.+-.+.+|..=.... .+--....++|+|.++|. ++-+.|.|+..+.
T Consensus 245 kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~---n~hl~~peaiDlldklLr-YDHqeRlTakEam 320 (338)
T KOG0668|consen 245 KIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSE---NQHLVSPEAIDLLDKLLR-YDHQERLTAKEAM 320 (338)
T ss_pred HHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcc---ccccCChHHHHHHHHHHh-hccccccchHHHh
Confidence 999999999999999999999999999999999999996533221 111235789999999996 9999999999999
Q ss_pred CCCC
Q 014307 421 ESAF 424 (427)
Q Consensus 421 ~~~~ 424 (427)
+||+
T Consensus 321 ~Hpy 324 (338)
T KOG0668|consen 321 AHPY 324 (338)
T ss_pred cCch
Confidence 9997
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-54 Score=410.60 Aligned_cols=279 Identities=25% Similarity=0.444 Sum_probs=236.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHH--HHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKK--IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~--~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
-++|.++++||.|+||.||+|+.+.++..||||.++..- .++ -.+|++.|++|..||||+++.+++.+.+. .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEee
Confidence 478999999999999999999999999999999987532 122 36899999999559999999999998643 8999
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
|||||+......+. +.|++.+++.|+.||++||+|+|.+|+.||||||||||+.... .+||+|||+|+.......+
T Consensus 88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~SkpPY 166 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLAREVRSKPPY 166 (538)
T ss_pred eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccccccccccCCCc
Confidence 99999987654433 3599999999999999999999999999999999999999554 8999999999999989999
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCChh
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~ 365 (427)
+.++.|++|+|||+++....|+.++||||+|||++|+.+-++.| +|.++.||+.+|...+|+|....|...
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF-PG~sE~Dqi~KIc~VLGtP~~~~~~eg-------- 237 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF-PGASEIDQIYKICEVLGTPDKDSWPEG-------- 237 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC-CCCcHHHHHHHHHHHhCCCccccchhH--------
Confidence 99999999999999988889999999999999999999998666 999999999999999999876554332
Q ss_pred HHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 366 LAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 366 ~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
-.+...+...|=+-...-+..+...+..+|.++|.+|+. |||..|||+++|++|||=
T Consensus 238 --~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~-WDP~kRpTA~~al~~pff 294 (538)
T KOG0661|consen 238 --YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLA-WDPDKRPTASQALQHPFF 294 (538)
T ss_pred --HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhc-CCCccCccHHHHhcCccc
Confidence 122333333332222223344555688999999999995 999999999999999994
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=383.57 Aligned_cols=245 Identities=33% Similarity=0.602 Sum_probs=218.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+.|+.+.++|+|+||.||+|+++.||+.||||.+.... ++...+|+++|++| +|+|+|.++++|.. ...++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrr--krklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRR--KRKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHh--cceeEE
Confidence 46888899999999999999999999999999985432 35578999999999 99999999999975 667899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-CCCc
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~~~~ 284 (427)
|+|||+..-|..+- ..++.+.++.++.|++.|+.|+|++++|||||||+||||+.++ .+||||||+|+.+. ++..
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcch
Confidence 99999998665443 4699999999999999999999999999999999999999888 89999999999887 7777
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------- 348 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~---------------- 348 (427)
++.++.|++|+|||.+.+...|+..+||||+||++.||++|.+.| ++.++.||+..|.+.+|.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~-PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW-PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC-CCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 899999999999999999899999999999999999999998655 999999999999998774
Q ss_pred ---------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHH
Q 014307 349 ---------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVI 384 (427)
Q Consensus 349 ---------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~ 384 (427)
.-... +.+.|+.+||..|.+.++|+.|+||+.+..
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld-~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLD-LLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHH-HHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 12223 344599999999999999999999987663
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-53 Score=394.17 Aligned_cols=249 Identities=25% Similarity=0.403 Sum_probs=209.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
..+.|.+.+.||+|+||.|-+|..+.+|+.||||++++.. ...+.+|++||++| +|||||+++++|+.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeeeeecC
Confidence 4577999999999999999999999999999999997532 12357999999999 999999999999874
Q ss_pred CCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--CCeEEEEeeeee
Q 014307 202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLA 276 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~~~ikl~DFGla 276 (427)
...|+||||++||+|.... ..+.+...+.+++|++.||.|||++||+||||||+|||+..+ ...+||+|||+|
T Consensus 249 --ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 249 --DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred --CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 4568999999999998765 358888889999999999999999999999999999999754 347999999999
Q ss_pred eeecCCCcceeeccCccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH---hCCh--
Q 014307 277 EFYHPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---LGTD-- 349 (427)
Q Consensus 277 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~---~~~~-- 349 (427)
+....+..+.+.|||+.|.|||++.+. ..+..++|+||+||+||-+++|.+||.....+.....+|.+. ++++
T Consensus 327 K~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 327 KVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred hccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 998878888999999999999999752 234458999999999999999999996555555445555553 2322
Q ss_pred ----HHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 350 ----ELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 350 ----~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+-...++.+|+..||+.|++++++|+||||+...
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 2223356669999999999999999999999644
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-53 Score=402.06 Aligned_cols=278 Identities=29% Similarity=0.516 Sum_probs=231.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.+.|+.+++||+|+||.||+|++..+|+.||+|.++... .....+||.||++| +||||++|.++..+.....+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecCCceEE
Confidence 467999999999999999999999999999999986433 34567999999999 999999999999987678899
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
||+|||+......... +|++.+++.+++||+.||+|||++||+|||||.+|||||.+| .+||+|||||+++....
T Consensus 195 lVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeeccCCCC
Confidence 9999999876544443 699999999999999999999999999999999999999777 89999999999887654
Q ss_pred -cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCC
Q 014307 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362 (427)
Q Consensus 284 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~ 362 (427)
.++.++.|.+|+|||.++|...|+.++|+||.||||.||++|++.| .+.++.+|+..|.+.+|+|....|- ..-+-.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~-~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~ 351 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL-QGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPH 351 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc-CCccHHHHHHHHHHHhCCCChhccc-cccCCc
Confidence 5788999999999999999899999999999999999999999666 9999999999999999998776554 211111
Q ss_pred ChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 363 DPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 363 dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
--.++| .+++ .+... +-+......+++||.+|| +++|.+|.|+...+.|.|=
T Consensus 352 ~~~~kp------~~~y-~r~l~---E~~~~~~~~~l~Ll~~lL-~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 352 ATIFKP------QQPY-KRRLR---ETFKDFPASALDLLEKLL-SLDPDKRGTASSALQSEYF 403 (560)
T ss_pred ccccCC------CCcc-cchHH---HHhccCCHHHHHHHHHHh-ccCccccccHHHHhcCccc
Confidence 111111 1111 11111 112235678999999999 5999999999999998873
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-52 Score=367.26 Aligned_cols=274 Identities=30% Similarity=0.537 Sum_probs=225.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH-----HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|..+++||+|.||.||+|++..+|+.||||.++..+. ....+||+.|+.+ +|+||+.++++|.. ...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~--~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPH--KSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccC--CCceEE
Confidence 468888999999999999999999999999999975443 3578999999999 89999999999965 567889
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~- 284 (427)
|+|||+...-.... ..++..+++.++.++++||+|||++.|+||||||.|+|++.+| .+||+|||+|+.+.+...
T Consensus 79 VfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 79 VFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCcc
Confidence 99999975433332 2489999999999999999999999999999999999999888 899999999998865543
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCCh
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp 364 (427)
.+..+.|.+|+|||.+.|.+.|+..+||||.|||+.||+-|. ||++|.++.||+..|.+.+|+|...+|-.-..+.-.
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY- 235 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY- 235 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCccccccccH-
Confidence 445589999999999999999999999999999999999876 777999999999999999999876665332111111
Q ss_pred hHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 365 HLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 365 ~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
.++...|.--. .+.+..+..+.+|+|.+||. +||..|+++..+++|++=
T Consensus 236 ------~~~~~~P~~~~-----~~lf~aas~d~ldLl~~m~~-ynP~~Rita~qaL~~~yf 284 (318)
T KOG0659|consen 236 ------VKIQQFPKPPL-----NNLFPAASSDALDLLSKMLT-YNPKKRITASQALKHPYF 284 (318)
T ss_pred ------HHHhcCCCCcc-----ccccccccHHHHHHHHhhhc-cCchhcccHHHHhcchhh
Confidence 11111111000 11334577888999999996 999999999999999863
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=382.24 Aligned_cols=259 Identities=20% Similarity=0.355 Sum_probs=221.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEe----ccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~----~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++.+.++.||+|..|+||+++|+.+++.+|+|++ ++...+++.+|+++++.. +||+||++||.|..... .++++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEee
Confidence 4677789999999999999999999999999999 445568899999999998 99999999999988544 68999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||||++|+|..++. ++++.....++.++++||.|||+ ++||||||||+|||++..| .|||||||.++.+... ..
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh-hc
Confidence 99999999998876 49999999999999999999996 8999999999999999888 8999999999877544 55
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CCCHHHHHHHHHHh--------CChHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG----HDNYDQLVKIAKVL--------GTDELNA 353 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~----~~~~~~l~~i~~~~--------~~~~~~~ 353 (427)
++.+||..|||||.+.+ ..|+.++||||||+.++||.+|+.||.+. .+..+.+..|.... -++++..
T Consensus 235 ~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~ 313 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRS 313 (364)
T ss_pred ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence 78899999999999998 79999999999999999999999999553 24455555555421 2356777
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhh
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLV 406 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~ 406 (427)
|+.. |++.||..|+++.+|+.|||+.+... ...+...++++++.
T Consensus 314 FV~~-CL~Kdp~~R~s~~qLl~Hpfi~~~~~--------~~vd~~~~~~~~~~ 357 (364)
T KOG0581|consen 314 FVSC-CLRKDPSERPSAKQLLQHPFIKKFED--------PNVDMASFVRKALS 357 (364)
T ss_pred HHHH-HhcCCcccCCCHHHHhcCHHHhhccc--------ccccHHHHHHHhcc
Confidence 7777 99999999999999999999998652 33334446677664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=396.19 Aligned_cols=241 Identities=23% Similarity=0.452 Sum_probs=213.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.+|+..+.||+|||++||.+++..+|+.||+|++.+ ..++.+.+||+|.+.| +|||||+++++|++ ..++|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~FED--s~nVY 94 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHFFED--SNNVY 94 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeEeec--CCceE
Confidence 679999999999999999999999999999999853 3457899999999999 99999999999987 67899
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-C
Q 014307 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~ 283 (427)
+|+|.|..++|..+++ .++|.+++.+++||+.||.|||+++|||||||..|+|++.+. +|||+|||||..+..+ +
T Consensus 95 ivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 95 IVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFGLATQLEYDGE 173 (592)
T ss_pred EEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccceeeeecCccc
Confidence 9999999999987765 599999999999999999999999999999999999999777 8999999999988755 5
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~~ 357 (427)
...+.|||+.|.|||++.. ..+++.+||||+||+||-|+.|++|| ...+-.+.+.+|...-. +.+...+|.+
T Consensus 174 rk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPF-etk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~ 251 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPF-ETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK 251 (592)
T ss_pred ccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCc-ccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence 5678899999999999986 78999999999999999999999999 55556666776665422 2344455555
Q ss_pred ccCCCChhHHHHHhHHhcCCchhh
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+|..+|..||+++++|.|+||..
T Consensus 252 -lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 252 -LLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred -HhcCCcccCCCHHHHhcCHhhhC
Confidence 89999999999999999999954
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-51 Score=377.19 Aligned_cols=246 Identities=28% Similarity=0.484 Sum_probs=215.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|++++.||+|+||+|+.++.+.+++.+|+|++++. ..+....|..||..+ +||+||+++..|.+ ...
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt--~~k 99 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQT--EEK 99 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEeccc--CCe
Confidence 357899999999999999999999999999999999753 235678999999998 99999999999966 678
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee-cC
Q 014307 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~-~~ 281 (427)
+|+|+||+.||.|..+++ .+++..++.++.+|+.||.|||++|||||||||+|||+|.+| +++|+|||+++.. ..
T Consensus 100 LylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhcccC
Confidence 999999999999988876 699999999999999999999999999999999999999888 8999999999844 44
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-------CChHHHHH
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAY 354 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~ 354 (427)
+....+.+||+.|||||++.+ ..|+..+|+||||+++|||++|.+|| .+.+..+....|.+.- -+....++
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF-~~~~~~~~~~~I~~~k~~~~p~~ls~~ardl 256 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPF-YAEDVKKMYDKILKGKLPLPPGYLSEEARDL 256 (357)
T ss_pred CCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCC-cCccHHHHHHHHhcCcCCCCCccCCHHHHHH
Confidence 455667899999999999998 69999999999999999999999999 6667677777777654 13455566
Q ss_pred HHhccCCCChhHH----HHHhHHhcCCchhhHHH
Q 014307 355 LNKYHIELDPHLA----ALVGRLVILSYFFQFVI 384 (427)
Q Consensus 355 l~~~~l~~dp~~r----~~~~~ll~~~~~~~~~~ 384 (427)
+.+ ++..||..| ..+.++-.||||....+
T Consensus 257 l~~-LL~rdp~~RLg~~~d~~~ik~HpfF~~inW 289 (357)
T KOG0598|consen 257 LKK-LLKRDPRQRLGGPGDAEEIKRHPFFKGINW 289 (357)
T ss_pred HHH-HhccCHHHhcCCCCChHHhhcCcccccCCH
Confidence 666 889999999 47889999999998664
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=379.15 Aligned_cols=207 Identities=32% Similarity=0.579 Sum_probs=184.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|.+.++||.|+||+||+|+++.++..||||.+... ..+.+..|+.||+.| +|||||.+++++.. ..+++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~--~~~i~ 85 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIED--DDFIY 85 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEec--CCeEE
Confidence 47899999999999999999999999999999998654 345578999999999 89999999999987 56899
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--C---CeEEEEeeeeeeee
Q 014307 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q---RKLRLIDWGLAEFY 279 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~---~~ikl~DFGla~~~ 279 (427)
+|||||+||+|..+++ .+++..++.++.||+.||++||+++||||||||+||||+.. . ..+||+|||+|+.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999988874 58999999999999999999999999999999999999754 1 36999999999999
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~ 344 (427)
.++....+.+|++.|||||++.. ..|+.|+|+||+|+|||+|++|+.|| ...+..|.+..+.+
T Consensus 166 ~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf-~a~t~~eL~~~~~k 228 (429)
T KOG0595|consen 166 QPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPF-DAETPKELLLYIKK 228 (429)
T ss_pred CchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCc-cccCHHHHHHHHhc
Confidence 98888888999999999999975 79999999999999999999999999 44455555554443
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=367.88 Aligned_cols=284 Identities=28% Similarity=0.486 Sum_probs=237.4
Q ss_pred ccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEc---
Q 014307 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRD--- 200 (427)
Q Consensus 129 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~--- 200 (427)
.+.....|..++.||+|+||.|..|.++.+|+.||||.+.. ...++..+|+++|+.+ +|+||+.+.+++..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSR 95 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccc
Confidence 34455677778999999999999999999999999998852 3346788999999999 89999999999876
Q ss_pred CCCCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 201 QQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
.....+|+|+|+|+. +|...++ .+++..+..+++||+.||+|+|+.||+||||||.|+|++.+- .+||+|||+|+
T Consensus 96 ~~f~DvYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR 173 (359)
T KOG0660|consen 96 DKFNDVYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLAR 173 (359)
T ss_pred cccceeEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEecccccee
Confidence 335578999999954 4444442 389999999999999999999999999999999999999776 78999999999
Q ss_pred eecC---CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHH
Q 014307 278 FYHP---GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354 (427)
Q Consensus 278 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~ 354 (427)
.... ....+..+.|.+|+|||++.....|+..+||||+|||+.||++|++.| +|.+..+|+..|...+|+|+...
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplF-pG~d~v~Ql~lI~~~lGtP~~e~- 251 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLF-PGKDYVHQLQLILELLGTPSEED- 251 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCC-CCCchHHHHHHHHHhcCCCCHHH-
Confidence 8753 455688899999999999998899999999999999999999999777 99999999999999999985433
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCCC
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFGS 426 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~~ 426 (427)
+.. .-++..|+-+..+...|-..= ...+..++..++|+|.+||+ +||++|+|+...+.|||=+
T Consensus 252 l~~---i~s~~ar~yi~slp~~p~~~f-----~~~fp~a~p~AidLlekmL~-fdP~kRita~eAL~hPYl~ 314 (359)
T KOG0660|consen 252 LQK---IRSEKARPYIKSLPQIPKQPF-----SSIFPNANPLAIDLLEKMLV-FDPKKRITAEEALAHPYLA 314 (359)
T ss_pred HHH---hccHHHHHHHHhCCCCCCCCH-----HHHcCCCCHHHHHHHHHHhc-cCccccCCHHHHhcChhhh
Confidence 333 235667777776655432110 11234588999999999997 9999999999999999843
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=366.76 Aligned_cols=277 Identities=27% Similarity=0.428 Sum_probs=228.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHH-----HHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.+.|+.+++|++|+||.||+|+++.+++.||+|.++....+ .-.+||.+|.++ +|||||.+-++....+-..+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEeccccceee
Confidence 46799999999999999999999999999999999865432 357999999999 899999999999987777899
Q ss_pred EEEeecCCCc---hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-C
Q 014307 208 LIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (427)
Q Consensus 208 lv~e~~~~~~---l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~ 283 (427)
+|||||+... +..+-+++...+++.++.|+++||+|||.+.|+|||||++|+|+++.| .+||+|||+|+.+... .
T Consensus 154 ~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 154 IVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhhhhcCCcc
Confidence 9999999864 233335799999999999999999999999999999999999999888 8999999999987654 4
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCC
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~d 363 (427)
.++..+-|.+|+|||.+.+...|+..+|+||+|||+.||+++++.| +|..+.+|+.+|.+.+|+|.-..|-.- ..-
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf-~G~sE~dQl~~If~llGtPte~iwpg~---~~l 308 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF-PGKSEIDQLDKIFKLLGTPSEAIWPGY---SEL 308 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC-CCCchHHHHHHHHHHhCCCccccCCCc---ccc
Confidence 5788899999999999999899999999999999999999998666 999999999999999998754433211 111
Q ss_pred hhHHHHHhHHhcCCch---hhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 364 PHLAALVGRLVILSYF---FQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 364 p~~r~~~~~ll~~~~~---~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
|... .-....+|+- .++.+ ...++...|+|+++|. +||.+|.|+..+++|.|
T Consensus 309 p~~k--~~~f~~~pyn~lr~kF~~------~~lse~g~~Lln~llt-~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 309 PAVK--KMTFSEHPYNNLRKKFGA------LSLSEQGFDLLNKLLT-YDPGKRITAEDGLKHEY 363 (419)
T ss_pred chhh--ccccCCCCchhhhhhccc------cccchhHHHHHHHHhc-cCccccccHHHhhcccc
Confidence 1110 0111222221 11111 1156889999999995 99999999999999987
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-50 Score=369.84 Aligned_cols=276 Identities=28% Similarity=0.493 Sum_probs=229.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC---CcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~---~~~lv~ 210 (427)
-.|.-.+.+|.|+||.||+|....+++.||||..-... +--.+|+++|+.+ .|||||++.-+|....+. ++.+||
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 35888999999999999999999999999999875432 2334799999998 999999999998865444 678999
Q ss_pred eecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 211 e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+........ ++++..+++-+..||++||.|||+.||+||||||.|+|+|.+.+.+||||||.|+.+..+..
T Consensus 102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 999987655443 56999999999999999999999999999999999999999978999999999999999988
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCCh
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp 364 (427)
...+..+++|+|||.+.|...|+.+.||||.||++.||+-|++.| +|.+..+|+..|.+.+|.|...+. ..+......
T Consensus 182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plF-pG~s~~dQL~eIik~lG~Pt~e~I-~~mn~~y~~ 259 (364)
T KOG0658|consen 182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLF-PGDSSVDQLVEIIKVLGTPTREDI-KSMNPNYTE 259 (364)
T ss_pred ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCccc-CCCCHHHHHHHHHHHhCCCCHHHH-hhcCccccc
Confidence 889999999999999999999999999999999999999998666 899999999999999998754432 221222111
Q ss_pred hHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 365 HLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 365 ~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
.. ..++..++|.+- +......+.+|++.++|. +.|..|.++-.++.|||
T Consensus 260 ~~---~p~ik~~~~~~~-------~~~~~~~d~~dll~~~L~-Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 260 FK---FPQIKAHPWHKV-------FFKRLPPDALDLLSKLLQ-YSPSKRLSALEALAHPF 308 (364)
T ss_pred cc---Ccccccccceee-------cccCCCHHHHHHHHHHhc-cChhhcCCHHHHhcchh
Confidence 11 122333444220 123467889999999995 99999999999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=347.93 Aligned_cols=243 Identities=22% Similarity=0.390 Sum_probs=210.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||.|+||+|.+++++.+|..+|+|++++.+ .+...+|..+|+.+ .||+++++++.+.+ ..++
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d--~~~l 119 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKD--NSNL 119 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeecc--CCeE
Confidence 467999999999999999999999999999999997643 24467899999999 89999999999976 6789
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.||.+..+++ ++++..++.++.||+.||+|||+++|++|||||||||+|.+| .+||+|||+|+.....
T Consensus 120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecCc-
Confidence 99999999999877764 699999999999999999999999999999999999999888 8999999999987543
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (427)
.-+.|||+.|+|||++.. ++|+.++|+|||||++|||+.|.+|| ...++.....+|.+.- -+++...++.+
T Consensus 198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF-~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPF-YDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCC-cCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 567899999999999987 89999999999999999999999999 4556677777776642 13455555555
Q ss_pred ccCCCChhHH-----HHHhHHhcCCchhhHHH
Q 014307 358 YHIELDPHLA-----ALVGRLVILSYFFQFVI 384 (427)
Q Consensus 358 ~~l~~dp~~r-----~~~~~ll~~~~~~~~~~ 384 (427)
+++.|-..| .-..++..|+||+...+
T Consensus 275 -LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W 305 (355)
T KOG0616|consen 275 -LLQVDLTKRFGNLKNGVEDIKNHPWFKGVDW 305 (355)
T ss_pred -HHhhhhHhhhcCcCCCccccccCcccccccH
Confidence 788888888 34667999999998664
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=372.47 Aligned_cols=247 Identities=30% Similarity=0.481 Sum_probs=216.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..+|..++.||.|+|++|++|+++.+++.+|||++.+ .+.+-+.+|-.+|.+|.+||.|++|+..|.+ +..+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--~~sL 149 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--EESL 149 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec--ccce
Confidence 4689999999999999999999999999999999864 3345578899999999999999999999977 6779
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
|+|+||+.+|+|..++. .+.+..++.++.||+.||+|||++|||||||||||||+|.++ ++||+|||.|+.+.+..
T Consensus 150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCChhh
Confidence 99999999999887764 599999999999999999999999999999999999999888 89999999998875421
Q ss_pred c--------------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---
Q 014307 284 E--------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--- 346 (427)
Q Consensus 284 ~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--- 346 (427)
. ....+||..|.+||++.+ +..++.+|||+||||||+|+.|.+|| .+.++.-..++|.+.-
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l~y~f 306 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQALDYEF 306 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHhcccC
Confidence 1 145799999999999887 78999999999999999999999999 7778888888888763
Q ss_pred --CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHH
Q 014307 347 --GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVI 384 (427)
Q Consensus 347 --~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~ 384 (427)
+.++...-|.+..+-.||.-|.++++|-.||||....+
T Consensus 307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred CCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 23444444444489999999999999999999998764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=352.05 Aligned_cols=231 Identities=28% Similarity=0.532 Sum_probs=195.1
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEec-----cccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.+|+|+++||+|+||+||++.+..+|..+|.|.++ ...+..+..|+.+|++| +|||||+++++-...+...+++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhHH
Confidence 56899999999999999999999999999999875 23456788999999999 9999999999544444566889
Q ss_pred EEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHH--CC--ceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 209 IFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 209 v~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~--~~--iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
|||+|..|+|..+++ .+++..+++++.|++.||..+|+ .+ |+||||||.||+++.+| .+||+|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchhHh
Confidence 999999999988863 49999999999999999999999 45 99999999999999887 89999999999
Q ss_pred eecCCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHhCC-------
Q 014307 278 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGT------- 348 (427)
Q Consensus 278 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~-~i~~~~~~------- 348 (427)
++..... ....+|||+||+||.+.+ .+|++++||||+||++|||+.-+.|| .+. +...+. +|.++-.+
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF-~g~-n~~~L~~KI~qgd~~~~p~~~Y 253 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPF-YGD-NLLSLCKKIEQGDYPPLPDEHY 253 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCc-ccc-cHHHHHHHHHcCCCCCCcHHHh
Confidence 8876554 356799999999999987 89999999999999999999999999 454 444444 55544221
Q ss_pred -hHHHHHHHhccCCCChhHHHHH
Q 014307 349 -DELNAYLNKYHIELDPHLAALV 370 (427)
Q Consensus 349 -~~~~~~l~~~~l~~dp~~r~~~ 370 (427)
.++.+ +...|+..||+.||..
T Consensus 254 S~~l~~-li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 254 STDLRE-LINMCIAVDPEQRPDT 275 (375)
T ss_pred hhHHHH-HHHHHccCCcccCCCc
Confidence 23334 4455999999999974
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=364.32 Aligned_cols=245 Identities=27% Similarity=0.441 Sum_probs=209.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|++++.||+|+||+||+|+.+.||..+|+|++++.. .+.++.|-.+|... .+|.||+|+..|.+ ..+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD--~~~ 215 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQD--KEY 215 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecC--CCe
Confidence 4688999999999999999999999999999999997532 35578899999996 99999999999976 678
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-
Q 014307 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~- 281 (427)
+||||||++||++..++. .+++..++.++.+++.|++-||+.|+|||||||+|+|||..| ++||+||||+..+..
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKK 294 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhh
Confidence 999999999999887764 599999999999999999999999999999999999999888 899999999853211
Q ss_pred ---------------------C--Cc----c--------------------eeeccCccccccccccCCCCCCchhhHHH
Q 014307 282 ---------------------G--KE----Y--------------------NVRVASRYFKGPELLVDLQDYDYSLDLWS 314 (427)
Q Consensus 282 ---------------------~--~~----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwS 314 (427)
. .. . ...+|||.|+|||++.+ ..|+..+|+||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHH
Confidence 0 00 0 01489999999999998 78999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHHHHHhccCCCChhHHHH---HhHHhcCCchhh
Q 014307 315 LGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHLAAL---VGRLVILSYFFQ 381 (427)
Q Consensus 315 lGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dp~~r~~---~~~ll~~~~~~~ 381 (427)
||||+|||+.|.+|| .+.++.+...+|...- ..+...++|.+.+. ||+-|-- ++++-.||||+.
T Consensus 374 LG~ImyEmLvGyPPF-~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~--d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPF-CSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC--DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc--CHHHhcCcccHHHHhcCCcccc
Confidence 999999999999999 6778888887776652 13566677777444 7777764 999999999999
Q ss_pred HHH
Q 014307 382 FVI 384 (427)
Q Consensus 382 ~~~ 384 (427)
..+
T Consensus 451 v~W 453 (550)
T KOG0605|consen 451 VDW 453 (550)
T ss_pred CCc
Confidence 774
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-47 Score=373.20 Aligned_cols=282 Identities=27% Similarity=0.445 Sum_probs=218.4
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH--HHHHHHHHHHHHhcCC-----CCeeeeeeEEEcCCCCCcE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGG-----PNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~~h-----~niv~l~~~~~~~~~~~~~ 207 (427)
+|++++.||+|+||.|-+|.+..|++.||||+++.... .+...|+.+|..|.+| -|+|+++++|.. ..++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cccee
Confidence 78999999999999999999999999999999986543 5567899999999533 499999999976 67899
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC-CCCeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~ikl~DFGla~~~~~~ 282 (427)
||+|.+.......+. ..++...++.++.||+.||.+||+.||||+|||||||||.. +...|||+|||.|++..
T Consensus 265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~-- 342 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES-- 342 (586)
T ss_pred eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC--
Confidence 999998875543332 35899999999999999999999999999999999999964 33479999999998643
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHH--------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY-------- 354 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~-------- 354 (427)
....+++.+++|+|||+++| .+|+.+.||||||||++||++|. |+++|.++.||+..|.+.+|.|+..-+
T Consensus 343 q~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~-PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 343 QRVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGE-PLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred Ccceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCc-cccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 33448899999999999999 79999999999999999999995 666999999999999999997643311
Q ss_pred -HHh------ccCCCC-------hhHHHHHhHHhcC---CchhhHHHhhhhhhh-hhhhhhHHHHHHhhhhcCchhhhhh
Q 014307 355 -LNK------YHIELD-------PHLAALVGRLVIL---SYFFQFVIYYYYYYY-FCLKTCNFLLRNFLVQAQPETMVKV 416 (427)
Q Consensus 355 -l~~------~~l~~d-------p~~r~~~~~ll~~---~~~~~~~~~~~~~~~-~~~~~~~dllr~~l~~~~P~~r~~~ 416 (427)
..+ .+.+.+ +..|.....+... |-..+.. -..+. -..+.++|+|++||. +||.+|+|.
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l---~~~~~~~~~~~F~dflk~~L~-~dP~~R~tp 496 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSL---ESGLPKADDKLFIDFLKRCLE-WDPAERITP 496 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCccc---chhcccccHHHHHHHHHHHhc-cCchhcCCH
Confidence 000 011111 1112211111111 1000000 00111 235678999999995 999999999
Q ss_pred ccccCCCCCC
Q 014307 417 HYCGESAFGS 426 (427)
Q Consensus 417 ~~~~~~~~~~ 426 (427)
.+.++|||=.
T Consensus 497 ~qal~Hpfl~ 506 (586)
T KOG0667|consen 497 AQALNHPFLT 506 (586)
T ss_pred HHHhcCcccc
Confidence 9999999943
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=357.70 Aligned_cols=208 Identities=30% Similarity=0.577 Sum_probs=178.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------------HHHHHHHHHHHHHhcCCCCeeeee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNIVKLL 195 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~~~~~~E~~il~~l~~h~niv~l~ 195 (427)
.++|+++++||+|.||.|.+|++..+++.||||++.+.. .+.+.+||.||++| +|||||+|+
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li 174 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI 174 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence 478999999999999999999999999999999986422 25688999999999 999999999
Q ss_pred eEEEcCCCCCcEEEEeecCCCchhhhcC--C-CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEe
Q 014307 196 DIVRDQQSKTPSLIFEHVNNTDFKVLYP--T-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (427)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~-~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~D 272 (427)
++..++....+|||+|||..|.+...-. . +++.+++.|+++++.||+|||.+|||||||||+|+||+.++ ++||+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKIsD 253 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKISD 253 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEeec
Confidence 9999999999999999999998765532 3 88999999999999999999999999999999999999887 999999
Q ss_pred eeeeeeecC------CCcceeeccCccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014307 273 WGLAEFYHP------GKEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343 (427)
Q Consensus 273 FGla~~~~~------~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~ 343 (427)
||.+..... +..+...+||+.|+|||.+.+. ...+.+.||||+||+||+|+.|+.||+ +....+...+|.
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~-~~~~~~l~~KIv 332 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF-DDFELELFDKIV 332 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-cchHHHHHHHHh
Confidence 999986622 2233457999999999998762 235678999999999999999999994 444445455554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=362.43 Aligned_cols=246 Identities=28% Similarity=0.477 Sum_probs=209.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|.+++.||+|+||+|++|.+..++..||+|+++.. ..+.+.+|+.+++.+..||||+++++++...
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-- 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-- 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC--
Confidence 357899999999999999999999999999999987653 2345778999999994499999999999874
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee-
Q 014307 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY- 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~- 279 (427)
..+++||||+.+|+|...+ .++.+.+++.+++||+.|++|||++||+||||||+|||++.+...+||+|||++...
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 4499999999999887665 469999999999999999999999999999999999999987238999999999987
Q ss_pred cCCCcceeeccCccccccccccCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-hC------ChHH
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDY-DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LG------TDEL 351 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~-~~------~~~~ 351 (427)
..+....+.+|++.|+|||++.+...| +.++||||+||+||.|++|+.||. ..+.......|.+. +. +++.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~-d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFD-DSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCC-CccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 466778899999999999999884426 488999999999999999999994 34444444444443 11 4444
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
..++.+ |+..+|..|+++.+++.|+||+.
T Consensus 252 ~~Li~~-mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 252 RSLIEK-MLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHH-HcCCCcccCCCHHHHhhChhhcc
Confidence 555555 99999999999999999999997
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=367.17 Aligned_cols=247 Identities=23% Similarity=0.388 Sum_probs=215.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|.+++.||+|+||+|+++..+.+++.+|||++++. ..+..+.|.+|+....+||.++.++..|.. ..+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--~~~ 443 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--KEH 443 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc--CCe
Confidence 457899999999999999999999999999999999863 236678899999998789999999999965 678
Q ss_pred cEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-CC
Q 014307 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~~ 282 (427)
+|+||||+.||++..+. +.+++..++.|++.|+.||.|||++||||||||.+|||+|.+| .+||+|||+++... .+
T Consensus 444 l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m~~g 522 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGMGQG 522 (694)
T ss_pred EEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccCCCC
Confidence 99999999999965554 3699999999999999999999999999999999999999998 89999999998654 45
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (427)
....+.+||+.|||||++.+ ..|+..+|+|||||+||||+.|+.|| +++++.+....|...- -+.+....+.
T Consensus 523 ~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gddEee~FdsI~~d~~~yP~~ls~ea~~il~ 600 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMR 600 (694)
T ss_pred CccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcCCCCCCCcccHHHHHHHH
Confidence 56778899999999999988 89999999999999999999999999 8888888887776531 1235555555
Q ss_pred hccCCCChhHHHHH-----hHHhcCCchhhHHH
Q 014307 357 KYHIELDPHLAALV-----GRLVILSYFFQFVI 384 (427)
Q Consensus 357 ~~~l~~dp~~r~~~-----~~ll~~~~~~~~~~ 384 (427)
+ ++..+|+.|--. +++..||||..+.+
T Consensus 601 ~-ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w 632 (694)
T KOG0694|consen 601 R-LLRKNPEKRLGSGERDAEDIKKHPFFRSIDW 632 (694)
T ss_pred H-HhccCcccccCCCCCCchhhhhCCccccCCH
Confidence 5 889999999764 78999999998663
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=348.72 Aligned_cols=277 Identities=29% Similarity=0.450 Sum_probs=220.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH-----HHHHHHHHHHHHhcCCCC-eeeeeeEEEcCC----C
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPN-IVKLLDIVRDQQ----S 203 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~il~~l~~h~n-iv~l~~~~~~~~----~ 203 (427)
..|+.+++||+|+||+||+|+.+.+|+.||+|.++.... ....+|+.+|++| +|+| |+.+++++...+ .
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeeccccccc
Confidence 457778889999999999999999999999999875432 4468999999999 8999 999999998643 2
Q ss_pred CCcEEEEeecCCCchhhh---c---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVL---Y---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~---~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
..+++|+||++...-..+ . ..++...++.+++||+.||+|||++||+||||||.||||+.+| .+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccchHH
Confidence 378899999987543222 1 2467788999999999999999999999999999999999877 89999999998
Q ss_pred eec-CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHH
Q 014307 278 FYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356 (427)
Q Consensus 278 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~ 356 (427)
.+. +...++..++|.+|+|||++.+...|+..+||||+|||++||++++..| ++..+.+|+..|.+.+|+|....|-.
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LF-pG~se~~ql~~If~~lGtP~e~~Wp~ 247 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLF-PGDSEIDQLFRIFRLLGTPNEKDWPG 247 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCC-CCCcHHHHHHHHHHHcCCCCccCCCC
Confidence 776 4455788899999999999999889999999999999999999987655 89999999999999999986654422
Q ss_pred hccCCCChhHHHHHhHHhcCCchhhH-HHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 357 KYHIELDPHLAALVGRLVILSYFFQF-VIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~~~~-~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
. ..-|+..+ +|+... ......-......+..|++.+|| +++|..|.++...++||+=
T Consensus 248 v---~~~~~~k~--------~f~~~~~~~~l~~~~~~~~~~~~dll~~~L-~y~p~~R~Sa~~al~h~yf 305 (323)
T KOG0594|consen 248 V---SSLPDYKA--------PFPKWPGPKDLSSILPKLDPDGIELLSKLL-QYDPAKRISAKGALTHPYF 305 (323)
T ss_pred c---cccccccc--------cCcCCCCccchHHhccccCccHHHHHHHHh-ccCcccCcCHHHHhcChhh
Confidence 1 11111111 111111 00000001112257899999999 5999999999999999873
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=361.79 Aligned_cols=246 Identities=22% Similarity=0.411 Sum_probs=217.3
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.....|...++||+|+-|.||.|+...+++.||||.+.. .+++.+.+|+.+|+.+ +|+|||.+++.|... ..++
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~--deLW 346 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG--DELW 346 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc--ceeE
Confidence 445679999999999999999999999999999999864 3456789999999999 999999999988763 5689
Q ss_pred EEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-c
Q 014307 208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~ 284 (427)
+|||||+||+|.+... .++|.++..++++++.||+|||.+||+|||||.+|||++.++ .+||+|||++..+.... .
T Consensus 347 VVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred EEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeeccccccCc
Confidence 9999999999988875 489999999999999999999999999999999999999888 79999999998876654 5
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHH
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYL 355 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l 355 (427)
..+.+||++|||||++.. ..|++++||||||++++||+-|++||+. .++...+..|...-. ++.+.+|+
T Consensus 426 R~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYln-E~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL 503 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPKLKNPEKLSPELKDFL 503 (550)
T ss_pred cccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccC-CChHHHHHHHhhcCCCCcCCccccCHHHHHHH
Confidence 677899999999999886 8999999999999999999999999965 566677776665422 36788888
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+ ||+.|++.|+++.+||.|||++...
T Consensus 504 ~~-cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 504 DR-CLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred HH-HhhcchhcCCCHHHHhcChhhhhcC
Confidence 88 9999999999999999999996533
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=364.37 Aligned_cols=241 Identities=28% Similarity=0.505 Sum_probs=207.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHH-----HHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+..+. .+.+|++|++.| +|||||.++++|+. ..++++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esfEt--~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESFET--SAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhhcc--cceEEE
Confidence 4688889999999999999999999999999999765543 388999999999 99999999999976 678999
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~- 284 (427)
|+||+.| +|..++ ..++++.++.++.|++.||.|||+.+|+|||+||.|||++.++ .+|+||||+|+.+..+..
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhhcccCcee
Confidence 9999999 666555 3699999999999999999999999999999999999999777 899999999998876654
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH-HHHHh------CChHHHHHHHh
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK-IAKVL------GTDELNAYLNK 357 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~-i~~~~------~~~~~~~~l~~ 357 (427)
.+...||+.|||||++.+ ++|+..+|+||||||+|||++|++||+. ...-++.+ |.+.. .+..+..++..
T Consensus 157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a--~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~g 233 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYA--RSITQLVKSILKDPVKPPSTASSSFVNFLQG 233 (808)
T ss_pred eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchH--HHHHHHHHHHhcCCCCCcccccHHHHHHHHH
Confidence 345689999999999886 8999999999999999999999999953 23333333 22211 13467777777
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.++.||..|.+..+|+.|||.+...
T Consensus 234 -LL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 234 -LLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred -HhhcChhhcccHHHHhcChHHhhhh
Confidence 7899999999999999999998755
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=364.92 Aligned_cols=244 Identities=23% Similarity=0.425 Sum_probs=210.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
+-|++++.||.|+-|.|.+|++..||+.+|||++.+. ....+.+||-||+-| .|||++++|+++++ ..++|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVwe~--~~~ly 88 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVWEN--KQHLY 88 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeeecc--CceEE
Confidence 3478999999999999999999999999999999653 235689999999999 99999999999976 67899
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+|.||+.+|.|..++ +++++.++.++++||+.|+.|||..+|+||||||+|+|+|.++ .|||+|||+|..-.++.-
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsLe~~gkl 167 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASLEVPGKL 167 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeecccCCcc
Confidence 999999999987765 4699999999999999999999999999999999999999888 599999999998777888
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHhC-----ChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLG-----TDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~-~i~~~~~-----~~~~~~~l~~~ 358 (427)
..+.||+++|.|||++.|....+.++||||.|||||.|++|+.||. +++...+. ++.++.. -+...+.+...
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--DdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--DDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--CccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 8899999999999999996666899999999999999999999994 34555444 4443321 12333445555
Q ss_pred cCCCChhHHHHHhHHhcCCchhhHH
Q 014307 359 HIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|++.||+.|.+++++++|||+....
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999988754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=349.55 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=202.1
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++..++.||+|+||.||++.+..+|...|||.+...+ .+.+.+|+.+|.+| +|||||+++|.........+++.|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEeee
Confidence 45677899999999999999999889999999987654 45689999999999 699999999975433224688999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC----C
Q 014307 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP----G 282 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~----~ 282 (427)
||+.+|++..++. ++++..++.+.+||++||+|||++|||||||||+|||++..++.+||+|||+++.... .
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999988764 5899999999999999999999999999999999999998333899999999987653 1
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChHHHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAY 354 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~~~~~ 354 (427)
.......||+.|||||++........++|||||||++.||+||+.||..-....+.+..+...-. +++...|
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~F 255 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDF 255 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHH
Confidence 22345789999999999985123345999999999999999999999432233333333332221 2366677
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+ |+..+|..||++++||.|||.....
T Consensus 256 l~~-C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 256 LRK-CFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred HHH-HhhcCcccCcCHHHHhhChhhhccc
Confidence 777 9999999999999999999987643
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=346.87 Aligned_cols=249 Identities=30% Similarity=0.520 Sum_probs=203.5
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
+..++|++.++||+|+||.||+|++..+++.||||+++... ...+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~ 78 (303)
T cd07869 2 GKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL 78 (303)
T ss_pred CccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEec--CCeE
Confidence 45688999999999999999999999999999999986432 24577899999999 99999999999976 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~- 282 (427)
++||||+.++.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 79 TLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVPS 157 (303)
T ss_pred EEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCCC
Confidence 9999999876544433 3488999999999999999999999999999999999999777 8999999999754322
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC--------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------------- 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~-------------- 348 (427)
.......++..|+|||++.+...++.++|||||||++|+|++|+.||....+..+++..+...++.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 223445788999999998765678999999999999999999999995444444555444333221
Q ss_pred ------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHH
Q 014307 349 ------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVI 384 (427)
Q Consensus 349 ------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~ 384 (427)
+...+++.+ |+..||..|+++.+++.||||.....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~-mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASK-LLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHH-HhccCchhccCHHHHhcCcccccCCh
Confidence 233345555 99999999999999999999987653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=359.03 Aligned_cols=284 Identities=18% Similarity=0.298 Sum_probs=207.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhc-----CCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~-----~h~niv~l~~~~~~~~~~ 204 (427)
..++|+++++||+|+||+||+|.+..+++.||||+++.. .......|+.+++.+. +|.+++++++++... ..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cc
Confidence 357899999999999999999999999999999999642 2345667888888772 234689999988754 45
Q ss_pred CcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCC---------------
Q 014307 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR--------------- 266 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~--------------- 266 (427)
++++|||++.+..+..+. ..+++..++.++.||+.||+|||+ .|||||||||+|||++.++.
T Consensus 206 ~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 789999998655444333 358999999999999999999998 59999999999999986542
Q ss_pred eEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh
Q 014307 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346 (427)
Q Consensus 267 ~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~ 346 (427)
.+||+|||.+... .......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.++.+++..+.+.+
T Consensus 286 ~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKTL 361 (467)
T ss_pred eEEECCCCccccC--ccccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHc
Confidence 4999999988542 233455689999999999987 68999999999999999999999998 6677788888888887
Q ss_pred CChHHHHHHHhccCCCChhHHHHHhHHhcC-Cchh-----hHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhcccc
Q 014307 347 GTDELNAYLNKYHIELDPHLAALVGRLVIL-SYFF-----QFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCG 420 (427)
Q Consensus 347 ~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~-~~~~-----~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~ 420 (427)
+..+. .|... +. .++.+......... +++. +...............+.|+|++||. +||++|+++..++
T Consensus 362 g~~p~-~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~-~dP~~R~ta~e~L 436 (467)
T PTZ00284 362 GRLPS-EWAGR-CG--TEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH-YDRQKRLNARQMT 436 (467)
T ss_pred CCCCH-HHHhh-cc--chhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC-cChhhCCCHHHHh
Confidence 75321 12111 10 11111111111000 0000 00000000001124567899999995 9999999999999
Q ss_pred CCCCC
Q 014307 421 ESAFG 425 (427)
Q Consensus 421 ~~~~~ 425 (427)
+|||=
T Consensus 437 ~Hp~~ 441 (467)
T PTZ00284 437 THPYV 441 (467)
T ss_pred cCccc
Confidence 99984
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=341.36 Aligned_cols=275 Identities=25% Similarity=0.461 Sum_probs=214.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..++|++.++||.|+||.||+|++..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.. ....+
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~ 79 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHT--ERCLT 79 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEE
Confidence 457899999999999999999999999999999998642 234677999999999 99999999999876 45789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~- 282 (427)
+||||+.+ ++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 80 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPT 157 (288)
T ss_pred EEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCCC
Confidence 99999987 554443 2378899999999999999999999999999999999999777 8999999999765322
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCC
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~ 362 (427)
.......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.+....+-.. ..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 233 (288)
T cd07871 158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTPTEETWPGI---TS 233 (288)
T ss_pred ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHHhhcc---cc
Confidence 22334577889999999876567899999999999999999999998 666777788888777776544322111 11
Q ss_pred ChhHHHHH-hHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 363 DPHLAALV-GRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 363 dp~~r~~~-~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+.+... ......+++. ......+++.|+|++||. ++|.+|+|+..++.|||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~dll~~mL~-~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLIN--------HAPRLDTDGIDLLSSLLL-YETKSRISAEAALRHSY 287 (288)
T ss_pred chhhhccccCccCCCchHH--------hCCCCCHHHHHHHHHhcC-cCcccCCCHHHHhcCCC
Confidence 11111110 0000111111 112346778999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=360.30 Aligned_cols=248 Identities=31% Similarity=0.525 Sum_probs=205.8
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC------CCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------QSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~------~~~~ 205 (427)
...+|++++.||+|+||.||+|++..+++.||||.+... .....+|+.+|+.+ +||||+++++++... ...+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceE
Confidence 456899999999999999999999999999999988543 23456799999999 999999999987532 1235
Q ss_pred cEEEEeecCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 206 PSLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
+++||||+.++....+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+|+.+
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 6799999997643322 1358899999999999999999999999999999999999976657999999999877
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-----------
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----------- 348 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~----------- 348 (427)
..........+++.|+|||++.+...|+.++|||||||++|||++|..|| .+....+++.++.+.++.
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 65555556688999999999877567999999999999999999999998 666677777776655432
Q ss_pred ------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 ------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++..+++.+ |+..||..|+++.+++.||||....
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~-~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQ-FLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHH-HCCCChhHCcCHHHHhCChhHHhhh
Confidence 234455555 9999999999999999999998754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=326.28 Aligned_cols=245 Identities=26% Similarity=0.456 Sum_probs=211.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.+.|++.+.||+|.|+.|+++.+..+|+.+|+|+++. ...+++.+|++|-+.| +||||+++.+.+.+ ..+.|
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti~~--~~~~y 86 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY 86 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhhcc--cceeE
Confidence 4778999999999999999999999999999998853 3457799999999999 99999999999866 67889
Q ss_pred EEEeecCCCchhhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC--CCCeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLY-P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~-~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~~ikl~DFGla~~~~~~ 282 (427)
+|+|+|.|+++..-+ + -+++..+..+++||+++|+|+|.+||||||+||+|+|+.. ++..+||+|||+|.....+
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g 166 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG 166 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence 999999999875332 3 3789999999999999999999999999999999999953 3447999999999988877
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELN 352 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~ 352 (427)
.....++||+.|||||++.. .+|+..+|||+.|||||-|+.|.+|| .+.+..+...+|.+.-. ++...
T Consensus 167 ~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF-~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak 244 (355)
T KOG0033|consen 167 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAK 244 (355)
T ss_pred cccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCC-CCccHHHHHHHHhccccCCCCcccCcCCHHHH
Confidence 77788999999999999886 78999999999999999999999999 55566666677766421 23444
Q ss_pred HHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 353 AYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.++.+ |+..||..|.++.+.|+|||..+..
T Consensus 245 ~Lvrr-ML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 245 SLIRR-MLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred HHHHH-HhccChhhhccHHHHhCCchhcchH
Confidence 55555 9999999999999999999998765
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=354.55 Aligned_cols=233 Identities=21% Similarity=0.373 Sum_probs=197.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
..++++++||+|.||+||+|.+ .....||+|.++. ...+.|.+|+++|++| +|+|||++++++..+ ..++||||
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~--~piyIVtE 281 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ--EPIYIVTE 281 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecC--CceEEEEE
Confidence 4456789999999999999998 4456899999975 4457899999999999 999999999999873 47899999
Q ss_pred ecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce
Q 014307 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (427)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~ 286 (427)
||..|+|..+++ .+...+...++.|||+|++||+++++|||||.++||||+.+. .+||+|||+|+.. .++.+.
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~-~d~~Y~ 359 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLARLI-GDDEYT 359 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEccccccccc-CCCcee
Confidence 999999988875 388889999999999999999999999999999999999777 9999999999944 445555
Q ss_pred eeccCc---cccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHH
Q 014307 287 VRVASR---YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLN 356 (427)
Q Consensus 287 ~~~~~~---~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~ 356 (427)
...+.. -|+|||++.. ..++.|+|||||||+||||+| |+.|| ++.++.+.+..+.+... .|+..-.+.
T Consensus 360 ~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py-~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM 437 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPY-PGMSNEEVLELLERGYRLPRPEGCPDEVYELM 437 (468)
T ss_pred ecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCC-CCCCHHHHHHHHhccCcCCCCCCCCHHHHHHH
Confidence 555543 4999999875 789999999999999999998 66665 88899999998888753 344444455
Q ss_pred hccCCCChhHHHHHhHHh
Q 014307 357 KYHIELDPHLAALVGRLV 374 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll 374 (427)
..||..+|+.||+.+.+.
T Consensus 438 ~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 438 KSCWHEDPEDRPTFETLR 455 (468)
T ss_pred HHHhhCCcccCCCHHHHH
Confidence 669999999999987543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=336.71 Aligned_cols=245 Identities=23% Similarity=0.384 Sum_probs=205.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.+.|++..+||.|.-++||+|+...+++.||||+++-.+ .+.+.+|+..+..+ +||||++++..|.. +..+++
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv--~~~LWv 101 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVV--DSELWV 101 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEe--cceeEE
Confidence 478999999999999999999999999999999997432 36789999999988 99999999999987 567999
Q ss_pred EEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
||.||.+|++.+++. .+.+..+..+++++++||.|||.+|.||||||+.||||+.+| .|||+|||.+..+....
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSASLFDSG 180 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeeeeecccC
Confidence 999999999877763 599999999999999999999999999999999999999888 89999999976554332
Q ss_pred c-c----eeeccCcccccccc-ccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 284 E-Y----NVRVASRYFKGPEL-LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 284 ~-~----~~~~~~~~y~aPE~-~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
. . +..+|+++|||||+ +.....|+.|+||||||++..||.+|..|| ..-.+...+..-.+.--
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf-~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF-SKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc-ccCChHHHHHHHhcCCCCCcccccCCh
Confidence 2 1 45599999999999 555678999999999999999999999999 33344443332222100
Q ss_pred ------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
...+.+++.. |+..||..||+++++|+|+||+...
T Consensus 260 d~~k~~~ksf~e~i~~-CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIAL-CLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHhhhhcHHHHHHHHH-HhhcCcccCCCHHHHhccHHHhhcc
Confidence 1133444555 9999999999999999999999855
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=345.51 Aligned_cols=236 Identities=20% Similarity=0.352 Sum_probs=192.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeE-EEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEK-CIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~-vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
+...+.+.||.|+||+||+|.+. |+. ||||++.... .+.|.+|+.+|.++ +|||||+++|++.++.. ..+
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~~~~~-~~~ 116 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACTSPPG-SLC 116 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCCCC-ceE
Confidence 34455667999999999999974 444 9999997543 45899999999999 99999999999987532 689
Q ss_pred EEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-ceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 208 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 208 lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
+||||+.+|+|..++ ..++...+..++.||+.||+|||+++ ||||||||+|||++.+...+||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 999999999998776 35899999999999999999999999 999999999999997755899999999987654
Q ss_pred C-CcceeeccCccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-C-------ChHH
Q 014307 282 G-KEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-G-------TDEL 351 (427)
Q Consensus 282 ~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-~-------~~~~ 351 (427)
. ...+...||..|||||++.+ ...|+.|+||||||++||||+||+.|| .+..+......+.... . .+.+
T Consensus 197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf-~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l 275 (362)
T KOG0192|consen 197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPF-EDLAPVQVASAVVVGGLRPPIPKECPPHL 275 (362)
T ss_pred ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence 4 34445789999999999985 268999999999999999999999999 4444434333333221 1 2345
Q ss_pred HHHHHhccCCCChhHHHHHhHHhc
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
..++.. ||..||..||+..+++.
T Consensus 276 ~~l~~~-CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 276 SSLMER-CWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHH-hCCCCCCcCCCHHHHHH
Confidence 555555 99999999999777654
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=341.42 Aligned_cols=245 Identities=22% Similarity=0.445 Sum_probs=217.1
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
....+|++.+.||+|.||.|-+|++...|+.||||.+++.+ .-.+.+||+||..| +||||+.+|++|+. ..
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFEN--kd 126 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFEN--KD 126 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhcC--Cc
Confidence 34578999999999999999999999999999999987533 23478999999999 99999999999976 56
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.+++||||..+|.|..++ +.+++.+++.+++||..|+.|+|.++++|||||.+|||+|.++ .+||+|||++..+..
T Consensus 127 KIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 127 KIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYAD 205 (668)
T ss_pred eEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhcc
Confidence 789999999999998886 4699999999999999999999999999999999999999887 899999999999998
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----ChHHHHHHHh
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----TDELNAYLNK 357 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----~~~~~~~l~~ 357 (427)
++...++||++.|.+||++.+...-++.+|-|||||+||-|+.|..|| .+.+....+.+|.+... .|.-...+++
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPF-DG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIR 284 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPF-DGRDHKRLVRQISRGAYREPETPSDASGLIR 284 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhccccc-CCchHHHHHHHhhcccccCCCCCchHHHHHH
Confidence 888999999999999999988545578999999999999999999999 56666566666665432 4556677889
Q ss_pred ccCCCChhHHHHHhHHhcCCchh
Q 014307 358 YHIELDPHLAALVGRLVILSYFF 380 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~ 380 (427)
||+-.+|+-|.+|+++-.|=|.+
T Consensus 285 wmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred HHHhcCcccchhHHHHhhhheee
Confidence 99999999999999999998754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=333.67 Aligned_cols=242 Identities=21% Similarity=0.347 Sum_probs=199.3
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.|++.+.||+|+||+||+|.+..+++.||+|.+.... ...+.+|+.+++++ +|+||+++++++.+ ....++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEcc--CCeEEE
Confidence 3788999999999999999999999999999986422 23467899999999 99999999999876 457899
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
||||+.+++|...+ ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCC
Confidence 99999999986543 2488999999999999999999999999999999999999776 89999999998765444
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (427)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ......+.+.. -++....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 234 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE-RVKREEVDRRVKEDQEEYSEKFSEDAKS 234 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCc-chhHHHHHHHhhcccccCCccCCHHHHH
Confidence 4455688999999999986 6899999999999999999999999954322 21111111111 1234555
Q ss_pred HHHhccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 354 YLNKYHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
++.+ |+..||..|++ +++++.||||....
T Consensus 235 li~~-~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 235 ICRM-LLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred HHHH-HhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 5555 99999999986 89999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=344.97 Aligned_cols=246 Identities=27% Similarity=0.530 Sum_probs=213.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..+.|++.+.||+|.||.||+|+++.+|+.+|+|++.+.. ...+.+|+.||+++.+|||||.++++|++. ..
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--~~ 110 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--DS 110 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC--Ce
Confidence 3567999999999999999999999999999999997533 257899999999996699999999999884 47
Q ss_pred cEEEEeecCCCchhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC---CeEEEEeeeeeeeec
Q 014307 206 PSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYH 280 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~ikl~DFGla~~~~ 280 (427)
+++|||++.||.|...+.. +++.++..++.|++.++.|||+.||+||||||+|+|+.... ..+|++|||+|....
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 8899999999998766543 99999999999999999999999999999999999996543 279999999999988
Q ss_pred CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChH
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDE 350 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~ 350 (427)
.+......+||+.|+|||++.. ..|+..+||||+||++|.|++|..|| .+.+..+....+.+.-- +..
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF-~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPF-WGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred CCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCC-cCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 7667888999999999999876 78999999999999999999999999 55566666666655411 234
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
...++.+ ++..||..|.++.++|.|||+...
T Consensus 269 akd~i~~-ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 269 AKDFIRK-LLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHH-hcccCcccCCCHHHHhcCccccCC
Confidence 4455555 999999999999999999998864
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=345.36 Aligned_cols=244 Identities=26% Similarity=0.483 Sum_probs=203.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC----
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~---- 203 (427)
.++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCcccc
Confidence 47899999999999999999999999999999998632 235677899999999 99999999999875322
Q ss_pred CCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
..+++||||+.++.+......+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 177 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNF 177 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCccccccCc
Confidence 35789999999877666666789999999999999999999999999999999999999877 89999999997654444
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC---------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------------- 348 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~--------------- 348 (427)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+++..+.+.++.
T Consensus 178 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (359)
T cd07876 178 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIF-QGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRN 255 (359)
T ss_pred cCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 4455688999999999887 68999999999999999999999999 444544444433332221
Q ss_pred ---------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 349 ---------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 349 ---------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+.+.+++.+ |+..||..|+++.+++.|||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 256 YVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSK-MLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHH-HhccCcccCCCHHHHhcCchhhh
Confidence 234455555 99999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=333.85 Aligned_cols=276 Identities=31% Similarity=0.489 Sum_probs=212.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|++.+.||+|+||.||+|+++.+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRR--RGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEec--CCEEEE
Confidence 4799999999999999999999999999999998642 235678999999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-- 283 (427)
||||+.++.+..+. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCcccccccccc
Confidence 99999998776553 3588999999999999999999999999999999999999777 89999999998664322
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCC
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~d 363 (427)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+..+..+...+-.. ..+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 231 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLF-PGESEIDQLFTIQKVLGPLPAEQMKLF---YSN 231 (287)
T ss_pred cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhhCCCCHHHHHhh---hcc
Confidence 2234578899999999876 67899999999999999999999998 566666777766666554322211110 111
Q ss_pred hhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 364 PHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 364 p~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
|............+. .....+.......+.|+|++||. .||++|+++..+++|||
T Consensus 232 ~~~~~~~~~~~~~~~-----~~~~~~~~~~s~~~~dll~~~L~-~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 232 PRFHGLRFPAVNHPQ-----SLERRYLGILSGVLLDLMKNLLK-LNPTDRYLTEQCLNHPA 286 (287)
T ss_pred chhcccccCcccCcc-----cHHHhhhcccCHHHHHHHHHHcc-CCcccCCCHHHHhcCCC
Confidence 211110000000000 00001122356779999999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=344.83 Aligned_cols=243 Identities=22% Similarity=0.392 Sum_probs=210.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..|..++.||+|+||.||+|.+..+++.||+|++.-. ..+.+.+|+.+|.++ +++||.++|+.|.. +..+.++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~--g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLK--GTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheee--cccHHHH
Confidence 4577889999999999999999999999999999743 235688999999998 99999999999876 5678899
Q ss_pred EeecCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-c
Q 014307 210 FEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~ 285 (427)
||||.||++..+++. +.+..+..++++++.||.|||.++.+|||||+.|||+..++ .+||+|||.+..+..... .
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeechhhcc
Confidence 999999998877753 58888999999999999999999999999999999999886 899999999987765433 3
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHHhc
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (427)
.+.+||++|||||++.+ ..|+.|+||||||++.+||.+|.+|+ ....++..+..|.+.. -++.+.+|+..
T Consensus 169 ~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~-s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~- 245 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPH-SKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA- 245 (467)
T ss_pred ccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCC-cccCcceEEEeccCCCCCccccccCHHHHHHHHH-
Confidence 78899999999999986 79999999999999999999999998 5555555555555432 23567777777
Q ss_pred cCCCChhHHHHHhHHhcCCchhhHH
Q 014307 359 HIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|++.+|+.||++.+||+|+|.++.+
T Consensus 246 CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 246 CLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HhhcCcccCcCHHHHhhhHHHHhcC
Confidence 9999999999999999999999855
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=342.24 Aligned_cols=242 Identities=22% Similarity=0.350 Sum_probs=202.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEc--CCEE
Confidence 36799999999999999999999999999999998643 234578999999999 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCCC-
Confidence 9999999999987665 3588999999999999999999999999999999999999777 8999999999865432
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (427)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.... -.+...+++.+
T Consensus 172 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFF-DDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCC-CCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 234578999999999887 678999999999999999999999994 444444444443321 12345555555
Q ss_pred ccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
|+..||..|++ +++++.||||....
T Consensus 249 -~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~ 278 (329)
T PTZ00263 249 -LLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278 (329)
T ss_pred -HhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence 99999999986 89999999998743
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=314.57 Aligned_cols=241 Identities=24% Similarity=0.406 Sum_probs=210.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|.||.||+|+.+.++-.||+|++-+. -..++.+|++|..+| +||||+++|++|.+ ...+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd--~~ri 97 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHD--SKRI 97 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheec--ccee
Confidence 47899999999999999999999999999999998542 346789999999999 99999999999987 6789
Q ss_pred EEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 207 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
||++||...|++...++ ++.+.....+++|++.||.|+|.+++|||||||+|+|++..+ .+||+|||.+....
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAP- 175 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeecC-
Confidence 99999999998766553 589999999999999999999999999999999999999888 89999999997543
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHH
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYL 355 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l 355 (427)
.....+.+||..|.+||...+ ..++..+|+|++|++.||++.|.+|| ......+...+|.+.-- +....++|
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppF-es~~~~etYkrI~k~~~~~p~~is~~a~dlI 253 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPF-ESQSHSETYKRIRKVDLKFPSTISGGAADLI 253 (281)
T ss_pred CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCch-hhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence 667788899999999999887 78999999999999999999999999 44456677777776522 23444555
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhh
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
.. ++..+|..|..+.+++.|||...
T Consensus 254 ~~-ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 254 SR-LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HH-HhccCccccccHHHHhhhHHHHh
Confidence 55 89999999999999999999865
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=336.29 Aligned_cols=241 Identities=21% Similarity=0.355 Sum_probs=201.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHD--QRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhcc--CCeEE
Confidence 4689999999999999999999999999999998642 234578899999999 99999999998876 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.+++|..++ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC--
Confidence 999999999987665 3588999999999999999999999999999999999999777 8999999999765432
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (427)
.....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.... -.+.+.+++.+
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~- 231 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFF-DDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK- 231 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCcCCCccCCHHHHHHHHH-
Confidence 234578999999999876 678999999999999999999999994 444444444443321 12344555555
Q ss_pred cCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 359 HIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
|+..||..|++ +++++.|+||....
T Consensus 232 ~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 232 LLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred HcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 99999999994 99999999998644
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=345.44 Aligned_cols=244 Identities=24% Similarity=0.390 Sum_probs=198.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|++..+++.||||+++... ...+.+|+.++..+ +|+||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~--~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQD--KLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCeEE
Confidence 47899999999999999999999999999999996422 24577899999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCccccccccc
Confidence 999999999987765 3589999999999999999999999999999999999999777 899999999875432110
Q ss_pred ------------------------------------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 014307 285 ------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328 (427)
Q Consensus 285 ------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~p 328 (427)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence 123478999999999887 6899999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHh----------CChHHHHHHHhccCC-CChhHHHHHhHHhcCCchhhHH
Q 014307 329 FFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIE-LDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 329 f~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~-~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
| .+.+..+....+.... -.+....++.+.+.. .++..||++++++.||||....
T Consensus 236 f-~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 236 F-CSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred C-CCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCC
Confidence 9 4555555555554321 134566666664332 1223468999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.46 Aligned_cols=277 Identities=21% Similarity=0.274 Sum_probs=207.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
..++|+++++||+|+||.||+|++..+++.||+|... ...+.+|+.+|+++ +||||+++++++.. ....++++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTY--NKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEE--CCeeEEEEe
Confidence 3468999999999999999999999999999999764 35578999999999 99999999999976 557889999
Q ss_pred ecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC--Cccee
Q 014307 212 HVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYNV 287 (427)
Q Consensus 212 ~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~--~~~~~ 287 (427)
++.+..+..+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... .....
T Consensus 164 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 164 RYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCccccccccccccccc
Confidence 99754433332 3588999999999999999999999999999999999999777 8999999999753222 22334
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------CCHHHHHHHHHHhCChHHHHHHHhccCC
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH------DNYDQLVKIAKVLGTDELNAYLNKYHIE 361 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~------~~~~~l~~i~~~~~~~~~~~~l~~~~l~ 361 (427)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.||+... +...++..+.+..+..+.. + ...
T Consensus 243 ~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~-~----~~~ 316 (391)
T PHA03212 243 WAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE-F----PID 316 (391)
T ss_pred ccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh-c----Ccc
Confidence 579999999999876 689999999999999999999999986532 2345666666666643211 0 000
Q ss_pred CChhHHHHHhHHhc---CCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 362 LDPHLAALVGRLVI---LSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 362 ~dp~~r~~~~~ll~---~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
....++.....+.. .....+.. +.........+.++|++||. +||++|+|+..+++|||-
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~Li~~mL~-~dP~~Rpta~elL~hp~f 379 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPL---WTNLYELPIDLEYLICKMLA-FDAHHRPSAEALLDFAAF 379 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCC---HHHHhhhhhhHHHHHHHHhc-CChhhCCCHHHHhcChhh
Confidence 00111111101100 00000000 00111245678899999995 999999999999999984
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=337.03 Aligned_cols=273 Identities=26% Similarity=0.493 Sum_probs=203.6
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC---CCc
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTP 206 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~---~~~ 206 (427)
+|++.++||+|+||.||+|++..+++.||||.++.. ....+.+|+.+++.+ +||||+++++++..... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 589999999999999999999999999999998632 234578999999999 99999999998865322 357
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+ ++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCcccccccccc
Confidence 999999975 554443 3589999999999999999999999999999999999999777 89999999997543221
Q ss_pred c----ceeeccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhc
Q 014307 284 E----YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358 (427)
Q Consensus 284 ~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~ 358 (427)
. .....|+..|+|||++.+. ..++.++|||||||++|||++|+.|| .+.+...++..+....+.+..... ...
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~-~~i 235 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLITDLLGTPSPETI-SRV 235 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCHHHH-HHh
Confidence 1 2345789999999997642 57899999999999999999999998 566666677666666665432211 110
Q ss_pred cCCCChhHHHHHhHHhcC---CchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 359 HIELDPHLAALVGRLVIL---SYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~---~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
. +...+..+..+... ++... +......+.++|++||. .+|++|+++..++.|||
T Consensus 236 ~---~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~li~~~l~-~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 236 R---NEKARRYLSSMRKKQPVPFSQK--------FPNADPLALRLLERLLA-FDPKDRPTAEEALADPY 292 (338)
T ss_pred h---hhhHHHHHHhhcccCCCchHHh--------cCCCChHHHHHHHHHcC-cCcccCCCHHHHhcCch
Confidence 0 01111111211111 11110 11234566788888884 88888888888888886
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=340.54 Aligned_cols=241 Identities=28% Similarity=0.460 Sum_probs=203.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||.||+|++..+++.||||+++.. ....+.+|+.++..+ +||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQD--DEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEc--CCEEE
Confidence 3699999999999999999999999999999998643 234577899999999 89999999999976 56789
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... .
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc--c
Confidence 9999999999987763 588999999999999999999999999999999999999777 899999999976533 3
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---C-----------ChH
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---G-----------TDE 350 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---~-----------~~~ 350 (427)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.... . .+.
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~ 232 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPF-SGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE 232 (333)
T ss_pred cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCC-CCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence 345678999999999887 58999999999999999999999999 4444444444443211 0 345
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+++.+ |+..+|..|+++.+++.|+||....
T Consensus 233 ~~~li~~-~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 233 AWDLITK-LINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred HHHHHHH-HhhChhhhcCCHHHHHhCcccCCCC
Confidence 5666666 8899999999999999999998743
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=330.22 Aligned_cols=273 Identities=27% Similarity=0.491 Sum_probs=206.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcC-CCeEEEEEEeccc-----cHHHHHHHHHHHHHhc--CCCCeeeeeeEEEc---CC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV-----KKKKIKREIKILQNLC--GGPNIVKLLDIVRD---QQ 202 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~-----~~~~~~~E~~il~~l~--~h~niv~l~~~~~~---~~ 202 (427)
++|++++.||+|+||.||+|++.. +++.||+|+++.. ....+.+|+.+++.+. .||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368999999999999999999854 5788999988632 1245667888887763 69999999999863 23
Q ss_pred CCCcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
...+++||||+.+ ++..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceE
Confidence 4568999999986 444443 2378899999999999999999999999999999999999777 89999999998
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHh
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~ 357 (427)
............|+..|+|||++.+ ..++.++|||||||++|||++|+.|| .+..+.+.+..+....+.+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 7655444455678999999999876 67999999999999999999999888 666777888888776664432222111
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
. ..... .... .....+.+ ......+...++|.+||. .+|+.|+++..+++|||
T Consensus 237 ~--~~~~~---~~~~-~~~~~~~~-------~~~~~~~~~~~li~~~l~-~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 237 V--ALPRQ---AFHS-KSAQPIEK-------FVTDIDELGKDLLLKCLT-FNPAKRISAYSALSHPY 289 (290)
T ss_pred h--cccch---hccC-CCCCCHHH-------HccCCCHHHHHHHHHHhc-cCchhcCCHHHHhcCCC
Confidence 0 00000 0000 00000111 111245677899999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.81 Aligned_cols=245 Identities=26% Similarity=0.460 Sum_probs=204.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---- 202 (427)
..++|++.+.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+ +||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence 357899999999999999999999999999999998642 235677899999999 9999999999886432
Q ss_pred CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
....++||||+.++........+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 179 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCCC
Confidence 245799999999876666656788999999999999999999999999999999999999777 8999999999866544
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC--------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------------- 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~-------------- 348 (427)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 44455688999999999887 68999999999999999999999999 555555555555443221
Q ss_pred ----------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 349 ----------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 349 ----------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+...+++.+ |+..||..|+++.++|.||||..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~-mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK-MLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHH-hcCcCcccCCCHHHHhcCccccc
Confidence 223445555 99999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=339.93 Aligned_cols=245 Identities=27% Similarity=0.478 Sum_probs=202.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---- 202 (427)
..++|++.+.||+|+||.||+|.+..+++.||||.+... ....+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccc
Confidence 357899999999999999999999999999999998642 235577899999999 9999999999986532
Q ss_pred CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
....+++|||++++........+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 172 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccCCCc
Confidence 235789999999876666666789999999999999999999999999999999999999777 8999999999866544
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC--------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------------- 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~-------------- 348 (427)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+.+.++.
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 44456688999999999877 67999999999999999999999999 444444444333322211
Q ss_pred ----------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 349 ----------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 349 ----------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
..+.+++.+ |+..||..||++.+++.|||+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK-MLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHH-HhcCCchhcCCHHHHhcCcchhc
Confidence 123445555 99999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=338.54 Aligned_cols=237 Identities=23% Similarity=0.366 Sum_probs=195.3
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|+++.+++.||||+++.. ....+.+|+.+++++ +||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 3699999999999999999999999998742 124567899999999 99999999999976 56789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~~ 289 (427)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCccccee
Confidence 999987665 3589999999999999999999999999999999999999777 899999999875322 23344567
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (427)
|++.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+.......+.... -.+.+.+++.+ |+..|
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~-~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~-~L~~d 233 (323)
T cd05571 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELILMEEIRFPRTLSPEAKSLLAG-LLKKD 233 (323)
T ss_pred cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCC-CCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-HccCC
Confidence 9999999999876 6899999999999999999999999943 33323233222111 13455566665 99999
Q ss_pred hhHHH-----HHhHHhcCCchhhHH
Q 014307 364 PHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 364 p~~r~-----~~~~ll~~~~~~~~~ 383 (427)
|..|+ ++.+++.|+||....
T Consensus 234 P~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 234 PKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred HHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 99999 899999999998743
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=316.08 Aligned_cols=245 Identities=22% Similarity=0.432 Sum_probs=207.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
+.|...+.||+|..+.|.++.++.+++.+|+|++... -.+...+|+.||+++.+||+|+++.++|+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 4566778899999999999999999999999998521 124567899999999999999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
...+++|+|.|..|.|.+++. .+++.+.+.+++|+++|++|||.++||||||||+|||+|++. ++||+|||+|+.+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~isDFGFa~~l 173 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKISDFGFACQL 173 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEeccceeecc
Confidence 678899999999999988875 489999999999999999999999999999999999999777 8999999999999
Q ss_pred cCCCcceeeccCccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH---hCCh--
Q 014307 280 HPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---LGTD-- 349 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~---~~~~-- 349 (427)
.++......|||+.|.|||.+.+ ...|+..+|+|++|||+|-|+.|.+||+.. ...-.+..|.+. ++++
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-kQmlMLR~ImeGkyqF~speW 252 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-KQMLMLRMIMEGKYQFRSPEW 252 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-HHHHHHHHHHhcccccCCcch
Confidence 99999999999999999999853 356899999999999999999999999642 112222333332 2233
Q ss_pred -----HHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 350 -----ELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 350 -----~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
...+++.+ ++..||..|.+.+++|.||||....
T Consensus 253 adis~~~KdLIsr-lLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 253 ADISATVKDLISR-LLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred hhccccHHHHHHH-HHeeCchhcccHHHHhcChHHHHHH
Confidence 23334444 8999999999999999999997654
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=341.82 Aligned_cols=242 Identities=25% Similarity=0.407 Sum_probs=200.0
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|++..+++.||||+++... ...+.+|+.+|+.+ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQD--ENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCeEE
Confidence 47999999999999999999999999999999996421 24467899999999 89999999999986 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+.....
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceecccccc
Confidence 999999999987765 3589999999999999999999999999999999999999777 899999999875432110
Q ss_pred ---------------------------------------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhC
Q 014307 285 ---------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 325 (427)
Q Consensus 285 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg 325 (427)
....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence 012368999999999876 6899999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHh----------CChHHHHHHHhccCCCChhHHHH---HhHHhcCCchhhHH
Q 014307 326 KEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHLAAL---VGRLVILSYFFQFV 383 (427)
Q Consensus 326 ~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dp~~r~~---~~~ll~~~~~~~~~ 383 (427)
..||. +.+..+....+.+.. -++...+++.+ |+. +|..|+. +.+++.||||+...
T Consensus 236 ~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~-ll~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 236 YPPFC-SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKR-LCC-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred CCCCC-CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHH-Hcc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 99994 444444444443311 13455566666 665 8999998 99999999998754
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=340.68 Aligned_cols=278 Identities=27% Similarity=0.454 Sum_probs=216.5
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC---CCc
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTP 206 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~---~~~ 206 (427)
+|++.+.||+|+||.||+|.+..+++.||||.+... ..+.+.+|+.+++.+ +|+||+++++++..... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 477889999999999999999999999999988542 235678999999999 99999999999876431 267
Q ss_pred EEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
++||||+.+..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCcc
Confidence 9999999865444332 3589999999999999999999999999999999999999777 89999999998654332
Q ss_pred -cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCC
Q 014307 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362 (427)
Q Consensus 284 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~ 362 (427)
......++..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+....+....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~---- 233 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSLEAMRSAC---- 233 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhh----
Confidence 2234567889999999887566899999999999999999999998 6677888888898888877654432221
Q ss_pred ChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 363 DPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 363 dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+..+......+... ...+.+.....+.+.++|++||. .||++|+++..++.|||
T Consensus 234 -~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~mL~-~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 234 -EGARAHILRGPHKPPSL---PVLYTLSSQATHEAVHLLCRMLV-FDPDKRISAADALAHPY 290 (372)
T ss_pred -HHHHHHHHhCCCCCCch---HHhcccCCCCCHHHHHHHHHhCC-CChhhCcCHHHHhcCHh
Confidence 12222222111111111 11112223346788999999995 99999999999999997
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=337.61 Aligned_cols=242 Identities=19% Similarity=0.336 Sum_probs=201.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCC-eEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEe--CCE
Confidence 467999999999999999999876655 78999998532 234577899999999 99999999999976 567
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
.++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCeecCC-
Confidence 899999999999877653 588999999999999999999999999999999999999777 899999999986543
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLN 356 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~ 356 (427)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+.......+.+... .+....++.
T Consensus 184 -~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 260 (340)
T PTZ00426 184 -RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFY-ANEPLLIYQKILEGIIYFPKFLDNNCKHLMK 260 (340)
T ss_pred -CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCC-CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 2345678999999999876 678999999999999999999999994 4444444444443321 334555555
Q ss_pred hccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 357 KYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 357 ~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
+ |+..+|..|+ ++++++.||||....
T Consensus 261 ~-~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 261 K-LLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred H-HcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 5 9999999995 899999999998644
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=330.74 Aligned_cols=281 Identities=22% Similarity=0.432 Sum_probs=203.5
Q ss_pred EeeeeecCCeeEEEEEEc--CCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 139 VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
.++||+|+||+||+|+++ .+++.+|+|.++... ...+.+|+.+|+++ +||||+++++++.......++++|||+.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 367999999999999975 367899999987533 35678999999999 99999999999987667788999999987
Q ss_pred Cchhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC---CCCeEEEEeeeeeeeecC
Q 014307 216 TDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 216 ~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~ikl~DFGla~~~~~ 281 (427)
....... ..+++..++.++.||+.||+|||++||+||||||+|||++. ....+||+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence 5432221 14888999999999999999999999999999999999942 223799999999987643
Q ss_pred CC----cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHHHhCCh
Q 014307 282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQLVKIAKVLGTD 349 (427)
Q Consensus 282 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--------~~~~l~~i~~~~~~~ 349 (427)
.. ......+|+.|+|||++.+...++.++|||||||++|||++|+.||..... ..+++..+.+.++.+
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07868 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244 (317)
T ss_pred CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence 22 233457889999999988756789999999999999999999999953322 245666777776655
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHH-hhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVI-YYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~-~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
....+-.. ..-|.............+...... +...........+.|+|++||. .||++|+|+..++.|||
T Consensus 245 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~-~dP~~R~t~~e~l~hp~ 316 (317)
T cd07868 245 ADKDWEDI---KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLT-MDPIKRITSEQAMQDPY 316 (317)
T ss_pred ChHHhHHH---hhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhc-cCcccCCCHHHHhcCCC
Confidence 43332111 001111111111111111110000 0000011123468899999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=342.39 Aligned_cols=243 Identities=21% Similarity=0.354 Sum_probs=196.6
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.|++++.||+|+||+||+|++..+++.||||+++... ...+.+|+.+++.+ +|+||+++++++.+ ...+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~--~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEec--CCEEEE
Confidence 5889999999999999999999999999999986421 24578899999999 99999999999986 557899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-- 283 (427)
||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCccccccccc
Confidence 99999999987765 3588999999999999999999999999999999999999777 89999999975331000
Q ss_pred ----------------------------------------------cceeeccCccccccccccCCCCCCchhhHHHHHH
Q 014307 284 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 317 (427)
Q Consensus 284 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv 317 (427)
.....+||..|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence 0123478999999999876 67999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHHHHHhc-cCCCChhHHHHHhHHhcCCchhhHH
Q 014307 318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKY-HIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 318 ll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~-~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++|||++|+.||.. .+..+....+.... -.++...++.+. |+..++..|+++.+++.|+||.+..
T Consensus 237 il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 237 ILFEMLVGQPPFLA-PTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHHHhCCCCCcC-CCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 99999999999954 34444333333211 134566666663 3345555699999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.94 Aligned_cols=241 Identities=22% Similarity=0.370 Sum_probs=198.2
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+|+++++||+|+||+||+|++..+++.||+|++.... ...+.+|+.+++++ +|+||+++++.+.+ ...+++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~--~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEe--CCEEEE
Confidence 5899999999999999999999999999999986432 24578899999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-- 283 (427)
||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+....
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCccccccccc
Confidence 999999999877653 478999999999999999999999999999999999999777 89999999975321000
Q ss_pred ----------------------------------------------cceeeccCccccccccccCCCCCCchhhHHHHHH
Q 014307 284 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 317 (427)
Q Consensus 284 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGv 317 (427)
.....+||+.|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechH
Confidence 0112468999999999876 68999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHHHHHhccCCCChhHHHH---HhHHhcCCchhhHH
Q 014307 318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHLAAL---VGRLVILSYFFQFV 383 (427)
Q Consensus 318 ll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dp~~r~~---~~~ll~~~~~~~~~ 383 (427)
++|||++|+.||. +.+..+....+.... -++...+++.+. + .+|..|+. +++++.||||....
T Consensus 237 il~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l-~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 237 ILYEMLVGQPPFL-AQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL-C-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHHHHHhCCCCCC-CCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHH-c-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 9999999999994 445555544444311 135666777773 3 48999987 99999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=327.47 Aligned_cols=247 Identities=28% Similarity=0.535 Sum_probs=201.2
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
+..++|++.++||+|+||.||+|+++.+++.||+|.++... ...+.+|+.+++++ +||||+++++++.. ....
T Consensus 3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~ 79 (309)
T cd07872 3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHT--DKSL 79 (309)
T ss_pred CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEee--CCeE
Confidence 34578999999999999999999999999999999986422 24577899999999 99999999999976 4568
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+..+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 80 TLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPT 158 (309)
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCCc
Confidence 9999999975443332 2378899999999999999999999999999999999999777 89999999997653322
Q ss_pred -cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 014307 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (427)
Q Consensus 284 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------------- 347 (427)
......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF-PGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 2334567889999999876567899999999999999999999998 44455555544443322
Q ss_pred ---------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ---------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ---------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++...+++.+ |+..||..|+++.+++.|+||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTK-FLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHH-hccCChhhCCCHHHHhcChhhhhcc
Confidence 1233445555 9999999999999999999998744
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=324.19 Aligned_cols=245 Identities=22% Similarity=0.353 Sum_probs=206.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
+.|++++.||+|.-|+||+|+...++..+|+|++.+.. ..+...|-+||+.+ +||.++.||..|+. ..+.|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~fet--~~~~c 153 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASFET--DKYSC 153 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhheeec--cceeE
Confidence 56889999999999999999999999999999997532 34567799999999 99999999999976 67899
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-
Q 014307 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~- 281 (427)
++||||.||+|..+.+ .+++..++.++.+++.||+|||..|||+||||||||||..+| +|-|+||.|+.....
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSLRCPVS 232 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeeccccccCCCC
Confidence 9999999999877764 499999999999999999999999999999999999999888 899999998743210
Q ss_pred --------------------------------C-C-----------------------cceeeccCccccccccccCCCC
Q 014307 282 --------------------------------G-K-----------------------EYNVRVASRYFKGPELLVDLQD 305 (427)
Q Consensus 282 --------------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~~~~ 305 (427)
. . .....+||..|.|||++.| ..
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G-~G 311 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG-EG 311 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-CC
Confidence 0 0 0122478999999999998 68
Q ss_pred CCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH----hCCh---HHHHHHHhccCCCChhHHHH----HhHHh
Q 014307 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----LGTD---ELNAYLNKYHIELDPHLAAL----VGRLV 374 (427)
Q Consensus 306 ~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~----~~~~---~~~~~l~~~~l~~dp~~r~~----~~~ll 374 (427)
.+.++|+|+|||+||||++|..|| .|.++.+.+..|... .+.+ .....+++.+|..||..|.- +.++-
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 999999999999999999999999 777888887766543 1222 22333444489999999999 99999
Q ss_pred cCCchhhHHH
Q 014307 375 ILSYFFQFVI 384 (427)
Q Consensus 375 ~~~~~~~~~~ 384 (427)
.||||+...+
T Consensus 391 ~HpFF~gVnW 400 (459)
T KOG0610|consen 391 RHPFFEGVNW 400 (459)
T ss_pred cCccccCCCh
Confidence 9999998764
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=332.25 Aligned_cols=237 Identities=22% Similarity=0.383 Sum_probs=194.8
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCEEEEEEeCC
Confidence 4699999999999999999999999998642 223466899999999 99999999999976 45789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~~ 289 (427)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCcccccc
Confidence 999986654 3589999999999999999999999999999999999999777 899999999875322 22334457
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (427)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||. ..+..+....+.... -.+.+.+++.+ |+..|
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~-~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~-~L~~d 233 (323)
T cd05595 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILMEEIRFPRTLSPEAKSLLAG-LLKKD 233 (323)
T ss_pred CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-HccCC
Confidence 8999999999876 688999999999999999999999994 333333333332211 13455555665 99999
Q ss_pred hhHHH-----HHhHHhcCCchhhHH
Q 014307 364 PHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 364 p~~r~-----~~~~ll~~~~~~~~~ 383 (427)
|..|+ ++.+++.|+||....
T Consensus 234 P~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 234 PKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred HHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 99998 899999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=324.40 Aligned_cols=240 Identities=30% Similarity=0.579 Sum_probs=195.4
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhc--CCCCeeeeeeEEEcC---CCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQ---QSK 204 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~--~h~niv~l~~~~~~~---~~~ 204 (427)
+|++.+.||+|+||+||+|+++.+++.||+|.++... ...+.+|+.+++.+. +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999999999999999986421 235667888887763 699999999988642 234
Q ss_pred CcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
.++++|||+.+ ++..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCccccc
Confidence 57899999987 443333 2388999999999999999999999999999999999999777 8999999999876
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-----------
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----------- 348 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~----------- 348 (427)
..........++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+.++....+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 54444455678889999999876 67999999999999999999999888 555556666655543321
Q ss_pred ----------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 349 ----------------------DELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 349 ----------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
....+++.+ |+..||..|+++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLE-MLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHH-HhccCcccCCCHHHHhcCCCC
Confidence 122344444 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=340.74 Aligned_cols=241 Identities=24% Similarity=0.416 Sum_probs=196.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|+++++||+|+||+||+|.+..+++.||||++... ..+.+.+|+++++.+ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQD--AQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCeeE
Confidence 4689999999999999999999999999999998542 124577899999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.+.....
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccc
Confidence 999999999987765 3588999999999999999999999999999999999999777 899999999863321000
Q ss_pred ------------------------------------------------ceeeccCccccccccccCCCCCCchhhHHHHH
Q 014307 285 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316 (427)
Q Consensus 285 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG 316 (427)
....+||+.|+|||++.+ ..++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG 235 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence 012468999999999876 6899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCHHHHHHHHHH---hC-------ChHHHHHHHhccCCCChhHH---HHHhHHhcCCchhhH
Q 014307 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAKV---LG-------TDELNAYLNKYHIELDPHLA---ALVGRLVILSYFFQF 382 (427)
Q Consensus 317 vll~elltg~~pf~~~~~~~~~l~~i~~~---~~-------~~~~~~~l~~~~l~~dp~~r---~~~~~ll~~~~~~~~ 382 (427)
|++|||++|..|| .+.+..+....+... +. .+...+++.+ |+. +|..| +++.+++.|+||...
T Consensus 236 vil~elltG~~Pf-~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~-lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 236 AIMFECLIGWPPF-CSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR-LIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhhhcCCCCC-CCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHH-Hhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9999999999999 444555555554431 11 2345566666 666 67765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=340.66 Aligned_cols=241 Identities=22% Similarity=0.352 Sum_probs=197.6
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+|+++++||+|+||.||+|++..+++.||||++... ....+.+|+.+|+.+ +|+||+++++.+.+ ...+++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~l 78 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLYF 78 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCEEEE
Confidence 689999999999999999999999999999998642 235578899999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC---
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--- 282 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~--- 282 (427)
||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|..+...
T Consensus 79 v~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 79 VMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCccccccccc
Confidence 999999999887753 478899999999999999999999999999999999999777 8999999997532100
Q ss_pred -----------------------------------------CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHH
Q 014307 283 -----------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAG 321 (427)
Q Consensus 283 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~e 321 (427)
......+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeee
Confidence 00012468999999999876 689999999999999999
Q ss_pred HHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHHHHHhccCCCChhHHH---HHhHHhcCCchhhHH
Q 014307 322 MIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHLAA---LVGRLVILSYFFQFV 383 (427)
Q Consensus 322 lltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dp~~r~---~~~~ll~~~~~~~~~ 383 (427)
|++|+.|| .+.+..+....+.... -.+...+++.+ ++ .+|..|+ ++.+++.|+||....
T Consensus 237 ll~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~-l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 237 MLVGQPPF-LADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred hhhCCCCC-CCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHH-Hh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99999999 4444444444433211 12455666666 44 5999999 999999999998743
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=338.62 Aligned_cols=242 Identities=28% Similarity=0.477 Sum_probs=203.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|++..+++.||||+++.. ....+.+|+.++..+ +|+||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQD--EEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheec--CCeEE
Confidence 4799999999999999999999999999999998642 234578899999999 89999999999876 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCc
Confidence 999999999987765 3589999999999999999999999999999999999999777 89999999997654433
Q ss_pred -----------------------------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 014307 284 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334 (427)
Q Consensus 284 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~ 334 (427)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||. ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~-~~~ 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFY-SDT 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCC-CCC
Confidence 2234578999999999887 689999999999999999999999994 444
Q ss_pred CHHHHHHHHHH---hC-------ChHHHHHHHhccCCCChhHHHH-HhHHhcCCchhhHH
Q 014307 335 NYDQLVKIAKV---LG-------TDELNAYLNKYHIELDPHLAAL-VGRLVILSYFFQFV 383 (427)
Q Consensus 335 ~~~~l~~i~~~---~~-------~~~~~~~l~~~~l~~dp~~r~~-~~~ll~~~~~~~~~ 383 (427)
..+....+... +. ++.+..++.. |+. +|..|++ +++++.||||....
T Consensus 235 ~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~-ll~-dp~~R~~s~~~ll~hp~~~~~~ 292 (350)
T cd05573 235 LQETYNKIINWKESLRFPPDPPVSPEAIDLICR-LLC-DPEDRLGSFEEIKSHPFFKGID 292 (350)
T ss_pred HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHH-Hcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence 44544444441 11 3455666666 776 9999999 99999999998744
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.31 Aligned_cols=243 Identities=22% Similarity=0.334 Sum_probs=199.5
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+|++++.||+|+||.||+|++..+++.||||+++.. ..+.+..|+.++..+.+|++|+++++++.. ...+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc--CCEEEE
Confidence 488999999999999999999999999999998642 234567899999998555678999998876 457899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-CCCc
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~~~~ 284 (427)
||||+.+++|...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.... ....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCCCc
Confidence 99999999987665 3588999999999999999999999999999999999999777 89999999987532 2233
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~~~ 358 (427)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+... .+....++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~- 234 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG- 234 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 445678999999999887 67899999999999999999999999 44454555555443221 2344455555
Q ss_pred cCCCChhHHHHH-----hHHhcCCchhhHH
Q 014307 359 HIELDPHLAALV-----GRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~~~-----~~ll~~~~~~~~~ 383 (427)
|+..+|..|++. .+++.||||.+..
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 235 LLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999975 8999999998744
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=321.36 Aligned_cols=242 Identities=22% Similarity=0.356 Sum_probs=199.5
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+|++.+.||+|+||+||++.+..+++.||+|++.... ...+.+|+.+++.+ +||||+++++.+.. ...+++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecC--CCeEEE
Confidence 4889999999999999999998899999999986422 23467899999999 99999999999876 457899
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
||||+.+++|...+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGE 156 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCC
Confidence 99999999987554 2488999999999999999999999999999999999999766 89999999998765444
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (427)
......|+..|+|||++.+ ..++.++||||+||++|||++|+.||. +.........+.... -.+.+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFR-QRKEKVKREEVERRVKEDQEEYSEKFSEAARS 234 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCC-CCchhhHHHHHHHHhhhcccccCcccCHHHHH
Confidence 4445678999999999876 679999999999999999999999994 333322222222111 1234455
Q ss_pred HHHhccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 354 YLNKYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
++.+ |+..||..|+ ++++++.|+||....
T Consensus 235 li~~-~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 235 ICRQ-LLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred HHHH-HccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 5555 9999999999 999999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.27 Aligned_cols=242 Identities=21% Similarity=0.346 Sum_probs=198.4
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhc--CCCCeeeeeeEEEcCCCCCcE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~--~h~niv~l~~~~~~~~~~~~~ 207 (427)
|++++.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|++++..+. +||||+++++++.. ...++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 67899999999999999999999999999999642 1245667777664331 79999999999976 56789
Q ss_pred EEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCc
Q 014307 208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~ 284 (427)
+||||+.+++|...+. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCCCc
Confidence 9999999999876653 589999999999999999999999999999999999999777 899999999875322 222
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (427)
.....|+..|+|||.+.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.... -++.+.+++.+
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~- 234 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF-PGDDEEEVFDSIVNDEVRYPRFLSREAISIMRR- 234 (324)
T ss_pred ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 345678999999999877 68899999999999999999999999 4444445554444321 13455566666
Q ss_pred cCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 359 HIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
|+..||..|+ ++.+++.|+||....
T Consensus 235 ~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 235 LLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred HhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 9999999999 799999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=332.50 Aligned_cols=237 Identities=23% Similarity=0.368 Sum_probs=194.7
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 3689999999999999999999999998642 224577899999999 99999999999976 56789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~~ 289 (427)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCccccccccc
Confidence 999986654 3588999999999999999999999999999999999999777 899999999875322 22234457
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (427)
|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. ..+..+....+.... -.+++..++.+ |+..|
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~-~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~-~L~~d 233 (328)
T cd05593 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFELILMEDIKFPRTLSADAKSLLSG-LLIKD 233 (328)
T ss_pred CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCC-CCCHHHHHHHhccCCccCCCCCCHHHHHHHHH-HcCCC
Confidence 8999999999876 678999999999999999999999994 333333333332110 12456666666 99999
Q ss_pred hhHHH-----HHhHHhcCCchhhHH
Q 014307 364 PHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 364 p~~r~-----~~~~ll~~~~~~~~~ 383 (427)
|..|+ ++.+++.|+||....
T Consensus 234 P~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 234 PNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 99997 899999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=329.47 Aligned_cols=234 Identities=21% Similarity=0.360 Sum_probs=193.7
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
||+|+||.||+|++..+++.||+|+++.. ....+.+|+.+|+++ +||||+++++++.. ...+++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 69999999999999999999999998642 224567899999999 99999999999876 5678999999999
Q ss_pred Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-CcceeeccC
Q 014307 216 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS 291 (427)
Q Consensus 216 ~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~~~~~~ 291 (427)
++|...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .......|+
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCC
Confidence 9987665 3589999999999999999999999999999999999999777 8999999999754322 223445789
Q ss_pred ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCChh
Q 014307 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELDPH 365 (427)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~dp~ 365 (427)
+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.+.. -.+.+.+++.+ |+..||.
T Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~ 233 (312)
T cd05585 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFY-DENVNEMYRKILQEPLRFPDGFDRDAKDLLIG-LLSRDPT 233 (312)
T ss_pred cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcC-CCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-HcCCCHH
Confidence 99999999887 689999999999999999999999994 333333333333211 12455666666 9999999
Q ss_pred HHH---HHhHHhcCCchhhH
Q 014307 366 LAA---LVGRLVILSYFFQF 382 (427)
Q Consensus 366 ~r~---~~~~ll~~~~~~~~ 382 (427)
.|+ .+.+++.||||.+.
T Consensus 234 ~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 234 RRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HcCCCCCHHHHHcCCCcCCC
Confidence 996 58999999999874
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.15 Aligned_cols=244 Identities=22% Similarity=0.376 Sum_probs=196.4
Q ss_pred CEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEecccc-------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~~-------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
+|++++.||+|+||.||+|++. .+++.||+|+++... .+.+.+|+.+++.+.+|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 4889999999999999999864 478999999986421 24567899999999779999999999876 55
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.+++||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~ 157 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCccccc
Confidence 788999999999987665 3589999999999999999999999999999999999999777 899999999976533
Q ss_pred CC--cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCHHHHH-HHHHH------hCChH
Q 014307 282 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLV-KIAKV------LGTDE 350 (427)
Q Consensus 282 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~--~~~~~l~-~i~~~------~~~~~ 350 (427)
.. ......|+..|+|||++.+...++.++|||||||++|||++|+.||.... .....+. .+.+. .-.+.
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPE 237 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHH
Confidence 32 22345789999999998764568899999999999999999999994322 2222222 22111 01234
Q ss_pred HHHHHHhccCCCChhHHH-----HHhHHhcCCchhhH
Q 014307 351 LNAYLNKYHIELDPHLAA-----LVGRLVILSYFFQF 382 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~-----~~~~ll~~~~~~~~ 382 (427)
+.+++.+ |+..||..|+ ++++++.|+||...
T Consensus 238 ~~~li~~-~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 238 AQDLLHK-LLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHH-HcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 4555555 9999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=336.96 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=201.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|++.+.||+|+||.||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~--~~~ 117 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQD--DKY 117 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCE
Confidence 357899999999999999999999999999999998642 223467899999999 99999999999876 567
Q ss_pred cEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 206 PSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+++||||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCCC
Confidence 899999999999987764 478889999999999999999999999999999999999777 89999999998664332
Q ss_pred c--ceeeccCccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CC
Q 014307 284 E--YNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GT 348 (427)
Q Consensus 284 ~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~ 348 (427)
. .....|++.|+|||++.+. ..++.++|||||||++|||++|+.|| .+.+.......+.... -+
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc-CCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 2 2345789999999998652 24889999999999999999999999 4444445555554321 12
Q ss_pred hHHHHHHHhccCCCChhH--HHHHhHHhcCCchhhH
Q 014307 349 DELNAYLNKYHIELDPHL--AALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~--r~~~~~ll~~~~~~~~ 382 (427)
.....++.. |+..+|.. |+++++++.|+||...
T Consensus 276 ~~~~~li~~-~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 276 KQAKDLICA-FLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHHH-HccChhhccCCCCHHHHhcCcccCCC
Confidence 344455555 88888876 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=327.67 Aligned_cols=242 Identities=22% Similarity=0.359 Sum_probs=200.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|+++++||+|+||.||+|++..++..+|+|+++.. ..+.+.+|+++|+++ +||||+++++++.. ...+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 80 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEISI 80 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEEE
Confidence 47899999999999999999999999999999998643 235688999999999 99999999999976 457899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
||||+.+++|..++. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++...... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc-c
Confidence 999999999987763 588999999999999999999986 699999999999999777 8999999999765332 2
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH----------------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI---------------------- 342 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i---------------------- 342 (427)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||... +..+ +..+
T Consensus 159 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPP-DAKE-LEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred cccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCC-CHHH-HHHHhcccccccccCCccccCccccc
Confidence 344578999999999886 67999999999999999999999999432 2111 1111
Q ss_pred ---------------------HHH------------hCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 343 ---------------------AKV------------LGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 343 ---------------------~~~------------~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
... .-.+++.+++.+ |+..||+.||++.+++.|+|+.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNK-CLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHH-HccCCcccCCCHHHHhcChHHhhcc
Confidence 000 012455566666 9999999999999999999998744
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=331.60 Aligned_cols=277 Identities=28% Similarity=0.484 Sum_probs=206.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---- 202 (427)
..++|++++.||.|+||.||+|.+..+++.||||++... ....+.+|+.+|+.+ +||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccc
Confidence 457899999999999999999999999999999998642 224567899999999 9999999999886422
Q ss_pred CCCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 203 SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
....++++|++ ++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccceecC
Confidence 23468899988 55665554 3599999999999999999999999999999999999999777 89999999998654
Q ss_pred CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccC
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l 360 (427)
. ......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.+... .+...
T Consensus 170 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~-~~~~~-- 243 (343)
T cd07878 170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGTPSPE-VLKKI-- 243 (343)
T ss_pred C--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCCCHH-HHHhc--
Confidence 3 3345678999999999877567899999999999999999999998 5566667777776665543321 11110
Q ss_pred CCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 361 ELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
.....+..+..+...+...- ...+....+.+.|+|++||. .+|++|+++..+++|||
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~mL~-~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 244 -SSEHARKYIQSLPHMPQQDL-----KKIFRGANPLAIDLLEKMLV-LDSDKRISASEALAHPY 300 (343)
T ss_pred -chhhHHHHhhccccccchhH-----HHhccCCCHHHHHHHHHHcC-CChhhCCCHHHHhcCcc
Confidence 01111111111111111000 00112234556788888884 88888888888888886
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.19 Aligned_cols=238 Identities=21% Similarity=0.315 Sum_probs=196.9
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|+++.+++.||+|+++.. ....+..|.+++..+.+||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~--~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT--KDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCeEEEEEeCC
Confidence 3699999999999999999999999998642 123466788998877689999999999976 45789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Ccceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~~~~ 289 (427)
.+++|...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... .......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccccc
Confidence 999987654 3588999999999999999999999999999999999999777 8999999998754322 2234457
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (427)
|+..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.... -.+....++.+ |+..|
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~-~L~~d 234 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPF-EADNEDDLFESILHDDVLYPVWLSKEAVSILKA-FMTKN 234 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-HhccC
Confidence 8999999999876 68999999999999999999999999 4445555555444321 13455566666 99999
Q ss_pred hhHHH-------HHhHHhcCCchhhHH
Q 014307 364 PHLAA-------LVGRLVILSYFFQFV 383 (427)
Q Consensus 364 p~~r~-------~~~~ll~~~~~~~~~ 383 (427)
|..|+ ++++++.||||....
T Consensus 235 p~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 235 PNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred HHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 99999 999999999997644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.34 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=198.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|++.+.||+|+||.||+|+++.+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~ 117 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD--DKY 117 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCE
Confidence 357899999999999999999999999999999998642 224477899999998 99999999999976 567
Q ss_pred cEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 206 PSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceecccCC
Confidence 899999999999987764 478899999999999999999999999999999999999777 89999999998764332
Q ss_pred c--ceeeccCccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------C
Q 014307 284 E--YNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------T 348 (427)
Q Consensus 284 ~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~ 348 (427)
. ....+||+.|+|||++.+. ..++.++|||||||++|||++|+.||. +.+.......+..... .
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY-ADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 2 2355799999999998652 237899999999999999999999994 4455555555544211 2
Q ss_pred hHHHHHHHhccCCCChh--HHHHHhHHhcCCchhhH
Q 014307 349 DELNAYLNKYHIELDPH--LAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~--~r~~~~~ll~~~~~~~~ 382 (427)
+....++.. ++..++. .|+++.+++.||||+..
T Consensus 276 ~~~~~li~~-~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 276 KHAKNLICA-FLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHH-HccCchhccCCCCHHHHhcCcccCCC
Confidence 233444444 6654333 27799999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.36 Aligned_cols=238 Identities=22% Similarity=0.354 Sum_probs=196.5
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|+++.+++.||||+++.. ....+..|..++..+.+||||+++++++.. ...+++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999998642 234567888888887689999999999976 56789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~~ 289 (427)
.+++|...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCcccccc
Confidence 999987655 3589999999999999999999999999999999999999777 899999999875432 22334457
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (427)
|++.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.+.. -.+...+++.+ |+..|
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~L~~d 234 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLSQDAVDILKA-FMTKN 234 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCC-CCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-HcccC
Confidence 8999999999876 67899999999999999999999999 4445455454444321 13445565655 99999
Q ss_pred hhHHHHH------hHHhcCCchhhHH
Q 014307 364 PHLAALV------GRLVILSYFFQFV 383 (427)
Q Consensus 364 p~~r~~~------~~ll~~~~~~~~~ 383 (427)
|..|+++ ++++.|+||....
T Consensus 235 P~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 235 PTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred HHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 9999998 8999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=332.45 Aligned_cols=243 Identities=24% Similarity=0.366 Sum_probs=200.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||+||+|+++.+++.||+|+++.. ..+.+.+|+.+++.+ +|+||+++++++.+ ...++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~--~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQD--KDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeEE
Confidence 4689999999999999999999999999999998743 234577899999988 99999999999876 45789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..+....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCC
Confidence 999999999988775 3589999999999999999999999999999999999999777 89999999998765433
Q ss_pred cc--eeeccCccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------
Q 014307 284 EY--NVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------- 346 (427)
Q Consensus 284 ~~--~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------- 346 (427)
.. ....|++.|+|||++.. ...++.++|||||||++|||++|+.||. .....+.+..+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAKTYNNIMNFQRFLKFPEDPK 235 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC-CCCHHHHHHHHHcCCCccCCCCCCC
Confidence 22 23478999999999863 2567899999999999999999999994 344444444443321
Q ss_pred CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 347 GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 ~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
-.+.+..++.. |+. +|..|+++.+++.||||....
T Consensus 236 ~~~~~~~li~~-ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 236 VSSDFLDLIQS-LLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred CCHHHHHHHHH-Hcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 12345555655 776 999999999999999998643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=328.34 Aligned_cols=244 Identities=24% Similarity=0.437 Sum_probs=215.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH-----HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.-|.+.+.||+|.|+.|-+|++.-+|+.||||++++.+. ..+.+|++.|+-+ +|||||++|++... ...+||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDT--QTKlyL 94 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDT--QTKLYL 94 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhcc--cceEEE
Confidence 347888999999999999999999999999999986543 5588999999998 99999999999865 456899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|+|..++|+|..++ ..+.+..+++|+.||+.|+.|+|+..+|||||||+||.+=...+.|||.|||++..+.++..
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k 174 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK 174 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch
Confidence 99999999988776 35899999999999999999999999999999999998765666899999999999999999
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC------hHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~------~~~~~~l~~~ 358 (427)
.++.+|+..|-|||+++|...-.+++||||||||||.|++|+.|| ...++.+.+.+|..+-.+ .+-..+|..
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF-qeANDSETLTmImDCKYtvPshvS~eCrdLI~s- 252 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF-QEANDSETLTMIMDCKYTVPSHVSKECRDLIQS- 252 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc-ccccchhhhhhhhcccccCchhhhHHHHHHHHH-
Confidence 999999999999999999555557899999999999999999999 566788999988876543 344455555
Q ss_pred cCCCChhHHHHHhHHhcCCchhhH
Q 014307 359 HIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
|+.-||..|.+++++..++|++..
T Consensus 253 MLvRdPkkRAslEeI~s~~Wlq~~ 276 (864)
T KOG4717|consen 253 MLVRDPKKRASLEEIVSTSWLQAG 276 (864)
T ss_pred HHhcCchhhccHHHHhccccccCC
Confidence 999999999999999999998763
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=327.05 Aligned_cols=243 Identities=22% Similarity=0.317 Sum_probs=199.4
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+|++.+.||+|+||.||+|++..+++.||+|+++... ...+..|..++..+.+|++|+++++++.. ...+++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 4889999999999999999999999999999987421 23456788888887678999999999876 457899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCc
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~ 284 (427)
||||+.+++|...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCCCc
Confidence 99999999987665 3589999999999999999999999999999999999999777 899999999975432 223
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (427)
.....|++.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.... -.+....++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 234 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG- 234 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH-
Confidence 345678999999999886 78999999999999999999999999 4444445444444321 12455555555
Q ss_pred cCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 359 HIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
|+..+|..|+. ..+++.|+||....
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 235 LMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred HcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 99999999997 48899999997543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=328.70 Aligned_cols=243 Identities=21% Similarity=0.400 Sum_probs=195.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|+++++||+|+||.||+|++..+++.||||++.... ...+.+|+++++.+ +|+||+++++++.. ...+++|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 150 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH--NGEIQVL 150 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc--CCeEEEE
Confidence 56788899999999999999999999999999985432 35688999999999 99999999999976 5678999
Q ss_pred EeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cceee
Q 014307 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR 288 (427)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~~~ 288 (427)
|||+.+++|... ....+..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+.... .....
T Consensus 151 ~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 151 LEFMDGGSLEGT-HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred EecCCCCccccc-ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceeccccccccccc
Confidence 999999988653 2456778889999999999999999999999999999999776 89999999998764332 23456
Q ss_pred ccCccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-CHHHHH-HHHHH-------hCChHHHHHH
Q 014307 289 VASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLV-KIAKV-------LGTDELNAYL 355 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~----~~~~~~~DvwSlGvll~elltg~~pf~~~~~-~~~~l~-~i~~~-------~~~~~~~~~l 355 (427)
.|+..|+|||++... ...+.++|||||||++|||++|+.||..... +...+. .+... ...+.+.+++
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 308 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFI 308 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHH
Confidence 789999999987431 2345689999999999999999999953221 111111 11111 1124556666
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
.. |+..||+.|+++.+++.|+|+.+.
T Consensus 309 ~~-~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 309 SC-CLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HH-HccCChhhCcCHHHHhcCcccccC
Confidence 66 999999999999999999999874
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=312.37 Aligned_cols=285 Identities=25% Similarity=0.440 Sum_probs=228.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCe----EEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..|++.++||+|+||.||+|..+.++. .+|||.++..+ ....-+|+.+++.| +|||++.+..+|-.. +.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-Cc
Confidence 568999999999999999997665543 68999987653 24466899999999 999999999998765 67
Q ss_pred CcEEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC---CeEEEEeee
Q 014307 205 TPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWG 274 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---~~ikl~DFG 274 (427)
.+++++||.+...+.... +.++...++.++.||+.|+.|||++-|+||||||+|||+..++ +.|||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 899999999987765332 3589999999999999999999999999999999999998662 389999999
Q ss_pred eeeeecCCC----cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CCHHHHHHH
Q 014307 275 LAEFYHPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--------DNYDQLVKI 342 (427)
Q Consensus 275 la~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~--------~~~~~l~~i 342 (427)
+|+.+...- .....+.|.+|+|||.+.|...|+.+.|||++|||+.||++-++.|.... -..+|+.+|
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rI 261 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRI 261 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHH
Confidence 998875432 23456789999999999998899999999999999999999987774221 135789999
Q ss_pred HHHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCC
Q 014307 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGES 422 (427)
Q Consensus 343 ~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~ 422 (427)
.+.+|.|....|..- ..-|+-.-.+...-.+-|..--+...|+....-.+..++||.+||. ++|..|+|+...++|
T Consensus 262 f~vLG~Pt~~~Wp~l---kk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~-yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 262 FEVLGTPTDKDWPDL---KKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLT-YDPIKRITAEQALEH 337 (438)
T ss_pred HHHcCCCccccchhh---hhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhc-cCchhhccHHHHhcc
Confidence 999998876655321 3346665566666666555543433444444455569999999995 999999999999999
Q ss_pred CC
Q 014307 423 AF 424 (427)
Q Consensus 423 ~~ 424 (427)
+|
T Consensus 338 ~y 339 (438)
T KOG0666|consen 338 PY 339 (438)
T ss_pred cc
Confidence 87
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=334.12 Aligned_cols=242 Identities=25% Similarity=0.409 Sum_probs=198.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||.||+|+++.+++.||+|+++.. ....+.+|+.++..+ +|+||+++++.+.+ ...++
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQD--KRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 4689999999999999999999999999999998642 234577899999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccc
Confidence 999999999987765 3589999999999999999999999999999999999999777 89999999986542210
Q ss_pred -----------------------------------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 014307 284 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328 (427)
Q Consensus 284 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~p 328 (427)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence 0113478999999999887 6899999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHh----------CChHHHHHHHhccCCCChhHHH---HHhHHhcCCchhhHH
Q 014307 329 FFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHIELDPHLAA---LVGRLVILSYFFQFV 383 (427)
Q Consensus 329 f~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l~~dp~~r~---~~~~ll~~~~~~~~~ 383 (427)
| .+.+..+....+.... -.+....++.+ ++ .+|..|+ .+++++.||||....
T Consensus 236 f-~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~-l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 236 F-CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILR-FC-TDSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred C-CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHH-hc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence 9 4445555544444311 13455566666 44 4898888 489999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=325.97 Aligned_cols=238 Identities=24% Similarity=0.380 Sum_probs=194.2
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|+++.+++.||+|+++.. .......|..++..+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 4699999999999999999999999999742 234567788888876689999999999976 56789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~~ 289 (427)
.+++|...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... ........
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceeccC
Confidence 999987665 3588999999999999999999999999999999999999777 899999999875322 22334567
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (427)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.... -.+++.+++.+ |+..|
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~d 234 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFH-GDDEDELFESIRVDTPHYPRWITKESKDILEK-LFERD 234 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-HccCC
Confidence 8999999999886 689999999999999999999999994 434333333332211 12455566665 99999
Q ss_pred hhHHHHH-hHHhcCCchhhHH
Q 014307 364 PHLAALV-GRLVILSYFFQFV 383 (427)
Q Consensus 364 p~~r~~~-~~ll~~~~~~~~~ 383 (427)
|..|+++ ++++.|+||....
T Consensus 235 P~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 235 PTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred HHHcCCChHHHHcCCCcCCCC
Confidence 9999997 5899999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=326.28 Aligned_cols=238 Identities=24% Similarity=0.387 Sum_probs=193.8
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|++..+++.||+|+++.. ..+.+..|..++..+.+||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999999999999998642 223456677777766689999999999976 56789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Ccceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~~~~ 289 (427)
.+++|...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..... .......
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCcccccc
Confidence 999987665 3589999999999999999999999999999999999999777 8999999999765332 2334557
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (427)
|+..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.... -.++..+++.+ |+..+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~-~l~~~ 234 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPF-HGEDEDELFDSILNDRPHFPRWISKEAKDCLSK-LFERD 234 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-HccCC
Confidence 8999999999876 67999999999999999999999999 4444444444443221 12345555555 99999
Q ss_pred hhHHHHH-hHHhcCCchhhHH
Q 014307 364 PHLAALV-GRLVILSYFFQFV 383 (427)
Q Consensus 364 p~~r~~~-~~ll~~~~~~~~~ 383 (427)
|..|+++ .+++.|+||....
T Consensus 235 P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 235 PTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred HHHcCCChHHHHcCcccCCCC
Confidence 9999976 5889999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.73 Aligned_cols=237 Identities=24% Similarity=0.388 Sum_probs=194.2
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+++++.+ +||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 3699999999999999999999999998742 124467899999998 99999999999876 55789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceee
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~ 288 (427)
.+++|...+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccc
Confidence 999987654 358999999999999999999997 7999999999999999777 899999999875432 2233445
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH------hCChHHHHHHHhccCCC
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNKYHIEL 362 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~~~l~~ 362 (427)
.|+..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+... .-.+++..++.. |+..
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~-~L~~ 233 (325)
T cd05594 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFELILMEEIRFPRTLSPEAKSLLSG-LLKK 233 (325)
T ss_pred cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCC-CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-Hhhc
Confidence 79999999999876 689999999999999999999999994 33333333333211 123455666655 9999
Q ss_pred ChhHHH-----HHhHHhcCCchhhHH
Q 014307 363 DPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 363 dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
||..|+ ++.+++.|+||....
T Consensus 234 dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 234 DPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 999996 899999999998643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=333.12 Aligned_cols=246 Identities=25% Similarity=0.452 Sum_probs=213.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|..++.+|+|+||.+++++++.++..+++|.+.-. .+....+|+.+++++ .|||||.+.+.|+.. +.+++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence 36799999999999999999999999999999998632 234678999999998 999999999999873 45589
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
|||+|++||++.+.+. .+++..+..++.|++.|+.|||+++|+|||||+.||+++.++ .|||.|||+|+.+.+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCc
Confidence 9999999999987763 389999999999999999999999999999999999999888 7899999999998877
Q ss_pred C-cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh------HHHHHH
Q 014307 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD------ELNAYL 355 (427)
Q Consensus 283 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~------~~~~~l 355 (427)
. ...+.+||++||.||.+.+ .+|+.|+|||||||++|||++-+.+| ...+......+|.+....| .-...+
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF-~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAF-KASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhccccc-CccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 6 5677899999999999988 79999999999999999999999998 5666666667777766332 223344
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+.|+..+|+.||++.+||.+|...+..
T Consensus 238 v~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 5559999999999999999998777533
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=330.63 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=195.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc--CCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
..+|++++.||.|+||.||+|... .++..||+|.+... ....+|+.+|+++ +||||+++++++.. ....+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRW--KSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEee--CCEEEEEe
Confidence 457999999999999999999764 35678999988643 3457899999999 99999999999976 45789999
Q ss_pred eecCCCchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc---c
Q 014307 211 EHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---Y 285 (427)
Q Consensus 211 e~~~~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~---~ 285 (427)
|++.+..+..+ ...+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........ .
T Consensus 166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccCcccccccc
Confidence 99986544433 24589999999999999999999999999999999999999777 899999999976543322 2
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhC----------------
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLG---------------- 347 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--~~~~l~~i~~~~~---------------- 347 (427)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||+.... ...++..+.+.++
T Consensus 245 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 245 YGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred cccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 23578999999999876 6799999999999999999999999964322 2334444433322
Q ss_pred ------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..++..++ ..|+..||..||++.+++.||||.+..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLI-AKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHH-HHHhccChhhCCCHHHHhhCchhhccc
Confidence 11233334 459999999999999999999999865
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=319.87 Aligned_cols=281 Identities=22% Similarity=0.427 Sum_probs=199.6
Q ss_pred EeeeeecCCeeEEEEEEcC--CCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 139 VRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~--~~~~vavK~~~~~~-~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
..+||+|+||+||+|+++. ++..||+|.++... ...+.+|+.+|+++ +||||+++++++.......++++|||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 3679999999999999754 56889999987543 34678999999999 99999999999987667788999999987
Q ss_pred Cchhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC---CCCeEEEEeeeeeeeecC
Q 014307 216 TDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 216 ~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~ikl~DFGla~~~~~ 281 (427)
+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +...+||+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 5443221 13788889999999999999999999999999999999942 223799999999986643
Q ss_pred CC----cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHHHHHhCCh
Q 014307 282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQLVKIAKVLGTD 349 (427)
Q Consensus 282 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--------~~~~l~~i~~~~~~~ 349 (427)
.. ......++..|+|||++.+...++.++|||||||++|||++|+.||..... ..+++..+...++.+
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence 32 123457788999999987656689999999999999999999999953322 134455555555543
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH-HhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV-IYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~-~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
....|-........+..... .....+..... ..+..........+.++|++||. .||++|+|+..++.|||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~-~dP~~R~t~~e~l~hp~ 316 (317)
T cd07867 245 ADKDWEDIRKMPEYPTLQKD---FRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT-MDPTKRITSEQALQDPY 316 (317)
T ss_pred Chhhhhhhhhcccchhhhhh---hcccccCCchhhhhhhcccCCCChHHHHHHHHHhc-cCcccccCHHHHhcCCC
Confidence 32222111001111111111 10000000000 00000011123468899999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.42 Aligned_cols=236 Identities=22% Similarity=0.344 Sum_probs=191.1
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
||+|+||+||+|.+..+++.||+|.+.... .+.+..|+.+++.+ +|+||+++.+++.. ....++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 699999999999999999999999986422 24467899999999 99999999999876 4568999999999
Q ss_pred Cchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-cee
Q 014307 216 TDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNV 287 (427)
Q Consensus 216 ~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~~~ 287 (427)
++|...+ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++..+..... ...
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCccccc
Confidence 9986543 2488999999999999999999999999999999999999766 899999999976644332 234
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH---HHHHHHH------hCChHHHHHHHhc
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ---LVKIAKV------LGTDELNAYLNKY 358 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~---l~~i~~~------~~~~~~~~~l~~~ 358 (427)
..|++.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+... .-++.+..++..
T Consensus 157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~- 234 (280)
T cd05608 157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEA- 234 (280)
T ss_pred cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHH-
Confidence 578899999999887 68899999999999999999999999543222111 1111111 012345555555
Q ss_pred cCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 359 HIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
|+..||..|+ ++++++.||||+...
T Consensus 235 ~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 235 LLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred HhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 9999999999 889999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=326.18 Aligned_cols=243 Identities=25% Similarity=0.375 Sum_probs=195.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||++++..+++.||+|+++.. ..+.+.+|+.++..+ +|+||+++++++.+ ..+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQD--ENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEec--CCeEE
Confidence 4799999999999999999999999999999998642 224477899999998 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCC
Confidence 999999999987765 3588999999999999999999999999999999999999777 89999999997664433
Q ss_pred cc--eeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-----------
Q 014307 284 EY--NVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------- 346 (427)
Q Consensus 284 ~~--~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------- 346 (427)
.. ....|++.|+|||++.+ ...++.++|||||||++|||++|+.||. +.+..+....+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~ 235 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKEHFQFPPDVTD 235 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC-CCCHHHHHHHHHcCCCcccCCCccCC
Confidence 22 23468999999999863 2457889999999999999999999994 444444444443221
Q ss_pred CChHHHHHHHhccCCCCh--hHHHHHhHHhcCCchhhH
Q 014307 347 GTDELNAYLNKYHIELDP--HLAALVGRLVILSYFFQF 382 (427)
Q Consensus 347 ~~~~~~~~l~~~~l~~dp--~~r~~~~~ll~~~~~~~~ 382 (427)
-++....++.+ |+..++ .-|+.+.+++.||||...
T Consensus 236 ~~~~~~~li~~-ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 236 VSEEAKDLIRR-LICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCHHHHHHHHH-HccCcccccCCCCHHHHhcCCCCCCC
Confidence 13345555555 554433 337799999999999763
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=325.94 Aligned_cols=238 Identities=24% Similarity=0.405 Sum_probs=193.0
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|..++..+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 3699999999999999999999999999742 124477899999998789999999999976 45789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee-cCCCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~-~~~~~~~~~~ 289 (427)
.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.. ..........
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCcccccc
Confidence 999987654 4699999999999999999999999999999999999999777 8999999998743 2233344568
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------CCHHHHHH-HHHHh------CChHHHHHH
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------DNYDQLVK-IAKVL------GTDELNAYL 355 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-------~~~~~l~~-i~~~~------~~~~~~~~l 355 (427)
|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.... ...+.+.+ +.... -.+.+..++
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li 236 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 8999999999887 689999999999999999999999994211 11122221 21110 123455555
Q ss_pred HhccCCCChhHHHH------HhHHhcCCchhhH
Q 014307 356 NKYHIELDPHLAAL------VGRLVILSYFFQF 382 (427)
Q Consensus 356 ~~~~l~~dp~~r~~------~~~ll~~~~~~~~ 382 (427)
.+ |+..||..|++ +.+++.||||...
T Consensus 237 ~~-~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 237 KG-FLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HH-HhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 55 99999999987 7899999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=326.20 Aligned_cols=237 Identities=24% Similarity=0.378 Sum_probs=194.6
Q ss_pred eeeeecCCeeEEEEEEc---CCCeEEEEEEecccc-------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 140 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~~-------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+.||+|+||.||+|++. .+++.||+|+++... ...+.+|+.+|+.+ +||||+++++++.. +..+++|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQT--GGKLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEec--CCeEEEE
Confidence 67999999999999864 468899999986421 23467899999999 99999999999976 4578999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cc
Q 014307 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~ 285 (427)
|||+.+++|...+. .+.+..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcc
Confidence 99999999876653 478889999999999999999999999999999999999777 89999999987543222 23
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhcc
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYH 359 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~ 359 (427)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+.. -.+.+.+++.+ |
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~ 234 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPF-TAENRKKTIDKILKGKLNLPPYLTPEARDLLKK-L 234 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-H
Confidence 34578999999999876 67899999999999999999999999 4444444444444321 13455566666 9
Q ss_pred CCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 360 IELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 360 l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
+..+|..|+ ++++++.|+||....
T Consensus 235 l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 235 LKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred cccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 999999999 899999999997643
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=330.19 Aligned_cols=233 Identities=17% Similarity=0.356 Sum_probs=187.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..+...++..||+|.||+||+|++ -..||||+++. ...+.|++|+.+|++- +|.||+-+.|++..+. +
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~w---hGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~~p~---~ 462 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRW---HGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACMNPP---L 462 (678)
T ss_pred CHHHhhccceeccccccceeeccc---ccceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhcCCc---e
Confidence 446678899999999999999998 34699999863 3457799999999998 9999999999998642 3
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee---e
Q 014307 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---Y 279 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~---~ 279 (427)
.+|+-+|+|.+|..++. +|.....+.|++||++|+.|||.++|||||||..||++..++ +|||+|||++.. +
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KVKIGDFGLATVKTRW 541 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cEEEecccceeeeeee
Confidence 79999999999987763 588888999999999999999999999999999999999766 999999999842 3
Q ss_pred cCCCcceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHhC---------
Q 014307 280 HPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLG--------- 347 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~-~i~~~~~--------- 347 (427)
..........|...|||||++.. ..+|++.+|||||||++|||++|..||. ..+.+++. ++-+...
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~l~pd~s~~~s 619 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGYLMPDLSKIRS 619 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccccCccchhhhc
Confidence 33444566678888999999853 3579999999999999999999999994 44455433 3333322
Q ss_pred --ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 --TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 --~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+..+.+++.. ||..+++.||...+||.
T Consensus 620 ~~pk~mk~Ll~~-C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 620 NCPKAMKRLLSD-CWKFDREERPLFPQLLS 648 (678)
T ss_pred cCHHHHHHHHHH-HHhcCcccCccHHHHHH
Confidence 2255555555 78888888887666554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=326.47 Aligned_cols=239 Identities=20% Similarity=0.361 Sum_probs=185.8
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.++||+|+||.||+|.+. .++..||||+++... ...+.+|+.+|..+.+||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 3578999999999999999999753 345689999986422 356889999999997899999999988754
Q ss_pred CCCcEEEEeecCCCchhhhcC-----------------------------------------------------------
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP----------------------------------------------------------- 223 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------------- 223 (427)
...++++|||+.+|+|..++.
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 456789999999999865542
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc---eeeccCccc
Q 014307 224 ------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYF 294 (427)
Q Consensus 224 ------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y 294 (427)
.+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++........ ....++..|
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCccc
Confidence 266778889999999999999999999999999999999776 8999999999765332221 123445679
Q ss_pred cccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH-HHHHHh-------CChHHHHHHHhccCCCChh
Q 014307 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV-KIAKVL-------GTDELNAYLNKYHIELDPH 365 (427)
Q Consensus 295 ~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~-~i~~~~-------~~~~~~~~l~~~~l~~dp~ 365 (427)
+|||++.+ ..++.++|||||||++|||++ |..||. +....+.+. .+.... -++.+..++.+ |+..||.
T Consensus 243 ~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dp~ 319 (338)
T cd05102 243 MAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQINEEFCQRLKDGTRMRAPENATPEIYRIMLA-CWQGDPK 319 (338)
T ss_pred cCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCC-CCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHH-HccCChh
Confidence 99999876 679999999999999999997 999984 333223222 222111 12345555555 8899999
Q ss_pred HHHHHhHHhc
Q 014307 366 LAALVGRLVI 375 (427)
Q Consensus 366 ~r~~~~~ll~ 375 (427)
.||++.+++.
T Consensus 320 ~RPs~~el~~ 329 (338)
T cd05102 320 ERPTFSALVE 329 (338)
T ss_pred hCcCHHHHHH
Confidence 9998887764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=340.54 Aligned_cols=258 Identities=24% Similarity=0.406 Sum_probs=214.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH---HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.+-|+|+..||.|+||.||+|..+.++-..|.|++..... +.+.-||.||..+ +||+||++++.|.. .+.++++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~--enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYF--ENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhc--cCceEEE
Confidence 3446688899999999999999998888899999976554 4466799999997 99999999998876 5568899
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee-cCCCc
Q 014307 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~-~~~~~ 284 (427)
.|||.||-....+ ..+++.++..+++|++.||.|||+++|||||||+.|||++.+| .|+|+|||.+... .....
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhHHhh
Confidence 9999999865443 5699999999999999999999999999999999999999988 8999999997533 22344
Q ss_pred ceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHH
Q 014307 285 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDEL 351 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~ 351 (427)
...+.||++|||||++.+ ..+|+.++||||||++|.||..+.+|. ...+++..+.+|.+.-- +..+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-helnpMRVllKiaKSePPTLlqPS~Ws~~F 265 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPPTLLQPSHWSRSF 265 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-cccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence 567899999999999864 367999999999999999999999887 66777777777776421 1244
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhh
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFL 405 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l 405 (427)
..++.+ |+..||..||.+.+|+.|||+.... .+++..+||-.+-
T Consensus 266 ~DfLk~-cL~Knp~~Rp~aaqll~Hpfv~~~~---------SnK~ireLlAEak 309 (1187)
T KOG0579|consen 266 SDFLKR-CLVKNPRNRPPAAQLLKHPFVQNAP---------SNKMIRELLAEAK 309 (1187)
T ss_pred HHHHHH-HHhcCCccCCCHHHHhhCcccccCC---------cchHHHHHHHHHH
Confidence 555555 9999999999999999999999655 5566666655543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=323.73 Aligned_cols=238 Identities=21% Similarity=0.352 Sum_probs=195.6
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||+||+|++..+++.||||+++.. ....+.+|+.+++.+.+||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 4699999999999999999999999998742 234567889999888689999999999976 45789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~~ 289 (427)
.+++|...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... .......+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCccccee
Confidence 999987654 3589999999999999999999999999999999999999777 899999999875322 22234457
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (427)
|+..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+.... -++...+++.+ |+..|
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~d 234 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPF-EGDDEDELFQSILEDEVRYPRWLSKEAKSILKS-FLTKN 234 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCC-CCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-HccCC
Confidence 8999999999887 68999999999999999999999999 4444333333332211 13445555555 99999
Q ss_pred hhHHHHH-----hHHhcCCchhhHH
Q 014307 364 PHLAALV-----GRLVILSYFFQFV 383 (427)
Q Consensus 364 p~~r~~~-----~~ll~~~~~~~~~ 383 (427)
|..|+++ .+++.|+||....
T Consensus 235 P~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 235 PEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred HHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 9999999 9999999998744
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=314.01 Aligned_cols=242 Identities=22% Similarity=0.357 Sum_probs=199.3
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+|++.+.||+|+||+||+|.+..+++.||+|.+.... ...+.+|+.+++++ +|++|+.+++.+.+ ...+++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEec--CCEEEE
Confidence 3778899999999999999999999999999886421 23467899999999 99999999999876 457899
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
||||+.+++|...+ ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCc
Confidence 99999999987654 2488999999999999999999999999999999999999777 79999999998665444
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHH-------hCChHHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKV-------LGTDELNAY 354 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~--~~~l~~i~~~-------~~~~~~~~~ 354 (427)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .+....+.+. ...+.+.++
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL 235 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence 4445678999999999876 67999999999999999999999999543221 1222222111 123445555
Q ss_pred HHhccCCCChhHHHH-----HhHHhcCCchhhH
Q 014307 355 LNKYHIELDPHLAAL-----VGRLVILSYFFQF 382 (427)
Q Consensus 355 l~~~~l~~dp~~r~~-----~~~ll~~~~~~~~ 382 (427)
+.. |+..||..|++ +++++.|+||.+.
T Consensus 236 i~~-~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 236 CKM-LLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred HHH-HhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 555 99999999999 8999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=328.39 Aligned_cols=240 Identities=21% Similarity=0.330 Sum_probs=192.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
..+|++++.||+|+||.||+|++..+++.||+|+... .....|+.+++++ +|+||+++++++.. ....++|||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVS--GAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEe--CCeeEEEEEc
Confidence 4579999999999999999999999999999998643 3345799999999 99999999999986 4567899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeec
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~ 289 (427)
+.+..+..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.............
T Consensus 139 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred cCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccccCccccccc
Confidence 9765544432 3589999999999999999999999999999999999999777 89999999997544333344567
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC---------HHHHHHHHHHhC-------------
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN---------YDQLVKIAKVLG------------- 347 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~---------~~~l~~i~~~~~------------- 347 (427)
|+..|+|||++.+ ..++.++|||||||++|||+++..|++..... ..++..+...++
T Consensus 218 gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 218 GTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred ccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 8999999999887 67999999999999999999876666443221 122222222221
Q ss_pred ---------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 348 ---------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 348 ---------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
..+... +...|+..||..||++.+++.||||++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEF-LVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHH-HHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 111222 344499999999999999999999975
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=321.60 Aligned_cols=238 Identities=23% Similarity=0.358 Sum_probs=194.0
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||+||+|++..+++.||||+++.. .......|..++..+.+||||+++++++.+ ...+++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 4699999999999999999999999998753 224456788888775599999999999976 45789999999
Q ss_pred CCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceeec
Q 014307 214 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~~ 289 (427)
.+++|...+. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... ........
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceeeec
Confidence 9999977753 588999999999999999999999999999999999999777 899999999875432 22334567
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~d 363 (427)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.... -.....+++.+ |+..+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~~ 234 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFH-GHDEEELFQSIRMDNPCYPRWLTREAKDILVK-LFVRE 234 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH-HhccC
Confidence 8999999999876 679999999999999999999999994 444333333332211 12345555655 99999
Q ss_pred hhHHHHHh-HHhcCCchhhHH
Q 014307 364 PHLAALVG-RLVILSYFFQFV 383 (427)
Q Consensus 364 p~~r~~~~-~ll~~~~~~~~~ 383 (427)
|..|+++. +++.||||....
T Consensus 235 P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 235 PERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HhhcCCChHHHHcCcccCCCC
Confidence 99999996 899999998744
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=329.94 Aligned_cols=244 Identities=25% Similarity=0.399 Sum_probs=197.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|++.+.||+|+||.||+|+++.+++.+|+|++... ....+.+|+.+++.+ +||||+++++.+.+ ...
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~~~ 117 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DRY 117 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCE
Confidence 457899999999999999999999999999999998632 124467899999998 99999999999976 567
Q ss_pred cEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 206 PSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCC
Confidence 899999999999887764 478889999999999999999999999999999999999777 89999999998764332
Q ss_pred c--ceeeccCccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------C
Q 014307 284 E--YNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------T 348 (427)
Q Consensus 284 ~--~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~ 348 (427)
. .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||. +.+.......+..... .
T Consensus 197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 2 2355799999999998652 238899999999999999999999994 4444444444443211 2
Q ss_pred hHHHHHHHhccCCCChhH---HHHHhHHhcCCchhhH
Q 014307 349 DELNAYLNKYHIELDPHL---AALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~---r~~~~~ll~~~~~~~~ 382 (427)
+....++.. |+. +|.. |++++++++|+||+..
T Consensus 276 ~~~~~li~~-~L~-~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 276 KEAKNLICA-FLT-DREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHH-HcC-ChhhhcCCCCHHHHhcCcccCCC
Confidence 233444444 666 4444 6789999999999763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=317.39 Aligned_cols=272 Identities=29% Similarity=0.503 Sum_probs=211.3
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||+|+||.||+|++..+|+.+|+|.++... ...+.+|+.+++++ +|+||+++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHS--DKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhcc--CCceEEE
Confidence 4889999999999999999999999999999986421 24577899999999 99999999999976 5578999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Ccc
Q 014307 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~ 285 (427)
+||+.++.+..+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...... ...
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCCCc
Confidence 9999875444332 3589999999999999999999999999999999999999776 8999999999765432 223
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCChh
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~ 365 (427)
....++..|+|||++.+...++.++|||||||++|+|++|+.||+.+.+..+.+..+.+.++.+....+...
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 228 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV-------- 228 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh--------
Confidence 345678889999998775568999999999999999999999988887777777777777665543322111
Q ss_pred HHHHHhHHhcCCchhhHH--HhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 366 LAALVGRLVILSYFFQFV--IYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 366 ~r~~~~~ll~~~~~~~~~--~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
.++.....+.... ...........+.+.++|++||. .+|.+|+|+..+++|||
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 229 -----SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLV-CNPVQRISAEEALQHPY 283 (284)
T ss_pred -----hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhc-CChhhcCCHHHHhcCCC
Confidence 1111100000000 00000112246788899999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=316.65 Aligned_cols=245 Identities=27% Similarity=0.553 Sum_probs=198.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..++|++.++||.|+||.||+|++..+++.||+|.++... ...+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEec--CCeEE
Confidence 4578999999999999999999999999999999986322 34577899999999 99999999999976 45789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+||||+.+ ++...+ ..+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCC
Confidence 99999986 444332 2478899999999999999999999999999999999999777 89999999997543222
Q ss_pred -cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 014307 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (427)
Q Consensus 284 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------------- 347 (427)
......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+...++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 2233466888999999876566889999999999999999999998 44444444443333221
Q ss_pred ---------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ---------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ---------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+...+++.+ |+..||..|+++.+++.|+||....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSK-LLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHH-HhcCCcccCcCHHHHhcCccccccc
Confidence 1233344444 9999999999999999999997644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=323.40 Aligned_cols=239 Identities=24% Similarity=0.393 Sum_probs=192.4
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|++..+++.||+|+++.. ....+.+|+.++.++.+||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 3699999999999999999999999998742 124467899888887789999999999976 46789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-CCCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~~~~~~~~~ 289 (427)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCcccccc
Confidence 999987654 3689999999999999999999999999999999999999877 89999999997532 223334567
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------CCHHHHHHHHHHh-------CChHHHHHH
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------DNYDQLVKIAKVL-------GTDELNAYL 355 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-------~~~~~l~~i~~~~-------~~~~~~~~l 355 (427)
|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.+.+..... -......++
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll 236 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVL 236 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 8999999999887 688999999999999999999999994211 1112222211111 123444555
Q ss_pred HhccCCCChhHHHH------HhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAAL------VGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~------~~~ll~~~~~~~~~ 383 (427)
.+ |+..||..|++ +.+++.||||....
T Consensus 237 ~~-~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 237 KS-FLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred HH-HhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 55 99999999998 58999999997643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=320.92 Aligned_cols=243 Identities=21% Similarity=0.310 Sum_probs=198.2
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+|+..+.||+|+||+||+|+++.+++.||+|+++.. ..+.+..|..++..+.+|++|+++++++.+ ...+++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT--VDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec--CCEEEE
Confidence 477889999999999999999999999999998642 123467788898888667888999998876 457899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-c
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~ 284 (427)
||||+.+++|...+ ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...... .
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCcc
Confidence 99999999987765 3589999999999999999999999999999999999999777 89999999987543222 2
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (427)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.... -.+....++.+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~- 234 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPF-DGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG- 234 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH-
Confidence 334568999999999876 67999999999999999999999999 4444444444444321 12344555555
Q ss_pred cCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 359 HIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
|+..+|..|+. ..+++.|+||....
T Consensus 235 ~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 235 LMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred HcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 89999999986 57899999998754
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=320.91 Aligned_cols=239 Identities=23% Similarity=0.399 Sum_probs=194.1
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||+||+|++..+++.||+|+++... .+.+.+|+.++.++.+||||+++++++.. ...+++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT--TSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe--CCEEEEEEeCC
Confidence 36999999999999999999999999997432 24477899999998789999999999976 45789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-CCCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~~~~~~~~~ 289 (427)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ........+
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceeccc
Confidence 999987654 4699999999999999999999999999999999999999777 89999999997532 233344567
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHHHHHh-------CChHHHHHHHh
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-----DNYDQLVKIAKVL-------GTDELNAYLNK 357 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-----~~~~~l~~i~~~~-------~~~~~~~~l~~ 357 (427)
|++.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.+....... -++....++.+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~ 236 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKG 236 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999999876 689999999999999999999999995321 1222232222111 12344455555
Q ss_pred ccCCCChhHHHH------HhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAAL------VGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~------~~~ll~~~~~~~~~ 383 (427)
|+..||..|++ +++++.|+||....
T Consensus 237 -~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 237 -FLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred -HhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 99999999987 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=311.07 Aligned_cols=238 Identities=31% Similarity=0.587 Sum_probs=193.1
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||.|++|.||+|++..+++.||+|.++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQ--ESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEee--CCeEEEE
Confidence 488999999999999999999889999999998632 235678999999999 89999999999976 5678999
Q ss_pred EeecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 210 FEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
|||+.+ ++..+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc
Confidence 999985 444332 3488999999999999999999999999999999999999777 89999999997654322
Q ss_pred -cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 014307 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (427)
Q Consensus 284 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------------- 347 (427)
......++..|+|||++.+...++.++|||||||++|+|++|+.||. +....+.+..+.+..+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 22334667889999998765568899999999999999999999984 4444333333222211
Q ss_pred --------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 --------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+++..+++.+ |+..||..||++.+++.|+||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEK-MLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHH-HhcCChhhCCCHHHHhcCCCC
Confidence 2334455555 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=333.39 Aligned_cols=243 Identities=23% Similarity=0.372 Sum_probs=201.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCC-CeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... ...+.+|+.+|+.+ +||||+++++++.. ....++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~--~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKS--DDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEE--CCEEEEE
Confidence 3499999999999999999998777 7889999764322 24567899999999 99999999999976 4678999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
|||+.+++|...+ ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+...
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDS 222 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCc
Confidence 9999999987543 2478999999999999999999999999999999999999777 8999999999876543
Q ss_pred Cc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHH
Q 014307 283 KE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELN 352 (427)
Q Consensus 283 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~ 352 (427)
.. ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+..... ++.+.
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 300 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPF-KGPSQREIMQQVLYGKYDPFPCPVSSGMK 300 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCCccCCHHHH
Confidence 22 234578999999999876 68999999999999999999999999 44444444544433211 24556
Q ss_pred HHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 353 AYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+++.+ |+..+|..||++.+++.++|++...
T Consensus 301 ~li~~-~L~~dP~~Rps~~~~l~~~~~~~~~ 330 (478)
T PTZ00267 301 ALLDP-LLSKNPALRPTTQQLLHTEFLKYVA 330 (478)
T ss_pred HHHHH-HhccChhhCcCHHHHHhCHHHHHHH
Confidence 66666 9999999999999999999987654
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=310.92 Aligned_cols=235 Identities=24% Similarity=0.308 Sum_probs=190.6
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
||+|+||.||+++++.+|+.+|+|.+... ....+..|+++++++ +||||+++++++.. ....++||||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 69999999999999999999999998632 123456799999999 99999999999976 5678999999999
Q ss_pred CchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeecc
Q 014307 216 TDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (427)
Q Consensus 216 ~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~ 290 (427)
++|..... .+++..+..++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++.............+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCC
Confidence 99875542 478888899999999999999999999999999999999776 899999999987765544455678
Q ss_pred CccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHH--HH-HHHHHH-------hCChHHHHHHHhccC
Q 014307 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD--QL-VKIAKV-------LGTDELNAYLNKYHI 360 (427)
Q Consensus 291 ~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~--~l-~~i~~~-------~~~~~~~~~l~~~~l 360 (427)
+..|+|||++.+ ..++.++|||||||++|||++|+.||........ .+ ..+... .-++...+++.+ |+
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L 234 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL-FL 234 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH-Hh
Confidence 899999999877 5699999999999999999999999954322221 11 111110 013445555555 99
Q ss_pred CCChhHHHHH----hHHhcCCchhhH
Q 014307 361 ELDPHLAALV----GRLVILSYFFQF 382 (427)
Q Consensus 361 ~~dp~~r~~~----~~ll~~~~~~~~ 382 (427)
..||..|+++ ++++.|+||+..
T Consensus 235 ~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 235 AKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred ccCHhhCCCCccchhhhhcChhhcCC
Confidence 9999999998 778899999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=347.68 Aligned_cols=248 Identities=25% Similarity=0.441 Sum_probs=204.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..++|+++++||+|+||+||+|.+..++..||+|++... ....+..|+.+|+.| +|||||+++++|.......+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCCCEE
Confidence 357899999999999999999999999999999998632 235688999999999 99999999999977666778
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-------CceeeccCCCceEEcCC--------
Q 014307 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE-------- 264 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~-------~iiHrDlkp~NILl~~~-------- 264 (427)
++||||+.+++|..++ ..+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999987665 3589999999999999999999984 49999999999999642
Q ss_pred --------CCeEEEEeeeeeeeecCCCcceeeccCccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 014307 265 --------QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335 (427)
Q Consensus 265 --------~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~ 335 (427)
...+||+|||++..+..........|++.|+|||++.+ ...++.++||||||||||||++|+.||. ..+.
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~-~~~~ 248 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH-KANN 248 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC-cCCc
Confidence 12489999999987654444455679999999999864 2458899999999999999999999994 3445
Q ss_pred HHHHHHHHHH-h------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 336 YDQLVKIAKV-L------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 336 ~~~l~~i~~~-~------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
..++...... . ..+++..+|.. ||..+|..||++.++|.++|+...
T Consensus 249 ~~qli~~lk~~p~lpi~~~S~eL~dLI~~-~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 249 FSQLISELKRGPDLPIKGKSKELNILIKN-LLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred HHHHHHHHhcCCCCCcCCCCHHHHHHHHH-HhcCChhHCcCHHHHhccHHHhhc
Confidence 5544433322 1 12455555555 999999999999999999998753
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=307.22 Aligned_cols=238 Identities=31% Similarity=0.556 Sum_probs=197.5
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHH-----HHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
|++++.||+|+||+||+|.+..+++.+|+|++...... ...+|+.+++++ +||||+++++++.. ....+++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence 78999999999999999999999999999999765432 234599999999 99999999999987 56788999
Q ss_pred eecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee-cCCCcce
Q 014307 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYN 286 (427)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~-~~~~~~~ 286 (427)
|++.++++..++ ..+++..+..++.||+.||++||++||+|+||||+||+++.++ .++|+|||.+... .......
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence 999999887655 4689999999999999999999999999999999999999666 8999999999764 2333445
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------------ChHHHH
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------------TDELNA 353 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------------~~~~~~ 353 (427)
...++..|+|||++.....++.++||||||+++|+|++|..||... ...+....+.+... ...+..
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-NSDDQLEIIEKILKRPLPSSSQQSREKSEELRD 235 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-SHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc-cchhhhhhhhhcccccccccccccchhHHHHHH
Confidence 6678899999999873378999999999999999999999999533 22233332222211 135555
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCch
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
++.. |+..||..||++.++++||||
T Consensus 236 li~~-~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 236 LIKK-MLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHH-HSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHH-HccCChhHCcCHHHHhcCCCC
Confidence 5555 999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=314.98 Aligned_cols=282 Identities=21% Similarity=0.357 Sum_probs=216.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCC-----CCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGG-----PNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h-----~niv~l~~~~~~~~~~ 204 (427)
..++|+++..+|+|.||.|-.+.+..++..||||+++... ++..+-|+++|+++..+ -.+|.+.+||.. .+
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--rg 164 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--RG 164 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--cC
Confidence 3689999999999999999999999999999999998644 46678899999999433 257888888876 67
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC----------------
Q 014307 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE---------------- 264 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~---------------- 264 (427)
++|+|+|.++......+- .+++...++.+++|++++++|||+.+++|.||||+|||+...
T Consensus 165 hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 899999998865554433 359999999999999999999999999999999999998422
Q ss_pred ---CCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 014307 265 ---QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (427)
Q Consensus 265 ---~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~ 341 (427)
...|||+|||.|.+.. ......+.|.+|+|||++++ -+|+.++||||+||||+||.+|...| +++++.|++..
T Consensus 245 ~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF-qtHen~EHLaM 320 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF-QTHENLEHLAM 320 (415)
T ss_pred cCCCcceEEEecCCcceec--cCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec-ccCCcHHHHHH
Confidence 1248999999998744 33467799999999999998 68999999999999999999999998 78899999999
Q ss_pred HHHHhCChHHHHHHHh---------ccCCCChhHHH-HHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCch
Q 014307 342 IAKVLGTDELNAYLNK---------YHIELDPHLAA-LVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPE 411 (427)
Q Consensus 342 i~~~~~~~~~~~~l~~---------~~l~~dp~~r~-~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~ 411 (427)
+.+.+|+.+.. ++.+ ..++++-..-. -+..++..+--.+.. ---.........|||++||. ++|.
T Consensus 321 MerIlGp~P~~-mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~---~~~~d~e~~~LfDLl~~mL~-fDP~ 395 (415)
T KOG0671|consen 321 MERILGPIPSR-MIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKY---MLQDDLEHVQLFDLLRRMLE-FDPA 395 (415)
T ss_pred HHHhhCCCcHH-HhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHH---hccCcHHHhHHHHHHHHHHc-cCcc
Confidence 99999954322 2222 11111100000 011111111111100 00112334568999999996 9999
Q ss_pred hhhhhccccCCCC
Q 014307 412 TMVKVHYCGESAF 424 (427)
Q Consensus 412 ~r~~~~~~~~~~~ 424 (427)
+|+|+...+.|||
T Consensus 396 ~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 396 RRITLREALSHPF 408 (415)
T ss_pred ccccHHHHhcCHH
Confidence 9999999999998
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=335.78 Aligned_cols=247 Identities=20% Similarity=0.333 Sum_probs=202.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC---
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~--- 203 (427)
..++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+|+.++..+ +|+||+++++.+.....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceecccccCc
Confidence 347899999999999999999999999999999998642 234577899999998 99999999887764322
Q ss_pred ---CCcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEee
Q 014307 204 ---KTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (427)
Q Consensus 204 ---~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DF 273 (427)
..+++||||+.+++|...+. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DF 187 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDF 187 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEec
Confidence 23689999999999876652 488999999999999999999999999999999999999777 8999999
Q ss_pred eeeeeecCC---CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---
Q 014307 274 GLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--- 347 (427)
Q Consensus 274 Gla~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--- 347 (427)
|+++.+... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.....
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf-~~~~~~~~~~~~~~~~~~~~ 265 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPF-DGENMEEVMHKTLAGRYDPL 265 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHhcCCCCCC
Confidence 999865432 12234578999999999887 67999999999999999999999999 44444444444433211
Q ss_pred ----ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ----TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ----~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+.+..++.. |+..+|..||++.+++.|||++...
T Consensus 266 ~~~~~~~l~~li~~-~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 266 PPSISPEMQEIVTA-LLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred CCCCCHHHHHHHHH-HcccChhhCcCHHHHHhCHHHHHhh
Confidence 2345555555 9999999999999999999987654
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=298.68 Aligned_cols=248 Identities=18% Similarity=0.339 Sum_probs=210.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
+.++.+.+..||.|+.|.||+++.+.+|...|||.+... ..++++..+.++....+.|+||+.+|+|... ....
T Consensus 90 dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n--~dV~ 167 (391)
T KOG0983|consen 90 DINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN--TDVF 167 (391)
T ss_pred ChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC--chHH
Confidence 345677888999999999999999999999999999642 3356777788777765689999999999874 3355
Q ss_pred EEEeecCC---CchhhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~---~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+.||.|.. ..|......+++..+-.+...+++||.||.++ ||+|||+||+|||+|..| .+||||||++.++-+..
T Consensus 168 IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 168 ICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccceeeccc
Confidence 66776643 34445556799999999999999999999874 999999999999999877 89999999999888888
Q ss_pred cceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHH
Q 014307 284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELN 352 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~ 352 (427)
..+...|.+.|||||.+.- ...|+.++||||||+.|+||.||+.||.....+++.+.++.+..- ++++.
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 8888899999999999853 357999999999999999999999999777889999998887432 36777
Q ss_pred HHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 353 AYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+|+.. |+..|+..||.-.+||+|+|..+..
T Consensus 327 ~fv~~-CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 327 SFVKD-CLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred HHHHH-HhhcCcccCcchHHHhcCcceeecc
Confidence 77777 9999999999999999999988744
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=305.62 Aligned_cols=198 Identities=26% Similarity=0.480 Sum_probs=171.6
Q ss_pred CCCEEEE-eeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--CCCCcEEE
Q 014307 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~--~~~~~~lv 209 (427)
+++|.+- ++||-|-.|.|..|.++.+++.+|+|++.. .....+|++.--....|||||.++++|+.. +...+.+|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 4566653 679999999999999999999999999974 355678888776667999999999999853 34577889
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeeecCC
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~~~~ 282 (427)
||.|+||.|...++ .+++.++..|++||..|+.|||+.+|.||||||+|+|....+ ..+||+|||+|+.-...
T Consensus 138 mE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 138 MECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred eecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 99999999877653 499999999999999999999999999999999999996433 37999999999977666
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~ 333 (427)
....+.+-|++|.|||++.. ..|+..+|+||+||++|-|++|.+||+..+
T Consensus 218 ~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~h 267 (400)
T KOG0604|consen 218 GDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_pred ccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccC
Confidence 77788899999999999765 789999999999999999999999997543
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=309.92 Aligned_cols=240 Identities=31% Similarity=0.596 Sum_probs=200.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|++.+.||+|+||.||+|+++.+++.||+|++... ..+.+.+|+.+++++ +|+|++++++++.. ....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRR--KRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEee--CCEEEE
Confidence 4799999999999999999999889999999988532 235578999999999 99999999999976 557889
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-c
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~ 284 (427)
+|||++++++..... .+++..++.++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCccc
Confidence 999999998876653 589999999999999999999999999999999999999777 89999999998765443 2
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------------- 347 (427)
.....++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.++.+.+..+.+..+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLW-PGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 334467788999999876556889999999999999999999998 45555555554433221
Q ss_pred --------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 --------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+.+.+++.+ |+..+|+.||++.+++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKG-CLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHH-HhcCCccccCCHHHHhcCCCC
Confidence 1234455555 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=324.97 Aligned_cols=237 Identities=26% Similarity=0.399 Sum_probs=195.3
Q ss_pred eeeeecCCeeEEEEEEc---CCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 140 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
+.||+|+||.||++++. .+++.+|+|+++... ...+.+|+++|+++ +||||+++++++.+ ...+++|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCEEEEEEc
Confidence 57999999999999863 578999999987422 24567899999999 99999999999976 567899999
Q ss_pred ecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Cccee
Q 014307 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 287 (427)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~~ 287 (427)
|+.+++|...+. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceec
Confidence 999999876653 489999999999999999999999999999999999999777 8999999999765433 22344
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHHhccCC
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNKYHIE 361 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~~~~l~ 361 (427)
..|+..|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+... .+.+..++.. |+.
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~-~l~ 234 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPF-QGKDRKETMTMILKAKLGMPQFLSPEAQSLLRA-LFK 234 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-Hhh
Confidence 578999999999876 67899999999999999999999999 44455555555443211 2444555555 999
Q ss_pred CChhHHHH-----HhHHhcCCchhhHH
Q 014307 362 LDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 362 ~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
.||..|++ +.+++.|+||....
T Consensus 235 ~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 235 RNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred cCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 99999999 88899999998643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=330.78 Aligned_cols=240 Identities=22% Similarity=0.326 Sum_probs=193.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
...|.+.+.||+|+||.||+|++..+++.||||... ...+.+|+++|+++ +|+||+++++++.. ....++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~--~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVV--GGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEEEEEEEc
Confidence 457999999999999999999999999999999653 23467899999999 99999999999876 4567899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc---ce
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YN 286 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~---~~ 286 (427)
+.+..+..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... ..
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceeccccccccccc
Confidence 9765444332 2589999999999999999999999999999999999999776 799999999986643322 12
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC------HHHHHHHHHHhC-------------
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN------YDQLVKIAKVLG------------- 347 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~------~~~l~~i~~~~~------------- 347 (427)
...||..|+|||++.+ ..++.++|||||||++|||++|..|++..... .+++.++.+..+
T Consensus 321 ~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 321 GIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred ccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 3468999999999987 67999999999999999999998877543321 233333332211
Q ss_pred ----------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 348 ----------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 348 ----------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
.++...++.+ |+..||..||++.++|+|+||+.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~-mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCR-ALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHH-HcccChhhCcCHHHHhhCcccCC
Confidence 0133344444 99999999999999999999964
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=321.21 Aligned_cols=242 Identities=22% Similarity=0.378 Sum_probs=198.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|++.++||.|+||.||+|.+..++..+|+|+++.. ....+.+|+++++.+ +|+||+++++++.+ ...+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 80 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEISI 80 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEE--CCEEEE
Confidence 47899999999999999999999999999999988643 235688999999999 89999999999987 557899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
||||+.+++|..++. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||++..... ..
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~-~~ 158 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID-SM 158 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhh-hc
Confidence 999999999987653 588889999999999999999985 799999999999999777 799999999975532 22
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH-----------------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK----------------------- 341 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~----------------------- 341 (427)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.... . ..+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 159 ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPD-A-KELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred cccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcc-h-hHHHHHhcCcccCCccccccCcccCCcc
Confidence 234578899999999876 679999999999999999999999995322 1 11110
Q ss_pred ------------------HHHHh------------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 342 ------------------IAKVL------------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 342 ------------------i~~~~------------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.... -.+++..++.+ |+..||..||++.+++.|+|++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNK-CLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHH-hccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000 11344455555 9999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=321.20 Aligned_cols=244 Identities=27% Similarity=0.482 Sum_probs=201.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----C
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----~ 203 (427)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +|+||+++++++.... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCcccc
Confidence 57899999999999999999999999999999998531 234577899999999 9999999999986432 2
Q ss_pred CCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
...++||||+.+.........+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 172 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCCCC
Confidence 35799999998755544444589999999999999999999999999999999999999877 89999999998765444
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh--------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD-------------- 349 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~-------------- 349 (427)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|| ...+..++...+.+.++.+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLF-PGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRN 250 (353)
T ss_pred CCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhH
Confidence 4445577889999999877 78999999999999999999999998 4445455544443332221
Q ss_pred -----------------------------------HHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 350 -----------------------------------ELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 350 -----------------------------------~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
...+++.+ |+..||..||++.++|.|+|+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 251 YVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSK-MLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHH-HcCCChhhCcCHHHHhcChhHhh
Confidence 23445555 99999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.57 Aligned_cols=192 Identities=27% Similarity=0.528 Sum_probs=159.8
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEec-----cccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
....|+++++||+||.+.||++.. .+.+.+|+|.+. .....-+.+|+..|.+|++|.+||+|+||-.. +.++
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~--d~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT--DGYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc--CceE
Confidence 356799999999999999999986 455666666543 22235588999999999999999999998765 7789
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
|+||||.+... ..+++ ..+.+.++.+..||+.|+.++|++||||.||||.|+|+- .| .+||+|||+|..+..+
T Consensus 436 YmvmE~Gd~DL-~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 436 YMVMECGDIDL-NKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEeecccccH-HHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEeeeechhcccCcc
Confidence 99999877654 33332 356678999999999999999999999999999999998 45 7999999999988766
Q ss_pred Ccc---eeeccCccccccccccCCC----------CCCchhhHHHHHHHHHHHHhCCCCC
Q 014307 283 KEY---NVRVASRYFKGPELLVDLQ----------DYDYSLDLWSLGCMFAGMIFRKEPF 329 (427)
Q Consensus 283 ~~~---~~~~~~~~y~aPE~~~~~~----------~~~~~~DvwSlGvll~elltg~~pf 329 (427)
... ...+||..||+||.+.... +.+.++||||||||||+|+.|+.||
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf 572 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF 572 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence 543 4569999999999986421 2568999999999999999999999
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=310.57 Aligned_cols=293 Identities=23% Similarity=0.381 Sum_probs=226.1
Q ss_pred ccccccCCC-CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCC-------CCeeee
Q 014307 125 SLTVQWGEQ-DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGG-------PNIVKL 194 (427)
Q Consensus 125 ~~~~~~~~~-~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h-------~niv~l 194 (427)
.+.+.-... .+|.+.++||.|.|++||+|.+..+.+.||+|+.+.. -.+....||++|+++..+ .+||+|
T Consensus 68 pV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~L 147 (590)
T KOG1290|consen 68 PVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQL 147 (590)
T ss_pred eeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeee
Confidence 333333334 8999999999999999999999999999999999743 346678999999998533 489999
Q ss_pred eeEEEc--CCCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCC-
Q 014307 195 LDIVRD--QQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQR- 266 (427)
Q Consensus 195 ~~~~~~--~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~- 266 (427)
++.|.. +++.++|||+|++....|.... +.++...++.|++||+.||+|||.. ||||.||||+|||+..+..
T Consensus 148 lD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~ 227 (590)
T KOG1290|consen 148 LDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEID 227 (590)
T ss_pred eccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccc
Confidence 999974 5678999999999988876553 5699999999999999999999975 9999999999999932200
Q ss_pred --------------------------------------------------------------------------------
Q 014307 267 -------------------------------------------------------------------------------- 266 (427)
Q Consensus 267 -------------------------------------------------------------------------------- 266 (427)
T Consensus 228 ~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~ 307 (590)
T KOG1290|consen 228 PAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEP 307 (590)
T ss_pred hhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccccccccc
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 014307 267 -------------------------------------------------------------------------------- 266 (427)
Q Consensus 267 -------------------------------------------------------------------------------- 266 (427)
T Consensus 308 ~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~ 387 (590)
T KOG1290|consen 308 RINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLP 387 (590)
T ss_pred CCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCC
Confidence
Q ss_pred ----eEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CCHH
Q 014307 267 ----KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-----DNYD 337 (427)
Q Consensus 267 ----~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-----~~~~ 337 (427)
+|||+|||-|++. .+.++.-+.|+.|+|||++.+ ..|++.+||||++|++|||.||...|.+-. .+.+
T Consensus 388 ~~di~vKIaDlGNACW~--~khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 388 ECDIRVKIADLGNACWV--HKHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred ccceeEEEeeccchhhh--hhhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 0899999999885 356677789999999999999 799999999999999999999999996432 4678
Q ss_pred HHHHHHHHhCChHHHHHHHhc----cCCCChhHHHHHhHHhcCCc-hhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchh
Q 014307 338 QLVKIAKVLGTDELNAYLNKY----HIELDPHLAALVGRLVILSY-FFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPET 412 (427)
Q Consensus 338 ~l~~i~~~~~~~~~~~~l~~~----~l~~dp~~r~~~~~ll~~~~-~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~ 412 (427)
++..|...+|.-+..-.+... ...-.-++|-+ .+ | ++| +.+.+..-|.+-....+.+.|+|..|| +++|++
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI-~~-L-K~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL-ef~PeK 540 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHI-RR-L-KPWPLYEVLIEKYEWSEEDAQQFSDFLSPML-EFDPEK 540 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecc-cc-c-CCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH-hcCccc
Confidence 999999988853322111110 00011111111 11 1 122 233334445555567888999999999 699999
Q ss_pred hhhhccccCCCC
Q 014307 413 MVKVHYCGESAF 424 (427)
Q Consensus 413 r~~~~~~~~~~~ 424 (427)
|+|+..|++||+
T Consensus 541 R~tA~~cl~hPw 552 (590)
T KOG1290|consen 541 RPTAAQCLKHPW 552 (590)
T ss_pred cccHHHHhcCcc
Confidence 999999999997
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=309.40 Aligned_cols=242 Identities=23% Similarity=0.367 Sum_probs=198.9
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.|+..+.||.|+||+||+|.+..+++.+|+|.++... ...+.+|+.+|+.+ +|+||+.+++.+.. ....++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEec--CCEEEE
Confidence 3778899999999999999999999999999986432 23467899999999 99999999999876 457899
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+|||+.++++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGE 156 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCC
Confidence 99999999886554 2489999999999999999999999999999999999999776 89999999997665444
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (427)
......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.. ..+......+.... -.+.+.+
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRG-RKEKVKREEVDRRVLETEEVYSAKFSEEAKS 234 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHhhhccccccCccCCHHHHH
Confidence 4455678999999999876 6799999999999999999999999953 33322222222211 1234555
Q ss_pred HHHhccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 354 YLNKYHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
++.. |+..+|..|++ +.+++.|+||....
T Consensus 235 li~~-~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 235 ICKM-LLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred HHHH-HccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 5555 99999999999 88999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=321.88 Aligned_cols=236 Identities=23% Similarity=0.390 Sum_probs=189.6
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHH-HHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~i-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
+.||+|+||+||+|++..+++.||+|++.... ...+..|..+ ++.+ +||||+++++++.. ....++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 36999999999999999999999999986421 2334555554 4566 99999999999976 5578999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceee
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~ 288 (427)
+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCccccc
Confidence 9999987655 3588999999999999999999999999999999999999777 899999999875322 2233445
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCC
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIEL 362 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~ 362 (427)
.|+..|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.... -.+...+++.+ |+..
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~ 233 (323)
T cd05575 157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNILNKPLRLKPNISVSARHLLEG-LLQK 233 (323)
T ss_pred cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-Hhhc
Confidence 78999999999876 689999999999999999999999994 444444444433221 13445555555 9999
Q ss_pred ChhHHHHH----hHHhcCCchhhH
Q 014307 363 DPHLAALV----GRLVILSYFFQF 382 (427)
Q Consensus 363 dp~~r~~~----~~ll~~~~~~~~ 382 (427)
||..|+++ .+++.|+||...
T Consensus 234 ~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 234 DRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CHHhCCCCCCCHHHHHcCCCcCCC
Confidence 99999987 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=319.95 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=195.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.++||+|+||+||+++++.+++.+|+|++.... ...+.+|+.++..+ +|++|+++++++.+ ...++
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQD--ENNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCEEE
Confidence 47899999999999999999999999999999986321 23467889999988 99999999999976 45789
Q ss_pred EEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCC
Confidence 9999999999877763 488999999999999999999999999999999999999777 89999999997654332
Q ss_pred c--ceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-----------
Q 014307 284 E--YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------- 346 (427)
Q Consensus 284 ~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------- 346 (427)
. .....|++.|+|||++.+ ...++.++|||||||++|||++|+.||. ..+..+....+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERFQFPAQVTD 235 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCC-CCCHHHHHHHHhCCCccccCCCcccc
Confidence 2 223578999999999862 3468899999999999999999999994 445555555443321
Q ss_pred CChHHHHHHHhccCCCChh--HHHHHhHHhcCCchhhHH
Q 014307 347 GTDELNAYLNKYHIELDPH--LAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 ~~~~~~~~l~~~~l~~dp~--~r~~~~~ll~~~~~~~~~ 383 (427)
-++....++.+ ++..++. .|+++.+++.|+||....
T Consensus 236 ~s~~~~~li~~-ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 236 VSEDAKDLIRR-LICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred CCHHHHHHHHH-HccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 12344555555 5544333 357899999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=310.34 Aligned_cols=244 Identities=29% Similarity=0.542 Sum_probs=196.6
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+|+.+++.+ +|+||+++++++.. ....
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~ 78 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHT--KETL 78 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEec--CCeE
Confidence 34578999999999999999999999999999999986422 23577899999999 99999999999876 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~- 282 (427)
++||||+.+..+.... ..+++..++.++.|++.||.|||+.||+|+||||+|||++.++ .+||+|||+++.....
T Consensus 79 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPS 157 (291)
T ss_pred EEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCCC
Confidence 9999999765544433 2467888999999999999999999999999999999999777 8999999998754322
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------------- 347 (427)
.......++..|+|||.+.+...++.++|||||||++|+|++|+.||....+..+++.++...++
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 22334467888999999876456889999999999999999999999654444455444433222
Q ss_pred -----------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 -----------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 -----------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+...+++.+ |+..||..||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~-~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQ-MLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHH-HhCcCcccCcCHHHHhcCCCC
Confidence 1233444544 999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.72 Aligned_cols=237 Identities=22% Similarity=0.382 Sum_probs=190.3
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHH-HHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~i-l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
+.||+|+||+||+|++..+++.+|+|++... ....+..|..+ ++.+ +||||+++++++.. ....++||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEec--CCEEEEEEcC
Confidence 4699999999999999999999999998642 12345556554 5556 99999999999976 5578999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceee
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~ 288 (427)
+.++++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccc
Confidence 9999986554 3589999999999999999999999999999999999999777 899999999875322 2233456
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCC
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIEL 362 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~ 362 (427)
+|+..|+|||++.+ ..++.++|||||||++|||++|+.||. ..+..+....+.... ......+++.+ |+..
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~-ll~~ 233 (325)
T cd05604 157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFY-CRDVAEMYDNILHKPLVLRPGASLTAWSILEE-LLEK 233 (325)
T ss_pred cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCC-CCCHHHHHHHHHcCCccCCCCCCHHHHHHHHH-Hhcc
Confidence 78999999999876 678999999999999999999999994 444444444443321 12344455555 8999
Q ss_pred ChhHHHHH----hHHhcCCchhhHH
Q 014307 363 DPHLAALV----GRLVILSYFFQFV 383 (427)
Q Consensus 363 dp~~r~~~----~~ll~~~~~~~~~ 383 (427)
+|..|+++ .+++.|+||....
T Consensus 234 ~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 234 DRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 99999865 5899999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=325.64 Aligned_cols=237 Identities=23% Similarity=0.355 Sum_probs=190.7
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhc--CCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
||+|+||+||+|++..+++.||||++.... ......|..++..+. +||||+++++++.. ...+++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 699999999999999999999999986421 123445777777664 79999999999976 45789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceeec
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 289 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~~ 289 (427)
.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..... .......+
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccCcc
Confidence 999986654 3589999999999999999999999999999999999999777 899999999875432 22334567
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-------hCChHHHHHHHhccCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-------LGTDELNAYLNKYHIEL 362 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~-------~~~~~~~~~l~~~~l~~ 362 (427)
|+..|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+....+... .-.+...+++.+ |+..
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~-~L~~ 235 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY-AEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKG-LLNR 235 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC-CCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH-HcCC
Confidence 99999999998765568999999999999999999999994 33433333333221 113455555555 9999
Q ss_pred ChhHHH----HHhHHhcCCchhhHH
Q 014307 363 DPHLAA----LVGRLVILSYFFQFV 383 (427)
Q Consensus 363 dp~~r~----~~~~ll~~~~~~~~~ 383 (427)
||..|+ ++.+++.|+||....
T Consensus 236 ~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 236 NPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CHHHCCCCCCCHHHHhcCccccCCC
Confidence 999997 799999999998643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=313.79 Aligned_cols=247 Identities=28% Similarity=0.488 Sum_probs=202.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..++|++.+.||.|+||.||+|.+..+++.||+|.++... ...+.+|+.+++++ +|+||+++++++.......+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence 3578999999999999999999999999999999986422 23456899999999 99999999999987655678
Q ss_pred EEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++||||+.+. +..++ ..+++.++..++.||+.||.|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCCCC-HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCc
Confidence 9999999864 33332 3589999999999999999999999999999999999999777 8999999999876543
Q ss_pred -CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------------
Q 014307 283 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------------- 347 (427)
Q Consensus 283 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------------- 347 (427)
.......++..|+|||.+.+...++.++|||||||++|||++|+.|| ...++.+.+..+...++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 22233455778999999876567899999999999999999999998 55566666665555322
Q ss_pred ----------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+...+++.+ |+..||+.||++++++.|+||.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNF-LLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHH-HhcCChhhCcCHHHHhcChhhccCC
Confidence 2333445555 9999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=319.99 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=195.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||+||++++..+++.||+|+++.. ....+.+|+.++..+ +|+||+++++++.+ ....+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~--~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQD--ENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 4799999999999999999999999999999998642 123467888999888 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCC
Confidence 999999999988765 3578999999999999999999999999999999999999777 89999999998765433
Q ss_pred cc--eeeccCccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-----------
Q 014307 284 EY--NVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------- 346 (427)
Q Consensus 284 ~~--~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------- 346 (427)
.. ....|+..|+|||++.+. ..++.++|||||||++|||++|+.||. ..+..+....+....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~ 235 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHEERFQFPSHITD 235 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCcc-CCCHHHHHHHHHcCCCcccCCCcccc
Confidence 22 235789999999998642 357889999999999999999999994 444444444443211
Q ss_pred CChHHHHHHHhccCCCChhH--HHHHhHHhcCCchhhHH
Q 014307 347 GTDELNAYLNKYHIELDPHL--AALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 ~~~~~~~~l~~~~l~~dp~~--r~~~~~ll~~~~~~~~~ 383 (427)
-.+...+++.+ |+..++.. |+.+++++.|+||....
T Consensus 236 ~~~~~~~li~~-ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 236 VSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred CCHHHHHHHHH-HccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 12445555555 56554432 45799999999998643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=308.63 Aligned_cols=242 Identities=20% Similarity=0.335 Sum_probs=198.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+|+++++++ +||||+++++.+.. ....++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFV--ENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEE--CCEEEEE
Confidence 3578899999999999999999999999999998532 235688999999999 99999999999987 4567899
Q ss_pred EeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeec
Q 014307 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (427)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~ 289 (427)
|||+.++++... ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++ .+||+|||++...... ......
T Consensus 78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-cccCCC
Confidence 999999988654 4678999999999999999999999999999999999999877 8999999999765432 334457
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH------HHHHHHHHH--------hCChHHHHHH
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY------DQLVKIAKV--------LGTDELNAYL 355 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~------~~l~~i~~~--------~~~~~~~~~l 355 (427)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... +....+... ...+.+.+++
T Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (279)
T cd06619 155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233 (279)
T ss_pred CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence 8889999999876 678999999999999999999999995422211 111111110 0124555666
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+ |+..+|..||++++++.|+|+....
T Consensus 234 ~~-~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 234 TQ-CMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred HH-HhhCChhhCCCHHHHhcCccccccc
Confidence 66 9999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=307.28 Aligned_cols=245 Identities=22% Similarity=0.393 Sum_probs=197.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|++.+.||+|+||.||+|++..+++.||+|.++.. ....+..|+.++.+..+||||+++++++.. ....+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence 4689999999999999999999999999999998643 234566677765554599999999999976 4568999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
|||+++. +..++ ..+++..++.++.||+.||+|||++ +++||||||+|||++.++ .+||+|||++..+..
T Consensus 79 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~ 156 (283)
T cd06617 79 MEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVD 156 (283)
T ss_pred hhhhccc-HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence 9999864 32221 2488999999999999999999997 999999999999999777 899999999986644
Q ss_pred CCcceeeccCccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChH
Q 014307 282 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDE 350 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~ 350 (427)
........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.......+.+..+.+... +..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPE 236 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccCHH
Confidence 3333445688889999987541 35788999999999999999999999655555666655544321 244
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+++.+ |+..+|..||++.+++.|+||....
T Consensus 237 l~~li~~-~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 237 FQDFVNK-CLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHHHHHH-HccCChhhCcCHHHHhcCchhhhcc
Confidence 5566666 9999999999999999999999855
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=308.95 Aligned_cols=242 Identities=32% Similarity=0.572 Sum_probs=195.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..++|++.+.||.|++|.||+|.++.+++.||||.+.... ...+.+|+.+++++ +|+||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 79 (291)
T cd07844 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTLT 79 (291)
T ss_pred CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeEE
Confidence 4578999999999999999999998899999999986422 24567899999999 99999999999876 56789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~- 282 (427)
+||||+.+ +|..++ ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 80 lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPS 157 (291)
T ss_pred EEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCCC
Confidence 99999996 555443 2478899999999999999999999999999999999999877 7999999998654321
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC--------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------------- 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~-------------- 348 (427)
.......++..|+|||++.+...++.++|||||||++|+|++|+.||.......+++..+.+.++.
T Consensus 158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 122233567789999998765568999999999999999999999995443344444433332211
Q ss_pred ------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 349 ------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 349 ------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+..+++.+ |+..+|..||++.+++.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALK-FLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHH-HhccCcccccCHHHHhcCCCC
Confidence 333455555 899999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=318.48 Aligned_cols=236 Identities=22% Similarity=0.383 Sum_probs=189.2
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHH-HHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
+.||+|+||+||+|++..+++.||+|++.... ...+..|.. +++.+ +||||+++++++.. ...+++||||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEc--CCeEEEEEeC
Confidence 36999999999999999999999999986422 123444544 45666 99999999999976 4568999999
Q ss_pred cCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceee
Q 014307 213 VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (427)
Q Consensus 213 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~ 288 (427)
+.+++|...+. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccc
Confidence 99999877653 488899999999999999999999999999999999999777 899999999975432 2233456
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCC
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIEL 362 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~ 362 (427)
+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.... -.+....++.+ |+..
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~ 233 (325)
T cd05602 157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNKPLQLKPNITNSARHLLEG-LLQK 233 (325)
T ss_pred cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCC-CCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHH-Hccc
Confidence 79999999999887 689999999999999999999999994 444445444443321 12344555555 9999
Q ss_pred ChhHHHHHh----HHhcCCchhhH
Q 014307 363 DPHLAALVG----RLVILSYFFQF 382 (427)
Q Consensus 363 dp~~r~~~~----~ll~~~~~~~~ 382 (427)
+|..|+++. ++++|+||...
T Consensus 234 ~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 234 DRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CHHHCCCCCCCHHHHhcCcccCCC
Confidence 999999765 89999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=321.29 Aligned_cols=239 Identities=23% Similarity=0.411 Sum_probs=206.1
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecC
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 214 (427)
+.||.|.||+||-|.++.+|+.||||++++ .....+.+|+.||+++ +||.||.+.-.|+. ...+++|||-+.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~ET--~ervFVVMEKl~ 646 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFET--PERVFVVMEKLH 646 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeecC--CceEEEEehhhc
Confidence 789999999999999999999999999964 3457799999999999 99999999999976 456889999999
Q ss_pred CCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--CCeEEEEeeeeeeeecCCCcceee
Q 014307 215 NTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGKEYNVR 288 (427)
Q Consensus 215 ~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~~~ikl~DFGla~~~~~~~~~~~~ 288 (427)
|.-|...+ .++++...+.++.||+.||.|||.+||+|+||||+|||+... ..++||||||+|+.+.+.......
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsV 726 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSV 726 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhh
Confidence 98887665 469999999999999999999999999999999999999643 348999999999998877777888
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhccCC
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYHIE 361 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l~ 361 (427)
+||+.|.|||++.+ +.|....|+||+|||+|--++|..||..+.+-.+|++.-.=..- .+...++|.. .++
T Consensus 727 VGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~-LLq 804 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINN-LLQ 804 (888)
T ss_pred cCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHH-HHH
Confidence 99999999999987 89999999999999999999999999776666666653221111 2344555666 678
Q ss_pred CChhHHHHHhHHhcCCchhhHH
Q 014307 362 LDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 362 ~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..-..|-++++.+.|+|++...
T Consensus 805 Vkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 805 VKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred HHHHHhcchHhhccchhhhcch
Confidence 8889999999999999999844
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=304.03 Aligned_cols=239 Identities=21% Similarity=0.377 Sum_probs=196.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
++|++.+.||+|++|.||+|.+..+++.+|+|.+.... ...+.+|+.+++++ +||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRD--DET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEcc--CCe
Confidence 46889999999999999999998899999999875321 24578899999999 99999999999976 458
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+++++||+.++++...+. .+++..++.++.|++.||.|||+.||+||||+|+||+++.++ .++|+|||+++.....
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecccc
Confidence 899999999998876653 578899999999999999999999999999999999999766 8999999999765432
Q ss_pred Ccc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChH
Q 014307 283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDE 350 (427)
Q Consensus 283 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~ 350 (427)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.. .+..+....+..... .+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAE-FEAMAAIFKIATQPTNPQLPSHVSPD 235 (263)
T ss_pred ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccc-cchHHHHHHHhccCCCCCCCccCCHH
Confidence 211 23457788999999887 6799999999999999999999999843 344444333332211 244
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+.+++.. |+..+|..||++.+++.|+||
T Consensus 236 ~~~li~~-~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 236 ARNFLRR-TFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHH-HhhcCcccCCCHHHHhhCCCC
Confidence 5555555 999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=305.17 Aligned_cols=240 Identities=30% Similarity=0.561 Sum_probs=196.1
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
|++.++||+|+||.||+|.+..+++.+|+|.++... .....+|+.++.++.+|+|++++++++.+.....+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678899999999999999999999999999986421 2234578999999867999999999998765578899999
Q ss_pred ecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceee
Q 014307 212 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288 (427)
Q Consensus 212 ~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~ 288 (427)
|+.+..+..+. ..+++..++.++.|++.||.|||+.|++||||||+||+++. + .+||+|||++............
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-CeEEEecccccccccCCCcCCC
Confidence 99875554443 24899999999999999999999999999999999999997 5 8999999999876554444455
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------------------
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------------- 347 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------------------- 347 (427)
.++..|+|||++.....++.++|||||||++|||++|..|| .+.+..+....+.+..+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFP 237 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCc
Confidence 67889999998765456789999999999999999999988 55555554444433222
Q ss_pred --------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 --------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 --------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+..+.+++.+ |+..+|..||++++++.|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 238 SKKGTGLRKLLPNASAEGLDLLKK-LLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccHHHHcccccHHHHHHHHH-HhccCcccccCHHHHhhCCCC
Confidence 1344455555 999999999999999999996
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=280.45 Aligned_cols=275 Identities=28% Similarity=0.474 Sum_probs=220.0
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.|...++||+|.||+||+|+.+.+++.||+|.++-.. .....+|+.+|+.+ .|.|||+++++... +..+.+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhs--dkkltlv 79 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhcc--CceeEEe
Confidence 4556789999999999999999999999999986422 36688999999999 99999999999866 5678899
Q ss_pred EeecCCCchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cc
Q 014307 210 FEHVNNTDFK---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (427)
Q Consensus 210 ~e~~~~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~ 285 (427)
+|||....-. .....+..+.++.++.|+++||.|+|++++.||||||.|.||+.+| .+||+|||+|+.+...- -+
T Consensus 80 fe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvrcy 158 (292)
T KOG0662|consen 80 FEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceEee
Confidence 9999875432 2335688999999999999999999999999999999999999888 89999999998765432 45
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCChh
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~ 365 (427)
...+.|.+|++|.++.+-+-|+...|+||-|||+.|+.....|.+++.+..+|+.+|.+.+|++...+|... ..-|+
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~---t~lpd 235 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM---TKLPD 235 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc---ccCCC
Confidence 566889999999999998889999999999999999998777888999999999999999998765544222 11111
Q ss_pred HHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 366 LAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 366 ~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
..+....-....|.+-.. .++..-.|+|.++|+ -||.+|+++.-.+.||+-
T Consensus 236 yk~yp~ypattswsqivp--------~lns~grdllqkll~-cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVP--------KLNSTGRDLLQKLLK-CNPAQRISAEAALQHPYF 286 (292)
T ss_pred CcccCCccccchHHHHhh--------hhcchhHHHHHHHhc-cCcccccCHHHHhcCccc
Confidence 111100001112222111 245567899999997 899999999999998864
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=305.50 Aligned_cols=239 Identities=31% Similarity=0.569 Sum_probs=199.3
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++.. ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence 5889999999999999999998899999999986432 35688999999999 89999999999976 5678999
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--
Q 014307 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-- 283 (427)
+||+ +++|...+ ..+++.+++.++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPR 155 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCCC
Confidence 9999 88887664 3489999999999999999999999999999999999999776 89999999998665433
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------------- 347 (427)
......++..|+|||.+.+...++.++|||||||++|||++|..|| .+..+.+.+..+.+.++
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLF-PGENDIEQLAIVFRTLGTPNEETWPGLTSLPDY 234 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCc-CCCCHHHHHHHHHHHcCCCChHHHhhccCcchh
Confidence 2344578889999999876556799999999999999999997665 66666665555544322
Q ss_pred --------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchh
Q 014307 348 --------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFF 380 (427)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~ 380 (427)
...+.+++.+ |+..+|..||++++++.|+||.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 235 NKITFPESKPIPLEEIFPDASPEALDLLKG-LLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hcccCCCCCcchHHHhCCCccHHHHHHHHH-HhccChhhCCCHHHHhhCcCcC
Confidence 1333445555 9999999999999999999973
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=308.76 Aligned_cols=274 Identities=24% Similarity=0.422 Sum_probs=204.1
Q ss_pred CEEEEeeeeecCCeeEEEEEEcC--CCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~--~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
+|++.++||+|+||.||+|.+.. +++.||+|.+.... ...+.+|+.+++.+ +||||+++++++.+.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 48899999999999999999988 79999999987522 35678899999999 99999999999987655789
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC----CCCeEEEEeeee
Q 014307 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----EQRKLRLIDWGL 275 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~----~~~~ikl~DFGl 275 (427)
++||||+.+..+.... ..+++..++.++.||+.||.|||+++|+||||||+||+++. ++ .+||+|||+
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDLGL 158 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECCCcc
Confidence 9999999875543221 25788999999999999999999999999999999999997 55 899999999
Q ss_pred eeeecCCCc----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH--------HHHHHHH
Q 014307 276 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--------DQLVKIA 343 (427)
Q Consensus 276 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~--------~~l~~i~ 343 (427)
+........ .....++..|+|||++.+...++.++|||||||++|+|++|+.||....... +.+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 986543222 2334678889999998765678999999999999999999999995332221 2333333
Q ss_pred HHhCChHHHHHHHhccCCCChhHHHHHhHHhc----------CCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhh
Q 014307 344 KVLGTDELNAYLNKYHIELDPHLAALVGRLVI----------LSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETM 413 (427)
Q Consensus 344 ~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~----------~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r 413 (427)
..++.+ ++..+.....+.. ..+-.................+.++|++||. .+|++|
T Consensus 239 ~~l~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~~P~~R 304 (316)
T cd07842 239 EVLGTP-------------TEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE-YDPTKR 304 (316)
T ss_pred HHhCCC-------------chhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhc-CCcccC
Confidence 333322 2222221111111 1111000000000112456789999999995 999999
Q ss_pred hhhccccCCCC
Q 014307 414 VKVHYCGESAF 424 (427)
Q Consensus 414 ~~~~~~~~~~~ 424 (427)
+++..+..|||
T Consensus 305 ps~~eil~~~~ 315 (316)
T cd07842 305 ITAEEALEHPY 315 (316)
T ss_pred cCHHHHhcCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.39 Aligned_cols=237 Identities=22% Similarity=0.357 Sum_probs=187.8
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHH-HHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~-il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
+.||+|+||.||+|++..+++.||+|++.... ...+.+|.. +++.+ +||||+++++++.+ ....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCEEEEEEcC
Confidence 36999999999999999999999999986422 233455554 46667 99999999999876 4578999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CCcceee
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 288 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~~~~~~ 288 (427)
+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.... .......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccc
Confidence 9999986654 3588999999999999999999999999999999999999777 899999999875322 2233445
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhccCCC
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKYHIEL 362 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~~l~~ 362 (427)
.|++.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.... ......+++.. |+..
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~-~l~~ 233 (321)
T cd05603 157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDVSQMYDNILHKPLQLPGGKTVAACDLLVG-LLHK 233 (321)
T ss_pred cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCC-CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-HccC
Confidence 78999999999876 679999999999999999999999994 333333333333211 12344455555 9999
Q ss_pred ChhHHHHH----hHHhcCCchhhHH
Q 014307 363 DPHLAALV----GRLVILSYFFQFV 383 (427)
Q Consensus 363 dp~~r~~~----~~ll~~~~~~~~~ 383 (427)
+|..|+.. .+++.|+||....
T Consensus 234 ~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 234 DQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 99999864 5899999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=305.18 Aligned_cols=244 Identities=30% Similarity=0.566 Sum_probs=195.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC---CC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~---~~ 205 (427)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+.+|+.+++.+.+|+||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999999999999999999876422 25678899999999667999999998875322 23
Q ss_pred cEEEEeecCCCchhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 206 PSLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
.+++|||+.+. +..++ ..+++..++.++.||+.||.|||++||+||||||+||+++.++..+||+|||++.
T Consensus 81 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCcC-HHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 78999999974 44332 2478999999999999999999999999999999999999744589999999997
Q ss_pred eecCC-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------
Q 014307 278 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------- 347 (427)
Q Consensus 278 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------- 347 (427)
.+... .......++..|+|||.+.+...++.++|||||||++|+|++|..|| .+.++.+.+..+.+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLF-PGDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 65332 22233456788999999876556899999999999999999999998 45555555444433221
Q ss_pred -------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchh
Q 014307 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFF 380 (427)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~ 380 (427)
.+.+..++.+ |+..+|..||++.+++.||||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQK-MLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhhccchhhcCcccchhHHHhccccCHHHHHHHHH-HccCChhhcCCHHHHhcCCCcC
Confidence 2334455555 9999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=313.18 Aligned_cols=247 Identities=30% Similarity=0.585 Sum_probs=197.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC---CCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---~~~ 205 (427)
.++|++.++||+|+||.||+|++..+++.||||.++.. ....+.+|+.+++++ +|+||+++++++.... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccce
Confidence 47899999999999999999999999999999998642 234577899999999 8999999999876532 245
Q ss_pred cEEEEeecCCCchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 206 PSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+++++||+.+....... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++ .+||+|||++........
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 83 VYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeecccccc
Confidence 79999999874433332 3589999999999999999999999999999999999999777 899999999976543221
Q ss_pred ----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------------
Q 014307 285 ----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------- 347 (427)
Q Consensus 285 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------------- 347 (427)
.....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+...++..+...++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-PGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 123467889999998766567899999999999999999999998 44443333333322221
Q ss_pred ------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+.+.+++.+ |+..+|..||++.+++.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDK-MLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHH-HcCCChhhCcCHHHHhcCccccccC
Confidence 2234445555 9999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=306.16 Aligned_cols=240 Identities=31% Similarity=0.591 Sum_probs=198.0
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|++.++||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+++++.+ +||||+++++++.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence 4689999999999999999999888999999987532 235678899999999 99999999999975 567899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-c
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~ 284 (427)
|+||+.++.+..+.. .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCccc
Confidence 999999998876643 488999999999999999999999999999999999999776 89999999998664332 2
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------------- 347 (427)
.....++..|+|||++.+...++.++|||||||++|||++|+.|| ......+....+....+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF-PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 234567888999999876556889999999999999999999888 44454554444433211
Q ss_pred --------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 --------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
...+.+++.. |+..+|+.||++.+++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ-CLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHH-HhcCCcccchhHHHHhcCCCC
Confidence 1233344444 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=306.35 Aligned_cols=248 Identities=22% Similarity=0.388 Sum_probs=200.8
Q ss_pred cCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 130 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
....+.|+++++||.|+||.||+|.+..+++.+|+|++.... .+.+.+|+.+++.+ +|+||+++++.+.. ....
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 84 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYW--DGKL 84 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEe--CCeE
Confidence 344578999999999999999999999999999999987543 34577899999999 89999999999876 4578
Q ss_pred EEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++||||+.++++...+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKT 163 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceecccc
Confidence 9999999999986553 3589999999999999999999999999999999999998766 8999999998654322
Q ss_pred -CcceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------C
Q 014307 283 -KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------T 348 (427)
Q Consensus 283 -~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~ 348 (427)
.......++..|+|||++.+ ...++.++|||||||++|||++|+.||. ..+..+...++.+... .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSEPPTLSQPSKWS 242 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCc-cccHHHHHHHHhcCCCccCCCCcccC
Confidence 22344567889999999852 2457889999999999999999999984 3333333333332211 1
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.++..++.+ |+..+|+.||++++++.|||+....
T Consensus 243 ~~~~~li~~-~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 243 MEFRDFLKT-ALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHHHHHHH-HhcCCcccCcCHHHHhcCccccccc
Confidence 244555555 9999999999999999999987533
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=305.56 Aligned_cols=245 Identities=22% Similarity=0.397 Sum_probs=198.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----CCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----~~~ 205 (427)
..+.|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++.+|+||+++++++.... ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 356788999999999999999999999999999998643 34578899999999877999999999987532 245
Q ss_pred cEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
++++|||+.++++..++. .+++..+..++.|++.||+|||+++|+||||||+||+++.++ .+||+|||++....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~ 162 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCceecc
Confidence 789999999998877643 478889999999999999999999999999999999999777 89999999997654
Q ss_pred CC-CcceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------C
Q 014307 281 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------G 347 (427)
Q Consensus 281 ~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~ 347 (427)
.. .......|+..|+|||++.+ ...++.++|||||||++|||++|+.||... ........+.... -
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM-HPMRALFLIPRNPAPRLKSKKW 241 (272)
T ss_pred cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcccc-CHHHHHHHHhcCCCCCCCCCCc
Confidence 32 22344578889999999853 236888999999999999999999999432 3222222222211 1
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
...+.+++.+ |+..+|..||++.+++.||||
T Consensus 242 ~~~~~~li~~-~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 242 SKKFQSFIES-CLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CHHHHHHHHH-HcCCChhhCCCHHHHhhCCCC
Confidence 2355555555 999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=324.26 Aligned_cols=241 Identities=24% Similarity=0.412 Sum_probs=203.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..|.-++.||.|+||.||-|++..+.+.||||.+... +-..+..|+..|+++ .|||++.+-|+|-. +...+
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLr--e~TaW 102 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLR--EHTAW 102 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeec--cchHH
Confidence 3477789999999999999999999999999998632 235688999999999 99999999999976 45678
Q ss_pred EEEeecCCC--c-hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNT--D-FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~--~-l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
||||||-|. + +..+.+++.+.++..|..+.+.||.|||+++.||||||+.|||++..| .|||+|||.|....+
T Consensus 103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcCc---
Confidence 999999886 2 344456799999999999999999999999999999999999999777 899999999986554
Q ss_pred ceeeccCcccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----C----hHHHHH
Q 014307 285 YNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----T----DELNAY 354 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----~----~~~~~~ 354 (427)
.+.++|||+|||||++. +.+.|+-++||||||++..||.-.++|+|.. +.+..+..|.+.-. . +.+..|
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 45789999999999984 3468999999999999999999999999653 44555555655422 1 345555
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.. |+..-|..||+.+.||.|+|..+..
T Consensus 258 vd~-CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 258 VDS-CLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred HHH-HHhhCcccCCcHHHHhhcchhccCC
Confidence 555 9999999999999999999998744
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=307.53 Aligned_cols=241 Identities=32% Similarity=0.548 Sum_probs=197.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|++.+.||.|+||.||+|.+..+++.+|+|.++... ...+.+|+.+++++ +||||+++++++...+....++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcEEE
Confidence 57899999999999999999998899999999986432 23467899999999 8999999999988765578999
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-C
Q 014307 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~ 283 (427)
||||+.+ ++..++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++...... .
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPLK 161 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCCcc
Confidence 9999986 554433 2489999999999999999999999999999999999999776 8999999999866543 2
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------------- 347 (427)
......++..|+|||.+.+...++.++|||||||++|+|++|+.|| ......+.+.++.+.++
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLF-PGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 3344567888999999876456789999999999999999999998 44455555544433322
Q ss_pred ----------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+.+.+++.. |+..+|+.||++.+++.|+||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNR-LLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHH-HhccCccccCCHHHHhcCCCC
Confidence 2233445555 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=304.84 Aligned_cols=241 Identities=22% Similarity=0.394 Sum_probs=201.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||.||++.+..+++.+|+|++... ..+.+.+|+++++++ +||||+++++++.+ ...++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQD--DSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCeEE
Confidence 4689999999999999999999999999999998642 235678899999999 89999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.+++|...+ ..+++..+..++.||+.||.|||++||+|+||+|+|||++.++ .+||+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC--
Confidence 999999999987665 3589999999999999999999999999999999999999777 8999999999876443
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (427)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.. .+..+....+.... -.+.+.+++.+
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 231 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFD-DNPIQIYEKILEGKVRFPSFFSPDAKDLIRN- 231 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCCccCCccCCHHHHHHHHH-
Confidence 334468889999999876 5788999999999999999999999943 33333333333211 13456666666
Q ss_pred cCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 359 HIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
|+..+|..|+ ++.+++.||||....
T Consensus 232 ~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 232 LLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred HccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999999 999999999998744
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=303.67 Aligned_cols=240 Identities=35% Similarity=0.596 Sum_probs=199.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ..+.+.+|+++++.+ .|+||+++++++.. ....++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence 4699999999999999999999989999999988642 236788999999999 89999999999976 557899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-- 283 (427)
+|||+.++.+..+.. .+++..+..++.||+.||.|||+.|++||||+|+||+++.++ .+||+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPAS 156 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCccc
Confidence 999999987765543 488999999999999999999999999999999999999766 89999999998765443
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------------- 347 (427)
......++..|+|||++.+...++.++||||||+++|+|++|+.|| .+....+.+..+....+
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF-PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence 2334567888999999887447899999999999999999999888 44444444443332211
Q ss_pred ----------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
++.+.+++.+ |+..+|+.||++++++.++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKA-CLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHH-HhccCchhcccHHHHhcCCCC
Confidence 2345555556 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=313.74 Aligned_cols=240 Identities=20% Similarity=0.243 Sum_probs=188.2
Q ss_pred EEeeeeec--CCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 138 VVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 138 ~~~~LG~G--~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
++++||+| +|++||++.++.+++.||+|.++.. ....+.+|+.+++.+ +||||+++++++.. ....++||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~--~~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIA--DNELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEE--CCEEEEEE
Confidence 45789999 7899999999999999999998643 124577899999999 99999999999986 45688999
Q ss_pred eecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-
Q 014307 211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 211 e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~- 284 (427)
||+.++++..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .++++|||.+........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccc
Confidence 999999987665 2488999999999999999999999999999999999999777 899999987543221110
Q ss_pred -------ceeeccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-----------
Q 014307 285 -------YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----------- 345 (427)
Q Consensus 285 -------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~----------- 345 (427)
.....++..|+|||++.+. ..++.++|||||||++|||++|+.||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA-TQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch-hHHHHHHhcCCccccccccch
Confidence 1123456679999998653 3689999999999999999999999953222 1111111100
Q ss_pred -----------------------------------------hCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 346 -----------------------------------------LGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 346 -----------------------------------------~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.-.+.+..++.. |+..||..||++++++.||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQ-CLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHH-HHhhCchhcCCHHHHhcChhhhhcc
Confidence 001234455555 9999999999999999999998743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=306.54 Aligned_cols=245 Identities=22% Similarity=0.408 Sum_probs=201.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.++|+++++||.|+||.||+|.+..++..+|+|+++... .+.+.+|+.+++++ +|+||+++++.+.. ....++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEec--CCeEEEE
Confidence 467999999999999999999998899999999986533 34577899999999 89999999999976 4578999
Q ss_pred EeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Cc
Q 014307 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~ 284 (427)
|||+.++++..++. .+++..++.++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhcccccc
Confidence 99999999877753 489999999999999999999999999999999999999777 8999999998654332 22
Q ss_pred ceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHH
Q 014307 285 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDEL 351 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~ 351 (427)
.....++..|+|||.+.. ...++.++|||||||++|+|++|+.|| ...+..+.+..+.+... ...+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPH-HELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCc-ccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 344568889999999752 245788999999999999999999998 44444444444433211 2345
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+++.. |+..+|..||++.+++.|+|+....
T Consensus 239 ~~li~~-~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 239 NDFLKS-CLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHH-HhccChhhCcCHHHHhcChhhcccc
Confidence 556665 9999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=303.08 Aligned_cols=245 Identities=31% Similarity=0.585 Sum_probs=197.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|++.++||.|++|.||+|.++.+++.||+|.++.. ..+.+.+|+++++.+ +|+||+++++++.+ ....++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS--EKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEec--CCeEEE
Confidence 5799999999999999999999889999999988542 235678899999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-C
Q 014307 209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~ 283 (427)
||||+.+..+..... .+++..++.++.||+.||+|||++|++||||+|+||+++.++..+||+|||++...... .
T Consensus 79 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 79 VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred EEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 999997644333322 25778888999999999999999999999999999999866658999999999765332 2
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------------- 347 (427)
......++..|+|||++.+...++.++|||||||++|+|++|+.|| ...+..+.+.++....+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLF-PGDSEIDELFKIFRILGTPNEETWPGVTSLPDY 237 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhccccccchhh
Confidence 2234467788999999876456899999999999999999999998 44444455444433221
Q ss_pred -------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 -------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 -------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+...+++.+ |+..+|+.||++.+++.|+||.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 238 KSAFPKWPPKDLATVVPTLEPAGVDLLSK-MLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hhhcccCCCCCHHHhCcCCChHHHHHHHH-HccCChhhCcCHHHHhcCchHhHHh
Confidence 2334455556 9999999999999999999998754
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.96 Aligned_cols=243 Identities=21% Similarity=0.389 Sum_probs=203.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|++.+.||.|+||.||+|++..+++.+|+|++.... ...+.+|+.+++.+ +|+||+++++++.+ ...+++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLK--GSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEE--CCeEEEE
Confidence 46888999999999999999999999999999986432 35678999999999 89999999999876 4678999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Ccce
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN 286 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~ 286 (427)
+||+.+++|..++. .+++..+..++.|++.||.|||+++++||||+|+||+++.++ .++|+|||++...... ....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeecccccccc
Confidence 99999999887765 589999999999999999999999999999999999999777 8999999999876543 2334
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChHHHHHHHhc
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAYLNKY 358 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~~~~~l~~~ 358 (427)
...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. ..+..+....+.+... .+++.+++..
T Consensus 157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~- 233 (274)
T cd06609 157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLS-DLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL- 233 (274)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcc-cCchHHHHHHhhhcCCCCCcccccCHHHHHHHHH-
Confidence 4577888999999887 569999999999999999999999994 3334444333333211 2345566666
Q ss_pred cCCCChhHHHHHhHHhcCCchhhHH
Q 014307 359 HIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..+|+.||++++++.|+|+.+..
T Consensus 234 ~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 234 CLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HhhCChhhCcCHHHHhhChhhcCCC
Confidence 8999999999999999999998855
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=297.60 Aligned_cols=240 Identities=24% Similarity=0.454 Sum_probs=198.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.++|++.+.||.|+||.||+|.+..+++.+++|++... ..+.+.+|+.+++.+ +||||+++++++.+ ...++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEe--CCEEEEE
Confidence 46899999999999999999999889999999998643 346688999999999 99999999999876 5578999
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-c
Q 014307 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~ 284 (427)
|||+.++++..++ ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .+||+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhhhc
Confidence 9999999987665 3589999999999999999999999999999999999999776 79999999987654322 2
Q ss_pred ceeeccCccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-hC----------ChHH
Q 014307 285 YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LG----------TDEL 351 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~-~~----------~~~~ 351 (427)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.. .+..+....+.+. +. ...+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD-LHPMRALFLISKSNFPPPKLKDKEKWSPVF 236 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence 3345678889999998652 2788999999999999999999999943 3334433333222 00 1344
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCc
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~ 378 (427)
.+++.. |+..+|..||++.+++.|+|
T Consensus 237 ~~li~~-~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 237 HDFIKK-CLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHH-HcCCChhhCCCHHHHhcCCC
Confidence 555555 99999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=301.98 Aligned_cols=247 Identities=26% Similarity=0.450 Sum_probs=200.2
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC---CCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKT 205 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---~~~ 205 (427)
...++|++.+.||+|+||.||+|.+..+++.+|+|++... ....+.+|+.+++++.+|||++++++++...+ ...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 3468899999999999999999999999999999998653 23567889999999878999999999987532 246
Q ss_pred cEEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 206 PSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
.++||||+.+++|..++ ..+++..++.++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++..
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~ 177 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQ 177 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccchh
Confidence 89999999999987654 3588999999999999999999999999999999999999776 799999999876
Q ss_pred ecCCC-cceeeccCccccccccccCCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------
Q 014307 279 YHPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------ 347 (427)
Q Consensus 279 ~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------ 347 (427)
..... ......++..|+|||.+.... .++.++|||||||++|||++|+.||. ..+..+.+..+.+...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~ 256 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF-DMHPVKTLFKIPRNPPPTLLHP 256 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCC-CCcHHHHHHHHhcCCCCCCCcc
Confidence 54322 223346788899999975422 36889999999999999999999994 3344444444432211
Q ss_pred ---ChHHHHHHHhccCCCChhHHHHHhHHhcCCchh
Q 014307 348 ---TDELNAYLNKYHIELDPHLAALVGRLVILSYFF 380 (427)
Q Consensus 348 ---~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~ 380 (427)
...+..++.+ |+..+|+.||++.+++.||||+
T Consensus 257 ~~~~~~l~~li~~-~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 257 EKWCRSFNHFISQ-CLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cccCHHHHHHHHH-HhhcChhhCcCHHHHhcCcccC
Confidence 1234455555 9999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.89 Aligned_cols=274 Identities=28% Similarity=0.429 Sum_probs=211.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEc------C
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRD------Q 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~------~ 201 (427)
...|+-+.+||+|.||+||+|+.+.+|+.||+|++-- .-.....+|+++|+.| .|+|++.++++|.. .
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCccc
Confidence 4567788999999999999999999999999886522 2235568999999999 99999999998763 1
Q ss_pred CCCCcEEEEeecCCCc---hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 202 QSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~---l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
....+|+|+.+|+... |.....+++..++..++.+++.||.|+|...|+|||+||+|+||+.++ .+||+|||+++.
T Consensus 95 ~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeeccccccc
Confidence 2345899999998754 344445799999999999999999999999999999999999999888 899999999977
Q ss_pred ecCC-----CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHH
Q 014307 279 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353 (427)
Q Consensus 279 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~ 353 (427)
+... ..++.++.|.+|++||.+.|+..|+++.|||.-|||+.||++|.+-+ .+..+..++..|...+|+-.-..
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim-qgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM-QGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc-cCChHHHHHHHHHHHhccCCccc
Confidence 6533 33567788999999999999999999999999999999999998655 88899999999999888521111
Q ss_pred HH------HhccCCCCh--hH-HHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 354 YL------NKYHIELDP--HL-AALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 354 ~l------~~~~l~~dp--~~-r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
|. .-..++..| .. .-.+...+ .||. ..+..+|+|.+||. ++|.+|+.++..++|-|
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~-kp~~-------------kd~~a~dLle~ll~-~DP~kR~~ad~alnh~~ 317 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRL-KPYV-------------KDDEALDLLEKLLK-LDPTKRIDADQALNHDF 317 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhc-cccc-------------CChhHHHHHHHHhc-cCcccCcchHhhhchhh
Confidence 10 000111111 00 00011111 1222 23578899999996 99999999988888765
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=305.09 Aligned_cols=243 Identities=30% Similarity=0.496 Sum_probs=193.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC-----
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----- 202 (427)
-++|++.++||+|+||.||+|.+..+++.||||.+.... ...+.+|+.+++++ +||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccccccC
Confidence 367999999999999999999999999999999885321 23457899999999 9999999999987532
Q ss_pred -CCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 203 -SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
....++||||+.+.....+.. .+++.+++.++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCCccc
Confidence 235689999998744333322 589999999999999999999999999999999999999777 899999999976
Q ss_pred ecCCCc-----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------
Q 014307 279 YHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------ 347 (427)
Q Consensus 279 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------ 347 (427)
...... .....++..|+|||.+.+...++.++||||||+++|||++|+.|| .+.+....+..+.+..+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM-QGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhh
Confidence 543221 123456778999999876556789999999999999999999888 44444444444443322
Q ss_pred --------------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 --------------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 --------------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+...+++.. |+..||..||++++++.|+||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~-~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDK-LLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHH-HhcCChhhccCHHHHhcCCCC
Confidence 1223344445 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=307.27 Aligned_cols=241 Identities=23% Similarity=0.370 Sum_probs=197.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|++.+.||+|+||.||++.+..++..+|+|.++.. ....+.+|+++++++ +||||+++++++.+ ...++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCEEEEE
Confidence 4689999999999999999999999999999998643 235578999999999 99999999999976 5678999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
|||+.+++|..++ ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++ .+||+|||++...... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc-cc
Confidence 9999999998776 358899999999999999999998 5999999999999999776 7999999998755322 23
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH---------------------
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK--------------------- 344 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~--------------------- 344 (427)
....++..|+|||++.+ ..++.++|||||||++|+|++|+.||... +.. ....+..
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPP-DAK-ELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCc-chh-hHHHhhcCccccccccCCcccccCCCCC
Confidence 44578889999999876 67899999999999999999999998432 211 1111110
Q ss_pred ------------H------------hCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 345 ------------V------------LGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 345 ------------~------------~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
. .-++.+.+++.+ |+..+|+.||++.+++.|+||.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK-CLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHH-HccCChhhCcCHHHHhcChhhhhcc
Confidence 0 012345555666 9999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=299.10 Aligned_cols=244 Identities=23% Similarity=0.402 Sum_probs=202.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---H---HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---K---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~---~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
-++|..++.||+|.||+|.+|+.+.+++.+|+|++++.- + .....|-++|+.. +||.+..+-..|.. ...+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsFQt--~drl 243 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSFQT--QDRL 243 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhhcc--CceE
Confidence 367899999999999999999999999999999997532 2 3346788999997 99999998877754 6789
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee-ecCC
Q 014307 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~-~~~~ 282 (427)
|+||||..||.|..++. .+++...+.+..+|+.||.|||+++||+||||.+|.|+|.+| +|||+|||+++. +..+
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhccccc
Confidence 99999999999877764 499999999999999999999999999999999999999988 899999999964 3345
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH--Hh-----CChHHHHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK--VL-----GTDELNAYL 355 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~--~~-----~~~~~~~~l 355 (427)
....+.|||+.|.|||++.. ..|+..+|+|.+||++|||++|+.||+.. +.+.+..++- .+ -+++...++
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~--dh~kLFeLIl~ed~kFPr~ls~eAktLL 399 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNK--DHEKLFELILMEDLKFPRTLSPEAKTLL 399 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCccccc--chhHHHHHHHhhhccCCccCCHHHHHHH
Confidence 66788999999999999876 79999999999999999999999999643 2333332221 11 134555566
Q ss_pred HhccCCCChhHHH-----HHhHHhcCCchhhHHH
Q 014307 356 NKYHIELDPHLAA-----LVGRLVILSYFFQFVI 384 (427)
Q Consensus 356 ~~~~l~~dp~~r~-----~~~~ll~~~~~~~~~~ 384 (427)
.. .+..||..|. .+.++..|+||....+
T Consensus 400 sG-LL~kdP~kRLGgGpdDakEi~~h~FF~~v~W 432 (516)
T KOG0690|consen 400 SG-LLKKDPKKRLGGGPDDAKEIMRHRFFASVDW 432 (516)
T ss_pred HH-HhhcChHhhcCCCchhHHHHHhhhhhccCCH
Confidence 66 7788998884 4788999999887664
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=305.64 Aligned_cols=242 Identities=33% Similarity=0.585 Sum_probs=199.6
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
+|++.+.||.|+||.||+|.+..+++.||||.++... ...+..|+.+++.+ +|+||+++++++.+ ...+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence 4788999999999999999998899999999986432 23467899999999 89999999999977 5678
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++||||+ +++|..++. .+++..++.++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++......
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCC
Confidence 9999999 778876653 488999999999999999999999999999999999999777 8999999999876543
Q ss_pred C-cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-------------
Q 014307 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------------- 348 (427)
Q Consensus 283 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~------------- 348 (427)
. ......++..|+|||.+.+...++.++|||||||++|||++|..|| .+.++.+.+..+...++.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL-PGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccc-cCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 2 2333456778999999866567899999999999999999996555 666666665555443221
Q ss_pred ---------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 ---------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ---------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..+.+++.+ |+..+|..||++.+++.|+||.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQR-LLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHH-HhcCCcccCcCHHHHhhCccccCCC
Confidence 233445555 9999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=302.25 Aligned_cols=245 Identities=25% Similarity=0.445 Sum_probs=198.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeeeeEEEc---CCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRD---QQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~niv~l~~~~~~---~~~~~~ 206 (427)
..++|++.+.||+|+||.||+|.+..+++.+|+|+++... ...+.+|+.+++.+.+|+||+++++++.. ..+..+
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 4578999999999999999999999999999999986532 35688899999998679999999998753 234578
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
++||||+++++|...+ ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++ .+||+|||++...
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~ 174 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQL 174 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCceeec
Confidence 9999999999987643 3478888999999999999999999999999999999999777 7999999999766
Q ss_pred cCCC-cceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 280 HPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 280 ~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
.... ......|+..|+|||++.. ...++.++|||||||++|||++|+.||.. ....+.+..+.+...
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD-LHPMRALFKIPRNPPPTLHQPE 253 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC-CchhHHHhhccccCCCcccCCC
Confidence 4322 2234568889999998753 14578899999999999999999999953 333344333322111
Q ss_pred --ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 --TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 --~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
...+..++.+ |+..+|+.||++.+++.|+|+
T Consensus 254 ~~~~~~~~li~~-~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 254 LWSNEFNDFIRK-CLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CcCHHHHHHHHH-HccCCcccCCCHHHHhhcccC
Confidence 1245555555 999999999999999999996
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=315.96 Aligned_cols=237 Identities=22% Similarity=0.328 Sum_probs=184.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCC-----eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.+.||+|+||.||+|++...+ ..||+|+++... ...+.+|+.+++.+.+|+||+++++++.. .
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--G 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC--C
Confidence 467999999999999999999865433 579999986432 34578999999998789999999999876 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------------------------------------------------------
Q 014307 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (427)
...++||||+.+++|..++.
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 57899999999998865531
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce---e
Q 014307 224 -------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN---V 287 (427)
Q Consensus 224 -------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~---~ 287 (427)
.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeeccC
Confidence 256778899999999999999999999999999999999666 89999999997654332211 1
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH-h-------CChHHHHHHHhc
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV-L-------GTDELNAYLNKY 358 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~-~-------~~~~~~~~l~~~ 358 (427)
..++..|+|||++.+ ..++.++|||||||++|||++ |+.||...... ..+..+.+. . -++++..++..
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 350 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN-SKFYKMVKRGYQMSRPDFAPPEIYSIMKM- 350 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCcccccc-HHHHHHHHcccCccCCCCCCHHHHHHHHH-
Confidence 234456999999876 689999999999999999997 99998443322 222222221 1 12445555555
Q ss_pred cCCCChhHHHHHhHHhc
Q 014307 359 HIELDPHLAALVGRLVI 375 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~ 375 (427)
|+..||..||++.++++
T Consensus 351 cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 351 CWNLEPTERPTFSQISQ 367 (374)
T ss_pred HcCCChhhCcCHHHHHH
Confidence 88888888888877654
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=303.56 Aligned_cols=245 Identities=22% Similarity=0.383 Sum_probs=198.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC----CCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~----~~~~ 205 (427)
..+.|++.+.||.|+||.||+|++..+++.+|+|++... ....+..|+.+++++.+|+||+++++++... ....
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 93 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ 93 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence 346789999999999999999999999999999998643 3356788999999987899999999998642 2457
Q ss_pred cEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
++++|||+.++++..++. .+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .++|+|||++....
T Consensus 94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~ 172 (282)
T cd06636 94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchhhhh
Confidence 899999999998876653 377888899999999999999999999999999999999777 79999999987543
Q ss_pred CC-CcceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------
Q 014307 281 PG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------- 347 (427)
Q Consensus 281 ~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------- 347 (427)
.. .......++..|+|||.+.. ...++.++|||||||++|||++|+.||.. ..+.+....+.+...
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 251 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD-MHPMRALFLIPRNPPPKLKSKKW 251 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc-cCHHhhhhhHhhCCCCCCccccc
Confidence 22 22344578889999999752 24688899999999999999999999943 333333333322211
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
++.+.+++.+ |+..||..||++.+++.|+||
T Consensus 252 ~~~~~~li~~-cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 252 SKKFIDFIEG-CLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CHHHHHHHHH-HhCCChhhCcCHHHHhcCCCC
Confidence 2355566665 999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=316.16 Aligned_cols=203 Identities=22% Similarity=0.348 Sum_probs=172.9
Q ss_pred ccccccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 125 SLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 125 ~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
++.....++++|.-...||+|+||.||+|.. .++..||||.+.... ..+|.+|+.+|.++ +|||+|+|+|||.+.
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEG 143 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecC
Confidence 3344445678999999999999999999997 455999999987643 46799999999999 799999999999874
Q ss_pred CCCCcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeeccCCCceEEcCCCCeEEEEee
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHEQRKLRLIDW 273 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~~ikl~DF 273 (427)
.. ..+||+|||.+|+|..++. .++|..+.+|+.++|.||+|||+.. |||||||++|||+|.+. .+||+||
T Consensus 144 ~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDF 221 (361)
T KOG1187|consen 144 GE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDF 221 (361)
T ss_pred Cc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCc
Confidence 33 5889999999999977752 5789999999999999999999853 99999999999999776 8999999
Q ss_pred eeeeeecC-CCcceee-ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 014307 274 GLAEFYHP-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 332 (427)
Q Consensus 274 Gla~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~ 332 (427)
|+|+.... ....... .||..|+|||++.. +..+.|+|||||||+|.||++|+.+....
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence 99976544 3333333 89999999999876 78999999999999999999999888543
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=301.53 Aligned_cols=272 Identities=28% Similarity=0.524 Sum_probs=206.6
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++++.||.|++|.||+|++..+++.||||.++.. ....+.+|+++++++ +||||+++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence 488999999999999999999999999999988632 225688999999999 99999999999875 5678999
Q ss_pred EeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
|||+.+ ++..++ ..+++..+..++.|++.||+|||+.|++||||+|+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 155 (284)
T ss_pred eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc
Confidence 999975 454433 3478999999999999999999999999999999999999777 89999999987654322
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCC
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~d 363 (427)
......++..|+|||++.+...++.++|||||||++|+|+||+.|| .+.++.+.+.++.+..+.+....+... ...
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 231 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGV---TSL 231 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCCChhhhhhh---hHH
Confidence 2233456788999999876555789999999999999999999998 555666677777666665432211000 001
Q ss_pred hhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 364 PHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 364 p~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
|.............+ .. ........+.++|++||. .||++|+++..++.|||
T Consensus 232 ~~~~~~~~~~~~~~~-~~-------~~~~~~~~~~~li~~~l~-~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 232 PDYKPSFPKWARQDF-SK-------VVPPLDEDGRDLLSQMLH-YDPNKRISAKAALAHPF 283 (284)
T ss_pred HHHHhhcccccccCH-HH-------HcccCCHHHHHHHHHhcC-CCcccCCCHHHHhcCCC
Confidence 222221111111000 00 011234567899999995 99999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.08 Aligned_cols=235 Identities=18% Similarity=0.336 Sum_probs=183.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC----------------CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv 192 (427)
.++|++.++||+|+||.||+|.+.. ++..||+|+++... ...+.+|+.+|.++ +||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence 4679999999999999999997532 34579999987532 34688999999999 999999
Q ss_pred eeeeEEEcCCCCCcEEEEeecCCCchhhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 014307 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----------------------TLSDYDVRYYIYELLKALDYCHSQGIM 250 (427)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~L~~LH~~~ii 250 (427)
++++++.+ ....+++|||+.+++|..++. .+++..+..++.||+.||.|||++||+
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEec--CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 99999976 456899999999999876542 256677889999999999999999999
Q ss_pred eeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh--C
Q 014307 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--R 325 (427)
Q Consensus 251 HrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt--g 325 (427)
||||||+|||++.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ +
T Consensus 161 H~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999776 8999999999865443321 12244677999999876 679999999999999999986 5
Q ss_pred CCCCCCCCCCHHHHHHHHHHh-------------C-ChHHHHHHHhccCCCChhHHHHHhHHh
Q 014307 326 KEPFFYGHDNYDQLVKIAKVL-------------G-TDELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 326 ~~pf~~~~~~~~~l~~i~~~~-------------~-~~~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
..|| ......+.+..+...+ . +..+.+++.. |+..+|..||++.++.
T Consensus 239 ~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 239 EQPY-GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQ-CWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCC-CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHH-HccCCchhCcCHHHHH
Confidence 6677 3334434333332211 0 2344455554 9999999999998873
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=305.52 Aligned_cols=248 Identities=24% Similarity=0.366 Sum_probs=201.6
Q ss_pred ccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 129 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
+....+.|..-+.||+||||+|+-|+-+.||+.+|.|.+.+.. .....+|-.||.++ +.+.||.+-..|+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~FiVslaYAfeT-- 256 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSPFIVSLAYAFET-- 256 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccCcEEEEeeeecC--
Confidence 4455688999999999999999999999999999999885422 23467899999999 88999999888876
Q ss_pred CCCcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
...+|+|+..|+||+|..++- .+++..++.++.+|+.||++||+.+||+|||||+|||+|+.| +|+|+|.|+|.
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~G-hvRISDLGLAv 335 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHG-HVRISDLGLAV 335 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCC-CeEeeccceEE
Confidence 456899999999999987652 599999999999999999999999999999999999999777 89999999999
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------C
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~ 347 (427)
.+..+.....++||..|||||++.+ ..|+..+|+|||||+||||+.|+.||.. ..+...-.++.+.. -
T Consensus 336 ei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~-~KeKvk~eEvdrr~~~~~~ey~~kF 413 (591)
T KOG0986|consen 336 EIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQ-RKEKVKREEVDRRTLEDPEEYSDKF 413 (591)
T ss_pred ecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhh-hhhhhhHHHHHHHHhcchhhccccc
Confidence 9988888888899999999999988 5699999999999999999999999942 22111111111111 1
Q ss_pred ChHHHHHHHhccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
+++...++.. .+..||..|-- .+++-.||||+...
T Consensus 414 S~eakslc~~-LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 414 SEEAKSLCEG-LLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred CHHHHHHHHH-HHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 2333333333 67777877754 55778888888755
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=305.52 Aligned_cols=243 Identities=22% Similarity=0.370 Sum_probs=200.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||.||+|.+..+++.+|+|.+... ..+.+.+|+++++.+ +|+||+++++.+.+ ....+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence 4699999999999999999999889999999998643 234578899999999 89999999999876 56789
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++|||+.+++|..++. .+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhccccc
Confidence 9999999999877653 488999999999999999999999999999999999999777 8999999998654322
Q ss_pred Cc------------------------------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 014307 283 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 332 (427)
Q Consensus 283 ~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~ 332 (427)
.. .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf-~~ 234 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPF-KG 234 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCC-CC
Confidence 11 112367888999999876 67899999999999999999999999 44
Q ss_pred CCCHHHHHHHHHH-h-------CChHHHHHHHhccCCCChhHHHH----HhHHhcCCchhhHH
Q 014307 333 HDNYDQLVKIAKV-L-------GTDELNAYLNKYHIELDPHLAAL----VGRLVILSYFFQFV 383 (427)
Q Consensus 333 ~~~~~~l~~i~~~-~-------~~~~~~~~l~~~~l~~dp~~r~~----~~~ll~~~~~~~~~ 383 (427)
.+..+.+..+... . -++.+.+++.. |+..+|..|++ +++++.|+||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 235 SNRDETFSNILKKEVTFPGSPPVSSSARDLIRK-LLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred CchHHHHHHHhcCCccCCCccccCHHHHHHHHH-HccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 4544544444321 1 12345555555 99999999999 99999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=302.17 Aligned_cols=243 Identities=23% Similarity=0.427 Sum_probs=202.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..+|++.++||.|+||.||+|++..+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++.. ...+++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLV--GDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEec--CceEEEE
Confidence 46799999999999999999999999999999988532 345678899999999 99999999999976 5678999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-ce
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~~ 286 (427)
+||+.+++|..+.. .+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........ ..
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccccCC
Confidence 99999999987664 488999999999999999999999999999999999999776 899999999876543322 23
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChHHHHHHHh
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNK 357 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~ 357 (427)
...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.... -.+.+.+++.+
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 174 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL-NENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 3467888999999876 678999999999999999999999994 444444444333211 12345555555
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
|+..||..||++.+++.|+||...
T Consensus 252 -~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 252 -CLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred -HhhcChhhCCCHHHHhhChHhhhc
Confidence 999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=298.52 Aligned_cols=241 Identities=22% Similarity=0.365 Sum_probs=194.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.+|++.+.||+|+||.||+|.+..++..||+|.++.. ....+.+|+.+++.+ +||||+++++++.......
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 4688899999999999999999999999999988532 124578899999999 8999999999987655667
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+++++||+.+++|...+ ..+++..++.++.|++.||+|||+.+|+||||||+||+++.++ .+||+|||++......
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCccccccc
Confidence 89999999999887665 3578899999999999999999999999999999999999776 8999999998755321
Q ss_pred ----CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChH
Q 014307 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDE 350 (427)
Q Consensus 283 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~ 350 (427)
.......++..|+|||.+.+ ..++.++|||||||++|||++|+.||. ..+.......+..... .+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWA-EYEAMAAIFKIATQPTNPQLPSHISEH 237 (266)
T ss_pred cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcc-ccchHHHHHHHhcCCCCCCCchhcCHH
Confidence 11223457788999999876 678999999999999999999999994 3333333333222111 123
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCchh
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYFF 380 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~ 380 (427)
+..+ .. |+..+|..||++++++.||||+
T Consensus 238 ~~~l-i~-~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 238 ARDF-LG-CIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHH-HH-HhcCChhhCcCHHHHhcCcccc
Confidence 3333 44 6678999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=294.73 Aligned_cols=239 Identities=22% Similarity=0.380 Sum_probs=199.9
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+|+.+|+.+ +|||++++++.+.. ....++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence 588999999999999999999999999999998542 245688999999999 99999999998875 5678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.+++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++..+||+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999877653 3788999999999999999999999999999999999987666789999999987655444
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHh
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNK 357 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~ 357 (427)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||. ..+.......+..... .+.+.+++..
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFE-AANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcc-cCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 444578889999999876 678899999999999999999999984 4444444444433211 2455566655
Q ss_pred ccCCCChhHHHHHhHHhcCCch
Q 014307 358 YHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
|+..+|..||++.+++.|||+
T Consensus 236 -~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 -MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.05 Aligned_cols=243 Identities=20% Similarity=0.302 Sum_probs=187.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeE-EEc---CC-CC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDI-VRD---QQ-SK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~-~~~---~~-~~ 204 (427)
..+++|.+.|.+|||+.||+|.+...+..||+|.+-. ...+.+.+||++|+.|.+|+|||.++|. ... .+ ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4578899999999999999999988889999998743 3346688999999999899999999993 222 11 23
Q ss_pred CcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
...|+||||.++.|-+++ .+|++.++++|+.|+++|+.+||... |||||||-|||||+.++ ..||||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCcccccc
Confidence 457889999987765554 35999999999999999999999987 99999999999999887 89999999985
Q ss_pred eecCCCc----------ceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 014307 278 FYHPGKE----------YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345 (427)
Q Consensus 278 ~~~~~~~----------~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~ 345 (427)
-...... ......|+.|+|||++.- ....+.|+|||+|||+||-||+...||..+ ....++.--...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s-g~laIlng~Y~~ 273 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES-GKLAILNGNYSF 273 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC-cceeEEeccccC
Confidence 4322211 122367889999999732 257899999999999999999999999432 222222211111
Q ss_pred hC----ChHHHHHHHhccCCCChhHHHHHhHHhcCCc
Q 014307 346 LG----TDELNAYLNKYHIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 346 ~~----~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~ 378 (427)
.- ...+.. |++.||+.||..||.|.+++..-+
T Consensus 274 P~~p~ys~~l~~-LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 274 PPFPNYSDRLKD-LIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred CCCccHHHHHHH-HHHHHhccCcccCCCHHHHHHHHH
Confidence 11 123333 455599999999999999887543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=315.08 Aligned_cols=237 Identities=21% Similarity=0.365 Sum_probs=185.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEE-----cCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.++||+|+||.||+|.+ ..++..||||+++.. ..+.+.+|+.+|+.+.+||||+++++++.. .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~--~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV--G 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--C
Confidence 46799999999999999999974 345678999998643 235678999999998789999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------------------------------------------------------
Q 014307 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (427)
...++||||+.+|+|..++.
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 56889999999998865542
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 224 ------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 224 ------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCcccc
Confidence 256777889999999999999999999999999999999766 8999999999866433221
Q ss_pred e---eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH-Hh-------CChHHHH
Q 014307 286 N---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK-VL-------GTDELNA 353 (427)
Q Consensus 286 ~---~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~-~~-------~~~~~~~ 353 (427)
. ...++..|+|||++.+ ..++.++|||||||++|||++ |..||. .........+..+ .. .+.++.+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYP-GMPVDSKFYKMIKEGYRMLSPECAPSEMYD 348 (375)
T ss_pred cccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCC-CCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence 1 1233456999999876 689999999999999999998 888884 3333333332222 11 1234555
Q ss_pred HHHhccCCCChhHHHHHhHHhc
Q 014307 354 YLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.. |+..||..||++.+++.
T Consensus 349 li~~-cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 349 IMKS-CWDADPLKRPTFKQIVQ 369 (375)
T ss_pred HHHH-HccCChhHCcCHHHHHH
Confidence 5555 99999999999988875
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=302.66 Aligned_cols=244 Identities=22% Similarity=0.403 Sum_probs=201.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..+|++.+.||+|+||.||+|++..+++.+|+|.+... ..+.+.+|+.+++.+ +|+|++++++.+.. ....++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~--~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEe--CCEEEEe
Confidence 46899999999999999999999899999999988642 235678899999998 99999999999876 4578999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-ce
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~~ 286 (427)
|||+.+++|..++. .+++.++..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++........ ..
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred ecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhccccccccC
Confidence 99999999987764 478899999999999999999999999999999999999776 899999999875543322 23
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChHHHHHHHh
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNK 357 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~ 357 (427)
...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. ..+..+.+..+.... -.+.+..++.+
T Consensus 175 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 252 (296)
T cd06654 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (296)
T ss_pred cccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCC-CCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence 4578889999999876 678899999999999999999999994 333333333222111 01344555555
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..+|..||++.+++.++|+....
T Consensus 253 -~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 253 -CLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred -HCcCCcccCcCHHHHhhChhhhccC
Confidence 9999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=296.73 Aligned_cols=240 Identities=23% Similarity=0.425 Sum_probs=194.1
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.+|++.+.||+|+||.||+|.+..++..||||.+... ..+.+.+|+.+++++ +||||+++++++.+.....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 4689999999999999999999999999999987521 124678899999999 9999999999987655567
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++++|||+.+++|..++ ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||++......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCccccccccc
Confidence 88999999999987765 3578888999999999999999999999999999999999776 8999999998754321
Q ss_pred ----CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChH
Q 014307 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDE 350 (427)
Q Consensus 283 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~ 350 (427)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||. ..+.......+..... ...
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCC-ccchHHHHHHHhcCCCCCCCchhhCHH
Confidence 12233467888999999876 678999999999999999999999994 3333333332221111 123
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
...++.+ |+ .+|..||++++++.|+|+
T Consensus 238 ~~~~i~~-~l-~~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 238 CRDFLKR-IF-VEAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHHHH-Hh-cChhhCCCHHHHhcCccc
Confidence 4455555 55 489999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=294.43 Aligned_cols=239 Identities=26% Similarity=0.417 Sum_probs=195.8
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||.|++|.||++.++.+++.+|+|.+... ..+.+.+|+++++++ +|+|++++++.+... ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence 489999999999999999999999999999998532 234578899999999 999999999987542 4467899
Q ss_pred EeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
|||+.++++...+ ..+++.++..++.|++.||.+||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCD 157 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccCC
Confidence 9999999887654 2488999999999999999999999999999999999999776 89999999998764322
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
......++..|+|||++.+ ..++.++|||||||++++|++|+.||. ..+..+....+..... .+.+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFN-AKDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235 (257)
T ss_pred ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence 2234467888999999876 678999999999999999999999984 3333333333333221 234555555
Q ss_pred hccCCCChhHHHHHhHHhcCCch
Q 014307 357 KYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+ |+..+|+.||++.+++.||||
T Consensus 236 ~-~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 236 T-MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred H-HhccCcccCCCHHHHhcCCCC
Confidence 5 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=319.74 Aligned_cols=228 Identities=18% Similarity=0.301 Sum_probs=191.6
Q ss_pred EEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCC
Q 014307 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (427)
Q Consensus 137 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (427)
.-++-||.|+.|.||+|+. .++.||||.++..+ +.+|+-|++| +|+||+.|.|+|.. ...+|||||||..|
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~elk----ETdIKHLRkL-kH~NII~FkGVCtq--sPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK----ETDIKHLRKL-KHPNIITFKGVCTQ--SPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhhh----hhhHHHHHhc-cCcceeeEeeeecC--CceeEEeeeccccc
Confidence 3467899999999999985 68899999876332 3578999999 99999999999975 67889999999999
Q ss_pred chhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCcc
Q 014307 217 DFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293 (427)
Q Consensus 217 ~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~ 293 (427)
-|...++ .++......+..+|+.|+.|||.+.|||||||.-||||..++ .|||+|||-++.+......-.++||..
T Consensus 198 qL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFaGTVa 276 (904)
T KOG4721|consen 198 QLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFAGTVA 276 (904)
T ss_pred cHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhhhhHh
Confidence 9988774 588889999999999999999999999999999999999887 899999999987766655667899999
Q ss_pred ccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH----HHHHH---hCChHHHHHHHhccCCCChhH
Q 014307 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV----KIAKV---LGTDELNAYLNKYHIELDPHL 366 (427)
Q Consensus 294 y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~----~i~~~---~~~~~~~~~l~~~~l~~dp~~ 366 (427)
|||||++.+ .+.+.|+|||||||+||||+||..||. +.+...++- .+... -..|+-..++.+.||.--|..
T Consensus 277 WMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYk-dVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 277 WMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYK-DVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred hhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCcc-ccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence 999999987 799999999999999999999999993 222221111 01111 113667788889999999999
Q ss_pred HHHHhHHhcC
Q 014307 367 AALVGRLVIL 376 (427)
Q Consensus 367 r~~~~~ll~~ 376 (427)
||++.+++.|
T Consensus 355 RPSFrqil~H 364 (904)
T KOG4721|consen 355 RPSFRQILLH 364 (904)
T ss_pred CccHHHHHHH
Confidence 9999998877
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=304.50 Aligned_cols=245 Identities=23% Similarity=0.404 Sum_probs=201.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
...+|+++++||.|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.+ +|+||+++++++.. ....++
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCEEEE
Confidence 347899999999999999999999889999999998642 335678899999998 99999999999976 557899
Q ss_pred EEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-c
Q 014307 209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 285 (427)
Q Consensus 209 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~ 285 (427)
||||+.++++..+.. .+++..+..++.|++.||.|||+.|++||||||+|||++.++ .++|+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~ 172 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKR 172 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCccCc
Confidence 999999999987763 478889999999999999999999999999999999999776 899999999976543322 2
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChHHHHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLN 356 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~ 356 (427)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.. .+....+..+.... -.+.+.+++.
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred CcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 34567888999999876 6789999999999999999999999943 33333322222110 1133445555
Q ss_pred hccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 357 KYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+ |+..+|..||++.+++.||||....
T Consensus 251 ~-~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 251 R-CLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred H-HccCChhhCcCHHHHhcCchhcccc
Confidence 5 9999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=297.51 Aligned_cols=239 Identities=32% Similarity=0.602 Sum_probs=196.2
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
|++.++||.|+||.||+|.+..+++.+|+|.+... ....+.+|+.+++.+ +|+|++++++++.+......++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 67889999999999999999889999999999754 234578899999999 899999999999865347889999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--c
Q 014307 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (427)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~--~ 284 (427)
||+.+ ++..++ ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++ .+||+|||++....... .
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCccc
Confidence 99986 554443 2588999999999999999999999999999999999999777 89999999998765443 2
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------------- 347 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------------- 347 (427)
.....++..|+|||.+.+...++.++|||||||++|||++|+.||. ..+..+.+..+.+..+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ-GSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 3344667889999988765568999999999999999999999984 4444444444433221
Q ss_pred --------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 --------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+.+.+++.+ |+..+|..||++.+++.++||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDK-LLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHH-HcCCChhhCcCHHHHhhCcCC
Confidence 3344455556 999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=307.07 Aligned_cols=248 Identities=28% Similarity=0.562 Sum_probs=199.2
Q ss_pred ccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC-
Q 014307 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ- 202 (427)
Q Consensus 129 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~- 202 (427)
.+...++|++.+.||+|+||.||+|.+..+++.||+|+++... .+.+.+|+.+++++ +|+||+++++++....
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARS 90 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeeccc
Confidence 3455689999999999999999999998999999999986422 34577899999999 9999999999886432
Q ss_pred ---CCCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 203 ---SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 203 ---~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
....+++++++ ++++..+. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++.
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~ 168 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLAR 168 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEecccccc
Confidence 23467888876 55665554 3589999999999999999999999999999999999999877 89999999987
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
... .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| ...+....+..+.+..+
T Consensus 169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T cd07877 169 HTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKKI 245 (345)
T ss_pred ccc--ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 543 23344577888999999876557899999999999999999999998 44444444433332211
Q ss_pred ---------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ---------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ---------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+...+++.. |+..||..|+++.+++.|+||.+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 246 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK-MLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred ccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHH-HcCCChhhcCCHHHHhcChhhhhcC
Confidence 2334455555 9999999999999999999998744
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=299.82 Aligned_cols=241 Identities=23% Similarity=0.403 Sum_probs=195.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
..++|++.++||+|+||.||+|++..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.. ....++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEe--CCEEEE
Confidence 456899999999999999999999999999999998643 234578899999999 99999999999976 457889
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-c
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~ 284 (427)
||||+.+++|..++ ..+++..+..++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++....... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeecccccc
Confidence 99999999987765 3588999999999999999999999999999999999999777 79999999998664322 2
Q ss_pred ceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-h----------CChHH
Q 014307 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-L----------GTDEL 351 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~-~----------~~~~~ 351 (427)
.....++..|+|||.+.. ...++.++|||||||++|||++|+.||... .+.+....+.+. . -...+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL-HPMRALFLMSKSNFQPPKLKDKTKWSSTF 241 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc-chhhhheeeecCCCCCCCCccccccCHHH
Confidence 234567889999998742 245788999999999999999999998533 222222111111 0 02345
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCc
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~ 378 (427)
.+++.+ |+..+|+.||++++++.|.|
T Consensus 242 ~~li~~-~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 242 HNFVKI-SLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHH-HhhCChhhCcCHHHHhcCCC
Confidence 566655 99999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=306.74 Aligned_cols=278 Identities=28% Similarity=0.494 Sum_probs=208.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC---C
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---K 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~---~ 204 (427)
.++|++.+.||+|+||.||+|++..+++.||||.++.. ....+.+|+.+++.+ +|+||+++++++..... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccC
Confidence 46799999999999999999999999999999988642 234577899999999 99999999998865322 4
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.+++++||+.+ ++...+ ..+++..+..++.|++.||.|||+++++||||||+||+++.++ .+||+|||++.....
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 83 DVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSE 160 (337)
T ss_pred cEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCC
Confidence 57999999975 444333 3589999999999999999999999999999999999999776 899999999986543
Q ss_pred C-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccC
Q 014307 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360 (427)
Q Consensus 282 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l 360 (427)
. .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+.......+....+.+....+ ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~----~~ 235 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF-PGKDYVHQLKLITELLGSPSEEDL----GF 235 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCChHHh----hh
Confidence 3 22334567888999999875456899999999999999999999998 555555666666666654332221 11
Q ss_pred CCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 361 ELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..++..+..+..+...+...... ....+...+.++|++||. .+|+.|+++..++.|||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~-~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFAR-----LFPHANPLAIDLLEKMLV-FDPSKRITVEEALAHPY 293 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHH-----HcccCCHHHHHHHHHHhc-CChhhccCHHHHHcCcc
Confidence 22233333333332222211100 112345667888888884 88888888888888887
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=297.89 Aligned_cols=245 Identities=22% Similarity=0.418 Sum_probs=200.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----CCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----~~~ 205 (427)
..++|++.+.||.|+||.||+|.++.+++.+++|++.... .+.+.+|+.+++++.+|+||+++++++.... ...
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 4588999999999999999999998899999999987533 4668899999999877999999999997643 456
Q ss_pred cEEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 206 PSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
++++|||+.+++|..+. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++..
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~ 162 (275)
T cd06608 84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCcccee
Confidence 79999999999876553 3578999999999999999999999999999999999999776 899999999876
Q ss_pred ecCCC-cceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------
Q 014307 279 YHPGK-EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------ 347 (427)
Q Consensus 279 ~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------ 347 (427)
..... ......++..|+|||++.. ...++.++|||||||++|+|++|+.||. .......+.++.+...
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~ 241 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC-DMHPMRALFKIPRNPPPTLKSP 241 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc-ccchHHHHHHhhccCCCCCCch
Confidence 54322 2334568888999998753 2357889999999999999999999994 3344444444443211
Q ss_pred ---ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 ---TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 ---~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
...+.+++.+ |+..||..||++.+++.|||+
T Consensus 242 ~~~~~~~~~li~~-~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 242 ENWSKKFNDFISE-CLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhcCHHHHHHHHH-HhhcChhhCcCHHHHhcCCCC
Confidence 1244555555 999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=299.80 Aligned_cols=245 Identities=20% Similarity=0.345 Sum_probs=199.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|+..++||.|++|.||+|.+..+++.+|+|.+... ....+.+|+++++++ +||||+++++++.+.....+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 4689999999999999999999999999999998642 235688999999999 99999999999977666678999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
|||+.+++|..++ ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccccccc
Confidence 9999999986653 2478889999999999999999999999999999999999776 8999999998754322
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CCHHHHHHHHHH----hC-------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH----DNYDQLVKIAKV----LG------- 347 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~----~~~~~l~~i~~~----~~------- 347 (427)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ...+....+... +.
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236 (287)
T ss_pred c-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCC
Confidence 2 223456788999999876 688999999999999999999999995441 222322222221 00
Q ss_pred --ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 --TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 --~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+.+.+++.. |+..+|..||++.+++.|+|+....
T Consensus 237 ~~~~~~~~li~~-~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 237 KWSEEFKDFIKQ-CLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred chHHHHHHHHHH-HcCCCcccCCCHHHHHhCccccccc
Confidence 1234455555 9999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=293.60 Aligned_cols=238 Identities=23% Similarity=0.409 Sum_probs=197.7
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||+|++|.||+|.+..+++.|++|.+.. .....+.+|+++++.+ +||||+++++++.+ ....++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLD--KGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeecc--CCEEEEE
Confidence 47889999999999999999999999999998753 2346688999999999 99999999999876 4678999
Q ss_pred EeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.+++|..++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||+++.+.....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc
Confidence 9999999987765 3478889999999999999999999999999999999999776 899999999987654332
Q ss_pred -ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||. ..+..+....+.+... ..++.+++.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd08529 157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFD-ANNQGALILKIIRGVFPPVSQMYSQQLAQLID 234 (256)
T ss_pred hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence 234467888999999876 678999999999999999999999994 3343343444333211 235556666
Q ss_pred hccCCCChhHHHHHhHHhcCCch
Q 014307 357 KYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+ |+..+|+.||++.+++.++|+
T Consensus 235 ~-~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 235 Q-CLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred H-HccCCcccCcCHHHHhhCCCC
Confidence 6 999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=295.31 Aligned_cols=240 Identities=23% Similarity=0.430 Sum_probs=199.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|++.+.||.|+||.||+|.+..+++.+++|.++... .+.+.+|+.+++++ +|+||+++++++.+ ....++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFK--NTDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeec--CCcEEEEEe
Confidence 367999999999999999999998889999999987543 56789999999999 99999999999976 467899999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cce
Q 014307 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (427)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~ 286 (427)
|+.+++|..++ ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||++....... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCccccc
Confidence 99999988765 3578999999999999999999999999999999999999777 89999999998664433 233
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChHHHHHHHh
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNK 357 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~ 357 (427)
...++..|+|||++.+ ..++.++|||||||++|+|++|+.||.. ....+....+.... -...+.+++..
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (256)
T cd06612 158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSD-IHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKK 235 (256)
T ss_pred cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-cchhhhhhhhccCCCCCCCchhhcCHHHHHHHHH
Confidence 4457888999999876 6789999999999999999999999843 33333322221110 12345566666
Q ss_pred ccCCCChhHHHHHhHHhcCCch
Q 014307 358 YHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
|+..+|..||++.+++.|+||
T Consensus 236 -~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 236 -CLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred -HHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=303.86 Aligned_cols=243 Identities=30% Similarity=0.551 Sum_probs=196.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC-----
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----- 202 (427)
.++|++.++||.|+||.||+|.++.+++.+|+|.+.... ...+.+|+++++.+ +|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheecccccccc
Confidence 478999999999999999999999999999999885321 23567899999999 9999999999876533
Q ss_pred -CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
...+++++||+.+..+..+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCccchh
Confidence 23578999999876544433 2589999999999999999999999999999999999999777 899999999976
Q ss_pred ecCCCc------------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh
Q 014307 279 YHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346 (427)
Q Consensus 279 ~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~ 346 (427)
...... .....++..|+|||.+.+...++.++|||||||++|||++|+.|| .+.+..+....+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~-~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL-QGKSDIDQLHLIFKLC 243 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHh
Confidence 533211 122356778999999876556899999999999999999999888 5555555555444332
Q ss_pred CC------------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 347 GT------------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 347 ~~------------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+. +.+.+++.+ |+..+|..||++.+++.|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSK-LLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHH-HcccCcccCcCHHHHhcCCCC
Confidence 21 234456666 999999999999999999997
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=296.42 Aligned_cols=238 Identities=24% Similarity=0.470 Sum_probs=194.3
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
+|.+.+.||.|+||.||+|.+..+++.+|+|.+.... .+.+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLD-- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Confidence 3667889999999999999998889999999885321 14578899999999 99999999999876
Q ss_pred CCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
....+++|||+.+++|..++. .+++..+..++.|++.||+|||++|++||||+|+||+++.++ .++|+|||+++..
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~ 156 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKL 156 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCccc
Confidence 457889999999999877763 588889999999999999999999999999999999999776 8999999998766
Q ss_pred cCCC-------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-----
Q 014307 280 HPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----- 347 (427)
Q Consensus 280 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----- 347 (427)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.. .+....+..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPD-CTQLQAIFKIGENASPEIPS 234 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCC-ccHHHHHHHHhccCCCcCCc
Confidence 4221 1122357788999999876 6788999999999999999999999943 333344333333211
Q ss_pred --ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 --TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 --~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
...+..++.+ |+..+|..||++.+++.|+||
T Consensus 235 ~~~~~~~~li~~-~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 235 NISSEAIDFLEK-TFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ccCHHHHHHHHH-HccCCchhCcCHHHHhhCCCC
Confidence 2344555555 999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=303.23 Aligned_cols=241 Identities=21% Similarity=0.365 Sum_probs=205.0
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
-|.++++||+|+||.||+|.++.+|+.+|||.+.. .+..++..|+.|++++ ..|++|++||.|.. ...+++|||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK--~sDLWIVMEYC 110 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFK--HSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhcc--CCceEeehhhc
Confidence 46788999999999999999999999999998853 4567889999999998 99999999998765 45689999999
Q ss_pred CCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Ccceee
Q 014307 214 NNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVR 288 (427)
Q Consensus 214 ~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~~~ 288 (427)
..|+....+ +.+++.++..+++..++||+|||...-||||||+.|||++.+| .+||+|||.|..+.+. -..++.
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHhhCcc
Confidence 999987665 4699999999999999999999999999999999999999888 8999999999766433 235678
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----C-----ChHHHHHHHhcc
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----G-----TDELNAYLNKYH 359 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----~-----~~~~~~~l~~~~ 359 (427)
.||+.|||||++.. -.|+.++||||||++..||..|++|| .+-.+...+..|.... . ++++..|+.. |
T Consensus 190 IGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPY-sDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~-C 266 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPY-SDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS-C 266 (502)
T ss_pred ccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCc-ccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH-H
Confidence 99999999999987 57999999999999999999999998 4444544444443221 1 2355566666 9
Q ss_pred CCCChhHHHHHhHHhcCCchhhH
Q 014307 360 IELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 360 l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+...|+.|.++.+|+.|+|.+..
T Consensus 267 LiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 267 LIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hcCCHHHHHHHHHHhhhhhhcCC
Confidence 99999999999999999998864
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=299.43 Aligned_cols=243 Identities=22% Similarity=0.411 Sum_probs=199.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..|+..++||.|+||.||+|.+..++..||+|+++.. ....+.+|+.+++.+ +|+||+++++++.+ ....++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEEEE
Confidence 3577889999999999999999889999999998643 235678899999999 99999999999976 5678999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-ce
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 286 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~~ 286 (427)
|||+.+++|..++. .+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++........ ..
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCccccc
Confidence 99999999877654 488889999999999999999999999999999999999776 899999999976543322 23
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhcc
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYH 359 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~ 359 (427)
...++..|+|||++.+ ..++.++|+|||||++|||++|+.||.. .........+..... ..++.+++.+ |
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~ 236 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSD-MHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDA-C 236 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCC-cChHhHhhhhhcCCCCCCchhhhHHHHHHHHH-H
Confidence 3467788999999876 6789999999999999999999999843 333333332221111 1344455555 9
Q ss_pred CCCChhHHHHHhHHhcCCchhhHH
Q 014307 360 IELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 360 l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+..+|..||++.+++.|+|+.+..
T Consensus 237 l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 237 LNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred cccCcccCcCHHHHHhChHhhhcc
Confidence 999999999999999999998866
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.16 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=184.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCC-eEEEEE------------------Eecc--ccHHHHHHHHHHHHHhcCCCCe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPNI 191 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vavK------------------~~~~--~~~~~~~~E~~il~~l~~h~ni 191 (427)
.++|+++++||+|+||+||+|..+... ...++| .++. .....+.+|+.+|+++ +|+||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCc
Confidence 468999999999999999998764322 222222 1111 1124578999999999 99999
Q ss_pred eeeeeEEEcCCCCCcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC
Q 014307 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (427)
Q Consensus 192 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~ 264 (427)
+++++++.. ....++++|++.+..+..+.. ......++.++.||+.||+|||++|||||||||+|||++.+
T Consensus 226 v~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 999999987 456789999987765544332 23456788899999999999999999999999999999977
Q ss_pred CCeEEEEeeeeeeeecCCCc--ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCHHHHH
Q 014307 265 QRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLV 340 (427)
Q Consensus 265 ~~~ikl~DFGla~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~--~~~~~l~ 340 (427)
+ .+||+|||+++.+..... .....|+..|+|||++.+ ..++.++|||||||++|||++|..+++... ....++.
T Consensus 304 ~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 G-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred C-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 7 899999999987654322 223578999999999887 689999999999999999999986554322 2333443
Q ss_pred HHHHHhC--------------------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 341 KIAKVLG--------------------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 341 ~i~~~~~--------------------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++...++ .+++.+++ ..|+..||..||++.++|.||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPL-VKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHH-HHHhccCcccCcCHHHHhhChhhhcC
Confidence 3333211 11222223 34999999999999999999999874
Q ss_pred H
Q 014307 383 V 383 (427)
Q Consensus 383 ~ 383 (427)
.
T Consensus 461 ~ 461 (501)
T PHA03210 461 E 461 (501)
T ss_pred C
Confidence 3
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.10 Aligned_cols=240 Identities=21% Similarity=0.425 Sum_probs=195.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.++|++.++||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++.+.. ....+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe--CCEEEEE
Confidence 457888999999999999999999999999999986533 24577899999999 99999999999876 4678999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cc
Q 014307 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~ 285 (427)
|||+.+++|..++ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .+||+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCccccc
Confidence 9999999998765 3589999999999999999999999999999999999999777 79999999987654322 22
Q ss_pred eeeccCcccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-hC----------ChHHH
Q 014307 286 NVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LG----------TDELN 352 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~-~~----------~~~~~ 352 (427)
....|+..|+|||++. ....++.++|||||||++|+|++|+.||.... +...+..+... .. +..+.
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH-PMRALFLMTKSNFQPPKLKDKMKWSNSFH 242 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc-chhhHHhhhccCCCCCcccccCCCCHHHH
Confidence 3457889999999874 22468899999999999999999999985432 22322222111 10 12344
Q ss_pred HHHHhccCCCChhHHHHHhHHhcCCc
Q 014307 353 AYLNKYHIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~~~~ 378 (427)
+++.+ |+..+|+.||++++++.|||
T Consensus 243 ~li~~-~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 243 HFVKM-ALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHH-HccCCchhCcCHHHHhcCCC
Confidence 55555 99999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=301.00 Aligned_cols=228 Identities=18% Similarity=0.215 Sum_probs=185.1
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEc--CCCCCcEEEEe
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIFE 211 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~--~~~~~~~lv~e 211 (427)
..||+|++|.||+|.+ +|+.||||+++... .+.+.+|+.+|+++ +||||+++++++.+ .....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEeeeEEecccCCCceEEEEE
Confidence 5689999999999987 78999999986432 25567999999999 99999999999876 44567899999
Q ss_pred ecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCccee
Q 014307 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (427)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~ 287 (427)
|+.+|+|..++. .+++.....++.|++.||.|||+. +++||||||+|||++.++ .+||+|||+++..... ...
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~--~~~ 179 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP--PFK 179 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc--ccc
Confidence 999999987763 478888999999999999999984 999999999999999777 8999999999765332 234
Q ss_pred eccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------CChHHHHHHHhc
Q 014307 288 RVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAYLNKY 358 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~~~~~~~~l~~~ 358 (427)
..++..|+|||++.+. ..++.++|||||||++|||++|+.||. +.+..+....+.+.. .++.+..++.+
T Consensus 180 ~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~- 257 (283)
T PHA02988 180 NVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE-NLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA- 257 (283)
T ss_pred ccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH-
Confidence 5678899999998652 578999999999999999999999994 444444444443221 12344444554
Q ss_pred cCCCChhHHHHHhHHhc
Q 014307 359 HIELDPHLAALVGRLVI 375 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~ 375 (427)
|+..||..||++.+++.
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999998874
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=296.73 Aligned_cols=238 Identities=30% Similarity=0.607 Sum_probs=194.0
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
+|++.++||.|++|.||+|++..+++.||||.++.. ....+.+|+.+++.+ +|+||+++++++.+ ....++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHT--ENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEee--CCcEEEEE
Confidence 488999999999999999999999999999998643 235677899999999 99999999999986 45678999
Q ss_pred eecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-C
Q 014307 211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (427)
Q Consensus 211 e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~ 283 (427)
||+.+ ++..++ ..+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||++...... .
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVN 155 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCcc
Confidence 99997 444332 2478999999999999999999999999999999999999776 8999999999755332 1
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------------- 347 (427)
......++..|++||++.+...++.++|||||||++|+|++|+.|| .+.+..+....+.+...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLF-PGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 2234466788999999876556889999999999999999999998 44455555444433211
Q ss_pred -------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 -------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 -------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+...+++.+ |+..+|..|+++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHR-LLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHH-HhcCCcccCCCHHHHhcCCCC
Confidence 2233344555 999999999999999999997
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=315.45 Aligned_cols=246 Identities=22% Similarity=0.446 Sum_probs=208.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
...|.+.++||+|.|++|.+|++..++..||||++++. ....+.+|+++|+.| +|||||+++.+.+. ...+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t--~~~ly 131 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIET--EATLY 131 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeee--cceeE
Confidence 46799999999999999999999999999999999753 234578999999999 99999999999986 56799
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.++.+..++ .++.+.+++.+..|+..|++|||+++|||||||++|||++.+. .+||+|||++.++..+..
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~~~~~~ 210 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFFDYGLM 210 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceeeccccc
Confidence 999999999988776 3578899999999999999999999999999999999999877 699999999999998888
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-hC-----ChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LG-----TDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~-~~-----~~~~~~~l~~~ 358 (427)
..+.+|++.|.|||++.+....++.+|+||+|++||-|+.|..||. +.+-.+.-...... ++ .-+... +.+.
T Consensus 211 lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD-G~~lk~Lr~rvl~gk~rIp~~ms~dce~-lLrk 288 (596)
T KOG0586|consen 211 LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD-GQNLKELRPRVLRGKYRIPFYMSCDCED-LLRK 288 (596)
T ss_pred ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC-CcccccccchheeeeecccceeechhHH-HHHH
Confidence 8999999999999999997767899999999999999999999994 33322221111111 11 123333 4444
Q ss_pred cCCCChhHHHHHhHHhcCCchhhHHH
Q 014307 359 HIELDPHLAALVGRLVILSYFFQFVI 384 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~~~ 384 (427)
++.++|..|.++++++.++|......
T Consensus 289 ~lvl~Pskr~~~dqim~~~W~n~~~~ 314 (596)
T KOG0586|consen 289 FLVLNPSKRGPCDQIMKDRWRNDLLE 314 (596)
T ss_pred hhccCccccCCHHHhhhhcccchhhh
Confidence 88999999999999999999877553
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=299.00 Aligned_cols=242 Identities=24% Similarity=0.399 Sum_probs=198.7
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
-|++.++||.|+||.||+|.+..++..+++|.+.... .+.+.+|+.+++.+ +|+||+++++++.. ....++|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEee--CCEEEEEEE
Confidence 3678899999999999999999999999999986433 34577899999999 99999999999876 457889999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Ccce
Q 014307 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN 286 (427)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~ 286 (427)
|+.++++...+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~ 161 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRD 161 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEccccccccccccccccc
Confidence 99999987653 3589999999999999999999999999999999999999777 8999999998654322 1223
Q ss_pred eeccCcccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHH
Q 014307 287 VRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNA 353 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~ 353 (427)
...++..|+|||++. ....++.++|||||||++|||++|+.|| ...+..+....+.+... +..+.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCc-cccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 456888999999974 2245788999999999999999999998 44445555444433221 235666
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++.+ |+..+|..||++.+++.|+|+...
T Consensus 241 li~~-~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 241 FLKK-CLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHH-HccCChhhCcCHHHHhcCCCEecc
Confidence 6665 999999999999999999998863
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=295.58 Aligned_cols=240 Identities=21% Similarity=0.404 Sum_probs=197.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|++.+.||.|+||+||+|....++..+|+|++... ..+.+.+|+.+++.+ +|+||+++++.+.. ....+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEee--CCEEEEE
Confidence 4799999999999999999999889999999998642 246688999999999 99999999998876 5678899
Q ss_pred EeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 210 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
||++.++++...+. .+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++..+....
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGG 156 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCc
Confidence 99999999877652 478889999999999999999999999999999999999776 79999999987655432
Q ss_pred cc-----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-----------
Q 014307 284 EY-----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------- 347 (427)
Q Consensus 284 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------- 347 (427)
.. ....++..|+|||++.....++.++|+|||||++|+|++|+.||.. .+.........+...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK-YPPMKVLMLTLQNDPPSLETGADYKK 235 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc-cChhhhHHHHhcCCCCCcCCcccccc
Confidence 22 3346788899999987644789999999999999999999999943 333333333222110
Q ss_pred -ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 -TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 -~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+.+.+++.+ |+..+|..||++.+++.||||
T Consensus 236 ~~~~~~~li~~-~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 236 YSKSFRKMISL-CLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ccHHHHHHHHH-HcCCChhhCcCHHHHhhCCCC
Confidence 1334555555 999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=297.46 Aligned_cols=236 Identities=14% Similarity=0.261 Sum_probs=187.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||.||+|.++ ..+..||+|.++... ...+.+|+.+++++ +||||+++++++.. ...
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~ 80 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITR--GNT 80 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEec--CCC
Confidence 467999999999999999999865 456789999987532 24578899999999 99999999999875 567
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.++||||+.+++|..++. .+++..++.++.||+.||+|||++|++||||||+|||++.++ .+|++|||.+.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~ 159 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKS 159 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccccccc
Confidence 899999999999886652 478999999999999999999999999999999999999776 899999998765432
Q ss_pred CCccee--eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHH
Q 014307 282 GKEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (427)
Q Consensus 282 ~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (427)
...... ..++..|+|||.+.+ ..++.++|||||||++|||++ |+.||. +....+.+..+.+... +..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYW-DMSGQDVIKAVEDGFRLPAPRNCPNLL 237 (266)
T ss_pred cchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 221111 234567999999876 789999999999999999775 999984 4444454444443221 2344
Q ss_pred HHHHHhccCCCChhHHHHHhHHhc
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+++.. |+..+|..||++++++.
T Consensus 238 ~~li~~-c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 238 HQLMLD-CWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHH-HcCCCchhCCCHHHHHH
Confidence 444444 89999999999888754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=339.08 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=202.6
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
...++|++++.||+|+||.|.+++++.+++.||+|++++ ....-|..|-.||..- +.+=|+.++-.|.+ +.
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD--~~ 148 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQD--ER 148 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcC--cc
Confidence 456889999999999999999999999999999999875 1224477788888876 78899999998966 78
Q ss_pred CcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
++|+|||||.||+|..++. ++++..++.|+..|+.||+-||+.|+|||||||+|||||..| ++||+|||.+-.+..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLKMDA 227 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHhcCC
Confidence 9999999999999877764 588999999999999999999999999999999999999888 899999999877764
Q ss_pred CCc--ceeeccCccccccccccC---C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH---hCCh---
Q 014307 282 GKE--YNVRVASRYFKGPELLVD---L-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---LGTD--- 349 (427)
Q Consensus 282 ~~~--~~~~~~~~~y~aPE~~~~---~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~---~~~~--- 349 (427)
++. ....+|||.|.+||++.. . +.|+..+|+||+||++|||+.|..||+ ...-.+...+|... ++.|
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY-adslveTY~KIm~hk~~l~FP~~~ 306 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY-ADSLVETYGKIMNHKESLSFPDET 306 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch-HHHHHHHHHHHhchhhhcCCCccc
Confidence 443 345699999999999842 2 579999999999999999999999994 45556666666554 3333
Q ss_pred ----HHHHHHHhccCCCChhHHHH---HhHHhcCCchhhHH
Q 014307 350 ----ELNAYLNKYHIELDPHLAAL---VGRLVILSYFFQFV 383 (427)
Q Consensus 350 ----~~~~~l~~~~l~~dp~~r~~---~~~ll~~~~~~~~~ 383 (427)
....+|.. +.-+|+.|-. ++++-.||||....
T Consensus 307 ~VSeeakdLI~~--ll~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 307 DVSEEAKDLIEA--LLCDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred ccCHHHHHHHHH--HhcChhhhcccccHHHHHhCccccCCC
Confidence 33333433 3456777776 89999999998765
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=301.32 Aligned_cols=243 Identities=21% Similarity=0.401 Sum_probs=196.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|++++.||+|+||.||+|.+..+++.||+|.++.. ....+.+|+.+++++ +|+||+++++.+.. ...+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec--CCeEEEE
Confidence 4688999999999999999999889999999988642 135688999999999 99999999998876 5678999
Q ss_pred EeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 210 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 210 ~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
|||+.++++..++. .+++..+..++.||+.||.|||+ .||+||||||+||+++.++ .+||+|||++..+...
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCC
Confidence 99999999876642 58899999999999999999997 5999999999999999766 8999999999765322
Q ss_pred CcceeeccCccccccccccCC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 283 KEYNVRVASRYFKGPELLVDL-----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||... ........+.....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE-TYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc-chhhHHHHHHHHhhcCCCCCCccc
Confidence 22344677889999997542 23588999999999999999999999443 22222222222111
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+++.+++.+ |+..+|..||++.+++.|+||....
T Consensus 235 ~~~~~~li~~-~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 235 SDDAQDFVAK-CLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CHHHHHHHHH-HcccCcccCCCHHHHhcChhhhhcc
Confidence 2345555655 9999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=302.08 Aligned_cols=242 Identities=23% Similarity=0.419 Sum_probs=198.3
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.|++.+.||.|+||.||+|.+..++..||+|.++... .+.+.+|+.+++++ +||||+++++++.. ....++||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 81 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLK--GTKLWIIM 81 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccccc--CCceEEEE
Confidence 4667788999999999999998899999999986322 34688999999999 99999999999976 55789999
Q ss_pred eecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-ccee
Q 014307 211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (427)
Q Consensus 211 e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~~ 287 (427)
||+.++++...+. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcchhhhc
Confidence 9999999877664 478999999999999999999999999999999999999776 89999999997654332 1233
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHHhccC
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHI 360 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l 360 (427)
..++..|+|||.+.+ ..++.++|||||||++|||++|+.||. ..........+.+.. -...+.+++.+ |+
T Consensus 161 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l 237 (277)
T cd06642 161 FVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNS-DLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA-CL 237 (277)
T ss_pred ccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCc-ccchhhHHhhhhcCCCCCCCcccCHHHHHHHHH-Hc
Confidence 467888999999876 678999999999999999999999984 333333333322211 12345555655 99
Q ss_pred CCChhHHHHHhHHhcCCchhhHH
Q 014307 361 ELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..+|..||++.+++.|+|+.+..
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHHh
Confidence 99999999999999999998755
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=306.74 Aligned_cols=246 Identities=30% Similarity=0.597 Sum_probs=199.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--CCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~--~~~~ 205 (427)
.++|++.+.||.|+||.||+|.++.+++.||+|++... ..+.+.+|+.+|+.+ +||||+++++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence 37899999999999999999999999999999998642 235677899999999 899999999988643 2456
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+++||||+.+ ++...+ ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeeccc
Confidence 8999999975 555544 3589999999999999999999999999999999999999777 8999999999765432
Q ss_pred Cc-----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 283 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
.. .....++..|+|||.+.+...++.++|||||||++|||++|+.|| .+.+...++..+....|
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf-~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF-PGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc-CCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 21 123467888999999866556899999999999999999999999 44444444433333222
Q ss_pred ---------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ---------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ---------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+.+.+++.. |+..+|..||++.+++.||||.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQ-MLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHH-HccCChhhCcCHHHHHhChhhhhcc
Confidence 2334445555 9999999999999999999998755
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=306.06 Aligned_cols=244 Identities=32% Similarity=0.582 Sum_probs=197.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC----
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~---- 203 (427)
.++|.+.+.||+|+||.||+|++..+++.||||.++.. ....+.+|+.+++.+ +|+||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCC
Confidence 46899999999999999999999889999999998632 124578899999999 99999999999875322
Q ss_pred CCcEEEEeecCCCchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 204 KTPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
...++|+||+.. ++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||+++...
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~-- 168 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHAD-- 168 (342)
T ss_pred ceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCC--
Confidence 345899999975 454443 3689999999999999999999999999999999999999877 89999999987542
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------------- 347 (427)
.......++..|+|||.+.+...++.++|||||||++|||++|+.||. +.+..+.+..+....+
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (342)
T cd07879 169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGPEFVQKLEDKAA 247 (342)
T ss_pred CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence 222344677889999998764568999999999999999999999994 4444444443332211
Q ss_pred ----------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+.+.+++.. |+..||..|+++.+++.|+||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEK-MLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHhhcCCcccchHHHHhcCCCHHHHHHHHH-HcCCChhhCcCHHHHhcCcchhhcc
Confidence 1234455555 9999999999999999999998854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=296.06 Aligned_cols=240 Identities=24% Similarity=0.412 Sum_probs=195.5
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
+|+..+.||+|+||.||+|.+..+++.+|+|+++... .+.+.+|+.+++++ +|+||+++++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCE--DSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceecc--CCe
Confidence 3778899999999999999999999999999986422 35688999999999 99999999999976 557
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
.++|+||+.+++|..++ ..+++..+..++.||+.||.|||++|++|+||||+||+++.++..+||+|||++......
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 88999999999987765 358889999999999999999999999999999999999877657999999999766432
Q ss_pred Cc-----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH---HhC-------
Q 014307 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK---VLG------- 347 (427)
Q Consensus 283 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~---~~~------- 347 (427)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||... +..+....+.+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAE-KHSNHLALIFKIASATTAPSIPEH 235 (268)
T ss_pred cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCC-CCcchHHHHHHHhccCCCCCCchh
Confidence 11 123457788999999876 67899999999999999999999999432 22222222211 111
Q ss_pred -ChHHHHHHHhccCCCChhHHHHHhHHhcCCchh
Q 014307 348 -TDELNAYLNKYHIELDPHLAALVGRLVILSYFF 380 (427)
Q Consensus 348 -~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~ 380 (427)
.+++.+++.. |+..+|..||++.+++.||||.
T Consensus 236 ~~~~~~~~i~~-~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 236 LSPGLRDVTLR-CLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hCHHHHHHHHH-HcCCCcccCcCHHHHhcCcccC
Confidence 2345555555 9999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=293.64 Aligned_cols=240 Identities=28% Similarity=0.475 Sum_probs=198.7
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||.|+||.||+|.+..+++.+|+|+++.. ..+.+.+|+.+++.+ +|+||+++++++........+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 488999999999999999999999999999998532 235678899999999 99999999998876666778999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHH-----HCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH-----~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
|||+.+++|..++ ..+++..++.++.||+.||.||| +.+++|+||||+||+++.++ .+||+|||++.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~ 158 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAK 158 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccccc
Confidence 9999999987664 35788999999999999999999 89999999999999999766 89999999998
Q ss_pred eecCCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 014307 278 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (427)
Q Consensus 278 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~ 349 (427)
....... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||. ..+..+....+.+... .+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFT-ARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCccc-CcCHHHHHHHHhcCCCCCCccccCH
Confidence 7654433 344578889999999876 678999999999999999999999994 3333333333332211 23
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+.+++.. |+..+|..||++.+++.|||+
T Consensus 237 ~~~~l~~~-~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKS-MLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHH-HccCCcccCCCHHHHhhCCCC
Confidence 45555665 999999999999999999984
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=298.39 Aligned_cols=242 Identities=21% Similarity=0.365 Sum_probs=199.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|++.+.||.|+||.||+|.++.+++.+|+|.+... ....+.+|+++++++ +||||+++++.+.. ....+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYN--NGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeec--CCEEEEE
Confidence 3578889999999999999999989999999998643 235688999999999 79999999999876 4678999
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||+.+++|..++ ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++ .++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHHh
Confidence 9999999987766 457889999999999999999999 9999999999999999766 899999999876543222
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----CCHHHHHHHHHHh--------CChHHH
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH----DNYDQLVKIAKVL--------GTDELN 352 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~----~~~~~l~~i~~~~--------~~~~~~ 352 (427)
. ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.... ...+.+..+.... -.+.+.
T Consensus 157 ~-~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (265)
T cd06605 157 K-TFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234 (265)
T ss_pred h-cccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHH
Confidence 2 2677888999999877 689999999999999999999999996542 2222332222211 123455
Q ss_pred HHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 353 AYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+++.. |+..+|..||++.+++.||||++.
T Consensus 235 ~li~~-~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 235 DFVNL-CLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHH-HcCCCchhCcCHHHHhhCchhhcc
Confidence 56655 999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=295.66 Aligned_cols=239 Identities=26% Similarity=0.428 Sum_probs=199.6
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+|++.+.||.|+||.||+|.+..+++.||+|++... ..+.+.+|+++++++ +||||+++++.+.+ ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQD--EENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcC--CCeEEE
Confidence 488999999999999999999889999999998642 246788999999999 99999999999865 567899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
|+||+.+++|...+. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.........
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTLT 156 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCccc
Confidence 999999999876653 588999999999999999999999999999999999999777 8999999999876554444
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-HHHHHHHHHHh-------CChHHHHHHHh
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVL-------GTDELNAYLNK 357 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~-~~~l~~i~~~~-------~~~~~~~~l~~ 357 (427)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... .+.+....... -++++.+++.+
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 235 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHH
Confidence 45667888999999876 56899999999999999999999999544321 22222222210 13466666666
Q ss_pred ccCCCChhHHHHH--hHHhcCCch
Q 014307 358 YHIELDPHLAALV--GRLVILSYF 379 (427)
Q Consensus 358 ~~l~~dp~~r~~~--~~ll~~~~~ 379 (427)
|+..+|..|+++ .+++.|+||
T Consensus 236 -~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 236 -LLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -HccCChhHcCCccHHHHhcCCCC
Confidence 999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=305.70 Aligned_cols=243 Identities=27% Similarity=0.492 Sum_probs=196.7
Q ss_pred CCCEEE-EeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH-----------------HHHHHHHHHHHHhcCCCCeeee
Q 014307 133 QDDYEV-VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNIVKL 194 (427)
Q Consensus 133 ~~~y~~-~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------------~~~~~E~~il~~l~~h~niv~l 194 (427)
.++|.. .+.||.|+||.||+|++..+++.||||+++.... ..+.+|+.+++.+ +|+||+++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 85 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGL 85 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeee
Confidence 356654 5779999999999999999999999999864221 1467899999999 99999999
Q ss_pred eeEEEcCCCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEE
Q 014307 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (427)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~ 271 (427)
++++.. ....+++|||+.+ ++...+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+
T Consensus 86 ~~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~ 161 (335)
T PTZ00024 86 VDVYVE--GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIA 161 (335)
T ss_pred eEEEec--CCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEEC
Confidence 999976 5678999999986 554443 3589999999999999999999999999999999999999777 89999
Q ss_pred eeeeeeeecCC---------------CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH
Q 014307 272 DWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336 (427)
Q Consensus 272 DFGla~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~ 336 (427)
|||++...... .......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.++.
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~~ 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-PGENEI 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHH
Confidence 99999765411 11223356778999999876556899999999999999999999888 555666
Q ss_pred HHHHHHHHHhC----------------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 337 DQLVKIAKVLG----------------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 337 ~~l~~i~~~~~----------------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+..+...++ .+.+.+++.+ |+..+|+.|+++++++.|+||...
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQS-LLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHH-HcCCCchhccCHHHHhcCcccCCC
Confidence 66665554332 2334455555 999999999999999999999863
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=306.25 Aligned_cols=245 Identities=27% Similarity=0.509 Sum_probs=196.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC------
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~------ 203 (427)
..+|++.+.||.|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccc
Confidence 47899999999999999999999999999999998643 235688999999999 99999999987765322
Q ss_pred ------CCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 204 ------KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 204 ------~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
...+++|||+.+ ++.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++..+||+|||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 346899999985 555444 35899999999999999999999999999999999999986666899999999
Q ss_pred eeeecCCCc----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-----
Q 014307 276 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----- 346 (427)
Q Consensus 276 a~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----- 346 (427)
+........ .....++..|+|||.+.+...++.++|||||||++|+|++|+.||. +..+.+....+.+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA-GAHELEQMQLILESVPVVRE 240 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCh
Confidence 976532211 1233577889999987654678899999999999999999999994 334333333322211
Q ss_pred -------------------------------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 347 -------------------------------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 347 -------------------------------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
-.....+++.+ |+..||..||++++++.|+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQ-ILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHH-HhCCCchhccCHHHHhCCCcccc
Confidence 11234455555 99999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=325.72 Aligned_cols=241 Identities=22% Similarity=0.396 Sum_probs=199.9
Q ss_pred cccccCCCCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeee
Q 014307 126 LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 196 (427)
Q Consensus 126 ~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~ 196 (427)
.........+.+..++||+|+||+||+|+... ..+.||||.++... ..+|++|+++|..| +|||||+|+|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlG 556 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLG 556 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEE
Confidence 33444456778889999999999999998532 34689999998543 46799999999999 9999999999
Q ss_pred EEEcCCCCCcEEEEeecCCCchhhhcC-------------C----CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCce
Q 014307 197 IVRDQQSKTPSLIFEHVNNTDFKVLYP-------------T----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 259 (427)
Q Consensus 197 ~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------~----~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 259 (427)
+|.+ +..+++|+|||..|+|.+++. . ++..+.+.|+.|||.|++||-++.+|||||.++|+
T Consensus 557 VC~~--~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCRE--GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC 634 (774)
T ss_pred EEcc--CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence 9987 567899999999999988862 2 77889999999999999999999999999999999
Q ss_pred EEcCCCCeEEEEeeeeeeeecCCCcceee---ccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 014307 260 MIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDN 335 (427)
Q Consensus 260 Ll~~~~~~ikl~DFGla~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~ 335 (427)
||..+. .|||+|||+++-....+.+... .-...|||||.+.. ++|+.++||||+||+|||+++ |+.|| .+..+
T Consensus 635 LVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy-~glSn 711 (774)
T KOG1026|consen 635 LVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY-YGLSN 711 (774)
T ss_pred eeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc-cccch
Confidence 999666 9999999999866555444333 23456999999986 899999999999999999996 88888 77888
Q ss_pred HHHHHHHHHHh------CC-hHHHHHHHhccCCCChhHHHHHhHH
Q 014307 336 YDQLVKIAKVL------GT-DELNAYLNKYHIELDPHLAALVGRL 373 (427)
Q Consensus 336 ~~~l~~i~~~~------~~-~~~~~~l~~~~l~~dp~~r~~~~~l 373 (427)
.|.+..|.+.- +. ..+.+++.. ||...|..||++.++
T Consensus 712 ~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~-CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 712 QEVIECIRAGQLLSCPENCPTEVYSLMLE-CWNENPKRRPSFKEI 755 (774)
T ss_pred HHHHHHHHcCCcccCCCCCCHHHHHHHHH-HhhcCcccCCCHHHH
Confidence 88888776642 22 345555555 999999999997765
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=298.19 Aligned_cols=243 Identities=21% Similarity=0.362 Sum_probs=197.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||.||++.+..+++.||+|.+.... .+.+.+|+++++.+ +||||+++++.+.. ...++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFET--KRHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEec--CCEEE
Confidence 46899999999999999999999999999999986432 24577899999998 99999999999876 55789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
+||||+.+++|..++ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||+++......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCcc
Confidence 999999999988776 3588999999999999999999999999999999999999766 89999999986321110
Q ss_pred ---------------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--
Q 014307 284 ---------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-- 346 (427)
Q Consensus 284 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-- 346 (427)
......++..|+|||.+.+ ..++.++|||||||++|||++|..||. +.+..+.+..+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~-~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcccC
Confidence 0012356778999999876 678999999999999999999999994 444444444433221
Q ss_pred -------CChHHHHHHHhccCCCChhHHHH---HhHHhcCCchhhHH
Q 014307 347 -------GTDELNAYLNKYHIELDPHLAAL---VGRLVILSYFFQFV 383 (427)
Q Consensus 347 -------~~~~~~~~l~~~~l~~dp~~r~~---~~~ll~~~~~~~~~ 383 (427)
-++.+.+++.+ |+..+|+.||+ +.+++.|+||....
T Consensus 235 ~~~~~~~~~~~~~~li~~-~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 235 WPEGDEALPADAQDLISR-LLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred CCCccccCCHHHHHHHHH-HhccChhhccCccCHHHHHhCccccCCC
Confidence 12345555555 99999999998 79999999996643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=306.10 Aligned_cols=247 Identities=32% Similarity=0.606 Sum_probs=201.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+.. .....+.+|+.+++++.+||||+++++++...+....+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4679999999999999999999988999999998743 22345678999999987899999999998766566789
Q ss_pred EEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--
Q 014307 208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-- 283 (427)
+||||+.+ +|..... .+.+..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 86 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhcccccccc
Confidence 99999986 5555443 478888899999999999999999999999999999999777 89999999997654332
Q ss_pred ----cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------------
Q 014307 284 ----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (427)
Q Consensus 284 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------------ 347 (427)
......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+....+...++....+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-PGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 2233467889999999876567889999999999999999999998 45555554444333321
Q ss_pred -------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
...+.+++.+ |+..+|..||++.+++.++|+....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKK-LLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHH-hccCCcccccCHHHHhhChhhhhhc
Confidence 2234455555 9999999999999999999998854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=291.77 Aligned_cols=257 Identities=23% Similarity=0.368 Sum_probs=198.5
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCC
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (427)
+.||+|+|+.|--|+...++..+|||++.++ .+.++.+|++++.+.++|+||++++++|++ +...|||||-|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd--d~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED--DTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc--cceEEEEEecccCc
Confidence 5699999999999999999999999999764 467899999999999999999999999987 56789999999999
Q ss_pred chhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeeecCC--------C
Q 014307 217 DFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG--------K 283 (427)
Q Consensus 217 ~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~~~~--------~ 283 (427)
.+...+. .+++.++..++++|+.||+|||.+||.||||||+|||....+ .-||||||.++..+... .
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 9876654 499999999999999999999999999999999999997544 25899999998654322 2
Q ss_pred cceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhcc
Q 014307 284 EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~ 359 (427)
...+.+|+..|||||++.- -..|+.++|.||||||||-|+.|.+|| .+.-..+ .|++.
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF-vG~Cg~d--------CGWdr--------- 303 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF-VGHCGAD--------CGWDR--------- 303 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc-cCccCCc--------CCccC---------
Confidence 3455688889999999632 246899999999999999999999999 3432211 11110
Q ss_pred CCCChhHHHHHhHHhcCCchhhHHHhhhhh----hhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 360 IELDPHLAALVGRLVILSYFFQFVIYYYYY----YYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 360 l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~----~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
-+.....++.|- ..+....|+| |--.....-|+++++|+ .++.+|-++...+.|||-
T Consensus 304 ----Ge~Cr~CQ~~LF----esIQEGkYeFPdkdWahIS~eakdlisnLlv-rda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 304 ----GEVCRVCQNKLF----ESIQEGKYEFPDKDWAHISSEAKDLISNLLV-RDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred ----CCccHHHHHHHH----HHHhccCCcCChhhhHHhhHHHHHHHHHHHh-ccHHhhhhhhhccCCccc
Confidence 000111111111 1111011111 22256778899999998 999999999999999973
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=299.98 Aligned_cols=246 Identities=20% Similarity=0.330 Sum_probs=194.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|+..+.||+|+||.||++.+..+++.+|+|.+... ....+.+|+.++.++.+|+||+++++++.. ....+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEE
Confidence 3566778899999999999999999999999998642 235678899999999559999999998876 4567799
Q ss_pred EeecCCCc--hhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 210 FEHVNNTD--FKVL-----YPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 210 ~e~~~~~~--l~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
|||+.... +... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++ .+||+|||++.....
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVD 160 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhcc
Confidence 99987632 2211 14589999999999999999999975 999999999999999776 899999999976544
Q ss_pred CCcceeeccCccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH----h-------CC
Q 014307 282 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----L-------GT 348 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~----~-------~~ 348 (427)
........++..|+|||++.+. ..++.++|||||||++|+|++|+.||.......+.+.++... + -.
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFS 240 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccC
Confidence 4333445678889999998763 368999999999999999999999995443223333322211 0 11
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.. |+..+|..||++++++.|+||.+..
T Consensus 241 ~~l~~li~~-~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 241 PSFVNFINL-CLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHHHHH-HccCChhhCcCHHHHhcChhhhchh
Confidence 344555565 9999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=297.48 Aligned_cols=235 Identities=18% Similarity=0.343 Sum_probs=189.0
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCC-----eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
++|++.+.||+|+||.||+|.+...+ ..||+|.++... ...+.+|+.++..+ +||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~~ 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTK--EQ 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcC--CC
Confidence 57889999999999999999876555 789999986432 35578999999999 99999999999875 45
Q ss_pred CcEEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC
Q 014307 205 TPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~ 265 (427)
..+++|||+.+++|..++ ..+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 688999999999987665 2367788899999999999999999999999999999999776
Q ss_pred CeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014307 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (427)
Q Consensus 266 ~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~ 341 (427)
.+||+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|||++ |..||+ +....+....
T Consensus 162 -~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~-~~~~~~~~~~ 238 (283)
T cd05048 162 -TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYY-GFSNQEVIEM 238 (283)
T ss_pred -cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHH
Confidence 899999999976543322 223355778999999876 679999999999999999998 999984 4444444444
Q ss_pred HHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 342 IAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 342 i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+... ++.+..++ ..|+..+|..||++.+++.
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~-~~c~~~~p~~Rp~~~~i~~ 278 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALM-IECWNEIPARRPRFKDIHT 278 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHH-HHHccCChhhCcCHHHHHH
Confidence 433211 23444444 4499999999999988865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=307.11 Aligned_cols=238 Identities=20% Similarity=0.335 Sum_probs=186.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.+.||.|+||.||+|++.. +++.||+|+++... .+.+.+|+.+++++.+|+||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 4689999999999999999997543 34789999986422 245778999999997899999999988754 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------------------------------------------------------
Q 014307 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (427)
..++++|||+.+++|..++.
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 57889999999998865541
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccc
Q 014307 224 ----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKG 296 (427)
Q Consensus 224 ----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~a 296 (427)
.+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+...... ....++..|+|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 467888999999999999999999999999999999999776 8999999999865433221 22344567999
Q ss_pred cccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH-HHh-------CChHHHHHHHhccCCCChhHH
Q 014307 297 PELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIA-KVL-------GTDELNAYLNKYHIELDPHLA 367 (427)
Q Consensus 297 PE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~-~~~-------~~~~~~~~l~~~~l~~dp~~r 367 (427)
||++.+ ..++.++|||||||++|||++ |..||. +....+.+.... ... ..+.+.+++.. |+..+|+.|
T Consensus 244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-cl~~~p~~R 320 (337)
T cd05054 244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYP-GVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLD-CWHNNPEDR 320 (337)
T ss_pred cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCC-CCCccHHHHHHHhccCCCCCCccCCHHHHHHHHH-HccCChhhC
Confidence 999877 789999999999999999998 998984 333333332222 211 12455555555 889999999
Q ss_pred HHHhHHhc
Q 014307 368 ALVGRLVI 375 (427)
Q Consensus 368 ~~~~~ll~ 375 (427)
|++.+++.
T Consensus 321 Ps~~ell~ 328 (337)
T cd05054 321 PTFSELVE 328 (337)
T ss_pred cCHHHHHH
Confidence 99888765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=302.87 Aligned_cols=278 Identities=28% Similarity=0.514 Sum_probs=206.6
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC--
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS-- 203 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~-- 203 (427)
...++|++++.||+|+||.||+|.+..++..||||.+... ....+.+|+.+|+++ +||||+++++++.....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCcccc
Confidence 3468899999999999999999999999999999998532 124578999999999 99999999999875322
Q ss_pred --CCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 --KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 --~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
...++||||+ ++++..+. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++...
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~ 168 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQT 168 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeccccccc
Confidence 2458999998 55665554 3689999999999999999999999999999999999999776 7999999999765
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhcc
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~ 359 (427)
.. ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+.......+.+..+... ..+.....
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 244 (343)
T cd07880 169 DS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF-KGHDHLDQLMEIMKVTGTPS-KEFVQKLQ 244 (343)
T ss_pred cc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCC-HHHHHhhc
Confidence 32 2234467888999999876456889999999999999999999998 44455555555555444321 11222210
Q ss_pred CCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 360 IELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 360 l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
.......+..+. -+.+.. ...........+.++|++||. .+|++|+++..++.|||
T Consensus 245 ---~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~~~li~~~l~-~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 245 ---SEDAKNYVKKLP---RFRKKD--FRSLLPNANPLAVNVLEKMLV-LDAESRITAAEALAHPY 300 (343)
T ss_pred ---chhHHHHHHhcc---ccCcch--HHHhccCCChHHHHHHHHHcC-CChhhCCCHHHHhcCcc
Confidence 111111111111 111100 111223456678899999994 99999999999998887
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.36 Aligned_cols=237 Identities=23% Similarity=0.393 Sum_probs=193.2
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
+|++.+.||+|+||+||+|.. .+++.+|+|.++... ...+.+|+.+++.+ +|+||+++++++.+ ...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLD--DNT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeec--CCe
Confidence 477889999999999999986 578899999886321 24578899999999 89999999999976 467
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
.++++||+.+++|..++. .+++..+..++.|++.||+|||+.||+|+||+|+||+++.++ .++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhc
Confidence 899999999999887753 488999999999999999999999999999999999999776 8999999998754211
Q ss_pred -------CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------
Q 014307 283 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------- 347 (427)
Q Consensus 283 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------- 347 (427)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+.......+....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLAS-MDRLAAMFYIGAHRGLMPRLPDS 233 (265)
T ss_pred cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCcccc-CChHHHHHHhhhccCCCCCCCCC
Confidence 11223467888999999876 6789999999999999999999999943 333333333322211
Q ss_pred -ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 -TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 -~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+.+..++.+ |+..+|..||++.+++.||||
T Consensus 234 ~~~~~~~~i~~-~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 234 FSAAAIDFVTS-CLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCHHHHHHHHH-HhcCCcccCCCHHHHhcCCCC
Confidence 2345566666 999999999999999999996
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=297.84 Aligned_cols=243 Identities=27% Similarity=0.550 Sum_probs=197.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC-----
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----- 202 (427)
.++|++.+.||.|+||.||+|.++.+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchhhhc
Confidence 46899999999999999999999989999999998642 224577899999999 9999999999987643
Q ss_pred ---CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 203 ---SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 203 ---~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
...+++++||+.+..+.... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCccccc
Confidence 23789999999985544333 2589999999999999999999999999999999999999776 8999999999
Q ss_pred eeecCCCc--ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 277 EFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 277 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
........ .....++..|+|||.+.+...++.++|||||||++|||++|+.|| ...+..+.+..+.+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF-QANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhhc
Confidence 86643321 222355778999998866456789999999999999999999888 44455555554444322
Q ss_pred -----------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 -----------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 -----------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
++.+.+++.. |+..+|..||++.+++.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDH-MLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhhcCCCCHHHHHHHHH-HccCChhhCCCHHHHhcCCCC
Confidence 2344444555 999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.29 Aligned_cols=237 Identities=23% Similarity=0.376 Sum_probs=194.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCe---E-EEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---K-CIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~-vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
.++-.+.++||+|+||+||+|..+..+. . ||||..+. ....++.+|+++++++ +|||||++||+...
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~yGVa~~-- 232 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRFYGVAVL-- 232 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--
Confidence 3555677999999999999999866532 3 89998873 2346789999999999 99999999999977
Q ss_pred CCCcEEEEeecCCCchhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
...+++|||+|.||+|..++++ ++..+...++.+.+.||+|||++++|||||-++|+|++.++ .+||+|||+++.
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKISDFGLs~~ 311 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKISDFGLSRA 311 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEeCccccccC
Confidence 5668999999999999988853 88999999999999999999999999999999999999766 789999999875
Q ss_pred ecCCCcce-eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH-------hCCh
Q 014307 279 YHPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV-------LGTD 349 (427)
Q Consensus 279 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~-------~~~~ 349 (427)
-..-.... ...-+..|+|||.+.. ..|++++|||||||++||+++ |..|| .+....+...+|... ...|
T Consensus 312 ~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py-~g~~~~~v~~kI~~~~~r~~~~~~~p 389 (474)
T KOG0194|consen 312 GSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPY-PGMKNYEVKAKIVKNGYRMPIPSKTP 389 (474)
T ss_pred CcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCC-CCCCHHHHHHHHHhcCccCCCCCCCH
Confidence 43111111 1234567999999987 699999999999999999998 78887 777777777777442 1245
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.....+...|+..+|+.|+++.++.+
T Consensus 390 ~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 390 KELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHHhccCChhhccCHHHHHH
Confidence 66666666799999999999888654
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=300.60 Aligned_cols=238 Identities=18% Similarity=0.293 Sum_probs=187.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCe--EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++.. ....+.+|+.++.++.+|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCc
Confidence 3679999999999999999999877765 4577776532 234678899999999789999999999866 5678
Q ss_pred EEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCe
Q 014307 207 SLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 267 (427)
+++|||+.+++|..++. .+++..++.++.||+.||+|||++|++||||||+|||++.++ .
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-~ 162 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-V 162 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-c
Confidence 99999999998876652 367889999999999999999999999999999999999777 8
Q ss_pred EEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 014307 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 346 (427)
Q Consensus 268 ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~ 346 (427)
+||+|||++.............++..|+|||.+.+ ..++.++|||||||++|||++ |..||. +.+..+....+....
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~~ 240 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQGY 240 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc-cCChHHHHHHHhcCC
Confidence 99999999864321111122233556999998866 678999999999999999998 999984 444444443333221
Q ss_pred C-------ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 347 G-------TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 347 ~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
. .+.+.+++.+ |+..+|..||++++++..
T Consensus 241 ~~~~~~~~~~~~~~li~~-~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 241 RLEKPLNCDDEVYDLMRQ-CWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 1 2445555555 999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=295.32 Aligned_cols=271 Identities=30% Similarity=0.552 Sum_probs=204.1
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
|++.++||.|++|.||+|.++.+|..||+|++.... .+.+.+|+.+++.+ +|||++++++++.+ ....+++|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~--~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHS--ENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheecc--CCeEEEEE
Confidence 567899999999999999998899999999986422 25678899999999 89999999999876 56789999
Q ss_pred eecCCCchhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Cc
Q 014307 211 EHVNNTDFKVLY---P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (427)
Q Consensus 211 e~~~~~~l~~~~---~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~ 284 (427)
||+.+ ++..++ . .+++..+..++.|++.||+|||+++++||||+|+||+++.++ .++|+|||++...... ..
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRT 155 (283)
T ss_pred eccCc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccc
Confidence 99964 555443 2 478999999999999999999999999999999999999866 8999999999755322 12
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCCh
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp 364 (427)
.....++..|+|||++.+...++.++|||||||++|+|++|+.|| ...++.+.+..+.+..+.+.-..+-. ....|
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 231 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLF-PGDSEIDQLFRIFRTLGTPDEDVWPG---VTSLP 231 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHHhhh---hhhch
Confidence 233456788999998876456789999999999999999999998 45556666666666555443222100 01112
Q ss_pred hHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 365 HLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 365 ~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+........... . .........+.++|++|| +.+|+.|+++..+.+|||
T Consensus 232 ~~~~~~~~~~~~~~-~-------~~~~~~~~~~~~li~~~l-~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 232 DYKPTFPKWARQDL-S-------KVVPNLDEDGLDLLSKML-VYDPAKRISAKAALQHPY 282 (283)
T ss_pred hhhhhcccccccch-h-------hhcCCCCHHHHHHHHHHh-cCChhhCcCHHHHhcCCC
Confidence 22221111000000 0 001123467889999999 499999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=292.64 Aligned_cols=236 Identities=26% Similarity=0.505 Sum_probs=191.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||.||+|++..+++.||||.++. .....+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIE--DNELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEE--CCeEE
Confidence 579999999999999999999999999999998753 1224578899999999 99999999999876 45678
Q ss_pred EEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
+++||+.++++..++. .+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~ 157 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceecc
Confidence 9999999999876542 378889999999999999999999999999999999999776 79999999998664
Q ss_pred CCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChH
Q 014307 281 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDE 350 (427)
Q Consensus 281 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~ 350 (427)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||+....+...+.......+ ...
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK 236 (267)
T ss_pred chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence 3322 223467888999999876 67899999999999999999999999655443333332222211 123
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+++.+ |+..+|+.||++.+++.
T Consensus 237 ~~~li~~-cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 237 LRELVSM-CIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHH-HCCCCcccCcCHHHHHH
Confidence 4455555 99999999999988875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=290.76 Aligned_cols=243 Identities=22% Similarity=0.412 Sum_probs=202.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|++.+.||.|++|.||+|.+..+++.|++|++.... ...+.+|+.++.++ +|+||+++++++.. ....+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYK--EGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcc--CCeEEEE
Confidence 36889999999999999999999999999999987542 46788999999999 89999999999876 4678999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
|||+.+++|..++. .+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCc
Confidence 99999999987763 58999999999999999999999 9999999999999999777 8999999999876544333
Q ss_pred e-eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-CHHH-HHHHHHHh--------CChHHHHH
Q 014307 286 N-VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQ-LVKIAKVL--------GTDELNAY 354 (427)
Q Consensus 286 ~-~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~-~~~~-l~~i~~~~--------~~~~~~~~ 354 (427)
. ...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||..... .... ...+.... -+..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 2 4567888999999876 6889999999999999999999999944321 2222 22222211 12345566
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.. |+..+|..||++.+++.+||+++.
T Consensus 236 i~~-~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 236 ISA-CLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred HHH-HccCChhhCCCHHHHHhCHHHHhc
Confidence 666 999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.64 Aligned_cols=239 Identities=25% Similarity=0.456 Sum_probs=197.2
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
+|+..+.||+|+||.||+|.+..+++.|++|.+... ..+.+.+|+.+++.+ +|+||+++++++.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTERE--EDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEec--CCeE
Confidence 466778999999999999999889999999988542 235688999999999 99999999999876 4678
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++++||+.+++|..++. .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++ .+||+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccc
Confidence 99999999999877753 478899999999999999999999999999999999999776 89999999998765444
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChHHHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAYL 355 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~~~~~l 355 (427)
......++..|+|||.+.....++.++|+|||||++|+|++|+.||... ...+....+.+... .+.+.+++
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 235 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL-EGVAAVFKIGRSKELPPIPDHLSDEAKDFI 235 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC-cHHHHHHHHHhcccCCCcCCCcCHHHHHHH
Confidence 3445678888999999876333899999999999999999999999443 34444444433111 24455666
Q ss_pred HhccCCCChhHHHHHhHHhcCCch
Q 014307 356 NKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+ |+..+|..||++.+++.|||+
T Consensus 236 ~~-~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 236 LK-CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HH-HhhcCcccCcCHHHHhcCCCC
Confidence 66 999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=289.71 Aligned_cols=238 Identities=23% Similarity=0.413 Sum_probs=198.9
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++++.||.|+||.||.+++..+++.+++|.+... ....+.+|+.+++++ +|+||+++++++.+ ...++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMD--DNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEec--CCeEEEE
Confidence 588999999999999999999999999999987532 235678999999999 99999999999987 5678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
|||+.+++|...+. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccc
Confidence 99999999887663 378889999999999999999999999999999999999776 89999999998664433
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (427)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..|| ...+..+....+.... -...+.+++.
T Consensus 157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTF-DATNPLNLVVKIVQGNYTPVVSVYSSELISLVH 234 (256)
T ss_pred cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHcCCCCCCccccCHHHHHHHH
Confidence 2334568889999999876 56889999999999999999999998 4444455554443321 1245566666
Q ss_pred hccCCCChhHHHHHhHHhcCCch
Q 014307 357 KYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+ |+..+|..||++.+++.++|+
T Consensus 235 ~-~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 235 S-LLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred H-HcccCcccCCCHHHHhhCcCC
Confidence 6 899999999999999999884
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=300.30 Aligned_cols=243 Identities=19% Similarity=0.371 Sum_probs=199.1
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
+.|.....||.|+||.||++.+..++..||||.+... ..+.+.+|+.+++.+ +|+||+++++.+.. ....++||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLV--GDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheec--CCeEEEEE
Confidence 3455567799999999999999889999999998642 235678999999999 99999999999876 46789999
Q ss_pred eecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-ccee
Q 014307 211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (427)
Q Consensus 211 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~~ 287 (427)
||+.++++..++ ..+++.++..++.||+.||+|||++||+||||||+||+++.++ .++|+|||++....... ....
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccccCce
Confidence 999999987765 3588999999999999999999999999999999999999776 89999999987543222 2234
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHHhc
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNKY 358 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~~ 358 (427)
..++..|+|||.+.+ ..++.++|||||||++|||++|+.||. ..+..+.+..+..... .+.+..++..
T Consensus 178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~- 254 (292)
T cd06658 178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYF-NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL- 254 (292)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH-
Confidence 578889999999876 678999999999999999999999994 4444444444433221 2344455555
Q ss_pred cCCCChhHHHHHhHHhcCCchhhHH
Q 014307 359 HIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..+|..||++++++.|+||....
T Consensus 255 ~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 255 MLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HccCChhHCcCHHHHhhChhhhccC
Confidence 8999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=297.06 Aligned_cols=260 Identities=18% Similarity=0.311 Sum_probs=204.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|++.+.||+|+||.||+|.+..+++.||||.++.. ....+..|+.++.++.+|+||+++++++.+ ....++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEEE
Confidence 47799999999999999999999888999999998642 234466788777777579999999999976 557899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+|||+.+ .+..+. ..+++..+..++.|++.||.|||+ .||+||||+|+||+++.++ .+||+|||++..+....
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSK 169 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCCC
Confidence 9999876 333322 358889999999999999999997 5999999999999999766 89999999997665444
Q ss_pred cceeeccCccccccccccCC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHH
Q 014307 284 EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDEL 351 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~ 351 (427)
......++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.....+.+.+..+..... .+.+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (296)
T cd06618 170 AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249 (296)
T ss_pred cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHH
Confidence 44445677889999998652 24788999999999999999999999544444444444332211 2234
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhh
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFL 405 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l 405 (427)
.+++.. |+..+|..||++++++.|+|+.... ....+..++++..|
T Consensus 250 ~~li~~-~l~~~p~~Rp~~~~il~~~~~~~~~--------~~~~~~~~~~~~~~ 294 (296)
T cd06618 250 CSFVDL-CLTKDHRKRPKYRELLQHPFIRRYE--------TAEVDVAGWFQDVM 294 (296)
T ss_pred HHHHHH-HccCChhhCCCHHHHhcChhhhccc--------hhHHHHHHHHHHHh
Confidence 555555 9999999999999999999999855 25556666666655
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=305.08 Aligned_cols=245 Identities=29% Similarity=0.590 Sum_probs=200.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC---
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~--- 203 (427)
..++|++.+.||+|+||.||+|++..+++.||+|++... ..+.+.+|+.+++.+ +|+||+++++++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence 457899999999999999999999999999999998632 234567899999999 99999999998764322
Q ss_pred -CCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 204 -KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 204 -~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
...++|+||+. ++|..++ ..+++..++.++.|++.||.|||+.||+||||||+||+++.++ .+||+|||++....
T Consensus 92 ~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccccccc
Confidence 35789999985 4665554 3589999999999999999999999999999999999999776 89999999997653
Q ss_pred CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------------
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------- 347 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------------- 347 (427)
. ......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (343)
T cd07851 170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF-PGSDHIDQLKRIMNLVGTPDEELLQKISSE 246 (343)
T ss_pred c--cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence 2 2344567888999999866457889999999999999999999999 44455555554433222
Q ss_pred ------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+.+.+++.+ |+..+|..||++.+++.||||.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~-~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEK-MLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHH-hCCCChhhCCCHHHHhcCCCccccC
Confidence 3344455666 9999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=292.40 Aligned_cols=242 Identities=24% Similarity=0.424 Sum_probs=198.8
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
-|++.++||.|+||.||+|.+..++..+|+|++.... ...+.+|+.++.++ +||||+++++++.. ....++||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEe--CCeEEEEE
Confidence 3778899999999999999998899999999976322 35678899999999 99999999999976 56789999
Q ss_pred eecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-ccee
Q 014307 211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 287 (427)
Q Consensus 211 e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~~ 287 (427)
||+.++++..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++....... ....
T Consensus 82 e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06641 82 EYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred EeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchhhhcc
Confidence 9999999887764 478999999999999999999999999999999999999776 89999999987654322 1233
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhccC
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYHI 360 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l 360 (427)
..++..|+|||.+.+ ..++.++|||||||++|+|++|..||. ..........+..... ...+.+++.. |+
T Consensus 161 ~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l 237 (277)
T cd06641 161 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHS-ELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA-CL 237 (277)
T ss_pred ccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-ccchHHHHHHHhcCCCCCCCcccCHHHHHHHHH-Hc
Confidence 467888999999876 678899999999999999999999984 3333333333322111 2345555555 99
Q ss_pred CCChhHHHHHhHHhcCCchhhHH
Q 014307 361 ELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..+|..||++.+++.|+||.+..
T Consensus 238 ~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 238 NKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred cCChhhCcCHHHHHhCHHHhhhh
Confidence 99999999999999999999855
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=289.66 Aligned_cols=238 Identities=20% Similarity=0.403 Sum_probs=196.2
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||+|+||.||++.+..+++.||+|.+.. ...+.+.+|+.+++++ +||||+++++++.. ....++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE--NGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC--CCeEEEE
Confidence 58899999999999999999999999999998853 2235688999999999 99999999999876 5678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||+.++++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh
Confidence 99999998876542 368888999999999999999999999999999999999776 899999999976543322
Q ss_pred -ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.....++..|+|||++.+ ..++.++|+|||||++++|++|+.||.. .+..+....+..... ..++..++.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234 (256)
T ss_pred hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccC-CCHHHHHHHHhcCCCCCCcccCCHHHHHHHH
Confidence 223457888999999876 6788999999999999999999999854 333444443332211 234555555
Q ss_pred hccCCCChhHHHHHhHHhcCCch
Q 014307 357 KYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
. |+..+|..||++.+++.|+||
T Consensus 235 ~-~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 235 Q-LFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred H-HhhCChhhCcCHHHHhhCcCC
Confidence 5 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=291.10 Aligned_cols=238 Identities=24% Similarity=0.378 Sum_probs=187.5
Q ss_pred CCEEEEeee--eecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 134 DDYEVVRKV--GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 134 ~~y~~~~~L--G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
++|++.+.+ |.|+||.||+++++.++..+|+|++........ |+.+...+.+|+||+++++.+.. ....++|||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~--~~~~~iv~e 89 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTT--LKGHVLIMD 89 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEec--CCeeEEEEE
Confidence 345565555 999999999999999999999999875432222 34333334479999999999987 447899999
Q ss_pred ecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceee
Q 014307 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288 (427)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~ 288 (427)
|+.+++|..++. .+++.+++.++.||+.||.|||+.|++||||||+||+++.++..++|+|||++...... ...
T Consensus 90 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~ 166 (267)
T PHA03390 90 YIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCY 166 (267)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccC
Confidence 999999977653 58999999999999999999999999999999999999977658999999999765422 234
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH---HHHHHHHHH------hCChHHHHHHHhcc
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---DQLVKIAKV------LGTDELNAYLNKYH 359 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~---~~l~~i~~~------~~~~~~~~~l~~~~ 359 (427)
.++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... +.+...... ..++.+..++.+ |
T Consensus 167 ~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~ 244 (267)
T PHA03390 167 DGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQS-M 244 (267)
T ss_pred CCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHH-H
Confidence 67888999999876 678999999999999999999999995332221 111111110 023455566665 9
Q ss_pred CCCChhHHHH-HhHHhcCCchh
Q 014307 360 IELDPHLAAL-VGRLVILSYFF 380 (427)
Q Consensus 360 l~~dp~~r~~-~~~ll~~~~~~ 380 (427)
+..+|..|++ +++++.|+||+
T Consensus 245 l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 245 LKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred hccChhhCCchHHHHhcCCccc
Confidence 9999999995 79999999985
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=297.15 Aligned_cols=237 Identities=18% Similarity=0.296 Sum_probs=185.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCe--EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||.||+|++..++. .+++|.++.. ..+.+.+|+.++.++.+||||+++++++.. ...++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 578999999999999999999877664 4688887642 234678899999998779999999999876 45688
Q ss_pred EEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeE
Q 014307 208 LIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~i 268 (427)
+++||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~ 158 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-AS 158 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-eE
Confidence 9999999999876652 377888999999999999999999999999999999999776 89
Q ss_pred EEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 014307 269 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG 347 (427)
Q Consensus 269 kl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~ 347 (427)
||+|||++..............+..|+|||++.+ ..++.++|||||||++|||++ |..|| ......+....+.+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf-~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPY-CGMTCAELYEKLPQGYR 236 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHhcCCC
Confidence 9999999864321111111223456999999876 678999999999999999997 99998 44444444444443221
Q ss_pred -------ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 348 -------TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 348 -------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.+.+.+++.+ |+..+|..||++++++..
T Consensus 237 ~~~~~~~~~~~~~li~~-~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 MEKPRNCDDEVYELMRQ-CWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 2345555555 899999999998887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.23 Aligned_cols=235 Identities=19% Similarity=0.343 Sum_probs=186.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeE----EEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..+|++.+.||+|+||.||+|.+..+++. ||+|+++.. ..+.+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC---
Confidence 46799999999999999999998666654 899998642 235688899999999 999999999998652
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++++||+.++++...+. .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEcccccccccc
Confidence 4679999999999876653 477888999999999999999999999999999999999776 89999999998765
Q ss_pred CCCccee---eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-C-------C
Q 014307 281 PGKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-G-------T 348 (427)
Q Consensus 281 ~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-~-------~ 348 (427)
....... ..++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.. ...+..+.... . .
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIP-ASEISSILEKGERLPQPPICT 237 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCC-HHHHHHHHhCCCCCCCCCCCC
Confidence 4332221 223557999999876 689999999999999999997 88888 3333 33333332221 1 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.++..++.+ |+..+|..||++.+++..
T Consensus 238 ~~~~~li~~-cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 238 IDVYMIMVK-CWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHHHH-HccCChhhCcCHHHHHHH
Confidence 344455555 999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=294.35 Aligned_cols=238 Identities=36% Similarity=0.670 Sum_probs=196.4
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
|++.+.||.|++|.||+|.+..+++.+++|.++... ...+.+|+.+++.+ +|+||+++++++.+ ....++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRH--KGDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhcc--CCCEEEEE
Confidence 567789999999999999998899999999986432 35678899999999 89999999999876 46788999
Q ss_pred eecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cce
Q 014307 211 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (427)
Q Consensus 211 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~ 286 (427)
||+.+.....+. ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++ .+||+|||.+....... ...
T Consensus 78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCccccc
Confidence 999874443332 2588999999999999999999999999999999999999776 89999999998765543 233
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------------------
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------------- 347 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------------------- 347 (427)
...++..|+|||.+.+...++.++|||||||++|+|++|+.|| ...+..+++..+...++
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 4567788999999877447899999999999999999999888 55565665555443322
Q ss_pred -----------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 -----------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 -----------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+.+..++.+ |+..||..||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQ-MLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHH-HhccCcccCcCHHHHhhCCCC
Confidence 2344455666 999999999999999999996
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=294.30 Aligned_cols=244 Identities=24% Similarity=0.441 Sum_probs=198.3
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhc--CCCCeeeeeeEEEcCCCCCcEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~--~h~niv~l~~~~~~~~~~~~~l 208 (427)
.|++.+.||.|+||.||+|.+..+++.+|+|.++.. ..+.+.+|+.+++.+. .|||++++++++.. ....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 477889999999999999999999999999998532 2356788999999984 39999999999875 567899
Q ss_pred EEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-c
Q 014307 209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 285 (427)
Q Consensus 209 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~ 285 (427)
+|||+.+++|..++. .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++........ .
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCcccc
Confidence 999999999877653 578899999999999999999999999999999999999766 899999999987654332 2
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH----h----CChHHHHHHHh
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----L----GTDELNAYLNK 357 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~----~----~~~~~~~~l~~ 357 (427)
....|+..|+|||.+.+...++.++|||||||++|+|++|..||. +.+.......+... + ..+.+.+++..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYS-DVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCC-CCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 344688889999998764567899999999999999999999994 33332222221111 0 12355555655
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..||..||++.+++.++|+.+..
T Consensus 238 -~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 238 -CLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -HcCCCcccCcCHHHHhhChHhhccc
Confidence 9999999999999999999998743
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=290.13 Aligned_cols=235 Identities=23% Similarity=0.422 Sum_probs=195.3
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
||.|+||.||+|++..+++.+|+|++... ..+.+.+|+.+++.+ +||||+++++.+.+ ....++++||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 69999999999999888999999998642 235688999999999 99999999999876 5678999999999
Q ss_pred CchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCc
Q 014307 216 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292 (427)
Q Consensus 216 ~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~ 292 (427)
++|...+. .+++..+..++.||+.||+|||++|++|+||+|+||+++.++ .++|+|||++.............++.
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCCc
Confidence 99987753 478999999999999999999999999999999999999777 89999999998765443334457788
Q ss_pred cccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHh--------CChHHHHHHHhccCCCC
Q 014307 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVL--------GTDELNAYLNKYHIELD 363 (427)
Q Consensus 293 ~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~-~~~~l~~i~~~~--------~~~~~~~~l~~~~l~~d 363 (427)
.|++||.+.+ ..++.++|+||||+++|+|++|..||..... ..+....+.... -.+.+..++.+ |+..+
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~ 234 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQ-LLRRN 234 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHH-HccCC
Confidence 9999999876 6789999999999999999999999954432 333333333111 12455566666 99999
Q ss_pred hhHHHH-----HhHHhcCCchhhH
Q 014307 364 PHLAAL-----VGRLVILSYFFQF 382 (427)
Q Consensus 364 p~~r~~-----~~~ll~~~~~~~~ 382 (427)
|..|++ +.+++.||||+.+
T Consensus 235 p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 235 PEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred hhhCcCCcccCHHHHhcChhhhCC
Confidence 999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=315.57 Aligned_cols=239 Identities=21% Similarity=0.367 Sum_probs=202.3
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCC
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (427)
-.||+|.||+||-|++..+....|||-+.... .+.+..||..-++| +|.|||+++|.+.+ ++++-+.||.+.||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~se--nGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSVSE--NGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhccCC--CCeEEEEeecCCCC
Confidence 35999999999999999999999999985433 34578999999999 99999999999865 66888999999999
Q ss_pred chhhhcC----CC--CHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-ceeec
Q 014307 217 DFKVLYP----TL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRV 289 (427)
Q Consensus 217 ~l~~~~~----~~--~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~~~~~ 289 (427)
+|..+++ ++ .+..+-.+.+||++||.|||++.|||||||-+||||+.-.+.+||+|||-++.+..-+. ..+..
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 9988874 45 78889999999999999999999999999999999987666999999999987754433 45678
Q ss_pred cCcccccccccc-CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-C-------ChHHHHHHHhccC
Q 014307 290 ASRYFKGPELLV-DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-G-------TDELNAYLNKYHI 360 (427)
Q Consensus 290 ~~~~y~aPE~~~-~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-~-------~~~~~~~l~~~~l 360 (427)
||..|||||++. |...|+.++|||||||++.||.||++||..-.++...+.++-=.- . +.....||.+ |.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr-cF 816 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR-CF 816 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH-Hc
Confidence 999999999984 445799999999999999999999999977666666555432110 0 1345567777 99
Q ss_pred CCChhHHHHHhHHhcCCchhhH
Q 014307 361 ELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.||..||++.+||..||++..
T Consensus 817 epd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 817 EPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCCcccCccHHHhccCcccccC
Confidence 9999999999999999998875
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=300.87 Aligned_cols=241 Identities=20% Similarity=0.372 Sum_probs=198.8
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
|....+||.|+||.||+|.+..+++.||+|.++. ...+.+.+|+.+++.+ +||||+++++++.. +...++++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLV--GEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheee--CCeEEEEEec
Confidence 4445679999999999999988999999999853 2345678999999999 99999999999876 5678999999
Q ss_pred cCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cceeec
Q 014307 213 VNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRV 289 (427)
Q Consensus 213 ~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~~~~ 289 (427)
+.++++..+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..+.... ......
T Consensus 100 ~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 100 LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhccccccccccee
Confidence 99999877654 588999999999999999999999999999999999999777 89999999987554322 233457
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChHHHHHHHhccC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNKYHI 360 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~~~l 360 (427)
++..|+|||++.+ ..++.++|||||||++|||++|+.||+ ..+..+.+..+.... -.+.+.+++.. |+
T Consensus 179 ~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~-~l 255 (297)
T cd06659 179 GTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYF-SDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER-ML 255 (297)
T ss_pred cCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH-Hh
Confidence 8889999999876 678999999999999999999999995 344444444433211 12345566666 99
Q ss_pred CCChhHHHHHhHHhcCCchhhHH
Q 014307 361 ELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..+|..||++.+++.|+||.+..
T Consensus 256 ~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 256 TREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred cCCcccCcCHHHHhhChhhccCC
Confidence 99999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=296.00 Aligned_cols=242 Identities=24% Similarity=0.398 Sum_probs=195.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
...|++.++||+|+||.||+|.+..+++.||+|.+... ..+.+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~--~~~~ 90 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLR--EHTA 90 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEe--CCeE
Confidence 45689999999999999999999889999999988532 124578999999999 99999999999986 4567
Q ss_pred EEEEeecCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++|+||+.+..+... ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .+||+|||++......
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA- 168 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC-
Confidence 899999987544333 23589999999999999999999999999999999999999777 8999999999765332
Q ss_pred cceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------CChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~~~~~~~ 353 (427)
....++..|+|||++.+ ...++.++||||||+++|||++|+.||.. .+.......+.... -...+..
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNDSPTLSSNDWSDYFRN 245 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC-ccHHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 34567888999998742 25688999999999999999999999843 33333333222110 1234455
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+ |+..+|..||++.+++.|+|+.+..
T Consensus 246 li~~-~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 246 FVDS-CLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHH-HhcCChhhCcCHHHHhcChhhcccC
Confidence 5555 9999999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=307.90 Aligned_cols=239 Identities=23% Similarity=0.324 Sum_probs=184.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++++.||+|+||.||+|.+... +..||||+++... .+.+.+|+.+|+++..||||+++++++.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-- 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-- 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc--
Confidence 357899999999999999999986433 3579999996432 35688999999999559999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC-----------------------------------------------------------
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP----------------------------------------------------------- 223 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------------- 223 (427)
...+++||||+.+++|..++.
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 567899999999998865431
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC
Q 014307 224 ----------------------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (427)
Q Consensus 224 ----------------------------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~ 263 (427)
.+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 2566778889999999999999999999999999999997
Q ss_pred CCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014307 264 EQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQL 339 (427)
Q Consensus 264 ~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l 339 (427)
++ .+||+|||+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....+....
T Consensus 273 ~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 273 GK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred CC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 66 8999999999865433221 22345677999999876 678999999999999999997 888984433322222
Q ss_pred HHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 340 VKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 340 ~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
..+..... ++.+.+++.+ |+..+|+.||++.++.+
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVK-CWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHH-HCccCHhHCcCHHHHHH
Confidence 22222111 2344455555 88999999998766543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=313.19 Aligned_cols=244 Identities=20% Similarity=0.372 Sum_probs=208.2
Q ss_pred CCCE-EEEeeeeecCCeeEEEEEEcCCCeEEE---EEEec----cccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDY-EVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILK----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~va---vK~~~----~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++| +...+||+|+|-+||+|.+..+|..|| ||+-+ +...+++..|+.+|+.| +||||+++|+.+.+....
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCc
Confidence 3444 345789999999999999988898887 44321 23347799999999999 999999999999988888
Q ss_pred CcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 205 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~--~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
.+.+|+|.+..|+|..+.+ ++....++.+++||++||.|||++ -|||||||-+||+|+.+.+.|||+|+|||...
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 8999999999999988864 588889999999999999999998 49999999999999988889999999999876
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------CChHH
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDEL 351 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~~~~~ 351 (427)
..... ...+|||.|||||++. ..|+..+||||||++++||+|+..||....+.-....++..+. ..|..
T Consensus 197 r~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPev 273 (632)
T KOG0584|consen 197 RKSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEV 273 (632)
T ss_pred hcccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHH
Confidence 54433 4479999999999986 4899999999999999999999999976666666666666543 34677
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
.++|.+ |+.. ...|+++.+||.++||..-
T Consensus 274 r~fIek-Cl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 274 REFIEK-CLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHH-HhcC-chhccCHHHHhhChhhccc
Confidence 788888 8877 9999999999999999984
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=289.51 Aligned_cols=239 Identities=22% Similarity=0.465 Sum_probs=196.5
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||.|+||.||+|.++.++..+|+|.+... ..+.+.+|+.+++.+ +|+||+++++.+.. ....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence 588999999999999999999999999999998542 345678999999999 99999999999866 5678999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||+.+++|...+. .+++..+..++.|++.||.|||+.+++|+||||+||+++.++..+||+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999877653 3688899999999999999999999999999999999997765689999999976643322
Q ss_pred -ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (427)
.....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||. ..+..+....+.... ....+.+++.
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 235 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFE-GNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence 223467888999999876 578999999999999999999999984 333333333332211 1234555555
Q ss_pred hccCCCChhHHHHHhHHhcCCch
Q 014307 357 KYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+ |+..+|+.||++.+++.|+||
T Consensus 236 ~-~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 236 Q-LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred H-HhccChhhCcCHHHHhhCCCC
Confidence 5 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=291.20 Aligned_cols=238 Identities=22% Similarity=0.345 Sum_probs=186.9
Q ss_pred eeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHh--cCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
.||+|+||.||++.+..+++.+|+|.+.... .....+|..+++.+ .+||||+.+++++.. ....++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 3899999999999998899999999885421 12234454444433 278999999999976 4568899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeec
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~ 289 (427)
+.+++|..++ ..+++..+..++.|++.||+|||++||+||||||+|||++.++ .++|+|||++...... ......
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASV 156 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc-CccCcC
Confidence 9999997665 3589999999999999999999999999999999999999776 8999999998755332 223457
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHh-------CChHHHHHHHhccCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVL-------GTDELNAYLNKYHIE 361 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~-~~~~l~~i~~~~-------~~~~~~~~l~~~~l~ 361 (427)
|+..|+|||.+.+...++.++|||||||++|+|++|..||..... ....+....... -.+.+.+++.+ |+.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~ 235 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG-LLQ 235 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH-Hhc
Confidence 889999999986435689999999999999999999999954322 222222221111 13456666666 999
Q ss_pred CChhHHH-----HHhHHhcCCchhhHH
Q 014307 362 LDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 362 ~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
.||..|+ ++.++++|+||+...
T Consensus 236 ~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 236 RDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred CCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 9999999 699999999998844
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=290.18 Aligned_cols=242 Identities=22% Similarity=0.371 Sum_probs=191.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
+.+.....||+|+||.||+|.+..++..||+|.+.... .+.+.+|+.+++.+ +|+||+++++++.. ....++++
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~ 84 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSE--NGFFKIFM 84 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeecc--CCEEEEEE
Confidence 33444568999999999999998899999999886532 35688999999999 99999999999876 46789999
Q ss_pred eecCCCchhhhcC----CC--CHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 211 EHVNNTDFKVLYP----TL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~--~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
||+.+++|...+. .+ ++..+..++.||+.||.|||++||+||||||+||+++.+...++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999999987653 24 77888899999999999999999999999999999986555899999999876543222
Q ss_pred -ceeeccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH--HH------hCChHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA--KV------LGTDELNAY 354 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~--~~------~~~~~~~~~ 354 (427)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.............. .. .-.+.+..+
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 244 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNF 244 (268)
T ss_pred ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHH
Confidence 2334578889999997542 3478999999999999999999999954333222222111 00 012345555
Q ss_pred HHhccCCCChhHHHHHhHHhcCCch
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+.. |+..+|..||++.+++.||||
T Consensus 245 i~~-~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 245 ILR-CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHH-HcCCCchhCCCHHHHHhCCCC
Confidence 555 999999999999999999996
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=300.53 Aligned_cols=244 Identities=34% Similarity=0.622 Sum_probs=201.1
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC---CCCc
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKTP 206 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---~~~~ 206 (427)
+|++.+.||.|+||.||+|.+..+++.||||.+... ..+.+.+|+.+++.+ +|+||+++++++.... ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 588999999999999999999888999999988642 235688999999999 8999999999987642 2467
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+++|||+.+ ++...+ ..+++..++.++.||+.||+|||+.||+||||||+|||++.++ .++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDE 157 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCceEeecccc
Confidence 999999996 454443 2588999999999999999999999999999999999999876 89999999998765543
Q ss_pred ----cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-----------
Q 014307 284 ----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----------- 348 (427)
Q Consensus 284 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~----------- 348 (427)
......++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 236 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PGRDYIDQLNLIVEVLGTPSEEDLKFITS 236 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence 2344567888999999987448899999999999999999999998 555555555544443321
Q ss_pred --------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 --------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 --------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.. |+..+|..||++.+++.|+||.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEK-MLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHH-HccCChhhCCCHHHHHhCccHHhhc
Confidence 233345555 9999999999999999999999855
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=288.26 Aligned_cols=235 Identities=17% Similarity=0.305 Sum_probs=189.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.+.||+|+||.||+|..+ ++..+|+|.++.. ....+.+|+.+|+++ +||||+++++++.. ....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~iv~ 78 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ--QKPLYIVT 78 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEcc--CCCEEEEE
Confidence 356899999999999999999874 5568999987643 346788999999999 99999999999876 45689999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce
Q 014307 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~ 286 (427)
||+.+++|...+. .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+..........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCceec
Confidence 9999999876653 378889999999999999999999999999999999999766 89999999987653322211
Q ss_pred --eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHH
Q 014307 287 --VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLN 356 (427)
Q Consensus 287 --~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~ 356 (427)
...++..|+|||++.+ ..++.++|||||||++|||++ |+.|| ...+..+.+..+.+.. ..+.+..++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPF-EKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1234457999999876 678999999999999999999 88888 4445555555554321 1234555555
Q ss_pred hccCCCChhHHHHHhHHhc
Q 014307 357 KYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~ 375 (427)
+ |+..+|..||++.+++.
T Consensus 236 ~-c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 236 S-CWHEKPEGRPTFAELLR 253 (256)
T ss_pred H-HccCCcccCcCHHHHHH
Confidence 5 99999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=291.73 Aligned_cols=236 Identities=23% Similarity=0.352 Sum_probs=191.9
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
||+|+||+||+|.+..+++.+|+|++.... ...+.+|+++|+.+ +||||+++++++.. ....++||||+.+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 699999999999999999999999985421 23457899999999 89999999999976 4578999999999
Q ss_pred Cchhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeecc
Q 014307 216 TDFKVLY---P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (427)
Q Consensus 216 ~~l~~~~---~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~ 290 (427)
++|...+ . .+++.++..++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++.............+
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccC
Confidence 9987654 2 588999999999999999999999999999999999999777 899999999976654433444567
Q ss_pred CccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHH-------hCChHHHHHHHhccCC
Q 014307 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKV-------LGTDELNAYLNKYHIE 361 (427)
Q Consensus 291 ~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--~~~~l~~i~~~-------~~~~~~~~~l~~~~l~ 361 (427)
+..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..+.+...... .-.+.+.+++.+ |+.
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~ 234 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEA-LLQ 234 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHH-Hcc
Confidence 788999999876 5689999999999999999999999954322 12222211110 013456666666 899
Q ss_pred CChhHHH-----HHhHHhcCCchhhHH
Q 014307 362 LDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 362 ~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
.+|..|+ ++.+++.|+||.+..
T Consensus 235 ~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 235 KDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred CChhHccCCCcccHHHHHhChhhhcCC
Confidence 9999999 899999999998744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=313.33 Aligned_cols=201 Identities=25% Similarity=0.440 Sum_probs=177.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----CCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----~~~ 205 (427)
..+..-+.||+|+||.||+|+++.+|+.||||.+++ ...+..-+|+++|++| +|+|||+++++=++.. ...
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccccCccccc
Confidence 345566889999999999999999999999999875 3356678999999999 7999999999876655 566
Q ss_pred cEEEEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--C-CeEEEEeeeee
Q 014307 206 PSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q-RKLRLIDWGLA 276 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~-~~ikl~DFGla 276 (427)
..++||||.+|+|...+. .+++.+++.++..+..||.|||++||+||||||.||++-.. | ..-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 789999999999988875 49999999999999999999999999999999999998432 2 25799999999
Q ss_pred eeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 014307 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335 (427)
Q Consensus 277 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~ 335 (427)
+-..++......+||+.|.+||++...+.|+..+|.|||||++|++.||..||-+...+
T Consensus 172 rel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99988888899999999999999874478999999999999999999999999765544
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=295.46 Aligned_cols=243 Identities=23% Similarity=0.410 Sum_probs=199.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
..++|++.+.||+|+||.||++.+..++..||+|.+... ..+.+.+|+.+++.+ +||||+++++++.. ....++
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~l 93 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLV--GDELWV 93 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeee--CCcEEE
Confidence 347899999999999999999998888999999998532 235678899999999 89999999999976 456889
Q ss_pred EEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-c
Q 014307 209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 285 (427)
Q Consensus 209 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~ 285 (427)
|+||+.++++..++. .+++.++..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........ .
T Consensus 94 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~~~ 172 (293)
T cd06647 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKR 172 (293)
T ss_pred EEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceeccccccccc
Confidence 999999999987764 478889999999999999999999999999999999999776 899999999875543322 2
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChHHHHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLN 356 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~ 356 (427)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. ..+..+++..+.... -...+..++.
T Consensus 173 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 250 (293)
T cd06647 173 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYL-NENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 250 (293)
T ss_pred ccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence 33467888999999876 678999999999999999999999994 333333333222110 0123445555
Q ss_pred hccCCCChhHHHHHhHHhcCCchhh
Q 014307 357 KYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
. |+..+|..||++.+++.|+||..
T Consensus 251 ~-~l~~~p~~Rp~~~~il~h~~~~~ 274 (293)
T cd06647 251 R-CLEMDVEKRGSAKELLQHPFLKI 274 (293)
T ss_pred H-HccCChhhCcCHHHHhcCHHHhc
Confidence 5 99999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=292.15 Aligned_cols=237 Identities=18% Similarity=0.334 Sum_probs=185.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.++||+|+||.||+|.+.. ++..||+|.++.. ....+.+|+.+++.+ +|+||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~-- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence 35789999999999999999998642 3578999988542 234578999999999 99999999999865
Q ss_pred CCCcEEEEeecCCCchhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEE
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ik 269 (427)
....++||||+.+++|..++.. ++...+..++.|++.||+|||+.|++||||||+||+++.++ .++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~~~ 159 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVK 159 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-CEE
Confidence 5578999999999998766532 35667888999999999999999999999999999999776 899
Q ss_pred EEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014307 270 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 345 (427)
Q Consensus 270 l~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~ 345 (427)
|+|||++......... ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~ 237 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGMSNEQVLRFVMEG 237 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHcC
Confidence 9999998755432221 12244667999999876 679999999999999999999 67777 444444444333322
Q ss_pred h-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 346 L-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 346 ~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
. -.+.+.+++.+ |+..+|+.||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 238 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIIS 273 (277)
T ss_pred CcCCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 1 12344455555 99999999999888875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=289.48 Aligned_cols=239 Identities=22% Similarity=0.421 Sum_probs=192.5
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-------------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
+|.+.+.||.|+||.||+|.+..+++.+|+|.++... .+.+.+|+.+++.+ +|+|++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETT- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEecc-
Confidence 4788899999999999999998899999999875311 13577899999999 99999999999876
Q ss_pred CCCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
...+++||||+.+++|...+. .+++..++.++.||+.||.|||++|++||||+|+||+++.++ .++|+|||++..
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~ 157 (272)
T cd06629 80 -EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKK 157 (272)
T ss_pred -CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeecccccc
Confidence 457889999999999877653 488889999999999999999999999999999999999776 899999999975
Q ss_pred ecCCC---cceeeccCccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------
Q 014307 279 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------- 346 (427)
Q Consensus 279 ~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------- 346 (427)
..... ......++..|+|||.+.... .++.++|+||||+++|+|++|..||. ..+..+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS-DEEAIAAMFKLGNKRSAPPIPPD 236 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc-CcchHHHHHHhhccccCCcCCcc
Confidence 43221 122345778899999986532 47899999999999999999999984 333333332221110
Q ss_pred ---C-ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 347 ---G-TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 347 ---~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
. ...+.+++.. |+..+|..||++++++.|||+
T Consensus 237 ~~~~~~~~~~~li~~-~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 237 VSMNLSPVALDFLNA-CFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ccccCCHHHHHHHHH-HhcCChhhCCCHHHHhhCCCC
Confidence 0 2345555555 999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=287.55 Aligned_cols=240 Identities=22% Similarity=0.386 Sum_probs=193.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.+|++.+.||+|+||.||+|.+..++..||+|.+.. .....+.+|+.+++++ +|+||+++++++.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 468999999999999999999999999999998742 1224678899999999 9999999999987765667
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+++++||+.+++|...+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||+++.....
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECccccccccccc
Confidence 88999999999887665 3478899999999999999999999999999999999999776 8999999999765321
Q ss_pred ----CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChH
Q 014307 283 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDE 350 (427)
Q Consensus 283 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~ 350 (427)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. .....+...++..... .+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWA-EYEAMAAIFKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCC-ccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence 11223467888999999876 678999999999999999999999994 3334444433332110 134
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
...++.. |+. ++..||++..++.|||.
T Consensus 238 ~~~~i~~-~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQ-IFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHH-Hhc-CcccCccHHHHhcCCCC
Confidence 5555555 666 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.14 Aligned_cols=246 Identities=30% Similarity=0.550 Sum_probs=197.1
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
...++|++++.||.|+||.||+|.+..+++.||+|.+.. ...+.+.+|+.+++.+ +||||+++++++... ...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~-~~~ 84 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISP-LED 84 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecC-CCc
Confidence 356889999999999999999999999999999998753 2245678999999999 999999999998753 446
Q ss_pred cEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 206 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
.++++||+.+ ++...+ ..+++..+..++.|++.||.|||++||+||||+|+||+++.++ .+||+|||++.....
T Consensus 85 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 85 IYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQDP-- 160 (328)
T ss_pred EEEEeehhcc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccCC--
Confidence 7899999854 565554 3578888999999999999999999999999999999999766 899999999975432
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------------- 347 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------------- 347 (427)
......++..|+|||.+.+...++.++|||||||++|+|++|+.|| ...+.......+.+.++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF-PGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2234467788999999766457899999999999999999999998 33332222222211111
Q ss_pred ---------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHH
Q 014307 348 ---------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVI 384 (427)
Q Consensus 348 ---------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~ 384 (427)
.+.+.+++.+ |+..+|+.||++++++.++|+.+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEK-MLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHH-HcCCChhhCCCHHHHhcCCccccccC
Confidence 2344555555 99999999999999999999976553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=288.02 Aligned_cols=235 Identities=19% Similarity=0.329 Sum_probs=188.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|+++++||+|+||.||+|.+ .++..||+|.+... ..+.+.+|+.+++.+ +|+||+++++++.. ....+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK--EEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--CCCcEEEE
Confidence 47899999999999999999986 46678999988643 346788999999999 99999999999865 55689999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.+++|..++. .++...+..++.|++.||+|||+.+++||||||+||+++.++ .+||+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYT 159 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCCCcee
Confidence 9999999877652 477888899999999999999999999999999999999776 8999999999865432211
Q ss_pred --eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHH
Q 014307 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (427)
Q Consensus 286 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (427)
....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| ......+....+.+... +..+.+++
T Consensus 160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 160 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPY-PGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred ccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 12234567999999876 678999999999999999998 88888 44444444444443322 23444545
Q ss_pred HhccCCCChhHHHHHhHHhc
Q 014307 356 NKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+ |+..+|+.||++++++.
T Consensus 238 ~~-~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KT-CWKEKAEERPTFDYLQS 256 (261)
T ss_pred HH-HccCCcccCcCHHHHHH
Confidence 54 88999999999877643
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=288.03 Aligned_cols=240 Identities=25% Similarity=0.445 Sum_probs=195.6
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||+|+||.||+|.+..+++.||+|.++.. ..+.+.+|+.+++.+ +|+||+++++++.. ....+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence 588999999999999999999889999999998643 235688999999999 99999999998865 5568899
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc-
Q 014307 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~- 285 (427)
+||+.+++|..+.. .+++..++.++.|++.||.|||+.||+|+||+|+||+++.++ .+||+|||++.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCCcc
Confidence 99999999987763 378889999999999999999999999999999999999766 8999999999766433221
Q ss_pred ----eeeccCccccccccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChH
Q 014307 286 ----NVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDE 350 (427)
Q Consensus 286 ----~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~ 350 (427)
....++..|+|||++.+.. .++.++|||||||++|+|++|+.||............+..... .+.
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE 236 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence 1245677899999987632 3889999999999999999999999543333332222222110 234
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+.+++.+ |+..+|..||++.+++.|+|+
T Consensus 237 ~~~li~~-~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 237 GKDFLDR-CLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHHH-HccCCcccCCCHHHHhcCCCC
Confidence 5566665 999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=292.12 Aligned_cols=238 Identities=29% Similarity=0.559 Sum_probs=195.1
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
|++.+.||.|+||+||+|....+++.|+||.+... ......+|+..++++.+|+|++++++++.+ ....++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 57889999999999999999888999999998643 223456799999999449999999999976 567899999
Q ss_pred ecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce
Q 014307 212 HVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (427)
Q Consensus 212 ~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~ 286 (427)
|+ ++++...+ ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++..........
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCCCcC
Confidence 99 55554433 2578999999999999999999999999999999999999766 89999999998776554555
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------------------
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------------- 347 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------------------- 347 (427)
...++..|+|||++.+...++.++|+||||+++|||++|+.|| ......+....+...++
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 5678889999999866567899999999999999999999888 55555555444333222
Q ss_pred -----------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 -----------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 -----------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+.+..++.+ |+..+|..||++.+++.++||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKD-MLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHH-hcccCcccCCCHHHHhhCCCC
Confidence 2345555556 999999999999999999996
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=295.63 Aligned_cols=278 Identities=28% Similarity=0.480 Sum_probs=206.8
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCC--CeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--CCCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTD--NEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~--~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~--~~~~ 205 (427)
+|++.+.||+|+||.||+|++..+ +..||+|.+... ..+.+.+|+.+++++.+||||+++++.+... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488999999999999999999887 899999998632 2345778999999996799999999975432 2345
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
.++++|++.+ +|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccc
Confidence 7888898875 444443 3589999999999999999999999999999999999999777 8999999999765432
Q ss_pred Cc-----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHh
Q 014307 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357 (427)
Q Consensus 283 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~ 357 (427)
.. .....|+..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+....+..+...++.+.... +..
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~-~~~ 236 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF-KGKDYVDQLNQILQVLGTPDEET-LSR 236 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC-CCCCHHHHHHHHHHHhCCCCHHH-HHh
Confidence 21 223468889999998766457899999999999999999999888 56666777888888777654322 111
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
. .++.....+..+-..+... + ............++|++||. .+|+.|+++..++.|||-
T Consensus 237 ~---~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~li~~~l~-~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 237 I---GSPKAQNYIRSLPNIPKKP-F----ESIFPNANPLALDLLEKLLA-FDPTKRISVEEALEHPYL 295 (332)
T ss_pred h---hhhhHHHHHHhccccCCcc-h----HhhCCCCCHHHHHHHHHHcc-CCcccCCCHHHHhcChhh
Confidence 1 1122111111111111000 0 00111235678889999995 999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=292.36 Aligned_cols=236 Identities=20% Similarity=0.355 Sum_probs=188.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|.+.+.||+|+||.||++... .++..+|+|.++... .+.+.+|+.+++++ +||||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--GD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence 467999999999999999999852 345679999986432 35688999999999 89999999999876 56
Q ss_pred CcEEEEeecCCCchhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeE
Q 014307 205 TPSLIFEHVNNTDFKVLYP----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~i 268 (427)
..+++|||+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+|||++.++ .+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~~ 159 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LV 159 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cE
Confidence 7899999999999876652 378999999999999999999999999999999999999777 89
Q ss_pred EEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH
Q 014307 269 RLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK 344 (427)
Q Consensus 269 kl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~ 344 (427)
||+|||++......... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| ......+.+..+.+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~-~~~~~~~~~~~i~~ 237 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPW-YQLSNNEVIECITQ 237 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc
Confidence 99999999765432211 12234567999999876 678999999999999999998 88888 44444444444443
Q ss_pred Hh-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 345 VL-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 345 ~~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.. -.+.+.+++.+ |+..+|..||++.+++.
T Consensus 238 ~~~~~~~~~~~~~l~~li~~-~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 238 GRVLQRPRTCPKEVYDLMLG-CWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCcCCCCCCCCHHHHHHHHH-HccCChhhCCCHHHHHH
Confidence 22 12455555666 99999999999888743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=287.74 Aligned_cols=235 Identities=20% Similarity=0.383 Sum_probs=191.5
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
+|++.++||.|+||.||++.+..+++.+|+|.++.. ..+.+.+|+.+++.+ +|+||+++++.+.+ ...++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEE
Confidence 488999999999999999999999999999988532 235678899999999 99999999999976 56789999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~- 284 (427)
||+.++++...+. .+++..+..++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++........
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeecccccc
Confidence 9999998866542 378899999999999999999999999999999999999777 899999999976643322
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHh
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNK 357 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~ 357 (427)
.....++..|+|||++.+ ..++.++||||||+++|+|++|+.||. ..+.......+..... ...+..++.+
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQ-ANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQ 234 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCC-CCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHH
Confidence 234568888999999876 678999999999999999999999994 3333333333322211 1334455555
Q ss_pred ccCCCChhHHHHHhHHhcC
Q 014307 358 YHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~ 376 (427)
|+..+|..||++.+++..
T Consensus 235 -~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 235 -MFKRNPRSRPSATTILSR 252 (255)
T ss_pred -HHhCCcccCCCHHHHhhc
Confidence 899999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=323.06 Aligned_cols=231 Identities=23% Similarity=0.345 Sum_probs=182.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.++||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+ ....+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d--~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSD--GDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEee--CCEEE
Confidence 5799999999999999999999999999999998642 235688999999999 99999999999976 45789
Q ss_pred EEEeecCCCchhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEee
Q 014307 208 LIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DF 273 (427)
++|||+++++|..++. .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDF 157 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDW 157 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEec
Confidence 9999999999876542 244566788999999999999999999999999999999777 8999999
Q ss_pred eeeeeecCCC-------------------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 014307 274 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334 (427)
Q Consensus 274 Gla~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~ 334 (427)
|+++...... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. .+
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~-~~ 235 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRR-KK 235 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCC-cc
Confidence 9998652110 0112468999999999877 6789999999999999999999999943 22
Q ss_pred CHHHHHHHHHHh---------C-ChHHHHHHHhccCCCChhHHHHHhH
Q 014307 335 NYDQLVKIAKVL---------G-TDELNAYLNKYHIELDPHLAALVGR 372 (427)
Q Consensus 335 ~~~~l~~i~~~~---------~-~~~~~~~l~~~~l~~dp~~r~~~~~ 372 (427)
..+.... .... . ++.+.+.+.+ |+..||..|+...+
T Consensus 236 ~~ki~~~-~~i~~P~~~~p~~~iP~~L~~LI~r-cL~~DP~kR~ss~e 281 (932)
T PRK13184 236 GRKISYR-DVILSPIEVAPYREIPPFLSQIAMK-ALAVDPAERYSSVQ 281 (932)
T ss_pred hhhhhhh-hhccChhhccccccCCHHHHHHHHH-HccCChhhCcCHHH
Confidence 2221111 0000 1 2334455555 88999999965433
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=294.26 Aligned_cols=238 Identities=23% Similarity=0.391 Sum_probs=185.6
Q ss_pred CCE-EEEeeeeecCCeeEEEEE----EcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 134 DDY-EVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 134 ~~y-~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
++| ++.+.||+|+||+||++. ...++..||+|+++.. ....+.+|+++|+.+ +||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence 455 899999999999998865 3356789999998743 235678999999999 999999999998776566
Q ss_pred CcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 205 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
.++++|||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCc
Confidence 7899999999999987754 589999999999999999999999999999999999999776 8999999999866433
Q ss_pred Ccc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH----------HHHH----
Q 014307 283 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV----------KIAK---- 344 (427)
Q Consensus 283 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~----------~i~~---- 344 (427)
... ....++..|+|||.+.+ ..++.++|||||||++|||++|..||.........+. .+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER 239 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence 221 12245567999999876 6789999999999999999999999843322111111 0110
Q ss_pred HhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 345 VLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 345 ~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
... +..+.+++.. |+..+|..||++++++.
T Consensus 240 ~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 240 GMRLPCPKNCPQEVYILMKN-CWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCCCCCCHHHHHHHHH-HhccChhhCCCHHHHHH
Confidence 000 1344444444 88899999999888774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=291.25 Aligned_cols=238 Identities=18% Similarity=0.313 Sum_probs=188.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ...+.+|+.+++.+ +|+||+++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFE--R 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--C
Confidence 4679999999999999999999877 77899999886322 34588899999999 99999999998876 4
Q ss_pred CCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEE
Q 014307 204 KTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLI 271 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~ 271 (427)
...+++|||+.+++|..++. .+++..+..++.||+.||+|||+++++||||||+|||++.++ ..+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 46789999999999887652 378889999999999999999999999999999999998543 368999
Q ss_pred eeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-
Q 014307 272 DWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL- 346 (427)
Q Consensus 272 DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~- 346 (427)
|||+++........ .....+..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf-~~~~~~~~~~~~~~~~~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY-PGRTNQEVMEFVTGGGR 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHcCCc
Confidence 99999865322111 11223456999999876 679999999999999999997 88888 4444444333332211
Q ss_pred ------CChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 347 ------GTDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 347 ------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
-++.+.+++.+ |+..+|+.||++.+++.+
T Consensus 240 ~~~~~~~~~~~~~~i~~-cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 240 LDPPKGCPGPVYRIMTD-CWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCCCHHHHHHHHH-HcCCCcccCcCHHHHHHH
Confidence 12345555555 999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=306.62 Aligned_cols=244 Identities=23% Similarity=0.410 Sum_probs=212.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..+++++..||-|+||.|=++..+.....+|+|++++ ...+.+..|-+||..+ +.|.||++|..|.+ +.++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~kyv 495 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKYV 495 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chhh
Confidence 3567888999999999999998766666689998864 2345678899999998 79999999999976 7899
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
|++||-|-||.+...++ .|.+..++.++..+++|++|||++|||+|||||+|.++|.+| -+||.|||+|+.+..+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHhccCC
Confidence 99999999999987764 599999999999999999999999999999999999999888 79999999999999999
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC--------hHHHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------DELNAYL 355 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~--------~~~~~~l 355 (427)
...+.+||+.|.|||++.+ +..+.++|.||||+++|||++|.+|| .+.+++.....|.+.+.. .....++
T Consensus 575 KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Li 652 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDPMKTYNLILKGIDKIEFPRRITKTATDLI 652 (732)
T ss_pred ceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhhhhhhcccccchhHHHHH
Confidence 9999999999999999998 78999999999999999999999999 788888888888887642 2233444
Q ss_pred HhccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
.+ ....+|..|-- +.++-+|.||..+.
T Consensus 653 k~-LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 653 KK-LCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HH-HHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 45 44667877765 89999999999877
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=287.74 Aligned_cols=235 Identities=16% Similarity=0.298 Sum_probs=188.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.+.||+|+||.||+|.+. .+..+|+|.++.. ..+.+.+|+.+++++ +||||+++++++.. ....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTK--QRPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEcc--CCCcEEEE
Confidence 357999999999999999999874 4556999988743 246788999999999 89999999999875 45679999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce
Q 014307 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~ 286 (427)
||+.++++..++. .+++..++.++.||+.||.|||+.|++|+||||+||+++.++ .+||+|||+++.........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCceee
Confidence 9999998877652 478999999999999999999999999999999999999776 89999999997654332211
Q ss_pred --eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 287 --VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 287 --~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. .....+....+.+... .+.+.+++.
T Consensus 158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYE-RFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1233456999999876 678999999999999999998 999983 3344444444433221 235556566
Q ss_pred hccCCCChhHHHHHhHHhc
Q 014307 357 KYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~ 375 (427)
. |+..+|..||++.+++.
T Consensus 236 ~-cl~~~p~~Rp~~~~ll~ 253 (256)
T cd05113 236 S-CWHEKAEERPTFQQLLS 253 (256)
T ss_pred H-HcCCCcccCCCHHHHHH
Confidence 5 99999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=293.50 Aligned_cols=236 Identities=21% Similarity=0.356 Sum_probs=189.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|.+.+.||+|+||.||+|.+.. ++..||||+++.. ..+.+.+|+++|+.+ +|+||+++++++.. .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~ 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTE--G 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEec--C
Confidence 4568899999999999999998743 3578999998643 235788999999999 99999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC
Q 014307 204 KTPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~ 266 (427)
...+++|||+.+++|..++. .+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~- 159 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL- 159 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-
Confidence 67899999999999876652 367888999999999999999999999999999999999776
Q ss_pred eEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 014307 267 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI 342 (427)
Q Consensus 267 ~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i 342 (427)
.+||+|||++........ .....++..|+|||++.+ ..++.++|||||||++|||++ |..||+ +.+..+....+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~-~~~~~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWY-GLSNEEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHH
Confidence 899999999976533221 122344677999999876 679999999999999999998 999984 33444444444
Q ss_pred HHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 343 AKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 343 ~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+... +..+.+++.+ |+..+|..||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQRPRTCPSEVYDIMLG-CWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCCCCCCCCHHHHHHHHH-HcCCCcccCCCHHHHHH
Confidence 32211 2344555555 99999999999888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=291.70 Aligned_cols=235 Identities=18% Similarity=0.345 Sum_probs=185.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEc----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
++|++.+.||+|+||.||+|... .++..+|+|.++... ...+.+|+.+++++ +||||+++++++.. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~ 81 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQ--EQP 81 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEec--CCc
Confidence 57899999999999999999853 356789999986422 25678999999999 99999999999876 456
Q ss_pred cEEEEeecCCCchhhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC
Q 014307 206 PSLIFEHVNNTDFKVLYP--------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~ 265 (427)
.+++|||+.+++|..++. .+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 889999999998876641 367788899999999999999999999999999999999776
Q ss_pred CeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014307 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (427)
Q Consensus 266 ~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~ 341 (427)
.+||+|||+++....... .....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+....
T Consensus 162 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~-~~~~~~~~~~~ 238 (283)
T cd05090 162 -HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPY-YGFSNQEVIEM 238 (283)
T ss_pred -cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCCHHHHHHH
Confidence 899999999976543321 122344567999999876 678999999999999999998 88888 44444444443
Q ss_pred HHHHh-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 342 IAKVL-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 342 i~~~~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.... -.+.+..++.. |+..+|..||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 239 VRKRQLLPCSEDCPPRMYSLMTE-CWQEGPSRRPRFKDIHT 278 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHH-HcccCcccCcCHHHHHH
Confidence 33221 12344455554 89999999999888754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=288.95 Aligned_cols=235 Identities=20% Similarity=0.354 Sum_probs=186.0
Q ss_pred EEEEeeeeecCCeeEEEEEEcCC---CeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC----
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~---- 203 (427)
|++++.||+|+||.||+|....+ +..||+|.++... ...+.+|+.+++.+ +|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 46788999999999999987653 4789999986422 24678999999999 99999999998765322
Q ss_pred CCcEEEEeecCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFG 274 (427)
...++++||+.++++...+ ..+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg 158 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFG 158 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCcc
Confidence 3478999999999986554 2478899999999999999999999999999999999999776 89999999
Q ss_pred eeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC---
Q 014307 275 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG--- 347 (427)
Q Consensus 275 la~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~--- 347 (427)
+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+..+.+.+..+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPY-PGVENHEIYDYLRHGNRLKQ 236 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCC
Confidence 99876443221 11234567999999865 678999999999999999999 77777 55555554444433211
Q ss_pred ----ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 ----TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 ----~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+.+++.+ |+..||..||++.+++.
T Consensus 237 ~~~~~~~~~~li~~-~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 237 PEDCLDELYDLMYS-CWRADPKDRPTFTKLRE 267 (273)
T ss_pred CcCCCHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 2455666666 99999999999888765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=301.04 Aligned_cols=240 Identities=20% Similarity=0.318 Sum_probs=186.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.+.||+|+||.||+|.+. .+++.||||+++... ...+.+|+.+|.++.+|+||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-C
Confidence 468999999999999999999843 457899999996422 245788999999997789999999988654 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------------------------------------------------------
Q 014307 204 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 223 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 223 (427)
..++++|||+.+++|..++.
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 56789999999998865531
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc---eeecc
Q 014307 224 ----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVA 290 (427)
Q Consensus 224 ----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~---~~~~~ 290 (427)
.++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++......... ....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCC
Confidence 256677788999999999999999999999999999999776 8999999999765332221 11234
Q ss_pred CccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHHhccCCC
Q 014307 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHIEL 362 (427)
Q Consensus 291 ~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~ 362 (427)
+..|+|||++.+ ..++.++|||||||++|+|++ |..||.......+....+.+.. ..+.+.+++.. |+..
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-cl~~ 321 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHG 321 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHH-HccC
Confidence 556999999876 679999999999999999997 8888843322322222222211 12455566665 8899
Q ss_pred ChhHHHHHhHHhcC
Q 014307 363 DPHLAALVGRLVIL 376 (427)
Q Consensus 363 dp~~r~~~~~ll~~ 376 (427)
+|..||++.+++.+
T Consensus 322 ~p~~Rps~~eil~~ 335 (343)
T cd05103 322 EPSQRPTFSELVEH 335 (343)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999998888753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=283.13 Aligned_cols=241 Identities=27% Similarity=0.466 Sum_probs=201.4
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|.+.+.||+|++|.||+|.+..+++.|++|+++... .+.+.+|+.+++++ +|+||+++++.+........+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 4778899999999999999998899999999987544 56788999999999 89999999999986433678999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc--
Q 014307 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-- 284 (427)
+||+.++++..++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEecccccccc
Confidence 99999999877653 578999999999999999999999999999999999999766 899999999987765543
Q ss_pred -ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH--------hCChHHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------LGTDELNAYL 355 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~--------~~~~~~~~~l 355 (427)
.....++..|+|||.+.+ ..++.++||||||+++++|++|..||....+....+..+... .-...+.+++
T Consensus 159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i 237 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFL 237 (260)
T ss_pred cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHH
Confidence 445678888999999876 568999999999999999999999995444333333333210 0134566666
Q ss_pred HhccCCCChhHHHHHhHHhcCCch
Q 014307 356 NKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+ |+..+|..||++.+++.||||
T Consensus 238 ~~-~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 238 RK-CLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HH-hCcCChhhCCCHHHHhhCCCC
Confidence 65 999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=287.46 Aligned_cols=234 Identities=17% Similarity=0.320 Sum_probs=185.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.++||+|+||.||+|.+..+ ..||+|+++. ...+.+.+|+.+++.+ +|+||+++++.+.. ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEEE
Confidence 46799999999999999999988554 5699999874 2346789999999999 89999999998743 4578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.++++..++. .+++..+..++.|++.||+|||+.||+||||||+||+++.++ .+||+|||.+..+......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccccccc
Confidence 9999999877763 377888999999999999999999999999999999999776 7999999999866433221
Q ss_pred --eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHH
Q 014307 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (427)
Q Consensus 286 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (427)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+....+..... ...+.+++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 236 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPESLHDLM 236 (262)
T ss_pred cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCChHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence 12234567999999876 678999999999999999999 77777 44444444444432211 23455555
Q ss_pred HhccCCCChhHHHHHhHHhc
Q 014307 356 NKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+ |+..+|..||++.+++.
T Consensus 237 ~~-~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 237 CQ-CWRKEPEERPTFEYLQA 255 (262)
T ss_pred HH-HccCCcccCCCHHHHHH
Confidence 55 88888888888777654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=289.84 Aligned_cols=239 Identities=31% Similarity=0.588 Sum_probs=193.6
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhc--CCCCeeeeeeEEEcCCC---CC
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQS---KT 205 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~--~h~niv~l~~~~~~~~~---~~ 205 (427)
|++.+.||+|+||.||+|+++.+++.+|+|.++.. ....+.+|+.+++++. .|+|++++++++..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 67889999999999999999888999999998632 1235667888887773 59999999999976432 24
Q ss_pred cEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
++++|||+.+ ++..++ ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcceecc
Confidence 8899999986 444332 2488999999999999999999999999999999999999876 89999999998765
Q ss_pred CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------------
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------- 347 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------------- 347 (427)
.........++..|+|||++.+ ..++.++|||||||++|||++|+.|| .+....+.+..+.+..+
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPSEEEWPRNVSL 236 (287)
T ss_pred CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCCChHHHHHHHHHHcCCCChHhcCCCccc
Confidence 4444444567888999999877 67899999999999999999998887 55566666665544321
Q ss_pred --------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 --------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 --------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+...+++.. |+..||..||++.+++.|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 237 PRSSFPSYTPRSFKSFVPEICEEGLDLLKK-MLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred chhhcccccccchhhhhhhhhHHHHHHHHH-HhccCCccCCCHHHHhcCcCC
Confidence 1233444555 999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=285.64 Aligned_cols=234 Identities=24% Similarity=0.375 Sum_probs=188.2
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccccH------HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||.|+||.||+|.+..+++.||+|+++.... ..+..|..++....+|+|++++++++.. ...+++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 568999999999999988999999999864321 2244555555544489999999999976 56789999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeecc
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~ 290 (427)
.+++|..++ ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||++..... .....+
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc---cccCCC
Confidence 999988776 3589999999999999999999999999999999999999776 899999999875432 233467
Q ss_pred CccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHHHHHhccC
Q 014307 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAYLNKYHI 360 (427)
Q Consensus 291 ~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~~l~~~~l 360 (427)
+..|+|||.+.+ ..++.++||||||+++|+|++|..||. ..+..+....+.... -++.+.+++.+ |+
T Consensus 156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l 232 (260)
T cd05611 156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFH-AETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR-LL 232 (260)
T ss_pred CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH-Hc
Confidence 788999999877 568999999999999999999999994 334333333332211 13455666666 99
Q ss_pred CCChhHHH---HHhHHhcCCchhhH
Q 014307 361 ELDPHLAA---LVGRLVILSYFFQF 382 (427)
Q Consensus 361 ~~dp~~r~---~~~~ll~~~~~~~~ 382 (427)
..+|+.|+ .+.+++.||||.+.
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhcC
Confidence 99999999 66899999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=284.67 Aligned_cols=236 Identities=26% Similarity=0.505 Sum_probs=191.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||.||+|.+..+++.||+|.++. ...+.+.+|+++++++ +|+|++++++++.. ....+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIE--NNELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeec--CCeEE
Confidence 579999999999999999999988999999998753 2245688999999999 99999999999976 45678
Q ss_pred EEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
++|||+.+++|..++. .+++..+..++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~ 157 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeecc
Confidence 9999999999876642 378899999999999999999999999999999999999777 79999999997654
Q ss_pred CCC-cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH-HHHHHHH--------hCChH
Q 014307 281 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ-LVKIAKV--------LGTDE 350 (427)
Q Consensus 281 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~-l~~i~~~--------~~~~~ 350 (427)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.....+... ...+... .....
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236 (267)
T ss_pred CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence 332 2234567888999999876 67899999999999999999999999544333222 2222211 11224
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+++.. |+..+|..||++.+++.
T Consensus 237 ~~~~i~~-cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 237 LRDLVSR-CINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHH-HcCCCcccCCCHHHHHH
Confidence 4455555 99999999999887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=287.63 Aligned_cols=235 Identities=18% Similarity=0.321 Sum_probs=189.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.+|.+.++||+|+||.||+|.+..+++.||+|+++... ...+.+|+++++.+ .|+||+++++++.. ...++++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcC--CCCcEEEEE
Confidence 56899999999999999999999899999999987543 35688999999999 99999999999876 556889999
Q ss_pred ecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce
Q 014307 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (427)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~ 286 (427)
|+.+++|..++. .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccccceeec
Confidence 999999877652 378888999999999999999999999999999999999776 89999999997654332111
Q ss_pred --eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 287 --VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 287 --~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
...++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+....+..... ++.+..++.
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 162 HAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred cCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1123456999999876 678999999999999999998 88887 44444443344433221 234555555
Q ss_pred hccCCCChhHHHHHhHHhc
Q 014307 357 KYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~ 375 (427)
+ |+..+|..||++.+++.
T Consensus 240 ~-cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 240 A-CWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred H-HccCCcccCCCHHHHHH
Confidence 5 89999999999888754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=285.06 Aligned_cols=234 Identities=21% Similarity=0.377 Sum_probs=188.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.+.||+|++|.||+|.+. +++.||+|.++.. ..+.+.+|+.+++++ +|+||+++++++.. ....+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTL--EEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEec--CCCeeeee
Confidence 467999999999999999999974 5678999998753 346788999999999 89999999999876 45678999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~-~ 158 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDI-Y 158 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCc-c
Confidence 9999999877753 478999999999999999999999999999999999999777 89999999998765322 1
Q ss_pred eeecc---CccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 286 NVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 286 ~~~~~---~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
....+ +..|+|||.+.+ ..++.++|||||||++|||++ |+.|| .+....+.+..+.+... .+.+.++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPY-PGMTNAEVLQQVDQGYRMPCPPGCPKELYDI 236 (261)
T ss_pred cccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 11222 346999999876 678999999999999999999 88888 45454444544443321 2445555
Q ss_pred HHhccCCCChhHHHHHhHHhc
Q 014307 355 LNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.. |+..+|..||++++++.
T Consensus 237 i~~-~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 237 MLD-CWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHH-HhhcCcccCCCHHHHHH
Confidence 554 88999999999888754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=308.99 Aligned_cols=240 Identities=25% Similarity=0.368 Sum_probs=198.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
..+.|++...+|.|+|+.|..+.+..+++..++|++... .....+|+.++....+||||+++.+++.+ ....++|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~--~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYED--GKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecC--Cceeeeeeh
Confidence 467899999999999999999999999999999999765 34456788888888899999999999976 678899999
Q ss_pred ecCCCchhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEc-CCCCeEEEEeeeeeeeecCCCcceee
Q 014307 212 HVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNVR 288 (427)
Q Consensus 212 ~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~-~~~~~ikl~DFGla~~~~~~~~~~~~ 288 (427)
.+.++.+...+.. ....++..|++||+.|+.|||++|+|||||||+|||++ ..+ +++|+|||.++..... ....
T Consensus 397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~--~~tp 473 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS--CDTP 473 (612)
T ss_pred hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-cEEEEEechhhhCchh--hccc
Confidence 9999987665543 33367778999999999999999999999999999995 455 8999999999865443 4455
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH---h-CChHHHHHHHhccCCCCh
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---L-GTDELNAYLNKYHIELDP 364 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~---~-~~~~~~~~l~~~~l~~dp 364 (427)
+-|..|.|||++.. ..|+.++||||||++||+|++|+.||.......+.+.++... . -++.... +...|++.||
T Consensus 474 ~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKd-Ll~~LL~~dP 551 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKD-LLQQLLQVDP 551 (612)
T ss_pred chhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHH-HHHHhccCCh
Confidence 67788999999885 899999999999999999999999996554443444444322 1 1233444 4455999999
Q ss_pred hHHHHHhHHhcCCch
Q 014307 365 HLAALVGRLVILSYF 379 (427)
Q Consensus 365 ~~r~~~~~ll~~~~~ 379 (427)
..|+++++++.|+|+
T Consensus 552 ~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 552 ALRLGADEIGAHPWF 566 (612)
T ss_pred hhCcChhhhccCcch
Confidence 999999999999999
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=294.21 Aligned_cols=243 Identities=21% Similarity=0.372 Sum_probs=197.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|+++++||+|+||+||+|.+..+++.||+|++... ..+.+.+|+++++.+ +||||+++++.+.. ....++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 80 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLN--ENNICM 80 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEec--CCEEEE
Confidence 36788999999999999999999889999999987542 235688999999999 99999999999987 467899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
||||+.+++|..+. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~-~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINS-I 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhh-c
Confidence 99999999987665 357899999999999999999997 6999999999999999776 8999999998654322 2
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC----------HHHHHHHHHH----h----
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN----------YDQLVKIAKV----L---- 346 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~----------~~~l~~i~~~----~---- 346 (427)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .+.+..+... +
T Consensus 159 ~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 159 ADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred cCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 234578889999999876 68899999999999999999999999533221 1112222111 0
Q ss_pred CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 347 GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 347 ~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
-...+.+++.+ |+..||+.||++.+++.++||.+.
T Consensus 238 ~~~~~~~li~~-~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 238 FPEDLRDFVDA-CLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred cCHHHHHHHHH-HhcCCcccCcCHHHHhcCcccccc
Confidence 11234455555 999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=287.85 Aligned_cols=234 Identities=19% Similarity=0.361 Sum_probs=182.3
Q ss_pred EEEeeeeecCCeeEEEEEEcCCCe--EEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC----CCCC
Q 014307 137 EVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKT 205 (427)
Q Consensus 137 ~~~~~LG~G~fg~V~~~~~~~~~~--~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~----~~~~ 205 (427)
.+.+.||+|+||.||+|.+..++. .+|+|.++.. ..+.+.+|+.+++.+ +|+||+++++++... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence 467889999999999999876665 6899987542 235678899999999 999999999987532 1235
Q ss_pred cEEEEeecCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 206 PSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
.+++|||+.++++...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 159 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLS 159 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCcc
Confidence 78999999999886553 2378889999999999999999999999999999999999776 8999999999
Q ss_pred eeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-----
Q 014307 277 EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG----- 347 (427)
Q Consensus 277 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~----- 347 (427)
+........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~ 237 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY-PGVENSEIYDYLRQGNRLKQPP 237 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHcCCCCCCCC
Confidence 876433221 12245667999999876 679999999999999999999 78887 44444444444433211
Q ss_pred --ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 --TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 --~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+.+++.+ |+..+|+.||++.+++.
T Consensus 238 ~~~~~~~~li~~-~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 238 DCLDGLYSLMSS-CWLLNPKDRPSFETLRC 266 (272)
T ss_pred CCCHHHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 1334444555 99999999999888765
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=288.14 Aligned_cols=234 Identities=19% Similarity=0.334 Sum_probs=185.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCe----EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|++.+.||+|+||+||+|.+..++. .||+|+++.. ....+.+|+.+++.+ +|+||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---C
Confidence 4679999999999999999999877765 4899998642 235678899999998 99999999999864 3
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++++||+.++++...+. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLD 160 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeecc
Confidence 4679999999999876652 478999999999999999999999999999999999998666 89999999998764
Q ss_pred CCCcce---eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC--------C
Q 014307 281 PGKEYN---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG--------T 348 (427)
Q Consensus 281 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~--------~ 348 (427)
...... ...++..|+|||.+.+ ..++.++|||||||++|||++ |..||. .... +.+........ .
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPA-REIPDLLEKGERLPQPPICT 237 (279)
T ss_pred cccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCCH-HHHHHHHHCCCcCCCCccCC
Confidence 332211 1233567999999876 679999999999999999998 888873 3332 22322222211 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+.+++.+ |+..||+.||++.+++.
T Consensus 238 ~~~~~li~~-~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 238 IDVYMIMVK-CWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 344455555 99999999999888874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=284.76 Aligned_cols=229 Identities=22% Similarity=0.379 Sum_probs=181.0
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
+.||+|+||.||+|.++.+++.+|+|.+... ....+.+|+++++++ +||||+++++++.. ....++||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3689999999999999889999999987532 235688999999999 99999999999876 4578999999999
Q ss_pred CchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce---ee
Q 014307 216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN---VR 288 (427)
Q Consensus 216 ~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~---~~ 288 (427)
++|..++. .+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.......... ..
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCC
Confidence 99887652 478899999999999999999999999999999999999776 89999999987543221111 11
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhccC
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYHI 360 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l 360 (427)
..+..|+|||.+.+ ..++.++|||||||++|||++ |..||. .....+....+..... +..+.+++.+ |+
T Consensus 157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l 233 (252)
T cd05084 157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYA-NLSNQQTREAIEQGVRLPCPELCPDAVYRLMER-CW 233 (252)
T ss_pred CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcc-ccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHH-Hc
Confidence 22345999999876 678999999999999999998 888873 3333333333322111 2445554555 99
Q ss_pred CCChhHHHHHhHHhc
Q 014307 361 ELDPHLAALVGRLVI 375 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~ 375 (427)
..+|..||++.+++.
T Consensus 234 ~~~p~~Rps~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=279.67 Aligned_cols=237 Identities=32% Similarity=0.546 Sum_probs=198.0
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
+|++.+.||+|++|.||++.+..+++.+++|++... ..+.+.+|+.+++.+ +|+|++++++++.. ....++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLK--KDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEec--CCeEEEEEe
Confidence 478889999999999999999888999999998654 346788999999999 89999999999876 456789999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCccee
Q 014307 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (427)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~ 287 (427)
|+.+++|...+ ..+++..+..++.|++.||.+||++|++||||+|+||+++.++ .++|+|||.+...........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeeccccccccccccccc
Confidence 99999988765 3579999999999999999999999999999999999999766 899999999987654433345
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHHhc
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNKY 358 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~~ 358 (427)
..++..|+|||.+.+ ..++.++||||||+++|+|++|+.||. ..+..+.+..+..... ...+.+++..
T Consensus 157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~- 233 (253)
T cd05122 157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYS-ELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK- 233 (253)
T ss_pred eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH-
Confidence 678888999999876 568899999999999999999999984 3333343333332111 2345555655
Q ss_pred cCCCChhHHHHHhHHhcCCc
Q 014307 359 HIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~ 378 (427)
|+..||..||++.+++.|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=288.54 Aligned_cols=237 Identities=17% Similarity=0.336 Sum_probs=184.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.+.||+|+||.||+|..+. .+..||+|.++... ...+.+|+.+++.+ +|+||+++++++.+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~-- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSK-- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence 35789999999999999999997642 34589999876432 24577899999999 99999999999876
Q ss_pred CCCcEEEEeecCCCchhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEE
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ik 269 (427)
....++||||+.+++|..++.. .+...+..++.|++.||.|||++||+||||||+|||++.++ .+|
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-~~~ 159 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVK 159 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-cEE
Confidence 4568999999999999877632 34567888999999999999999999999999999999776 899
Q ss_pred EEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014307 270 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 345 (427)
Q Consensus 270 l~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~ 345 (427)
|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.+..+....+...
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~ 237 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPY-QGLSNEQVLKFVMDG 237 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC
Confidence 999999875533221 112234567999999876 678999999999999999998 67787 444444433333221
Q ss_pred h------C-ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 346 L------G-TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 346 ~------~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
. . .+.+.+++.. |+..+|..||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 238 GYLDQPDNCPERVTDLMRM-CWQFNPKMRPTFLEIVN 273 (288)
T ss_pred CCCCCCCCCCHHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 1 1 2345555555 99999999999888765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=287.66 Aligned_cols=244 Identities=19% Similarity=0.365 Sum_probs=194.4
Q ss_pred CEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
+|++.+.||.|+||.||+|++. .+|+.||+|+++.. ..+.+.+|+.++..+.+|+||+++++++.. +.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4789999999999999999874 47899999998642 235578899999999779999999999876 45
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
..++||||+.+++|..++ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++ .+||+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~ 157 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHE 157 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceeccc
Confidence 788999999999887765 3488999999999999999999999999999999999999776 899999999976543
Q ss_pred CC--cceeeccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH---hC-------C
Q 014307 282 GK--EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---LG-------T 348 (427)
Q Consensus 282 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~---~~-------~ 348 (427)
.. ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||... ........+.+. .. .
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD-GEKNSQAEISRRILKSEPPYPQEMS 236 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC-CccccHHHHHHHhhccCCCCCccCC
Confidence 32 12234678889999998642 35788999999999999999999998432 211111222211 11 2
Q ss_pred hHHHHHHHhccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
+.+..++.+ |+..+|..|+ .+++++.|+||.+..
T Consensus 237 ~~~~~ll~~-~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 237 ALAKDIIQR-LLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHHH-HhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 334455555 9999999997 899999999999855
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.62 Aligned_cols=237 Identities=19% Similarity=0.347 Sum_probs=188.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.+.||+|+||.||++.+... ...+|+|.++... ...+.+|+.+++++.+|+||+++++++.. .
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ--E 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC--C
Confidence 46799999999999999999987643 3789999986432 24577899999998779999999999875 5
Q ss_pred CCcEEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC
Q 014307 204 KTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~ 264 (427)
..++++|||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 5689999999999987665 247888899999999999999999999999999999999977
Q ss_pred CCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014307 265 QRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 340 (427)
Q Consensus 265 ~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~ 340 (427)
+ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| ......+...
T Consensus 169 ~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~ 245 (293)
T cd05053 169 H-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEELFK 245 (293)
T ss_pred C-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCC-CCCCHHHHHH
Confidence 6 8999999999865433221 11233456999999876 678999999999999999997 88888 4444334333
Q ss_pred HHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 341 KIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 341 ~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+..... .+.+.+++.+ |+..+|..||++.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 246 LLKEGYRMEKPQNCTQELYHLMRD-CWHEVPSQRPTFKQLVE 286 (293)
T ss_pred HHHcCCcCCCCCCCCHHHHHHHHH-HcccCcccCcCHHHHHH
Confidence 3333211 2455565666 99999999999988876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=288.05 Aligned_cols=237 Identities=18% Similarity=0.321 Sum_probs=188.8
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.+.||+|+||.||+|.++.. +..||+|.+.... ...+.+|+.+++.+ +|+||+++++++..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~-- 80 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVST-- 80 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC--
Confidence 357899999999999999999987643 3889999986432 34578899999999 99999999999876
Q ss_pred CCCcEEEEeecCCCchhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEE
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ik 269 (427)
....+++|||+.+++|..++. .+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~~k 159 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVK 159 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-CEE
Confidence 467899999999999877653 256778899999999999999999999999999999999877 899
Q ss_pred EEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014307 270 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 345 (427)
Q Consensus 270 l~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~ 345 (427)
|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+...
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~-~~~~~~~~~~~~~~~ 237 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY-QGLSNEEVLKFVIDG 237 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCC-ccCCHHHHHHHHhcC
Confidence 999999876543321 123345678999999876 678999999999999999998 88887 444444444433321
Q ss_pred hC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 346 LG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 346 ~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.. ...+.+++.+ |+..+|..||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~li~~-~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 GHLDLPENCPDKLLELMRM-CWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCCCCCHHHHHHHHH-HcCCChhhCCCHHHHHH
Confidence 10 2345555555 99999999999988865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=292.49 Aligned_cols=235 Identities=19% Similarity=0.319 Sum_probs=185.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.+|++.++||+|+||.||+|.+..+ ++.||+|+++... ...+.+|+.++..+ +||||+++++++.. ..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~--~~ 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTK--EQ 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CC
Confidence 4577889999999999999987543 5789999987432 24578899999999 99999999999976 34
Q ss_pred CcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC
Q 014307 205 TPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~ 265 (427)
..++++||+.++++..++. .+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 6789999999998776641 367888899999999999999999999999999999999766
Q ss_pred CeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014307 266 RKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (427)
Q Consensus 266 ~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~ 341 (427)
.+||+|||+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+....+....
T Consensus 162 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~~ 238 (283)
T cd05091 162 -NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVIEM 238 (283)
T ss_pred -ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHH
Confidence 7999999998765433221 22345678999999876 678999999999999999998 77777 45555555555
Q ss_pred HHHHhC------Ch-HHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 342 IAKVLG------TD-ELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 342 i~~~~~------~~-~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+... .+ .+..++.. |++.+|..||++.+++.
T Consensus 239 i~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 239 IRNRQVLPCPDDCPAWVYTLMLE-CWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHH-HhCCCcccCCCHHHHHH
Confidence 444321 22 34444444 99999999999988765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=285.46 Aligned_cols=233 Identities=17% Similarity=0.314 Sum_probs=186.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.+|++.+.||+|+||.||+|.++ ++..+|+|++... ....+.+|+.+++++ +|+||+++++++.. ....++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK--QRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--CCceEEEEe
Confidence 45888999999999999999875 5678999998643 345788999999999 99999999999865 457899999
Q ss_pred ecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCccee
Q 014307 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (427)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~ 287 (427)
|+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++....... ..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceecccccc-cc
Confidence 999999876652 478899999999999999999999999999999999999777 899999999976543221 11
Q ss_pred ec---cCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 288 RV---ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 288 ~~---~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.. ++..|+|||.+.+ ..++.++|||||||++|+|++ |+.|| ...++.+....+..... ++.+.+++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPY-ERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCC-CCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 22 2346999999876 679999999999999999999 78888 44444554444443321 234444444
Q ss_pred hccCCCChhHHHHHhHHhc
Q 014307 357 KYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~ 375 (427)
+ |+..+|+.||++.+++.
T Consensus 236 ~-cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 236 S-CWHEKPEDRPAFKKLLS 253 (256)
T ss_pred H-HhcCChhhCcCHHHHHH
Confidence 4 89999999999888875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=292.45 Aligned_cols=209 Identities=24% Similarity=0.394 Sum_probs=180.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
...+|..+..||+|+||.|.+|..+.+.+.+|||++++.. .+--..|-++|....+-|.+++++.+|.. -..
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDR 424 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDR 424 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhh
Confidence 3467899999999999999999999999999999997521 12235677787776667899999999865 557
Q ss_pred cEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-C
Q 014307 206 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~ 281 (427)
+|+||||+.||+|...++ ++.+..+..++.+|+-||-+||++|||+||||.+|||+|.+| .|||+|||+++.-- .
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIFD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccccccccC
Confidence 899999999999987765 689999999999999999999999999999999999999988 89999999997432 3
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~ 345 (427)
+....+.+||+.|+|||++. +++|+.++|+||+||+||||+.|+.|| .+.++.+....|...
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPF-dGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQAIMEH 565 (683)
T ss_pred CcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHc
Confidence 45567889999999999987 489999999999999999999999999 677777777766553
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=288.05 Aligned_cols=240 Identities=20% Similarity=0.398 Sum_probs=197.5
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.|...+.||.|++|.||+|.+..+++.+++|.++.. ..+.+.+|+.+++.+ +|+||+++++++.. ....++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~--~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLV--GDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEc--CCeEEEEEe
Confidence 455668999999999999999889999999988532 235578999999999 99999999999876 456899999
Q ss_pred ecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cceee
Q 014307 212 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR 288 (427)
Q Consensus 212 ~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~~~ 288 (427)
|+.+++|...+. ++++..+..++.|++.||+|||++||+||||+|+||+++.++ .++|+|||.+....... .....
T Consensus 97 ~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 97 FLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred ccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCcccccc
Confidence 999999887653 588899999999999999999999999999999999999776 89999999886543322 22334
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChHHHHHHHhcc
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAYLNKYH 359 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~~~~~l~~~~ 359 (427)
.++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.. .+..+.+..+.... -++.+.+++.. |
T Consensus 176 ~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~ 252 (285)
T cd06648 176 VGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR-M 252 (285)
T ss_pred cCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcC-CCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH-H
Confidence 68889999999876 6789999999999999999999999843 34444444333321 12345555666 9
Q ss_pred CCCChhHHHHHhHHhcCCchhh
Q 014307 360 IELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 360 l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+..+|..||++.+++.|+|+..
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred cccChhhCcCHHHHccCccccc
Confidence 9999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=287.50 Aligned_cols=236 Identities=27% Similarity=0.494 Sum_probs=189.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||.||+|.+..++..+|||.+... ....+.+|+.+++.+ +|+||+++++++.. ....+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEe--CCeEE
Confidence 4688899999999999999999889999999987531 235678899999999 99999999999876 45788
Q ss_pred EEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
++|||+.+++|..++. .+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccc
Confidence 9999999999876542 478899999999999999999999999999999999999776 89999999987654
Q ss_pred CCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHh--------CChH
Q 014307 281 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVL--------GTDE 350 (427)
Q Consensus 281 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~-~i~~~~--------~~~~ 350 (427)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.....+...+. .+.... -.+.
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 236 (267)
T ss_pred cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence 3322 233468888999999876 6789999999999999999999999954433322222 222111 1134
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+..++.+ |+..+|..||++.+++.
T Consensus 237 ~~~li~~-~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 237 LRQLVNM-CINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHH-hcCCCcccCCCHHHHHH
Confidence 5555555 88899999999886653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=284.95 Aligned_cols=236 Identities=17% Similarity=0.309 Sum_probs=188.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC---CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||.||+|.+..+ ...||||.++... ...+.+|+.+++.+ +||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEec--CCc
Confidence 46799999999999999999998644 4689999986432 34678899999999 99999999999876 556
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.+++|||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .++|+|||++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~ 158 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLED 158 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhcccc
Confidence 899999999999887753 588999999999999999999999999999999999999776 899999999987642
Q ss_pred C-Cccee--eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChH
Q 014307 282 G-KEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDE 350 (427)
Q Consensus 282 ~-~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~ 350 (427)
. ..... ..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ....+....+.+... ++.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDGYRLPPPMDCPSA 236 (266)
T ss_pred cccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 2 11121 233457999999876 678999999999999999998 9999843 333444444433211 234
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+++.. |+..+|..||++.+++.
T Consensus 237 l~~li~~-cl~~~p~~Rp~~~ei~~ 260 (266)
T cd05033 237 LYQLMLD-CWQKDRNERPTFSQIVS 260 (266)
T ss_pred HHHHHHH-HcCCCcccCcCHHHHHH
Confidence 5555555 99999999999888765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=283.61 Aligned_cols=235 Identities=18% Similarity=0.338 Sum_probs=189.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++|+++++||+|+||.||+|.. .+++.||+|.+... ....+.+|+.+++++ +|+||+++++++.. ...+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEE
Confidence 357899999999999999999986 46788999998743 346788999999999 99999999998743 457899
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.++++...+. .+++..+..++.|++.||+|||+.|++||||||+||+++.++ .++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCc
Confidence 99999999876642 478889999999999999999999999999999999999776 899999999976642221
Q ss_pred c--eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 285 Y--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 285 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
. ....++..|+|||++.. ..++.++|||||||++|||++ |+.|| .+.+..+....+.+... ...+.++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPY-PGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred ccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCC-CCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 12244567999999876 678999999999999999998 99998 44555555444443322 2345555
Q ss_pred HHhccCCCChhHHHHHhHHhc
Q 014307 355 LNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+ |+..+|+.||++++++.
T Consensus 236 i~~-~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRL-CWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHH-HccCChhhCCCHHHHHH
Confidence 555 89999999999888764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=280.58 Aligned_cols=238 Identities=24% Similarity=0.484 Sum_probs=196.3
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||.|+||.||++.+..+++.+|+|++... ....+.+|+++++.+ +|+|++++.+.+.. ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~--~~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEE--KGKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEec--CCEEEEE
Confidence 588999999999999999999888999999998642 345688999999999 89999999999876 4678999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+||+++++|...+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccC
Confidence 9999999887664 3488999999999999999999999999999999999999766 8999999999766444
Q ss_pred C-cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-------CChHHHHH
Q 014307 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAY 354 (427)
Q Consensus 283 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~ 354 (427)
. ......++..|+|||.+.+ ..++.++||||+|+++++|++|+.||.. .+..+....+.+.. -...+.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKILKGQYPPIPSQYSSELRNL 234 (258)
T ss_pred cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCC-CcHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 3 2234567888999999876 6789999999999999999999999843 33333333322211 12344445
Q ss_pred HHhccCCCChhHHHHHhHHhcCCch
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
+.. |+..+|+.||++.+++.+|||
T Consensus 235 i~~-~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 235 VSS-LLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHH-HcCCChhhCcCHHHHhcCCCC
Confidence 554 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=290.27 Aligned_cols=237 Identities=22% Similarity=0.354 Sum_probs=186.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|.+.+.||+|+||.||+|.+. .++..+|+|.++... .+.+.+|+.+++++.+|+||+++++++.. .
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI--G 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--C
Confidence 468999999999999999999752 345689999886432 24578999999999679999999999876 4
Q ss_pred CCcEEEEeecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
...+++|||+.+++|..++.. +++.++..++.|++.||.|||+++|+|+||||+|||++.++ .+||+|||+++.
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~dfg~~~~ 190 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARD 190 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEECCCccccc
Confidence 568999999999998776532 78999999999999999999999999999999999999666 899999999976
Q ss_pred ecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHH-Hh-------
Q 014307 279 YHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK-VL------- 346 (427)
Q Consensus 279 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~-~~------- 346 (427)
....... ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||.. ....+....... ..
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPG-MPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCC-CCchHHHHHHHHcCCcCCCCCC
Confidence 5433221 12234567999999876 678999999999999999998 9999843 333333322222 11
Q ss_pred CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 ~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.++.+.+++.+ |+..+|+.||++.+++.
T Consensus 269 ~~~~~~~li~~-cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKT-CWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHH-HcCCCchhCcCHHHHHH
Confidence 12445555555 88999999999888764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=286.65 Aligned_cols=238 Identities=22% Similarity=0.352 Sum_probs=186.3
Q ss_pred eeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHh--cCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l--~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
.||+|+||.||+|++..+++.||+|++.... ......|..+++.+ ..||+|+++++++.. ....++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec--CCEEEEEEec
Confidence 3899999999999998899999999986421 12234444433332 278999999999976 4578899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeec
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~ 289 (427)
+.+++|..++ ..+++..++.++.|++.||.|||+.+|+||||||+||+++.++ .+||+|||++..+... ......
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~-~~~~~~ 156 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASV 156 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc-CCcCcC
Confidence 9999987665 3489999999999999999999999999999999999999776 8999999998755332 223457
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-CHHHHHHHHHHh-------CChHHHHHHHhccCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVL-------GTDELNAYLNKYHIE 361 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~-~~~~l~~i~~~~-------~~~~~~~~l~~~~l~ 361 (427)
|+..|+|||++.+...++.++||||+||++|+|++|+.||..... ............ .++.+..++.+ |+.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~-~l~ 235 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG-LLQ 235 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH-Hhh
Confidence 889999999987545689999999999999999999999954321 112222111110 13455566655 899
Q ss_pred CChhHHH-----HHhHHhcCCchhhHH
Q 014307 362 LDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 362 ~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
.+|..|+ ++.+++.|+||.+..
T Consensus 236 ~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 236 RDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred cCHHhccCCCCCCHHHHHhCccccCCC
Confidence 9999999 999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=286.54 Aligned_cols=235 Identities=19% Similarity=0.349 Sum_probs=191.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..+|+++++||.|+||.||+|.+.. +..+|+|++.... ...+.+|+.+++.+ +|+||+++++++.. ....+++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSV--GEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEec--CCCeEEE
Confidence 4568899999999999999999866 8999999987543 36688999999999 99999999999876 4568899
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVY 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCccc
Confidence 99999999987763 478889999999999999999999999999999999999776 899999999976543221
Q ss_pred c-eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHH
Q 014307 285 Y-NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (427)
Q Consensus 285 ~-~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (427)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.|| .+.+..+.+..+..... ++.+.+++
T Consensus 160 ~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPY-PGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred cccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCC-CcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 1 12234567999999876 678999999999999999998 78888 45555555555544321 23455555
Q ss_pred HhccCCCChhHHHHHhHHhc
Q 014307 356 NKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~ 375 (427)
.. |+..+|..||++.+++.
T Consensus 238 ~~-~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LE-CWAAEPEDRPSFKALRE 256 (261)
T ss_pred HH-HcCCCchhCcCHHHHHH
Confidence 54 89999999999888764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=283.09 Aligned_cols=233 Identities=18% Similarity=0.352 Sum_probs=187.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.++||+|+||.||+|.+. ++..+|+|.++.. ..+.+.+|+.+++++ +|+|++++++++.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEEE
Confidence 467999999999999999999874 6677999998753 346789999999999 99999999998743 4578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.+++|..++. .+++..++.++.|++.||.|||+.||+||||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccc
Confidence 9999999877652 378899999999999999999999999999999999999766 8999999999865433211
Q ss_pred --eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHH
Q 014307 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (427)
Q Consensus 286 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (427)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+..... +..+.+++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMNNREVLEQVERGYRMPCPQDCPISLHELM 236 (260)
T ss_pred cccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 11234456999999876 678999999999999999999 88887 55555555555543211 23445555
Q ss_pred HhccCCCChhHHHHHhHHh
Q 014307 356 NKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll 374 (427)
.+ |+..+|..||++.++.
T Consensus 237 ~~-~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 237 LQ-CWKKDPEERPTFEYLQ 254 (260)
T ss_pred HH-HcccCcccCcCHHHHH
Confidence 55 8999999999887765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=289.72 Aligned_cols=236 Identities=17% Similarity=0.317 Sum_probs=184.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC--------------CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD--------------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKL 194 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~--------------~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l 194 (427)
.++|++.++||+|+||.||+|++..+ ...||+|.++... ...+.+|+++++++ +|+|++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence 46899999999999999999987543 2358999986532 34688999999999 99999999
Q ss_pred eeEEEcCCCCCcEEEEeecCCCchhhhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCce
Q 014307 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYP---------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 259 (427)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 259 (427)
++++.. ....++||||+.+++|..++. .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999975 557899999999999876642 257778899999999999999999999999999999
Q ss_pred EEcCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCC
Q 014307 260 MIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGHD 334 (427)
Q Consensus 260 Ll~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt--g~~pf~~~~~ 334 (427)
+++.++ .+||+|||++......... ....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| ....
T Consensus 161 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~-~~~~ 237 (295)
T cd05097 161 LVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPY-SLLS 237 (295)
T ss_pred EEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCC-cccC
Confidence 999766 7999999999765433221 12234567999999876 679999999999999999988 66677 3334
Q ss_pred CHHHHHHHHHHh--------------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 335 NYDQLVKIAKVL--------------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 335 ~~~~l~~i~~~~--------------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
..+.+..+.+.. .++.+.+++.+ |+..+|..||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 238 DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMR-CWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHH-HcCCCchhCcCHHHHHH
Confidence 344333332211 12445555555 99999999999888753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=284.72 Aligned_cols=281 Identities=25% Similarity=0.436 Sum_probs=223.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----C
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----~ 203 (427)
..+|.-++.+|.|.- .|-.|.+...++.||+|.+.. ...+...+|..++..+ .|+||++++.+|.... .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHHH
Confidence 467888899999998 788888889999999998642 2335678999999999 9999999999997532 2
Q ss_pred CCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
...|+|||+|....-...+-.+.-..+..+..|++.|++|||+.||+||||||+||++..+. .+||.|||+|+.....-
T Consensus 94 ~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGLARTEDTDF 172 (369)
T ss_pred HhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchhhcccCccc
Confidence 34689999999877666666788888999999999999999999999999999999999777 89999999998766555
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCC
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~d 363 (427)
..+..+.+++|+|||++.+. .|...+||||+||++.||++|+..| +|.+..+|..++.+.+|.++.. | +-++.
T Consensus 173 ~mtpyVvtRyyrapevil~~-~~ke~vdiwSvGci~gEli~~~Vlf-~g~d~idQ~~ki~~~lgtpd~~-F----~~qL~ 245 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELILGTVLF-PGKDHIDQWNKIIEQLGTPDPS-F----MKQLQ 245 (369)
T ss_pred ccCchhheeeccCchheecc-CCcccchhhhhhhHHHHHhhceEEe-cCchHHHHHHHHHHHhcCCCHH-H----HHHhh
Confidence 66788999999999999984 5999999999999999999999888 7999999999999999987643 2 22234
Q ss_pred hhHHHHHhHHhcCCchh---hHHHhh----hhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 364 PHLAALVGRLVILSYFF---QFVIYY----YYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 364 p~~r~~~~~ll~~~~~~---~~~~~~----~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
|..|.-.....++..+. .+.... .+.-......+-|+|++||+ .||+.|++++.++.||+
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLv-i~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLV-IDPEKRISVDDALRHPY 312 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhc-cChhhcccHHHHhcCCe
Confidence 44444443222221110 000000 00001224568899999998 99999999999999997
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=287.28 Aligned_cols=235 Identities=17% Similarity=0.294 Sum_probs=182.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCe----EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|++++.||+|+||+||+|.+..+++ .+++|.+.... ...+..|+.+++++ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence 3678999999999999999999877766 47778775322 24567788888888 99999999998743 4
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++++||+.+++|..++. .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccceecc
Confidence 4679999999999887752 478999999999999999999999999999999999999766 89999999998764
Q ss_pred CCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 014307 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (427)
Q Consensus 281 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~ 349 (427)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+.........+.+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPY-AGMRPHEVPDLLEKGERLAQPQICTI 238 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHCCCcCCCCCCCCH
Confidence 3322 122345667999999876 679999999999999999998 99888 33333332222221111 12
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+...++.+ |+..+|..||++.+++.
T Consensus 239 ~~~~li~~-c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 239 DVYMVMVK-CWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 34444444 99999999999888754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=286.57 Aligned_cols=239 Identities=20% Similarity=0.376 Sum_probs=185.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEE----cCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~----~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..+|++++.||+|+||.||+|.. ..++..||+|.++... .+.+.+|+++++.+ +||||+++++++...+...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCCc
Confidence 35789999999999999999974 4578899999986543 34678999999999 9999999999887655667
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
+++||||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~ 160 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQ 160 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCcccccccC
Confidence 899999999999987653 478899999999999999999999999999999999999777 899999999986644
Q ss_pred CCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH--------------HHHHHHH
Q 014307 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--------------DQLVKIA 343 (427)
Q Consensus 282 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~--------------~~l~~i~ 343 (427)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|..++....... ..+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 3321 11123445999999876 678999999999999999999877653221110 0111111
Q ss_pred HHh--------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 344 KVL--------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 344 ~~~--------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.. -.+.+.+++.+ |+..+|+.||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKE-CWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHH-HccCChhhCCCHHHHHH
Confidence 110 02345555555 89999999999888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=288.35 Aligned_cols=235 Identities=20% Similarity=0.314 Sum_probs=186.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.+|.+.+.||+|+||.||+|.+. .++..+++|.++... .+.+.+|+.+++++ +|+||+++++++.. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGD--GDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEcc--CCc
Confidence 56899999999999999999853 345678999986533 35688999999999 99999999999976 456
Q ss_pred cEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC
Q 014307 206 PSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~ 266 (427)
.++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~- 160 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL- 160 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-
Confidence 899999999999877652 267888999999999999999999999999999999999777
Q ss_pred eEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 014307 267 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI 342 (427)
Q Consensus 267 ~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i 342 (427)
.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||.. ....+.+..+
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQ-LSNTEVIECI 238 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHH
Confidence 899999999975543321 122345678999999876 678999999999999999998 9999843 3444444333
Q ss_pred HHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 343 AKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 343 ~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
..... +..+.+++.+ |+..+|..||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLG-CWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHH-HcccChhhCcCHHHHHH
Confidence 32211 2344445555 89999999998887754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=290.20 Aligned_cols=241 Identities=20% Similarity=0.375 Sum_probs=197.8
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
|....+||+|+||.||++....+++.||||.+.. .....+.+|+.+++.+ +|+||+++++.+.. ....+++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEe--CCEEEEEEec
Confidence 3344679999999999999999999999998753 2335688899999999 89999999999976 5678999999
Q ss_pred cCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cceeec
Q 014307 213 VNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRV 289 (427)
Q Consensus 213 ~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~~~~ 289 (427)
+.++++..+. ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++ .++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceecccccccccccc
Confidence 9999987765 3578999999999999999999999999999999999999776 79999999987654322 223456
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHHhccC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNKYHI 360 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~~~l 360 (427)
++..|+|||.+.+ ..++.++|+|||||++|+|++|..||. +.+..+.+..+..... ++.+..++.+ |+
T Consensus 178 ~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l 254 (292)
T cd06657 178 GTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDR-LL 254 (292)
T ss_pred cCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHH-HH
Confidence 7888999998865 678999999999999999999999984 4444444443332221 2445555555 99
Q ss_pred CCChhHHHHHhHHhcCCchhhHH
Q 014307 361 ELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..+|..|+++.+++.|+||.+..
T Consensus 255 ~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 255 VRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred hCCcccCcCHHHHhcChHHhccC
Confidence 99999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=287.72 Aligned_cols=246 Identities=25% Similarity=0.442 Sum_probs=202.2
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
...+.|++.+.||.|++|.||+|.+..++..+++|+++... .+.+.+|+++++.+ +|+|++++++.+.. ....++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLV--GDELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEE--CCEEEE
Confidence 34577999999999999999999998889999999997644 56788999999999 99999999999987 467899
Q ss_pred EEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 209 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
++||+.+++|..++. .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKEKS 171 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccchh
Confidence 999999999887753 588999999999999999999999999999999999999776 89999999986543322
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChHHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDELNAY 354 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~~~~~ 354 (427)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. ..++......+.... -...+..+
T Consensus 172 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYL-REPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 2233457788999999876 678999999999999999999999984 333333333332211 01234444
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.. |+..+|..||++.+++.++|+.+.+
T Consensus 250 i~~-~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 250 LNK-CLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHH-HhccChhhCcCHHHHhhChHhhccC
Confidence 444 9999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.65 Aligned_cols=238 Identities=17% Similarity=0.247 Sum_probs=184.9
Q ss_pred eeeeec--CCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 140 RKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 140 ~~LG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
.+||+| +||+||+|.+..+++.||+|+++... .+.+.+|+.+++.+ +||||++++++|.. ....++++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTT--GSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEec--CCceEEEEec
Confidence 456666 99999999999999999999986422 25678899999888 99999999999987 4568999999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cc-
Q 014307 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY- 285 (427)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~- 285 (427)
+.++++..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .++++|||.+....... ..
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccc
Confidence 99998876653 378899999999999999999999999999999999999776 89999998653221111 00
Q ss_pred ------eeeccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-------------
Q 014307 286 ------NVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------------- 345 (427)
Q Consensus 286 ------~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~------------- 345 (427)
....++..|+|||++.+. ..++.++|||||||++|||++|+.||... ...+.+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM-LRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-ChHHHHHHHhcCCCCCCccccccch
Confidence 111344569999998652 35789999999999999999999998433 222222111100
Q ss_pred ----------------------------------------hCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 346 ----------------------------------------LGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 346 ----------------------------------------~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.-.+.+.+++.+ |+..||+.||++.+++.|+||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVEL-CLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHH-HccCCcccCCCHHHHhhCHHHHHHH
Confidence 011234455555 9999999999999999999999866
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=291.15 Aligned_cols=236 Identities=22% Similarity=0.347 Sum_probs=182.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-------CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
.++|.+.+.||+|+||.||+|++.. +...+|+|.++... ...+.+|+.+++.+.+|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 3689999999999999999998643 23579999987532 24577899999999789999999999976
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEc
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~ 262 (427)
....++||||+.+++|..++. .++..++..++.|++.||+|||++|++||||||+|||++
T Consensus 96 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 96 -DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 456889999999999876652 267788999999999999999999999999999999999
Q ss_pred CCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014307 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (427)
Q Consensus 263 ~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~ 338 (427)
.++ .+||+|||++......... ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+. +.+.
T Consensus 175 ~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~-~~~-~~~~ 250 (307)
T cd05098 175 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGV-PVEE 250 (307)
T ss_pred CCC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC-CcC-CHHH
Confidence 776 8999999999765322111 11223457999999876 678999999999999999998 77777 433 3343
Q ss_pred HHHHHHHh-C-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 339 LVKIAKVL-G-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 339 l~~i~~~~-~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+....... . ...+..++.+ |+..+|..||++.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHH-HcccChhhCcCHHHHHH
Confidence 33322221 1 1344444444 88888888888777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=285.44 Aligned_cols=229 Identities=18% Similarity=0.304 Sum_probs=176.8
Q ss_pred eeeecCCeeEEEEEEcCCCe--EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecC
Q 014307 141 KVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~~~--~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 214 (427)
.||+|+||.||+|.+..++. .+++|.++.. ..+.+.+|+.++.++.+||||+++++++.. ....+++|||+.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeCC
Confidence 58999999999999877765 4688887642 235678899999999789999999999976 456899999999
Q ss_pred CCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 215 NTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 215 ~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
+++|..++. .+++..++.++.|++.||+|||++|++||||||+|||++.++ .+||+|||+
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfgl 158 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGL 158 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCCC
Confidence 999876642 367888999999999999999999999999999999999777 899999999
Q ss_pred eeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 276 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 276 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
+..............+..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~ 236 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPY-CGMTCAELYEKLPQGYRLEKPLNC 236 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-cccCHHHHHHHHhCCCCCCCCCcC
Confidence 853221111112233456999999866 678999999999999999997 99998 33343343433332211
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
..++.+++.+ |+..+|..||++.+++.
T Consensus 237 ~~~~~~li~~-~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 237 DDEVYDLMRQ-CWREKPYERPSFAQILV 263 (270)
T ss_pred CHHHHHHHHH-HcccChhhCCCHHHHHH
Confidence 1344444445 88888888888777654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=291.20 Aligned_cols=237 Identities=20% Similarity=0.328 Sum_probs=186.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-------CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
.++|.+.++||+|+||.||+|.+.. ....+|+|.++... ...+.+|+.+++.+.+||||+++++++..
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ- 89 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-
Confidence 4689999999999999999997532 34579999987432 24578899999998669999999999875
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEc
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~ 262 (427)
....+++|||+.+++|..++. .++..++..++.||+.||.|||++||+||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 90 -EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 456899999999999876652 367788899999999999999999999999999999999
Q ss_pred CCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014307 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (427)
Q Consensus 263 ~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~ 338 (427)
.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+.
T Consensus 169 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~-~~~~~~~~ 245 (314)
T cd05099 169 EDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPY-PGIPVEEL 245 (314)
T ss_pred CCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCC-CCCCHHHH
Confidence 776 8999999999765432211 11223456999999876 679999999999999999999 88888 44444444
Q ss_pred HHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 339 LVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 339 l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...+..... ...+.+++.+ |+..+|..||++.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLREGHRMDKPSNCTHELYMLMRE-CWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 444333211 2345555555 99999999999888774
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=319.47 Aligned_cols=238 Identities=22% Similarity=0.370 Sum_probs=195.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCC-----eEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++.++.+.||+|.||.||.|...... ..||||.++. ....+|.+|..+|+++ +|||||+++|++-+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~-- 766 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD-- 766 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC--
Confidence 4567889999999999999999875433 3499999875 3457799999999999 99999999999987
Q ss_pred CCCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEe
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~D 272 (427)
....++++|||.+|+|..+++ .++..+...++.|||+|+.||+++++|||||.++|+|++... .+||+|
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKIaD 845 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKIAD 845 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEEcc
Confidence 566789999999999988874 278889999999999999999999999999999999999775 899999
Q ss_pred eeeeeeecCCCcceee---ccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh--
Q 014307 273 WGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-- 346 (427)
Q Consensus 273 FGla~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-- 346 (427)
||+|+-+.....+... .-...|||||.+.. +.++.|+|||||||+|||++| |..|| +..++.+.+....+.-
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY-~~~~n~~v~~~~~~ggRL 923 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPY-PSRSNFEVLLDVLEGGRL 923 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCC-CCcchHHHHHHHHhCCcc
Confidence 9999854433322211 12345999999987 799999999999999999998 55565 8888888887555431
Q ss_pred ----CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 ----GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.|+....+...||..+|+.||++..|++
T Consensus 924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 22333334555599999999999999888
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=281.54 Aligned_cols=226 Identities=17% Similarity=0.303 Sum_probs=177.5
Q ss_pred eeeecCCeeEEEEEEc--CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecC
Q 014307 141 KVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 214 (427)
.||+|+||.||+|.+. .++..||+|+++... .+.+.+|+.+++++ +|+||+++++++.. ...++||||+.
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999764 445679999986532 35588999999999 99999999998753 45789999999
Q ss_pred CCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc-e---
Q 014307 215 NTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-N--- 286 (427)
Q Consensus 215 ~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~-~--- 286 (427)
+++|..++. .+++..++.++.||+.||.|||++|++||||||+|||++.++ .+||+|||++......... .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccC
Confidence 999887653 489999999999999999999999999999999999999776 8999999999765433221 1
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHHhc
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (427)
...++..|+|||.+.+ ..++.++|||||||++|||++ |..||. .....+....+.+.. ..+++.+++.+
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 233 (257)
T cd05115 157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYK-KMKGPEVMSFIEQGKRLDCPAECPPEMYALMKD- 233 (257)
T ss_pred CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-
Confidence 1122457999999876 678999999999999999996 999984 444444444333321 13455555555
Q ss_pred cCCCChhHHHHHhHHh
Q 014307 359 HIELDPHLAALVGRLV 374 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll 374 (427)
|+..+|..||++.++.
T Consensus 234 c~~~~~~~Rp~~~~i~ 249 (257)
T cd05115 234 CWIYKWEDRPNFAKVE 249 (257)
T ss_pred HcCCChhhCcCHHHHH
Confidence 8888888888877764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=288.87 Aligned_cols=237 Identities=19% Similarity=0.316 Sum_probs=184.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc-------CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
.++|.+.+.||+|+||.||+|++. .++..||+|.++.. ....+.+|+.+++.+.+||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence 578999999999999999999753 23457999998642 235688999999998789999999999976
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEc
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~ 262 (427)
....+++|||+.+++|..++. .++...+..++.||+.||.|||++||+||||||+|||++
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 93 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 457889999999999876642 256778889999999999999999999999999999999
Q ss_pred CCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014307 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (427)
Q Consensus 263 ~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~ 338 (427)
.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+.
T Consensus 172 ~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~~ 248 (304)
T cd05101 172 ENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEEL 248 (304)
T ss_pred CCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHHH
Confidence 766 8999999999866432221 22234567999999876 679999999999999999998 77777 44443333
Q ss_pred HHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 339 LVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 339 l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...+..... ...+..++.+ |+..+|..||++.+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 249 FKLLKEGHRMDKPANCTNELYMMMRD-CWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHH-HcccChhhCCCHHHHHH
Confidence 333322211 2345555555 88888998888777665
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=287.51 Aligned_cols=234 Identities=17% Similarity=0.327 Sum_probs=182.2
Q ss_pred CEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
+|++.+.||+|+||.||+|.+.. ....+++|.+.... ...+.+|+.+++.+ +||||+++++.+.. ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQ--DGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEec--CCC
Confidence 47788999999999999998643 23578999886432 34688999999999 99999999999876 456
Q ss_pred cEEEEeecCCCchhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCc
Q 014307 206 PSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N 258 (427)
.++++||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 789999999999876542 36778889999999999999999999999999999
Q ss_pred eEEcCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 014307 259 VMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHD 334 (427)
Q Consensus 259 ILl~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~ 334 (427)
||++.++ .+||+|||+++........ ....++..|+|||.+.+ ..++.++|||||||++|||++ |..|| .+..
T Consensus 158 ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~ 234 (290)
T cd05045 158 VLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY-PGIA 234 (290)
T ss_pred EEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCC-CCCC
Confidence 9999766 8999999999765433221 22234567999999876 679999999999999999998 88888 4444
Q ss_pred CHHHHHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 335 NYDQLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 335 ~~~~l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
..+....+.+... ...+.+++.. |+..+|..||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 235 PERLFNLLKTGYRMERPENCSEEMYNLMLT-CWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHHhCCCCCCCCCCCCHHHHHHHHH-HccCCcccCCCHHHHHH
Confidence 3333333322111 2355555555 88888888888777653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=298.52 Aligned_cols=238 Identities=23% Similarity=0.332 Sum_probs=185.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|.+.++||+|+||.||+|++. .++..||+|+++... ...+.+|+.+|.++..||||+++++++..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 4567899999999999999999864 345689999997432 24678899999999449999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC-----------------------------------------------------------
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP----------------------------------------------------------- 223 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------------- 223 (427)
...+++||||+.+++|..++.
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 457899999999999865542
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE
Q 014307 224 ------------------------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (427)
Q Consensus 224 ------------------------------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 261 (427)
.++...+..++.||+.||+|||+.+|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 14556678899999999999999999999999999999
Q ss_pred cCCCCeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014307 262 DHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYD 337 (427)
Q Consensus 262 ~~~~~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~ 337 (427)
+.++ .+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ |+.|| ......+
T Consensus 273 ~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~-~~~~~~~ 349 (401)
T cd05107 273 CEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPY-PELPMNE 349 (401)
T ss_pred eCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCC-CCCCchH
Confidence 9766 899999999986533222 122356678999999876 678999999999999999998 88888 3334444
Q ss_pred HHHHHHH-Hh-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 338 QLVKIAK-VL-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 338 ~l~~i~~-~~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+..... .. -...+.+++.+ |+..+|..||++.+++.
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~-cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQK-CWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 4333222 11 12344455555 88999999998887765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=281.01 Aligned_cols=233 Identities=16% Similarity=0.308 Sum_probs=185.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|++.+.||+|+||.||++.. .+..+|+|.++... .+.+.+|+.+++++ +|+|++++++++... ....+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEEE
Confidence 35789999999999999999976 47889999987533 35688999999999 999999999986543 456799999
Q ss_pred ecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce
Q 014307 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (427)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~ 286 (427)
|+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~--~ 157 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--D 157 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceeccccC--C
Confidence 999999877653 277888999999999999999999999999999999999777 89999999987543322 2
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhc
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKY 358 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~ 358 (427)
...++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. ..+..+....+.+... ++.+.+++.+
T Consensus 158 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~- 234 (256)
T cd05082 158 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQ- 234 (256)
T ss_pred CCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH-
Confidence 2334567999999876 678999999999999999997 898883 3333333333332211 2345555555
Q ss_pred cCCCChhHHHHHhHHhc
Q 014307 359 HIELDPHLAALVGRLVI 375 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~ 375 (427)
|+..+|..||++.+++.
T Consensus 235 ~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 235 CWHLDAATRPSFLQLRE 251 (256)
T ss_pred HhcCChhhCcCHHHHHH
Confidence 89999999999888764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=280.78 Aligned_cols=234 Identities=18% Similarity=0.319 Sum_probs=184.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.++||.|+||.||+|.+..+ ..+|+|.+... ..+.+.+|+.+++.+ +|+|++++++++.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEEE
Confidence 36799999999999999999987544 46899988643 346688999999999 99999999998743 4578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCCccc
Confidence 9999998876653 267888999999999999999999999999999999999776 8999999999866433211
Q ss_pred --eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHH
Q 014307 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (427)
Q Consensus 286 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (427)
....++..|+|||.+.+ ..++.++|||||||++|||++ |+.|| .+..+.+....+..... ...+.+++
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPY-PGMVNREVLEQVERGYRMPCPQGCPESLHELM 236 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 12234567999998876 678999999999999999999 88888 44455555554443321 12344444
Q ss_pred HhccCCCChhHHHHHhHHhc
Q 014307 356 NKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+ |+..+|..||++++++.
T Consensus 237 ~~-~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KL-CWKKDPDERPTFEYIQS 255 (260)
T ss_pred HH-HccCCcccCcCHHHHHH
Confidence 44 88999999998777653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=287.45 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=193.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
+.|...++||+|+||+||+|.+..+++.|++|++... ....+.+|+.+++.+ +|||++++++++.+ ....+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 97 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLK--EHTAW 97 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEE
Confidence 3477788899999999999999899999999998632 124577899999999 99999999999977 45678
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
++|||+.+..+..+. ..+++.++..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++.... .
T Consensus 98 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~---~ 173 (313)
T cd06633 98 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS---P 173 (313)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC---C
Confidence 999999765443332 3588899999999999999999999999999999999999776 89999999986432 2
Q ss_pred ceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChHHHHH
Q 014307 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAY 354 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~~~~~ 354 (427)
.....++..|+|||++.. ...++.++|||||||++|+|++|..||.. .+....+..+..... ...+..+
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 252 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNDSPTLQSNEWTDSFRGF 252 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 334578889999999742 25688899999999999999999999844 344444443332211 1245555
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+ |+..+|..||++.+++.|+||....
T Consensus 253 i~~-~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 253 VDY-CLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHH-HccCChhhCcCHHHHhcCcccCCCc
Confidence 555 9999999999999999999998744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=287.14 Aligned_cols=236 Identities=17% Similarity=0.320 Sum_probs=188.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCC----------------eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN----------------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIV 192 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----------------~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv 192 (427)
.++|+++++||+|+||.||+|.+...+ ..||+|.+... ..+.+.+|+++++++ +||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCEe
Confidence 467999999999999999999876543 56899998643 245678899999999 999999
Q ss_pred eeeeEEEcCCCCCcEEEEeecCCCchhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCc
Q 014307 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258 (427)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N 258 (427)
++++++.. ....+++||++.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTV--DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEec--CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 99999976 467899999999998876652 47888999999999999999999999999999999
Q ss_pred eEEcCCCCeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 014307 259 VMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGH 333 (427)
Q Consensus 259 ILl~~~~~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt--g~~pf~~~~ 333 (427)
|+++.++ .++|+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|||++ +..|| ...
T Consensus 161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~-~~~ 237 (296)
T cd05051 161 CLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPY-EHL 237 (296)
T ss_pred eeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCC-CCc
Confidence 9999776 899999999976543321 122345667999999876 679999999999999999998 67777 333
Q ss_pred CCHHHHHHHHHHh-------------C-ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 334 DNYDQLVKIAKVL-------------G-TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 334 ~~~~~l~~i~~~~-------------~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...+.+..+.... . ++++.+++.. |+..+|..||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE-CWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHH-HhccChhcCCCHHHHHH
Confidence 4444444433321 0 2355565555 99999999999988753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=285.61 Aligned_cols=236 Identities=17% Similarity=0.322 Sum_probs=186.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..+|.+.++||+|+||.||+|... .++..+|+|.++... ...+.+|+++++.+ +|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTE--GR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEec--CC
Confidence 356888999999999999999742 356789999886433 35688999999999 99999999999876 45
Q ss_pred CcEEEEeecCCCchhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC
Q 014307 205 TPSLIFEHVNNTDFKVLYP------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~ 266 (427)
..+++|||+.+++|..++. .+++..+..++.||+.||+|||++|++||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~- 159 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL- 159 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC-
Confidence 6789999999999876642 367888999999999999999999999999999999999766
Q ss_pred eEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHH
Q 014307 267 KLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI 342 (427)
Q Consensus 267 ~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i 342 (427)
.+||+|||++......... ....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. .....+.+..+
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~ 237 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWY-QLSNTEAIECI 237 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCc-cCCHHHHHHHH
Confidence 8999999999765433221 12234567999999876 678999999999999999998 888883 34444444444
Q ss_pred HHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 343 AKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 343 ~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+... ++.+.+++ ..|+..||..||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li-~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 238 TQGRELERPRTCPPEVYAIM-QGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HcCccCCCCCCCCHHHHHHH-HHHccCChhhCCCHHHHHH
Confidence 33211 24444444 4499999999999888764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=283.39 Aligned_cols=236 Identities=18% Similarity=0.321 Sum_probs=186.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCC---eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||.||+|.++.++ ..+|+|.++.. ..+.+.+|+.+++++ +||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCc
Confidence 357899999999999999999876444 37999988642 235688999999999 99999999999875 457
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.+++|||+.+++|..++. .++..++..++.|++.||.|||++|++||||||+|||++.++ .++|+|||++..+..
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCccccccc
Confidence 899999999999877753 478889999999999999999999999999999999999776 899999999987644
Q ss_pred CCcce----eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 014307 282 GKEYN----VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (427)
Q Consensus 282 ~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~ 349 (427)
..... ...++..|+|||.+.+ ..++.++|||||||++||+++ |..||. .....+....+.+... ++
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-EMSNQDVIKAIEEGYRLPAPMDCPA 236 (267)
T ss_pred ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcc-cCCHHHHHHHHhCCCcCCCCCCCCH
Confidence 32211 1122456999999876 679999999999999999886 999984 3344444444443321 23
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+++.+ |+..+|..||++.+++.
T Consensus 237 ~~~~li~~-~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 237 ALHQLMLD-CWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHHH-HcccCchhCCCHHHHHH
Confidence 44455555 88888888888777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=285.90 Aligned_cols=237 Identities=35% Similarity=0.625 Sum_probs=194.9
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
|++.+.||+|++|.||+|.+..+++.+|+|++.... .+.+.+|+.+++.+ +|+|++++++++.+ ....++|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHT--ERKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhc--CCceEEEe
Confidence 567788999999999999999899999999987532 25677899999999 89999999999876 46789999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cc
Q 014307 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (427)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~ 285 (427)
||+.+ ++..++ ..+++..+..++.|++.||.|||++||+||||+|+||+++.++ .+||+|||++....... ..
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCcccc
Confidence 99986 565554 2588999999999999999999999999999999999999776 89999999997654332 23
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------------------
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------------ 347 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------------------ 347 (427)
....++..|+|||.+.+...++.++|||||||++|||++|+.|| ...+..+.+..+.+.++
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence 34456778999999876448899999999999999999998888 55555555444443222
Q ss_pred -----------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 -----------------TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 -----------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
...+.+++.. |+..+|..||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSK-MLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHH-hhccCcccCCCHHHHhhCcCC
Confidence 2344555555 999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=286.54 Aligned_cols=240 Identities=32% Similarity=0.545 Sum_probs=196.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++++.+|+||+++++++.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 4689999999999999999999889999999998642 235678899999999339999999999865 55789
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
++||++.+++|...+. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccc
Confidence 9999999999876663 589999999999999999999999999999999999999777 79999999987654322
Q ss_pred --------------------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014307 284 --------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343 (427)
Q Consensus 284 --------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~ 343 (427)
......++..|+|||.+.+ ..++.++||||||+++++|++|+.||. ..+.......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~ 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFR-GSNEYLTFQKIL 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCC-CccHHHHHHHHH
Confidence 1123356788999999876 678999999999999999999999994 333333333333
Q ss_pred HHhC------ChHHHHHHHhccCCCChhHHHHH----hHHhcCCch
Q 014307 344 KVLG------TDELNAYLNKYHIELDPHLAALV----GRLVILSYF 379 (427)
Q Consensus 344 ~~~~------~~~~~~~l~~~~l~~dp~~r~~~----~~ll~~~~~ 379 (427)
.... ++.+..++.. |+..+|..||++ ++++.|+||
T Consensus 236 ~~~~~~~~~~~~~~~~li~~-~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 236 KLEYSFPPNFPPDAKDLIEK-LLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred hcCCCCCCccCHHHHHHHHH-HhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2211 2355566666 999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=282.71 Aligned_cols=235 Identities=18% Similarity=0.344 Sum_probs=185.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCe---EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.+|++.+.||+|+||.||+|.+..++. .||||+++.. ....+..|+.+++.+ +||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~ 80 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SRPV 80 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECC--CCce
Confidence 468999999999999999999876654 6999998643 235688999999999 99999999999865 5568
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+++|||+.+++|..++. .+++.+++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCccccccccC
Confidence 89999999999876653 478899999999999999999999999999999999999766 8999999998765433
Q ss_pred Ccc---eeecc---CccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 014307 283 KEY---NVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (427)
Q Consensus 283 ~~~---~~~~~---~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~ 348 (427)
... ....+ +..|+|||.+.+ ..++.++|||||||++|||++ |..||. ..+..+....+..... +
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~~ 237 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMSNQDVINAIEQDYRLPPPMDCP 237 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCC-CCCHHHHHHHHHcCCcCCCcccCC
Confidence 221 11111 346999999876 688999999999999999886 999984 3444444444432211 1
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+.+++.. |+..+|..||++.+++.
T Consensus 238 ~~~~~li~~-~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 238 TALHQLMLD-CWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 244444555 89999999999888764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=282.24 Aligned_cols=232 Identities=24% Similarity=0.429 Sum_probs=179.5
Q ss_pred EEEeeeeecCCeeEEEEEEc----CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 137 EVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 137 ~~~~~LG~G~fg~V~~~~~~----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++.+.||.|.||.||+|.+. ..+..|+||+++.. ..+.+.+|+++++++ +||||++++|++.. ....++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~--~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIE--NEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEES--SSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-cccccccccccccc--cccccc
Confidence 46789999999999999987 45688999999642 246789999999999 99999999999984 445889
Q ss_pred EEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
|+||+.+++|..++ ..+++..+..++.||+.||.|||+++++|+||+++|||++.++ .+||+|||++.......
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence 99999999987654 2588999999999999999999999999999999999999777 99999999998763222
Q ss_pred cc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHH
Q 014307 284 EY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELN 352 (427)
Q Consensus 284 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~ 352 (427)
.. ........|+|||.+.+ ..++.++||||||+++|||++ |+.|| ...+..+....+.+... +..+.
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPF-SDYDNEEIIEKLKQGQRLPIPDNCPKDIY 235 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTT-TTSCHHHHHHHHHTTEETTSBTTSBHHHH
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccc-cccccccccccccccccceeccchhHHHH
Confidence 21 22345567999999876 568999999999999999999 67887 44455554555533221 23444
Q ss_pred HHHHhccCCCChhHHHHHhHHhc
Q 014307 353 AYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+ ...|+..+|..||++.+++.
T Consensus 236 ~l-i~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 236 SL-IQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HH-HHHHT-SSGGGS--HHHHHH
T ss_pred HH-HHHHcCCChhhCcCHHHHHh
Confidence 44 44499999999999998864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=280.60 Aligned_cols=226 Identities=17% Similarity=0.313 Sum_probs=179.0
Q ss_pred eeeecCCeeEEEEEE--cCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 141 KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+||+|+||.||+|.+ ..++..+|+|+++... .+.+.+|+.+++.+ +|+||+++++++.. ...++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence 589999999999965 4567899999986432 35688999999999 99999999998753 3568999999
Q ss_pred CCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc----e
Q 014307 214 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----N 286 (427)
Q Consensus 214 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~----~ 286 (427)
.+++|..++ ..+++..+..++.|++.||+|||++||+||||||.||+++.++ .+||+|||++......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecC
Confidence 999887665 3589999999999999999999999999999999999999766 8999999999765433221 1
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHHhc
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (427)
...++..|+|||.+.. ..++.++|||||||++|||++ |..|| ......+....+.+.. ..+++.+++..
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~- 233 (257)
T cd05116 157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-KGMKGNEVTQMIESGERMECPQRCPPEMYDLMKL- 233 (257)
T ss_pred CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-
Confidence 1223467999999865 678999999999999999998 89888 4444444444444321 12455555555
Q ss_pred cCCCChhHHHHHhHHh
Q 014307 359 HIELDPHLAALVGRLV 374 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll 374 (427)
|+..||..||++..+.
T Consensus 234 ~~~~~p~~Rp~~~~i~ 249 (257)
T cd05116 234 CWTYGVDERPGFAVVE 249 (257)
T ss_pred HhccCchhCcCHHHHH
Confidence 8899999999887764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=279.82 Aligned_cols=235 Identities=19% Similarity=0.351 Sum_probs=190.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++|++.+.||.|+||.||+|.+. ++..+|||.+.. ...+.+.+|+.+++++ +|+||+++++++.. ....+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE--EEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeec--CCceEEE
Confidence 3578999999999999999999974 567899999874 3346789999999999 89999999999875 4568999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.+++|..++. .++...+..++.|++.||.|||++|++|+||||+||+++.++ .+||+|||++..+.....
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEY 158 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccchhh
Confidence 99999999877753 478899999999999999999999999999999999999776 899999999986643211
Q ss_pred c--eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 285 Y--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 285 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.|| .+.+....+..+..... +..+.++
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPY-PGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 12233457999999876 678999999999999999998 89888 55555566666554322 2345555
Q ss_pred HHhccCCCChhHHHHHhHHh
Q 014307 355 LNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll 374 (427)
+.+ |+..+|..||+++++.
T Consensus 237 i~~-~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 237 MLQ-CWDKDPEERPTFEYLQ 255 (261)
T ss_pred HHH-HcccCcccCCCHHHHH
Confidence 555 8899999999887765
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=305.12 Aligned_cols=271 Identities=20% Similarity=0.389 Sum_probs=225.8
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEc---CCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRD---QQSKT 205 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~---~~~~~ 205 (427)
...+.|++.+.||.|.+|.||+++++.+++.+|+|++... ..++++.|.+||+.++.|||++.++++|.- ..+..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 3467899999999999999999999999999999998753 347788899999999999999999999873 34567
Q ss_pred cEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
++||||||.+|+..++.+ ++.|..+.+|++.++.||.+||...++|||||-.|||++.++ .|||+|||++....
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLD 174 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeeeeeee
Confidence 899999999999877764 588999999999999999999999999999999999999888 89999999987765
Q ss_pred CC-CcceeeccCccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------
Q 014307 281 PG-KEYNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------- 347 (427)
Q Consensus 281 ~~-~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------- 347 (427)
.. ...++.+||++|||||++.+. ..|+..+|+||||++..||--|.+|+. +..+...+..|.+..-
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~-DmHPmraLF~IpRNPPPkLkrp~k 253 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLIPRNPPPKLKRPKK 253 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc-CcchhhhhccCCCCCCccccchhh
Confidence 33 456788999999999999763 357889999999999999999999984 4445555555443321
Q ss_pred -ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhh
Q 014307 348 -TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMV 414 (427)
Q Consensus 348 -~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~ 414 (427)
+..+..||.. |+..|-+.||+..++|.|||..+.. ..+.....|+.++ +.+++.+.
T Consensus 254 Ws~~FndFIs~-cL~Kd~e~RP~~~~ll~hpFi~e~~---------~e~qir~~ik~~~-~~~r~~k~ 310 (953)
T KOG0587|consen 254 WSKKFNDFIST-CLVKDYEQRPSTEELLKHPFITEQP---------NERQVRIQIKDHI-DRSRKKRG 310 (953)
T ss_pred HHHHHHHHHHH-HHhhccccCcchhhhccCCcccccc---------cHHHHHHHHHHHH-hhccchhh
Confidence 2466677777 9999999999999999999998633 5666667778888 57775543
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=283.39 Aligned_cols=238 Identities=21% Similarity=0.377 Sum_probs=188.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcC----CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~----~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|++.+.||+|+||.||+|.+.. ++..|++|.++.. ..+.+.+|+.+++.+ +|+||+++++++... .
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~-~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIED-G 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecC-C
Confidence 35789999999999999999999865 3688999988643 235578899999999 999999999987754 4
Q ss_pred CCcEEEEeecCCCchhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEe
Q 014307 204 KTPSLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 272 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~D 272 (427)
...++++||+.++++..++. .+++..+..++.|++.||+|||+++++||||||+||+++.++ .+||+|
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kl~d 160 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVKITD 160 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEEECC
Confidence 56789999999998876642 378889999999999999999999999999999999999776 899999
Q ss_pred eeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-
Q 014307 273 WGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG- 347 (427)
Q Consensus 273 FGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~- 347 (427)
||+++.+...... ....++..|+|||++.+ ..++.++|||||||++||+++ |+.||. ..+..+....+.....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~ 238 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYV-EIDPFEMAAYLKDGYRL 238 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcC-cCCHHHHHHHHHcCCCC
Confidence 9999865433221 12234566999999876 678999999999999999998 999984 3344443333332211
Q ss_pred ------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 ------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 ------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+.+++.. |+..+|+.||++.+++.
T Consensus 239 ~~~~~~~~~~~~li~~-~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 AQPINCPDELFAVMAC-CWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCcCCHHHHHHHHH-HcCCChhhCCCHHHHHH
Confidence 2345555555 88999999998888764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=300.52 Aligned_cols=249 Identities=22% Similarity=0.398 Sum_probs=198.8
Q ss_pred ccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 129 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
...+..-|..++.||-|+||+|.+++...|...+|+|.+++.+ ...++.|-.||... +++-||+||-.|.+
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQD-- 700 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD-- 700 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEecc--
Confidence 3345566999999999999999999998999999999987532 24467899999998 99999999999976
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
...+|+||+|+.||++..++ .-|.|..++.++.++..|+++.|..|+|||||||+|||||.+| .|||+||||+.-+
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGF 779 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeeccccccc
Confidence 56799999999999987665 4589999999999999999999999999999999999999888 8999999998432
Q ss_pred ---------cCCCc-----------c-----------------------eeeccCccccccccccCCCCCCchhhHHHHH
Q 014307 280 ---------HPGKE-----------Y-----------------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316 (427)
Q Consensus 280 ---------~~~~~-----------~-----------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlG 316 (427)
..+.. + ...+||+.|+|||++.. ..|+..+|+||.|
T Consensus 780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVG 858 (1034)
T ss_pred eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhh
Confidence 11100 0 11379999999999987 7899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCHHHHHHHH---HHhC-------ChHHHHHHHhccCCCChhHH-HHHhHHhcCCchhhHH
Q 014307 317 CMFAGMIFRKEPFFYGHDNYDQLVKIA---KVLG-------TDELNAYLNKYHIELDPHLA-ALVGRLVILSYFFQFV 383 (427)
Q Consensus 317 vll~elltg~~pf~~~~~~~~~l~~i~---~~~~-------~~~~~~~l~~~~l~~dp~~r-~~~~~ll~~~~~~~~~ 383 (427)
||||||+.|+.||. ...+.+.-.+++ +.+. +++...+|.+.|...|..+- .-.+++-.||||+.+.
T Consensus 859 vil~em~~g~~pf~-~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFL-ADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred HHHHHHhhCCCCcc-CCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccc
Confidence 99999999999994 334433333222 2222 35566677777776665553 3455699999999855
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=328.81 Aligned_cols=243 Identities=23% Similarity=0.396 Sum_probs=202.0
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
-+++-..+||.|.||.||.|.+..+|...|+|-++-+. .+.+.+|..+|..+ +|||+|++||+=... ...+|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHR--ekv~I 1311 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHR--EKVYI 1311 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecH--HHHHH
Confidence 45677789999999999999999999999999876322 24578999999999 999999999987663 34668
Q ss_pred EEeecCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--
Q 014307 209 IFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-- 283 (427)
-||||++|+|..+.+. .++...+.+..|++.|+.|||++|||||||||+||+++.+| .+|++|||.|..+....
T Consensus 1312 FMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhc
Confidence 8999999999888753 56667788999999999999999999999999999999888 89999999998876542
Q ss_pred ---cceeeccCccccccccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-------hHH
Q 014307 284 ---EYNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------DEL 351 (427)
Q Consensus 284 ---~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~-------~~~ 351 (427)
+.....||+.|||||++.+.+ ...-+.|||||||++.||+||+.||..-+++...+..+...-.+ +.-
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g 1470 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEG 1470 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhH
Confidence 345568999999999997633 45678999999999999999999997666676666665543221 233
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
.+||.. |++.||..|-++.+|+.|.|-+.
T Consensus 1471 ~dFle~-Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1471 RDFLEH-CLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHH-HHhcCchhhhHHHHHHHhhcccc
Confidence 456666 99999999999999999988553
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=290.98 Aligned_cols=232 Identities=20% Similarity=0.259 Sum_probs=180.0
Q ss_pred CCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhh
Q 014307 146 KYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220 (427)
Q Consensus 146 ~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~ 220 (427)
++|.||.++...+++.||||+++.. ..+.+.+|+.+++.+ +|+||+++++++.+ ....+++|||+.++++..
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIV--DSELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeec--CCeEEEEEeccCCCCHHH
Confidence 4455666666679999999998643 235688999999999 89999999999976 456799999999999876
Q ss_pred hcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc--------cee
Q 014307 221 LYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--------YNV 287 (427)
Q Consensus 221 ~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~--------~~~ 287 (427)
++. .+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+........ ...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccccccccccc
Confidence 653 478899999999999999999999999999999999999776 899999999865532211 123
Q ss_pred eccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------------------
Q 014307 288 RVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------------------- 346 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------------------- 346 (427)
..++..|+|||++.+. ..++.++|||||||++|||++|+.||.........+..+....
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSR 247 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccc
Confidence 3566779999998652 3588999999999999999999999954322222111111000
Q ss_pred -------------------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 347 -------------------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 347 -------------------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
-.+.+..++.. |+..||+.||++++++.||||...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 248 SSNEHPNNRDSVDHPYTRTFSEHFHQFVEL-CLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred ccccccchhhhhhcchhhHHHHHHHHHHHH-HhhcCCCcCcCHHHHhcCchHhhh
Confidence 01233444555 999999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=279.14 Aligned_cols=232 Identities=19% Similarity=0.337 Sum_probs=187.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.+.||.|+||.||+|.. .++.||+|.++... .+.+.+|+.+++.+ +|+||+++++++.+ ....++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEEE
Confidence 46788999999999999999986 47899999997543 46788999999999 89999999999876 56788999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.+++|..++. .+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccccc--
Confidence 9999999887753 478999999999999999999999999999999999999777 89999999998653222
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHh
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNK 357 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~ 357 (427)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||. .....+....+.+... ++.+.+++.+
T Consensus 157 ~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 234 (256)
T cd05039 157 DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKD 234 (256)
T ss_pred ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHH
Confidence 22334556999999876 678999999999999999997 998883 3333333333322211 2455566666
Q ss_pred ccCCCChhHHHHHhHHhc
Q 014307 358 YHIELDPHLAALVGRLVI 375 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~ 375 (427)
|+..+|..||++.+++.
T Consensus 235 -~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 235 -CWELDPAKRPTFKQLRE 251 (256)
T ss_pred -HhccChhhCcCHHHHHH
Confidence 99999999999888764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=276.86 Aligned_cols=238 Identities=26% Similarity=0.503 Sum_probs=198.0
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.+.||+|++|.||+|.+..+++.+++|.+.... .+.+.+|++++.++ +|+|++++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIET--SDSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEe--CCEEEEE
Confidence 4889999999999999999998899999999986432 35688999999999 99999999999876 4678999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-c
Q 014307 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~ 285 (427)
|||+.+++|..+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .++|+|||++........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcccc
Confidence 99999999887653 589999999999999999999999999999999999999766 899999999987654432 2
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHHhc
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKY 358 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~ 358 (427)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.. .++...+..+.... ..+.+..++..
T Consensus 157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~- 233 (254)
T cd06627 157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYD-LNPMAALFRIVQDDHPPLPEGISPELKDFLMQ- 233 (254)
T ss_pred cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHhccCCCCCCCCCCHHHHHHHHH-
Confidence 34567888999999876 4588999999999999999999999943 33333333332111 12455566666
Q ss_pred cCCCChhHHHHHhHHhcCCch
Q 014307 359 HIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~ 379 (427)
|+..+|+.||++.+++.++||
T Consensus 234 ~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 234 CFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHhCChhhCcCHHHHhcCCCC
Confidence 899999999999999999996
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=284.84 Aligned_cols=229 Identities=16% Similarity=0.268 Sum_probs=179.3
Q ss_pred eeeeecCCeeEEEEEEcCCCe-------EEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 140 RKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~-------~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+.||+|+||.||+|.+...+. .+|+|.+.... .+.+.+|+.+++.+ +||||+++++++.. ....++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVC--GDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEe--CCCcEEE
Confidence 358999999999998865544 38888876432 25678899999998 99999999999976 4567899
Q ss_pred EeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCe-------EEEEeeeeeee
Q 014307 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-------LRLIDWGLAEF 278 (427)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~-------ikl~DFGla~~ 278 (427)
|||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++.. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999977763 37888899999999999999999999999999999999866532 79999999865
Q ss_pred ecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-----ChHHHH
Q 014307 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-----TDELNA 353 (427)
Q Consensus 279 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-----~~~~~~ 353 (427)
.... ....++..|+|||++.+...++.++|||||||++|||++|..+++...+............. ..++.+
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELAN 234 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHH
Confidence 4322 23467788999999876456899999999999999999996555454444443332221111 134555
Q ss_pred HHHhccCCCChhHHHHHhHHhc
Q 014307 354 YLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+ |+..+|+.||++++++.
T Consensus 235 li~~-~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 235 LINQ-CMDYEPDFRPSFRAIIR 255 (258)
T ss_pred HHHH-HhccChhhCCCHHHHHH
Confidence 5666 99999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=285.47 Aligned_cols=238 Identities=24% Similarity=0.381 Sum_probs=185.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEE----cCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..|+++++||+|+||.||+|.. ..++..||+|.++... ...+.+|+.+++.+ +||||+++++++...+...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCCc
Confidence 4578999999999999999974 4568899999986432 35688999999999 9999999999998765567
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.+++|||+.+++|..++. .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||++..+..
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~ 161 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIET 161 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCcccccccc
Confidence 899999999999987753 478899999999999999999999999999999999999776 899999999986644
Q ss_pred CCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-------------CHHHHHHHHH
Q 014307 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-------------NYDQLVKIAK 344 (427)
Q Consensus 282 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~-------------~~~~l~~i~~ 344 (427)
.... ....++..|+|||++.+ ..++.++|||||||++|||++++.|+..... ..........
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence 3221 22345667999999876 6789999999999999999998776532111 1111111111
Q ss_pred -Hh-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 345 -VL-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 345 -~~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.. -++.+.+++.. |+..+|..||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 241 EGKRLPRPPNCPEEVYQLMRK-CWEFQPSKRTTFQNLIE 278 (284)
T ss_pred cCccCCCCCCCCHHHHHHHHH-HccCCcccCcCHHHHHH
Confidence 00 02344455555 88888999988888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=287.15 Aligned_cols=236 Identities=18% Similarity=0.326 Sum_probs=182.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC----------------CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV 192 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~----------------~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv 192 (427)
.++|++.++||+|+||.||++.+.. ++..+|+|+++... ...+.+|+.+++.+ +|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence 4679999999999999999986432 34578999987432 35688999999999 999999
Q ss_pred eeeeEEEcCCCCCcEEEEeecCCCchhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCc
Q 014307 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258 (427)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N 258 (427)
++++++.. ....+++|||+.+++|..++. .+++..+..++.|++.||+|||++|++||||||+|
T Consensus 83 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 99999876 456899999999999876653 25567899999999999999999999999999999
Q ss_pred eEEcCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCC
Q 014307 259 VMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGH 333 (427)
Q Consensus 259 ILl~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt--g~~pf~~~~ 333 (427)
||++.++ .++|+|||++..+...... ....++..|+|||+..+ ..++.++|||||||++|||++ |..||. ..
T Consensus 161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~-~~ 237 (296)
T cd05095 161 CLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYS-QL 237 (296)
T ss_pred EEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcc-cc
Confidence 9999766 8999999999765433211 11233567999998776 679999999999999999998 778883 33
Q ss_pred CCHHHHHHHHHHh--------------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 334 DNYDQLVKIAKVL--------------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 334 ~~~~~l~~i~~~~--------------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...+.+....+.. -.+.+.+++.. |+..||..||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLS-CWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHH-HcCCCcccCCCHHHHHH
Confidence 3333333221110 01344444444 99999999999888754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.93 Aligned_cols=236 Identities=18% Similarity=0.337 Sum_probs=186.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCe---EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|+..+.||+|+||.||+|+++.+++ .+|+|.++.. ..+.+.+|+++++.+ +|+||+++.+++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 80 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTK--FKP 80 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEcc--CCC
Confidence 3578899999999999999999876554 7999998643 235688999999999 99999999999976 456
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.++||||+.+++|..++. .+++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~ 159 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLED 159 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceeccc
Confidence 889999999999877652 478899999999999999999999999999999999999766 899999999976643
Q ss_pred CCcce--e--eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 014307 282 GKEYN--V--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (427)
Q Consensus 282 ~~~~~--~--~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~ 349 (427)
..... . ...+..|+|||++.+ ..++.++|||||||++|||++ |+.||. ..+..+....+..... ..
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~~~ 237 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYW-DMSNHEVMKAINDGFRLPAPMDCPS 237 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCC-cCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 22111 1 122346999999876 678999999999999999997 999984 3344444444443222 23
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...+++.. |+..+|..||++.+++.
T Consensus 238 ~~~~li~~-c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 238 AVYQLMLQ-CWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 44455555 88999999998887763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=287.54 Aligned_cols=266 Identities=17% Similarity=0.299 Sum_probs=199.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCe----EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|++.+.||+|+||.||+|.+..++. .+|+|.+.... ...+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~-- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP-- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC--
Confidence 34678999999999999999999877775 57888876432 23578899999999 999999999998642
Q ss_pred CCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
..++++||+.++++..... .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~ 159 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLL 159 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEccccccccc
Confidence 3578999999998876653 478889999999999999999999999999999999998766 7999999999866
Q ss_pred cCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC--------
Q 014307 280 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------- 347 (427)
Q Consensus 280 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------- 347 (427)
...... ....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||. +. .......+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~-~~-~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYD-GI-PTREIPDLLEKGERLPQPPIC 236 (303)
T ss_pred cCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCC-CC-CHHHHHHHHHCCCCCCCCCCC
Confidence 433221 12234567999999876 679999999999999999997 888883 32 2333333333211
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..++..++.. |+..+|+.||++.+++.. +. +...+. ++++ ...|+.+..+..+..+||
T Consensus 237 ~~~~~~li~~-c~~~~p~~Rp~~~~l~~~--l~--------------~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~ 294 (303)
T cd05110 237 TIDVYMVMVK-CWMIDADSRPKFKELAAE--FS--------------RMARDP-QRYL-VIQGDDRMKLPSPNDSKF 294 (303)
T ss_pred CHHHHHHHHH-HcCCChhhCcCHHHHHHH--HH--------------HHHhch-hhhe-eeccCCcCCCCCCchhhH
Confidence 2344455555 899999999999887662 11 112222 3444 366777766666665554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=282.75 Aligned_cols=233 Identities=28% Similarity=0.467 Sum_probs=191.4
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
||.|+||.||+|++..+++.+++|++... ..+.+.+|+++++++ +|+||+++++.+.. ....++++||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheec--CcEEEEEEecCCC
Confidence 68999999999999888999999998643 235678899999999 89999999998875 5678999999999
Q ss_pred Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC---------
Q 014307 216 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------- 283 (427)
Q Consensus 216 ~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~--------- 283 (427)
++|..++ ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccc
Confidence 9987665 3589999999999999999999999999999999999999877 89999999987543331
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-h-------CChHHHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-L-------GTDELNAYL 355 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~-~-------~~~~~~~~l 355 (427)
......++..|+|||.+.+ ..++.++||||||+++|+|++|..||. .....+....+... . ..+.+.+++
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFH-GETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcCCcCCCccccCCHHHHHHH
Confidence 1233467778999999876 568899999999999999999999994 33333333333221 0 034556666
Q ss_pred HhccCCCChhHHHHH---hHHhcCCchhh
Q 014307 356 NKYHIELDPHLAALV---GRLVILSYFFQ 381 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~---~~ll~~~~~~~ 381 (427)
.+ |+..+|..||++ .+++.++||.+
T Consensus 235 ~~-~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 235 SK-LLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HH-HhcCCHhhcCCCccHHHHhcCccccC
Confidence 66 899999999999 99999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=285.36 Aligned_cols=237 Identities=19% Similarity=0.313 Sum_probs=186.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.++||+|+||.||+|.+.. ++..+|+|++.... .+.+.+|+.+++.+ +||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~-- 79 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAV-- 79 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcC--
Confidence 35789999999999999999998743 67899999986432 35688899999999 99999999999876
Q ss_pred CCCcEEEEeecCCCchhhhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP-------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 257 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~ 257 (427)
....+++|||+.+++|..++. .+++..++.++.|++.||.|||++|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 456899999999998876653 2577788999999999999999999999999999
Q ss_pred ceEEcCCCCeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 014307 258 NVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGH 333 (427)
Q Consensus 258 NILl~~~~~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~ 333 (427)
||+++.++ .++|+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|||++ |..||. +.
T Consensus 160 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~-~~ 236 (288)
T cd05050 160 NCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYY-GM 236 (288)
T ss_pred heEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CC
Confidence 99999777 899999999875533221 112234556999999876 679999999999999999997 878884 33
Q ss_pred CCHHHHHHHHHHh-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 334 DNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 334 ~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...+....+.+.. -...+.+++.+ |+..+|..||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 237 AHEEVIYYVRDGNVLSCPDNCPLELYNLMRL-CWSKLPSDRPSFASINR 284 (288)
T ss_pred CHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH-HcccCcccCCCHHHHHH
Confidence 3333333332221 12345555555 99999999999888764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=280.31 Aligned_cols=237 Identities=22% Similarity=0.434 Sum_probs=195.6
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|++.++||.|+||.||++.+..+++.+|+|.+... ....+.+|+.+++.+ +|+||+++++++.+ ....++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLD--GNKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhcc--CCEEEEE
Confidence 488999999999999999999999999999998642 234577899999999 89999999999876 4678999
Q ss_pred EeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 210 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 210 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+||+.++++..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .+||+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC
Confidence 9999999987665 2478889999999999999999999999999999999999766 8999999999766544
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (427)
......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||. ..+..+....+..... ..++..++
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 233 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI 233 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcCCCCCCchhhCHHHHHHH
Confidence 3334567888999999876 678999999999999999999999994 3343333333322211 23455555
Q ss_pred HhccCCCChhHHHHHhHHhcCCch
Q 014307 356 NKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+ |+..+|..||++.+++.||++
T Consensus 234 ~~-~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 234 RS-MLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HH-HcCCCcccCCCHHHHhcCCCC
Confidence 55 999999999999999999873
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=280.43 Aligned_cols=228 Identities=17% Similarity=0.263 Sum_probs=175.0
Q ss_pred eeeeecCCeeEEEEEEcC------------CCeEEEEEEeccccH---HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 140 RKVGRGKYSEVFEGVHCT------------DNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~------------~~~~vavK~~~~~~~---~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
+.||+|+||.||+|.... ....|++|++..... ..+.+|+.++..+ +||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~--~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVR--DV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CC
Confidence 358999999999998532 233689998865333 3577889999999 99999999999876 45
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC------eEEEEeee
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWG 274 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~------~ikl~DFG 274 (427)
..+++|||+.++.+..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++. .+|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 6789999999998876542 4889999999999999999999999999999999999986542 38999999
Q ss_pred eeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHHHHH-h-----C
Q 014307 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAKV-L-----G 347 (427)
Q Consensus 275 la~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ell-tg~~pf~~~~~~~~~l~~i~~~-~-----~ 347 (427)
++..... .....++..|+|||.+.+...++.++|||||||++|||+ .|..|| ......+. ..+... . .
T Consensus 158 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~-~~~~~~~~~~~~~~ 232 (262)
T cd05077 158 IPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL-KDKTLAEK-ERFYEGQCMLVTPS 232 (262)
T ss_pred CCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCcchhHH-HHHHhcCccCCCCC
Confidence 9865432 233467788999999875467899999999999999998 577776 33322222 211111 1 1
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.+++..++.+ |+..||..||++.+++.+
T Consensus 233 ~~~~~~li~~-cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 233 CKELADLMTH-CMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred hHHHHHHHHH-HcCCChhhCcCHHHHHHh
Confidence 2344454555 999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=290.42 Aligned_cols=238 Identities=19% Similarity=0.299 Sum_probs=186.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC-------CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
..+|++++.||+|+||.||+|++... +..||+|+++.. ..+.+.+|+.+++++.+||||+++++++..
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 89 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 89 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence 35799999999999999999986432 246899988642 235688999999999789999999999976
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEc
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~ 262 (427)
...+++++||+.+++|..++. .++...+..++.|++.||.|||++||+||||||+|||++
T Consensus 90 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 90 -DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 457899999999999876642 256778889999999999999999999999999999999
Q ss_pred CCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014307 263 HEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (427)
Q Consensus 263 ~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~ 338 (427)
.++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+.
T Consensus 169 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~ 245 (334)
T cd05100 169 EDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPY-PGIPVEEL 245 (334)
T ss_pred CCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCC-CCCCHHHH
Confidence 776 8999999999765432211 11223456999999876 679999999999999999998 78887 44444444
Q ss_pred HHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 339 LVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 339 l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
...+..... ...+..++.+ |+..+|..||++.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 246 FKLLKEGHRMDKPANCTHELYMIMRE-CWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHH-HcccChhhCcCHHHHHHH
Confidence 333332221 2345555555 999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=279.94 Aligned_cols=235 Identities=22% Similarity=0.405 Sum_probs=186.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC---CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|.+.++||+|+||.||+|.+... ...||||..... ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~~ 80 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---NP 80 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---CC
Confidence 46789999999999999999987544 357899987643 235688999999999 99999999998864 34
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.++||||+.+++|..++. .+++..++.++.|++.||+|||+.|++||||||+||+++.++ .+||+|||+++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeeccc
Confidence 689999999999887753 478999999999999999999999999999999999999776 899999999987654
Q ss_pred CCccee--eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHH
Q 014307 282 GKEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (427)
Q Consensus 282 ~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (427)
...... ..++..|+|||.+.. ..++.++|||||||++|||++ |..|| .+....+.+..+.+... ++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTL 237 (270)
T ss_pred ccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 322211 223457999999865 678999999999999999986 99998 44454555544443211 2344
Q ss_pred HHHHHhccCCCChhHHHHHhHHhc
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+++.+ |+..+|..||++.+++.
T Consensus 238 ~~li~~-~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 238 YSLMTK-CWAYDPSKRPRFTELKA 260 (270)
T ss_pred HHHHHH-HcCCChhhCcCHHHHHH
Confidence 454555 88899999998877654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=281.37 Aligned_cols=234 Identities=20% Similarity=0.329 Sum_probs=184.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCe----EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|++.+.||+|+||.||+|.++.++. .+|+|.++... ...+.+|+.+++.+ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~ 81 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS---S 81 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---C
Confidence 4679999999999999999999876654 68999886432 35678999999999 99999999999875 5
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..+++|||+.++++...+. .+++..+..++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+++...
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCccccccc
Confidence 6889999999999877653 488999999999999999999999999999999999999776 89999999998765
Q ss_pred CCCccee---eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 014307 281 PGKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (427)
Q Consensus 281 ~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~ 349 (427)
....... ..++..|+|||.+.. ..++.++|||||||++|||++ |+.|| .+....+....+.+... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPY-EGIPAVEIPDLLEKGERLPQPPICTI 238 (279)
T ss_pred CcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCC-CCCCHHHHHHHHhCCCCCCCCCCCCH
Confidence 3332211 122456999999865 678999999999999999998 99998 34333333333332111 13
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHh
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
++..++.+ |+..+|..||++.+++
T Consensus 239 ~~~~~~~~-~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 239 DVYMVLVK-CWMIDAESRPTFKELI 262 (279)
T ss_pred HHHHHHHH-HcCCChhhCCCHHHHH
Confidence 44444555 8888899888877654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.08 Aligned_cols=243 Identities=19% Similarity=0.285 Sum_probs=189.7
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEc---CCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRD---QQSK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~---~~~~ 204 (427)
...++|.+.+.||.|||+-||++....++..+|+|.+.- ...+...+|++..+++ +|||+++++++... ....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHhhccCce
Confidence 356899999999999999999999999999999998854 3456688999999999 99999999987543 1345
Q ss_pred CcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 205 TPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
..|++++|...|++.+.+. .+++.++..++.+|++||++||+.. +.||||||.|||+..++ .++|.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEeccC
Confidence 6899999999998876653 4899999999999999999999998 99999999999999766 899999999
Q ss_pred eeeecCC----------CcceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHH------
Q 014307 276 AEFYHPG----------KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD------ 337 (427)
Q Consensus 276 a~~~~~~----------~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~------ 337 (427)
+...... .+......|..|+|||.+.. ....+.++|||||||+||.|+.|..||......-.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv 255 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV 255 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee
Confidence 8643211 11123356778999999743 24578899999999999999999999942211000
Q ss_pred ---HHHHHHHHhCChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 338 ---QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 338 ---~l~~i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
++....+...+..+.+++.. |++.||..||++.+++.+
T Consensus 256 ~n~q~s~P~~~~yse~l~~lik~-mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 256 QNAQISIPNSSRYSEALHQLIKS-MLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eccccccCCCCCccHHHHHHHHH-HhcCCcccCCCHHHHHHH
Confidence 00000011123455555544 999999999999998763
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=285.50 Aligned_cols=241 Identities=24% Similarity=0.404 Sum_probs=193.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..|+..+.||+|+||.||+|++..++..+|+|.+... ....+.+|+.+++.+ +|+|++++++++.+ ....+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 101 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLR--EHTAW 101 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--CCeEE
Confidence 4578889999999999999999889999999998632 124578899999999 99999999999976 45678
Q ss_pred EEEeecCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.+..+... ...+++..+..++.|++.||.|||++||+||||+|+||+++.++ .+||+|||++.....
T Consensus 102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASP--- 177 (317)
T ss_pred EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCC---
Confidence 99999987543332 23588999999999999999999999999999999999999776 899999999875432
Q ss_pred ceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChHHHHH
Q 014307 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAY 354 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~~~~~ 354 (427)
.....++..|+|||.+.. .+.++.++|||||||++|||++|+.||.. .+....+..+.+... .+.+..+
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 256 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPTLQSNEWSDYFRNF 256 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC-ccHHHHHHHHHhccCCCCCCccccHHHHHH
Confidence 234567888999999742 25688999999999999999999999854 344444444443221 1234444
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+ |+..+|..||++.+++.|+|+....
T Consensus 257 i~~-~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 257 VDS-CLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred HHH-HccCCcccCcCHHHHHhChhhhccC
Confidence 444 9999999999999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=282.01 Aligned_cols=228 Identities=14% Similarity=0.210 Sum_probs=176.4
Q ss_pred eeeecCCeeEEEEEEcCC------------------------CeEEEEEEeccccH---HHHHHHHHHHHHhcCCCCeee
Q 014307 141 KVGRGKYSEVFEGVHCTD------------------------NEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVK 193 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~------------------------~~~vavK~~~~~~~---~~~~~E~~il~~l~~h~niv~ 193 (427)
.||+|+||.||+|....+ ...||+|+++.... ..+.+|+.+++.+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 599999999999975322 24588998865332 4577889999998 9999999
Q ss_pred eeeEEEcCCCCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC----
Q 014307 194 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---- 265 (427)
Q Consensus 194 l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~---- 265 (427)
+++++.. ....++||||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 81 ~~~~~~~--~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 81 VHGVCVR--GSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEEe--CCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999976 456789999999999876652 478999999999999999999999999999999999997543
Q ss_pred --CeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHH
Q 014307 266 --RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKI 342 (427)
Q Consensus 266 --~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ell-tg~~pf~~~~~~~~~l~~i 342 (427)
..+|++|||++...... ....++..|+|||.+.+...++.++|||||||++|||+ +|+.||. .....+....+
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~ 234 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK-ERTPSEKERFY 234 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcc-ccChHHHHHHH
Confidence 14899999998643222 23456778999999876567899999999999999995 6888884 33333322222
Q ss_pred HHHhC-----ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 343 AKVLG-----TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 343 ~~~~~-----~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
..... .+.+.+++.+ |+..+|..||++.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EKKHRLPEPSCKELATLISQ-CLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HhccCCCCCCChHHHHHHHH-HcccChhhCcCHHHHHHh
Confidence 22111 2355666666 999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=283.44 Aligned_cols=240 Identities=18% Similarity=0.211 Sum_probs=169.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC---CeEEEEEEeccccHH--------------HHHHHHHHHHHhcCCCCeeeee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKKK--------------KIKREIKILQNLCGGPNIVKLL 195 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~~--------------~~~~E~~il~~l~~h~niv~l~ 195 (427)
.++|++.+.||+|+||.||+|.+..+ +..+|+|+....... ....+...+..+ .|+++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~ 89 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DHLGIPKYY 89 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CCCCCCcEE
Confidence 46899999999999999999998777 667788864322110 011222334445 899999999
Q ss_pred eEEEcCCC--CCcEEEEeecCCCch--hhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEE
Q 014307 196 DIVRDQQS--KTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (427)
Q Consensus 196 ~~~~~~~~--~~~~lv~e~~~~~~l--~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~ 271 (427)
++...... ...++++|++..... .......++..+..++.|++.||+|||+++|+||||||+|||++.++ .++|+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~-~~~l~ 168 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN-RGYII 168 (294)
T ss_pred EeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-cEEEE
Confidence 97654322 234667777654332 22233467888999999999999999999999999999999999776 89999
Q ss_pred eeeeeeeecCCC--------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH---
Q 014307 272 DWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV--- 340 (427)
Q Consensus 272 DFGla~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~--- 340 (427)
|||+|+.+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......+...
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~ 247 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK 247 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence 999998764322 1123468999999999876 6899999999999999999999999954323322221
Q ss_pred -----HHHHH----hCChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 341 -----KIAKV----LGTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 341 -----~i~~~----~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+. ...+.....+...|+..+|+.||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 248 CDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11111 122222223334477788888887776653
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=277.29 Aligned_cols=230 Identities=24% Similarity=0.407 Sum_probs=187.5
Q ss_pred eeeeecCCeeEEEEEEcCC---CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 140 RKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
+.||+|+||.||+|.+... +..+++|+++... .+.+.+|+.+++.+ +|+||+++++++.. ....+++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence 4689999999999998765 8999999987533 46788999999999 79999999999976 6678999999
Q ss_pred cCCCchhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 213 VNNTDFKVLY------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 213 ~~~~~l~~~~------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
+.+++|..++ ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||.+....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~ 156 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVY 156 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccccccc
Confidence 9999987664 3478999999999999999999999999999999999999776 89999999998765
Q ss_pred CCC---cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-------CCh
Q 014307 281 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTD 349 (427)
Q Consensus 281 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-------~~~ 349 (427)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| ......+....+.+.. -++
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPY-PGLSNEEVLEYLRKGYRLPKPEYCPD 234 (262)
T ss_pred cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCccCCh
Confidence 432 1233456778999999876 578999999999999999999 58888 4444444444444321 124
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.+.+++.+ |+..+|..||++.+++.+
T Consensus 235 ~~~~li~~-~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 235 ELYELMLS-CWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHHH-HccCCcccCcCHHHHHHh
Confidence 55555555 999999999999988763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=277.08 Aligned_cols=233 Identities=16% Similarity=0.308 Sum_probs=185.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.++||+|+||.||+|.+ ..+..+|+|.+.... .+.+.+|+.+++.+ +|+||+++++++.. ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEEE
Confidence 57899999999999999999986 456679999886533 35688999999999 89999999999865 4578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.++++..++. .++...+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcc
Confidence 9999999877653 367788899999999999999999999999999999999776 8999999999765433211
Q ss_pred --eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHH
Q 014307 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (427)
Q Consensus 286 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (427)
....++..|+|||++.. ..++.++|||||||++|+|++ |+.|| .+.+..+....+..... +..+.+++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 236 (260)
T cd05073 159 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYRMPRPENCPEELYNIM 236 (260)
T ss_pred cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHhCCCCCCCcccCCHHHHHHH
Confidence 12234556999999876 678999999999999999998 88888 44444444444433221 23455555
Q ss_pred HhccCCCChhHHHHHhHHh
Q 014307 356 NKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll 374 (427)
.+ |+..+|..||++.+++
T Consensus 237 ~~-~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 237 MR-CWKNRPEERPTFEYIQ 254 (260)
T ss_pred HH-HcccCcccCcCHHHHH
Confidence 55 8888999998877654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.74 Aligned_cols=140 Identities=29% Similarity=0.517 Sum_probs=125.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|.++++||+|+||.||+|++..+++.||||+++... ...+.+|+.+++.+ +|+||+++++++.. ...++
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~~ 80 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQS--ANNVY 80 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEE--CCEEE
Confidence 67999999999999999999999899999999986432 25678899999998 99999999998876 56789
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
+||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 81 lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence 9999999999877653 578899999999999999999999999999999999999777 89999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=281.90 Aligned_cols=245 Identities=20% Similarity=0.318 Sum_probs=203.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++.+-+..||.|+||+|++..++.+|+..|||.++.. ..++++.|.....+-.+.||||++||..-. ++.-++.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceeee
Confidence 4455678899999999999999999999999998742 346688888887777689999999998765 3445688
Q ss_pred EeecCCCchhhhc--------CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 210 FEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 210 ~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
||.|+-.. ..++ ..+++..+-.|..-.+.||+||.. ..||||||||+|||++..| .+||||||++..+.
T Consensus 142 MELMd~Sl-DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 142 MELMDISL-DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQLV 219 (361)
T ss_pred HHHHhhhH-HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHhHH
Confidence 89887643 2222 358888888888889999999986 5899999999999999887 89999999998777
Q ss_pred CCCcceeeccCccccccccccCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------------C
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------------G 347 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------------~ 347 (427)
..-..+...|...|||||.+..... |+.++||||||++|||+.||+.|+....+-+||+.++...- .
T Consensus 220 ~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~ 299 (361)
T KOG1006|consen 220 DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHY 299 (361)
T ss_pred HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccccc
Confidence 6666777899999999999965444 99999999999999999999999987788888888776531 1
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+..+..++.. |+..|...||.-.+|+.++|+....
T Consensus 300 s~~~~~fint-Cl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 300 SFSMVRFINT-CLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred CHHHHHHHHH-HhhcccccCcchhhhhcCchhhhhh
Confidence 3466777777 9999999999999999999987644
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=276.71 Aligned_cols=228 Identities=18% Similarity=0.319 Sum_probs=178.8
Q ss_pred eeeeecCCeeEEEEEEcCCC---eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 140 RKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
++||+|+||.||+|.+..++ ..+|+|.+.... .+.+.+|+.+++.+ .|+||+++++++.. ...+++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence 46999999999999876655 789999987433 35688999999999 99999999998753 357899999
Q ss_pred cCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce-e-
Q 014307 213 VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN-V- 287 (427)
Q Consensus 213 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~-~- 287 (427)
+.+++|..++. .+++..+..++.|++.||+|||+.|++||||||+|||++.++ .+||+|||+++......... .
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccc
Confidence 99999887663 488999999999999999999999999999999999999777 89999999998764433221 1
Q ss_pred --eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHh
Q 014307 288 --RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNK 357 (427)
Q Consensus 288 --~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~ 357 (427)
..++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. ..+..+....+..... ++.+.+++.+
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 233 (257)
T cd05060 156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYG-EMKGAEVIAMLESGERLPRPEECPQEIYSIMLS 233 (257)
T ss_pred cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 112356999999876 679999999999999999998 898884 3333333333322211 1344455555
Q ss_pred ccCCCChhHHHHHhHHhc
Q 014307 358 YHIELDPHLAALVGRLVI 375 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~ 375 (427)
|+..+|..||++.+++.
T Consensus 234 -cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 234 -CWKYRPEDRPTFSELES 250 (257)
T ss_pred -HhcCChhhCcCHHHHHH
Confidence 88888999988877654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=276.15 Aligned_cols=232 Identities=23% Similarity=0.389 Sum_probs=188.2
Q ss_pred EEEeeeeecCCeeEEEEEEcCCC----eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 137 EVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 137 ~~~~~LG~G~fg~V~~~~~~~~~----~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++.+.||.|+||.||+|.+...+ ..||+|+++... .+.+.+|+.+++.+ +|+||+++++++.+. ...++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~ 78 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLMI 78 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeEE
Confidence 46788999999999999997766 899999997533 45788999999999 999999999999763 57889
Q ss_pred EEeecCCCchhhhcC---C--CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLYP---T--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+|||+.++++..++. . +++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDD 157 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceeccccc
Confidence 999999999876653 2 89999999999999999999999999999999999999776 89999999998765442
Q ss_pred ccee--eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHH
Q 014307 284 EYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNA 353 (427)
Q Consensus 284 ~~~~--~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~ 353 (427)
.... ..++..|+|||.+.+ ..++.++|||||||++++|++ |..|| ...+..+....+.+... +..+.+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY-PGMSNEEVLEYLKKGYRLPKPENCPPEIYK 235 (258)
T ss_pred ccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcCCCCCCCCcCCHHHHH
Confidence 2221 235678999999865 678999999999999999998 67776 44444444444433211 345555
Q ss_pred HHHhccCCCChhHHHHHhHHhc
Q 014307 354 YLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+ |+..+|..||++.+++.
T Consensus 236 ~i~~-~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 236 LMLQ-CWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHH-HCcCChhhCcCHHHHHh
Confidence 5555 99999999999998875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=280.37 Aligned_cols=236 Identities=19% Similarity=0.367 Sum_probs=186.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.+.||.|+||.||+|+.+. +.+.+++|.+.... .+.+.+|+++++++ +|+||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCRE--A 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECC--C
Confidence 3678999999999999999999653 34689999886533 24688999999999 99999999999865 4
Q ss_pred CCcEEEEeecCCCchhhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEE
Q 014307 204 KTPSLIFEHVNNTDFKVLYP------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~ 271 (427)
...++||||+.+++|..++. .+++..+..++.|++.||+|||+.||+||||||+||+++.++ .++|+
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~ 159 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVS 159 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEEc
Confidence 56899999999999987652 478999999999999999999999999999999999999777 89999
Q ss_pred eeeeeeeecCCC--cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh--
Q 014307 272 DWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-- 346 (427)
Q Consensus 272 DFGla~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-- 346 (427)
|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| ....+.+.+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~-~~~~~~~~~~~~~~~~~~ 237 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPF-YGLSDEEVLNRLQAGKLE 237 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCc-cccchHHHHHHHHcCCcC
Confidence 999986543221 1233355677999999876 578899999999999999998 77788 3333334333333111
Q ss_pred ------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 ------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 ------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
-++.+.+++.+ |+..+|..||++.+++.
T Consensus 238 ~~~~~~~~~~l~~~i~~-~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 238 LPVPEGCPSRLYKLMTR-CWAVNPKDRPSFSELVS 271 (275)
T ss_pred CCCCCCCCHHHHHHHHH-HcCCCcccCCCHHHHHH
Confidence 12344455555 99999999999988775
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=292.52 Aligned_cols=288 Identities=25% Similarity=0.397 Sum_probs=222.4
Q ss_pred ccccccccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcC-----CCCeeeee
Q 014307 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCG-----GPNIVKLL 195 (427)
Q Consensus 123 ~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~-----h~niv~l~ 195 (427)
|..+.+......+|.+....|+|-|++|..|.+...|+.||||+++... .+.-+.|++||++|.. --|+++|+
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 5566677777899999999999999999999999999999999997543 3556789999999942 24889999
Q ss_pred eEEEcCCCCCcEEEEeecCCCchhhhc--C---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEE
Q 014307 196 DIVRDQQSKTPSLIFEHVNNTDFKVLY--P---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (427)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~~l~~~~--~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl 270 (427)
..|.. ..++|||+|.+....-..+. . .+....++.|+.|+..||..|-..||+|.||||+|||++.....+||
T Consensus 501 r~F~h--knHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 501 RHFKH--KNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred HHhhh--cceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeee
Confidence 88866 67899999987764432221 1 37888999999999999999999999999999999999988789999
Q ss_pred EeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChH
Q 014307 271 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350 (427)
Q Consensus 271 ~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~ 350 (427)
||||.|.+.. .+..+++..+.+|+|||+++| -.|+...|+||+||+||||.||+..| +|..+..++......-|.-+
T Consensus 579 CDfGSA~~~~-eneitPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF-pG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 579 CDFGSASFAS-ENEITPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF-PGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccCccccccc-cccccHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec-CCCCcHHHHHHHHHhcCCCc
Confidence 9999998654 456777888899999999999 79999999999999999999999998 88888888877766655311
Q ss_pred HHHHHH-----------------------------hccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHH
Q 014307 351 LNAYLN-----------------------------KYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLL 401 (427)
Q Consensus 351 ~~~~l~-----------------------------~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dll 401 (427)
..++. ..|....|. +.+-..|...+-+-+.. -.....+.|||
T Consensus 656 -~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPt-kdl~s~l~~~q~~~deq-------~~~~~~~rdLL 726 (752)
T KOG0670|consen 656 -NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPT-KDLGSELIAVQRLPDEQ-------PKIVQQLRDLL 726 (752)
T ss_pred -HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcc-hhHHHHHhccCCCCchh-------HHHHHHHHHHH
Confidence 11111 111111221 12222222221111100 01345688999
Q ss_pred HHhhhhcCchhhhhhccccCCCCC
Q 014307 402 RNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 402 r~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
.+||. ++|++|.++...+.|||-
T Consensus 727 dkml~-LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 727 DKMLI-LDPEKRITVNQALKHPFI 749 (752)
T ss_pred HHHhc-cChhhcCCHHHHhcCCcc
Confidence 99996 999999999999999993
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=280.45 Aligned_cols=245 Identities=24% Similarity=0.394 Sum_probs=191.9
Q ss_pred CEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
+|++.+.||+|+||.||++++. .++..||||+++.. ..+.+.+|+.++.++.+||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4789999999999999999864 46788999998632 124577899999999779999999999865 56
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
..++||||+.++++...+ ..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 157 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECcccccccc
Confidence 788999999999887664 3478899999999999999999999999999999999999776 899999999876543
Q ss_pred CCc--ceeeccCccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--HHHH-HHHHHHh------CCh
Q 014307 282 GKE--YNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQL-VKIAKVL------GTD 349 (427)
Q Consensus 282 ~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~--~~~l-~~i~~~~------~~~ 349 (427)
... .....++..|+|||.+.+.. ..+.++||||||+++|+|++|..||...... ...+ ..+.... -.+
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA 237 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence 322 12245788899999976522 3788999999999999999999998432211 1111 1111111 124
Q ss_pred HHHHHHHhccCCCChhHHHH---HhHHhcCCchhhHH
Q 014307 350 ELNAYLNKYHIELDPHLAAL---VGRLVILSYFFQFV 383 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~---~~~ll~~~~~~~~~ 383 (427)
.+.+++.+ |+..+|+.||+ +.+++.|+||+...
T Consensus 238 ~l~~li~~-~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 238 EARDFIQK-LLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHH-HhcCCHhhccCcchHHHHhcCcccccCC
Confidence 55566666 99999999998 56789999998744
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=276.81 Aligned_cols=231 Identities=21% Similarity=0.361 Sum_probs=177.8
Q ss_pred eeeeecCCeeEEEEEEcC---CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 140 RKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
+.||+|+||.||+|.+.. .+..+|+|.+... ..+.+.+|+.+++.+ +||||+++++++... +...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPS-EGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecC-CCCcEEEEec
Confidence 358999999999998643 3467999988532 235677899999998 999999999977643 4457899999
Q ss_pred cCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc----
Q 014307 213 VNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---- 284 (427)
Q Consensus 213 ~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~---- 284 (427)
+.+++|..++. ..++..+..++.|++.||.|||+.+++||||||+|||++.++ .+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeec
Confidence 99999987753 356777888999999999999999999999999999999776 899999999975533211
Q ss_pred -ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.....++..|+|||.+.+ ..++.++|||||||++|||++|..|++...+..+....+..... ++.+.+++.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 236 (262)
T cd05058 158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVML 236 (262)
T ss_pred ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHH
Confidence 112234567999999876 67999999999999999999966555455554444443332111 234555555
Q ss_pred hccCCCChhHHHHHhHHhc
Q 014307 357 KYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~ 375 (427)
. |+..+|..||++.+++.
T Consensus 237 ~-cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 237 S-CWHPKPEMRPTFSELVS 254 (262)
T ss_pred H-HcCCChhhCCCHHHHHH
Confidence 5 89999999999888764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=274.09 Aligned_cols=234 Identities=18% Similarity=0.350 Sum_probs=186.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.+|++.+.||.|+||.||+|.+. .+..+|+|.++.. ....+.+|+++++++ +|||++++++++.. ....+++||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE--RSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEcc--CCceEEEEE
Confidence 57899999999999999999874 4678999988643 346789999999999 99999999999876 456899999
Q ss_pred ecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc--
Q 014307 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-- 285 (427)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~-- 285 (427)
|+.+++|..++. .+++..++.++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccCccccc
Confidence 999999876653 478889999999999999999999999999999999999666 8999999998765332111
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH-------hCChHHHHHHHh
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV-------LGTDELNAYLNK 357 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~-------~~~~~~~~~l~~ 357 (427)
....++..|+|||.+.+ ..++.++|||||||++|||++ |..||. .....+....+.+. .....+..++.+
T Consensus 159 ~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 159 TGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred CCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 11233457999999876 679999999999999999998 888883 33334444443321 123445555555
Q ss_pred ccCCCChhHHHHHhHHhc
Q 014307 358 YHIELDPHLAALVGRLVI 375 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~ 375 (427)
|+..+|..||++.+++.
T Consensus 237 -~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 237 -CWKERPEDRPSFSLLLH 253 (256)
T ss_pred -HcccChhhCCCHHHHHH
Confidence 99999999999988875
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=278.22 Aligned_cols=237 Identities=24% Similarity=0.439 Sum_probs=190.4
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
+|.+.++||+|+||.||++++..++..+++|+++. .....+..|+.+++.+ +||||+++++++.+ ....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLE--RDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhc--CCce
Confidence 58899999999999999999987777777777653 1223466799999999 99999999999876 4568
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
++++||+.++++...+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++. + .+||+|||++...
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~-~~~l~d~g~~~~~ 155 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N-LLKIGDFGVSRLL 155 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C-CEeecccCceeec
Confidence 8999999999987553 35889999999999999999999999999999999999984 4 6999999999776
Q ss_pred cCCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHH
Q 014307 280 HPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (427)
Q Consensus 280 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (427)
..... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..|| ...........+..... ...+
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAF-EGQNFLSVVLRIVEGPTPSLPETYSRQL 233 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHcCCCCCCcchhcHHH
Confidence 44322 234467888999999865 67889999999999999999999998 33343333333322111 2344
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
.+++.+ |+..+|+.||++.+++.|||+
T Consensus 234 ~~li~~-~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 234 NSIMQS-MLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHH-HhcCChhhCcCHHHHhhCCCC
Confidence 455555 999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=275.41 Aligned_cols=230 Identities=17% Similarity=0.318 Sum_probs=182.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
++|++.+.||+|+||.||++. .+++.+|+|.++.. ....+.+|+.+++++ +|||++++++++... ..+++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~---~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILHN---GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC---CcEEEEEC
Confidence 568999999999999999986 47888999998643 345788999999999 999999999998642 36899999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCccee
Q 014307 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287 (427)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~ 287 (427)
+.+++|..++. .+++..+..++.|++.||.|||+.|++||||||+||+++.++ .+||+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc--CCC
Confidence 99999876653 378888999999999999999999999999999999999777 8999999999764322 122
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhcc
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYH 359 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~ 359 (427)
...+..|+|||.+.+ ..++.++|||||||++|+|++ |+.|| ...+..+....+.+... ++.+.+++.. |
T Consensus 157 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~ 233 (254)
T cd05083 157 SKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPY-PKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTS-C 233 (254)
T ss_pred CCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCC-ccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHH-H
Confidence 234567999999876 679999999999999999997 88888 44444343333332221 1334444444 8
Q ss_pred CCCChhHHHHHhHHhc
Q 014307 360 IELDPHLAALVGRLVI 375 (427)
Q Consensus 360 l~~dp~~r~~~~~ll~ 375 (427)
+..+|..||++.+++.
T Consensus 234 l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 234 WETEPKKRPSFHKLRE 249 (254)
T ss_pred cCCChhhCcCHHHHHH
Confidence 8888988888877654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=283.99 Aligned_cols=242 Identities=24% Similarity=0.401 Sum_probs=192.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.+.|+..+.||+|+||.||+|++..+++.+|+|.+... ....+.+|+++++.+ +|+|++++++++.. ....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 90 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTA 90 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCee
Confidence 45588889999999999999999989999999988531 124577899999999 99999999999876 4567
Q ss_pred EEEEeecCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+..+... ...+++..+..++.|++.||.|||+.+++||||||+||+++.++ .+||+|||++......
T Consensus 91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc-
Confidence 899999986443322 23488899999999999999999999999999999999999776 8999999999765432
Q ss_pred cceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~~~~ 353 (427)
....++..|+|||.+.+ ...++.++|||||||++|+|++|+.||.. .+..+.+..+.+... ...+..
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 169 --NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc-ccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 23467888999999752 24678899999999999999999999843 333333333332211 123444
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+ |+..+|..||++++++.|+|+....
T Consensus 246 li~~-cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 246 FVDS-CLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred HHHH-HhhCCcccCCCHHHHhhCccccccC
Confidence 4444 9999999999999999999987743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=272.66 Aligned_cols=228 Identities=22% Similarity=0.373 Sum_probs=180.0
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
+.||+|+||.||+|.. .++..+|+|+++... ...+.+|+.+++.+ +||||+++++++.. ....++||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQ--RQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEec--CCccEEEEECCCC
Confidence 3689999999999986 468899999986432 24578999999999 99999999999876 4568899999999
Q ss_pred CchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc--eeec
Q 014307 216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRV 289 (427)
Q Consensus 216 ~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~--~~~~ 289 (427)
+++...+. .+.+..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++......... ....
T Consensus 77 ~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 77 GDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCC
Confidence 99877653 378889999999999999999999999999999999999776 8999999999754332211 1123
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhccCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYHIE 361 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l~ 361 (427)
++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+....+.+... ...+..++.+ |+.
T Consensus 156 ~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~ 232 (250)
T cd05085 156 IPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPY-PGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQR-CWD 232 (250)
T ss_pred CcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH-Hcc
Confidence 3456999999876 678999999999999999998 88898 44444443333333221 2455555555 889
Q ss_pred CChhHHHHHhHHhc
Q 014307 362 LDPHLAALVGRLVI 375 (427)
Q Consensus 362 ~dp~~r~~~~~ll~ 375 (427)
.+|+.||++.+++.
T Consensus 233 ~~p~~Rp~~~~l~~ 246 (250)
T cd05085 233 YKPENRPKFSELQK 246 (250)
T ss_pred cCcccCCCHHHHHH
Confidence 99999999888754
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=277.73 Aligned_cols=229 Identities=18% Similarity=0.304 Sum_probs=171.2
Q ss_pred eeeeecCCeeEEEEEEcC--CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~--~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
++||+|+||.||+|.... ....+|+|.+.... ...+.+|+.+++.+ +|+||+++++.+.. ....++||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIE--SIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECC--CCceEEEEEeC
Confidence 369999999999996533 34678888775332 24578899999998 99999999999875 45689999999
Q ss_pred CCCchhhhcCC--------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 214 NNTDFKVLYPT--------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 214 ~~~~l~~~~~~--------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
.+++|..++.. .++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchhe
Confidence 99999876532 35667889999999999999999999999999999999777 8999999998654322211
Q ss_pred ---eeeccCccccccccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC--------
Q 014307 286 ---NVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------- 347 (427)
Q Consensus 286 ---~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------- 347 (427)
....++..|+|||++.. ...++.++|||||||++|||++ |..|| ....+.+.+..+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQVLKQVVREQDIKLPKPQL 235 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC-CcCCHHHHHHHHhhccCccCCCCcc
Confidence 22244567999998742 2357889999999999999999 66676 44455554444333211
Q ss_pred ----ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 ----TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 ----~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+.. +...|+ .||+.||+++++++
T Consensus 236 ~~~~~~~~~~-~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 236 DLKYSDRWYE-VMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cccCCHHHHH-HHHHHh-cCcccccCHHHHHH
Confidence 112223 333355 58999999888765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=278.38 Aligned_cols=273 Identities=25% Similarity=0.432 Sum_probs=211.7
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC---CcEEEEe
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIFE 211 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~---~~~lv~e 211 (427)
+.||.|+||.||.+.+..+|+.||+|.+-. ...+.+.+|+++|.-+ +|.|++..+++...++-. .+|+++|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 569999999999999999999999998753 3357788999999999 999999999987644322 2567788
Q ss_pred ecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc--cee
Q 014307 212 HVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNV 287 (427)
Q Consensus 212 ~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~--~~~ 287 (427)
.|......... +.++...++-+++||++||+|||+.||.||||||.|.|++.+- .+||||||+|+..+.+.. .+.
T Consensus 138 LmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~~hMTq 216 (449)
T KOG0664|consen 138 LMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDRLNMTH 216 (449)
T ss_pred HHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccchhhhhhhHH
Confidence 77765544443 3588889999999999999999999999999999999999766 899999999998765543 455
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCChhHH
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 367 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~~r 367 (427)
.+-|.+|+|||++.|...|+..+||||+|||+.||+..+..| ...++.+++..|.+.+|+|.+..+--- |- -..-
T Consensus 217 EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF-QAq~PiqQL~lItdLLGTPs~EaMr~A-CE---GAk~ 291 (449)
T KOG0664|consen 217 EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF-QAAGPIEQLQMIIDLLGTPSQEAMKYA-CE---GAKN 291 (449)
T ss_pred HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh-hccChHHHHHHHHHHhCCCcHHHHHHH-hh---hhHH
Confidence 688999999999999889999999999999999999888887 778999999999999999877654222 11 0111
Q ss_pred HHHhHHhcCCchhhHHHhhhhhhh--hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 368 ALVGRLVILSYFFQFVIYYYYYYY--FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 368 ~~~~~ll~~~~~~~~~~~~~~~~~--~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
-++..-++.|-+.. .|..-. ...-..++++..||. .+|..|+++...+.+++
T Consensus 292 H~LR~~~k~Ps~~v----LYtlsS~~~~~heav~~~~~~l~-~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 292 HVLRAGLRAPDTQR----LYKIASPDDKNHEAVDLLQKLLH-FDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhccCCCCCCccc----eeeecCCcccchHHHHHHHHHhC-CCCcccccHhhhccccc
Confidence 11112222222222 111111 123467888899996 99999999888777765
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=280.38 Aligned_cols=238 Identities=21% Similarity=0.383 Sum_probs=187.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcC----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
+.|++.+.||+|+||.||+|.... ++..+|||+++... .+.+.+|+++++.+ .|+||+++++++.......
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCCc
Confidence 567888999999999999998643 47899999987543 35788999999999 9999999999998766678
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.+++|||+.++++..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 161 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLAKVLPE 161 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEccccccccccc
Confidence 899999999999877763 388899999999999999999999999999999999999776 899999999987653
Q ss_pred CCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH-------------HHHHHHHH
Q 014307 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY-------------DQLVKIAK 344 (427)
Q Consensus 282 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~-------------~~l~~i~~ 344 (427)
.... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.|+....... ..+....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 3221 12234556999999876 578999999999999999999999985432221 11111111
Q ss_pred Hh--------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 345 VL--------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 345 ~~--------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.. -...+.+++.. |+..+|..||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~-cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKL-CWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHH-HhccChhhCCCHHHHHH
Confidence 10 01234444444 88999999999888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=294.68 Aligned_cols=234 Identities=20% Similarity=0.380 Sum_probs=194.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC----CCeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~----~~~~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.+...+.+.||.|.||.||+|.... ..-.||||+.+. .+.+.|.+|..+|+++ +||||++++|++++ .
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e---~ 463 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVE---Q 463 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeec---c
Confidence 4456667899999999999998643 245789999875 4467899999999999 99999999999986 3
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++|||.+..|.|..+++ .++......++.||+.||.|||++++|||||..+|||+.... .+||+|||+++++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFGLSRYLE 542 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccchhhhcc
Confidence 5789999999999998875 378888889999999999999999999999999999999877 89999999999988
Q ss_pred CCCcceeecc--CccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC------ChHH
Q 014307 281 PGKEYNVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG------TDEL 351 (427)
Q Consensus 281 ~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~------~~~~ 351 (427)
+...+....| +.-|||||.+. +..++.++|||.|||++||++. |..|| .+..+.|.+..+.+.-. .|+.
T Consensus 543 d~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPf-qgvkNsDVI~~iEnGeRlP~P~nCPp~ 620 (974)
T KOG4257|consen 543 DDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPF-QGVKNSDVIGHIENGERLPCPPNCPPA 620 (974)
T ss_pred ccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCcc-ccccccceEEEecCCCCCCCCCCCChH
Confidence 7765554444 34499999976 4889999999999999999875 89999 67777777776665432 3444
Q ss_pred HHHHHhccCCCChhHHHHHhHH
Q 014307 352 NAYLNKYHIELDPHLAALVGRL 373 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~l 373 (427)
...+...||.++|..||...++
T Consensus 621 LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 621 LYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred HHHHHHHHhccCcccCCcHHHH
Confidence 4466666999999999987665
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=317.93 Aligned_cols=242 Identities=25% Similarity=0.408 Sum_probs=190.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--------
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ-------- 201 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~-------- 201 (427)
.+|+.++.||+||||.||+++++-+|+.||||.+.-. ....+.+|+..|.+| +|||||+++..+.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcccccc
Confidence 5688899999999999999999999999999998532 235688999999999 999999996521100
Q ss_pred --------------------------------------------------------------------------------
Q 014307 202 -------------------------------------------------------------------------------- 201 (427)
Q Consensus 202 -------------------------------------------------------------------------------- 201 (427)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ---------------------CC--------CCcEEEEeecCCCchhhhcCC--C--CHHHHHHHHHHHHHHHHHHHHCC
Q 014307 202 ---------------------QS--------KTPSLIFEHVNNTDFKVLYPT--L--SDYDVRYYIYELLKALDYCHSQG 248 (427)
Q Consensus 202 ---------------------~~--------~~~~lv~e~~~~~~l~~~~~~--~--~~~~~~~i~~qi~~~L~~LH~~~ 248 (427)
.+ ..+||-||||+..++..++.. + .....+++++||++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 00 356888999999888877753 3 36778999999999999999999
Q ss_pred ceeeccCCCceEEcCCCCeEEEEeeeeeeeec-------------------CCCcceeeccCccccccccccCCC--CCC
Q 014307 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ--DYD 307 (427)
Q Consensus 249 iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~--~~~ 307 (427)
||||||||.||+++.++ .|||+|||+|+... .....+..+||..|+|||++.+.. .|+
T Consensus 718 iIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn 796 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN 796 (1351)
T ss_pred eeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence 99999999999999766 89999999997611 112346679999999999997755 699
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh---------HHHHHHHhccCCCChhHHHHHhHHhcCCc
Q 014307 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD---------ELNAYLNKYHIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 308 ~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~---------~~~~~l~~~~l~~dp~~r~~~~~ll~~~~ 378 (427)
.|+|+||||||++||+. ||....+....+..+.+..-+. ....-++.+++..||..||++.+||.+.|
T Consensus 797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l 873 (1351)
T KOG1035|consen 797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSEL 873 (1351)
T ss_pred chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence 99999999999999985 5744333333344333221111 22233566699999999999999999999
Q ss_pred hh
Q 014307 379 FF 380 (427)
Q Consensus 379 ~~ 380 (427)
+-
T Consensus 874 lp 875 (1351)
T KOG1035|consen 874 LP 875 (1351)
T ss_pred CC
Confidence 88
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=276.23 Aligned_cols=229 Identities=17% Similarity=0.259 Sum_probs=172.2
Q ss_pred eeeeecCCeeEEEEEEc--CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+.||+|+||.||+|... .++..+|+|.++... ...+.+|+.+++++ +||||+++++++.+ ....++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTE--VTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCCcEEEEECC
Confidence 35899999999999864 345689999886432 24678899999999 99999999999876 45678999999
Q ss_pred CCCchhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 214 NNTDFKVLYP--------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 214 ~~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
.+++|..++. ..++..+..++.|++.||+|||+.|++||||||+||+++.++ .+||+|||++.........
T Consensus 78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCccee
Confidence 9999876653 245567788999999999999999999999999999999766 8999999998654322211
Q ss_pred ---eeeccCccccccccccCC------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh---------
Q 014307 286 ---NVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL--------- 346 (427)
Q Consensus 286 ---~~~~~~~~y~aPE~~~~~------~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~--------- 346 (427)
....++..|+|||++.+. ..++.++|||||||++|||++ |+.||. ...+.+.........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYR-HLSDEQVLTYTVREQQLKLPKPRL 235 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCC-CCChHHHHHHHhhcccCCCCCCcc
Confidence 223566779999997532 135789999999999999996 999984 333333333222111
Q ss_pred --C-ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 --G-TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 --~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
. .+.+..++ ..|+ .+|+.||+++++..
T Consensus 236 ~~~~~~~~~~l~-~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 236 KLPLSDRWYEVM-QFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCChHHHHHH-HHHh-cCcccCCCHHHHHH
Confidence 1 12333344 4466 57999999888763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=302.23 Aligned_cols=270 Identities=18% Similarity=0.217 Sum_probs=177.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCC----CeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEE----cCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD----NEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR----DQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~----~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~----~~~~ 203 (427)
..++|++.++||+|+||.||+|++..+ +..||+|.++.....+...+. .+... .+.++..++..+. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~-~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRA-CPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhh-chhhHHHHHHhhhcccccccC
Confidence 467899999999999999999999888 899999988643322221111 11222 2223332222211 1335
Q ss_pred CCcEEEEeecCCCchhhhcCC-----------------------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceE
Q 014307 204 KTPSLIFEHVNNTDFKVLYPT-----------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 260 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~-----------------------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 260 (427)
...++|+||+.+++|..++.. .....+..++.||+.||+|||++||+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 678999999999988766531 112346678999999999999999999999999999
Q ss_pred EcCCCCeEEEEeeeeeeeecCCC--cceeeccCccccccccccCCC---------------------CCCchhhHHHHHH
Q 014307 261 IDHEQRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---------------------DYDYSLDLWSLGC 317 (427)
Q Consensus 261 l~~~~~~ikl~DFGla~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DvwSlGv 317 (427)
++.+...+||+|||+|+.+.... ......+++.|+|||.+.... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 98654489999999998654332 224567889999999753211 2445679999999
Q ss_pred HHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhh
Q 014307 318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTC 397 (427)
Q Consensus 318 ll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~ 397 (427)
+||||+++..++ .++..++..+.+..+.+ ...|.....-...++.+.. +........+.
T Consensus 368 iL~el~~~~~~~---~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~-----------------~~~~d~~~~~~ 426 (566)
T PLN03225 368 IFLQMAFPNLRS---DSNLIQFNRQLKRNDYD-LVAWRKLVEPRASPDLRRG-----------------FEVLDLDGGAG 426 (566)
T ss_pred HHHHHHhCcCCC---chHHHHHHHHHHhcCCc-HHHHHHhhccccchhhhhh-----------------hhhccccchHH
Confidence 999999876553 33444444444433332 1122111000111111110 01111233456
Q ss_pred HHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 398 NFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 398 ~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
.|+|++||. .||++|+|+..++.|||=
T Consensus 427 ~dLi~~mL~-~dP~kR~ta~e~L~Hpff 453 (566)
T PLN03225 427 WELLKSMMR-FKGRQRISAKAALAHPYF 453 (566)
T ss_pred HHHHHHHcc-CCcccCCCHHHHhCCcCc
Confidence 689999995 999999999999999983
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=271.49 Aligned_cols=228 Identities=21% Similarity=0.365 Sum_probs=180.1
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
++||.|+||.||+|.+.. ++.||+|.++.. ....+.+|+++++++ .|+||+++++++.. ....++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQ--KQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEec--CCCeEEEEEcCCC
Confidence 369999999999999866 999999988642 235688999999999 99999999999876 4578899999999
Q ss_pred CchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc---eee
Q 014307 216 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR 288 (427)
Q Consensus 216 ~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~---~~~ 288 (427)
+++..++. .+++..+..++.|++.||+|||++|++||||||+|||++.++ .+||+|||++......... ...
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccC
Confidence 99877652 478888999999999999999999999999999999999777 8999999999755322111 112
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhccC
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKYHI 360 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l 360 (427)
..+..|+|||.+.+ ..++.++|||||||++|||++ |..|| ......+....+..... ...+..++.+ |+
T Consensus 156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l 232 (251)
T cd05041 156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPY-PGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQ-CW 232 (251)
T ss_pred cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCC-ccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHH-Hh
Confidence 23456999999876 679999999999999999999 77777 44443333333332211 1344444555 89
Q ss_pred CCChhHHHHHhHHhc
Q 014307 361 ELDPHLAALVGRLVI 375 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~ 375 (427)
..+|..||++.+++.
T Consensus 233 ~~~p~~Rp~~~ell~ 247 (251)
T cd05041 233 AYDPENRPSFSEIYN 247 (251)
T ss_pred ccChhhCcCHHHHHH
Confidence 999999999888765
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=301.90 Aligned_cols=237 Identities=19% Similarity=0.348 Sum_probs=199.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCC---eEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
+.....|.+.||.|.||+|++|+.+..+ ..||||.++. ..+..|+.|+.||-++ +||||++|.|+... ..
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTk--s~ 703 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTK--SK 703 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEec--Cc
Confidence 3455789999999999999999988766 5799999985 3346699999999999 99999999999976 66
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
...+|+|||++|.|..+++ +|+..+...+++.|+.|++||-+.|+|||||.++|||++.+- .+|++|||+++.++
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGLSRvle 782 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE 782 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccceeecc
Confidence 7889999999999998875 488888999999999999999999999999999999999877 89999999999886
Q ss_pred CCCc--ceeecc--CccccccccccCCCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCHHHHHHHHHHhCC-------
Q 014307 281 PGKE--YNVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAKVLGT------- 348 (427)
Q Consensus 281 ~~~~--~~~~~~--~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ell-tg~~pf~~~~~~~~~l~~i~~~~~~------- 348 (427)
++.+ +++..| +..|.|||.+.- .+++.++||||+|++|||.+ .|+.||+ +..+.|.+..|.+.+.-
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYW-dmSNQdVIkaIe~gyRLPpPmDCP 860 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEQGYRLPPPMDCP 860 (996)
T ss_pred cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCccc-ccchHHHHHHHHhccCCCCCCCCc
Confidence 6542 233333 345999999885 89999999999999999976 5999994 56889999999987653
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
..+.+++.. ||+.|...||...++..
T Consensus 861 ~aL~qLMld-CWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 861 AALYQLMLD-CWQKDRNRRPKFAQIVS 886 (996)
T ss_pred HHHHHHHHH-HHHHHhhcCCCHHHHHH
Confidence 245555555 88888888887666544
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=275.97 Aligned_cols=235 Identities=19% Similarity=0.415 Sum_probs=188.0
Q ss_pred CEEEEeeeeecCCeeEEEEEEcC-CCeEEEEEEeccc-------------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEc
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~-------------~~~~~~~E~~il~~l~~h~niv~l~~~~~~ 200 (427)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+... ....+.+|+.++.+..+||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788999999999999999877 6889999987521 113466788888764499999999999876
Q ss_pred CCCCCcEEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEe
Q 014307 201 QQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLID 272 (427)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~D 272 (427)
....+++|||+.++++...+ ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++ .+||+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~d 157 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITD 157 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEec
Confidence 56789999999999886553 248889999999999999999996 6899999999999999777 899999
Q ss_pred eeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------
Q 014307 273 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------ 346 (427)
Q Consensus 273 FGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------ 346 (427)
||++.............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||. ..+.......+....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~ 235 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFY-STNMLSLATKIVEAVYEPLPE 235 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCccc-ccCHHHHHHHHhhccCCcCCc
Confidence 999987654444455678888999999876 678999999999999999999999984 333333333333221
Q ss_pred --CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 --GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 --~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
-.+.+..++.. |+..||+.||++.++..
T Consensus 236 ~~~~~~l~~li~~-cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 236 GMYSEDVTDVITS-CLTPDAEARPDIIQVSA 265 (269)
T ss_pred ccCCHHHHHHHHH-HCCCCCccCCCHHHHHH
Confidence 12455555555 99999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=272.32 Aligned_cols=231 Identities=26% Similarity=0.442 Sum_probs=190.9
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
||.|+||.||++.+..+++.+|+|+++... ...+..|+.+++.+ +|+||+++++.+.. ...++++|||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQT--EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence 699999999999998889999999986432 34688899999999 89999999999875 5678999999999
Q ss_pred CchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-CcceeeccC
Q 014307 216 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS 291 (427)
Q Consensus 216 ~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~~~~~~ 291 (427)
++|..++. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++...... .......++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCC
Confidence 88876653 478999999999999999999999999999999999999777 8999999999766443 223445678
Q ss_pred ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH------hCChHHHHHHHhccCCCChh
Q 014307 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNKYHIELDPH 365 (427)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~~~l~~dp~ 365 (427)
..|++||.+.+ ..++.++|+||||+++|+|++|..||. ..+..+....+... ..++.+.+++.+ |+..||+
T Consensus 157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~-~l~~~p~ 233 (250)
T cd05123 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFY-AEDRKEIYEKILKDPLRFPEFLSPEARDLISG-LLQKDPT 233 (250)
T ss_pred ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHH-HhcCCHh
Confidence 88999999876 568899999999999999999999994 33333333333321 113456666666 9999999
Q ss_pred HHHHH---hHHhcCCch
Q 014307 366 LAALV---GRLVILSYF 379 (427)
Q Consensus 366 ~r~~~---~~ll~~~~~ 379 (427)
.||++ ++++.|+||
T Consensus 234 ~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 234 KRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hCCCcccHHHHHhCCCC
Confidence 99999 999999997
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=284.60 Aligned_cols=238 Identities=20% Similarity=0.330 Sum_probs=189.4
Q ss_pred cccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 128 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
+.....+...++++||+|.||+|.+|.- ..+..||||++++.. ++.|.+|+++|.+| +||||++++|+|.. +
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~--D 607 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQ--D 607 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeec--C
Confidence 3344567788999999999999999986 457999999998633 47799999999999 99999999999986 5
Q ss_pred CCcEEEEeecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
..+++|+|||++|+|.+++.. ........|+.||+.||+||.+.++|||||.+.|+|+|.+. ++||+|||+++-
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~ 686 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRN 686 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCcccccc
Confidence 678999999999999888743 23445567999999999999999999999999999999777 899999999987
Q ss_pred ecCCCcceee---ccCccccccccccCCCCCCchhhHHHHHHHHHHHH--hCCCCCCCCCCCHHHHHHHHHHhC------
Q 014307 279 YHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI--FRKEPFFYGHDNYDQLVKIAKVLG------ 347 (427)
Q Consensus 279 ~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ell--tg~~pf~~~~~~~~~l~~i~~~~~------ 347 (427)
+..++.+... +-+..|||+|.+.. ++++.++|||+||+++||++ +.+.||. ...+.+.....-..+.
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~-~lt~e~vven~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYS-QLTDEQVVENAGEFFRDQGRQV 764 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchh-hhhHHHHHHhhhhhcCCCCcce
Confidence 6666554433 45677999999986 79999999999999999986 4778883 3333222222222221
Q ss_pred --------ChHHHHHHHhccCCCChhHHHHHhHH
Q 014307 348 --------TDELNAYLNKYHIELDPHLAALVGRL 373 (427)
Q Consensus 348 --------~~~~~~~l~~~~l~~dp~~r~~~~~l 373 (427)
+..+.+++.+ |+..+...||+.+++
T Consensus 765 ~l~~P~~cp~~lyelml~-Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLR-CWRRESEQRPSFEQL 797 (807)
T ss_pred eccCCCcCcHHHHHHHHH-HhchhhhcCCCHHHH
Confidence 1345555666 888888888887765
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=272.89 Aligned_cols=227 Identities=17% Similarity=0.235 Sum_probs=178.4
Q ss_pred eeeeecCCeeEEEEEEcCCC----------eEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 140 RKVGRGKYSEVFEGVHCTDN----------EKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~----------~~vavK~~~~~~--~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
+.||+|+||.||+|.+..++ ..+++|+++... ...+.+|+.+++.+ +||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence 36899999999999997766 458888876533 46788999999999 99999999999876 3468
Q ss_pred EEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC------eEEEEeeeeee
Q 014307 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWGLAE 277 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~------~ikl~DFGla~ 277 (427)
+||||+.+++|..++. .++...+..++.||+.||+|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999887653 4788899999999999999999999999999999999986552 59999999997
Q ss_pred eecCCCcceeeccCccccccccccCC-CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-----CChH
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-----GTDE 350 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-----~~~~ 350 (427)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||.. .+..+......... ....
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST-LSSSEKERFYQDQHRLPMPDCAE 232 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc-CCchhHHHHHhcCCCCCCCCchH
Confidence 6543 2234566779999998763 378999999999999999999 5666633 32322222211110 1235
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+++.+ |+..+|..||++.+++.
T Consensus 233 ~~~li~~-~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 233 LANLINQ-CWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHH-HhccChhhCCCHHHHHH
Confidence 5566655 89999999999888765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=272.58 Aligned_cols=228 Identities=19% Similarity=0.290 Sum_probs=180.8
Q ss_pred eeeeecCCeeEEEEEEcC-CC--eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 140 RKVGRGKYSEVFEGVHCT-DN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~-~~--~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
+.||+|++|.||+|.+.. ++ ..||||.++... .+.+.+|+.+++++ +||||+++++++.. ...+++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999999855 33 368999987533 35688999999999 99999999999875 568899999
Q ss_pred cCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc---
Q 014307 213 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--- 284 (427)
Q Consensus 213 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~--- 284 (427)
+.+++|...+. .+++..++.++.|++.||.|||++|++||||||+||+++.++ .+||+|||++..+.....
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEecccccccccccccccee
Confidence 99999876652 478889999999999999999999999999999999999776 899999999987644221
Q ss_pred -ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh--------CChHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL--------GTDELNAY 354 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~--------~~~~~~~~ 354 (427)
.....++..|+|||.+.+ ..++.++|||||||++|||++ |+.||. .....+....+.... .+..+.++
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 233 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKIDKEGERLERPEACPQDIYNV 233 (257)
T ss_pred cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence 112345677999999876 678999999999999999998 999983 334444444333211 12344444
Q ss_pred HHhccCCCChhHHHHHhHHhc
Q 014307 355 LNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.. |+..+|..||++.+++.
T Consensus 234 i~~-~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 234 MLQ-CWAHNPADRPTFAALRE 253 (257)
T ss_pred HHH-HCCCCcccCCCHHHHHH
Confidence 554 89999999999888764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=256.32 Aligned_cols=209 Identities=20% Similarity=0.386 Sum_probs=179.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++...+..||+|++|.|=+.++..+|+..|+|.++. +..+++.+|+.+..+...+|.+|++||.+.. +..+.+
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r--egdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR--EGDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc--cccEEE
Confidence 3556677899999999999999999999999998863 3446688899988887789999999997765 456778
Q ss_pred EEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 209 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 209 v~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
.||.|.... ..++ ..+++..+-+|+..+..||.|||++ .+||||+||+|||++.+| ++|+||||++-.+.
T Consensus 123 cME~M~tSl-dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 123 CMELMDTSL-DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLV 200 (282)
T ss_pred eHHHhhhhH-HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeeh
Confidence 899988643 2222 3589999999999999999999986 899999999999999888 89999999998887
Q ss_pred CCCcceeeccCccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH
Q 014307 281 PGKEYNVRVASRYFKGPELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~ 345 (427)
+.-..+...|...|||||.+.. ...|+.++||||||+.+.||.+++.||..+..+++|+.++.+.
T Consensus 201 dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 201 DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 7766676789999999999843 2479999999999999999999999999999999999988764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=274.12 Aligned_cols=235 Identities=19% Similarity=0.343 Sum_probs=180.4
Q ss_pred EEEEeeeeecCCeeEEEEEEcC---CCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC----
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~---- 203 (427)
|++.+.||+|+||.||+|.+.. +++.||||+++.. ..+.+.+|+++++.+ +||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 5677899999999999998643 5789999988642 235678999999999 99999999998865322
Q ss_pred CCcEEEEeecCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFG 274 (427)
...++++||+.++++..++ ..++...++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg 158 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFG 158 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECccc
Confidence 2347889999999876543 1368888999999999999999999999999999999999766 89999999
Q ss_pred eeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh----
Q 014307 275 LAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL---- 346 (427)
Q Consensus 275 la~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~---- 346 (427)
+++....... .....++..|++||.+.+ ..++.++|||||||++|+|++ |+.|| .+.+..+....+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~ 236 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY-AGVENSEIYNYLIKGNRLKQ 236 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC-CCCCHHHHHHHHHcCCcCCC
Confidence 9986543321 122344567999999876 678999999999999999999 77777 4444433333333211
Q ss_pred --C-ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 --G-TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 --~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
. .+.+.+++.. |+..+|+.||++.+++.
T Consensus 237 ~~~~~~~~~~l~~~-~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 237 PPDCLEDVYELMCQ-CWSPEPKCRPSFQHLRD 267 (273)
T ss_pred CCCCCHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 1 1344444555 89999999999888764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=283.01 Aligned_cols=288 Identities=27% Similarity=0.435 Sum_probs=229.1
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcC---CCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~-~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+.|.++++||.|+|+.||++.+.. .++.||+|.+.. .....+.+|+++|..+.++.||+++.+++.. +....+|
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd~v~iv 113 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--NDQVAIV 113 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CCeeEEE
Confidence 568899999999999999999877 788999998864 5568899999999999999999999999976 5567899
Q ss_pred EeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec---------
Q 014307 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH--------- 280 (427)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~--------- 280 (427)
+||++......++..++..+++.+++.++.||.++|.+|||||||||.|+|.+.....-.|+|||+|...+
T Consensus 114 lp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~ 193 (418)
T KOG1167|consen 114 LPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSR 193 (418)
T ss_pred ecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999877788999999996210
Q ss_pred --------C--C--------------------------CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh
Q 014307 281 --------P--G--------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF 324 (427)
Q Consensus 281 --------~--~--------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt 324 (427)
+ + .....+.||++|+|||++..+..-+.++||||.|||+..+++
T Consensus 194 ~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls 273 (418)
T KOG1167|consen 194 SYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLS 273 (418)
T ss_pred hhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhc
Confidence 0 0 001124789999999999988889999999999999999999
Q ss_pred CCCCCCCCCCCHHHHHHHHHHhCChHHHHHH--Hhc--cCC-----CChhHHHHHhHHh-cCCchhhH-HHhhhhhhhhh
Q 014307 325 RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL--NKY--HIE-----LDPHLAALVGRLV-ILSYFFQF-VIYYYYYYYFC 393 (427)
Q Consensus 325 g~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l--~~~--~l~-----~dp~~r~~~~~ll-~~~~~~~~-~~~~~~~~~~~ 393 (427)
++.||+...++.+.+.++...+|...+.+.- ... .++ ..++++-..+.+. .+..-.+. ..... -+...
T Consensus 274 ~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~-~~~d~ 352 (418)
T KOG1167|consen 274 RRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE-IGSDV 352 (418)
T ss_pred cccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec-ccccc
Confidence 9999999999999999999999986655431 111 111 2333333333331 11111000 00001 11222
Q ss_pred -hhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 394 -LKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 394 -~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
.-.|+|+|++.|. .||..|+|+...+.|||=
T Consensus 353 ~~~~~~dlLdk~le-~np~kRitAEeALkHpFF 384 (418)
T KOG1167|consen 353 FPALLLDLLDKCLE-LNPQKRITAEDALKHPFF 384 (418)
T ss_pred ccHHHHHHHHHHcc-CChhhcccHHHHhcCcCC
Confidence 3389999999995 999999999999999994
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=288.12 Aligned_cols=234 Identities=20% Similarity=0.374 Sum_probs=196.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
..+.....+||-|.||.||.|+++...-.||||.++. +..++|+.|+.+|+.+ +|||+|+|+|+|.. +..+|||+
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~--EpPFYIiT 342 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTH--EPPFYIIT 342 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhcc--CCCeEEEE
Confidence 3456678999999999999999999999999999974 4568899999999999 99999999999976 56789999
Q ss_pred eecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
|||..|.|.++++. ++.-...+++.||..|++||..+++|||||.++|+|+..+. .||++|||+++++. ++.+
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMt-gDTY 420 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMT-GDTY 420 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchhhhhc-CCce
Confidence 99999999888764 44455678889999999999999999999999999999766 89999999999875 5556
Q ss_pred eeeccCc---cccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh------CChHHHHHH
Q 014307 286 NVRVASR---YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL------GTDELNAYL 355 (427)
Q Consensus 286 ~~~~~~~---~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l 355 (427)
+...|.. -|.|||-+.- ..++.|+|||+|||+|||+.| |..|| ++.+-......+.+.+ |.|+-..-+
T Consensus 421 TAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPY-PGidlSqVY~LLEkgyRM~~PeGCPpkVYeL 498 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYGLLEKGYRMDGPEGCPPKVYEL 498 (1157)
T ss_pred ecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCC-CCccHHHHHHHHhccccccCCCCCCHHHHHH
Confidence 6666644 4999999874 889999999999999999987 55665 7776655555555543 455666666
Q ss_pred HhccCCCChhHHHHHhHH
Q 014307 356 NKYHIELDPHLAALVGRL 373 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~l 373 (427)
.+.||++.|.-||...++
T Consensus 499 MraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 499 MRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHhcCCcccCccHHHH
Confidence 777999999999987664
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=274.80 Aligned_cols=229 Identities=21% Similarity=0.347 Sum_probs=178.8
Q ss_pred eeeecCCeeEEEEEEcCCC------eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 141 KVGRGKYSEVFEGVHCTDN------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~~------~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.||+|+||.||+|.++... +.+|+|.+... ....+.+|+.+++.+ +||||+++++++.. ....+++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLL--NEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecC--CCCeEEEE
Confidence 5899999999999875433 78999987542 345688999999999 99999999999876 45689999
Q ss_pred eecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC----CeEEEEeeeee
Q 014307 211 EHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLA 276 (427)
Q Consensus 211 e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~~ikl~DFGla 276 (427)
||+.+++|..++. .+++.++..++.|++.||.|||+++++|+||||+||+++.++ ..++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999876652 267788999999999999999999999999999999998644 26999999999
Q ss_pred eeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh------
Q 014307 277 EFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL------ 346 (427)
Q Consensus 277 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~------ 346 (427)
........ .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| ...++.+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~-~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY-PALNNQEVLQHVTAGGRLQKPE 236 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCC-cccCHHHHHHHHhcCCccCCcc
Confidence 76533221 112244567999999876 678999999999999999998 99998 4444444433332211
Q ss_pred -CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 -GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 -~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.++.+.+++.+ |+..+|..||+++++++
T Consensus 237 ~~~~~~~~li~~-~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 237 NCPDKIYQLMTN-CWAQDPSERPTFDRIQE 265 (269)
T ss_pred cchHHHHHHHHH-HcCCCcccCCCHHHHHH
Confidence 12345555555 89999999999888754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=271.10 Aligned_cols=225 Identities=17% Similarity=0.254 Sum_probs=177.1
Q ss_pred cCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhc--
Q 014307 145 GKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-- 222 (427)
Q Consensus 145 G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-- 222 (427)
|.+|.||+++++.+++.+|+|.++... ...+|...+... .||||+++++++.. ....+++|||+.+++|...+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheec--CCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999997542 344555555555 79999999999876 46789999999999987654
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCcccccccccc
Q 014307 223 -PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301 (427)
Q Consensus 223 -~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~ 301 (427)
..+++..+..++.|++.||+|||++||+||||||+||+++.++ .++++|||.+...... .....++..|+|||.+.
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCccccCCcccC
Confidence 3589999999999999999999999999999999999999777 7999999988654322 23345567799999986
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH-HHHhCChHHHHHHHhccCCCChhHHHHH-----hHHhc
Q 014307 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI-AKVLGTDELNAYLNKYHIELDPHLAALV-----GRLVI 375 (427)
Q Consensus 302 ~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i-~~~~~~~~~~~~l~~~~l~~dp~~r~~~-----~~ll~ 375 (427)
+ ..++.++||||+||++|||++|+.|+............+ ....-.+.+.+++.+ |+..||..|+++ ++++.
T Consensus 156 ~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~R~~~~~~~~~~~~~ 233 (237)
T cd05576 156 I-SEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ-LLQFNPTERLGAGVAGVEDIKS 233 (237)
T ss_pred C-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHH-HccCCHHHhcCCCccchHHHHc
Confidence 5 678999999999999999999998874221111100000 001123455566666 999999999984 99999
Q ss_pred CCch
Q 014307 376 LSYF 379 (427)
Q Consensus 376 ~~~~ 379 (427)
||||
T Consensus 234 h~~~ 237 (237)
T cd05576 234 HPFF 237 (237)
T ss_pred CCCC
Confidence 9996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=268.06 Aligned_cols=248 Identities=23% Similarity=0.414 Sum_probs=199.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|.+++.||+|+|++|.+++++.+.+.+|+|++++. +.+-+..|-.+..+..+||.+|.+..+|.. +..+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence 46899999999999999999999999999999999752 224467788888888899999999999965 6789
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee-ecCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~-~~~~ 282 (427)
++|.||++||+|.... ++++++.++.+..+|+.||.|||+.|||+||||.+|||+|.+| .+||+|+|+++. +.++
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmcke~l~~g 405 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhhcCCCCC
Confidence 9999999999986554 4699999999999999999999999999999999999999998 899999999864 3456
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC------CCCCHHHHHHHH--HHhCCh----H
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY------GHDNYDQLVKIA--KVLGTD----E 350 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~------~~~~~~~l~~i~--~~~~~~----~ 350 (427)
....+.+||+.|.|||++.+ ..|++.+|+|+|||+++||+.|+.||.- ..+..+.+.+++ +.+.-| -
T Consensus 406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv 484 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV 484 (593)
T ss_pred cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence 66788999999999999998 7999999999999999999999999951 112223333222 111111 1
Q ss_pred HHHHHHhccCCCChhHHHH------HhHHhcCCchhhHHH
Q 014307 351 LNAYLNKYHIELDPHLAAL------VGRLVILSYFFQFVI 384 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~------~~~ll~~~~~~~~~~ 384 (427)
-..-+.+-.++.||..|.- +.++-.|+||.-..+
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 1122334456778877653 567788888876554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=282.54 Aligned_cols=246 Identities=24% Similarity=0.427 Sum_probs=198.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
.++|-++..||+|||++||+|.+...++.||||+-...+ .+..-+|.+|-+.| +||.||++|++|.-.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfslD- 539 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSLD- 539 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeeec-
Confidence 467889999999999999999999999999999864211 13456899999999 999999999999864
Q ss_pred CCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC--CceeeccCCCceEEcCCC--CeEEEEeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ--GIMHRDVKPHNVMIDHEQ--RKLRLIDWGL 275 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~--~iiHrDlkp~NILl~~~~--~~ikl~DFGl 275 (427)
...+|-|+|||+|.+|..+++ -+++.+++.|+.||+.||.||.+. -|||-||||.|||+..+. +.|||+|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 456799999999999988875 499999999999999999999986 599999999999996432 3799999999
Q ss_pred eeeecCCCc--------ceeeccCccccccccccC---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH--H
Q 014307 276 AEFYHPGKE--------YNVRVASRYFKGPELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK--I 342 (427)
Q Consensus 276 a~~~~~~~~--------~~~~~~~~~y~aPE~~~~---~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~--i 342 (427)
++.+..+.. .....||-+|++||.+.- ....+.|+||||+|||+|..+.|+.||.......+.+.. |
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 998764321 123478999999999853 245789999999999999999999999655555555442 2
Q ss_pred HHHh---------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 343 AKVL---------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 343 ~~~~---------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
.+.- -++...+||.+ |+.+.-+-|..+.+|-.+|+|.-
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRR-CLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRR-CLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHH-HHHhhhhhhhhHHHHccCccccc
Confidence 2221 12455566666 88888888888888888888654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=270.17 Aligned_cols=228 Identities=17% Similarity=0.252 Sum_probs=169.8
Q ss_pred eeeecCCeeEEEEEEcCC--CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecC
Q 014307 141 KVGRGKYSEVFEGVHCTD--NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~--~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 214 (427)
+||+|+||.||+|....+ ...+++|.++.. ..+.+.+|+.+++.+ +||||+++++.+.. ....++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecC--CCccEEEEecCC
Confidence 599999999999975433 245667776532 235688999999999 99999999999976 456899999999
Q ss_pred CCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC---c
Q 014307 215 NTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---E 284 (427)
Q Consensus 215 ~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~---~ 284 (427)
+++|..++. ..+...++.++.||+.||+|||+++++||||||+|||++.++ .+||+|||++....... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhhc
Confidence 999876653 245667788999999999999999999999999999999777 89999999986432211 1
Q ss_pred ceeeccCccccccccccC------CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 285 YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGvll~elltg-~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
.....++..|+|||++.. ...++.++|||||||++|||+++ ..|| ...++.+.+..+.+...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY-SHLSDREVLNHVIKDQQVKLFKPQLEL 236 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHhhcccccCCCccCC
Confidence 123467788999999743 12457899999999999999975 5566 55555555554433211
Q ss_pred --ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 --TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 --~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+.+++.. |+ .+|+.||+++++++
T Consensus 237 ~~~~~~~~l~~~-c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 237 PYSERWYEVLQF-CW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCcHHHHHHHHH-Hh-hCcccCCCHHHHHH
Confidence 1233333333 65 67888888887753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=284.35 Aligned_cols=244 Identities=18% Similarity=0.267 Sum_probs=198.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCC---eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++..+.++||+|.||.|++|.+...+ ..||||+++... ...|.+|+.+|.+| +|+|+++|||++.+ ..
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl~---qp 184 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVLD---QP 184 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeecc---ch
Confidence 345667789999999999999986533 468999997533 46799999999999 99999999999975 34
Q ss_pred cEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
+.+|+|.+..|+|...+. .|.......|+.||+.||.||.++++|||||.++|+|+-... .|||+||||.+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFGLMRALG 263 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeecccceeccC
Confidence 779999999999876654 377788899999999999999999999999999999998755 89999999999886
Q ss_pred CCCcceee----ccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC------Ch
Q 014307 281 PGKEYNVR----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG------TD 349 (427)
Q Consensus 281 ~~~~~~~~----~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~------~~ 349 (427)
.++.+... .-...|.|||.+.. ..++.++|||++||+||||++ |+.|| .+....+.+..|.+.-. .+
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW-~G~~g~qIL~~iD~~erLpRPk~cs 341 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPW-VGCRGIQILKNIDAGERLPRPKYCS 341 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCC-CCCCHHHHHHhccccccCCCCCCCh
Confidence 66544322 22335999999876 799999999999999999997 77888 78888888887764321 23
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+..+.+.||...|.-||++..|...-+..++.
T Consensus 342 edIY~imk~cWah~paDRptFsair~~~~l~eaq 375 (1039)
T KOG0199|consen 342 EDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQ 375 (1039)
T ss_pred HHHHHHHHHhccCCccccccHHHHHHhHHHHhcC
Confidence 4444455559999999999999887666655533
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=307.57 Aligned_cols=230 Identities=20% Similarity=0.282 Sum_probs=178.4
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 214 (427)
.+...+.||+|+||.||+|++..++..||||.++.... ....|+++++++ +|||||++++++.+ ....++||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l-~HpnIv~~~~~~~~--~~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKL-QHPNIVKLIGLCRS--EKGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhC-CCCCcceEEEEEEc--CCCCEEEEeCCC
Confidence 45667889999999999999988999999999864332 234678999999 99999999999976 456789999999
Q ss_pred CCchhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccC
Q 014307 215 NTDFKVLYPTLSDYDVRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291 (427)
Q Consensus 215 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~ 291 (427)
+++|..++..+++..+..++.|++.||+||| +.+|+||||||+||+++.++ ..++. ||.+...... ....++
T Consensus 767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~~---~~~~~t 841 (968)
T PLN00113 767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCTD---TKCFIS 841 (968)
T ss_pred CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-eccccccccC---CCcccc
Confidence 9999999988999999999999999999999 66999999999999999766 55654 6665433221 233678
Q ss_pred ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-----------------C---h--
Q 014307 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-----------------T---D-- 349 (427)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-----------------~---~-- 349 (427)
..|+|||++.+ ..++.++|||||||++|||++|+.||.........+....+... . .
T Consensus 842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 920 (968)
T PLN00113 842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI 920 (968)
T ss_pred ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHH
Confidence 89999999876 78999999999999999999999998543222222222111100 0 0
Q ss_pred -HHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 350 -ELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 350 -~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...+ +...|+..+|+.||++.++++
T Consensus 921 ~~~~~-l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 921 VEVMN-LALHCTATDPTARPCANDVLK 946 (968)
T ss_pred HHHHH-HHHhhCcCCchhCcCHHHHHH
Confidence 1112 334488888888888777654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=273.13 Aligned_cols=195 Identities=27% Similarity=0.502 Sum_probs=170.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhc--CCCCeeeeeeEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLC--GGPNIVKLLDIVR 199 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~--~h~niv~l~~~~~ 199 (427)
..+|..++.||.|+||.|++|.++.+...|+||.+.+.+ ...+..||.||..|. .|+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 456999999999999999999999999999999986533 123567999999992 3899999999998
Q ss_pred cCCCCCcEEEEeecCC-Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 200 DQQSKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 200 ~~~~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
+ +.+.||+||.-.. .+|..++ +++.+.+++.|.+|++.|+++||+.||||||||-+||.++.+| .+||+|||.
T Consensus 640 d--dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidfgs 716 (772)
T KOG1152|consen 640 D--DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFGS 716 (772)
T ss_pred c--CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEeeccc
Confidence 7 6678899997654 4565555 4799999999999999999999999999999999999999888 899999999
Q ss_pred eeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 014307 276 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331 (427)
Q Consensus 276 a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~ 331 (427)
|... ........+||..|.|||++.|....+..-|||+||++||-++..+.||+.
T Consensus 717 aa~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAYT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9755 455678899999999999999866678889999999999999999999963
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=250.13 Aligned_cols=228 Identities=31% Similarity=0.544 Sum_probs=189.1
Q ss_pred CCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhh
Q 014307 146 KYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221 (427)
Q Consensus 146 ~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~ 221 (427)
+||.||+|.+..+++.+|+|++.... .+.+.+|++.++++ +|+|++++++++.. ....++++|++.+++|..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHH
Confidence 58999999998889999999987533 47789999999999 99999999999876 4568899999999988877
Q ss_pred cCC---CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCccccccc
Q 014307 222 YPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298 (427)
Q Consensus 222 ~~~---~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE 298 (427)
+.. ++...+..++.+++.+|.+||+.+++|+||+|+||+++.++ .++|+|||.+.............++..|++||
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCCcCCCCHH
Confidence 642 78899999999999999999999999999999999999776 89999999998776554555667888899999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHHhccCCCChhHHHH
Q 014307 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNKYHIELDPHLAAL 369 (427)
Q Consensus 299 ~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~~~l~~dp~~r~~ 369 (427)
.+.+ ..++.++||||||+++++|++|..||....+.......+.+... ...+..++.+ |+..+|..||+
T Consensus 157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~~p~~Rp~ 234 (244)
T smart00220 157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRK-LLVKDPEKRLT 234 (244)
T ss_pred HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHH-HccCCchhccC
Confidence 9875 67888999999999999999999999543333333333322211 2344555555 99999999999
Q ss_pred HhHHhcCCch
Q 014307 370 VGRLVILSYF 379 (427)
Q Consensus 370 ~~~ll~~~~~ 379 (427)
+.++++++||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999996
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=275.03 Aligned_cols=247 Identities=19% Similarity=0.284 Sum_probs=171.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc----------------CCCeEEEEEEeccccH---HH--------------HHHH
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC----------------TDNEKCIIKILKPVKK---KK--------------IKRE 178 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~----------------~~~~~vavK~~~~~~~---~~--------------~~~E 178 (427)
..++|++.++||+|+||.||+|.+. ..++.||||.++.... +. ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 2346799999864221 11 2346
Q ss_pred HHHHHHhcCCCC-----eeeeeeEEEcC------CCCCcEEEEeecCCCchhhhcC------------------------
Q 014307 179 IKILQNLCGGPN-----IVKLLDIVRDQ------QSKTPSLIFEHVNNTDFKVLYP------------------------ 223 (427)
Q Consensus 179 ~~il~~l~~h~n-----iv~l~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~------------------------ 223 (427)
+.++.++ +|.+ +++++++|... .....++||||+.+++|..++.
T Consensus 223 ~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 223 AYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777 4443 46777777532 1345789999999998866542
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceee--ccCccccccc
Q 014307 224 ---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPE 298 (427)
Q Consensus 224 ---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~--~~~~~y~aPE 298 (427)
.+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||++............ .+++.|+|||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 124556788999999999999999999999999999999776 8999999999765443332222 3478899999
Q ss_pred cccCCCC-------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCC---CCHHH----HHHHHHH----
Q 014307 299 LLVDLQD-------------------Y--DYSLDLWSLGCMFAGMIFRKE-PFFYGH---DNYDQ----LVKIAKV---- 345 (427)
Q Consensus 299 ~~~~~~~-------------------~--~~~~DvwSlGvll~elltg~~-pf~~~~---~~~~~----l~~i~~~---- 345 (427)
.+..... | ..+.||||+||++++|++|.. ||.... .+... +..+...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 9753110 1 134799999999999999986 552111 01110 1111000
Q ss_pred -------hCChHHHHHHHhccCCCCh---hHHHHHhHHhcCCchhh
Q 014307 346 -------LGTDELNAYLNKYHIELDP---HLAALVGRLVILSYFFQ 381 (427)
Q Consensus 346 -------~~~~~~~~~l~~~~l~~dp---~~r~~~~~ll~~~~~~~ 381 (427)
...+...+++.+ ++..+| ..|+++.++|.||||..
T Consensus 461 ~~~~~~d~~s~~~~dLi~~-LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 461 YDFSLLDRNKEAGWDLACK-LITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CCcccccccChHHHHHHHH-HhccCCCCcccCCCHHHHhCCCCcCC
Confidence 012344555666 555544 68999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.9e-34 Score=279.40 Aligned_cols=272 Identities=23% Similarity=0.398 Sum_probs=221.7
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
+.+++|+++..+|.|+||.||+++++.+++..|+|+++-. ..+-+.+|+-+++.. +|||||.+++.+-. ...+.
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsylr--~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYLR--RDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhhh--hcCcE
Confidence 3568899999999999999999999999999999999743 345578899999997 99999999998865 45578
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-C
Q 014307 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~ 283 (427)
+.||||.+|+|+..+. .+++.++.+..++.++||+|||++|=+|||||-.|||+++.+ .+|++|||.+..+... .
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATIA 167 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhhhh
Confidence 9999999999988764 689999999999999999999999999999999999999877 8999999998655322 3
Q ss_pred cceeeccCcccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-----------ChH
Q 014307 284 EYNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-----------TDE 350 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-----------~~~ 350 (427)
+.....||++|||||+.. ..+.|...+|||++|+...|+---+.|.+ ...++..+..+.+-.- ++.
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf-dlhpmr~l~LmTkS~~qpp~lkDk~kws~~ 246 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF-DLHPMRALFLMTKSGFQPPTLKDKTKWSEF 246 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc-ccchHHHHHHhhccCCCCCcccCCccchHH
Confidence 346679999999999962 23579999999999999999988887774 3344555554444321 134
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCC
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGES 422 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~ 422 (427)
+..|+.. ++..+|..||+.+.+|.|+|....+ ......++|.+ ++||. +.+.|.++.
T Consensus 247 fh~fvK~-altknpKkRptaeklL~h~fvs~~l---------~~rl~~eLLdK---~n~P~--~~v~~~~d~ 303 (829)
T KOG0576|consen 247 FHNFVKG-ALTKNPKKRPTAEKLLQHPFVSQTL---------SRRLAIELLDK---VNNPN--PVVRYLEDY 303 (829)
T ss_pred HHHHHHH-HhcCCCccCCChhhheeceeeccch---------hhHHHHHHHHH---ccCCC--CcccccccC
Confidence 4454444 8999999999999999999998765 56677777777 67887 666666654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=260.97 Aligned_cols=194 Identities=22% Similarity=0.323 Sum_probs=163.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeeeeEEEcCC--CCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQ--SKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~~h~niv~l~~~~~~~~--~~~~~lv 209 (427)
.+..++.+.||+|.||.||+|.. +++.||||++....+..+.+|-+|.... ..|+||+++++.-.-.. ...+.||
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 34566788999999999999985 6799999999988889999999888763 38999999999754322 3467899
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---------CceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---------~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
+||...|+|.+++. .+++.+..+++..+++||+|||+. .|+|||||..||||..|. ++.|+|||+|..
T Consensus 287 t~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~ 365 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGLALR 365 (534)
T ss_pred eeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccceeEE
Confidence 99999999998886 489999999999999999999963 599999999999999887 899999999988
Q ss_pred ecCCCc---ceeeccCccccccccccCCCCCC-----chhhHHHHHHHHHHHHhCCCCC
Q 014307 279 YHPGKE---YNVRVASRYFKGPELLVDLQDYD-----YSLDLWSLGCMFAGMIFRKEPF 329 (427)
Q Consensus 279 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~-----~~~DvwSlGvll~elltg~~pf 329 (427)
+.++.. ....+||..|||||++.+--.+. .+.||||+|.+||||+++..-+
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~ 424 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA 424 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence 876543 34479999999999987633333 3689999999999999865444
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=256.36 Aligned_cols=212 Identities=19% Similarity=0.318 Sum_probs=170.5
Q ss_pred cccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeeeeEEEcCC--CC
Q 014307 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQ--SK 204 (427)
Q Consensus 128 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~~h~niv~l~~~~~~~~--~~ 204 (427)
+|..-..+..+.+.||+|.||+||+|++ .|+.||||++...+.....+|.+|.+.. .+|+||+.+++.-...+ ..
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 3434456788999999999999999997 5899999999988889999999998862 49999999998644322 23
Q ss_pred CcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC--------CceeeccCCCceEEcCCCCeEEEEeee
Q 014307 205 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~~ikl~DFG 274 (427)
.++||++|.+.|+|.+++. .++.....+++..++.||++||.. .|.|||||..|||+..++ .+.|+|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeece
Confidence 5799999999999998886 488889999999999999999963 499999999999999888 89999999
Q ss_pred eeeeecCCC-----cceeeccCccccccccccCCCC---C-C-chhhHHHHHHHHHHHHh----------CCCCCCCC--
Q 014307 275 LAEFYHPGK-----EYNVRVASRYFKGPELLVDLQD---Y-D-YSLDLWSLGCMFAGMIF----------RKEPFFYG-- 332 (427)
Q Consensus 275 la~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~---~-~-~~~DvwSlGvll~ellt----------g~~pf~~~-- 332 (427)
||.....+. ..+.++||..|||||++.+.-. + + ..+||||||.++||+.- -+.||+.-
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 997765442 3467899999999999854211 1 1 35899999999999864 25677533
Q ss_pred -CCCHHHHHHH
Q 014307 333 -HDNYDQLVKI 342 (427)
Q Consensus 333 -~~~~~~l~~i 342 (427)
+...+.+.++
T Consensus 442 ~DPs~eeMrkV 452 (513)
T KOG2052|consen 442 SDPSFEEMRKV 452 (513)
T ss_pred CCCCHHHHhcc
Confidence 2344555433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-33 Score=280.67 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=190.0
Q ss_pred EEEEeeeeecCCee-EEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecC
Q 014307 136 YEVVRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (427)
Q Consensus 136 y~~~~~LG~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 214 (427)
|.-.+.+|.|+.|+ ||+|.. .|+.||||.+-....+...+|+..|+.--.|||||++++.- .+..++|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhh
Confidence 44456789999997 799986 78899999987777778899999999988999999998764 44778899999998
Q ss_pred CCchhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC---CC-CeEEEEeeeeeeeecCCC
Q 014307 215 NTDFKVLYPT-------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQ-RKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 215 ~~~l~~~~~~-------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~-~~ikl~DFGla~~~~~~~ 283 (427)
... ..++.. ....+.+.++.|++.||++||+.+||||||||.||||+. ++ ..++|+|||+++.+..+.
T Consensus 587 ~sL-~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 CSL-QDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred hhH-HHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 643 222221 122456788899999999999999999999999999986 23 479999999999887664
Q ss_pred c----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCHHHHHHHHHHh------CChH--
Q 014307 284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVL------GTDE-- 350 (427)
Q Consensus 284 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg-~~pf~~~~~~~~~l~~i~~~~------~~~~-- 350 (427)
. .....||..|+|||++.. ..-+.++||+||||++|+.++| ..||. +..+.-..|.+.. .+..
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFG---d~~~R~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFG---DSLERQANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred chhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCC---chHHhhhhhhcCccceeeeccCchH
Confidence 3 344578999999999987 4556799999999999999886 88983 3344433333321 1222
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhh
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYY 389 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~ 389 (427)
....++..|+..+|..||++.++|.||+|+........+
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl 780 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFL 780 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHH
Confidence 444455559999999999999999999999877544333
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=274.83 Aligned_cols=237 Identities=23% Similarity=0.369 Sum_probs=187.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-------CCeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
.++.++.+.||.|.||.|++|.... ....||||.++. ...+.+..|+++|+.+..|+||+.++|++..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~- 373 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ- 373 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc-
Confidence 3455677899999999999997431 256799999874 2346789999999999889999999999987
Q ss_pred CCCCcEEEEeecCCCchhhhcC--C-----------------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEc
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP--T-----------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~--~-----------------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~ 262 (427)
...+++|+||+..|+|..+++ + ++..+...++.||+.|++||++.++|||||.++|||+.
T Consensus 374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 677899999999999877652 3 78889999999999999999999999999999999999
Q ss_pred CCCCeEEEEeeeeeeeecCCCcceeec----cCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC-CH
Q 014307 263 HEQRKLRLIDWGLAEFYHPGKEYNVRV----ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHD-NY 336 (427)
Q Consensus 263 ~~~~~ikl~DFGla~~~~~~~~~~~~~----~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~-~~ 336 (427)
.+. .+||+|||+|+.......+.... -...|||||.+.. ..|+.++|||||||+||||++ |..|| ++.. ..
T Consensus 453 ~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PY-p~~~~~~ 529 (609)
T KOG0200|consen 453 KNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPY-PGIPPTE 529 (609)
T ss_pred CCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCC-CCCCcHH
Confidence 765 89999999998665544443222 1334999999987 799999999999999999998 56666 6544 44
Q ss_pred HHHHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 337 DQLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 337 ~~l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+..+.+... .+++.. +.+.||..+|+.||+..++..
T Consensus 530 ~l~~~l~~G~r~~~P~~c~~eiY~-iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 530 ELLEFLKEGNRMEQPEHCSDEIYD-LMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHH-HHHHHhCCCcccCCCHHHHHH
Confidence 44443443322 234443 455599999999998777543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=268.72 Aligned_cols=232 Identities=19% Similarity=0.333 Sum_probs=184.1
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCe----EEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.+..++||.|+||+||+|.+...++ +||||++.. .+..++..|+-+|..+ +|||++++++++... .+.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s---~~q 773 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLS---TLQ 773 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccc---hHH
Confidence 4556889999999999999866554 688998853 3457899999999999 999999999999753 377
Q ss_pred EEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
||++||..|.|.++.+ .+..++.+.+..||++||.|||.+++|||||-++|||+...+ .+||.|||+|+...++.
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhccCccc
Confidence 9999999999877753 588899999999999999999999999999999999999766 89999999999887654
Q ss_pred c-ceeecc--CccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH--hCC-----hHHH
Q 014307 284 E-YNVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV--LGT-----DELN 352 (427)
Q Consensus 284 ~-~~~~~~--~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~--~~~-----~~~~ 352 (427)
. +....| ..-|||=|.+.. ..|+.++|||||||++||++| |..|++ +....+.-..+.+. +.. -+..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~-gi~~~eI~dlle~geRLsqPpiCtiDVy 930 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYD-GIPAEEIPDLLEKGERLSQPPICTIDVY 930 (1177)
T ss_pred ccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccC-CCCHHHhhHHHhccccCCCCCCccHHHH
Confidence 3 333222 345999998876 799999999999999999987 888884 33333332222222 222 2555
Q ss_pred HHHHhccCCCChhHHHHHhHHhc
Q 014307 353 AYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
..+.+ ||-.|+..||.++++..
T Consensus 931 ~~mvk-Cwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 931 MVMVK-CWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHH-HhccCcccCccHHHHHH
Confidence 55666 89999999998777643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=230.96 Aligned_cols=192 Identities=33% Similarity=0.624 Sum_probs=166.6
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
|.+.+.||.|++|.||+|.+..+++.+|+|.+... ..+.+.+|++.++++ +|+|++++++++.. ....++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~--~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFED--PEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeec--CCceEEEEe
Confidence 45778999999999999999888999999999754 456788999999999 99999999999876 456889999
Q ss_pred ecCCCchhhhcC---C-CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--cc
Q 014307 212 HVNNTDFKVLYP---T-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EY 285 (427)
Q Consensus 212 ~~~~~~l~~~~~---~-~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~--~~ 285 (427)
++.+++|..++. . +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++ .++|+|||.+....... ..
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccccc
Confidence 999988877763 2 78889999999999999999999999999999999999776 89999999998775543 33
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~ 331 (427)
....++..|++||.+.+...++.++|||+||+++++|++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4567778899999973336788899999999999999999999943
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=232.63 Aligned_cols=195 Identities=21% Similarity=0.395 Sum_probs=160.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.+.|.|.+.||+|.||.+-+|+++.+++.+++|.+.. .....|.+|..-=-.|..|.||+.-|++--.. ....++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEEee
Confidence 4779999999999999999999999999999999864 33577888887666677899999988864332 45778999
Q ss_pred eecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE-cCCCCeEEEEeeeeeeeecCCCccee
Q 014307 211 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNV 287 (427)
Q Consensus 211 e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl-~~~~~~ikl~DFGla~~~~~~~~~~~ 287 (427)
||++.|+|..-.. .+.+...+.++.|++.||+|+|++++||||||.+|||| +.+...|||||||+.+.. +.....
T Consensus 102 E~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~--g~tV~~ 179 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV--GTTVKY 179 (378)
T ss_pred ccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccccc--Cceehh
Confidence 9999999987765 47888899999999999999999999999999999997 566679999999998642 222222
Q ss_pred eccCccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 014307 288 RVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFF 330 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGvll~elltg~~pf~ 330 (427)
..-+..|.+||+.... -...+.+|||.||+++|.++||+.||.
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 3344568899986431 124678999999999999999999995
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-28 Score=217.08 Aligned_cols=205 Identities=30% Similarity=0.544 Sum_probs=174.5
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCc
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~ 217 (427)
||.|++|.||++....+++.+++|++..... +.+.+|+.+++.+ .|++++++++++.. ....++++|++.+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFED--ENHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeec--CCeEEEEEecCCCCc
Confidence 6899999999999977799999999986544 6789999999999 88999999999976 367889999999999
Q ss_pred hhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC-CCCeEEEEeeeeeeeecCCC-cceeeccC
Q 014307 218 FKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGK-EYNVRVAS 291 (427)
Q Consensus 218 l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~ikl~DFGla~~~~~~~-~~~~~~~~ 291 (427)
+..++. .++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++ .++|+|||.+....... ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchhhcccCC
Confidence 887764 4788999999999999999999999999999999999997 45 89999999998664332 13335677
Q ss_pred ccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCChhHHHHHh
Q 014307 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 371 (427)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~ 371 (427)
..|++||.+.....++.+.|+|++|+++++| +.+.+++.. |+..+|..|+++.
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------~~~~~~l~~-~l~~~p~~R~~~~ 209 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------PELKDLIRK-MLQKDPEKRPSAK 209 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------HHHHHHHHH-HhhCCcccCcCHH
Confidence 7899999987633788999999999999999 444555555 8889999999999
Q ss_pred HHhcCC
Q 014307 372 RLVILS 377 (427)
Q Consensus 372 ~ll~~~ 377 (427)
++++++
T Consensus 210 ~l~~~~ 215 (215)
T cd00180 210 EILEHL 215 (215)
T ss_pred HHhhCC
Confidence 988753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=227.31 Aligned_cols=239 Identities=18% Similarity=0.320 Sum_probs=190.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCC-----eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
.++++++...+-+|.||+||.|.+...+ +.|-+|.++... ...+.+|.-.|..+ .|||+..+.++..+.
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~ie~- 359 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSIED- 359 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEeec-
Confidence 4577889999999999999999765433 445677765432 34577888888888 899999999998764
Q ss_pred CCCcEEEEeecCCCchhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEE
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~ 271 (427)
....+.++.++.-+.|..++. .++..+...++.|++.|++|||++|+||.||.++|++||+.- ++||+
T Consensus 360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L-qVklt 438 (563)
T KOG1024|consen 360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL-QVKLT 438 (563)
T ss_pred cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe-eEEec
Confidence 556788999999999887763 377788889999999999999999999999999999999654 99999
Q ss_pred eeeeeeeecCCCcce---eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH--
Q 014307 272 DWGLAEFYHPGKEYN---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV-- 345 (427)
Q Consensus 272 DFGla~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~-- 345 (427)
|=.+++-+-+.+... ....+..||+||.+.+ ..|+..+|||||||+||||+| |+.|+ ...+++|.-..+.+.
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Py-aeIDPfEm~~ylkdGyR 516 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPY-AEIDPFEMEHYLKDGYR 516 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCc-cccCHHHHHHHHhccce
Confidence 999998765554321 1233456999999987 789999999999999999997 78887 667777777666654
Q ss_pred ----hCChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 346 ----LGTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 346 ----~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.|+..--+.-+||...|+.||+.+++..
T Consensus 517 laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 517 LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 334554444566699999999999888654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-28 Score=259.49 Aligned_cols=188 Identities=10% Similarity=0.152 Sum_probs=134.7
Q ss_pred CCeeeeeeEEEc-----CCCCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCce
Q 014307 189 PNIVKLLDIVRD-----QQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 259 (427)
Q Consensus 189 ~niv~l~~~~~~-----~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 259 (427)
+||++++++|.. .....+++++|++.+ +|..++. .+++.+++.++.||+.||+|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECEDV-SLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCCc-cHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 577777776621 112456778888755 6665552 389999999999999999999999999999999999
Q ss_pred EEcCC------------------CCeEEEEeeeeeeeecCCC-----------------cceeeccCccccccccccCCC
Q 014307 260 MIDHE------------------QRKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLVDLQ 304 (427)
Q Consensus 260 Ll~~~------------------~~~ikl~DFGla~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~ 304 (427)
||+.. ...+|++|||+++...... .....+||++|||||++.+ .
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~ 190 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-S 190 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-C
Confidence 99532 2256777777775421100 0012357889999999887 6
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHHhccCCCChhHHHHHhHHhcCC
Q 014307 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRLVILS 377 (427)
Q Consensus 305 ~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~ 377 (427)
.|+.++|||||||+||||++|..|+... ...+..+.... ..+....++. .|+..+|..||++.+++.||
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQILLNWPKEASFCL-WLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChhhhhcCHHHHHHHH-HhCCCChhhCcChHHHhhch
Confidence 7999999999999999999998876321 11222221111 1223334444 48999999999999999999
Q ss_pred chhhH
Q 014307 378 YFFQF 382 (427)
Q Consensus 378 ~~~~~ 382 (427)
|+.+.
T Consensus 267 ~~~~~ 271 (793)
T PLN00181 267 FINEP 271 (793)
T ss_pred hhhhh
Confidence 99763
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=221.13 Aligned_cols=158 Identities=18% Similarity=0.262 Sum_probs=125.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-CCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeee-eeeEEEcCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVK-LLDIVRDQQ 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~h~niv~-l~~~~~~~~ 202 (427)
.++|.+.+.||+|+||+||+|+++. +++.+|||++... ....+.+|+++|+++ +|+|++. +++.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~~----- 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLAT----- 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEEc-----
Confidence 4679999999999999999998876 6788899986422 235588999999999 8999885 5432
Q ss_pred CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecc-CCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDl-kp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
...++||||+.+++|.... ... ...++.|++.||.|||++||+|||| ||+|||++.++ .+||+|||+|+.+..
T Consensus 91 -~~~~LVmE~~~G~~L~~~~-~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR-PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFRR 164 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC-ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccceeccc
Confidence 2468999999999986432 111 2467889999999999999999999 99999998766 799999999987654
Q ss_pred CCc---------ceeeccCccccccccccC
Q 014307 282 GKE---------YNVRVASRYFKGPELLVD 302 (427)
Q Consensus 282 ~~~---------~~~~~~~~~y~aPE~~~~ 302 (427)
... .....++..|+|||.+..
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 321 123466777999999743
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=202.33 Aligned_cols=258 Identities=20% Similarity=0.304 Sum_probs=194.1
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEec-cccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~-~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
-.|+++++||+|+||..+.|...-+++.||||.-. +.+.-++..|.+..+.|.+.+.|...|-+-.+ +.+=.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqe--G~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQE--GKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccc--cchhhhhhhh
Confidence 36999999999999999999999999999999753 33446788999999999888999998776543 5555688888
Q ss_pred cCCC--chhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC----CCeEEEEeeeeeeeecCCCc-
Q 014307 213 VNNT--DFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 213 ~~~~--~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~----~~~ikl~DFGla~~~~~~~~- 284 (427)
+... +|.++. ++|+...+..++.|++.-++|+|++.+|+|||||+|+||... ...|.|+|||+|+.+.+...
T Consensus 106 LGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tk 185 (449)
T KOG1165|consen 106 LGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTK 185 (449)
T ss_pred hCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcccc
Confidence 7654 344444 469999999999999999999999999999999999999643 34799999999998765432
Q ss_pred -------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CCCHHHHHHHHHHhCChHHHHHH
Q 014307 285 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG--HDNYDQLVKIAKVLGTDELNAYL 355 (427)
Q Consensus 285 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~--~~~~~~l~~i~~~~~~~~~~~~l 355 (427)
.....||..||+-....+ ..-+.+.|+-|||-++++.+-|..||..- .++.+...+|-..-..-++..
T Consensus 186 qHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~-- 262 (449)
T KOG1165|consen 186 QHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV-- 262 (449)
T ss_pred ccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH--
Confidence 234578999999888887 78899999999999999999999999432 233444444443333333333
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHh
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNF 404 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~ 404 (427)
.|..+.-++---+..+-+..|++.+. |+++ .+.+.|+|++.
T Consensus 263 --Lc~g~P~efa~Yl~yvR~L~F~E~PD---Ydyl---r~Lf~dvldr~ 303 (449)
T KOG1165|consen 263 --LCEGFPEEFATYLRYVRRLDFFETPD---YDYL---RKLFDDVLDRL 303 (449)
T ss_pred --HHhcCHHHHHHHHHHHHhcCcccCCC---HHHH---HHHHHHHHHhc
Confidence 24444446666666777778887766 4443 33444444443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=207.22 Aligned_cols=193 Identities=24% Similarity=0.338 Sum_probs=155.8
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCC-eEEEEEEecccc---HHHHHHHHHHHHHhc---CCCCeeeeeeEEEcCCCCCcE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPVK---KKKIKREIKILQNLC---GGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~-~~vavK~~~~~~---~~~~~~E~~il~~l~---~h~niv~l~~~~~~~~~~~~~ 207 (427)
+|++.++||+|+||.||+|.+..++ ..+|+|+..... ...+..|+.++..+. ...++..+++... ....+-+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 8999999999999999999987664 688999876432 226889999999985 2368899988874 2245667
Q ss_pred EEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC----CeEEEEeeeeeee
Q 014307 208 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEF 278 (427)
Q Consensus 208 lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~~ikl~DFGla~~ 278 (427)
+||+.+... |..+. +.++...+..++.|++.+|++||+.|++||||||+|+++.... ..+.|.|||+|+.
T Consensus 98 iVM~l~G~s-L~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLLGPS-LEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEeccCcc-HHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 887766554 33332 4699999999999999999999999999999999999998653 4799999999983
Q ss_pred ec--CCC--------c-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 014307 279 YH--PGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330 (427)
Q Consensus 279 ~~--~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 330 (427)
+. ... . .....||..|.++.+..+ ...+.+.|+||++.++.||+.|..||.
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~ 238 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWE 238 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCc
Confidence 22 111 0 123458999999999887 789999999999999999999999993
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=189.41 Aligned_cols=196 Identities=21% Similarity=0.348 Sum_probs=160.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
..+.|.++++||.|+||.+|.|....+|..||||+-+.. ...++..|.++...|++...|+.+..+..+ ..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e--~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTE--KDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccc--cccceeee
Confidence 357899999999999999999999999999999987643 346688899999999777888888887765 45667999
Q ss_pred eecCCCc--hhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeeecCCCc-
Q 014307 211 EHVNNTD--FKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 211 e~~~~~~--l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~~~~~~- 284 (427)
+.+.... |..+. +.++...+..++-|++.-++|+|.+++|||||||+|+|+.-+. .++.|+|||+|+.+.+..+
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 9876542 23333 4699999999999999999999999999999999999986432 4789999999987754322
Q ss_pred -------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 014307 285 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330 (427)
Q Consensus 285 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 330 (427)
.....||..|.+--...+ ..-+.+.|+-|+|.+|.++.-|..||.
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCccc
Confidence 233467888877666655 466788999999999999999999994
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=193.14 Aligned_cols=144 Identities=19% Similarity=0.266 Sum_probs=115.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCC
Q 014307 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303 (427)
Q Consensus 224 ~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~ 303 (427)
.+++.+++.++.||+.||.|||+++ ||+|||++.++ .+|+ ||+++...... ..|++.|+|||++.+
T Consensus 13 ~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~~----~~g~~~y~aPE~~~~- 78 (176)
T smart00750 13 PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPEQ----SRVDPYFMAPEVIQG- 78 (176)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeecccc----CCCcccccChHHhcC-
Confidence 4899999999999999999999999 99999999777 7888 99998764332 368899999999987
Q ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh---------------HHHHHHHhccCCCChhHHH
Q 014307 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD---------------ELNAYLNKYHIELDPHLAA 368 (427)
Q Consensus 304 ~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~---------------~~~~~l~~~~l~~dp~~r~ 368 (427)
..++.++|||||||++|||++|+.||.........+..+....... .+.+++.. |+..+|..||
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-cl~~~p~~Rp 157 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV-CASRLPQRRE 157 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH-HHhccccccc
Confidence 7899999999999999999999999954333233333333221111 35555555 9999999999
Q ss_pred HHhHHhcCCchhhH
Q 014307 369 LVGRLVILSYFFQF 382 (427)
Q Consensus 369 ~~~~ll~~~~~~~~ 382 (427)
++.+++.|+|+...
T Consensus 158 ~~~~ll~~~~~~~~ 171 (176)
T smart00750 158 AANHYLAHCRALFA 171 (176)
T ss_pred CHHHHHHHHHHHHH
Confidence 99999999997753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-23 Score=198.11 Aligned_cols=236 Identities=31% Similarity=0.499 Sum_probs=182.2
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCC-CeeeeeeEEEcCCCCCcEE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~-niv~l~~~~~~~~~~~~~l 208 (427)
|.+.+.||.|+||.||++.+. ..+++|.+... ....+.+|+.++..+ .|+ +++++.+.+.. ....++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~--~~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQD--EGSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEec--CCEEEE
Confidence 678899999999999999985 88899988642 245688999999999 655 89999999954 344789
Q ss_pred EEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 209 IFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 209 v~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+++++.++.+..... .+....+..++.|++.++.|+|+.+++|||+||+||+++..+..++++|||.+......
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999999885553 58889999999999999999999999999999999999976646999999999865443
Q ss_pred C-------cceeeccCccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhCCh--
Q 014307 283 K-------EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLGTD-- 349 (427)
Q Consensus 283 ~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~--~~~~l~~i~~~~~~~-- 349 (427)
. ......++..|+|||.+.+. ..++...|+||+|++++++++|..||..... ..............+
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 3 24667899999999998763 4788999999999999999999999743332 133333333332222
Q ss_pred --------------HHHHHHHhccCCCChhHHHHHhHHhcCCc
Q 014307 350 --------------ELNAYLNKYHIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 350 --------------~~~~~l~~~~l~~dp~~r~~~~~ll~~~~ 378 (427)
....++.. ++..+|..|........+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~r~~~~~~~~~~~ 277 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKK-LLAKDPKNRLSSSSDLSHDL 277 (384)
T ss_pred ccccCccccchhhHHHHHHHHH-HHhcCchhcCCHHHHhhchH
Confidence 23333334 55566666666666555533
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=190.45 Aligned_cols=168 Identities=14% Similarity=0.192 Sum_probs=130.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HH---------HHHHHHHHHHHhcCCCCeeeeeeEEEc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KK---------KIKREIKILQNLCGGPNIVKLLDIVRD 200 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~---------~~~~E~~il~~l~~h~niv~l~~~~~~ 200 (427)
.++|++.+.||.|+||.||++.. ++..+|||++++.. .. .+.+|+..+.++ .|++|..+.+++..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~~~ 106 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFYLL 106 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEeeee
Confidence 58899999999999999999755 57789999996422 11 157899999999 99999999998764
Q ss_pred CC------CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeee
Q 014307 201 QQ------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (427)
Q Consensus 201 ~~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFG 274 (427)
.. ....+++|||++|.++.+.. .+++ ....+++.+|..||+.|++|||+||.||+++.++ ++|+|||
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDfg 179 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDLS 179 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEECC
Confidence 32 23578999999999987763 2333 3456999999999999999999999999999765 9999999
Q ss_pred eeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHH
Q 014307 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM 322 (427)
Q Consensus 275 la~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~el 322 (427)
............. .+.. ..|+.++|+|+||+++..+
T Consensus 180 ~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 180 GKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHH
Confidence 8865432221111 2233 5677899999999987654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-24 Score=224.06 Aligned_cols=250 Identities=23% Similarity=0.341 Sum_probs=184.4
Q ss_pred EEEeeeeecCCeeEEEEEEcCCCeEEEEEEec----cccH-----HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 137 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~----~~~~-----~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.....+|.|++|.|+.+........++.|..+ +... ..+..|+.+-..+ .|+|++..+..+.+... ..
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~--~~ 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDG--IL 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhccc--ch
Confidence 45678999999988888877777766666543 1111 1144566666667 89999888777665322 22
Q ss_pred EEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
-.||||.. +|..++. .+...++..+++|++.||+|||+.||.|||||++|+++..++ .+||+|||.+..+..+.+
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcc
Confidence 33999999 7765553 589999999999999999999999999999999999999887 899999999987754433
Q ss_pred -----ceeeccCccccccccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhc
Q 014307 285 -----YNVRVASRYFKGPELLVDLQDYDY-SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358 (427)
Q Consensus 285 -----~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~ 358 (427)
....+|+..|+|||++.+ ..|++ .+||||.|+++..|++|+.||.......++.
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~-~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------------------- 535 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTG-KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------------------- 535 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccc-cccCcchhhhhhccceEEEEecCCCccccccccccch-------------------
Confidence 345688999999999987 56665 5899999999999999999995443322222
Q ss_pred cCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 359 HIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
.+.....|++.+ ..++..+..+...+..+|.+|| +.+|++|++++.++++++.
T Consensus 536 ------------~~~~~~~~~~~~-~~~~~~~~~lp~~~~~~~~~~l-~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 536 ------------KTNNYSDQRNIF-EGPNRLLSLLPRETRIIIYRML-QLDPTKRITIEQILNDEWI 588 (601)
T ss_pred ------------hhhccccccccc-cChHHHHHhchhhHHHHHHHHc-cCChhheecHHHHhhChHh
Confidence 000011111111 1122334456778899999999 5999999999999998874
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.2e-23 Score=181.41 Aligned_cols=182 Identities=17% Similarity=0.137 Sum_probs=138.2
Q ss_pred EEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
+...|++|+||+|+.+.. .+.+++.+.+.... ...+.+|+++|++|.+++++++++++. ..+++|
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lvm 77 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLDR 77 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEEE
Confidence 457899999999998764 67888877765322 225789999999997778999998862 257999
Q ss_pred eecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeecc-CCCceEEcCCCCeEEEEeeeeeeeecCCCcc----
Q 014307 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---- 285 (427)
Q Consensus 211 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDl-kp~NILl~~~~~~ikl~DFGla~~~~~~~~~---- 285 (427)
||+.|.+|...... ....+..|++.+|+++|++||+|||| ||+|||++.++ .++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 78 SYLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eeecCccHHhhhhh----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHH
Confidence 99999988654321 12457789999999999999999999 79999999776 7999999999865443321
Q ss_pred e----------eeccCccccccccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCC
Q 014307 286 N----------VRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYG 332 (427)
Q Consensus 286 ~----------~~~~~~~y~aPE~~~~~~~~~-~~~DvwSlGvll~elltg~~pf~~~ 332 (427)
. -...++.|+.|+.-.-....+ ...++++.|+-+|.++|++.+.+.+
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 012455677776643322334 5679999999999999999988654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=181.44 Aligned_cols=133 Identities=20% Similarity=0.253 Sum_probs=104.4
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH-----------------------------HHHHHHHHHHHHhcCCC
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----------------------------KKIKREIKILQNLCGGP 189 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----------------------------~~~~~E~~il~~l~~h~ 189 (427)
...||+|+||.||+|.+. +|+.||||++++... ....+|+++|.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 357999999999999986 899999999975311 1123599999999 666
Q ss_pred CeeeeeeEEEcCCCCCcEEEEeecCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHH-HHCCceeeccCCCceEEcCCC
Q 014307 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHEQ 265 (427)
Q Consensus 190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~L-H~~~iiHrDlkp~NILl~~~~ 265 (427)
++.....+... . .++||||++++++... ...++..++..++.|++.+|.++ |+.||+||||||+|||++ ++
T Consensus 80 ~v~~p~~~~~~--~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 80 GIPCPEPILLK--S--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCCcEEEec--C--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 66433322211 1 3799999999766432 24688899999999999999999 799999999999999998 44
Q ss_pred CeEEEEeeeeeeee
Q 014307 266 RKLRLIDWGLAEFY 279 (427)
Q Consensus 266 ~~ikl~DFGla~~~ 279 (427)
.++|+|||+|...
T Consensus 155 -~v~LiDFG~a~~~ 167 (190)
T cd05147 155 -KLYIIDVSQSVEH 167 (190)
T ss_pred -cEEEEEccccccC
Confidence 7999999999743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=175.97 Aligned_cols=134 Identities=17% Similarity=0.211 Sum_probs=106.6
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------------------------HHHHHHHHHHHHHhcCCC
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGGP 189 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~il~~l~~h~ 189 (427)
.+.||+|+||.||+|.+. +|+.||||+++... ...+..|...+.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 467999999999999986 89999999987531 11235789999999 788
Q ss_pred CeeeeeeEEEcCCCCCcEEEEeecCCCchhhh-c--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCC
Q 014307 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQ 265 (427)
Q Consensus 190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~ 265 (427)
++.....+... ..++||||+.++++... + ..++..++..++.|++.+|.++|+ .||+||||||+|||++ ++
T Consensus 80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 77544443322 13799999998754222 2 357788899999999999999999 9999999999999998 55
Q ss_pred CeEEEEeeeeeeeec
Q 014307 266 RKLRLIDWGLAEFYH 280 (427)
Q Consensus 266 ~~ikl~DFGla~~~~ 280 (427)
.++|+|||+|....
T Consensus 155 -~~~liDFG~a~~~~ 168 (190)
T cd05145 155 -KPYIIDVSQAVELD 168 (190)
T ss_pred -CEEEEEcccceecC
Confidence 79999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-23 Score=205.96 Aligned_cols=229 Identities=25% Similarity=0.335 Sum_probs=178.3
Q ss_pred eeecCCeeEEEEEE---cCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 142 VGRGKYSEVFEGVH---CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 142 LG~G~fg~V~~~~~---~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
+|+|.||.|++++. ...+..+|+|++++.. +.....|..++..+++||.+|++...+.. ...+++++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt--~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT--DGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc--ccchhHhhhhc
Confidence 79999999998753 2346778888876421 12345688888888779999999999876 55677999999
Q ss_pred CCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeecc
Q 014307 214 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290 (427)
Q Consensus 214 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~ 290 (427)
.++++..... .+.+.....+...++.+++++|+.+|+|||+|++||+++.+| .+++.|||+++..-..+. .+|
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~---~cg 155 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKI---ACG 155 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhh---ccc
Confidence 9998876654 477888899999999999999999999999999999999888 899999999986543332 299
Q ss_pred CccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH-HhCChH----HHHHHHhccCCCChh
Q 014307 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK-VLGTDE----LNAYLNKYHIELDPH 365 (427)
Q Consensus 291 ~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~-~~~~~~----~~~~l~~~~l~~dp~ 365 (427)
+..|||||++. .+...+|+||||++++||++|..||.. +.+..|.+ .++.|. ..+-+...+...+|.
T Consensus 156 t~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 156 TYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPE 227 (612)
T ss_pred chhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHH
Confidence 99999999976 467899999999999999999999943 67777766 333321 111122335556666
Q ss_pred HHHH-----HhHHhcCCchhhHHH
Q 014307 366 LAAL-----VGRLVILSYFFQFVI 384 (427)
Q Consensus 366 ~r~~-----~~~ll~~~~~~~~~~ 384 (427)
.|-- +.++.+|++|+...+
T Consensus 228 nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 228 NRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred HHhccCcchhHHHhccchheeeeH
Confidence 6643 578889999887663
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.6e-22 Score=208.43 Aligned_cols=193 Identities=21% Similarity=0.409 Sum_probs=155.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhc--CCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~--~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..+.|.|-+.||+|+||+||+|.+.. |+.||+|+-++...-+|.--.+++.+|. --+-|..+...+...+. -++|
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~--S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA--SVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc--ceee
Confidence 34679999999999999999999855 9999999988776655444444555551 11344555554444434 3599
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC------CCCeEEEEeeeeee---
Q 014307 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------EQRKLRLIDWGLAE--- 277 (427)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~------~~~~ikl~DFGla~--- 277 (427)
+||...|+|..++. .+++..++.++.|++..++.||..+|||+||||+|+||.. +...++|+|||.+.
T Consensus 773 ~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 99999999988874 4899999999999999999999999999999999999942 23369999999984
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~p 328 (427)
.+.++......++|..+-.+|...| ..|++.+|.|.|+-+++.|+.|+..
T Consensus 853 lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 853 LFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHHH
Confidence 4445557788899999999999888 8999999999999999999999743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-21 Score=202.60 Aligned_cols=206 Identities=24% Similarity=0.412 Sum_probs=147.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
.++|+.++.|-.|+||.||.++|+.+.+.+|+|+-+. +.+.+- ||... +.|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq---~lilRn--ilt~a-~npfvv-------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ---NLILRN--ILTFA-GNPFVV-------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc---chhhhc--ccccc-CCccee--------------------
Confidence 3679999999999999999999999999999964431 222221 22222 444444
Q ss_pred cCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC---------
Q 014307 213 VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------- 283 (427)
Q Consensus 213 ~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~--------- 283 (427)
.+..++......++.. ++.+++|||+.||+|||+||+|.||+.-| .+|+.|||+++..-...
T Consensus 136 gDc~tllk~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 136 GDCATLLKNIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred chhhhhcccCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccchhhhcch
Confidence 1111222222333333 37899999999999999999999999777 89999999986432110
Q ss_pred -----c--ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHH
Q 014307 284 -----E--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 356 (427)
Q Consensus 284 -----~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~ 356 (427)
+ -...+||+.|.|||++.. +.|+..+|+|++|+|+||.+.|+.||+ ++.+.+.+..++.. ...|..
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpff-Gdtpeelfg~visd-----~i~wpE 279 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFF-GDTPEELFGQVISD-----DIEWPE 279 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeecc-CCCHHHHHhhhhhh-----hccccc
Confidence 0 123489999999999886 789999999999999999999999994 55566666555532 234444
Q ss_pred hccCCCChhHHHHHhHHhcCCchhh
Q 014307 357 KYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
. .....|+.+..+++||.+-...+
T Consensus 280 ~-dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 280 E-DEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred c-CcCCCHHHHHHHHHHHHhChHhh
Confidence 5 66777888888888887766555
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=169.23 Aligned_cols=133 Identities=20% Similarity=0.245 Sum_probs=103.4
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhc----CCCCeeeeeeEEEcCCC-CCcE-EE
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQQS-KTPS-LI 209 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~----~h~niv~l~~~~~~~~~-~~~~-lv 209 (427)
.+.||+|+||.||. ++.++.. +||++... ..+.+.+|+.+++.+. .||||++++|++++..+ ..++ +|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 36799999999995 6666666 69988653 4567899999999993 47999999999987532 3333 78
Q ss_pred Eee--cCCCchhhhcCC--CCHHHHHHHHHHHHHHH-HHHHHCCceeeccCCCceEEcCC---CCeEEEEeeeee
Q 014307 210 FEH--VNNTDFKVLYPT--LSDYDVRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLA 276 (427)
Q Consensus 210 ~e~--~~~~~l~~~~~~--~~~~~~~~i~~qi~~~L-~~LH~~~iiHrDlkp~NILl~~~---~~~ikl~DFGla 276 (427)
+|| +.+++|.+++.. +++. ..++.|++.++ +|||+++|+||||||+|||++.. ...++|+||+-+
T Consensus 84 ~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred ecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999 447899888753 4444 45678888888 99999999999999999999742 237999994444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.2e-21 Score=179.09 Aligned_cols=192 Identities=22% Similarity=0.321 Sum_probs=121.2
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcC---------CCCeeeeeeEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCG---------GPNIVKLLDIVR 199 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~---------h~niv~l~~~~~ 199 (427)
.+...+.||.|+++.||.+.+..+++.+|+|++.. ...+.+++|.-....+.+ |-.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46788999999999999999999999999999742 122445555543333211 212332233222
Q ss_pred cC---------CC---C---CcEEEEeecCCCchhhhcC------CC----CHHHHHHHHHHHHHHHHHHHHCCceeecc
Q 014307 200 DQ---------QS---K---TPSLIFEHVNNTDFKVLYP------TL----SDYDVRYYIYELLKALDYCHSQGIMHRDV 254 (427)
Q Consensus 200 ~~---------~~---~---~~~lv~e~~~~~~l~~~~~------~~----~~~~~~~i~~qi~~~L~~LH~~~iiHrDl 254 (427)
.+ .+ . ..+++|+-+.+ +|..+.. .. .......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 11 1 23556666643 4433321 11 12223445589999999999999999999
Q ss_pred CCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCC-------CCCCchhhHHHHHHHHHHHHhCCC
Q 014307 255 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAGMIFRKE 327 (427)
Q Consensus 255 kp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwSlGvll~elltg~~ 327 (427)
||+|++++.+| .++|+||+..... +........+..|.+||..... -.++.+.|.|+||+++|.|+++..
T Consensus 172 ~~~nfll~~~G-~v~Lg~F~~~~r~--g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDG-GVFLGDFSSLVRA--GTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS--EEE--GGGEEET--TEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCC-CEEEcChHHHeec--CceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999888 8999999988653 2222224455778899976431 247889999999999999999999
Q ss_pred CCC
Q 014307 328 PFF 330 (427)
Q Consensus 328 pf~ 330 (427)
||.
T Consensus 249 Pf~ 251 (288)
T PF14531_consen 249 PFG 251 (288)
T ss_dssp STC
T ss_pred CCC
Confidence 995
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=202.16 Aligned_cols=236 Identities=19% Similarity=0.329 Sum_probs=166.1
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHH-HHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il-~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+|...+.||.+.|=+|.+|++. .|. |+||++-+.. ...++++++-+ ..+.++||++.+.-+.+. ....|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t--~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT--DKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh--hHHHHHH
Confidence 5777899999999999999873 344 8999985433 23333333222 233489999999887554 5566788
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee--cCCC--
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY--HPGK-- 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~--~~~~-- 283 (427)
-+|........+-- -+..-+.+.|+.|++.||.-+|..||+|||||.+||||+.-+ -+.|+||..-+.. ..++
T Consensus 100 RqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN-WLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-hhhhhcccccCCccCCCCCcc
Confidence 88887765544432 267778889999999999999999999999999999999776 6899999876432 1111
Q ss_pred ccee----eccCccccccccccCCC---------C-CCchhhHHHHHHHHHHHHh-CCCCCC------CCCCCHHHHHHH
Q 014307 284 EYNV----RVASRYFKGPELLVDLQ---------D-YDYSLDLWSLGCMFAGMIF-RKEPFF------YGHDNYDQLVKI 342 (427)
Q Consensus 284 ~~~~----~~~~~~y~aPE~~~~~~---------~-~~~~~DvwSlGvll~ellt-g~~pf~------~~~~~~~~l~~i 342 (427)
.++. ...-.+|.|||.+.... . .+++.||||+||+++||++ |++||. +...+.+...+.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~ 258 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL 258 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence 1222 22334699999985411 1 5788999999999999987 566662 000112222233
Q ss_pred HHHhCChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 343 AKVLGTDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 343 ~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.+.+....+..++.. |++.||+.|.++++.|..
T Consensus 259 Le~Ied~~~Rnlil~-Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 259 LEKIEDVSLRNLILS-MIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHhCcCccHHHHHHH-HHccCchhccCHHHHHHh
Confidence 333445566666666 899999999999998886
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.2e-20 Score=168.66 Aligned_cols=136 Identities=15% Similarity=0.200 Sum_probs=107.7
Q ss_pred CEEEEeeeeecCCeeEEEEE-EcCCCeEEEEEEecccc---------------------------HHHHHHHHHHHHHhc
Q 014307 135 DYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVK---------------------------KKKIKREIKILQNLC 186 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~-~~~~~~~vavK~~~~~~---------------------------~~~~~~E~~il~~l~ 186 (427)
-|.+.+.||+|+||.||+|. +..+|+.||+|+++... ...+.+|+.++.++
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L- 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL- 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 47788999999999999998 66789999999986421 12256899999999
Q ss_pred CC--CCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-ceeeccCCCceE
Q 014307 187 GG--PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVM 260 (427)
Q Consensus 187 ~h--~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~-iiHrDlkp~NIL 260 (427)
.+ ..+++++++ . ..++||||+.+.++.... ......++..++.||+.+|.+||++| |+||||||+||+
T Consensus 108 ~~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 108 YEAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HhcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 43 233444432 1 247999999998875443 23555667899999999999999999 999999999999
Q ss_pred EcCCCCeEEEEeeeeeeee
Q 014307 261 IDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 261 l~~~~~~ikl~DFGla~~~ 279 (427)
++ ++ .++|+|||.|...
T Consensus 182 i~-~~-~i~LiDFg~a~~~ 198 (237)
T smart00090 182 VH-DG-KVVIIDVSQSVEL 198 (237)
T ss_pred EE-CC-CEEEEEChhhhcc
Confidence 99 55 7999999998743
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.1e-19 Score=170.62 Aligned_cols=146 Identities=23% Similarity=0.337 Sum_probs=105.7
Q ss_pred cCCCCeeeeeeEEEcC-------------------------CCCCcEEEEeecCCCchhhhc-CCCCHHHHHHHHHHHHH
Q 014307 186 CGGPNIVKLLDIVRDQ-------------------------QSKTPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLK 239 (427)
Q Consensus 186 ~~h~niv~l~~~~~~~-------------------------~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~ 239 (427)
..|||||++.+.|.+. ....+|+||-.+.......+. +..+....+-++.|+++
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCCchHHHHHHHHHHHH
Confidence 4799999999987642 234567777666554333222 34677778889999999
Q ss_pred HHHHHHHCCceeeccCCCceEEcCCC---CeEEEEeeeeeeeecCC-------CcceeeccCccccccccccCCCC----
Q 014307 240 ALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHPG-------KEYNVRVASRYFKGPELLVDLQD---- 305 (427)
Q Consensus 240 ~L~~LH~~~iiHrDlkp~NILl~~~~---~~ikl~DFGla~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~---- 305 (427)
|+.|||.+||.|||||.+|||+.-+. ..+.|+|||.+-..+.- .......|....||||+......
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 99999999999999999999984332 36899999987422110 11122345566899999754211
Q ss_pred -CCchhhHHHHHHHHHHHHhCCCCCCC
Q 014307 306 -YDYSLDLWSLGCMFAGMIFRKEPFFY 331 (427)
Q Consensus 306 -~~~~~DvwSlGvll~elltg~~pf~~ 331 (427)
--.|+|.|+.|.+.||++....||+.
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccc
Confidence 12489999999999999999999965
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=158.46 Aligned_cols=131 Identities=24% Similarity=0.365 Sum_probs=108.1
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
+.||+|++|.||+|++ .+..+++|+..... ...+.+|+.++..+ .|++++....++.+ ....++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~--~~~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVD--PENFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEe--CCCCEE
Confidence 5699999999999986 67789999764311 13467899999999 78888766666554 345689
Q ss_pred EEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 209 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
+|||++|++|......... ....++.+++.+|.++|+.|++|||++|.|||++ ++ .++|+|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence 9999999999887765444 7788999999999999999999999999999999 44 799999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=156.41 Aligned_cols=133 Identities=20% Similarity=0.345 Sum_probs=105.4
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-------------------------HHHHHHHHHHHHHhcCCC-
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------------KKKIKREIKILQNLCGGP- 189 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------------~~~~~~E~~il~~l~~h~- 189 (427)
|.+.+.||.|+||.||+|.. .+|+.||||+++... ......|+.++..+ .++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HHcC
Confidence 77789999999999999987 479999999865321 12356788899988 665
Q ss_pred -CeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeE
Q 014307 190 -NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (427)
Q Consensus 190 -niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~i 268 (427)
.++..++. ...+++|||+.++++...... .....++.+++.++.++|+.||+||||||+||+++.++ .+
T Consensus 95 i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~~ 164 (198)
T cd05144 95 FPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-KI 164 (198)
T ss_pred CCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-cE
Confidence 44444432 235899999999988765431 44567889999999999999999999999999999766 89
Q ss_pred EEEeeeeeeeec
Q 014307 269 RLIDWGLAEFYH 280 (427)
Q Consensus 269 kl~DFGla~~~~ 280 (427)
+|+|||++....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.5e-18 Score=173.46 Aligned_cols=134 Identities=18% Similarity=0.324 Sum_probs=105.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEe--ccc---------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~--~~~---------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
...|...+.||+|+||+||+|.+... .+++|+. +.. ..+.+.+|+++++.+ +|++++....+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~- 407 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVD- 407 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEe-
Confidence 34456789999999999999987433 3333332 110 124578899999999 88998887666654
Q ss_pred CCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
....++||||+++++|...+. ....++.|++.+|.+||+.|++||||||+|||++ ++ .++|+|||+++.
T Consensus 408 -~~~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~ 476 (535)
T PRK09605 408 -PEEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKY 476 (535)
T ss_pred -CCCCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCccccc
Confidence 334679999999999987654 4577899999999999999999999999999995 44 799999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.7e-18 Score=151.04 Aligned_cols=127 Identities=20% Similarity=0.373 Sum_probs=98.6
Q ss_pred eeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.||+|+||.||+|.+ ++..+++|...... ...+.+|++++..+ .++++.....++.. ....+++
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~--~~~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVD--PDNKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEE--CCCCEEE
Confidence 389999999999984 67889999854211 24567899999999 66654433333333 3346799
Q ss_pred EeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 210 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 210 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
|||++|+++......... .++.|++.+|.+||+.|++|||++|+||+++ ++ .++++|||++..
T Consensus 76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence 999999998776533211 7889999999999999999999999999999 55 799999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-18 Score=155.91 Aligned_cols=226 Identities=18% Similarity=0.238 Sum_probs=164.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.+..+..+|.....|+.|+|++ .|..+++|+++. .....|..|.-.|+-+ .||||+.+++.|.. ..++.+
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacns--ppnlv~ 264 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNS--PPNLVI 264 (448)
T ss_pred hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccC--CCCceE
Confidence 4456778899999999999997 455677777753 2335688888888888 99999999999976 467889
Q ss_pred EEeecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCCeEEE--Eeeeeeeee
Q 014307 209 IFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRL--IDWGLAEFY 279 (427)
Q Consensus 209 v~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~ikl--~DFGla~~~ 279 (427)
+..||.-++|...+.. ....++.+++.++++|+.|||+.. |.---|....|++|.+. +.+| +|--++..
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsfq- 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSFQ- 342 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeeee-
Confidence 9999999998877642 567788999999999999999974 34446889999999765 4444 34333321
Q ss_pred cCCCcceeeccCccccccccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH-Hh------CChH
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK-VL------GTDE 350 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~-~~------~~~~ 350 (427)
...+.-.+.||+||.+..... .-..+|+|||++++|||.|.+.|| .+..+.+...+|.- .+ |...
T Consensus 343 -----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf-adlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 343 -----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF-ADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred -----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc-ccCCchhhhhhhhhccccccCCCCccH
Confidence 112344677999999865221 224789999999999999999999 66677777665542 11 2222
Q ss_pred HHHHHHhccCCCChhHHHHHhH
Q 014307 351 LNAYLNKYHIELDPHLAALVGR 372 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ 372 (427)
--.-+...|..-||..||..+.
T Consensus 417 hm~klm~icmnedpgkrpkfdm 438 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDM 438 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcce
Confidence 2233445588888888886544
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.1e-17 Score=144.82 Aligned_cols=133 Identities=20% Similarity=0.321 Sum_probs=96.8
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH-----HH----------------------HHHHHHHHHHhcCC-CC
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KK----------------------IKREIKILQNLCGG-PN 190 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~-----~~----------------------~~~E~~il~~l~~h-~n 190 (427)
.+.||+|+||+||+|.+. +++.||||+++.... .. ...|...+.++..+ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999985 899999999864221 11 13566666666222 23
Q ss_pred eeeeeeEEEcCCCCCcEEEEeecCCCchhh-hcCCCCH-HHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCe
Q 014307 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LYPTLSD-YDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRK 267 (427)
Q Consensus 191 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~~~~~-~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ 267 (427)
+.+.+++ ...+++|||+.++.+.. .+..... .++..++.+++.++.++|. .||+||||||+||+++ ++ .
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~ 152 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-K 152 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-c
Confidence 4444443 13589999999954321 1122222 6788899999999999999 9999999999999999 55 7
Q ss_pred EEEEeeeeeeeec
Q 014307 268 LRLIDWGLAEFYH 280 (427)
Q Consensus 268 ikl~DFGla~~~~ 280 (427)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-18 Score=166.47 Aligned_cols=159 Identities=18% Similarity=0.294 Sum_probs=120.3
Q ss_pred CCcEEEEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
.++++.|++|...+|..++. ..+......++.|++.|++| +|.+|||+||.||+...+. ++||.|||+..
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~t 404 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVT 404 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhhee
Confidence 36889999999999998884 25667788899999999999 9999999999999998776 89999999987
Q ss_pred eecCCC-------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH----
Q 014307 278 FYHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV---- 345 (427)
Q Consensus 278 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~---- 345 (427)
...... ..+..+||..||+||.+.+ ..|+.++||||||+||+||+. =...+. ....+..+...
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~e----r~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQFE----RIATLTDIRDGIIPP 479 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHHH----HHHhhhhhhcCCCCh
Confidence 665444 4566799999999999998 799999999999999999997 222221 11112222111
Q ss_pred ---hCChHHHHHHHhccCCCChhHHHHHhH
Q 014307 346 ---LGTDELNAYLNKYHIELDPHLAALVGR 372 (427)
Q Consensus 346 ---~~~~~~~~~l~~~~l~~dp~~r~~~~~ 372 (427)
...|....++.. ++...|..||.+..
T Consensus 480 ~~~~d~p~e~~ll~~-lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 480 EFLQDYPEEYTLLQQ-LLSPSPEERPSAIE 508 (516)
T ss_pred HHhhcCcHHHHHHHH-hcCCCcccCchHHH
Confidence 122333344444 67777887774433
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=144.90 Aligned_cols=131 Identities=18% Similarity=0.320 Sum_probs=99.2
Q ss_pred eeee-ecCCeeEEEEEEcCCCeEEEEEEecc----------------ccHHHHHHHHHHHHHhcCCCCe--eeeeeEEEc
Q 014307 140 RKVG-RGKYSEVFEGVHCTDNEKCIIKILKP----------------VKKKKIKREIKILQNLCGGPNI--VKLLDIVRD 200 (427)
Q Consensus 140 ~~LG-~G~fg~V~~~~~~~~~~~vavK~~~~----------------~~~~~~~~E~~il~~l~~h~ni--v~l~~~~~~ 200 (427)
..|| .|+.|+||.+.. .+..++||.++. .....+.+|+.++.+| .|++| +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4477 788888888875 477889987742 1124577899999999 77664 677776543
Q ss_pred CCCC--CcEEEEeecCC-CchhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 201 QQSK--TPSLIFEHVNN-TDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 201 ~~~~--~~~lv~e~~~~-~~l~~~~~~--~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
.... ..++|||++.+ .++..++.. +++. .+.||+.+|.+||++||+||||||+|||++.++ .++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCC
Confidence 2221 23599999997 577766543 3332 367899999999999999999999999999766 899999999
Q ss_pred eee
Q 014307 276 AEF 278 (427)
Q Consensus 276 a~~ 278 (427)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=5e-16 Score=132.36 Aligned_cols=132 Identities=22% Similarity=0.314 Sum_probs=109.5
Q ss_pred EEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHHHhcCC-CCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
+++.||.|.++.||++... +..+++|...... ...+.+|+.+++.+.++ .+++++++++.. ....+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~--~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGES--DGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCccEEEEEecCC
Confidence 4578999999999999873 4789999986543 35788999999999444 688999887765 3567899999999
Q ss_pred CchhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 216 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 216 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
..+... +......++.+++.+|.+||.. +++|+|++|+||+++.++ .++++|||.+..
T Consensus 78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY 138 (155)
T ss_pred eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence 877654 5566778899999999999985 799999999999999755 899999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.3e-15 Score=151.09 Aligned_cols=187 Identities=20% Similarity=0.296 Sum_probs=139.9
Q ss_pred HHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCc-eeeccCCC
Q 014307 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGI-MHRDVKPH 257 (427)
Q Consensus 183 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~i-iHrDlkp~ 257 (427)
+.+ .|.|+.+++|.+.+. ...+.|.+||..|+|.+.+. ++...-...++++|+.||.|||.-.| .|+.|+..
T Consensus 2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 456 899999999999874 67889999999999988764 46677778899999999999998765 99999999
Q ss_pred ceEEcCCCCeEEEEeeeeeeeecCC---CcceeeccCccccccccccCCC--C----CCchhhHHHHHHHHHHHHhCCCC
Q 014307 258 NVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ--D----YDYSLDLWSLGCMFAGMIFRKEP 328 (427)
Q Consensus 258 NILl~~~~~~ikl~DFGla~~~~~~---~~~~~~~~~~~y~aPE~~~~~~--~----~~~~~DvwSlGvll~elltg~~p 328 (427)
|+++|..- .+||+|||+....... .......-...|.|||.+.+.. . .+.+.||||||++++|+++.+.|
T Consensus 79 nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 79 NCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred cceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999655 9999999998765321 1111122334599999986621 1 46779999999999999999999
Q ss_pred CCCCCCCH---HHHHHHHHHhC-------------ChHHHHHHHhccCCCChhHHHHHhHHh
Q 014307 329 FFYGHDNY---DQLVKIAKVLG-------------TDELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 329 f~~~~~~~---~~l~~i~~~~~-------------~~~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
|....... +.+..+.+... .+.+...+ ..||.-+|..||+++++-
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~-~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLV-ARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHH-HHhcccChhhCccHHHHH
Confidence 96543332 33344433111 12233334 449999999999988864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-17 Score=169.96 Aligned_cols=245 Identities=21% Similarity=0.336 Sum_probs=184.0
Q ss_pred CCEEEEeeeeecCCeeEEEEEEc-CCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..|.+.+.||+|+|+.|-.+... .....+|+|.+.... ...+..|..+-+.+.+|.|++++++...+ ....+
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~~~ 97 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRSYL 97 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccccc
Confidence 34677788999999999888763 334566777664322 23345588887777559999999998876 44567
Q ss_pred EEEeecCCCchhhhc-C----CCCHHHHHHHHHHHHHHHHHHH-HCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 208 LIFEHVNNTDFKVLY-P----TLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 208 lv~e~~~~~~l~~~~-~----~~~~~~~~~i~~qi~~~L~~LH-~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
+.++|..++++.... . ..+...+..+..|+..++.|+| ..++.||||||+|.+++..+..++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 899999998877665 2 4677788999999999999999 999999999999999996664799999999987655
Q ss_pred -CCc---ceeecc-CccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHh--C------
Q 014307 282 -GKE---YNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVL--G------ 347 (427)
Q Consensus 282 -~~~---~~~~~~-~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~-~i~~~~--~------ 347 (427)
... ....+| +..|+|||...+........|+||.|+++.-+++|..|+........... .+.... .
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 222 344578 99999999988744567889999999999999999999954322221111 111110 0
Q ss_pred -ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 348 -TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 348 -~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
.......+.+ ++..+|..|.+++++-.++|+..
T Consensus 258 ~~~~~~~~l~k-~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHK-ILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccc-cccCCchhccccccccccccccc
Confidence 1233444455 56689999999999999999887
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.1e-14 Score=142.02 Aligned_cols=137 Identities=18% Similarity=0.291 Sum_probs=95.4
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHH-------------------------------------------
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------------------------------------- 176 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------------------- 176 (427)
+.||.|++|.||+|+. .+|+.||||+.++...+.+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5699999999999987 57899999998765333322
Q ss_pred HHHHHHHHhc---CCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCC--CCHHHHHHHHHHHHH-HHHHHHHCCce
Q 014307 177 REIKILQNLC---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLK-ALDYCHSQGIM 250 (427)
Q Consensus 177 ~E~~il~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~-~L~~LH~~~ii 250 (427)
+|+..+.++. .+.+-+.+-.++.+. ...-++||||++|.++...... ... +...++.+++. .+..+|..|++
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCce
Confidence 3444443331 222334444444332 2345899999999988665321 111 23456666665 47889999999
Q ss_pred eeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 251 HrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
|+|+||.||+++.++ .++|+|||++..+.
T Consensus 280 H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 999999999998776 89999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.6e-13 Score=136.37 Aligned_cols=224 Identities=19% Similarity=0.246 Sum_probs=147.7
Q ss_pred EEEEcCCCeEEEEEEeccccH---HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHH
Q 014307 152 EGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228 (427)
Q Consensus 152 ~~~~~~~~~~vavK~~~~~~~---~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~ 228 (427)
.|..+.++.+|.|++.+.... ....+-++.|+.+ +||||+++++.++. ...+|+|+|-+.--. ..+..+...
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~--~~~~ylvTErV~Pl~--~~lk~l~~~ 104 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEE--EGTLYLVTERVRPLE--TVLKELGKE 104 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhcc--cCceEEEeeccccHH--HHHHHhHHH
Confidence 455667888999988875544 5567788899999 99999999999977 457899999887533 334455688
Q ss_pred HHHHHHHHHHHHHHHHH-HCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-ceeeccCccccccccccCCCCC
Q 014307 229 DVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 306 (427)
Q Consensus 229 ~~~~i~~qi~~~L~~LH-~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~ 306 (427)
.+...+.||+.||.||| +.+++|++|..+.|+|+..| ..||++|-++........ ......-..|..|+.+.. .
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~-s-- 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP-S-- 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-c--
Confidence 88899999999999998 56899999999999999888 899999999865432221 111111223566765433 1
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhh
Q 014307 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYY 386 (427)
Q Consensus 307 ~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~ 386 (427)
....|.|.|||+++|++.|..+- ..+......|.+....-........-....+ .+|+...-.+-+.||.......
T Consensus 181 ~~s~D~~~Lg~li~el~ng~~~~---~~~~~~~~~ipk~~~~~~~k~~~~~~~~r~n-~~~~~~~~~~~~gff~n~fvd~ 256 (690)
T KOG1243|consen 181 EWSIDSWGLGCLIEELFNGSLLT---KTDLSNTGKIPKALIELYCKKLGATELKRPN-KLRFILECRLLGGFFRNDFVDT 256 (690)
T ss_pred ccchhhhhHHHHHHHHhCcccCc---chhhhccCccchhHHHHHHHHhccccccccc-hhhHHHHHHhccccccchHHHH
Confidence 24579999999999999983221 1111111112111100000011111122334 5677766677788877755444
Q ss_pred hh
Q 014307 387 YY 388 (427)
Q Consensus 387 ~~ 388 (427)
+.
T Consensus 257 ~~ 258 (690)
T KOG1243|consen 257 LL 258 (690)
T ss_pred HH
Confidence 33
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.8e-13 Score=119.77 Aligned_cols=126 Identities=21% Similarity=0.253 Sum_probs=96.3
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCC
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (427)
++.|+.|.++.||++.. .+..+++|+..... ...+.+|+.+++.+.+...+++++.+... ..++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~----~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPE----TGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCC----CCeEEEEecCCC
Confidence 46789999999999986 47889999976543 24467899999998443344566655422 246999999998
Q ss_pred chhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 217 ~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i-----iHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
.+... . .....++.+++.+|..||..++ +|+|++|.||+++ ++ .++++|||.+.
T Consensus 77 ~l~~~--~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE--D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG 135 (170)
T ss_pred ccccc--c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence 87643 1 1123456799999999999885 9999999999999 44 79999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.7e-14 Score=138.75 Aligned_cols=245 Identities=21% Similarity=0.230 Sum_probs=182.3
Q ss_pred CCEEEEeeeee--cCCeeEEEEEE--cCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 134 DDYEVVRKVGR--GKYSEVFEGVH--CTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 134 ~~y~~~~~LG~--G~fg~V~~~~~--~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+. .....-.+|+....++..|+|.++.+..+.. ..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~--~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG--SG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc--CC
Confidence 45667788999 99999999987 78889999987331 2233345788777888789999998887765 56
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHH----HHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~----~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
..++-+|.+......... .-+++..++....+... ||.++|+.+++|-|+||+||++..+...++++|||+..
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 778888988854433322 23788889999999999 99999999999999999999999884589999999998
Q ss_pred eecCCCccee-----e-ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----CHHHHHHHHHHh-
Q 014307 278 FYHPGKEYNV-----R-VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD----NYDQLVKIAKVL- 346 (427)
Q Consensus 278 ~~~~~~~~~~-----~-~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~----~~~~l~~i~~~~- 346 (427)
.+.+..-... + .+...|++||...+ -++...|++++|.++.+-.++-.++..+.. ..+++..-.+.+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 8776542211 1 56667999999765 789999999999999998887666644311 111111111111
Q ss_pred -CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 347 -GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 -~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+...+.. ....+++.+|.+|++...+..+.+.....
T Consensus 350 ~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 350 GGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred Ccchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh
Confidence 1222222 45558899999999999999999988755
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.9e-13 Score=136.06 Aligned_cols=138 Identities=14% Similarity=0.317 Sum_probs=92.7
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHH----------------------------------------
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---------------------------------------- 174 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~---------------------------------------- 174 (427)
.|+. +.||.|++|.||+|+.+.+|+.||||++++...+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 78999999999999998779999999997542211
Q ss_pred ---HHHHHHHHHHhc---CCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhc--C--C-----CCHHHHHHHHHHHHH
Q 014307 175 ---IKREIKILQNLC---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--P--T-----LSDYDVRYYIYELLK 239 (427)
Q Consensus 175 ---~~~E~~il~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~--~-----~~~~~~~~i~~qi~~ 239 (427)
+.+|+..+.++. .+.+.+.+-.++.+- ....+|||||+.|+.+.... . . +.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--- 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--- 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH---
Confidence 223443444331 233445555555432 34467999999999886531 1 1 222222333333
Q ss_pred HHHHHHHCCceeeccCCCceEEcCCC---CeEEEEeeeeeeeecC
Q 014307 240 ALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHP 281 (427)
Q Consensus 240 ~L~~LH~~~iiHrDlkp~NILl~~~~---~~ikl~DFGla~~~~~ 281 (427)
+...|++|+|+||.||+++.++ ..++++|||++..+..
T Consensus 276 ----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 4468999999999999998665 3799999999987654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.9e-12 Score=113.02 Aligned_cols=133 Identities=17% Similarity=0.260 Sum_probs=98.1
Q ss_pred eeeeecCCeeEEEEEEcC------CCeEEEEEEecccc-------------------------HHHH----HHHHHHHHH
Q 014307 140 RKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVK-------------------------KKKI----KREIKILQN 184 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~------~~~~vavK~~~~~~-------------------------~~~~----~~E~~il~~ 184 (427)
..||.|.=+.||.|.... .+..+|||+.+... .+.+ ++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 35799999875210 1223 389999999
Q ss_pred hcCC-CCeeeeeeEEEcCCCCCcEEEEeecCCCchhh-hcC--CCCHHHHHHHHHHHHHHHHHH-HHCCceeeccCCCce
Q 014307 185 LCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LYP--TLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNV 259 (427)
Q Consensus 185 l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~-~~~--~~~~~~~~~i~~qi~~~L~~L-H~~~iiHrDlkp~NI 259 (427)
+... -++++.+++. .-++||||+.+..+.. .+. .+++.++..+..|++.+|..| |..||||+||++.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8433 5677777652 2469999998754321 111 344556777889999999999 899999999999999
Q ss_pred EEcCCCCeEEEEeeeeeeeec
Q 014307 260 MIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 260 Ll~~~~~~ikl~DFGla~~~~ 280 (427)
|++. + .+.|+|||.|....
T Consensus 157 L~~~-~-~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWHD-G-KVWFIDVSQSVEPT 175 (197)
T ss_pred EEEC-C-cEEEEECCCceeCC
Confidence 9973 4 69999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.5e-13 Score=135.11 Aligned_cols=248 Identities=19% Similarity=0.098 Sum_probs=174.6
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEc-CCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
....+|..+..||.|.|+.|+.+... .++..+++|-+.... ...-..|+.+...+..|.+++.++..+.. ..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~--~r 339 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ--LR 339 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc--cc
Confidence 34578999999999999999998755 677888988765322 12234677777777778888887776654 33
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
..++-.||+.+++..... ..+.+...+.+..|++.++.++|++.++|+|+||+||++..++...++.|||.+..+.
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~- 418 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA- 418 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc-
Confidence 455889999998765433 3578888999999999999999999999999999999998765578999999986421
Q ss_pred CCcceeeccCcccc-ccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHhCChHHHHHHHhcc
Q 014307 282 GKEYNVRVASRYFK-GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAYLNKYH 359 (427)
Q Consensus 282 ~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~-~i~~~~~~~~~~~~l~~~~ 359 (427)
-..........++ ..|++.....+..+.|++|||.-+.|.+++...-..+..-..... ......+..+..+-+.+.+
T Consensus 419 -~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~q~~~kv~ 497 (524)
T KOG0601|consen 419 -FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQLQVLLKVM 497 (524)
T ss_pred -eecccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhhhhhhhhh
Confidence 1112223333444 366666556788999999999999999988643322211111111 1111122223444455668
Q ss_pred CCCChhHHHHHhHHhcCCchhhH
Q 014307 360 IELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 360 l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+..++..|+++.++..+.-|.+.
T Consensus 498 ~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 498 INPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred cCCccccchhhhhhcccchhhhh
Confidence 88899999999888887776653
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.3e-11 Score=101.09 Aligned_cols=126 Identities=19% Similarity=0.333 Sum_probs=90.7
Q ss_pred eeeecCCeeEEEEEEcCCCeEEEEEEeccc-----------cHHHHHHHHHHHHHhcC-CCCeeeeeeEEEcCCCCCcEE
Q 014307 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----------KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~il~~l~~-h~niv~l~~~~~~~~~~~~~l 208 (427)
.+++|+-+.++.+.+ -|..+++|.--+. ......+|+++|.++.. --+.+.++++. + ....+
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~--~~~~I 76 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--P--DNGLI 76 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--C--CCCEE
Confidence 478899999999865 3445677753211 12456789999998732 13445555543 2 33459
Q ss_pred EEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 209 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
+|||++|..+.+.+.... ..++..+-.-+.-||..||+|+||.++||++..+ .+.++|||++.+
T Consensus 77 ~me~I~G~~lkd~l~~~~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEAR----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhcc----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 999999999987665432 3455666667778999999999999999999854 489999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.8e-10 Score=97.75 Aligned_cols=136 Identities=20% Similarity=0.295 Sum_probs=96.6
Q ss_pred EEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.+..|-+|+-+.|+++.+ .|+.++||.--. -.+...++|+++|.++ .--.|.--.=++.+... -
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~--~ 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYG--G 85 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCC--C
Confidence 456788999999999985 688888885311 1235678999999987 33233322223444333 3
Q ss_pred EEEEeecCCC-chhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeE--EEEeeeeeee
Q 014307 207 SLIFEHVNNT-DFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL--RLIDWGLAEF 278 (427)
Q Consensus 207 ~lv~e~~~~~-~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~i--kl~DFGla~~ 278 (427)
.++|||++|. ++..+. ..........++.+|-..+.-||..+|||+||..+||++..++.++ .++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 5999999984 333332 2233333467888898999999999999999999999998777655 8999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.3e-10 Score=104.39 Aligned_cols=138 Identities=24% Similarity=0.410 Sum_probs=104.4
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCC-CCeeeeeeEEEcCC-CCCcEEEEeec
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGG-PNIVKLLDIVRDQQ-SKTPSLIFEHV 213 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h-~niv~l~~~~~~~~-~~~~~lv~e~~ 213 (427)
+.||.|..+.||++.. .+|+.+++|+..... ...+.+|+.+++.+..+ ..+++++.+..... ....++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5689999999999986 335889999876432 45788999999999432 34677777654321 12568999999
Q ss_pred CCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 014307 214 NNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS--------------------------------------------- 246 (427)
Q Consensus 214 ~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~--------------------------------------------- 246 (427)
+|..+.... ..++..+...++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 999887654 356777777888888888888873
Q ss_pred -----------CCceeeccCCCceEEcCC-CCeEEEEeeeeeee
Q 014307 247 -----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEF 278 (427)
Q Consensus 247 -----------~~iiHrDlkp~NILl~~~-~~~ikl~DFGla~~ 278 (427)
..++|+|+++.||+++.+ +..+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235899999999999973 33689999999864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-11 Score=114.31 Aligned_cols=200 Identities=18% Similarity=0.220 Sum_probs=140.0
Q ss_pred HHHHHHhcCCCCeeeeeeEEEcCC---CCCcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC-
Q 014307 179 IKILQNLCGGPNIVKLLDIVRDQQ---SKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQ- 247 (427)
Q Consensus 179 ~~il~~l~~h~niv~l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~- 247 (427)
..-|.++ .|.|||+++.|+.+.. .....++.|||..+++..+++ .+......+++-||+.||.|||+.
T Consensus 118 Fdnllql-vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQL-VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHH-HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 3444555 7889999999887532 345678999999999988875 377888899999999999999987
Q ss_pred -CceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC------CcceeeccCccccccccccCCCCCCchhhHHHHHHHHH
Q 014307 248 -GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 320 (427)
Q Consensus 248 -~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ 320 (427)
-|+|+++..+-|++..++ -||+.--.- ....+. .+.....+-++|.+||.=.. ...+..+|||+||....
T Consensus 197 PpiihgnlTc~tifiq~ng-LIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNG-LIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCAL 273 (458)
T ss_pred CccccCCcchhheeecCCc-eEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHH
Confidence 599999999999999777 555531111 111110 01112245577889987322 45667899999999999
Q ss_pred HHHhCCCCCCCCCCC---HHHHHHHHHHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 321 GMIFRKEPFFYGHDN---YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 321 elltg~~pf~~~~~~---~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
||..+..---.+... .+.+....-.+..+....++.+ |++-.|.-||.+..++.|+-.-+..
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~k-cl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANVIIGLENGLQRGSITK-CLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhheeeccCccccCcCcc-cccCCCCCCcchhhhhcCceeeecc
Confidence 998887543233322 2333333333334444455555 9999999999999999999876654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.9e-10 Score=98.72 Aligned_cols=122 Identities=24% Similarity=0.385 Sum_probs=82.2
Q ss_pred eEEEEEEcCCCeEEEEEEecccc-----------------------------HHHHHHHHHHHHHhcCC-CCeeeeeeEE
Q 014307 149 EVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQNLCGG-PNIVKLLDIV 198 (427)
Q Consensus 149 ~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~il~~l~~h-~niv~l~~~~ 198 (427)
.||.|.. .+|..+|||+.+... .....+|.++|.++... -++++.+++-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899986 678899999975210 13357899999999433 2677777653
Q ss_pred EcCCCCCcEEEEeecC--CCchhhhcCC-CCHHHHHHHHHHHHHHHHH-HHHCCceeeccCCCceEEcCCCCeEEEEeee
Q 014307 199 RDQQSKTPSLIFEHVN--NTDFKVLYPT-LSDYDVRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (427)
Q Consensus 199 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-~~~~~~~~i~~qi~~~L~~-LH~~~iiHrDlkp~NILl~~~~~~ikl~DFG 274 (427)
. -++||||++ |..+..+... ++..+...++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||
T Consensus 80 ----~--~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 ----R--NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp ----T--TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred ----C--CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 1 359999999 6555544322 2355667788888886555 579999999999999999955 69999999
Q ss_pred eeeee
Q 014307 275 LAEFY 279 (427)
Q Consensus 275 la~~~ 279 (427)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 98654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-11 Score=129.81 Aligned_cols=245 Identities=19% Similarity=0.242 Sum_probs=165.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..+.+.+.+-+-+|.++.++.+.-..++...++|+... ...+...++-.++-.- .+|.++...-.+ .....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rsP 878 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRSP 878 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCCC
Confidence 45778899999999999999998777776666665432 1222333333333222 445555444332 33556
Q ss_pred cEEEEeecCCCchhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-
Q 014307 206 PSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~- 281 (427)
.+|+++|..++++...+.. ....-++.++..+..++++||+..+.|||++|.|+|+..++ ..+++|||.......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCccccccccccc
Confidence 7899999999888766543 55666778888899999999999999999999999999777 789999984321100
Q ss_pred --------------------C-----------CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 014307 282 --------------------G-----------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330 (427)
Q Consensus 282 --------------------~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 330 (427)
. .......+|+.|.+||...+ ......+|+|++|++++|.++|..||
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~- 1035 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF- 1035 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC-
Confidence 0 00122367889999999988 67888999999999999999999998
Q ss_pred CCCCCHHHHHHHHHHh---------CChHHHHHHHhccCCCChhHHHHHh---HHhcCCchhhHH
Q 014307 331 YGHDNYDQLVKIAKVL---------GTDELNAYLNKYHIELDPHLAALVG---RLVILSYFFQFV 383 (427)
Q Consensus 331 ~~~~~~~~l~~i~~~~---------~~~~~~~~l~~~~l~~dp~~r~~~~---~ll~~~~~~~~~ 383 (427)
...........|.+.- +.+.....+.+ .+..++..|..+. +.-.|++|+...
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~-ll~~~~~qr~~a~~~~e~k~~~~~~~~~ 1099 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINR-LLTEEPTQRLGAKGAAEVKGHPFFQDVD 1099 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhh-hhccCchhccCcccccccccCCccCCCC
Confidence 4444444444333321 11222222222 4455566665555 566667766544
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.2e-09 Score=96.81 Aligned_cols=127 Identities=17% Similarity=0.157 Sum_probs=89.8
Q ss_pred eEEEEEEcCCCeEEEEEEeccccH--------------HHHHHHHHHHHHhcCC-CCeeeeeeEEEcCC---CCCcEEEE
Q 014307 149 EVFEGVHCTDNEKCIIKILKPVKK--------------KKIKREIKILQNLCGG-PNIVKLLDIVRDQQ---SKTPSLIF 210 (427)
Q Consensus 149 ~V~~~~~~~~~~~vavK~~~~~~~--------------~~~~~E~~il~~l~~h-~niv~l~~~~~~~~---~~~~~lv~ 210 (427)
.|.++.. .|+.+.||....... ..+.+|...+.++... -..+..+.+.+... ...-++|+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555543 577888886643221 1367899988887221 23344455554321 22457999
Q ss_pred eecCCC-chhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC------CCCeEEEEeeeeee
Q 014307 211 EHVNNT-DFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------EQRKLRLIDWGLAE 277 (427)
Q Consensus 211 e~~~~~-~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~------~~~~ikl~DFGla~ 277 (427)
|++++. ++..+.. .........++.+++..+.-||..||+|+|+++.|||++. +...+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 999986 6766642 3455677789999999999999999999999999999985 23479999999885
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.95 E-value=3.3e-08 Score=97.24 Aligned_cols=163 Identities=17% Similarity=0.266 Sum_probs=126.6
Q ss_pred CCeeEEEEEEcCCCeEEEEEEec---cccHHHHHHHHHHHHHhcCCCCeeeeeeEEEc--CCCCCcEEEEeecCCC-chh
Q 014307 146 KYSEVFEGVHCTDNEKCIIKILK---PVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIFEHVNNT-DFK 219 (427)
Q Consensus 146 ~fg~V~~~~~~~~~~~vavK~~~---~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~--~~~~~~~lv~e~~~~~-~l~ 219 (427)
--.+.|++....+|..|++|.+. .........-+++++++ .|+|+|++.++|.. -.+..+++|++|..+. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34578999999999999999993 23333445568889999 89999999998873 2345688999998875 343
Q ss_pred hhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 220 VLY------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 220 ~~~------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
+++ ...++..+|.++.|+..||.++|+.|+.-+-|.+.+||++.+. +++|...|.......
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE 445 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence 332 1367889999999999999999999999999999999998665 789998888877655
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCC
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKE 327 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~ 327 (427)
+. .+| +.+ -.+-|.=.||.+++.|.||..
T Consensus 446 d~-----------~~~--le~----~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP-----------TEP--LES----QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC-----------Ccc--hhH----HhhhhHHHHHHHHHHHhhccc
Confidence 43 011 222 135799999999999999954
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=93.23 Aligned_cols=133 Identities=20% Similarity=0.338 Sum_probs=99.4
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------------------------cHHHHHHHHHHHHHhcCC-C
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------------------------KKKKIKREIKILQNLCGG-P 189 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------------------------~~~~~~~E~~il~~l~~h-~ 189 (427)
+.++.+||-|.-|.||.|.+ ..|.++|||.-+.. .+...++|.++|++|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45778999999999999997 47899999975311 113357899999999433 3
Q ss_pred CeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEE
Q 014307 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (427)
Q Consensus 190 niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ik 269 (427)
.+++.+++ +...+|||+++|..|.... +.......++..|+.-+.-+-..||||+|+.+=||+++.++ .+.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~~~ 242 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-DIV 242 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC-CEE
Confidence 66666664 3356999999997765443 13445555666666666666689999999999999999887 789
Q ss_pred EEeeeeeee
Q 014307 270 LIDWGLAEF 278 (427)
Q Consensus 270 l~DFGla~~ 278 (427)
++||--+..
T Consensus 243 vIDwPQ~v~ 251 (304)
T COG0478 243 VIDWPQAVP 251 (304)
T ss_pred EEeCccccc
Confidence 999987653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3e-08 Score=95.31 Aligned_cols=189 Identities=16% Similarity=0.203 Sum_probs=123.9
Q ss_pred EEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeE----EEcCC-CCCcEEEEee
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDI----VRDQQ-SKTPSLIFEH 212 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~----~~~~~-~~~~~lv~e~ 212 (427)
..+.||+|+-+.+|-.-. -...+.|+....-...-.+.+..|.+.-.||-+-.=+.| ....+ +..+.++|..
T Consensus 15 ~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~ 91 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK 91 (637)
T ss_pred CCccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence 346799999999996542 222355776532222222333344443344433221111 11111 2235667766
Q ss_pred cCCCc-h---------hhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 213 VNNTD-F---------KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 213 ~~~~~-l---------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+.+.. . .+....+.+.-..+.++.++.+.+.||..|.+-+|+.++|+|+++++ .+.|.|=..-.....+
T Consensus 92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~ng 170 (637)
T COG4248 92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINANG 170 (637)
T ss_pred CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccceeeccCC
Confidence 66542 1 11223467778889999999999999999999999999999999777 8888875544333445
Q ss_pred CcceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhC-CCCCC
Q 014307 283 KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFR-KEPFF 330 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg-~~pf~ 330 (427)
..+...+|...|.+||.-.- .-.-+...|.|.||+++++++.| +.||.
T Consensus 171 ~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 171 TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 55667789999999998431 12346679999999999999887 88983
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.5e-07 Score=84.13 Aligned_cols=134 Identities=16% Similarity=0.155 Sum_probs=96.7
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEec---------cccHHHHHHHHHHHHHhcCC-CCeeeeeeEEE---cCCCCCcEE
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQNLCGG-PNIVKLLDIVR---DQQSKTPSL 208 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~---------~~~~~~~~~E~~il~~l~~h-~niv~l~~~~~---~~~~~~~~l 208 (427)
-|+||-+.|+.... .|+.+-+|.-. +.....+.+|+..|++|... -.+++.. ++. ......-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36789999998764 44467788654 34457799999999988322 1244444 222 222334579
Q ss_pred EEeecCCC-chhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC-CeEEEEeeeeeee
Q 014307 209 IFEHVNNT-DFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEF 278 (427)
Q Consensus 209 v~e~~~~~-~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~ikl~DFGla~~ 278 (427)
|+|-+.+. +|..++. +.+......++.+++..+.-||+.|+.|+|+-+.|||++.++ ..++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99977754 5655542 346666788999999999999999999999999999998555 2499999998753
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-07 Score=86.17 Aligned_cols=108 Identities=25% Similarity=0.369 Sum_probs=82.1
Q ss_pred HHHHHHHHHHHHHhcC-CCCeeeeeeEEEcCCC--CCcEEEEeecCCC-chhhhcCC---CCHHHHHHHHHHHHHHHHHH
Q 014307 172 KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQS--KTPSLIFEHVNNT-DFKVLYPT---LSDYDVRYYIYELLKALDYC 244 (427)
Q Consensus 172 ~~~~~~E~~il~~l~~-h~niv~l~~~~~~~~~--~~~~lv~e~~~~~-~l~~~~~~---~~~~~~~~i~~qi~~~L~~L 244 (427)
.....+|...+..|.. .-.+++.+++.+.... ..-++|+|++++. +|..+... .+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3567789888887732 2244566666554222 2347999999985 67776654 56777889999999999999
Q ss_pred HHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeee
Q 014307 245 HSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFY 279 (427)
Q Consensus 245 H~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~ 279 (427)
|.+||+|+|+++.|||++.++ ..+.|+||+.++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999998654 36899999998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.2e-09 Score=108.80 Aligned_cols=151 Identities=16% Similarity=0.280 Sum_probs=106.3
Q ss_pred HHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc-----eee-----ccCccccccccccCCC
Q 014307 236 ELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-----NVR-----VASRYFKGPELLVDLQ 304 (427)
Q Consensus 236 qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~-----~~~-----~~~~~y~aPE~~~~~~ 304 (427)
+++.||.|+|.. ++||++|.|++|.++.++ .+||+.|+.+........+ ... .....|.|||++.+ .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 455999999964 899999999999999877 8999999998654442221 111 23345999999887 6
Q ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH-----HHHhC-----ChHHHHHHHhccCCCChhHHHHHhHHh
Q 014307 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI-----AKVLG-----TDELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 305 ~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i-----~~~~~-----~~~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
..+.++|++|+||++|-+..|..+.............- ....+ ++++.+.+.+ ++..+...||.+..++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k-~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKK-LLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHH-HhcCCcccCcchhhhh
Confidence 78899999999999999884444443333221111111 11111 2455566666 7889999999999999
Q ss_pred cCCchhhHHHhhhhh
Q 014307 375 ILSYFFQFVIYYYYY 389 (427)
Q Consensus 375 ~~~~~~~~~~~~~~~ 389 (427)
..+||.+......-|
T Consensus 264 ~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 264 SIPFFSDPGLKALRF 278 (700)
T ss_pred cccccCCchhhhhhh
Confidence 999999877544333
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.4e-08 Score=97.82 Aligned_cols=137 Identities=17% Similarity=0.321 Sum_probs=89.8
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHH-------------------------------------------H
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------------------------------------K 176 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------------~ 176 (427)
+-|+.++-|.||+|+. .+|+.||||+.++.-.+.+ .
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 5689999999999998 4599999999876432222 2
Q ss_pred HHHHHHHHhc---CCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHH-HHHHHHCC
Q 014307 177 REIKILQNLC---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA-LDYCHSQG 248 (427)
Q Consensus 177 ~E~~il~~l~---~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~-L~~LH~~~ 248 (427)
+|...+.++. +...-+++-.+|.+- ...-+|+|||++|..+.... ..++... ++..++.+ +..+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~-t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY-TTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc-cCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 3444444431 222333444444432 33457999999998766552 2244333 33333222 23333589
Q ss_pred ceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 249 iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++|.|.+|-||+++.++ .+.+.|||+...+.+.
T Consensus 286 ffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 FFHADPHPGNILVRSDG-RIVLLDFGIVGRLDPK 318 (517)
T ss_pred ccccCCCccceEEecCC-cEEEEcCcceecCCHH
Confidence 99999999999999887 8999999999776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.67 E-value=6e-07 Score=80.57 Aligned_cols=136 Identities=16% Similarity=0.256 Sum_probs=90.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH------------HHHHHHHHHHHHhc--CCCCeeeeeeEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------------KKIKREIKILQNLC--GGPNIVKLLDIV 198 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~------------~~~~~E~~il~~l~--~h~niv~l~~~~ 198 (427)
..+|++.+.+-......|.+.. .+|+.+++|..+.... ....+++..+..+. +-.....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4678888888887777777665 5789999998765332 11233444444441 222333333332
Q ss_pred EcCC---CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 199 RDQQ---SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 199 ~~~~---~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
+-.. ....+++|||++|..+.... .+++ .+...+.+++.-||+.|++|+|.+|.|++++.+ .++++||+.
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~-~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~~~ 180 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIE-DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDTQG 180 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccch-hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEECcc
Confidence 2111 12346899999998876542 2232 244567788999999999999999999999954 489999987
Q ss_pred ee
Q 014307 276 AE 277 (427)
Q Consensus 276 a~ 277 (427)
.+
T Consensus 181 k~ 182 (229)
T PF06176_consen 181 KR 182 (229)
T ss_pred cc
Confidence 65
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.54 E-value=2e-06 Score=78.68 Aligned_cols=138 Identities=20% Similarity=0.393 Sum_probs=83.8
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC-CCeeeeeeEEEcC-CCCCcEEEEeecCC
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQ-QSKTPSLIFEHVNN 215 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h-~niv~l~~~~~~~-~~~~~~lv~e~~~~ 215 (427)
++.|+.|..+.||++.... ..+++|+.... ....+.+|..+++.+..+ ..+++++...... .....+++|+++.+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4679999999999998633 58999998765 456788999999988544 2356777654332 23346899999999
Q ss_pred Cchhhhc-----------------------CC---CCHHH------HHHH---------------HHHHHH-HHHHHHH-
Q 014307 216 TDFKVLY-----------------------PT---LSDYD------VRYY---------------IYELLK-ALDYCHS- 246 (427)
Q Consensus 216 ~~l~~~~-----------------------~~---~~~~~------~~~i---------------~~qi~~-~L~~LH~- 246 (427)
..+.... .. ..... .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 8776600 00 00000 0000 111222 2333332
Q ss_pred ------CCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 247 ------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 247 ------~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
..++|+|+.|.|||++.++..+-|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 35999999999999994443668999998863
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.2e-06 Score=77.79 Aligned_cols=133 Identities=15% Similarity=0.241 Sum_probs=94.7
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----------------------H-----HHHHHHHHHHHHhc-CCCC
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------------------K-----KKIKREIKILQNLC-GGPN 190 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------------------~-----~~~~~E~~il~~l~-~h~n 190 (427)
...|.+|.-+.||+|.. .++..+|+|+++... . .-..+|+..|+++. .+-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888889999985 678999999986321 0 11356888888873 2345
Q ss_pred eeeeeeEEEcCCCCCcEEEEeecCCCchh-hhcC--CCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCC
Q 014307 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYP--TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR 266 (427)
Q Consensus 191 iv~l~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~--~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~ 266 (427)
+++-+++.. -.|||||+...... -.+. .+...++..+..++++.+.-|-. .++||+||..=|||+. ++
T Consensus 132 vP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~- 203 (268)
T COG1718 132 VPEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG- 203 (268)
T ss_pred CCCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC-
Confidence 556666542 25999999876321 1111 23333677888899999988866 8999999999999999 55
Q ss_pred eEEEEeeeeeeeec
Q 014307 267 KLRLIDWGLAEFYH 280 (427)
Q Consensus 267 ~ikl~DFGla~~~~ 280 (427)
.+.|+|||-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 79999999986543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.4e-06 Score=78.38 Aligned_cols=129 Identities=19% Similarity=0.262 Sum_probs=80.1
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCC-CeeeeeeEEEcCCCCCcEEEEeecCCCc
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~ 217 (427)
..||.|..+.||+. .+..+++|..... ....+.+|.++++.+.... .+++.+++... .....+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~--~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVED--GGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEec--CCeeeeeeeecCCcc
Confidence 46899999999984 2446788987653 3456889999999984332 25677777654 334568999999963
Q ss_pred -hhhhcCCCCHHHHHHHHHHHHH---------------------------------------HHHHHHH----CCceeec
Q 014307 218 -FKVLYPTLSDYDVRYYIYELLK---------------------------------------ALDYCHS----QGIMHRD 253 (427)
Q Consensus 218 -l~~~~~~~~~~~~~~i~~qi~~---------------------------------------~L~~LH~----~~iiHrD 253 (427)
+..... .+......++.+++. ...+|.. ..++|+|
T Consensus 81 ~~~~~~~-~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIIS-DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhc-CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 111100 000000011111111 1122221 2478999
Q ss_pred cCCCceEEcCCCCeEEEEeeeeee
Q 014307 254 VKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 254 lkp~NILl~~~~~~ikl~DFGla~ 277 (427)
+.|.||+++.++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~--~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG--TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC--cEEEechhcC
Confidence 999999998654 8899999885
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2e-06 Score=87.19 Aligned_cols=138 Identities=19% Similarity=0.251 Sum_probs=87.6
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccccHH----------------------------------H------HHHHH
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----------------------------------K------IKREI 179 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~----------------------------------~------~~~E~ 179 (427)
+.||..+.|.||+|+.+. |+.||||+-++.-++ . |.+|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999855 999999997653211 1 22344
Q ss_pred HHHHHhc---CCCC---eeeeeeEEEcCCCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014307 180 KILQNLC---GGPN---IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGI 249 (427)
Q Consensus 180 ~il~~l~---~h~n---iv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~i 249 (427)
+...++. .|-+ -|.+-.++.+- ...-+|+||||+|.-+.+.. ..++..++...+.+... +-|=..|+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~Gf 322 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL-STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTGF 322 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc-CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcCC
Confidence 3332221 3334 12233334332 33468999999998654432 24666654443333222 22234689
Q ss_pred eeeccCCCceEEcC---CCCeEEEEeeeeeeeecC
Q 014307 250 MHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 250 iHrDlkp~NILl~~---~~~~ikl~DFGla~~~~~ 281 (427)
+|+|-+|-||+++. .+..+.+.|||+...+..
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999984 345899999999876543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.6e-06 Score=77.43 Aligned_cols=74 Identities=20% Similarity=0.209 Sum_probs=53.7
Q ss_pred eeecCC-eeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchh
Q 014307 142 VGRGKY-SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 219 (427)
Q Consensus 142 LG~G~f-g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~ 219 (427)
|-.|.. +.||+... .+..+.+|+........+.+|+.+++.+..+--+++++++.... ...++|||+++|..+.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHh
Confidence 444555 78999864 34688899886543456788999999986565567888776542 4567999999997665
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.9e-06 Score=73.00 Aligned_cols=129 Identities=19% Similarity=0.303 Sum_probs=92.3
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecC
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 214 (427)
.++.+.||+|++|.||+|.+ .|..+|+|+-+. ..+..+..|+++|..+..-.--.++|.+-.+ ++.|||+.
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~------~i~me~i~ 95 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED------FIRMEYID 95 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh------hhhhhhhc
Confidence 34568899999999999986 566899998765 4457799999999999554455667666432 35699999
Q ss_pred CCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCC--CceEEcCCCCeEEEEeeeeeee
Q 014307 215 NTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP--HNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 215 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp--~NILl~~~~~~ikl~DFGla~~ 278 (427)
|-.|...-..... .-+..+++.---|-..||-|..|.- .||++. ++ .+.|+||..|+.
T Consensus 96 G~~L~~~~~~~~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGGDR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATF 155 (201)
T ss_pred CcchhhhhhcccH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEec-CC-cEEEEEccchhh
Confidence 9887665433322 3334455554446678999999863 366665 44 689999999973
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.3e-05 Score=71.26 Aligned_cols=125 Identities=24% Similarity=0.329 Sum_probs=89.9
Q ss_pred CCEEEEeeeeecCC-eeEEEEEEcCCCeEEEEEEecc------------c------------cHHHHHHHHHHHHHhc--
Q 014307 134 DDYEVVRKVGRGKY-SEVFEGVHCTDNEKCIIKILKP------------V------------KKKKIKREIKILQNLC-- 186 (427)
Q Consensus 134 ~~y~~~~~LG~G~f-g~V~~~~~~~~~~~vavK~~~~------------~------------~~~~~~~E~~il~~l~-- 186 (427)
.+++.++.||.|.- |.||+++. +|+.+|+|+++. . ....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 67899999999999 99999985 788999999321 0 0123678888877774
Q ss_pred CCCCe--eeeeeEEEcCC----------------CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 014307 187 GGPNI--VKLLDIVRDQQ----------------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG 248 (427)
Q Consensus 187 ~h~ni--v~l~~~~~~~~----------------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 248 (427)
++.++ |+.+||..-.. .....||.||+.... .+ ...-+.+|++-|..+|..|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~----~~~~~~~~~~dl~~~~k~g 184 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PL----QIRDIPQMLRDLKILHKLG 184 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------cc----chhHHHHHHHHHHHHHHCC
Confidence 33455 99999874220 111245666665543 11 2234567888888999999
Q ss_pred ceeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 249 iiHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
|+-+|+++.|.. +| ||+|||.+
T Consensus 185 I~~~Dv~~~ny~---~G---~lvDfs~~ 206 (207)
T PF13095_consen 185 IVPRDVKPRNYR---GG---KLVDFSSS 206 (207)
T ss_pred eeeccCcccccc---CC---EEEecccC
Confidence 999999999986 44 89999965
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.26 E-value=2e-05 Score=85.91 Aligned_cols=79 Identities=18% Similarity=0.272 Sum_probs=56.6
Q ss_pred EeeeeecCCeeEEEEEEcCCC--eEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCe--eeeeeEEEcCC-CCCcEEE
Q 014307 139 VRKVGRGKYSEVFEGVHCTDN--EKCIIKILKP----VKKKKIKREIKILQNLCGGPNI--VKLLDIVRDQQ-SKTPSLI 209 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~--~~vavK~~~~----~~~~~~~~E~~il~~l~~h~ni--v~l~~~~~~~~-~~~~~lv 209 (427)
++.|+.|.++.+|+......+ ..+++|+... .....+.+|+++|+.+..|.++ ++++.++.+.. ....++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 577899999999998764332 4677776533 1235688999999999545554 78888776532 2457899
Q ss_pred EeecCCCc
Q 014307 210 FEHVNNTD 217 (427)
Q Consensus 210 ~e~~~~~~ 217 (427)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=3.5e-07 Score=92.26 Aligned_cols=180 Identities=16% Similarity=0.186 Sum_probs=130.4
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCC-eeeeeeEEEcCCCCCcEEEEeecC
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN-IVKLLDIVRDQQSKTPSLIFEHVN 214 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~n-iv~l~~~~~~~~~~~~~lv~e~~~ 214 (427)
+...+.+++|++++++|.+...+...+ .+++... ....-++++|.++ +||| .+..++- ++.+.+..++++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~~~v~~~~d--~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPNPVVRYLED--YDGEDYLWIPMRICS 317 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCCCccccccc--CCcccccchhhhhhc
Confidence 455677899999999999875555444 6666543 4455688899998 9999 4443333 344667788999998
Q ss_pred CC-chhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeec
Q 014307 215 NT-DFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289 (427)
Q Consensus 215 ~~-~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~ 289 (427)
++ +-..... .+...+...+.+.-+++|+++|+--=+|+| |||...+ ..|..||+....+......++..
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~~t~~ 391 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKPRTAI 391 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccccc--ccccccccCCcccCcccccccCC
Confidence 87 2111111 133334455566677889999988778998 8888743 58999999998776655567778
Q ss_pred cCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCC
Q 014307 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 328 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~p 328 (427)
+++.++|||+... ..+....|+|++|+--.+|--|-.|
T Consensus 392 ~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 392 GTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred CCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCC
Confidence 9999999999876 7899999999999866666555544
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.10 E-value=7.1e-05 Score=71.68 Aligned_cols=79 Identities=10% Similarity=0.159 Sum_probs=58.4
Q ss_pred EEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC--CCeeeeeeEEEcCC-CCCcEEEEeec
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQ-SKTPSLIFEHV 213 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h--~niv~l~~~~~~~~-~~~~~lv~e~~ 213 (427)
-.+.||.|..+.||.... ++..+.+|..+.. ....+..|...|+.|.++ -.++++++++.... ....++|||++
T Consensus 18 ~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 18 RVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 456799999999999864 3335777876542 456899999999999554 46888888876432 34578999999
Q ss_pred CCCch
Q 014307 214 NNTDF 218 (427)
Q Consensus 214 ~~~~l 218 (427)
++..+
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98643
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.6e-05 Score=66.75 Aligned_cols=124 Identities=20% Similarity=0.392 Sum_probs=86.9
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc-------------------HHHHHHHHHHHHHhc-----CCCCeeeee
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNIVKLL 195 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------~~~~~~E~~il~~l~-----~h~niv~l~ 195 (427)
..||+|+.-.||.- ..+....||+.++.. .++..+|+.-...+. .+.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45899999999963 456677899988766 577788888777772 267999999
Q ss_pred eEEEcCCCCCcEEEEeecCCC------chhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--
Q 014307 196 DIVRDQQSKTPSLIFEHVNNT------DFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-- 265 (427)
Q Consensus 196 ~~~~~~~~~~~~lv~e~~~~~------~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-- 265 (427)
|+.+. +.-+.+|+|.+.+. +|..++. .+++ .+...+-+-.+||-+.+|+.+||+|.||++....
T Consensus 84 G~veT--~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 84 GFVET--NLGLGLVVELIRDADGNISPTLEDYLKEGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred EEEec--CCceEEEEEEEECCCCCcCccHHHHHHcCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99976 34467888887553 2444442 2333 2333334445688899999999999999996433
Q ss_pred C-eEEEEe
Q 014307 266 R-KLRLID 272 (427)
Q Consensus 266 ~-~ikl~D 272 (427)
. .+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 2 456665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.2e-05 Score=71.46 Aligned_cols=75 Identities=11% Similarity=0.150 Sum_probs=46.9
Q ss_pred eeeeecCCe-eEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC--CCeeeeeeEEEcCC-CCCcEEEEeecC
Q 014307 140 RKVGRGKYS-EVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQ-SKTPSLIFEHVN 214 (427)
Q Consensus 140 ~~LG~G~fg-~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h--~niv~l~~~~~~~~-~~~~~lv~e~~~ 214 (427)
+.|+.|+.. .||+. +..+++|+.+.. ....+.+|.++|..+..+ -.+.++++...... ....+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457766666 48875 235678876553 345789999999998433 13444444332211 124578999999
Q ss_pred CCchh
Q 014307 215 NTDFK 219 (427)
Q Consensus 215 ~~~l~ 219 (427)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00015 Score=66.73 Aligned_cols=74 Identities=14% Similarity=0.254 Sum_probs=50.3
Q ss_pred EeeeeecCCeeEEEEEEcC-CCeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 139 VRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~~~--~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
++.|..|-...||++.... .++.+++|+...... -...+|+.+++.+..+.-.+++++.+. . .++|||++|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~---~---~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ---N---GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC---C---cEEEEeeCC
Confidence 4568888889999987432 257888998764322 123579999998855545566665432 1 279999998
Q ss_pred Cch
Q 014307 216 TDF 218 (427)
Q Consensus 216 ~~l 218 (427)
..+
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.5e-05 Score=67.26 Aligned_cols=95 Identities=22% Similarity=0.176 Sum_probs=77.9
Q ss_pred HHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchh-------hhcCCCCHHHHHHHHHHHHHHHHHHHH--
Q 014307 176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPTLSDYDVRYYIYELLKALDYCHS-- 246 (427)
Q Consensus 176 ~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~-------~~~~~~~~~~~~~i~~qi~~~L~~LH~-- 246 (427)
..|.-+|+.+.+.+++++++|.|.. .++.||...+.+. ++ -..++..+.+++.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~------~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR------FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC------EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 3588888888666799999999832 4789999976542 22 246888999999999999999997
Q ss_pred -CCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 247 -QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 247 -~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
..+.-.|++++|+-++.++ .+|++|...+..
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~ 111 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV 111 (188)
T ss_pred CCcEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence 3588899999999999776 799999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00019 Score=68.62 Aligned_cols=136 Identities=14% Similarity=0.218 Sum_probs=84.2
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCC-CeeeeeeEEE----cCCCCCcEEEEeec
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVR----DQQSKTPSLIFEHV 213 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~-niv~l~~~~~----~~~~~~~~lv~e~~ 213 (427)
.+.|..|....+|+... ++..+++|+........+..|+.++..|..+. .+++++.... .......+++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 46678888889999864 44578999887655677888999999884331 2445443210 01133467899999
Q ss_pred CCCchhhhc------------------CCCCHH-------H-HH------------HHHHHHHHHHHHHHH-------CC
Q 014307 214 NNTDFKVLY------------------PTLSDY-------D-VR------------YYIYELLKALDYCHS-------QG 248 (427)
Q Consensus 214 ~~~~l~~~~------------------~~~~~~-------~-~~------------~i~~qi~~~L~~LH~-------~~ 248 (427)
+|..+.... ..+... . .. .....+..++.++.. .+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 987643210 001000 0 00 011112334444443 37
Q ss_pred ceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 249 iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
++|+|+.|.|||++.++ .+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDE-LSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence 99999999999999654 56899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.85 E-value=4.9e-05 Score=81.97 Aligned_cols=201 Identities=16% Similarity=0.164 Sum_probs=134.2
Q ss_pred HHHHHHHHHHhcCCCCeeeeeeEEEcCCCC--CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014307 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSK--TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGI 249 (427)
Q Consensus 175 ~~~E~~il~~l~~h~niv~l~~~~~~~~~~--~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i 249 (427)
..-|...+.++ .|+|++.++.|-...... .+.+..|++...++.... ...+....+.+..++++||.|+|+...
T Consensus 229 ~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 34566777888 899999999886643222 223345677766665554 457888899999999999999999976
Q ss_pred eeeccCCC---ceEEcCCCCeEEEE--eeeeeeeecCCCcceeeccCccccccccccCCCCCCc--hhhHHHHHHHHHHH
Q 014307 250 MHRDVKPH---NVMIDHEQRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY--SLDLWSLGCMFAGM 322 (427)
Q Consensus 250 iHrDlkp~---NILl~~~~~~ikl~--DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~--~~DvwSlGvll~el 322 (427)
.|.-|... +...+.++ .+.+. ||+.++.............+..+.++|.... ..+.. ..|+|.+|.++..+
T Consensus 308 ~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhh
Confidence 66666555 34444444 45566 8888876655544444555666778888654 44444 36999999999999
Q ss_pred HhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 323 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 323 ltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..|..+-.. ......+............+.+ |..-+++.|....+++.|+|..-..
T Consensus 386 ~~~~~i~~~----~~~~~~~l~~~~~~~~~d~~~~-~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 386 SQGEDISEK----SAVPVSLLDVLSTSELLDALPK-CLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhcCccccc----ccchhhhhccccchhhhhhhhh-hcchhhhhccchhhhhhchhccccc
Confidence 887654322 2222222222222223333444 7888899999999999999976543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00017 Score=67.42 Aligned_cols=126 Identities=22% Similarity=0.263 Sum_probs=75.8
Q ss_pred eeecCCeeEEEEEEcCCCeEEEEEEeccccHH---HHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCch
Q 014307 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK---KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218 (427)
Q Consensus 142 LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~---~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l 218 (427)
+..|-.+.+|+.. .+++.+++|+....... ...+|..+++.+..+.-.++++.... -.+||||++|..+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~------~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE------HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC------CEEEEEeccCccc
Confidence 4567788899886 45678888976432211 35789999999854433355554431 2589999998664
Q ss_pred hhh-------c-----------C------CCCHH-HHHHHHHHH---------HHHHHHHHH--------CCceeeccCC
Q 014307 219 KVL-------Y-----------P------TLSDY-DVRYYIYEL---------LKALDYCHS--------QGIMHRDVKP 256 (427)
Q Consensus 219 ~~~-------~-----------~------~~~~~-~~~~i~~qi---------~~~L~~LH~--------~~iiHrDlkp 256 (427)
... . . .+... .+..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 321 0 0 01111 111211111 111222221 2489999999
Q ss_pred CceEEcCCCCeEEEEeeeeee
Q 014307 257 HNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 257 ~NILl~~~~~~ikl~DFGla~ 277 (427)
.||+++.++ +.|+||..|.
T Consensus 156 ~Nil~~~~~--~~lIDwE~a~ 174 (256)
T TIGR02721 156 YNLVVTPQG--LKLIDWEYAS 174 (256)
T ss_pred CcEEEeCCC--CEEEeccccC
Confidence 999998655 7899999885
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00044 Score=68.49 Aligned_cols=74 Identities=16% Similarity=0.248 Sum_probs=53.3
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEecc----------ccHHHHHHHHHHHHHhcCC--CCeeeeeeEEEcCCCCCc
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~il~~l~~h--~niv~l~~~~~~~~~~~~ 206 (427)
.+.||.|.+..||++....+++.++||.-.+ ...+....|.+.|+.+..+ .++++++.+- ...-
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D----~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD----EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC----CCCC
Confidence 3679999999999999854446899997431 2345677888888886433 4677887763 2345
Q ss_pred EEEEeecCCC
Q 014307 207 SLIFEHVNNT 216 (427)
Q Consensus 207 ~lv~e~~~~~ 216 (427)
++|||++++.
T Consensus 107 ~lVME~L~~~ 116 (401)
T PRK09550 107 VTVMEDLSDH 116 (401)
T ss_pred EEEEecCCCc
Confidence 7999999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00042 Score=66.48 Aligned_cols=73 Identities=16% Similarity=0.200 Sum_probs=49.4
Q ss_pred eeeeecCCeeEEEEEEcC------CCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 140 RKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~------~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
+.|..|--..||++.... .++.+++|+..... .....+|..++..+..+.-.+++++.+.. .+|+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN------GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC------Cchhh
Confidence 456677777899887532 25789999976532 24567899999998554445566666532 25889
Q ss_pred ecCCCch
Q 014307 212 HVNNTDF 218 (427)
Q Consensus 212 ~~~~~~l 218 (427)
|++|..+
T Consensus 78 ~i~G~~l 84 (302)
T cd05156 78 FIPSRTL 84 (302)
T ss_pred eeCCCcC
Confidence 9888654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00042 Score=67.03 Aligned_cols=136 Identities=12% Similarity=0.217 Sum_probs=77.3
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC-CCeeeeeeE----EEcCCCCCcEEEEeec
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI----VRDQQSKTPSLIFEHV 213 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h-~niv~l~~~----~~~~~~~~~~lv~e~~ 213 (427)
.+.|+.|....+|+... ++..+++|+......+.+..|+.++..|..+ -.+++.+.. ......+..++++||+
T Consensus 27 ~~~l~~G~~n~~y~v~t--~~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT--TQGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred cchhccccccceEEEEe--CCCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 35577788889999864 3447889988633456667788888877322 123343321 0001134467999999
Q ss_pred CCCchhh-----h------c-------CCCC----------HH-HH-H-----------HHHHH-HHHHHHHHH------
Q 014307 214 NNTDFKV-----L------Y-------PTLS----------DY-DV-R-----------YYIYE-LLKALDYCH------ 245 (427)
Q Consensus 214 ~~~~l~~-----~------~-------~~~~----------~~-~~-~-----------~i~~q-i~~~L~~LH------ 245 (427)
+|..... . + ..++ .. .. . ..+.+ +...++.+.
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 9874311 0 0 0110 00 00 0 01111 111222332
Q ss_pred -HCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 246 -SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 246 -~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
..++||+|+++.|||++.+. ..-|+||+.+.
T Consensus 185 lp~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~ 216 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDR-LSGFIDFYFAC 216 (319)
T ss_pred CCcccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence 23899999999999998443 45799999885
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=6e-05 Score=71.04 Aligned_cols=132 Identities=18% Similarity=0.298 Sum_probs=95.0
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-------c--c----------------HHHHHHHHHHHHHhcCCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------V--K----------------KKKIKREIKILQNLCGGP 189 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-------~--~----------------~~~~~~E~~il~~l~~h~ 189 (427)
-+.+++.||-|.-+.||.+.+ ..|++.++|+-+- . + +-...+|...|+.|..|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 467889999999999999987 5688899986431 0 0 112457888888885543
Q ss_pred -CeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeE
Q 014307 190 -NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 268 (427)
Q Consensus 190 -niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~i 268 (427)
-+++.+++ ...++|||.+.+..+.+...-.... .+...++.-+.-|-.+|+||+|..-=||+++.++ .+
T Consensus 172 fpVPkpiD~------~RH~Vvmelv~g~Pl~~v~~v~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-~i 241 (465)
T KOG2268|consen 172 FPVPKPIDH------NRHCVVMELVDGYPLRQVRHVEDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-KI 241 (465)
T ss_pred CCCCCcccc------cceeeHHHhhcccceeeeeecCChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCC-CE
Confidence 34455543 3457999999998876655333333 3334455556677889999999999999999666 79
Q ss_pred EEEeeeeee
Q 014307 269 RLIDWGLAE 277 (427)
Q Consensus 269 kl~DFGla~ 277 (427)
+++||--..
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999998653
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.001 Score=64.06 Aligned_cols=138 Identities=17% Similarity=0.222 Sum_probs=82.8
Q ss_pred EEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC-CCeeeeeeEEE----cCCCCCcEEEE
Q 014307 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVR----DQQSKTPSLIF 210 (427)
Q Consensus 137 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h-~niv~l~~~~~----~~~~~~~~lv~ 210 (427)
..++.++.|.-..||++.. ++..+++|+.... ..+.+..|++++..|..+ -.+++++.... ....+..++++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eeccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3456678888889998864 3446788987653 245677888888888322 12444444211 11134568999
Q ss_pred eecCCCchhhh---------------c---CCCC--------HHHH-----H----------HHHHHHHHHHHHHHH---
Q 014307 211 EHVNNTDFKVL---------------Y---PTLS--------DYDV-----R----------YYIYELLKALDYCHS--- 246 (427)
Q Consensus 211 e~~~~~~l~~~---------------~---~~~~--------~~~~-----~----------~i~~qi~~~L~~LH~--- 246 (427)
+|++|...... . ..++ .... . .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 99988543110 0 0110 0000 0 001123334555542
Q ss_pred ----CCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 247 ----QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 247 ----~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
.+++|+|+++.||+++.++ .+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence 5899999999999998665 56899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0011 Score=63.64 Aligned_cols=134 Identities=21% Similarity=0.295 Sum_probs=95.0
Q ss_pred EEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-------------------------HH----HHHHHHHHHHHhcC
Q 014307 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------------KK----KIKREIKILQNLCG 187 (427)
Q Consensus 137 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-------------------------~~----~~~~E~~il~~l~~ 187 (427)
.+-..|..|.-+-||.|.. .+|..+|||+++..- ++ -...|++.|+++ +
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl-~ 224 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL-N 224 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-H
Confidence 3556788899999999986 677789999976310 11 145789999998 4
Q ss_pred CCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhh-c--CCCCHHHHHHHHHHHHHHHHHH-HHCCceeeccCCCceEEcC
Q 014307 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y--PTLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDH 263 (427)
Q Consensus 188 h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~i~~qi~~~L~~L-H~~~iiHrDlkp~NILl~~ 263 (427)
...|+----+.. ...+|||+++.......- + ..++...+..+-.|++.-+.-| |..++||.||.-=|+|+-
T Consensus 225 ~aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh- 299 (520)
T KOG2270|consen 225 NAGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH- 299 (520)
T ss_pred hcCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-
Confidence 444332222221 224699999986553221 1 2467778888888888888877 457999999999999997
Q ss_pred CCCeEEEEeeeeeee
Q 014307 264 EQRKLRLIDWGLAEF 278 (427)
Q Consensus 264 ~~~~ikl~DFGla~~ 278 (427)
+| .+.|+|.+-+.-
T Consensus 300 dG-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 DG-KLYIIDVSQSVE 313 (520)
T ss_pred CC-EEEEEEcccccc
Confidence 55 799999998754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0065 Score=59.43 Aligned_cols=134 Identities=20% Similarity=0.266 Sum_probs=80.2
Q ss_pred EeeeeecCCeeEEEEEEcC----CCeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 139 VRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~----~~~~vavK~~~~~~~--~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
+..|-.|-...+|++.... .++.+++|+...... -.-.+|..+++.+..+.--+++++.+.. + .|.||
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~--g----~v~ef 114 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN--G----RVEEF 114 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC--c----eEEEe
Confidence 3455558888999986432 246889998754321 1126799999998555555677776632 2 57899
Q ss_pred cCCCchhhh--c----------------C-C------CC-HHHHHHHHHH-----------------HHHHHHHHH----
Q 014307 213 VNNTDFKVL--Y----------------P-T------LS-DYDVRYYIYE-----------------LLKALDYCH---- 245 (427)
Q Consensus 213 ~~~~~l~~~--~----------------~-~------~~-~~~~~~i~~q-----------------i~~~L~~LH---- 245 (427)
+++..+... . . . .. ...+..+..+ +...+..|.
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 987654311 0 0 0 11 1112222211 111122221
Q ss_pred ----HCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 246 ----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 246 ----~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
...++|+|+++.|||++.++..+.|+||..|..
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 125899999999999986444799999998863
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0035 Score=60.99 Aligned_cols=137 Identities=16% Similarity=0.259 Sum_probs=79.0
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCC---CeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~~--~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++ +.|..|=...+|++..... +..|++|+...... -.-.+|..+++.+..+.--+++++++.. + +|
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~--G----~i 88 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGN--G----MI 88 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCC--c----Ee
Confidence 3444 4455577788998865332 24788998754322 1235799999998555444677766621 2 58
Q ss_pred EeecCCCchhhh-------c-----------C-C------CC-HHHHHHHHHHH----------------------HHHH
Q 014307 210 FEHVNNTDFKVL-------Y-----------P-T------LS-DYDVRYYIYEL----------------------LKAL 241 (427)
Q Consensus 210 ~e~~~~~~l~~~-------~-----------~-~------~~-~~~~~~i~~qi----------------------~~~L 241 (427)
.+|+++..+... . . . .. ...+..+..++ ..-+
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 889877654211 0 0 0 11 11122222111 1112
Q ss_pred HHHH----HCC----ceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 242 DYCH----SQG----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 242 ~~LH----~~~----iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
..+. ..+ ++|.|+.+.|||++.++..++++||..|..
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 2221 112 799999999999975544799999999853
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.11 E-value=7.1e-05 Score=82.66 Aligned_cols=151 Identities=11% Similarity=-0.051 Sum_probs=107.7
Q ss_pred HHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcC----C---CCHHHHHHHHHHHHHHHHHHHHC-
Q 014307 176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----T---LSDYDVRYYIYELLKALDYCHSQ- 247 (427)
Q Consensus 176 ~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~---~~~~~~~~i~~qi~~~L~~LH~~- 247 (427)
..|..-++.. .|+++...+.-.........+..++|+.+|.+...+- + ..+.-+.....+...+..-+|+.
T Consensus 1277 l~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3444455555 7888887766655554556678999999998766642 1 22222333333436677777754
Q ss_pred ----CceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHH
Q 014307 248 ----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGM 322 (427)
Q Consensus 248 ----~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~el 322 (427)
-.+|++||+.|.+|..+. .+|+.++|+.+...+. ......++++.|+.|+.... -.++.++|+|..|+.+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence 268999999999999776 7999999999833222 23345678888999998765 6788889999999999998
Q ss_pred HhCCCCC
Q 014307 323 IFRKEPF 329 (427)
Q Consensus 323 ltg~~pf 329 (427)
.-|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 8877666
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.012 Score=56.49 Aligned_cols=139 Identities=18% Similarity=0.291 Sum_probs=79.4
Q ss_pred EEeeeeecCCeeEEEEEEcCCCeEEEEEEec-----cccHHHHHHHHHHHHHhcC-CCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~-----~~~~~~~~~E~~il~~l~~-h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
+++.+-.|.-..+|.... +++.+++. .. ........+|..+++.+.. .--+...++++.+..-...+.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 334443344344555543 37777777 22 1223556789999998843 223445566665543346789999
Q ss_pred ecCCCchhhhcCCCCH-----------------------------------HHHHHHHHH--------------HHHHHH
Q 014307 212 HVNNTDFKVLYPTLSD-----------------------------------YDVRYYIYE--------------LLKALD 242 (427)
Q Consensus 212 ~~~~~~l~~~~~~~~~-----------------------------------~~~~~i~~q--------------i~~~L~ 242 (427)
|++|............ .++..+..+ ...-..
T Consensus 106 ~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~ 185 (321)
T COG3173 106 WVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK 185 (321)
T ss_pred EecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence 9999432221111000 011111111 112244
Q ss_pred HHHHC--------CceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 243 YCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 243 ~LH~~--------~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
+|+.+ .++|+|+.+.|++++.++ .+=+.||+++..-.
T Consensus 186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lGD 230 (321)
T COG3173 186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATLGD 230 (321)
T ss_pred HHHhcCCCcCCCceeeeCCcccCCEEEeCCC-eeEEEeccccccCC
Confidence 55543 489999999999999777 58999999997543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0075 Score=58.36 Aligned_cols=134 Identities=25% Similarity=0.338 Sum_probs=82.2
Q ss_pred eeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCC-----eeeeeeEEEcCCC--CCcEEEEee
Q 014307 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN-----IVKLLDIVRDQQS--KTPSLIFEH 212 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~n-----iv~l~~~~~~~~~--~~~~lv~e~ 212 (427)
.|.. .-..||+... .+| .+++|+.++. ...++.-|...|+.|..+.- +..+-|-....-. .+..-+++|
T Consensus 33 ~l~s-~eN~~f~~~~-~~g-~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQT-EDG-RYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEe-cCC-CeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 4457888875 333 3499999885 67788899999999844311 2222221111112 367788999
Q ss_pred cCCCchhh-hc------------------CCC----------CHHH--------------HHHHHHHHHHHHHHHHH---
Q 014307 213 VNNTDFKV-LY------------------PTL----------SDYD--------------VRYYIYELLKALDYCHS--- 246 (427)
Q Consensus 213 ~~~~~l~~-~~------------------~~~----------~~~~--------------~~~i~~qi~~~L~~LH~--- 246 (427)
++|..+.. .. +.+ ..+. -.....++...++.+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987662 11 011 1111 01123455555665554
Q ss_pred -----CC--ceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 247 -----QG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 247 -----~~--iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
.+ +||+|+.|.|||++.+...+.++|||-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 99999999999999765337899999885
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.012 Score=55.62 Aligned_cols=31 Identities=35% Similarity=0.705 Sum_probs=25.4
Q ss_pred CceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 248 ~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
.++|+|+++.|||++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999996453457999999863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.015 Score=56.72 Aligned_cols=72 Identities=17% Similarity=0.283 Sum_probs=47.6
Q ss_pred eeeecCCeeEEEEEEcCCCeEEEEEEecc----------ccHHHHHHHHHHHHHhcCC-C-CeeeeeeEEEcCCCCCcEE
Q 014307 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~il~~l~~h-~-niv~l~~~~~~~~~~~~~l 208 (427)
+||.|...-||++....+++.|+||.-.+ ...++..-|...|+..... | .++++|.+- .....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D----~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD----TEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc----ccccee
Confidence 58999999999999754446899996421 1224456788888776332 3 566666653 233458
Q ss_pred EEeecCCC
Q 014307 209 IFEHVNNT 216 (427)
Q Consensus 209 v~e~~~~~ 216 (427)
|||++...
T Consensus 78 vMEdL~~~ 85 (370)
T TIGR01767 78 VMEDLSHH 85 (370)
T ss_pred hHhhCccc
Confidence 99998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0047 Score=55.89 Aligned_cols=54 Identities=15% Similarity=0.121 Sum_probs=34.1
Q ss_pred CeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCch
Q 014307 159 NEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218 (427)
Q Consensus 159 ~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l 218 (427)
++.|+||+.... ..-.-..|..+++.+..+..-+++++.+.. .+|.+|+++..+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~------g~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN------GRVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT------EEEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC------CcEEEEeccccc
Confidence 467888887654 334456788899988666666778887633 267799977654
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.028 Score=54.00 Aligned_cols=29 Identities=24% Similarity=0.595 Sum_probs=25.1
Q ss_pred CCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 247 ~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 47899999999999986 4 57899999774
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.048 Score=54.08 Aligned_cols=75 Identities=16% Similarity=0.169 Sum_probs=47.3
Q ss_pred EeeeeecCCeeEEEEEEcCCC-e-----EEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 139 VRKVGRGKYSEVFEGVHCTDN-E-----KCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~-~-----~vavK~~~~~~~--~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
++.|..|-...+|++...... . .|.+++...... -.-.+|+.+++.+..+..-.++++.+.. .++.
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------g~l~ 128 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------FTIQ 128 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------EEEE
Confidence 345656888899998753321 1 244444321111 1125689999999666667888887732 4899
Q ss_pred eecCCCchh
Q 014307 211 EHVNNTDFK 219 (427)
Q Consensus 211 e~~~~~~l~ 219 (427)
||++|..+.
T Consensus 129 efIeGr~l~ 137 (383)
T PTZ00384 129 EWVEGNTMG 137 (383)
T ss_pred EEeccccCC
Confidence 999987653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.014 Score=57.06 Aligned_cols=125 Identities=20% Similarity=0.183 Sum_probs=74.0
Q ss_pred eeeeecCCeeEEEEEE---------------cCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeee--------
Q 014307 140 RKVGRGKYSEVFEGVH---------------CTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD-------- 196 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~---------------~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~-------- 196 (427)
..||.|.-+.||+|.. +.+.+.+|||+..+...+.+.....||.....-+|++.-..
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~v 274 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEV 274 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchH
Confidence 3589999999998852 23456799999987766666555555543311111111111
Q ss_pred -------------------------EEE-----------cCCCCCcEEEEeecCCCchhhhcCC--CCHHHHHHHHHHHH
Q 014307 197 -------------------------IVR-----------DQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELL 238 (427)
Q Consensus 197 -------------------------~~~-----------~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~ 238 (427)
-|. .+-.....++-+|+.|..+..++.. .++.-...++.-..
T Consensus 275 kqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~ 354 (565)
T KOG1236|consen 275 KQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGV 354 (565)
T ss_pred HHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHH
Confidence 010 0112233456667777777666643 34444555555455
Q ss_pred HHHHH-HHHCCceeeccCCCceEEcCC
Q 014307 239 KALDY-CHSQGIMHRDVKPHNVMIDHE 264 (427)
Q Consensus 239 ~~L~~-LH~~~iiHrDlkp~NILl~~~ 264 (427)
.||.- |--.+++|.|+.|.||++..+
T Consensus 355 ~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 355 NALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred HHHHHHHHhhcceecccCCCcEEEEec
Confidence 55443 334689999999999999643
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.025 Score=53.76 Aligned_cols=77 Identities=16% Similarity=0.198 Sum_probs=50.9
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhc--CCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~--~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
.+-.+.++.|....+|+.. .+++.+.||+-.......+..|..-|+.|. ..-.+++.+++....+ .-+|+|||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~--~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD--DAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS--CCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC--CceEEEEee
Confidence 3456779999999999986 688899999988666778999999999983 3346778888876643 348999999
Q ss_pred CCC
Q 014307 214 NNT 216 (427)
Q Consensus 214 ~~~ 216 (427)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 877
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.027 Score=54.24 Aligned_cols=29 Identities=14% Similarity=0.233 Sum_probs=25.9
Q ss_pred CceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 248 ~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
+++|+|+.+.|||++.++ .+-++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhcc
Confidence 799999999999998666 68899999885
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.078 Score=59.32 Aligned_cols=137 Identities=20% Similarity=0.313 Sum_probs=77.7
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHHHhcCC-CC--eeeeee--------EEEc-CCCCCc
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGG-PN--IVKLLD--------IVRD-QQSKTP 206 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~h-~n--iv~l~~--------~~~~-~~~~~~ 206 (427)
+.|+ |..-.+|+... .++..+++|+.++.. ...+..|...|..|..+ +. +.+++- .... ......
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 4564 34577888764 567789999998643 34555677777776432 22 223322 1111 112256
Q ss_pred EEEEeecCCCchhhhc---------------------CC---------CC-----------------HHHHHHHHHHHHH
Q 014307 207 SLIFEHVNNTDFKVLY---------------------PT---------LS-----------------DYDVRYYIYELLK 239 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---------------------~~---------~~-----------------~~~~~~i~~qi~~ 239 (427)
+.+++|++|..+.... +. +. ..+.+.++.+++.
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 7789999997664310 00 00 1111223333333
Q ss_pred HHHH-----HHH--CCceeeccCCCceEEcCCC--CeEEEEeeeeeee
Q 014307 240 ALDY-----CHS--QGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEF 278 (427)
Q Consensus 240 ~L~~-----LH~--~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~ 278 (427)
...- +.+ .++||+|+.+.|||++.++ ...=|+|||.+..
T Consensus 189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3221 211 4799999999999998664 2344999998853
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.05 E-value=0.022 Score=56.24 Aligned_cols=73 Identities=19% Similarity=0.230 Sum_probs=49.4
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEecc---------ccHHHHHHHHHHHHHhcCC-C-CeeeeeeEEEcCCCCCcE
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---------VKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---------~~~~~~~~E~~il~~l~~h-~-niv~l~~~~~~~~~~~~~ 207 (427)
.+.||.|.-.-||++.+..+++.|+||.-.+ ...++..-|.++|+.+... | .+++++.+-. ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~----e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS----VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc----HHhh
Confidence 5789999999999999744456789986421 2235566788888776322 3 5666766532 2345
Q ss_pred EEEeecCC
Q 014307 208 LIFEHVNN 215 (427)
Q Consensus 208 lv~e~~~~ 215 (427)
+|||++..
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 88998865
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.11 Score=51.55 Aligned_cols=71 Identities=17% Similarity=0.235 Sum_probs=49.7
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEecc----------ccHHHHHHHHHHHHHhcC--CCCeeeeeeEEEcCCCCCc
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCG--GPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~il~~l~~--h~niv~l~~~~~~~~~~~~ 206 (427)
.+.||.|....||+..+ .+..++||.-.+ ....+-..|...|+.+.. ..++++++.++.+ .-
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----MA 110 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----CC
Confidence 57799999999999886 345688987431 123444556777776622 2478888888753 34
Q ss_pred EEEEeecCC
Q 014307 207 SLIFEHVNN 215 (427)
Q Consensus 207 ~lv~e~~~~ 215 (427)
+++||++++
T Consensus 111 vlvME~L~~ 119 (418)
T PLN02756 111 LIGMRYLEP 119 (418)
T ss_pred EEEEeecCC
Confidence 689999977
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.13 Score=49.99 Aligned_cols=69 Identities=14% Similarity=0.186 Sum_probs=42.4
Q ss_pred CCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCC-Ceeeee---e--EEEcCCCCCcEEEEeecCCCc
Q 014307 146 KYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLL---D--IVRDQQSKTPSLIFEHVNNTD 217 (427)
Q Consensus 146 ~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~-niv~l~---~--~~~~~~~~~~~lv~e~~~~~~ 217 (427)
.-..||+... .++..+++|+.++. ....+..|+..+..|..+. .++... | +... ++..+.++++++|..
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~--~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEH--QGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEE--CCEEEEEEeeeCCCC
Confidence 3457888864 45678999998753 3567888999988884321 122211 1 1111 345677888888754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.039 Score=55.59 Aligned_cols=158 Identities=18% Similarity=0.235 Sum_probs=93.7
Q ss_pred cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 014307 171 KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIM 250 (427)
Q Consensus 171 ~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ii 250 (427)
...++.-...+++.+ .|+|...++++.... .....+|+|++....-.....+. . .+-.++ .+|+.
T Consensus 25 ~s~~ilgr~~~lktl-~~~~l~~yl~~~r~~-~~r~IVV~e~~~~Sled~~~~~~-l-----------~~~s~~-~~~~~ 89 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSL-QHDNLCQYLDFSRGK-HERVIVVMEHYTMSLEDILKTGN-L-----------KDESLL-AHGVL 89 (725)
T ss_pred cHHHHhhhhHHHHhh-cCccceeeEeeecCc-cceEEEEehhhccchHHHHHhcc-c-----------chhhhc-ccccc
Confidence 345566778899999 899999999987654 33477899998764432221111 0 000000 11211
Q ss_pred eeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 014307 251 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330 (427)
Q Consensus 251 HrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 330 (427)
|- + .++.+| -++. . | |- ...+|+|||++|.++.++.-|...+
T Consensus 90 ~~------------~-~~~~td-~~~t----~-----------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~- 131 (725)
T KOG1093|consen 90 HL------------N-IIYITD-HFLT----K-----------Y--PS------PIGPKSDVWSLGFIILELYLGISLE- 131 (725)
T ss_pred ee------------h-hhhccc-cccc----c-----------C--CC------CCCcchhhhhHHHHHHHHHHhhHHH-
Confidence 11 1 234444 0000 0 0 11 1124999999999999999987766
Q ss_pred CCCCCHHHHHHHHHHhCC------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 331 YGHDNYDQLVKIAKVLGT------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 331 ~~~~~~~~l~~i~~~~~~------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
....+.+++..+.+..-. .....++.+ |+...|..||....+.+++-|.+.
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~-c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKK-CLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhcc-CCccccccccchhHHhcCccHHHH
Confidence 444555555544443221 222333444 888899999998889998888875
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.064 Score=48.40 Aligned_cols=87 Identities=22% Similarity=0.301 Sum_probs=60.8
Q ss_pred HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--CCc
Q 014307 172 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS--QGI 249 (427)
Q Consensus 172 ~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~--~~i 249 (427)
..-+..+.+++.+. -.|+++.. .+.....++.|.|...... ...++.-=+.+|.-.|+ .+.
T Consensus 102 ~~~y~nky~v~Arm---hGilrL~N----Dn~~~yGvIlE~Cy~~~i~----------~~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 102 DALYFNKYRVFARM---HGILRLKN----DNNYKYGVILERCYKIKIN----------FSNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhhhHHHHh---hheeEeec----CCCceeEEEEeeccCcccc----------hhHHHHHhHHHHHHhhccCCCe
Confidence 45578889999987 26777762 2455567888988753211 11222222466778884 479
Q ss_pred eeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 250 MHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 250 iHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
+|+|-.|+||+.|..| .+||.|=+.-
T Consensus 165 lHGD~np~NiM~D~~G-~lKlVDP~~L 190 (308)
T PF07387_consen 165 LHGDCNPDNIMCDKFG-YLKLVDPVCL 190 (308)
T ss_pred ecCCCChhheeecCCC-CEEecChhhh
Confidence 9999999999999888 7999997753
|
The function of this family is unknown. |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.22 Score=55.70 Aligned_cols=76 Identities=9% Similarity=0.176 Sum_probs=44.4
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCC---CCeeeeee--------EEEcCCCCCcE
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG---PNIVKLLD--------IVRDQQSKTPS 207 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h---~niv~l~~--------~~~~~~~~~~~ 207 (427)
..|+.+. -.+|+... ++..+++|+.+.. ....+..|..++..|... -.+.+.+- ........+.+
T Consensus 37 ~~L~s~~-d~nf~v~t--~~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~v 113 (972)
T PRK06149 37 TELGSQQ-DRNFRVDS--DGGRFVLKICHAAYAAVELEAQHAALRHLAEREPALRVPVVIPALDGEELLTLDVRGQGLRV 113 (972)
T ss_pred EecCCcC-cceEEEEe--cCCcEEEEeCCccCChHHHHHHHHHHHHHHhhCCCCCCceeeECCCCCeEEEEecCCceEEE
Confidence 4555333 36787764 3457888998743 345677788888887433 22233322 11112234567
Q ss_pred EEEeecCCCch
Q 014307 208 LIFEHVNNTDF 218 (427)
Q Consensus 208 lv~e~~~~~~l 218 (427)
.+++|++|..+
T Consensus 114 rL~~~l~G~~~ 124 (972)
T PRK06149 114 RLLDYLPGQPL 124 (972)
T ss_pred EEEEecCCccc
Confidence 88999998654
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.14 E-value=0.29 Score=49.47 Aligned_cols=75 Identities=13% Similarity=0.157 Sum_probs=47.9
Q ss_pred EEeeeeecCCeeEEEEEEcCC--------CeEEEEEEeccccHH--HHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 138 VVRKVGRGKYSEVFEGVHCTD--------NEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~--------~~~vavK~~~~~~~~--~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
-++.|..|-.-.+|++..... ++.|.+++.-..... .-.+|..+++.+..+.--.++++.+.. .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~g------g 182 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFSG------G 182 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeCC------C
Confidence 456677777788998875321 467889987542221 235688888888544444567776631 2
Q ss_pred EEEeecCCCch
Q 014307 208 LIFEHVNNTDF 218 (427)
Q Consensus 208 lv~e~~~~~~l 218 (427)
.|.||++|..+
T Consensus 183 ~I~efi~g~~l 193 (442)
T PTZ00296 183 RIEEWLYGDPL 193 (442)
T ss_pred EEEEeeCCccC
Confidence 67899988643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 427 | ||||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-134 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-134 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-134 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-134 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-133 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-133 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-133 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-133 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-133 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-133 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-116 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-115 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-115 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-115 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-115 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-115 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-115 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-115 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-115 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-115 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-115 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-115 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-115 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-115 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-114 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-111 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-110 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-26 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-26 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-26 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-26 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-26 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-25 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-25 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-25 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-25 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-24 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-24 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-24 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-24 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-24 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-24 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-24 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-24 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-24 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-24 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-24 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-24 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-24 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-24 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-24 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-24 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-24 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-24 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-24 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-24 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-24 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-24 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-24 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-24 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-24 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-24 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-24 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-24 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-24 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-24 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-24 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-24 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-24 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-24 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-24 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-24 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-24 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-24 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-24 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-24 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-24 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-24 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-24 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-24 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-24 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-24 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-24 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-24 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-24 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-23 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-23 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-23 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-23 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-23 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-23 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-22 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-22 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 9e-22 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-21 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-21 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-21 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-21 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-21 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-21 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 8e-21 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-21 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-21 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-21 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-21 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-21 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-21 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-20 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-20 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-20 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-20 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-20 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-20 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-20 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-20 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-20 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-20 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-20 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-20 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-20 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-20 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-20 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-20 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-20 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-20 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-20 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-20 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-20 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-20 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-20 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-20 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-20 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-20 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-20 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-20 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-20 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-20 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-20 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-20 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-20 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-20 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-20 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-20 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-20 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-20 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-20 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-20 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-20 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-20 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-20 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-20 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-20 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-20 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-20 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-20 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-20 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-20 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-20 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-20 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-20 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-20 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-20 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-20 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-20 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-20 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-20 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-20 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-20 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-20 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-20 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-20 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-19 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-19 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-17 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-17 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-17 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-16 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-16 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-14 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-14 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-12 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-10 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-10 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-04 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 8e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-04 |
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 475 bits (1225), Expect = e-169
Identities = 209/270 (77%), Positives = 243/270 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 5 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 64
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 65 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 124
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 125 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGR 372
AKVLGT++L Y++KY+IELDP ++GR
Sbjct: 245 AKVLGTEDLYDYIDKYNIELDPRFNDILGR 274
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-55
Identities = 83/275 (30%), Positives = 134/275 (48%), Gaps = 15/275 (5%)
Query: 85 PPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGR 144
P T + K V++ A +V D + + ++ Y + +G
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64
Query: 145 GKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203
G + V++ C E IK +L+ K+ RE++I++ L NIV+L
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGE 121
Query: 204 KTPS----LIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
K L+ ++V T ++V TL V+ Y+Y+L ++L Y HS GI HRD
Sbjct: 122 KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRD 181
Query: 254 VKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+ DY S+D+W
Sbjct: 182 IKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVW 241
Query: 314 SLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
S GC+ A ++ + P F G DQLV+I KVLGT
Sbjct: 242 SAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGT 275
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 74/229 (32%), Positives = 121/229 (52%), Gaps = 14/229 (6%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 189
+ Y + +G G + VF+ +E I K+L+ K+ RE++I++ + P
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHP 92
Query: 190 NIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYELLK 239
N+V L K L+ E+V T ++ Y T+ ++ Y+Y+LL+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
+L Y HS GI HRD+KP N+++D L+LID+G A+ G+ + SRY++ PEL
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPEL 212
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ +Y ++D+WS GC+ A ++ + P F G DQLV+I KVLGT
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGT 260
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 5e-51
Identities = 65/232 (28%), Positives = 116/232 (50%), Gaps = 17/232 (7%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCGGP 189
E D ++V R G+G + V G + IK I P + + + ++ L L P
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHP 79
Query: 190 NIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYELL 238
NIV+L + ++ E+V +T + Y ++ ++++L+
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 239 KALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
+++ H S + HRD+KPHNV+++ L+L D+G A+ P + + SRY++
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
PEL+ Q Y ++D+WS+GC+FA M+ + P F G ++ QL +I +VLG
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGC 250
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 5e-51
Identities = 71/232 (30%), Positives = 119/232 (51%), Gaps = 30/232 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
+ YE + K+G G Y VF+ + + IK K REI+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYEL 237
+L+ L PN+V LL++ R ++ L+FE+ ++T L Y + ++ V+ ++
Sbjct: 55 MLKQLKH-PNLVNLLEVFRRKRRLH--LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 296
L+A+++CH +HRDVKP N++I ++L D+G A P Y+ VA+R+++
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
PELLV Y +D+W++GC+FA ++ P + G + DQL I K LG
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGD 221
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-50
Identities = 73/224 (32%), Positives = 119/224 (53%), Gaps = 14/224 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQNLCGG 188
+ YE + VG G Y V + + IK K +K REIK+L+ L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH- 83
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALDYCH 245
N+V LL++ + ++ L+FE V++T L +P L V+ Y+++++ + +CH
Sbjct: 84 ENLVNLLEVCKKKKRWY--LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S I+HRD+KP N+++ ++L D+G A PG+ Y+ VA+R+++ PELLV
Sbjct: 142 SHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y ++D+W++GC+ M F EP F G + DQL I LG
Sbjct: 201 KYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGN 243
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 71/255 (27%), Positives = 122/255 (47%), Gaps = 45/255 (17%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
Y + + +G G + V E ++ +K + + K RE+ I++ L NI+KL+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66
Query: 196 DIVRDQQSKTPS------------------------------------LIFEHVNNTDFK 219
D + P +I E+V +T K
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 220 VLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
VL ++ + YIY+L +A+ + HS GI HRD+KP N++++ + L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 274 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
G A+ P + + SR+++ PEL++ +Y S+DLWS+GC+F +I K P F G
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGE 245
Query: 334 DNYDQLVKIAKVLGT 348
+ DQLV+I +++GT
Sbjct: 246 TSIDQLVRIIQIMGT 260
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-49
Identities = 73/233 (31%), Positives = 123/233 (52%), Gaps = 31/233 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
YE + K+G G Y VF+ + +E V K+++ REI
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 236
+L+ L NIV+L D++ + T L+FE + D K L V+ ++++
Sbjct: 54 LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 295
LLK L +CHS+ ++HRD+KP N++I+ L+L ++GLA + P + Y+ V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L + Y S+D+WS GC+FA + P F G+D DQL +I ++LGT
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 9e-49
Identities = 68/236 (28%), Positives = 121/236 (51%), Gaps = 34/236 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
D Y + K+G G Y EV++ + NE V K+I+ RE+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIREVS 85
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYEL 237
+L+ L NI++L ++ LIFE+ D K P +S ++ ++Y+L
Sbjct: 86 LLKELQH-RNIIELKSVIHHNHRLH--LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYH-PGKEYNVRVASR 292
+ +++CHS+ +HRD+KP N+++ L++ D+GLA + P +++ + +
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITL 201
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+++ PE+L+ + Y S+D+WS+ C++A M+ K P F G DQL KI +VLG
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEVLGL 256
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-48
Identities = 70/233 (30%), Positives = 123/233 (52%), Gaps = 33/233 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
+ Y + K+G G Y V++ + + KKI+ REI
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG---------ETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 236
IL+ L NIVKL D++ ++ L+FEH++ D K L L + ++ +
Sbjct: 53 ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 295
LL + YCH + ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L+ + Y ++D+WS+GC+FA M+ P F G DQL++I ++LGT
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGT 219
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-48
Identities = 71/232 (30%), Positives = 125/232 (53%), Gaps = 31/232 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 181
+ Y + K+G G Y+ V++G + V K+I+ RE+ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYEL 237
L++L NIV L DI+ ++S T L+FE+++ D K ++ ++V+ ++++L
Sbjct: 54 LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 296
L+ L YCH Q ++HRD+KP N++I+ L+L D+GLA P K Y+ V + +++
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P++L+ DY +D+W +GC+F M + P F G +QL I ++LGT
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGT 219
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 5e-48
Identities = 78/236 (33%), Positives = 127/236 (53%), Gaps = 33/236 (13%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------R 177
G + Y+ + KVG G Y V++ + V K+I+ R
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQG---------RIVALKRIRLDAEDEGIPSTAIR 68
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYY 233
EI +L+ L PNIV L+D++ ++ T L+FE + D K + L D ++ Y
Sbjct: 69 EISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFME-KDLKKVLDENKTGLQDSQIKIY 124
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASR 292
+Y+LL+ + +CH I+HRD+KP N++I+ + L+L D+GLA + P + Y V +
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+++ P++L+ + Y S+D+WS+GC+FA MI K P F G + DQL KI +LGT
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGT 238
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-48
Identities = 69/242 (28%), Positives = 116/242 (47%), Gaps = 40/242 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----------------R 177
YE V ++G G Y V++ V K ++ R
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPISTVR 60
Query: 178 EIKILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPTLSD 227
E+ +L+ L PN+V+L+D+ ++ L+FEHV+ D + P L
Sbjct: 61 EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPA 119
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
++ + + L+ LD+ H+ I+HRD+KP N+++ ++L D+GLA Y
Sbjct: 120 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQMALTP 178
Query: 288 RVASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
V + +++ PE+L LQ Y +D+WS+GC+FA M FR++P F G+ DQL KI ++
Sbjct: 179 VVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLI 235
Query: 347 GT 348
G
Sbjct: 236 GL 237
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 72/239 (30%), Positives = 123/239 (51%), Gaps = 36/239 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
YE V ++G G Y +VF+ + + V K+++ RE+
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIREVA 63
Query: 181 ILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPTLSDYDV 230
+L++L PN+V+L D+ ++ + L+FEHV+ D P + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETI 122
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 290
+ +++LL+ LD+ HS ++HRD+KP N+++ + ++L D+GLA Y V
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVV 181
Query: 291 SRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ +++ PE+L LQ Y +DLWS+GC+FA M FR++P F G + DQL KI V+G
Sbjct: 182 TLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGL 237
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-47
Identities = 74/228 (32%), Positives = 126/228 (55%), Gaps = 19/228 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNL 185
YE + +G G+++ V++ N+ IK +K + + K REIK+LQ L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKAL 241
PNI+ LLD + + + L+F+ + TD +V+ L+ ++ Y+ L+ L
Sbjct: 70 SH-PNIIGLLDAFGHKSNIS--LVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGL 125
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 300
+Y H I+HRD+KP+N+++D L+L D+GLA F P + Y +V +R+++ PELL
Sbjct: 126 EYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELL 184
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ Y +D+W++GC+ A ++ R PF G + DQL +I + LGT
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGT 231
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 2e-47
Identities = 69/237 (29%), Positives = 124/237 (52%), Gaps = 36/237 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 181
++ + K+G G Y+ V++G++ T V K++K REI +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---------YPTLSDYDVRY 232
++ L NIV+L D++ + T L+FE ++ D K L V+Y
Sbjct: 57 MKELKH-ENIVRLYDVIHTENKLT--LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVAS 291
+ ++LL+ L +CH I+HRD+KP N++I+ + L+L D+GLA + P ++ V +
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+++ P++L+ + Y S+D+WS GC+ A MI +P F G ++ +QL I ++GT
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIMGT 227
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 72/243 (29%), Positives = 112/243 (46%), Gaps = 40/243 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 180
YE + K+G+G + EVF+ H +K V KK+ REIK
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALREIK 68
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPS------LIFEHVNNTDFKVL----YPTLSDYDV 230
ILQ L N+V L++I R + S L+F+ D L + ++
Sbjct: 69 ILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEI 126
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-----PGKEY 285
+ + LL L Y H I+HRD+K NV+I + L+L D+GLA + Y
Sbjct: 127 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRY 185
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
RV + +++ PELL+ +DY +DLW GC+ A M + + P G+ QL I+++
Sbjct: 186 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALISQL 244
Query: 346 LGT 348
G+
Sbjct: 245 CGS 247
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-45
Identities = 72/248 (29%), Positives = 129/248 (52%), Gaps = 18/248 (7%)
Query: 112 INVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPV 170
++++R + ++ + W Y VG G Y V + EK IK + +P
Sbjct: 2 LSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61
Query: 171 KK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVL 221
+ K+ RE+ +L+++ N++ LLD+ S L+ + TD K++
Sbjct: 62 QSEIFAKRAYRELLLLKHMQH-ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM 119
Query: 222 YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
S+ ++Y +Y++LK L Y HS G++HRD+KP N+ ++ E +L+++D+GLA
Sbjct: 120 GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADA 178
Query: 282 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
Y V +R+++ PE+++ Y+ ++D+WS+GC+ A M+ K F G D DQL
Sbjct: 179 EMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLT 234
Query: 341 KIAKVLGT 348
+I KV G
Sbjct: 235 QILKVTGV 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-45
Identities = 61/233 (26%), Positives = 109/233 (46%), Gaps = 22/233 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNIV 192
Y ++ +G G VF V +++ IK + P K REIKI++ L NIV
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLK 239
K+ +I+ S+ + ++ L + R ++Y+LL+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFK 295
L Y HS ++HRD+KP N+ I+ E L++ D+GLA P + + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
P LL+ +Y ++D+W+ GC+FA M+ K F G +Q+ I + +
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESIPV 243
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-44
Identities = 72/238 (30%), Positives = 127/238 (53%), Gaps = 19/238 (7%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKR 177
E W + Y ++ VG G Y V V K IK + +P + K+ R
Sbjct: 14 QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 73
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYP-TLSDYDVR 231
E+++L+++ N++ LLD+ ++ L+ + TD K++ L + ++
Sbjct: 74 ELRLLKHMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQ 131
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVA 290
+ +Y++LK L Y H+ GI+HRD+KP N+ ++ E +L+++D+GLA Y V
Sbjct: 132 FLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTGY---VV 187
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+R+++ PE++++ Y ++D+WS+GC+ A MI K F G D+ DQL +I KV GT
Sbjct: 188 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVTGT 244
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-44
Identities = 70/241 (29%), Positives = 121/241 (50%), Gaps = 24/241 (9%)
Query: 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQ 183
+ + D+++ +G G Y V H E IK ++P K + REIKIL+
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILK 64
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP-TLSDYDVRYYIYELL 238
+ NI+ + +I R + + +I E + TD +V+ LSD ++Y+IY+ L
Sbjct: 65 HF-KHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---------- 288
+A+ H ++HRD+KP N++I+ L++ D+GLA N
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 289 -VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
VA+R+++ PE+++ Y ++D+WS GC+ A + R+ P F G D QL+ I ++G
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIG 240
Query: 348 T 348
T
Sbjct: 241 T 241
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-44
Identities = 68/244 (27%), Positives = 122/244 (50%), Gaps = 32/244 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 188
YE+V+K+G+G Y V++ + E +K I + ++ REI IL L G
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKALDYCHS 246
NIV LL+++R + L+F+++ TD V+ L +Y +Y+L+K + Y HS
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------------------ 288
G++HRD+KP N++++ + +++ D+GL+ + +
Sbjct: 128 GGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 289 ----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
VA+R+++ PE+L+ Y +D+WSLGC+ ++ K P F G +QL +I
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQLERIIG 245
Query: 345 VLGT 348
V+
Sbjct: 246 VIDF 249
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-44
Identities = 68/254 (26%), Positives = 115/254 (45%), Gaps = 26/254 (10%)
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK-- 172
E + + Q Y V R + G Y V GV ++ IK + V
Sbjct: 4 AKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGR 62
Query: 173 -----------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF 218
K++ REI++L + PNI+ L DI + L+ E + TD
Sbjct: 63 TVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDL 120
Query: 219 -KVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
+V++ +S ++Y++Y +L L H G++HRD+ P N+++ + + + D+
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFN 179
Query: 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
LA V R+++ PEL++ + + +D+WS GC+ A M RK F G
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGST 238
Query: 335 NYDQLVKIAKVLGT 348
Y+QL KI +V+GT
Sbjct: 239 FYNQLNKIVEVVGT 252
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-43
Identities = 66/242 (27%), Positives = 126/242 (52%), Gaps = 19/242 (7%)
Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKK 173
++ E W + Y+ + VG G Y V + +K L + K
Sbjct: 14 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYP-TLSD 227
+ RE+++L+++ N++ LLD+ +S L+ + D ++ L+D
Sbjct: 74 RTYRELRLLKHMKH-ENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTD 131
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286
V++ IY++L+ L Y HS I+HRD+KP N+ ++ E +L+++D+GLA Y
Sbjct: 132 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTGY- 189
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLV 246
Query: 347 GT 348
GT
Sbjct: 247 GT 248
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-43
Identities = 61/242 (25%), Positives = 116/242 (47%), Gaps = 13/242 (5%)
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK-- 172
R ++ E + Y+ ++ +G G V IK + +P +
Sbjct: 7 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 66
Query: 173 --KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLS 226
K+ RE+ +++ + NI+ LL++ Q+S ++ E ++ +V+ L
Sbjct: 67 HAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ Y +Y++L + + HS GI+HRD+KP N+++ L+++D+GLA
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMT 184
Query: 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
V +RY++ PE+++ Y ++D+WS+GC+ MI F G D+ DQ K+ + L
Sbjct: 185 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQL 242
Query: 347 GT 348
GT
Sbjct: 243 GT 244
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 67/232 (28%), Positives = 121/232 (52%), Gaps = 17/232 (7%)
Query: 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNL 185
+ Y + +G G Y V + + IK + P + ++ REIKIL
Sbjct: 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 82
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKA 240
NI+ + DI+R + ++ + + TD K+L LS+ + Y++Y++L+
Sbjct: 83 -RHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRG 140
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 296
L Y HS ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
PE++++ + Y S+D+WS+GC+ A M+ + P F G DQL I +LG+
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 250
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 61/244 (25%), Positives = 118/244 (48%), Gaps = 19/244 (7%)
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK--- 172
+++ E + Y+ ++ +G G V + IK + +P +
Sbjct: 45 DNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104
Query: 173 -KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLSD 227
K+ RE+ +++ + NI+ LL++ Q++ L+ E ++ +V+ L
Sbjct: 105 AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---E 284
+ Y +Y++L + + HS GI+HRD+KP N+++ L+++D+GLA
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTP 222
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Y V +RY++ PE+++ Y ++D+WS+GC+ M+ K F G D DQ K+ +
Sbjct: 223 Y---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIE 277
Query: 345 VLGT 348
LGT
Sbjct: 278 QLGT 281
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 64/268 (23%), Positives = 121/268 (45%), Gaps = 49/268 (18%)
Query: 121 WDYESLTVQWGE--QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK- 176
+D++ E +D +E KVGRG Y V++ + + K+I+
Sbjct: 5 YDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEG 58
Query: 177 --------REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL------- 221
REI +L+ L PN++ L + + L+F++ D +
Sbjct: 59 TGISMSACREIALLRELKH-PNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRAS 116
Query: 222 -----YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK---LRLIDW 273
L V+ +Y++L + Y H+ ++HRD+KP N+++ E + +++ D
Sbjct: 117 KANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 274 GLA-EFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
G A F P K + V + +++ PELL+ + Y ++D+W++GC+FA ++ EP
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPI 235
Query: 330 FYGHD---------NYDQLVKIAKVLGT 348
F+ ++DQL +I V+G
Sbjct: 236 FHCRQEDIKTSNPYHHDQLDRIFNVMGF 263
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-40
Identities = 61/292 (20%), Positives = 109/292 (37%), Gaps = 31/292 (10%)
Query: 74 HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQ 133
H H P + ++ + + +D + E ++V+
Sbjct: 1 HHHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSS--ANECISVKGR-- 56
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG- 187
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 57 -IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCH 245
I++L D Q ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 115 SDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD 302
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 173 QHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 303 ----------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
D+WSLGC+ M + K PF + +L I
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 8e-40
Identities = 54/231 (23%), Positives = 94/231 (40%), Gaps = 26/231 (11%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 188
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 246
I++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 88 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 303
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D+
Sbjct: 146 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 304 ----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
D+WSLGC+ M + K PF + +L I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-39
Identities = 57/253 (22%), Positives = 96/253 (37%), Gaps = 37/253 (14%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 188
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 246
I++L D Q ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 69 DKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 302
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 127 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 303 ---------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
D+WSLGC+ M + K PF + +L I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 235
Query: 354 YLNKYHIELDPHL 366
+ IE
Sbjct: 236 --PNHEIEFPDIP 246
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 51/251 (20%), Positives = 97/251 (38%), Gaps = 21/251 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 189
+ + +G+G + VF G H + IK+ + + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 243
NIVKL I + ++ LI E + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 244 CHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
GI+HR++KP N+M + Q +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 301 -------VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 353
+ Y ++DLWS+G F PF + K++ A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 354 YLNKYHIELDP 364
E P
Sbjct: 248 ISGVQKAENGP 258
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 54/208 (25%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
+ Y+ V+K+G G Y EV + + IKI + K+ E+ +L+ L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PNI+KL D D+++ L+ E D + ++ D I ++L + Y
Sbjct: 95 HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 245 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
H I+HRD+KP N++++ + ++++D+GL+ + K+ R+ + Y+ PE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+ YD D+WS+G + ++ PF
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFG 238
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-38
Identities = 47/199 (23%), Positives = 94/199 (47%), Gaps = 18/199 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
D + RK+G G + +V + + +IK + V ++I+ EI++L++L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYELLKAL 241
PNI+K+ ++ D + ++ E + LS+ V + +++ AL
Sbjct: 80 PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
Y HSQ ++H+D+KP N++ +++ID+GLAE + + + + PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 300 LVDLQDYDYSLDLWSLGCM 318
+D + D+WS G +
Sbjct: 198 F--KRDVTFKCDIWSAGVV 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 78/328 (23%), Positives = 135/328 (41%), Gaps = 72/328 (21%)
Query: 90 AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSE 149
AQ+ + + + S+ + W D YE+ +G G Y
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68
Query: 150 VFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204
V E + IK IL+ + K+I REI IL L ++VK+LDIV + +
Sbjct: 69 VCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVE 127
Query: 205 TPS---LIFEHVNNTDF-KVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 258
++ E + +DF K+ L++ ++ +Y LL + Y HS GI+HRD+KP N
Sbjct: 128 KFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPAN 186
Query: 259 VMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----------------------------VA 290
+++ + +++ D+GLA + N + V
Sbjct: 187 CLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV 245
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------FRKEPFFYGHD------ 334
+R+++ PEL++ ++Y ++D+WS+GC+FA ++ + P F G
Sbjct: 246 TRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSP 305
Query: 335 --------------NYDQLVKIAKVLGT 348
N DQL I +LGT
Sbjct: 306 DQKAGNDFKFHTRGNRDQLNVIFNILGT 333
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-37
Identities = 47/230 (20%), Positives = 91/230 (39%), Gaps = 25/230 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
D++ + +G G + +VF+ H D + +IK +K +K +RE+K L L NIV
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VNIV 67
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------------------PTLSDYDVRY 232
+ + K L+ L
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++ K +DY HS+ +++RD+KP N+ + + ++++ D+GL + +
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRTRSKGTL 185
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+ PE + QDY +DL++LG + A ++ + F + L
Sbjct: 186 RYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDG 234
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 53/245 (21%), Positives = 101/245 (41%), Gaps = 28/245 (11%)
Query: 90 AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGE-QDDYEVVRKV-GRGKY 147
A P + ++ L ++ DDY+V +V G G
Sbjct: 16 APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGIN 75
Query: 148 SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207
+V + + EK +K+L+ K +RE+++ P+IV+++D+ + +
Sbjct: 76 GKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 208 --LIFEHVN------------NTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 253
++ E ++ + F ++ + + + +A+ Y HS I HRD
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIGEAIQYLHSINIAHRD 186
Query: 254 VKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 311
VKP N++ ++ L+L D+G A+ + Y+ PE+L + YD S D
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL-GPEKYDKSCD 245
Query: 312 LWSLG 316
+WSLG
Sbjct: 246 MWSLG 250
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-37
Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 24/234 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 189
+ + +G+G + VF G H + IK+ + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 243
NIVKL I + ++ LI E + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 244 CHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
GI+HR++KP N+M Q +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 301 -------VDLQDYDYSLDLWSLGCMFAGMIFRKEPF---FYGHDNYDQLVKIAK 344
+ Y ++DLWS+G F PF N + + KI
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 186
D Y+ R +G+G + EV ++C +K++ K+ + RE+++L+ L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
PNI+KL + D+ L+ E D + S+ D I ++L + Y
Sbjct: 84 DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 244 CHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
H I+HRD+KP N++++ + +R+ID+GL+ + K+ ++ + Y+ PE+L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200
Query: 302 DLQDYDYSLDLWSLGCM 318
YD D+WS G +
Sbjct: 201 -HGTYDEKCDVWSTGVI 216
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 57/272 (20%), Positives = 95/272 (34%), Gaps = 21/272 (7%)
Query: 71 HARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQW 130
H H H L T + RV + Y+ +
Sbjct: 2 HHHHHHSSGVDLGTE--------NLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPES 53
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNL 185
Q ++ + ++G G Y EVF+ D +K P + + E+ + +
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALD 242
P V+L ++ L E + + +L + V Y+ + L AL
Sbjct: 114 GQHPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
+ HSQG++H DVKP N+ + R +L D+GL V+ + PELL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
Y + D++SLG + E G
Sbjct: 231 --SYGTAADVFSLGLTILEVACNMELPHGGEG 260
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-37
Identities = 50/199 (25%), Positives = 96/199 (48%), Gaps = 21/199 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
+ Y +V +G+G + EV + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKAL 241
PNI+KL +I+ D S ++ E + L+ S++D I ++ +
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
Y H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 300 LVDLQDYDYSLDLWSLGCM 318
L YD D+WS G +
Sbjct: 195 L--RGTYDEKCDVWSAGVI 211
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-37
Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
DDY++ ++V G G +V E H +KC +K+L K ++E+ GGP+I
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84
Query: 192 VKLLDIVRDQQSKTPS--LIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKALDYC 244
V +LD+ + +I E + + + ++ + + ++ A+ +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 245 HSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
HS I HRDVKP N++ +++ L+L D+G A+ + Y+ PE+L
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202
Query: 303 LQDYDYSLDLWSLG 316
+ YD S D+WSLG
Sbjct: 203 PEKYDKSCDMWSLG 216
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-37
Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 37/242 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 190
D+E + +G+G + +V + + D+ IK ++ K I E+ +L +L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQY 63
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y---PTLSDY-----------DVRYYIY 235
+V+ ++++ + +T F + Y TL D +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+ H + +
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 296 G---------------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
E+L Y+ +D++SLG +F MI+ PF G + + L
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK 239
Query: 341 KI 342
K+
Sbjct: 240 KL 241
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 44/196 (22%), Positives = 89/196 (45%), Gaps = 21/196 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPN 190
+ Y + +GRG++ V V + + + K + K + +K+EI IL N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62
Query: 191 IVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
I+ L + + +I FE +N + F+ L++ ++ Y++++ +AL
Sbjct: 63 ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115
Query: 242 DYCHSQGIMHRDVKPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
+ HS I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 301 VDLQDYDYSLDLWSLG 316
+ D+WSLG
Sbjct: 176 -QHDVVSTATDMWSLG 190
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 53/251 (21%), Positives = 98/251 (39%), Gaps = 27/251 (10%)
Query: 84 TPPDTLAQKIGKSVRRSGAPSKAR----VYSDINVVRPREYWDYESLTVQWGE-QDDYEV 138
P D ++ G V G + + D V + + + + ++ D Y++
Sbjct: 102 IPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDI 161
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 195
++G G + V + K+ +++EI+ + L P +V L
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLH 220
Query: 196 DIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
D D +I FE V + K +S+ + Y+ ++ K L + H
Sbjct: 221 DAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKGLCHMHE 273
Query: 247 QGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+H D+KP N+M +L+LID+GL P + V + F PE+ + +
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA-EGKP 332
Query: 306 YDYSLDLWSLG 316
Y D+WS+G
Sbjct: 333 VGYYTDMWSVG 343
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-36
Identities = 53/194 (27%), Positives = 85/194 (43%), Gaps = 13/194 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
Y + +GRG + EV V + K + + K+EI+I+++L P
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
NI++L + D L+ E + V + D + ++L A+ YCH
Sbjct: 67 NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 247 QGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
+ HRD+KP N + L+LID+GLA + PGK +V + Y+ P++L
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 305 DYDYSLDLWSLGCM 318
Y D WS G M
Sbjct: 183 LYGPECDEWSAGVM 196
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-36
Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 22/197 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGP 189
D Y+++ ++G G + V V I P+ K +K EI I+ L P
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108
Query: 190 NIVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
++ L D D+ LI F+ + D+K +S+ +V Y+ + +
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161
Query: 241 LDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
L + H I+H D+KP N+M + +++ID+GLA +P + V A+ F PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
Query: 300 LVDLQDYDYSLDLWSLG 316
+ D + + D+W++G
Sbjct: 222 V-DREPVGFYTDMWAIG 237
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 52/206 (25%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----------------PVKKKKIKR 177
+ Y VRK+G G Y EV + + IK++K ++I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FK--VLYPTLSDYDVRYYI 234
EI +L++L PNI+KL D+ D++ L+ E + F+ + + D +
Sbjct: 96 EISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++L + Y H I+HRD+KP N++++ + ++++D+GL+ F+ + R+ +
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 293 YFKGPELLVDLQDYDYSLDLWSLGCM 318
Y+ PE+L + Y+ D+WS G +
Sbjct: 213 YYIAPEVL--KKKYNEKCDVWSCGVI 236
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 50/199 (25%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
+D Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 240
+ N++ L D+ ++ LI E V+ DF +LS+ + +I ++L
Sbjct: 71 QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
++Y H++ I H D+KP N+M+ + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 298 ELLVDLQDYDYSLDLWSLG 316
E++ + + D+WS+G
Sbjct: 188 EIV-NYEPLGLEADMWSIG 205
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 19/227 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
+E+ ++G G + V +H E K + L P +++ EI+I++ L P
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72
Query: 190 NIVKLLDIVRDQQSKTPS----LIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLK 239
N+V ++ Q P+ L E+ D K L L + +R + ++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 240 ALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
AL Y H I+HRD+KP N+++ ++ ++ID G A+ G+ V + + P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
ELL + + Y ++D WS G + I P F + Q +
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVR 237
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 60/227 (26%), Positives = 111/227 (48%), Gaps = 18/227 (7%)
Query: 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEK 161
P A + + R E+ S D+Y+V ++G+G +S V VH T +
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFS----DNYDVKEELGKGAFSVVRRCVHKTTGLE 56
Query: 162 CIIKI-----LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216
KI L +K++RE +I + L PNIV+L D ++++ L+F+ V
Sbjct: 57 FAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH--YLVFDLVTGG 113
Query: 217 ---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLI 271
+ V S+ D + I ++L+++ YCHS GI+HR++KP N+++ + ++L
Sbjct: 114 ELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
D+GLA + + ++ + + PE+L Y +D+W+ G +
Sbjct: 174 DFGLAIEVNDSEAWHGFAGTPGYLSPEVL-KKDPYSKPVDIWACGVI 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 41/197 (20%), Positives = 89/197 (45%), Gaps = 16/197 (8%)
Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLC 186
+ Y + K GRGK++ V + + + ++ K + +I EI +L+
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F----KVLYPTLSDYDVRYYIYELLKAL 241
P ++ L ++ + LI E+ + F L +S+ DV I ++L+ +
Sbjct: 87 SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 242 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 299
Y H I+H D+KP N+++ + ++++D+G++ E + + + PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204
Query: 300 LVDLQDYDYSLDLWSLG 316
L + + D+W++G
Sbjct: 205 L-NYDPITTATDMWNIG 220
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 46/227 (20%), Positives = 93/227 (40%), Gaps = 18/227 (7%)
Query: 132 EQDDYEVVRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
+ + +G G V+ G+ DN +K + P RE+++L+ PN
Sbjct: 22 GKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPN 79
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 247
+++ +D+Q + + E T + + + + + L + HS
Sbjct: 80 VIRYFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 248 GIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 299
I+HRD+KPHN++I + K + D+GL + G+ R + + PE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 300 LVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
L + ++ Y++D++S GC+F +I F + +
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGA 244
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 66/276 (23%), Positives = 120/276 (43%), Gaps = 64/276 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 188
D+Y + +GRG Y V+ + IK + + + K+I REI IL L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84
Query: 189 PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP--TLSDYDVRYYIYELLKALD 242
I++L D++ ++ E + +D K+ L++ ++ +Y LL +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-------------- 288
+ H GI+HRD+KP N +++ + +++ D+GLA + K+ N+
Sbjct: 144 FIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 289 ---------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------FRKEPF 329
V +R+++ PEL++ ++Y S+D+WS GC+FA ++ + P
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 330 FYG-----------------HDNYDQLVKIAKVLGT 348
F G N DQL I ++GT
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGT 298
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 67/251 (26%), Positives = 111/251 (44%), Gaps = 24/251 (9%)
Query: 74 HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQ 133
H H + + L + SV S AP A + D + + + ++L+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWI----DGSNRDALS------ 52
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNIV 192
D +EV ++GRG S V+ + +K + K V KK ++ EI +L L PNI+
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNII 111
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
KL +I SL+ E V T D V S+ D + ++L+A+ Y H
Sbjct: 112 KLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 248 GIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
GI+HRD+KP N++ L++ D+GL++ + + PE+L
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-CA 226
Query: 306 YDYSLDLWSLG 316
Y +D+WS+G
Sbjct: 227 YGPEVDMWSVG 237
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-35
Identities = 49/206 (23%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------------PVKKKKIKREIK 180
++YE +GRG S V +H ++ +KI+ ++ +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYEL 237
IL+ + G PNI++L D L+F+ + D+ TLS+ + R + L
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
L+ + H I+HRD+KP N+++D + ++L D+G + PG++ + + P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 298 ELL-----VDLQDYDYSLDLWSLGCM 318
E++ + Y +D+WS G +
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-35
Identities = 50/196 (25%), Positives = 95/196 (48%), Gaps = 15/196 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
+ Y +V +G+G + EV + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PNI+KL +I+ D S ++ E D + S++D I ++ + Y
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 245 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195
Query: 303 LQDYDYSLDLWSLGCM 318
YD D+WS G +
Sbjct: 196 RGTYDEKCDVWSAGVI 211
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-35
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 25/201 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 184
Y+V +G G + V+ G+ +DN IK + + ++ E+ +L+
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 185 LC-GGPNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYIYE 236
+ G +++LLD + P LI E DF L + R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
+L+A+ +CH+ G++HRD+K N++ID + +L+LID+G Y +R +
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216
Query: 297 PELLVDLQDYD-YSLDLWSLG 316
PE + Y S +WSLG
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLG 236
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 19/199 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
+D Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 240
+ PNI+ L D+ ++ LI E V+ DF +LS+ + +I ++L
Sbjct: 71 QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 241 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
++Y H++ I H D+KP N+M+ + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 298 ELLVDLQDYDYSLDLWSLG 316
E++ + + D+WS+G
Sbjct: 188 EIV-NYEPLGLEADMWSIG 205
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 184
+D YE+ +G+G +S V ++ ++ +KI+ + + +KRE I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYEL 237
L P+IV+LL+ ++FE ++ S+ +Y+ ++
Sbjct: 83 L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 238 LKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 294
L+AL YCH I+HRDVKPH V++ ++L +G+A + G RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 295 KGPELLVDLQDYDYSLDLWSLGCM 318
PE++ + Y +D+W G +
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVI 222
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 50/247 (20%), Positives = 100/247 (40%), Gaps = 49/247 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
D+E ++ +GRG + VFE + D+ IK ++ + ++K+ RE+K L L P
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH-P 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------PTLSDY------------- 228
IV+ + ++ + + ++ LY L D+
Sbjct: 64 GIVRYFNAWLEKNTTE-----KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EFYHP 281
+ ++ +A+++ HS+G+MHRD+KP N+ + +++ D+GL E
Sbjct: 119 VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTV 177
Query: 282 GKEYNVRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
G PE + Y + +D++SLG + +++ PF +
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQMER 233
Query: 336 YDQLVKI 342
L +
Sbjct: 234 VRTLTDV 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 7e-34
Identities = 55/275 (20%), Positives = 109/275 (39%), Gaps = 22/275 (8%)
Query: 61 RGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREY 120
R L + + +R + D + + ++ + ++
Sbjct: 21 RARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPE 80
Query: 121 WDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------- 173
+ Y+ +GRG S V VH + +KI++ ++
Sbjct: 81 DELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLE 140
Query: 174 ----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLS 226
+RE IL+ + G P+I+ L+D L+F+ + D+ LS
Sbjct: 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALS 198
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ + R + LL+A+ + H+ I+HRD+KP N+++D + ++RL D+G + PG++
Sbjct: 199 EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLR 257
Query: 287 VRVASRYFKGPELL-----VDLQDYDYSLDLWSLG 316
+ + PE+L Y +DLW+ G
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-34
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 18/196 (9%)
Query: 133 QDDYEV---VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 189
Y++ + +G G +S + VH N+ +KI+ + ++EI L+ G P
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALDY 243
NIVKL ++ DQ L+ E +N + F K + S+ + Y + +L+ A+ +
Sbjct: 67 NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121
Query: 244 CHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 300
H G++HRD+KP N++ E ++++ID+G A P + + ++ PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 301 VDLQDYDYSLDLWSLG 316
+ YD S DLWSLG
Sbjct: 182 -NQNGYDESCDLWSLG 196
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 55/194 (28%), Positives = 102/194 (52%), Gaps = 14/194 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 187
D+Y+V ++G+G +S V VH T + KI L +K++RE +I + L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PNIV+L D ++++ L+F+ V + V S+ D + I ++L+++ YC
Sbjct: 65 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 245 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
HS GI+HR++KP N+++ + ++L D+GLA + + ++ + + PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180
Query: 303 LQDYDYSLDLWSLG 316
Y +D+W+ G
Sbjct: 181 KDPYSKPVDIWACG 194
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 52/201 (25%), Positives = 101/201 (50%), Gaps = 23/201 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
+D YE+ ++G G+++ V + ++ K +K V +++I+RE+ IL+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELL 238
+ PNI+ L DI ++ LI E V + DF +L++ + ++ ++L
Sbjct: 64 EI-RHPNIITLHDIFENKTDVV--LILELV--SGGELFDFLAEKESLTEDEATQFLKQIL 118
Query: 239 KALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
+ Y HS+ I H D+KP N+M+ + +++LID+G+A G E+ + F
Sbjct: 119 DGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFV 178
Query: 296 GPELLVDLQDYDYSLDLWSLG 316
PE++ + + D+WS+G
Sbjct: 179 APEIV-NYEPLGLEADMWSIG 198
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-33
Identities = 48/201 (23%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 183
D Y+ ++G G+++ V + + + K +K V ++ I+RE+ IL+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELL 238
+ PN++ L ++ ++ LI E V DF +L++ + ++ ++L
Sbjct: 70 EI-QHPNVITLHEVYENKTDVI--LILELV--AGGELFDFLAEKESLTEEEATEFLKQIL 124
Query: 239 KALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
+ Y HS I H D+KP N+M+ + + ++++ID+GLA G E+ + F
Sbjct: 125 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 296 GPELLVDLQDYDYSLDLWSLG 316
PE++ + + D+WS+G
Sbjct: 185 APEIV-NYEPLGLEADMWSIG 204
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 41/244 (16%), Positives = 88/244 (36%), Gaps = 37/244 (15%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
++ + +G G V +K + EIK+L PN++
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 72
Query: 193 KLLDIVRDQQSKTPSLIFEH---------VNNTDFKVLYPTLSDYDVRYYIYELLKALDY 243
+ + + E + +Y+ + ++ + +
Sbjct: 73 RYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 244 CHSQGIMHRDVKPHNVMID------------HEQRKLRLIDWGLAEFYHPGKEY-----N 286
HS I+HRD+KP N+++ E ++ + D+GL + G+ N
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 287 VRVASRYFKGPELLVDLQD------YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+ ++ PELL + + S+D++S+GC+F ++ + + F D Y +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRES 248
Query: 341 KIAK 344
I +
Sbjct: 249 NIIR 252
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 24/230 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 188
+DYEV+ +G G Y + +D + + K + +K+ + E+ +L+ L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 241
PNIV+ D + D+ + T ++ E+ D L + V + +L AL
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 295
CH + ++HRD+KP NV +D +Q ++L D+GLA + + V + Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAK 344
PE + Y+ D+WSLGC+ + PF + +L KI +
Sbjct: 184 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAGKIRE 230
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-33
Identities = 52/268 (19%), Positives = 101/268 (37%), Gaps = 58/268 (21%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 184
Q Y + +G+G Y V + IKI+ P ++IK E+++++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 185 LCGGPNIVKLLDIVRDQQS----------------------------------------- 203
L PNI +L ++ D+Q
Sbjct: 85 LHH-PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263
+ + + L + + + ++ AL Y H+QGI HRD+KP N +
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 264 -EQRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG 316
+ +++L+D+GL++ ++ + + YF PE+L + Y D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 317 CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ ++ P F G ++ D + ++
Sbjct: 264 VLLHLLLMGAVP-FPGVNDADTISQVLN 290
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-33
Identities = 50/243 (20%), Positives = 108/243 (44%), Gaps = 25/243 (10%)
Query: 90 AQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGE-QDDYEVVRK--VGRGK 146
R SK +++ P +D+ +T + G Y V + +G G+
Sbjct: 42 VWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGR 101
Query: 147 YSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203
+ +V + K IIK K+++K EI ++ L N+++L D +
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKND 160
Query: 204 KTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
L+ F+ + + + L++ D ++ ++ + + + H I+H D+
Sbjct: 161 IV--LVMEYVDGGELFDRIIDESYN-----LTELDTILFMKQICEGIRHMHQMYILHLDL 213
Query: 255 KPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 313
KP N++ ++ + +++++ID+GLA Y P ++ V + F PE++ + + D+W
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVV-NYDFVSFPTDMW 272
Query: 314 SLG 316
S+G
Sbjct: 273 SVG 275
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 27/203 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 184
+Y + +G+G + VF G TD + IK++ E+ +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 185 LCGG---PNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYI 234
+ G P +++LLD +T L+ E D+ L + R +
Sbjct: 91 VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
+++ A+ +CHS+G++HRD+K N++ID + +LID+G H Y +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204
Query: 295 KGPELLVDLQDYD-YSLDLWSLG 316
PE + Y +WSLG
Sbjct: 205 SPPEWISR-HQYHALPATVWSLG 226
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 48/251 (19%), Positives = 101/251 (40%), Gaps = 29/251 (11%)
Query: 117 PREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKK 173
RE ++ V + Y ++K+G G +S V D +K + + ++
Sbjct: 13 GRENLYFQGHMVIIDNKH-YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE 71
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS--LIFEHVNNTD-------FKVLYPT 224
+ +RE + + PNI++L+ ++ L+ K
Sbjct: 72 EAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
L++ + + + + + L+ H++G HRD+KP N+++ ++ + L+D G E
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVE 189
Query: 285 YNVRVASR----------YFKGPELLVDLQDY---DYSLDLWSLGCMFAGMIFRKEPFFY 331
+ + + ++ PE L +Q + D D+WSLGC+ M+F + P+
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 332 GHDNYDQLVKI 342
D +
Sbjct: 249 VFQKGDSVALA 259
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-32
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 22/204 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKI 181
+D+Y + + +G G EV +K IKI+ K ++ EI+I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELL 238
L+ L P I+K+ + ++ ++ E + D V L + + Y Y++L
Sbjct: 69 LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 239 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 297 PELLVDLQD--YDYSLDLWSLGCM 318
PE+LV + Y+ ++D WSLG +
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 30/234 (12%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKREIKI 181
+D+Y + + +G G EV +K I+I+ + ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELL 238
L+ L P I+K+ + ++ ++ E + D V L + + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 239 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 297 PELLVDLQD--YDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE+LV + Y+ ++D WSLG +G PF +I
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS 359
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-32
Identities = 38/229 (16%), Positives = 78/229 (34%), Gaps = 31/229 (13%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCG 187
++ + K+G G++ VF+ V D IK K V ++ RE+ L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF-EHVNN-------TDFKVLYPTLSDYDVRYYIYELLK 239
++V+ + LI E+ N ++ + + +++ + ++ +
Sbjct: 70 HSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-------------- 285
L Y HS ++H D+KP N+ I + G + + K
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 286 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
V F E+L + + D+++L + G
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 56/226 (24%), Positives = 99/226 (43%), Gaps = 31/226 (13%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----------PVKKKKIKREIKILQ 183
Y + +G G + V+ V N++ ++K +K K K+ EI IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIF----EHVNNT---DFKVLYPTLSDYDVRYYIYE 236
+ NI+K+LDI + +H + F +P L + Y +
Sbjct: 85 RVEH-ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
L+ A+ Y + I+HRD+K N++I E ++LID+G A + GK + + +
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197
Query: 297 PELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
PE+L+ Y L++WSLG ++F + PF ++ V+
Sbjct: 198 PEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF----CELEETVE 238
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-32
Identities = 43/208 (20%), Positives = 96/208 (46%), Gaps = 29/208 (13%)
Query: 133 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGG 188
+D Y++ V G G ++ V ++ +++ +KI+ + ++ RE+++L G
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALD 242
N+++L++ ++ L+FE + + + ++ + + ++ ALD
Sbjct: 71 RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNV--------RVASR 292
+ H++GI HRD+KP N++ +H + +++ D+ L + + S
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 293 YFKGPELL----VDLQDYDYSLDLWSLG 316
+ PE++ + YD DLWSLG
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLG 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 11/190 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 193
D YEV +G G YS +H N + +KI+ K+ EI+IL PNI+
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80
Query: 194 LLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIM 250
L D+ D + ++ E + D + S+ + ++ + K ++Y H+QG++
Sbjct: 81 LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 251 HRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 306
HRD+KP N++ +R+ D+G A+ + F PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197
Query: 307 DYSLDLWSLG 316
D + D+WSLG
Sbjct: 198 DAACDIWSLG 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 48/200 (24%)
Query: 134 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
DDY+V +V G G +V + + EK +K+L+ K +RE+++ P+IV
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 74
Query: 193 KLLDIVRDQQSKTPS--LIFEHV------------NNTDFKVLYPTLSDYDVRYYIYELL 238
+++D+ + + ++ E + + F ++ + + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIG 127
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
+A+ Y HS I HRDVKP N++ ++ L+L D+G A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------------- 167
Query: 297 PELLVDLQDYDYSLDLWSLG 316
E + YD S D+WSLG
Sbjct: 168 KETT--GEKYDKSCDMWSLG 185
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 47/196 (23%), Positives = 88/196 (44%), Gaps = 17/196 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
+ + + +G G +SEVF + +K + + ++ EI +L+ +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYC 244
NIV L DI L+ + V + D + ++ D I ++L A+ Y
Sbjct: 67 NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 245 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
H GI+HRD+KP N++ E K+ + D+GL++ G + + + PE+L
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181
Query: 303 LQDYDYSLDLWSLGCM 318
+ Y ++D WS+G +
Sbjct: 182 -KPYSKAVDCWSIGVI 196
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 35/240 (14%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKRE 178
D+ TV+ GE V R + G ++ V+E + +K L + K + I +E
Sbjct: 17 DFVGQTVELGELR-LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE 75
Query: 179 IKILQNLCGGPNIVKLLD--IVRDQQSKTPSLIF----EHVNNTDFKVLYPT-----LSD 227
+ ++ L G PNIV+ + ++S T F E + L LS
Sbjct: 76 VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 228 YDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
V Y+ +A+ + H Q I+HRD+K N+++ Q ++L D+G A +Y
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDY 194
Query: 286 NVRVASR-------------YFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ R ++ PE ++DL D+W+LGC+ + FR+ PF
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF 253
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-31
Identities = 38/239 (15%), Positives = 84/239 (35%), Gaps = 31/239 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVKKKKIKREIKILQNLCGG 188
V +G G +++V+E N +K ++K+ KP + ++++ L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124
Query: 189 --PNIVKLLDIVRDQQSKTPSLIFEHVN--------NTDFKVLYPTLSDYDVRYYIYELL 238
+K Q L+ E + N + V + +L
Sbjct: 125 MQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDH----------EQRKLRLIDWGLA---EFYHPGKEY 285
++ H I+H D+KP N ++ + L LID G + + + G +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + F+ E+L + + ++Y +D + + M+F + + +
Sbjct: 243 TAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 50/194 (25%), Positives = 96/194 (49%), Gaps = 15/194 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 188
++Y++ ++G+G +S V V ++ I L +K++RE +I + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
PNIV+L D + ++ LIF+ V + V S+ D + I ++L+A+ +CH
Sbjct: 70 PNIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 246 SQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 302
G++HR++KP N+++ + ++L D+GLA + + + + PE+L
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-R 186
Query: 303 LQDYDYSLDLWSLG 316
Y +DLW+ G
Sbjct: 187 KDPYGKPVDLWACG 200
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCG 187
Y R +G+G +++ FE E KI+ KP +++K+ EI I ++L
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
++V D + ++ E + L++ + RYY+ +++ Y
Sbjct: 101 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 157
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 294
H ++HRD+K N+ ++ E ++++ D+GLA E Y +A
Sbjct: 158 HRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 209
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE+L + + + +D+WS+GC+ ++ K PF
Sbjct: 210 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 241
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCG 187
Y R +G+G +++ FE E KI+ KP +++K+ EI I ++L
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 244
++V D + ++ E + L++ + RYY+ +++ Y
Sbjct: 75 -QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYL 131
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVASRYF 294
H ++HRD+K N+ ++ E ++++ D+GLA E Y +A
Sbjct: 132 HRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA---- 183
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE+L + + + +D+WS+GC+ ++ K PF
Sbjct: 184 --PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 47/234 (20%), Positives = 106/234 (45%), Gaps = 17/234 (7%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIK 176
D + + + + Y ++K+G G + + D + +IK + ++++ +
Sbjct: 12 DLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR 71
Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----YPTLSDYDVR 231
RE+ +L N+ PNIV+ + + S ++ ++ D FK + + +
Sbjct: 72 REVAVLANMKH-PNIVQYRESFEENGSL--YIVMDYCEGGDLFKRINAQKGVLFQEDQIL 128
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVA 290
+ ++ AL + H + I+HRD+K N+ + + ++L D+G+A + E +
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIG 187
Query: 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ Y+ PE+ + + Y+ D+W+LGC+ + K F + ++KI
Sbjct: 188 TPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHA-FEAGSMKNLVLKIIS 239
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 57/232 (24%), Positives = 116/232 (50%), Gaps = 34/232 (14%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 188
YEV++ +G+G + +V + ++ +K+++ K+ ++ EI+IL++L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 189 PNIVKLLD---------IVRDQQSKTPSL---IFEHVNNTDFKVLYPTLSDYDVRYYIYE 236
N++ +L+ + L ++E + F+ L VR + +
Sbjct: 159 MNVIHMLENFTFRNHICMT------FELLSMNLYELIKKNKFQGFSLPL----VRKFAHS 208
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFK 295
+L+ LD H I+H D+KP N+++ + R +++ID+G + + H + Y + SR+++
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYR 266
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
PE+++ Y +D+WSLGC+ A + P G D DQL + ++LG
Sbjct: 267 APEVILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIELLG 316
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 20/226 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCG 187
++ + +K+GRG++SEV+ D +K ++ + +EI +L+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 240
PN++K + +++ E + D FK + + V Y +L A
Sbjct: 92 -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 299
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAK 344
+ + Y++ D+WSLGC+ M + PF+ N L KI +
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ 252
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-31
Identities = 54/226 (23%), Positives = 106/226 (46%), Gaps = 35/226 (15%)
Query: 125 SLTVQWGEQ-DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKR 177
SL GE+ +D++V +G+G ++ V+ + IK++ K ++++
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP---TLSDYDVRYY 233
E+KI L P+I++L + D S L+ E +N + + L S+ + R++
Sbjct: 61 EVKIHCQLKH-PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF 117
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--------- 284
+++++ + Y HS GI+HRD+ N+++ +++ D+GLA E
Sbjct: 118 MHQIITGMLYLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTP 176
Query: 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
Y ++ PE+ + D+WSLGCMF ++ + PF
Sbjct: 177 NY---IS------PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPF 212
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 57/231 (24%), Positives = 107/231 (46%), Gaps = 36/231 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNL 185
+D+E+ R +G+GK+ V+ +K+L K + +++RE++I +L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKALD 242
PNI++L D + LI E+ ++ L + YI EL AL
Sbjct: 67 RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 294
YCHS+ ++HRD+KP N+++ +L++ D+G + + +Y +
Sbjct: 124 YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
PE++ + +D +DLWSLG + + K P F + + +I++V
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 52/194 (26%), Positives = 102/194 (52%), Gaps = 20/194 (10%)
Query: 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 189
+Y +++ +G+G +++V H + IKI L P +K+ RE++I++ L P
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74
Query: 190 NIVKLLDIVRDQQSKTPS---LIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
NIVKL +++ +T LI E+ + D+ V + + + + R +++ A+ Y
Sbjct: 75 NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
CH + I+HRD+K N+++D +++ D+G + + G + + + + PEL
Sbjct: 130 CHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187
Query: 304 QDYD-YSLDLWSLG 316
+ YD +D+WSLG
Sbjct: 188 KKYDGPEVDVWSLG 201
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 42/283 (14%), Positives = 78/283 (27%), Gaps = 45/283 (15%)
Query: 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQN 184
+ ++V + G S VF E +K+ + +++
Sbjct: 59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 185 L-----------------------CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
L P +L D L+ + D ++L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELL 177
Query: 222 YPTLSDYD----------VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271
+ TL + +L++ S+G++H P N+ I + R L L
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LMLG 236
Query: 272 DWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
D + G + E L + ++L+ W LG + PF
Sbjct: 237 DVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 331 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRL 373
K L ++ L + L+GR
Sbjct: 295 LVTPGIKGSWKRP-SLRVPGTDSLAFGSCTPLPDFVKTLIGRF 336
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 62/277 (22%), Positives = 102/277 (36%), Gaps = 29/277 (10%)
Query: 80 RQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVV 139
LA+ T + K R ++P +Y +Y Q
Sbjct: 11 HSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDY-EYREEVHWMTHQP----- 64
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 199
+VGRG + EV +C +K ++ + E+ L P IV L VR
Sbjct: 65 -RVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-PRIVPLYGAVR 120
Query: 200 DQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256
+ ++ E + L + YY+ + L+ L+Y H++ I+H DVK
Sbjct: 121 EGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSL 310
NV++ + + L D+G A P + Y G PE +V + D +
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKV 237
Query: 311 DLWSLGCMFAGMIFRKEPFFYGHDNYDQ---LVKIAK 344
D+WS CM M+ P+ Y + +KIA
Sbjct: 238 DIWSSCCMMLHMLNGCHPWT----QYFRGPLCLKIAS 270
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 17/196 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PVKKKKIKREIKILQNLCGG 188
Y + +G G Y +V E + + +KILK P + +K+EI++L+ L
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTLSDYDVRYYIYELLKALDYC 244
N+++L+D++ +++ + ++ E+ V Y +L+ L+Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLV 301
HSQGI+H+D+KP N+++ L++ G+AE HP + S F+ PE+
Sbjct: 126 HSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 302 DLQDYD-YSLDLWSLG 316
L + + +D+WS G
Sbjct: 185 GLDTFSGFKVDIWSAG 200
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 60/231 (25%), Positives = 117/231 (50%), Gaps = 30/231 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 188
YE+ +G+G + +V + + E IKI+K K + + E+++L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 189 PNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 239
IV L +V + S +L ++ + NT+F+ +S R + ++
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFR----GVSLNLTRKFAQQMCT 168
Query: 240 ALDYCHSQ--GIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 296
AL + + I+H D+KP N+++ + +R ++++D+G + + + SR+++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
PE+L+ + YD ++D+WSLGC+ M EP F G + DQ+ KI +VLG
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLG 275
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-29
Identities = 53/232 (22%), Positives = 107/232 (46%), Gaps = 38/232 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNL 185
DD+++ R +G+GK+ V+ + +K+L K + +++REI+I +L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLF--KSQLEKEGVEHQLRREIEIQSHL 71
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALD 242
PNI+++ + D K L+ E + +K L + + ++ EL AL
Sbjct: 72 RH-PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------EYNVRVASRY 293
YCH + ++HRD+KP N+++ + + +L++ D+G + + P +Y +
Sbjct: 129 YCHERKVIHRDIKPENLLMGY-KGELKIADFGWS-VHAPSLRRRTMCGTLDY---LP--- 180
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
PE++ + +D +DLW G + + P F + + +I V
Sbjct: 181 ---PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPP-FDSPSHTETHRRIVNV 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 63/254 (24%), Positives = 108/254 (42%), Gaps = 58/254 (22%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC------- 186
Y +VRK+G G +S V+ +N +KI++ K + + EIK+LQ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 187 ---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD------FKVLYPTLSDY--------- 228
G +I+KLLD F H F+VL L
Sbjct: 81 DSMGANHILKLLD------------HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 229 ---DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQR-----KLRLIDWGLAEFY 279
V+ +LL LDY H + GI+H D+KP NV+++ ++++ D G A +Y
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD----- 334
+ Y + +R ++ PE+L+ + D+WS C+ +I F +
Sbjct: 189 D--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYT 244
Query: 335 -NYDQLVKIAKVLG 347
+ D + +I ++LG
Sbjct: 245 KDDDHIAQIIELLG 258
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 59/247 (23%), Positives = 110/247 (44%), Gaps = 46/247 (18%)
Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 187
YE+V +G G + +V E + H + +KI++ V K + + EI +L+ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 188 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
V + D I + + FE + +F+ VR+ Y+L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQ----PYPLPHVRHMAYQLC 133
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRK------------------LRLIDWGLAEFYH 280
AL + H + H D+KP N++ + + + +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
+ VA+R+++ PE++++L + D+WS+GC+ +R F H+N + LV
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLV 249
Query: 341 KIAKVLG 347
+ K+LG
Sbjct: 250 MMEKILG 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 52/251 (20%), Positives = 108/251 (43%), Gaps = 54/251 (21%)
Query: 136 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 187
YE+V +G G + +V E + H +KI+K V + + + EI++L++L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 188 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 238
V++L+ IV + S ++ + F +R Y++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFL----PFRLDHIRKMAYQIC 128
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQR------------------KLRLIDWGLAEFYH 280
K++++ HS + H D+KP N++ ++++D+G A +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNY 336
+ V++R+++ PE+++ L + D+WS+GC + G F HD+
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLG-----FTVFPTHDSK 240
Query: 337 DQLVKIAKVLG 347
+ L + ++LG
Sbjct: 241 EHLAMMERILG 251
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 56/229 (24%), Positives = 109/229 (47%), Gaps = 38/229 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKK------------------- 173
Y + ++G+G Y V + DN +K+L K +++
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 174 -------KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT- 224
++ +EI IL+ PN+VKL++++ D ++FE VN +V
Sbjct: 75 QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
LS+ R+Y +L+K ++Y H Q I+HRD+KP N+++ E +++ D+G++ +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDA 192
Query: 285 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDLWSLGC-MFAGMIFRKEPF 329
+ V + F PE L + + + +LD+W++G ++ +F + PF
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC-FVFGQCPF 240
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 55/196 (28%), Positives = 95/196 (48%), Gaps = 25/196 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNLCG 187
Y + +G G + +V G H K +KIL ++K KIKREI+ L+
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN--RQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
P+I+KL ++ TP+ F E+V+ D+ + + + + R ++L A+
Sbjct: 71 -PHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
DYCH ++HRD+KP NV++D ++ D+GL+ G+ S + PE++
Sbjct: 125 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 183
Query: 302 DLQDYD-YSLDLWSLG 316
+ Y +D+WS G
Sbjct: 184 G-RLYAGPEVDIWSCG 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 47/193 (24%), Positives = 89/193 (46%), Gaps = 17/193 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNI 191
D Y+ V+ +G G + E +K + + ++REI ++L PNI
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNI 78
Query: 192 VKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
V+ +++ TP+ + E+ + + S+ + R++ +LL + YCH
Sbjct: 79 VRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 246 SQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S I HRD+K N ++D +L++ D+G ++ + V + + PE+L+ Q
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-Q 192
Query: 305 DYD-YSLDLWSLG 316
+YD D+WS G
Sbjct: 193 EYDGKIADVWSCG 205
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 189
Y + +G G + +V H +K +K + K +++REI L+ L P
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69
Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDYC 244
+I+KL D++ TP+ I E+ D+ V +++ + R + +++ A++YC
Sbjct: 70 HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
H I+HRD+KP N+++D + +++ D+GL+ G S + PE++ +
Sbjct: 125 HRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182
Query: 305 DYD-YSLDLWSLG 316
Y +D+WS G
Sbjct: 183 LYAGPEVDVWSCG 195
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 56/251 (22%), Positives = 112/251 (44%), Gaps = 50/251 (19%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNL----CGGP 189
+ V+RK+G G + V H + + +K+++ +KK + K E IL+ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 190 NIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 240
NIVK ++ + PSL +E + ++ + ++ Y E+LKA
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRK------------------------LRLIDWGLA 276
L+Y + H D+KP N+++D + ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336
F ++ + +R ++ PE++++L +D S D+WS GC+ A + + F H++
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEHM 265
Query: 337 DQLVKIAKVLG 347
+ L + ++
Sbjct: 266 EHLAMMESIIQ 276
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 30/229 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
N+VK + ++ + E+ + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 300
H GI HRD+KP N+++D E+ L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 301 VDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE 223
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 47/215 (21%), Positives = 91/215 (42%), Gaps = 17/215 (7%)
Query: 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPNIVKLL 195
++GRG + V++G+ + L+ K K K E ++L+ L PNIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91
Query: 196 DIVRDQQSKTPSLIF--EHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG-- 248
D ++ E + + + + + +R + ++LK L + H++
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
I+HRD+K N+ I +++ D GLA V + + F PE+ + YD
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208
Query: 309 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
S+D+++ G M + P + N Q+ +
Sbjct: 209 SVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRV 242
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 56/196 (28%), Positives = 94/196 (47%), Gaps = 25/196 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNLCG 187
Y + +G G + +V G H K +KIL ++K KI+REI+ L+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILN--RQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
P+I+KL ++ TPS IF E+V+ D+ L + + R ++L +
Sbjct: 76 -PHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
DYCH ++HRD+KP NV++D ++ D+GL+ G+ S + PE++
Sbjct: 130 DYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVIS 188
Query: 302 DLQDYD-YSLDLWSLG 316
+ Y +D+WS G
Sbjct: 189 G-RLYAGPEVDIWSSG 203
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 42/319 (13%), Positives = 91/319 (28%), Gaps = 67/319 (21%)
Query: 71 HARHQHQRLRQ---LATPPDTLAQKIGKSVRRSGAPSKA-RVYSDINVVRPREYWDYES- 125
H H H R+ P D + +++ + ++ + + + S + + W+
Sbjct: 2 HHHHHHSSGRENLYFQGPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQP 61
Query: 126 ---LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIK 176
+ +G+ E E + + ++ K++K
Sbjct: 62 FRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMK 121
Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------ 230
E+ L+ L G N + +R P + + + D V
Sbjct: 122 EEVLRLRLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 178
Query: 231 ------------------------------RYYIYELLKALDYCHSQGIMHRDVKPHNVM 260
++++ L H G++H ++P +++
Sbjct: 179 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 238
Query: 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSL 310
+D + L + V SR F+ PEL +S
Sbjct: 239 LDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSF 294
Query: 311 DLWSLGCMFAGMIFRKEPF 329
D W+LG + + P
Sbjct: 295 DAWALGLVIYWIWCADLPI 313
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 54/229 (23%), Positives = 104/229 (45%), Gaps = 30/229 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 190 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 243
N+VK + ++ + E+ + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 300
H GI HRD+KP N+++D E+ L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 301 VDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 50/246 (20%), Positives = 99/246 (40%), Gaps = 42/246 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------------------PVKKK 173
+DY ++R + +GK++++ DN+ +K + K
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----------Y 222
K E++I+ ++ + I+ + +I+E++ N K
Sbjct: 89 DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281
+ ++ I +L + Y H++ I HRDVKP N+++D + +++L D+G +E Y
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESE-YMV 203
Query: 282 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
K+ + F PE + Y+ +D+WSLG M + P F + +L
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP-FSLKISLVELF 262
Query: 341 -KIAKV 345
I
Sbjct: 263 NNIRTK 268
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKREIKILQNLCGGPN 190
+E+V VG G Y +V++G H + IK+ + ++++IK+EI +L+ N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 191 IVKLLDIVRDQQSKTPS----LIFEH---------VNNTDFKVLYPTLSDYDVRYYIYEL 237
I + L+ E + NT TL + + Y E+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 296
L+ L + H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 297 PELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
PE++ ++ YD+ DLWSLG M P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 235
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 47/218 (21%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
+DDYE+ +G G + V EK IK + ++ +EI+ + C
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS-QCHH 72
Query: 189 PNIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS 226
PNIV +LDI++ +K L
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------------SGVLD 119
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ + + E+L+ L+Y H G +HRDVK N+++ E +++ D+G++ F G +
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDIT 178
Query: 287 VRVASRYFKG------PELLVDLQDYDYSLDLWSLGCM 318
+ F G PE++ ++ YD+ D+WS G
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGIT 216
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 47/200 (23%), Positives = 85/200 (42%), Gaps = 28/200 (14%)
Query: 142 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIV 198
+G+G Y V+ G ++ + IK + + + EI + ++L NIV+ L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88
Query: 199 RDQQSKTPSLIFEHVNN----TDFKVLYPTLSDYD--VRYYIYELLKALDYCHSQGIMHR 252
+ + E V + + L D + + +Y ++L+ L Y H I+HR
Sbjct: 89 SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 253 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 305
D+K NV+I+ L++ D+G + + + + F G PE + +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 306 YDYSLDLWSLGC----MFAG 321
Y + D+WSLGC M G
Sbjct: 202 YGKAADIWSLGCTIIEMATG 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 50/288 (17%), Positives = 103/288 (35%), Gaps = 84/288 (29%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGG 188
D+E ++ +GRG + VFE + D+ IK + + + ++K+ RE+K L L
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EH 63
Query: 189 PNIVKLLD----------------------------------------IVRDQQSKTPSL 208
P IV+ + I R T +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 209 IFEHVNNTDFKVLY--------PTLSDY-------------DVRYYIYELLKALDYCHSQ 247
+ + ++ LY L D+ + ++ +A+++ HS+
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----------- 296
G+MHRD+KP N+ + +++ D+GL +E +
Sbjct: 184 GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 297 --PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
PE + +Y + +D++SLG + +++ F + + +
Sbjct: 243 MSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDV 286
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 59/282 (20%), Positives = 113/282 (40%), Gaps = 42/282 (14%)
Query: 69 LSHARHQHQRLRQLATPPDTLAQKIGKSV---RRSGAPSKARVYSDINVVRPREYWDYES 125
+S+ H H + T + Q + R+G+ V P +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEK------ 54
Query: 126 LTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREI 179
+ +R++G G + V+ ++E IK + K+ I +E+
Sbjct: 55 ---------LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 105
Query: 180 KILQNLCGGPNIVKLLD-IVRDQQSKTPSL--IFEHVN---NTDFKVLYPTLSDYDVRYY 233
+ LQ PN ++ +R+ + E+ + +V L + ++
Sbjct: 106 RFLQK-LRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 159
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 293
+ L+ L Y HS ++HRDVK N+++ E ++L D+G A P + V + Y
Sbjct: 160 THGALQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANSF---VGTPY 215
Query: 294 FKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
+ PE+++ + + YD +D+WSLG + RK P F +
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 45/195 (23%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNI 191
++ ++V+ K+G G Y V++ +H + IK + ++I +EI I+Q C P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86
Query: 192 VKLLD-IVRDQQSKTPSL--IFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYC 244
VK ++ L + E+ +D ++ TL++ ++ + LK L+Y
Sbjct: 87 VKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 303
H +HRD+K N++++ + +L D+G+ + + N + + ++ PE++ +
Sbjct: 142 HFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE- 199
Query: 304 QDYDYSLDLWSLGCM 318
Y+ D+WSLG
Sbjct: 200 IGYNCVADIWSLGIT 214
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 36/322 (11%), Positives = 83/322 (25%), Gaps = 69/322 (21%)
Query: 71 HARHQH---------QRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW 121
H H H Q R + + + + + + + S + + W
Sbjct: 2 HHHHHHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLW 61
Query: 122 ----DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----- 172
+ + +G+ E E + + ++
Sbjct: 62 NTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNA 121
Query: 173 -KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV- 230
K++K E+ L+ L G N + +R P + + + D V
Sbjct: 122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVL 178
Query: 231 -----------------------------------RYYIYELLKALDYCHSQGIMHRDVK 255
++++ L H G++H ++
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLR 238
Query: 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQD----YD 307
P ++++D + L + G + + +L Q
Sbjct: 239 PVDIVLDQRGG-VFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMT 295
Query: 308 YSLDLWSLGCMFAGMIFRKEPF 329
++ D W+LG + P
Sbjct: 296 FAFDTWTLGLAIYWIWCADLPN 317
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 53/209 (25%), Positives = 100/209 (47%), Gaps = 20/209 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 188
++ + + K+G+G + EVF+G+ + IKI+ + + I++EI +L C
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79
Query: 189 PNIVKLLD-IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
P + K ++D + L I E++ D + L + + + E+LK LD
Sbjct: 80 PYVTKYYGSYLKDTK-----LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLD 133
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
Y HS+ +HRD+K NV++ E +++L D+G+ + + N V + ++ PE++
Sbjct: 134 YLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
YD D+WSLG + + P
Sbjct: 193 Q-SAYDSKADIWSLGITAIELARGEPPHS 220
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 3e-21
Identities = 43/203 (21%), Positives = 80/203 (39%), Gaps = 17/203 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPN 190
YEV + G ++ + + ++K L + E + L + P+
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140
Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS 246
IV++ + V + + E+V K L + Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
G+++ D+KP N+M+ EQ K LID G + + F+ PE++
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK--LIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254
Query: 307 DYSLDLWSLGCMFAGMIFRKEPF 329
+ D++++G A +
Sbjct: 255 VAT-DIYTVGRTLAALTLDLPTR 276
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCG 187
+D++ + +G G +S V + + IKIL+ +K+ K+ RE ++ L
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 244
P VKL +D + + N + K + + + R+Y E++ AL+Y
Sbjct: 89 HPFFVKLYFTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE 298
H +GI+HRD+KP N++++ + +++ D+G A+ + R S F G PE
Sbjct: 147 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQYVSPE 202
Query: 299 LLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAK 344
LL + + S DLW+LGC + AG+ P F + Y KI K
Sbjct: 203 LLTE-KSACKSSDLWALGCIIYQLVAGL-----PPFRAGNEYLIFQKIIK 246
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-21
Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 22/216 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGP 189
+ +E+V ++G G + +V++ + K+++ + + EI+IL C P
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76
Query: 190 NIVKLLD-IVRDQQSKTPSL--IFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALD 242
IVKLL D + L + E L L++ ++ ++L+AL+
Sbjct: 77 YIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALN 131
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS+ I+HRD+K NV++ + +RL D+G+ A+ ++ + + + Y+ PE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190
Query: 302 DLQ----DYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
YDY D+WSLG M + P +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
+ Y K+G+G V+ + ++ I+ + + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 190 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
NIV LD +V D+ L + E++ TD V + + + E L+AL+
Sbjct: 78 NIVNYLDSYLVGDE------LWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALE 130
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
+ HS ++HRD+K N+++ ++L D+G A+ + + V + Y+ PE +V
Sbjct: 131 FLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VV 188
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
+ Y +D+WSLG M MI + P+ +
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-21
Identities = 46/212 (21%), Positives = 97/212 (45%), Gaps = 21/212 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 189
+ + K+G G V + +K++ K +++ + E+ I+++
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102
Query: 190 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 242
N+V++ +V ++ L + E + TD V L++ + +L+AL
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 301
Y H+QG++HRD+K ++++ +++L D+G A+ + V + Y+ PE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333
Y +D+WSLG M M+ + P+F
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 8e-21
Identities = 49/227 (21%), Positives = 85/227 (37%), Gaps = 39/227 (17%)
Query: 132 EQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQN 184
E YE++ +G+G V + E ++ + ++ E+ + +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81
Query: 185 LCGGPNIVKLLD-IVRDQQ-----------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRY 232
L PNIV + D + S LI H + +++ + Y
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDG--------MNELAIAY 132
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVA 290
+ +LKALDY H G +HR VK +++I K+ L H ++ V
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 291 SRYFKG------PELLV-DLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+Y PE+L +LQ YD D++S+G + PF
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 59/276 (21%), Positives = 111/276 (40%), Gaps = 41/276 (14%)
Query: 122 DYESLTVQWGEQ-------DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK 174
Y + +QW + + R +G+G + EV + K L+ KK+
Sbjct: 165 IYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKR 221
Query: 175 IKR---------EIKILQNLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD----- 217
IK+ E +IL+ +V L +T L+ +N D
Sbjct: 222 IKKRKGEAMALNEKQILE-KVNSRFVVSLA-----YAYETKDALCLVLTLMNGGDLKFHI 275
Query: 218 FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277
+ + + +Y E+ L+ H + I++RD+KP N+++D +R+ D GLA
Sbjct: 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAV 334
Query: 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
G+ RV + + PE++ + + Y +S D W+LGC+ MI + P F
Sbjct: 335 HVPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKI 392
Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRL 373
+ ++ +++ +Y P +L +L
Sbjct: 393 KREEVERLVKEVPE-----EYSERFSPQARSLCSQL 423
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 84/347 (24%), Positives = 139/347 (40%), Gaps = 38/347 (10%)
Query: 46 PLSQSSRIFTPFGTLRGLASSASLS--HARHQHQRLRQLATPPDTLAQKIGKSVRRSGAP 103
L S IF + LA S S H L + PPD L Q + + ++
Sbjct: 101 RLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPD-LFQPYIEEICQNLRG 159
Query: 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI 163
+ + + + W L + +D+ V R +GRG + EV+ +
Sbjct: 160 DVFQKFIESDKFTRFCQWKNVELNIHLTM-NDFSVHRIIGRGGFGEVYGCRKADTGKMYA 218
Query: 164 IKILKPVKKKKIKR---------EIKILQ--NLCGGPNIVKLLDIVRDQQSKTPS---LI 209
+K L KK+IK E +L + P IV + TP I
Sbjct: 219 MKCLD---KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCM-----SYAFHTPDKLSFI 270
Query: 210 FEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 266
+ +N D L S+ D+R+Y E++ L++ H++ +++RD+KP N+++D
Sbjct: 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330
Query: 267 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326
+R+ D GLA K+ + V + + PE+L YD S D +SLGCM ++
Sbjct: 331 -VRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
Query: 327 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRL 373
P F H D+ L T + + P L +L+ L
Sbjct: 389 SP-FRQHKTKDKHEIDRMTL-TMAV-----ELPDSFSPELRSLLEGL 428
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 43/241 (17%), Positives = 90/241 (37%), Gaps = 51/241 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 189
+D E + ++G G +V++ +K + + K+I ++ ++ P
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 190 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
IV+ + + + I E +
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKK----RMQGPIPERI--------------- 125
Query: 229 DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
+ ++KAL Y + G++HRDVKP N+++D + +++L D+G++ K +
Sbjct: 126 -LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFGISGRLVDDKAKDR 183
Query: 288 RVASRYFKGPE----LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343
+ PE DYD D+WSLG + + P+ +++ L K+
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243
Query: 344 K 344
+
Sbjct: 244 Q 244
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 65/284 (22%), Positives = 109/284 (38%), Gaps = 54/284 (19%)
Query: 122 DYESLTVQWGEQ-------DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK 174
Y +QW D + R +GRG + EVF + K L KK+
Sbjct: 166 LYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKR 222
Query: 175 IKR---------EIKILQNLCGGPNIVKL-------------LDIVR--DQQSKTPSLIF 210
+K+ E KIL IV L + I+ D I
Sbjct: 223 LKKRKGYQGAMVEKKILA-KVHSRFIVSLAYAFETKTDLCLVMTIMNGGD--------IR 273
Query: 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270
H+ N D P + +Y +++ L++ H + I++RD+KP NV++D + +R+
Sbjct: 274 YHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRI 330
Query: 271 IDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
D GLA E + + F PELL+ ++YD+S+D ++LG MI + P
Sbjct: 331 SDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP- 388
Query: 330 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRL 373
F + ++ + + + Y + P L
Sbjct: 389 FRARGEKVENKELKQRVLEQAV-----TYPDKFSPASKDFCEAL 427
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 47/246 (19%), Positives = 93/246 (37%), Gaps = 58/246 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 189
+D + + ++GRG Y V + VH + +K + ++K++ ++ ++ P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 190 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 228
IV+ + S +I E +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126
Query: 229 DVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 287
+ +KAL++ I+HRD+KP N+++D ++L D+G++ +
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCDFGIS------GQLVD 178
Query: 288 RVASRYFKG------PELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338
+A G PE + Q YD D+WSLG + + P+ + +DQ
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238
Query: 339 LVKIAK 344
L ++ K
Sbjct: 239 LTQVVK 244
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 50/214 (23%), Positives = 85/214 (39%), Gaps = 60/214 (28%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI----LKPVKKKKIKREIKILQNLCGGP 189
DD+E + ++G G VF+ H K+ +KP + +I RE+++L C P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91
Query: 190 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 227
IV L ++ K I E +
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQI-------------- 132
Query: 228 YDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 283
+ ++K L Y + IMHRDVKP N++++ + +++L D+G++ G+
Sbjct: 133 --LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS-----GQLID 184
Query: 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 316
N V +R + PE L Y D+WS+G
Sbjct: 185 SMANSFVGTRSYMSPERL-QGTHYSVQSDIWSMG 217
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 82.3 bits (203), Expect = 2e-17
Identities = 61/323 (18%), Positives = 114/323 (35%), Gaps = 100/323 (30%)
Query: 109 YSDINVVRPREYWDYESLTVQWGE--QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI 166
D P +Y V+ G+ Y V+RK+G G +S V+ + +K+
Sbjct: 10 SDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKV 69
Query: 167 LKPVKK--KKIKREIKILQNLC-------GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 217
+K + + EI++L+++ +V+LLD F+
Sbjct: 70 VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD------------FKISGVNG 117
Query: 218 ------FKVLYPTLSDY------------DVRYYIYELLKALDYCHSQ-GIMHRDVKPHN 258
F+VL L + V+ I ++L+ LDY H++ I+H D+KP N
Sbjct: 118 THICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177
Query: 259 VMI------------------------------------------------DHEQRKLRL 270
+++ + E+ K+++
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237
Query: 271 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
D G A K + + +R ++ E+L+ Y+ D+WS CM + + F
Sbjct: 238 ADLGNA--CWVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFE-LATGDYLF 293
Query: 331 YGHDNY------DQLVKIAKVLG 347
H D + I ++LG
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLG 316
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 56/237 (23%), Positives = 96/237 (40%), Gaps = 50/237 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
DD+E+++ +GRG +SEV + +KI+ K +KR E +L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117
Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 237
I +L + + + L+ E+ D +L + R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 295
+ A+D H G +HRD+KP N+++D +RL D+G + V S
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSC------LKLRADGTVRSLVAV 224
Query: 296 G------PELL------VDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQL 339
G PE+L Y D W+LG + M + + PF+ D+ +
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE-MFYGQTPFY--ADSTAET 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
Y++V K+G G S V+ N K IK + K+ +RE+ L
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
NIV ++D+ + L+ E++ + LS + ++L + + H
Sbjct: 72 NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
I+HRD+KP N++ID + L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 18/156 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKL 194
+ V +K+G G + E+ G + NE IK+ + ++ E + + L G I ++
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+ PSL E + F + T S V +L+ ++Y HS+
Sbjct: 71 YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 248 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 279
+++RDVKP N +I + Q+ + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 54/225 (24%), Positives = 96/225 (42%), Gaps = 44/225 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
+D+E+++ +GRG + EV ++ +KIL K + +KR E +L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130
Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 237
I L + + + L+ ++ D +L L + R+Y+ E+
Sbjct: 131 GDSKWITTL------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFK 295
+ A+D H +HRD+KP N+++D +RL D+G + + V S
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSC------LKLMEDGTVQSSVAV 237
Query: 296 G------PELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 330
G PE+L ++ Y D WSLG M++ + PF+
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY 282
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 48/218 (22%), Positives = 80/218 (36%), Gaps = 44/218 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIV 192
+ EV VGRG + V + + IK ++ +K E++ L + PNIV
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNH-PNIV 64
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK---ALD------Y 243
KL L+ E+ LY L + Y L Y
Sbjct: 65 KLYGACL----NPVCLVMEYAEGGS---LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 244 CHS---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
HS + ++HRD+KP N+++ L++ D+G A +
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHMTNNKGS 166
Query: 297 -----PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE+ +Y D++S G + +I R++PF
Sbjct: 167 AAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 48/230 (20%), Positives = 96/230 (41%), Gaps = 36/230 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D +E++R +G+G + +V + +K + ++ + +E++I+Q L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73
Query: 188 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKA 240
P +V L S + ++ + + D L + V+ +I EL+ A
Sbjct: 74 HPFLVNL------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
LDY +Q I+HRD+KP N+++D E + + D+ +A G
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIA------AMLPRETQITTMAGTKPY 180
Query: 297 --PELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFF-YGHDNYDQLVK 341
PE+ Y +++D WSLG ++ + P+ + ++V
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 46/223 (20%), Positives = 90/223 (40%), Gaps = 33/223 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPN 190
D +G+G + + + H E ++K L ++ +E+K+++ L PN
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PN 68
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD------Y 243
++K + ++ + K + I E++ L + D +Y + + A D Y
Sbjct: 69 VLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---------YHPGKEYNVRVASRYF 294
HS I+HRD+ HN ++ E + + + D+GLA + R
Sbjct: 124 LHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTV 182
Query: 295 KG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331
G PE++ + YD +D++S G + +I R
Sbjct: 183 VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
Y + RK+G G + +++ G E+ IK+ K ++ E KI + + GG I +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+ PSL E + F S V +++ ++Y HS+
Sbjct: 71 RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 248 GIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFY 279
+HRDVKP N ++ ++ + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKI---LQNLC 186
Y + R VGRG +V+E +K++ PV + +++RE + LQ
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 243
P++V + D + + +N D + L+ + ++ ALD
Sbjct: 94 --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLV 301
H+ G HRDVKP N+++ + L+D+G+A K + V + Y+ PE
Sbjct: 150 AHAAGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ Y D+++L C+ + P+
Sbjct: 209 E-SHATYRADIYALTCVLYECLTGSPPY 235
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D ++ ++ +G G + V H +KIL V K K E +ILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 241
P +VKL + K S ++ E+V + F L S+ R+Y +++
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
+Y HS +++RD+KP N++ID + +++ D+G A K R + G
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFA------KRVKGRTWT--LCGTPEAL 205
Query: 297 -PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
PE+++ + Y+ ++D W+LG + M PFF D Q+
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQI 246
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 33/156 (21%), Positives = 67/156 (42%), Gaps = 18/156 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
Y+V R++G G + +FEG + +N++ IK +++ E + + L G I +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
++ PSL E + + S V ++L + H +
Sbjct: 72 YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 248 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 279
+++RD+KP N +I + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKR---EIKILQNLCG 187
+DYEVV+ +GRG + EV H + + +K+L +K+ E I+
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-AN 127
Query: 188 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELL 238
P +V+L + + ++ E++ D L +S+YD R+Y E++
Sbjct: 128 SPWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 296
ALD HS G +HRDVKP N+++D L+L D+G + N V G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTC------MKMNKEGMVRCDTAVG 231
Query: 297 ------PELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
PE+L Y D WS+G M+ PF+
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-16
Identities = 44/211 (20%), Positives = 83/211 (39%), Gaps = 45/211 (21%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 189
DD E + ++GRG Y V + H + K I + ++K++ ++ I P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 190 NIVKL--------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD 229
V LD Q I E +
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI---------------- 110
Query: 230 VRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ ++KAL++ HS+ ++HRDVKP NV+I+ ++++ D+G++ + ++
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDID 169
Query: 289 VASRYFKGPE---LLVDLQDYDYSLDLWSLG 316
+ + PE ++ + Y D+WSLG
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLG 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 46/223 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D++++R +GRG Y++V + +K++K V + ++ E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 188 GPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
P +V L T S + E+VN D + L + R+Y E+
Sbjct: 69 HPFLVGL---------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 119
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNV 287
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y
Sbjct: 120 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 176
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+A PE+L +DY +S+D W+LG + M+ + PF
Sbjct: 177 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 211
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-16
Identities = 50/229 (21%), Positives = 89/229 (38%), Gaps = 52/229 (22%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQ 183
++ E +++G+G + V +G D IK L K ++ +RE+ I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD 242
NL PNIVKL ++ + P ++ E V D LY L D L+ LD
Sbjct: 79 NLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWSVKLRLMLD 130
Query: 243 ------YCHSQG--IMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYHPGKEYNVRVA 290
Y +Q I+HRD++ N+ + ++ D+GL+ + +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-----------QQS 179
Query: 291 SRYFKG---------PELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 329
G PE + ++ Y D +S + ++ + PF
Sbjct: 180 VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 29/169 (17%), Positives = 60/169 (35%), Gaps = 21/169 (12%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNIVK 193
+ + +K+G G + ++ EK ++K + + E+K Q + I K
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 194 LLDIVRDQQSKTPSLIF---EHVNNTDFKV-----LYPTLSDY----------DVRYYIY 235
++ + P ++ L L V
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGK 283
+L L+Y H +H D+K N+++ ++ ++ L D+GL+ Y P
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 57/231 (24%), Positives = 100/231 (43%), Gaps = 46/231 (19%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
D+ ++ +G+G + +V H + +K+L+ KK +K+ E +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95
Query: 186 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELL 238
P +V L S +T + +++N + F L + R+Y E+
Sbjct: 96 VKHPFLVGL------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 149
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 288
AL Y HS I++RD+KP N+++D + + L D+GL E EY
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEY--- 205
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
+A PE+L Q YD ++D W LG + M++ PF+ N ++
Sbjct: 206 LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY--SRNTAEM 247
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 46/223 (20%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D++++R +GRG Y++V + ++++K V + ++ E + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 188 GPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
P +V L T S + E+VN D + L + R+Y E+
Sbjct: 112 HPFLVGL---------HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI 162
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNV 287
AL+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y
Sbjct: 163 SLALNYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY-- 219
Query: 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330
+A PE+L +DY +S+D W+LG + M+ + PF
Sbjct: 220 -IA------PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFD 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 13/152 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 189
YE+ +G G SEV D+ +K+L+ P + +RE + L P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72
Query: 190 NIVKLLDI--VRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
IV + D P ++ E+V+ + + ++ I + +AL++
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
H GI+HRDVKP N+MI ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 55/230 (23%), Positives = 96/230 (41%), Gaps = 53/230 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 184
D++E +R +G+G + +V + +K+LK K I E +IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79
Query: 185 LCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYI 234
P + +L TP + E VN D + + + R+Y
Sbjct: 80 ARNHPFLTQL---------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------E 284
E++ AL + H +GI++RD+K NV++DHE +L D+G+ E G +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPD 189
Query: 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
Y +A PE+L + Y ++D W++G + M+ P F +
Sbjct: 190 Y---IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP-FEAEN 228
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 56/224 (25%), Positives = 102/224 (45%), Gaps = 42/224 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
+D++ ++ +G+G + +V +KIL+ K+ I + E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 239
P + L +T + E+ N + F L ++ R+Y E++
Sbjct: 62 TRHPFLTALK-----YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 296
AL+Y HS+ +++RD+K N+M+D + +++ D+GL KE + + F G
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--FCG 167
Query: 297 ------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
PE+L D DY ++D W LG + M+ + P FY D
Sbjct: 168 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 194
+ + RK+G G + E++ G + NE+ IK+ K ++ E KI + L GG I +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 195 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
+ PSL E + F LS V +++ +++ HS+
Sbjct: 69 RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 248 GIMHRDVKPHNVMI--DHEQRKLRLIDWGLAEFY 279
+HRD+KP N ++ ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 41/224 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
D+ + +G+G + +V +E +KILK K I+ E ++L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLK 239
P + +L +T + E+VN D + + +Y E+
Sbjct: 399 GKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 296
L + S+GI++RD+K NVM+D E +++ D+G+ KE V + F G
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KENIWDGVTTKT--FCG 504
Query: 297 ------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
PE++ Q Y S+D W+ G + M+ + P F G D
Sbjct: 505 TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEGED 546
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 7e-15
Identities = 48/224 (21%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
D++++R +G G + V + +K+LK V + K E +L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64
Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 241
P I+++ + +I +++ + F +L + ++Y E+ AL
Sbjct: 65 HPFIIRMWG-----TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
+Y HS+ I++RD+KP N+++D +++ D+G A K + G
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFA------KYVPDVTYT--LCGTPDYI 170
Query: 297 -PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339
PE++ + Y+ S+D WS G + M+ PF+ N +
Sbjct: 171 APEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKT 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 53/230 (23%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 184
D+ + +G+G + +V +E +KILK K + E ++L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76
Query: 185 LCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELL 238
P + +L +T + E+VN D + + +Y E+
Sbjct: 77 PGKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 288
L + S+GI++RD+K NVM+D E +++ D+G+ E G +Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDY--- 187
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHD 334
+A PE++ Q Y S+D W+ G M AG + F G D
Sbjct: 188 IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAG-----QAPFEGED 225
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-14
Identities = 22/190 (11%), Positives = 53/190 (27%), Gaps = 38/190 (20%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGP 189
Y ++ G + ++ + + + + + P ++ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
+ ++LD+V + ++ E + + V + S + L A D H G
Sbjct: 92 GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 308
+ P V + + V +A +
Sbjct: 150 VALSIDHPSRVRVSIDGD--------------------VVLAYPATMPDA--------NP 181
Query: 309 SLDLWSLGCM 318
D+ +G
Sbjct: 182 QDDIRGIGAS 191
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 50/223 (22%), Positives = 96/223 (43%), Gaps = 39/223 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 187
+D+ + + +G+G + +VF N+ IK LK V E ++L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 188 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 241
P + + +T + E++N D + +Y E++ L
Sbjct: 77 HPFLTHMF-----CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVRVAS 291
+ HS+GI++RD+K N+++D + +++ D+G+ E +Y +A
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDY---IA- 186
Query: 292 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
PE+L+ Q Y++S+D WS G + M+ + P F+G D
Sbjct: 187 -----PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQD 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 63/272 (23%), Positives = 122/272 (44%), Gaps = 57/272 (20%)
Query: 134 DDYEVVRKVGRGKYSEVF--EGVHCTDNEK-CIIKILKP---VKKKK----IKREIKILQ 183
+++E+++ +G G Y +VF + D K +K+LK V+K K + E ++L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 184 NLCGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYE 236
++ P +V L + +T + LI +++N + F L ++++V+ Y+ E
Sbjct: 114 HIRQSPFLVTL------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 237 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----YNVRVASR 292
++ AL++ H GI++RD+K N+++D + L D+GL+ KE R
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLS------KEFVADETERAYD- 219
Query: 293 YFKG------PELLVDL-QDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVK 341
F G P+++ +D ++D WSLG + G F + +
Sbjct: 220 -FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQAE 273
Query: 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRL 373
I++ + E Y E+ L+ RL
Sbjct: 274 ISRRILKSEP-----PYPQEMSALAKDLIQRL 300
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 185
+++E ++ +G+G + +V +KILK K+ + + E ++LQN
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204
Query: 186 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 239
P + L +T + E+ N + F L S+ R+Y E++
Sbjct: 205 SRHPFLTALK-----YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 240 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGP 297
ALDY HS+ +++RD+K N+M+D + +++ D+GL E G + + P
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
E+L D DY ++D W LG + M+ + P FY D
Sbjct: 319 EVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD 353
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 9e-14
Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 33/211 (15%)
Query: 126 LTVQWG-EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREI 179
+ G + + K+ E+++G ++K+LK K + E
Sbjct: 1 MNKHSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEEC 58
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYPTLSDYDVRYYIYELL 238
L+ PN++ +L + + P+LI + + + VL + + +
Sbjct: 59 PRLRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAV 114
Query: 239 K-ALD------YCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 288
K ALD + H+ I + +VMID E R+ + F PG+ Y
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPA 173
Query: 289 -VASRYFKGPELLVDLQDYDYSL--DLWSLG 316
VA PE L + D+WS
Sbjct: 174 WVA------PEALQKKPEDTNRRSADMWSFA 198
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 56/233 (24%)
Query: 134 DDYEVVRKVGRGKYSEVF--EGVHCTDNEK-CIIKILKPVKKKKIKR--------EIKIL 182
+E+++ +G+G + +VF + + +D + +K+LK K +K E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDIL 80
Query: 183 QNLCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRY 232
P IVKL T LI + + D F L ++ DV++
Sbjct: 81 VE-VNHPFIVKL---------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKF 130
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK-------- 283
Y+ EL ALD+ HS GI++RD+KP N+++D E ++L D+GL+ E K
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGT 189
Query: 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
EY +A PE++ + + S D WS G + M+ P F G D
Sbjct: 190 VEY---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP-FQGKDR 231
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 49/241 (20%), Positives = 94/241 (39%), Gaps = 40/241 (16%)
Query: 98 RRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCT 157
P + + D + + + W D + K+G G + V
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPW---CDLNIKEKIGAGSFGTVHRAEWH- 59
Query: 158 DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212
+KIL + RE+ I++ L PNIV + V S++ E+
Sbjct: 60 -GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPP--NLSIVTEY 115
Query: 213 VNNTDFKVLYPTLSDYDVRYYI--YELLK-ALD------YCHSQG--IMHRDVKPHNVMI 261
++ LY L R + L A D Y H++ I+HR++K N+++
Sbjct: 116 LSRGS---LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
Query: 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDLWSL 315
D ++ +++ D+GL+ + + ++S+ G PE+L D + + D++S
Sbjct: 173 D-KKYTVKVCDFGLSRL-----KASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSF 225
Query: 316 G 316
G
Sbjct: 226 G 226
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 30/173 (17%), Positives = 65/173 (37%), Gaps = 26/173 (15%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 190
++V +G+G + ++ + + C++K+ +P + E+K Q
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95
Query: 191 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFKVLY-----PTLSDY-----------DVR 231
I K + + + P N ++ + L V
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGK 283
+L L+Y H +H D+K N++++++ ++ L+D+GLA Y P
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 66/245 (26%), Positives = 108/245 (44%), Gaps = 60/245 (24%)
Query: 134 DDYEVVRKVGRGKYSEVF---EGVHCTDNEKCIIKILKP---VKKKK----IKREIKILQ 183
+ +E++R +G+G Y +VF + + +K+LK V+ K K E IL+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 184 NLCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYY 233
P IV L T LI E+++ + F L + +Y
Sbjct: 77 E-VKHPFIVDL---------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 234 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK--------- 283
+ E+ AL + H +GI++RD+KP N+M++H+ ++L D+GL E H G
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQL 339
EY +A PE+L+ ++ ++D WSLG M G P F G + +
Sbjct: 186 EY---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTGENRKKTI 230
Query: 340 VKIAK 344
KI K
Sbjct: 231 DKILK 235
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.4 bits (166), Expect = 7e-13
Identities = 42/258 (16%), Positives = 73/258 (28%), Gaps = 67/258 (25%)
Query: 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKR 177
+ + K+G G + EVF+ + D+ IKI+ ++I
Sbjct: 15 HCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 178 EIKILQNLCG--------GPNIVKLLDIVRDQQSKTPSLI-------------------- 209
EI I + L + L + Q S P L+
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 210 ----------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHN 258
FE ++ S + +++L +L + HRD+ N
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 259 VMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318
V++ + Y + S L V + DY S +
Sbjct: 193 VLLK--------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 319 FAGMIFRKEPFFYGHDNY 336
F + E F G +Y
Sbjct: 239 FCDV-SMDEDLFTGDGDY 255
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 39/213 (18%), Positives = 84/213 (39%), Gaps = 28/213 (13%)
Query: 128 VQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLC 186
VQ + +G+G++ EV+ G E+ +KI +++ RE +I Q +
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVML 93
Query: 187 GGPNIVKLLDIVRDQQSKTP--SLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALD 242
NI+ + L+ + H + + F L + + L
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 153
Query: 243 YCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 294
+ H + I HRD+K N+++ + + D GLA + + + +A +
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDT-IDIAPNHR 211
Query: 295 KG------PELL---VDLQDYDYSL--DLWSLG 316
G PE+L ++++ ++ D++++G
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 50/216 (23%), Positives = 88/216 (40%), Gaps = 28/216 (12%)
Query: 125 SLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ- 183
L VQ ++V+++G+G+Y EV+ G EK +K+ ++ RE +I Q
Sbjct: 28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQT 85
Query: 184 NLCGGPNIVKLL--DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLK 239
L NI+ + DI LI + H N + + L T D + Y +
Sbjct: 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVS 145
Query: 240 ALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 291
L + H++ I HRD+K N+++ + + D GLA + V +
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTN-EVDIPP 203
Query: 292 RYFKG------PELL---VDLQDYDYSL--DLWSLG 316
G PE+L ++ + + D++S G
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 44/224 (19%), Positives = 87/224 (38%), Gaps = 41/224 (18%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
+ E+ +G+G++ +V+ G + I+++ + K KRE+ +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88
Query: 189 PNIVKLLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD--- 242
N+V + P L I LY + D + + + + A +
Sbjct: 89 ENVVLFMGAC----MSPPHLAIITSLCKGRT---LYSVVRDAKIVLDVNKTRQIAQEIVK 141
Query: 243 ---YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--- 296
Y H++GI+H+D+K NV D+ K+ + D+GL + R G
Sbjct: 142 GMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 297 ---PELL--------VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
PE++ D + D+++LG ++ + R+ PF
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 44/227 (19%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
V +++G G + V++G D +K+L P + + K E+ +L+
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 79
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD----- 242
NI+ + Q +++ + + LY L + ++ + +L+ A
Sbjct: 80 VNILLFMGYSTAPQ---LAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIARQTARGM 133
Query: 243 -YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 296
Y H++ I+HRD+K +N+ + E +++ D+GLA + G
Sbjct: 134 DYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQL---SGSILWM 189
Query: 297 -PELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
PE++ YS D+++ G + ++ + P+ +N DQ++
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII 235
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 28/204 (13%)
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIVKLL 195
++ VG+G+Y EV+ G E +KI +K RE ++ + NI+ +
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 196 --DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALDYCHSQ---- 247
D+ S LI H + + L T D I + L + H +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 248 ----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 297
I HRD+K N+++ + + + D GLA + + V + G P
Sbjct: 129 QGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186
Query: 298 ELL-----VDLQDYDYSLDLWSLG 316
E+L VD D +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 40/229 (17%), Positives = 83/229 (36%), Gaps = 44/229 (19%)
Query: 122 DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181
++ D+ +++ +GRG+Y V++G D +K+ ++ E I
Sbjct: 4 AASEPSLDL---DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNI 58
Query: 182 -----LQNLCGGPNIVKLL--DIVRDQQSKTP-SLIFE-HVNNTDFKVLYPTLSDYDVRY 232
+++ NI + + D + L+ E + N + K L SD+
Sbjct: 59 YRVPLMEH----DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC 114
Query: 233 YI-YELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
+ + + + L Y H++ I HRD+ NV++ + D+GL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGN 173
Query: 283 KEYNVRVASRYFKG---------PELL------VDLQDYDYSLDLWSLG 316
+ PE+L D + +D+++LG
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 40/221 (18%), Positives = 86/221 (38%), Gaps = 38/221 (17%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLC 186
+ + +G G + +V+ ++ +K + + +++E K+ L
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYI-YELLKALDYC 244
PNI+ L + + L+ E +VL D+ ++ + ++Y
Sbjct: 65 H-PNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121
Query: 245 HSQG---IMHRDVKPHNVMIDHEQRK-------LRLIDWGLAEFYHPGKEYNVRVASRYF 294
H + I+HRD+K N++I + L++ D+GLA +H + +
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS-------A 174
Query: 295 KG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
G PE++ + D+WS G + ++ + PF
Sbjct: 175 AGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 29/175 (16%), Positives = 57/175 (32%), Gaps = 28/175 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVH--------CTDNEKCIIKILKPVKKKKIKREIKILQNLCG 187
+++ R ++E +K +K+ K ++ E Q
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-----LYPTLSDY------------DV 230
+ K + P+ + V+ ++ L +L V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE 284
LL AL++ H +H +V N+ +D E Q ++ L +G A Y P +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 7e-10
Identities = 46/242 (19%), Positives = 87/242 (35%), Gaps = 36/242 (14%)
Query: 121 WDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKRE 178
E+L Q +++ RG++ V++ NE +KI K+ + + E
Sbjct: 14 LGTENLYFQS---MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYE 68
Query: 179 IKILQNLCGGPNIVKLL--DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI- 234
+ L + NI++ + + LI H + L + ++ +I
Sbjct: 69 VYSLPGMKH-ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 235 YELLKALDYCHSQ----------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284
+ + L Y H I HRD+K NV++ + D+GLA + GK
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKS 186
Query: 285 YNVRVASRYFKG------PELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
+ G PE+L +D +D++++G + + R D
Sbjct: 187 A---GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 335 NY 336
Y
Sbjct: 244 EY 245
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 26/199 (13%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGP 189
+D + ++GRG + EVF G DN +K + K K +E +IL+ P
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HP 172
Query: 190 NIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDY 243
NIV+L+ + +Q P I E V DF + L + + + ++Y
Sbjct: 173 NIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 244 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF--K--GPEL 299
S+ +HRD+ N ++ E+ L++ D+G++ G Y R K PE
Sbjct: 229 LESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADG-VYAASGGLRQVPVKWTAPEA 286
Query: 300 LVDLQDYDYSL--DLWSLG 316
L + YS D+WS G
Sbjct: 287 LNYGR---YSSESDVWSFG 302
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 16/167 (9%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKREIKILQ 183
E+ + +R +G G + +V + + + +K LKP +K+EI+IL+
Sbjct: 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILR 78
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELL 238
NL NIVK I + LI E + + K Y ++ Y ++
Sbjct: 79 NLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKYAVQIC 136
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
K +DY S+ +HRD+ NV+++ + ++++ D+GL + KEY
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEY 182
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 54/313 (17%), Positives = 114/313 (36%), Gaps = 47/313 (15%)
Query: 63 LASSASLSHARHQHQRLRQLA----TPPDTLAQKIGKSVRRSGAPSKARVYSDINVV--- 115
++ + H H H R R P G + S + N+
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQG 60
Query: 116 RPREYWDYESLTVQWGEQ-DDYEV---------VRKVGRGKYSEVFEGVHCTDNEKCI-- 163
+ D +L + + + +GRG + V+ G ++ K I
Sbjct: 61 ANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHC 120
Query: 164 -IKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 218
+K L + + + E I+++ PN++ LL I + P ++ ++ + D
Sbjct: 121 AVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDL 178
Query: 219 KVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
+ + + D+ + ++ K + + S+ +HRD+ N M+D E+ +++ D+
Sbjct: 179 RN-FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADF 236
Query: 274 GLAEFYHPGKEYNVRVASRYFKG--------PELLVDLQDYDYSLDLWSLG-CMFAGMIF 324
GLA + + +V + E L Q + D+WS G ++ M
Sbjct: 237 GLARDMYDKEFDSVHNKT---GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTR 292
Query: 325 RKEPFFYGHDNYD 337
P + + +D
Sbjct: 293 GAPP-YPDVNTFD 304
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 46/192 (23%), Positives = 86/192 (44%), Gaps = 17/192 (8%)
Query: 139 VRKVGRGKYSEVFEGV--HCTDNEKCI--IKILK----PVKKKKIKREIKILQNLCGGPN 190
+R +G G + +V D + +K LK P + K+EI IL+ L +
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EH 94
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 248
I+K D + + L+ E+V + + ++ + + ++ + + Y H+Q
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQ 304
+HRD+ NV++D R +++ D+GLA + Y VR PE L + +
Sbjct: 155 YIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 305 DYDYSLDLWSLG 316
+ Y+ D+WS G
Sbjct: 214 -FYYASDVWSFG 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 46/223 (20%), Positives = 97/223 (43%), Gaps = 20/223 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + PN+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 278
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELLKALDYCH 245
V+LL + + P I E + D+ + +S + Y ++ A++Y
Sbjct: 279 VQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVD 302
+ +HR++ N ++ E +++ D+GL+ G Y +++ + PE L
Sbjct: 336 KKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAY 393
Query: 303 LQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+W+ G ++ + P + G D + K
Sbjct: 394 -NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 434
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 8e-08
Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 25/164 (15%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKR 177
DYE+ R +G G++ +V +G++ + + IK K ++K +
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ 65
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRY 232
E ++ P+IVKL+ ++ ++ P I E + +V +L +
Sbjct: 66 EALTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLIL 120
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y Y+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 121 YAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 163
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 48/227 (21%), Positives = 100/227 (44%), Gaps = 24/227 (10%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCI----IKILK---PVKKKKIKREIKILQNLCGGPNI 191
+ ++G+G + V + + +K L+ P +++ +REI+IL+ L I
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFI 86
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
VK + ++ L+ E++ + DF + L + Y ++ K ++Y S+
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY-FK--GPELLVDL 303
+HRD+ N++++ + +++ D+GLA+ K+ Y VR + PE L D
Sbjct: 147 RCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
+ D+WS G + E F Y + + +++G +
Sbjct: 206 I-FSRQSDVWSFG------VVLYELFTYCDKSCSPSAEFLRMMGCER 245
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 41/221 (18%), Positives = 89/221 (40%), Gaps = 32/221 (14%)
Query: 76 HQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTVQWGEQDD 135
+ ++ ++ + + + + + +D E Y + D
Sbjct: 330 IRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPS-----TRD 384
Query: 136 YEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKI 181
YE+ R +G G++ +V +G++ + + IK K ++K +E
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALT 444
Query: 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIY 235
++ P+IVKL+ ++ ++ P I E + + + +L + Y Y
Sbjct: 445 MRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLILYAY 498
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 499 QLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 538
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 44/262 (16%), Positives = 111/262 (42%), Gaps = 33/262 (12%)
Query: 109 YSDINVVRPREYWDYESLTVQWGEQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEK 161
+ D ++ + ++ + ++D + ++++G+G + V + +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68
Query: 162 CI----IKILKPVKKKKIK---REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 214
+K L+ ++ ++ REI+IL++L NIVK + + LI E++
Sbjct: 69 TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLP 127
Query: 215 N---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270
D+ + + + Y ++ K ++Y ++ +HRD+ N++++ + ++++
Sbjct: 128 YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE-NENRVKI 186
Query: 271 IDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFR 325
D+GL + Y V+ PE L + + + + D+WS G ++
Sbjct: 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLY------ 239
Query: 326 KEPFFYGHDNYDQLVKIAKVLG 347
E F Y + + +++G
Sbjct: 240 -ELFTYIEKSKSPPAEFMRMIG 260
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 47/248 (18%), Positives = 105/248 (42%), Gaps = 27/248 (10%)
Query: 109 YSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IK 165
+ D++ + P + + + +GRG + V+ G ++ K I +K
Sbjct: 1 HIDLSALNPELVQAVQHVVIG-PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVK 59
Query: 166 ILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 221
L + + + E I+++ PN++ LL I + +P ++ ++ + D +
Sbjct: 60 SLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN- 116
Query: 222 Y-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ + D+ + ++ K + Y S+ +HRD+ N M+D E+ +++ D+GLA
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLA 175
Query: 277 ------EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPF 329
E+Y + ++ ++ E L Q + D+WS G ++ M P
Sbjct: 176 RDMYDKEYYSVHNKTGAKLPVKWM-ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP- 232
Query: 330 FYGHDNYD 337
+ + +D
Sbjct: 233 YPDVNTFD 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 2e-07
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 25/164 (15%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKR 177
Y + R +G G + EV+EGV+ + I +K K K+K
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 62
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRY 232
E I++NL P+IVKL+ I+ + P+ I E + + +L +
Sbjct: 63 EAVIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVL 117
Query: 233 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y ++ KA+ Y S +HRD+ N+++ ++L D+GL+
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLS 160
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 45/223 (20%), Positives = 92/223 (41%), Gaps = 22/223 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ + K+G+G + EV+ G + IK LKP + + +E ++++ L +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 324
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKALDYCH 245
V+L +V S+ P I E+++ L + ++ + Y
Sbjct: 325 VQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 380
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVD 302
+HRD++ N+++ E ++ D+GLA EY R +++ K PE +
Sbjct: 381 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY 438
Query: 303 LQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + + P + G N + L ++ +
Sbjct: 439 -GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 479
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 44/223 (19%), Positives = 92/223 (41%), Gaps = 22/223 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ + K+G+G + EV+ G + IK LKP + + +E ++++ L +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 241
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKALDYCH 245
V+L +V S+ P I E+++ L + ++ + Y
Sbjct: 242 VQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 297
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPELLVD 302
+HRD++ N+++ E ++ D+GLA EY R +++ + PE +
Sbjct: 298 RMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY 355
Query: 303 LQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + + P + G N + L ++ +
Sbjct: 356 -GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 396
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 41/204 (20%), Positives = 84/204 (41%), Gaps = 26/204 (12%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPV----KKKKIKREIKILQN 184
E+ R +G+G + V+ G + + I IK L + + + RE +++
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRG 78
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----VLYPTLSDYDVRYYIYELLKA 240
L PN++ L+ I+ + P ++ ++ + D + D+ + ++ +
Sbjct: 79 LN-HPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARG 136
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 296
++Y Q +HRD+ N M+D E +++ D+GLA + Y+V+
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHR---HARLPV 192
Query: 297 ----PELLVDLQDYDYSLDLWSLG 316
E L + D+WS G
Sbjct: 193 KWTALESLQT-YRFTTKSDVWSFG 215
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 30/185 (16%), Positives = 68/185 (36%), Gaps = 34/185 (18%)
Query: 111 DINVVRPREYWDYESLTVQWGEQDDYEVVR----KVGRGKYSEVFEGVHCTDNEKCIIKI 166
D + P + + + V W ++ + + +G+G +++ + + IIK
Sbjct: 311 DETKIIPN--YRTDMVEVNWIKEIKGKKRKIPEHLIGKGAEADIKRDSY--LDFDVIIKE 366
Query: 167 LKP-----------VKKKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEHV 213
++K + RE + L + G P + D ++ ++
Sbjct: 367 RVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPA-----PYIFDVDLDNKRIMMSYI 421
Query: 214 NNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273
N K + D Y++ + + H ++H D+ N + D + L +ID+
Sbjct: 422 NGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTTSNFIFD---KDLYIIDF 473
Query: 274 GLAEF 278
GL +
Sbjct: 474 GLGKI 478
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 38/177 (21%), Positives = 78/177 (44%), Gaps = 23/177 (12%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
D +E+ K+G G+Y EV+EGV + +K LK ++ ++ +E ++
Sbjct: 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 63
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIY 235
+ + PN+V+LL + + P I E + + Y +S + Y
Sbjct: 64 KEIK-HPNLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMAT 118
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
++ A++Y + +HRD+ N ++ E +++ D+GL+ G Y ++
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 46/240 (19%), Positives = 97/240 (40%), Gaps = 40/240 (16%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIK 176
+ +D + R +G+G++ V E ++ + +K+LK ++
Sbjct: 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 177 REIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFK---------VLYP 223
RE ++ P++ KL+ + ++K +I + + D
Sbjct: 74 REAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
L + ++ ++ ++Y S+ +HRD+ N M+ E + + D+GL+ + G
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGD 191
Query: 284 EYNVRVASRY-FK--GPELLVDLQDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYD 337
Y AS+ K E L D Y++ D+W+ G M+ M + P + G +N +
Sbjct: 192 YYRQGCASKLPVKWLALE---SLADNLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAE 247
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 43/225 (19%), Positives = 100/225 (44%), Gaps = 26/225 (11%)
Query: 139 VRKVGRGKYSEVFEGV--HCTDNEKCI--IKILKPVKKKKIK---REIKILQNLCGGPNI 191
++++G+G + V DN + +K L+ ++ ++ REI+IL++L NI
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-DNI 73
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
VK + + LI E++ D+ + + + Y ++ K ++Y ++
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK--GPELLVDL 303
+HRD+ N++++ + ++++ D+GL + + V+ PE L +
Sbjct: 134 RYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 304 QDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347
+ + + D+WS G ++ E F Y + + +++G
Sbjct: 193 K-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMIG 229
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 36/213 (16%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 134 DDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIKRE 178
+D + + +G G++ V EG ++ + +K +K + ++ E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 179 IKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIFEHVNNTDFK---------VLYPTLS 226
+++ PN+++LL + + S+ P +I + D +
Sbjct: 87 AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ ++ ++ ++Y ++ +HRD+ N M+ + + + D+GL++ + G Y
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYR 204
Query: 287 VRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
++ K E L D + Y D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFG 236
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 63/437 (14%), Positives = 132/437 (30%), Gaps = 110/437 (25%)
Query: 36 TTSVSKILFSP--LSQSSRIFTPFGTLRGLASSASLSHARHQHQRLRQLATPPDT--LAQ 91
+ I+ S +S + R+F LS Q+ + + L
Sbjct: 48 KEEIDHIIMSKDAVSGTLRLFWTL-----------LSKQEEMVQKFVEEVLRINYKFLMS 96
Query: 92 KIGKSVRRSGAPSKA------------RVYSDINVVRPREYWDYESLTVQWGEQDDYEVV 139
I R+ ++ +V++ NV R + Y ++ + +
Sbjct: 97 PIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLID 156
Query: 140 RKVGRGKYSEVFEGVHCTDNE-KCII--KI--LKPVKKKKIKREIKILQNLCGGPNIVKL 194
+G GK + C + +C + KI L + +++LQ L
Sbjct: 157 GVLGSGKTWVALDV--CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL------YQ 208
Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV 254
+D +S S I ++ ++ + LLK+ Y + ++ +V
Sbjct: 209 IDPNWTSRSDHSSNIKLRIH--------------SIQAELRRLLKSKPYENCLLVL-LNV 253
Query: 255 KPHNV--MIDHEQRKL---RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYS 309
+ + + L R + +F ++ + + D
Sbjct: 254 QNAKAWNAFNLSCKILLTTR--FKQVTDFLSAATTTHISL--------DHHSMTLTPDEV 303
Query: 310 LDLWS--LGC------------------MFAGMIFRKEPF---FYGHDNYDQLVKIAK-- 344
L L C + A I R + H N D+L I +
Sbjct: 304 KSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESI-RDGLATWDNWKHVNCDKLTTIIESS 362
Query: 345 --VLGTDELNAYLNKYHI-ELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLL 401
VL E ++ + H+ ++ L ++ ++ + N L
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTIL--LSLI--------WFDVIKSDVMVVVNKLH 412
Query: 402 RNFLVQAQP-ETMVKVH 417
+ LV+ QP E+ + +
Sbjct: 413 KYSLVEKQPKESTISIP 429
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 6e-06
Identities = 38/272 (13%), Positives = 75/272 (27%), Gaps = 83/272 (30%)
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREI 179
+ D+E+ Q+ +D V + + F+ D K I+ K EI
Sbjct: 6 HMDFETGEHQYQYKDILSVFED----AFVDNFDCKDVQDMPKSILS----------KEEI 51
Query: 180 KILQNLCGGPNIV----KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS----DYDVR 231
++ + V +L + +Q + E V ++K L + +
Sbjct: 52 D---HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMM 108
Query: 232 YYIYELLKALDYCHSQGIMHRDV---KPHNVMIDHEQRKLR-----------LIDWGLAE 277
+Y + ++ D +NV KLR ++ G+
Sbjct: 109 TRMYI------EQRDR--LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160
Query: 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 337
GK V Y + C IF
Sbjct: 161 S---GK--TWVALD---------V-CLSYK-------VQCKMDFKIF------------- 185
Query: 338 QLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 369
+ + + + L K ++DP+ +
Sbjct: 186 -WLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 9e-06
Identities = 65/463 (14%), Positives = 121/463 (26%), Gaps = 140/463 (30%)
Query: 2 AIRPFQFTIHRNNYKNTTLFSSFFAISSNTSSSRTTSVSKILFSPLSQSSRIFTP----- 56
++ F + R NYK L S S + + L +++F
Sbjct: 78 MVQKFVEEVLRINYK--FLMSPIKTEQRQPSMMTRMYIEQR--DRLYNDNQVFAKYNVSR 133
Query: 57 ---FGTLR--------------------G---LASSASLSHARHQHQ-------RLRQLA 83
+ LR G +A LS+ L+
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 84 TPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYE--SLTVQWGEQDDYEVVRK 141
+P L + K + + +R N+ E L ++ V+
Sbjct: 194 SPETVLEM-LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN 252
Query: 142 VGRGKYSEVFEGVHC----TDNEKCIIKILKPVKKKKI----------KREIKILQNLCG 187
V K F + C T K + L I E+K L
Sbjct: 253 VQNAKAWNAFN-LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 188 GPNIVKLLDIVRDQQSKTP---SLI-------------FEHVN----NTDFKVLYPTLSD 227
+ D+ R+ + P S+I ++HVN T + L
Sbjct: 312 D---CRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEP 368
Query: 228 YDVRYYIYELLKALDYCHSQGIMHRDVK-PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
+ R ++ L + P ++ + W +
Sbjct: 369 AEYRKM-FDRL---------SVFPPSAHIPTILLS---------LIWF-------DVIKS 402
Query: 287 VRVASRYFKGPELLVDLQDYDYSL-DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
++V+ + + YSL + KE Y +L K+
Sbjct: 403 D---------VMVVVN-KLHKYSLVEKQ-----------PKESTISIPSIYLELKV--KL 439
Query: 346 LGTDELNAYL-NKYHI--ELDPHLAALVGRLVILSYFFQFVIY 385
L+ + + Y+I D + YF+ + +
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIP---PYLDQYFYSHIGH 479
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 6e-05
Identities = 27/231 (11%), Positives = 62/231 (26%), Gaps = 78/231 (33%)
Query: 198 VRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 257
+ Q + ++ V F ++D + ++ K++ + ++ H
Sbjct: 11 TGEHQYQYKDIL--SVFEDAFV------DNFDC-KDVQDMPKSI-------LSKEEID-H 53
Query: 258 NVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 317
+M + W L + ++ + V +Y + +
Sbjct: 54 IIMSKDAVSGTLRLFWTL-------LSKQEEMVQKFVEE----VLRINYKFLMSPIKTEQ 102
Query: 318 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE-LDPHLAALVGRLVIL 376
++P ++ L D N KY++ L P+L
Sbjct: 103 --------RQP----SMMTRMYIEQRDRLYND--NQVFAKYNVSRLQPYLK--------- 139
Query: 377 SYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFGSS 427
LR L++ +P V + G G +
Sbjct: 140 ------------------------LRQALLELRPAKNVLID--GVLGSGKT 164
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 33/172 (19%), Positives = 68/172 (39%), Gaps = 33/172 (19%)
Query: 134 DDYEV-------VRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKP----VKKKKIKR 177
D++EV R++G+G + V+EGV + IK + ++ +
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 178 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------VLYPT 224
E +++ ++V+LL +V Q +I E + D K +
Sbjct: 78 EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 225 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
S + E+ + Y ++ +HRD+ N M+ E +++ D+G+
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMT 185
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 35/217 (16%), Positives = 75/217 (34%), Gaps = 36/217 (16%)
Query: 74 HQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYW--DYESLTVQWG 131
H H ++ + L + + A Y + + + +
Sbjct: 4 HHHH-----SSGRENLYFQGKLPEPQFYAEPH--TYEEPGRAGRSFTREIEASRIHI--- 53
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKILQN 184
+ +G G EV G ++ + IK LK +++ E I+
Sbjct: 54 -------EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLK 239
PNI++L +V + ++I E++ N + + + + +
Sbjct: 107 FD-HPNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ Y G +HRD+ NV++D ++ D+GL+
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLS 198
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 32/236 (13%), Positives = 80/236 (33%), Gaps = 39/236 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKPV---KKKKIKREIKILQ 183
+D +G+G ++++F+GV + ++K+L + ++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYEL 237
L ++V + +++ E V Y ++ +L
Sbjct: 68 KLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWKLEVAKQL 122
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI-------DWGLAEFYHPGKEYNVRV- 289
A+ + ++H +V N+++ E+ + D G++ P R+
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 290 --ASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKI 342
PE + + ++ + + D WS G ++ +P D+ +L
Sbjct: 183 WVP------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKLQFY 231
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 43/227 (18%), Positives = 99/227 (43%), Gaps = 23/227 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNL 185
+++ ++ +G G + V++G+ + EK IK L+ P K+I E ++ ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKAL 241
P++ +LL I LI + + D+ + + + + ++ K +
Sbjct: 75 D-NPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPE 298
+Y + ++HRD+ NV++ + +++ D+GLA+ ++ + K E
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 299 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
++ Y + D+WS G ++ M F +P+ G + + K
Sbjct: 190 SILHRI-YTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEK 234
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 26/151 (17%), Positives = 65/151 (43%), Gaps = 15/151 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
++ +++++G G++ V G +K++K + + + +E + + L P +
Sbjct: 8 EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKL 65
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCH 245
VK + + P I E+++N Y L + Y++ + + +
Sbjct: 66 VKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVCEGMAFLE 121
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
S +HRD+ N ++D +++ D+G+
Sbjct: 122 SHQFIHRDLAARNCLVD-RDLCVKVSDFGMT 151
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 43/223 (19%), Positives = 88/223 (39%), Gaps = 41/223 (18%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKI 175
+ +E + +GRG + +V E +K+LK + + +
Sbjct: 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 176 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---------------- 219
E+KIL ++ N+V LL + +I E +
Sbjct: 78 MSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 220 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ L+ + Y +++ K +++ S+ +HRD+ N+++ E+ +++ D+GLA
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLA 195
Query: 277 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
+ +Y + +R K PE + D + Y D+WS G
Sbjct: 196 RDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 30/159 (18%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
+E+ ++++G G++ V G IK++K + + + E K++
Sbjct: 15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVM 73
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYEL 237
NL +V+L + Q+ P I E++ N + + + ++
Sbjct: 74 MNLS-HEKLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+A++Y S+ +HRD+ N +++ +Q +++ D+GL+
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLS 167
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 33/155 (21%), Positives = 65/155 (41%), Gaps = 17/155 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREIKILQNLC 186
+ + + VG G++ EV G ++K I IK LK +++ E I+
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 187 GGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKAL 241
PNI++L +V + P +I E++ N + + + + + +
Sbjct: 105 -HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
Y G +HRD+ N++I+ ++ D+GL
Sbjct: 161 KYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLG 194
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 29/156 (18%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKREIKILQNL 185
+ +G G++ EV++G+ T + K IK LK ++ E I+
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKA 240
NI++L ++ + P +I E++ N + S + + +
Sbjct: 104 S-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ Y + +HRD+ N++++ ++ D+GL+
Sbjct: 160 MKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLS 194
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 8e-06
Identities = 31/161 (19%), Positives = 71/161 (44%), Gaps = 24/161 (14%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKIL 182
+D++EV V ++G G++ EV+ G + K +K LK + E ++
Sbjct: 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLM 62
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIY 235
+ L +V+L +V ++ P I E++ N + L+ +
Sbjct: 63 KQLQ-HQRLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAA 116
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
++ + + + + +HRD++ N+++ + ++ D+GLA
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLA 156
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 32/164 (19%), Positives = 78/164 (47%), Gaps = 17/164 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNL 185
+++ ++ +G G + V++G+ + EK IK L+ P K+I E ++ ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKAL 241
P++ +LL I + T LI + + D+ + + + + ++ K +
Sbjct: 75 D-NPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+Y + ++HRD+ NV++ + +++ D+GLA+ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 40/223 (17%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKI 175
+E + +G G + +V E + +K+LKP +++ +
Sbjct: 14 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREAL 73
Query: 176 KREIKILQNLCGGPNIVKLLDIVRDQQ-------------------SKTPSLIFEHVNNT 216
E+K+L L NIV LL K S I +
Sbjct: 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 217 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ L D+ + Y++ K + + S+ +HRD+ N+++ R ++ D+GLA
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA 192
Query: 277 EFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
Y V+ +R K PE + + Y + D+WS G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 24/150 (16%), Positives = 65/150 (43%), Gaps = 13/150 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ V+++G G++ V G + +K IK ++ + ++ E +++ L P +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKL 65
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLKALDYCHS 246
V+L + +Q P + E + + + + + ++ + + Y
Sbjct: 66 VQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
++HRD+ N ++ E + +++ D+G+
Sbjct: 123 ACVIHRDLAARNCLVG-ENQVIKVSDFGMT 151
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 35/231 (15%), Positives = 85/231 (36%), Gaps = 15/231 (6%)
Query: 56 PFGTLRGLASSASLSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVV 115
G A+ +H R++ T + P + + +
Sbjct: 258 SASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFES 317
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILK----P 169
+ + + + + ++G G + V +GV+ ++ IK+LK
Sbjct: 318 PFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK 377
Query: 170 VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTL 225
+++ RE +I+ L P IV+L+ + Q++ L+ E +
Sbjct: 378 ADTEEMMREAQIMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEI 433
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+V ++++ + Y + +HR++ NV++ + ++ D+GL+
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLS 483
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 40/224 (17%), Positives = 92/224 (41%), Gaps = 27/224 (12%)
Query: 139 VRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREIKILQNLCGGPN 190
++ +G G + V +GV + E IK+++ + + + + +L +
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAH 76
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIYELLKALDYCHS 246
IV+LL + L+ +++ D + L + + ++ K + Y
Sbjct: 77 IVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDL 303
G++HR++ NV++ ++++ D+G+A+ P + + ++ K E +
Sbjct: 134 HGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE---SI 189
Query: 304 QDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Y+ D+WS G ++ M F EP+ G + + K
Sbjct: 190 HFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEK 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 32/182 (17%), Positives = 68/182 (37%), Gaps = 40/182 (21%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKK 173
E +E + +G G + +V + +K+LK
Sbjct: 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------- 219
+ E+++++ + NI+ LL +I E+ + + +
Sbjct: 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYS 143
Query: 220 -----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
V ++ D+ Y+L + ++Y SQ +HRD+ NV++ E +++ D+G
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFG 202
Query: 275 LA 276
LA
Sbjct: 203 LA 204
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 32/167 (19%), Positives = 71/167 (42%), Gaps = 16/167 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ ++ +K+G G++ EV+ + K +K +KP + + E +++ L +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKL 245
Query: 192 VKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELLKALDYCH 245
VKL +V +K P I E + DF + + ++ + + +
Sbjct: 246 VKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE 301
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 292
+ +HRD++ N+++ ++ D+GLA EY R ++
Sbjct: 302 QRNYIHRDLRAANILVS-ASLVCKIADFGLARVIE-DNEYTAREGAK 346
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 28/152 (18%), Positives = 68/152 (44%), Gaps = 17/152 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
+ ++++ +G+G++ +V G + K +K +K + E ++ L N+V
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLV 77
Query: 193 KLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYC 244
+LL ++ +++ L + E++ Y L + + ++ +A++Y
Sbjct: 78 QLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+HRD+ NV++ E ++ D+GL
Sbjct: 134 EGNNFVHRDLAARNVLVS-EDNVAKVSDFGLT 164
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 39/251 (15%), Positives = 83/251 (33%), Gaps = 49/251 (19%)
Query: 72 ARHQHQRLRQLATPPDTLAQKIG----KSVRRSGAPSKARVYSDINVVRPREYWDYESLT 127
+ H H Q L ++I +V + S + + +
Sbjct: 3 SSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPML 62
Query: 128 VQWGEQ-----DDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILK 168
E +E + +G G + +V + +K+LK
Sbjct: 63 AGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK 122
Query: 169 P----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----- 219
+ E+++++ + NI+ LL +I E+ + + +
Sbjct: 123 DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRA 180
Query: 220 --------------VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265
V ++ D+ Y+L + ++Y SQ +HRD+ NV++ E
Sbjct: 181 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-EN 239
Query: 266 RKLRLIDWGLA 276
+++ D+GLA
Sbjct: 240 NVMKIADFGLA 250
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 47/234 (20%), Positives = 89/234 (38%), Gaps = 35/234 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP------VKKKKIKREIKILQN 184
D ++ K+G G + V G + K + +K LKP RE+ + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL------ 238
L N+++L +V K ++ E L L + + + L
Sbjct: 78 LD-HRNLIRLYGVVLTPPMK---MVTELAPLGS---LLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 239 -KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-FK 295
+ + Y S+ +HRD+ N+++ + +++ D+GL Y ++ + F
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 296 --GPELLVDLQDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE L +S D W G ++ + +EP + G + L KI K
Sbjct: 190 WCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKIDK 239
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 9e-05
Identities = 34/187 (18%), Positives = 64/187 (34%), Gaps = 40/187 (21%)
Query: 117 PREYW--DYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILKP--- 169
P Y D+ + Q +G G + +V + D + IK +K
Sbjct: 16 PTIYPVLDWNDIKFQ----------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS 65
Query: 170 -VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK--------- 219
+ E+++L L PNI+ LL + L E+ + +
Sbjct: 66 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVL 123
Query: 220 ---VLYPTLSDYDVRYYIYELLK-ALD------YCHSQGIMHRDVKPHNVMIDHEQRKLR 269
+ + +LL A D Y + +HRD+ N+++ E +
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAK 182
Query: 270 LIDWGLA 276
+ D+GL+
Sbjct: 183 IADFGLS 189
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 32/164 (19%), Positives = 66/164 (40%), Gaps = 29/164 (17%)
Query: 134 DDYEVVR--------KVGRGKYSEVFEGVHCTDNEKCI--IKILKP----VKKKKIKREI 179
+ R ++G G + V +GV+ ++ IK+LK +++ RE
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL- 238
+I+ L P IV+L+ + Q++ L+ E L+ L + +
Sbjct: 62 QIMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGP---LHKFLVGKREEIPVSNVAE 114
Query: 239 ------KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
+ Y + +HRD+ NV++ + ++ D+GL+
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLS 157
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 30/168 (17%), Positives = 66/168 (39%), Gaps = 36/168 (21%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------VKKKKI------------- 175
+ + +G GK S VF +C++K K VK+K+
Sbjct: 92 DAIGKLMGEGKESAVFNCY-SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 176 -KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI 234
+ E + LQ L G + K+ + +++ E ++ + + + +
Sbjct: 151 ARNEFRALQKLQGLA-VPKVYAWEGN------AVLMELIDAKEL----YRVRVENPDEVL 199
Query: 235 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHP 281
+L+ + + +GI+H D+ +NV++ E + +ID+ + E
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVEVGEE 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 2e-04
Identities = 31/156 (19%), Positives = 69/156 (44%), Gaps = 15/156 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNE--KCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 192
+++G G + V +G + +KILK P K ++ E ++Q L P IV
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIV 81
Query: 193 KLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+++ I ++++ L+ E + + D ++ ++++ + Y
Sbjct: 82 RMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+HRD+ NV++ Q ++ D+GL++ + Y
Sbjct: 139 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 173
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 49/213 (23%), Positives = 85/213 (39%), Gaps = 35/213 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKREIKILQN 184
++ + + +G G + +V E K +K+LK +K+ + E+KI+ +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSL-IFEHVNNTDFK-----------------VLYPTLS 226
L NIV LL P L I E+ D + T S
Sbjct: 106 LGQHENIVNLLGACTHGG---PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 227 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286
D+ ++ ++ + + + S+ +HRDV NV++ ++ D+GLA Y
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 287 VRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 316
V+ +R K PE + D Y D+WS G
Sbjct: 222 VKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 28/161 (17%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
+ ++++ +G+G++ +V G + K +K +K + E ++ L N+V
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLV 249
Query: 193 KLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYC 244
+LL ++ +++ L + E++ Y L + + ++ +A++Y
Sbjct: 250 QLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+HRD+ NV++ E ++ D+GL + ++
Sbjct: 306 EGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQDT 345
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 32/182 (17%), Positives = 68/182 (37%), Gaps = 40/182 (21%)
Query: 132 EQDDYEV-------VRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKK 173
E +E+ + +G G + +V K +K+LK
Sbjct: 60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 119
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------- 219
+ E+++++ + NI+ LL +I E+ + + +
Sbjct: 120 DLISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYS 177
Query: 220 -----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274
LS D+ Y++ + ++Y S+ +HRD+ NV++ E +++ D+G
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFG 236
Query: 275 LA 276
LA
Sbjct: 237 LA 238
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 40/236 (16%), Positives = 81/236 (34%), Gaps = 33/236 (13%)
Query: 69 LSHARHQHQRLRQLATPPDTLAQKIGKSVRRSGAPSKARVYSDINVVRPREYWDYESLTV 128
+S+ H H + T + Q S +S +++ + + + +Y
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRT--STIMTDYNPNYCFAGK 58
Query: 129 QWGEQDDYEV-------VRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPV----KK 172
D EV +R +G G + EV+EG + + +K L V +
Sbjct: 59 TSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDE 118
Query: 173 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------VLY 222
E I+ NIV+ + + ++ E + D K
Sbjct: 119 LDFLMEALIISKFN-HQNIVRCIGVSLQSLP--RFILLELMAGGDLKSFLRETRPRPSQP 175
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLA 276
+L+ D+ + ++ Y +HRD+ N ++ R ++ D+G+A
Sbjct: 176 SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 26/166 (15%), Positives = 62/166 (37%), Gaps = 30/166 (18%)
Query: 137 EVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGG 188
+ ++G G + +VF + D +K LK + + RE ++L L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-H 102
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------------------VLYPTLSDYDV 230
+IV+ + + + ++FE++ + D V L +
Sbjct: 103 QHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 231 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
++ + Y +HRD+ N ++ + +++ D+G++
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMS 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 33/183 (18%), Positives = 63/183 (34%), Gaps = 31/183 (16%)
Query: 122 DYESLTVQWGEQDDYEV-------VRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKP 169
+Y D EV +R +G G + EV+EG + + +K L
Sbjct: 11 NYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE 70
Query: 170 V----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------ 219
V + E I+ NIV+ + + ++ E + D K
Sbjct: 71 VCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLP--RFILMELMAGGDLKSFLRET 127
Query: 220 ----VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDW 273
+L+ D+ + ++ Y +HRD+ N ++ R ++ D+
Sbjct: 128 RPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF 187
Query: 274 GLA 276
G+A
Sbjct: 188 GMA 190
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 427 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.26 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.93 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.7 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.57 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.44 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.06 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.7 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.54 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.51 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.33 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.31 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.25 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.79 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.12 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.64 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 93.44 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 89.76 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 88.58 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 87.07 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 85.6 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 85.27 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 84.68 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 83.66 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 83.26 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 83.16 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 82.01 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 81.91 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 81.84 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 81.19 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 81.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 80.95 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 80.9 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 80.62 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 80.55 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 80.31 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 80.13 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 80.11 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=440.39 Aligned_cols=242 Identities=19% Similarity=0.372 Sum_probs=212.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
+.|+++++||+|+||+||+|+++.+|+.||||+++. ...+.+.+|+.+|+++ +|||||+++++|.+ ...+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEE
Confidence 569999999999999999999999999999999964 2345688999999999 99999999999987 56789999
Q ss_pred eecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Cccee
Q 014307 211 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 287 (427)
Q Consensus 211 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~~ 287 (427)
|||.+|+|..++ .++++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+... .....
T Consensus 151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCC
T ss_pred eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCCcccc
Confidence 999999998776 4699999999999999999999999999999999999999877 8999999999877544 34567
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHHhc
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNKY 358 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~~ 358 (427)
.+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+... ++++.+++.+
T Consensus 230 ~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF-~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~- 306 (346)
T 4fih_A 230 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR- 306 (346)
T ss_dssp CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH-
T ss_pred cccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH-
Confidence 799999999999876 78999999999999999999999999 55666677766665421 2455666666
Q ss_pred cCCCChhHHHHHhHHhcCCchhhH
Q 014307 359 HIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
|+..||..|+++.++++||||.+.
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999999873
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=439.02 Aligned_cols=244 Identities=19% Similarity=0.388 Sum_probs=206.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
-++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|++| +|||||++++++.+ ...+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~--~~~~y 99 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEE--NGSLY 99 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEEE
Confidence 47899999999999999999999999999999999642 245688999999999 99999999999987 56789
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+|||||.||+|..++. .+++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+...
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecCC
Confidence 9999999999987762 368999999999999999999999999999999999999877 8999999999876533
Q ss_pred Cc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 283 KE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 283 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
.. ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+.++.+... ++++.++
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 22 345689999999999987 78999999999999999999999999 56666677777765432 2456666
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+ |+..||..||+++++|+||||.+..
T Consensus 257 i~~-~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 257 VSQ-LFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHH-HTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHH-HccCChhHCcCHHHHhcCHHhhcCC
Confidence 666 9999999999999999999998744
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-57 Score=430.41 Aligned_cols=243 Identities=25% Similarity=0.422 Sum_probs=211.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|+++.+++.||||++++. ..+.+.+|+++|+++ +|||||+++++|.+ ...+|
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~y 108 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKLY 108 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEE
Confidence 5799999999999999999999999999999999642 346789999999999 99999999999987 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
+|||||.||+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+....
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTTT
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCCC
Confidence 999999999998776 4699999999999999999999999999999999999999877 89999999999875432
Q ss_pred --cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHH
Q 014307 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYL 355 (427)
Q Consensus 284 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l 355 (427)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+.+|.+.-- +++..+++
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF-~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli 265 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPF-RAGNEGLIFAKIIKLEYDFPEKFFPKARDLV 265 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCTTCCHHHHHHH
T ss_pred cccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCcccCHHHHHHH
Confidence 3456799999999999987 78999999999999999999999999 55566666666665421 35566666
Q ss_pred HhccCCCChhHHHHHhH------HhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALVGR------LVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~------ll~~~~~~~~~ 383 (427)
.+ |+..||..|+++++ +++||||+...
T Consensus 266 ~~-lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 266 EK-LLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp HH-HSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HH-HccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 66 99999999999988 57889988744
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-57 Score=422.28 Aligned_cols=241 Identities=22% Similarity=0.458 Sum_probs=191.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+.+|+++ +|||||++++++.+ ...+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ 89 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKS--KDEII 89 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEEE
Confidence 6799999999999999999999999999999998642 235689999999999 99999999999986 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||++ |+|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 90 ivmEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 90 MVIEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EEEECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC--------
T ss_pred EEEeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCCc
Confidence 9999995 5655443 4699999999999999999999999999999999999999777 899999999988766666
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~~~ 358 (427)
....+||+.|||||++.+...++.++|||||||++|||++|+.|| .+.+..+.+..+.+..- +++..+++.+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 245 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF-DDESIPVLFKNISNGVYTLPKFLSPGAAGLIKR- 245 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH-
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 677899999999999987444578999999999999999999999 44444455555554321 3456666666
Q ss_pred cCCCChhHHHHHhHHhcCCchhh
Q 014307 359 HIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
|+..||..|++++++++||||+.
T Consensus 246 ~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 246 MLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=444.20 Aligned_cols=243 Identities=19% Similarity=0.373 Sum_probs=214.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.+.|+++++||+|+||.||+|+++.+|+.||||+++. ...+.+.+|+.+|+.+ +|||||+++++|.+ ...+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~--~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999999964 3346688999999999 99999999999987 5678999
Q ss_pred EeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Ccce
Q 014307 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN 286 (427)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~~ 286 (427)
||||.||+|..++ .++++.+++.++.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+... ....
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBC
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCcccc
Confidence 9999999998776 4699999999999999999999999999999999999999887 8999999999877544 3456
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHHh
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNK 357 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~ 357 (427)
..+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+..... ++.+.+++.+
T Consensus 306 ~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF-~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 306 SLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPY-FNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred ccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 7799999999999877 78999999999999999999999999 55666677776665421 3456666666
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
||..||..|+++.++|.||||.+.
T Consensus 384 -~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 384 -LLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -HcCCChhHCcCHHHHhcCHHhcCC
Confidence 999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-56 Score=420.24 Aligned_cols=243 Identities=21% Similarity=0.371 Sum_probs=203.0
Q ss_pred CCCE-EEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--CCC
Q 014307 133 QDDY-EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSK 204 (427)
Q Consensus 133 ~~~y-~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~--~~~ 204 (427)
..+| ++.++||+|+||+||+|+++.++..||+|++... ..+.+.+|+.+|++| +|||||+++++|.+. ...
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCc
Confidence 3455 7888999999999999999999999999998642 235689999999999 999999999998753 245
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
.+++|||||.+|+|..++ ..+++..++.++.||+.||+|||++| ||||||||+|||++...+.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 689999999999998776 36999999999999999999999998 9999999999999854348999999999854
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH-HHHHhC--------ChH
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK-IAKVLG--------TDE 350 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~-i~~~~~--------~~~ 350 (427)
........+||+.|||||++.+ .|+.++|||||||++|||+||+.||. +..+...+.. +..... .++
T Consensus 183 -~~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 258 (290)
T 3fpq_A 183 -RASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGVKPASFDKVAIPE 258 (290)
T ss_dssp -CTTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT-TCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred -CCCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCC-CCCcHHHHHHHHHcCCCCCCCCccCCHH
Confidence 3444567799999999999864 69999999999999999999999994 4445444443 322211 245
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+.+++.+ |+..||..||++.++|+||||++
T Consensus 259 ~~~li~~-~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 259 VKEIIEG-CIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHH-HSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHHH-HccCChhHCcCHHHHhcCccccC
Confidence 5566666 99999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=432.44 Aligned_cols=289 Identities=24% Similarity=0.360 Sum_probs=231.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|+++++||+|+||+||+|+++ .+++.||||.+.. .....+.+|+++|+.+.+||||++++++|.+ ..++|+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCEEEE
Confidence 467999999999999999999875 4678999998864 3456788999999999789999999999987 567899
Q ss_pred EEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-----
Q 014307 209 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK----- 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~----- 283 (427)
||||+++++|..+++.+++.+++.++.||+.||+|||++||+||||||+|||++.+.+.+||+|||+|+......
T Consensus 98 vmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~ 177 (361)
T 4f9c_A 98 AMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177 (361)
T ss_dssp EEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGG
T ss_pred EEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccc
Confidence 999999999999999999999999999999999999999999999999999998775589999999998654321
Q ss_pred ------------------------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014307 284 ------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339 (427)
Q Consensus 284 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l 339 (427)
.....+||+.|+|||++.+...|+.++||||+||++|||++|+.||+.+.++.+++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l 257 (361)
T 4f9c_A 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL 257 (361)
T ss_dssp GC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred cccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 12345899999999999876679999999999999999999999999999999999
Q ss_pred HHHHHHhCChHHHHHHHhccC-------CCChhHHHHHhHHhcCCchhhH-------HHhhhhhhhhhhhhhHHHHHHhh
Q 014307 340 VKIAKVLGTDELNAYLNKYHI-------ELDPHLAALVGRLVILSYFFQF-------VIYYYYYYYFCLKTCNFLLRNFL 405 (427)
Q Consensus 340 ~~i~~~~~~~~~~~~l~~~~l-------~~dp~~r~~~~~ll~~~~~~~~-------~~~~~~~~~~~~~~~~dllr~~l 405 (427)
..|.+.+|+++.......... ......+...+.+......... .......+....+.+.|+|++||
T Consensus 258 ~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL 337 (361)
T 4f9c_A 258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLL 337 (361)
T ss_dssp HHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHT
T ss_pred HHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 999999998766554332110 1223344444443322111100 00111223446778999999999
Q ss_pred hhcCchhhhhhccccCCCC
Q 014307 406 VQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 406 ~~~~P~~r~~~~~~~~~~~ 424 (427)
. .||++|+|+..++.|||
T Consensus 338 ~-~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 338 D-LNPASRITAEEALLHPF 355 (361)
T ss_dssp C-SCTTTSCCHHHHHTSGG
T ss_pred c-CChhHCcCHHHHhcCcc
Confidence 5 99999999999999998
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-56 Score=421.75 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=203.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|++++.||+|+||+||+|++. .+++.||||+++.. ....+.+|+.+|+++ +|||||++++++.+ ..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~ 99 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQT--EG 99 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEE--TT
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CC
Confidence 367999999999999999999984 46789999998642 234688999999999 99999999999987 56
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.+|+|||||.||+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccceeccC
Confidence 789999999999998776 4699999999999999999999999999999999999999887 899999999986543
Q ss_pred C-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHH
Q 014307 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAY 354 (427)
Q Consensus 282 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~ 354 (427)
. ......+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+..- +++..++
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 256 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKETMTMILKAKLGMPQFLSPEAQSL 256 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCC-CCcCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 3 33456799999999999987 78999999999999999999999999 56666676766665321 3556666
Q ss_pred HHhccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 355 LNKYHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 355 l~~~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
+.+ |+..||..|++ ++++++||||+...
T Consensus 257 i~~-~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 257 LRM-LFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp HHH-HTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HHH-HcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 666 99999999998 68999999998744
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-55 Score=432.28 Aligned_cols=246 Identities=28% Similarity=0.571 Sum_probs=211.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC----C
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----Q 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~----~ 202 (427)
..++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+++|+.| +|||||++++++... +
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeeccccccc
Confidence 357899999999999999999999999999999999642 235678999999999 999999999998643 3
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
...+|+|||||+|+ |..++ ..+++.+++.+++||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+
T Consensus 131 ~~~~~ivmE~~~g~-L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~ 208 (398)
T 4b99_A 131 FKSVYVVLDLMESD-LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGL 208 (398)
T ss_dssp CCCEEEEEECCSEE-HHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC
T ss_pred CCEEEEEEeCCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeeec
Confidence 46789999999754 55444 3599999999999999999999999999999999999999877 8999999999865
Q ss_pred cCC-----CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCCh-----
Q 014307 280 HPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD----- 349 (427)
Q Consensus 280 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~----- 349 (427)
... ......+||+.|||||++.+...|+.++||||+||++|||++|+.|| .+.+..+++..|.+..+.+
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCChHHh
Confidence 432 23456799999999999988667899999999999999999999999 7788889999888776532
Q ss_pred --------------------------------HHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 350 --------------------------------ELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 350 --------------------------------~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
....++.+ ||..||..|+++.++|+||||.+.
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~-mL~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGR-MLRFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHH-HSCSSTTTSCCHHHHTTSGGGTTT
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHH-HCcCChhHCcCHHHHhcCHhhCcC
Confidence 33445555 999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=422.50 Aligned_cols=234 Identities=23% Similarity=0.312 Sum_probs=196.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
.+.|++.++||+|+||+||+|+++.+|+.||||+++... ...+|+.+|+.+ +|||||++++++.+ ...+|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~--~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVRE--GPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEE--TTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEEec
Confidence 367999999999999999999999999999999997532 235799999999 99999999999987 5678999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-----
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----- 284 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~----- 284 (427)
|+||+|..++ ..+++.+++.++.||+.||+|||++|||||||||+||||+.++..+||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 9999998876 36999999999999999999999999999999999999998775799999999987754322
Q ss_pred -ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAY 354 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~ 354 (427)
....+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+... ++.+.++
T Consensus 212 ~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~l 289 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPW-TQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289 (336)
T ss_dssp --CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-TTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHH
T ss_pred cCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCC-CCCCHHHHHHHHHcCCCCchhcCccCCHHHHHH
Confidence 123579999999999987 78999999999999999999999999 44444444555544211 2345555
Q ss_pred HHhccCCCChhHHHHHhHHh
Q 014307 355 LNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll 374 (427)
+.+ |+..||..||++.+++
T Consensus 290 i~~-~L~~dP~~R~sa~el~ 308 (336)
T 4g3f_A 290 IQE-GLRKEPVHRASAMELR 308 (336)
T ss_dssp HHH-HTCSSGGGSCCHHHHH
T ss_pred HHH-HccCCHhHCcCHHHHH
Confidence 655 9999999999999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=407.35 Aligned_cols=239 Identities=21% Similarity=0.381 Sum_probs=186.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC------
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 203 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~------ 203 (427)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|++| +|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999999999999999998642 235688999999999 99999999999876432
Q ss_pred ----CCcEEEEeecCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEee
Q 014307 204 ----KTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (427)
Q Consensus 204 ----~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DF 273 (427)
.++|+|||||.+++|..++.. ..+..++.++.||+.||+|||++|||||||||+|||++.++ .+||+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DF 162 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDF 162 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccC
Confidence 247999999999999877642 44556889999999999999999999999999999999877 8999999
Q ss_pred eeeeeecCCCc-------------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014307 274 GLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340 (427)
Q Consensus 274 Gla~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~ 340 (427)
|+|+.+..... ....+||+.|||||++.+ ..|+.++|||||||++|||++ ||.. ..+...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~---~~~~~~ 235 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFST---QMERVR 235 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSS---HHHHHH
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCC---ccHHHH
Confidence 99987654321 234589999999999987 789999999999999999996 7732 223332
Q ss_pred HHHHHh--C-C-------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 341 KIAKVL--G-T-------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 341 ~i~~~~--~-~-------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
.+.... . + +....++.+ |+..||..||++.++++|+||++.
T Consensus 236 ~~~~~~~~~~p~~~~~~~~~~~~li~~-~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 236 TLTDVRNLKFPPLFTQKYPCEYVMVQD-MLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHTTCCCHHHHHHCHHHHHHHHH-HTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHhcCCCCCCCcccCHHHHHHHHH-HcCCChhHCcCHHHHhcCHhhCCC
Confidence 222221 1 1 233344444 999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=406.18 Aligned_cols=241 Identities=20% Similarity=0.352 Sum_probs=198.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|.+.++||+|+||+||+|++. .++..||||+++... .+.+.+|+++|+++ +|||||+++|++.+ .
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~ 87 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--G 87 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--C
Confidence 4578999999999999999999875 357899999997543 46689999999999 99999999999976 5
Q ss_pred CCcEEEEeecCCCchhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCe
Q 014307 204 KTPSLIFEHVNNTDFKVLYP----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 267 (427)
..+++|||||.+|+|..++. .+++.++..++.||+.||+|||+++||||||||+|||++.++ .
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~-~ 166 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-L 166 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-C
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-c
Confidence 57899999999999987762 489999999999999999999999999999999999999877 8
Q ss_pred EEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHH
Q 014307 268 LRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIA 343 (427)
Q Consensus 268 ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~ 343 (427)
+||+|||+|+........ ....||+.|||||++.+ ..|+.++|||||||+||||+| |+.|| .+.++.+.+..+.
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf-~~~~~~~~~~~i~ 244 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPW-YQLSNNEVIECIT 244 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHH
Confidence 999999999866443322 23468999999999987 789999999999999999998 89999 5556666666666
Q ss_pred HHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 344 KVLG-------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 344 ~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+... ++.+.+++.. ||..||..||++.++. +++++
T Consensus 245 ~~~~~~~p~~~~~~~~~li~~-cl~~dP~~RPs~~~i~--~~L~~ 286 (299)
T 4asz_A 245 QGRVLQRPRTCPQEVYELMLG-CWQREPHMRKNIKGIH--TLLQN 286 (299)
T ss_dssp HTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHH--HHHHH
T ss_pred cCCCCCCCccchHHHHHHHHH-HcCCChhHCcCHHHHH--HHHHH
Confidence 5421 2355555555 9999999999988873 34443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=402.07 Aligned_cols=317 Identities=67% Similarity=1.121 Sum_probs=280.0
Q ss_pred CCcccccCCCcCCCCCcccccccccccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHH
Q 014307 104 SKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ 183 (427)
Q Consensus 104 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~ 183 (427)
+.++...+.....+.+.|+++.....+...++|+++++||+|+||+||+|++..+++.||||+++....+.+.+|+.+++
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~ 85 (330)
T 3nsz_A 6 SRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILE 85 (330)
T ss_dssp CCCSSSTTTTTTSCHHHHCGGGCCCCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHH
T ss_pred CceeEeccccccCchhHHHhhhhhhcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHH
Confidence 34444566666778888888888888888999999999999999999999999999999999999888899999999999
Q ss_pred HhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC
Q 014307 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (427)
Q Consensus 184 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~ 263 (427)
++.+||||+++++++.+......++||||+.++++..+...+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 86 ~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~ 165 (330)
T 3nsz_A 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH 165 (330)
T ss_dssp HHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET
T ss_pred HcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC
Confidence 99669999999999998767788999999999999999999999999999999999999999999999999999999997
Q ss_pred CCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014307 264 EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343 (427)
Q Consensus 264 ~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~ 343 (427)
++..+||+|||+++............++..|+|||++.+...++.++|||||||++|+|++|+.||+.+.+..+++..+.
T Consensus 166 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~ 245 (330)
T 3nsz_A 166 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245 (330)
T ss_dssp TTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred CCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHH
Confidence 77689999999999877766667778999999999988767899999999999999999999999998889999999999
Q ss_pred HHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCC
Q 014307 344 KVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESA 423 (427)
Q Consensus 344 ~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~ 423 (427)
+.++.+....++.......+|.............|-.... ........+.+.++|++||. .||++|+|+..+++||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~-~dP~~Rpta~e~l~hp 321 (330)
T 3nsz_A 246 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH---SENQHLVSPEALDFLDKLLR-YDHQSRLTAREAMEHP 321 (330)
T ss_dssp HHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCC---TTTGGGCCHHHHHHHHTTSC-SSGGGSCCHHHHHTSG
T ss_pred HhcCCchhhhHHHHhccccccchhhhhhhccccchhhhcc---ccccccCCHHHHHHHHHHhc-CCcccCCCHHHHhcCc
Confidence 9999999999998888888888877766655555533211 11222356789999999995 9999999999999999
Q ss_pred C
Q 014307 424 F 424 (427)
Q Consensus 424 ~ 424 (427)
|
T Consensus 322 ~ 322 (330)
T 3nsz_A 322 Y 322 (330)
T ss_dssp G
T ss_pred c
Confidence 8
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=401.92 Aligned_cols=237 Identities=17% Similarity=0.300 Sum_probs=191.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|.+.++||+|+||+||+|+++ .+++.||||+++... .+.|.+|+++|+++ +|||||++++++.+ .
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTE--G 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence 3467999999999999999999865 368899999997543 46689999999999 99999999999976 5
Q ss_pred CCcEEEEeecCCCchhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC
Q 014307 204 KTPSLIFEHVNNTDFKVLYP------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~ 265 (427)
..+++|||||.+|+|..++. .+++.++..++.||+.||+|||+++||||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 67899999999999987652 388999999999999999999999999999999999999777
Q ss_pred CeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014307 266 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (427)
Q Consensus 266 ~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~ 341 (427)
.+||+|||+|+....... ....+||+.|||||++.+ ..|+.++|||||||+||||+| |+.|| .+.++.+.+..
T Consensus 196 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf-~~~~~~~~~~~ 272 (329)
T 4aoj_A 196 -VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPW-YQLSNTEAIDC 272 (329)
T ss_dssp -EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTT-CSSCHHHHHHH
T ss_pred -cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCC-CCCCHHHHHHH
Confidence 899999999987644332 234578999999999887 789999999999999999999 89999 55566666666
Q ss_pred HHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 342 IAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 342 i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+... ++.+.+++.+ ||..||..||++.+++.
T Consensus 273 i~~g~~~~~p~~~~~~~~~li~~-cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 273 ITQGRELERPRACPPEVYAIMRG-CWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHH-HCCSSTTTSCCHHHHHH
T ss_pred HHcCCCCCCcccccHHHHHHHHH-HcCcChhHCcCHHHHHH
Confidence 655421 2455555555 99999999999888754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=397.95 Aligned_cols=236 Identities=18% Similarity=0.308 Sum_probs=196.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.+++++.++||+|+||+||+|++. .+++.||||+++.. ..+.|.+|+.+|+++ +|||||+++|++.+ .
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~--~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTK--D 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECS--S
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEE--C
Confidence 467889999999999999999863 36789999999643 347799999999999 99999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC
Q 014307 204 KTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~ 264 (427)
..+++|||||.+|+|..++ ..+++.++..++.||+.||+|||+++||||||||+||||+.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 5689999999999998775 238899999999999999999999999999999999999977
Q ss_pred CCeEEEEeeeeeeeecCCC---cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHH
Q 014307 265 QRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 340 (427)
Q Consensus 265 ~~~ikl~DFGla~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~ 340 (427)
+ .+||+|||+|+...... .....+||+.|||||++.+ +.|+.++|||||||+||||+| |+.|| .+.++.+.+.
T Consensus 182 ~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf-~~~~~~~~~~ 258 (308)
T 4gt4_A 182 L-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVVE 258 (308)
T ss_dssp G-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTCCHHHHHH
T ss_pred C-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCC-CCCCHHHHHH
Confidence 7 89999999998654332 2344578999999999987 789999999999999999998 88898 5666666666
Q ss_pred HHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 341 KIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 341 ~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+... ++.+.+++.. ||..||..||++.+++.
T Consensus 259 ~i~~~~~~~~p~~~~~~~~~li~~-C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 259 MIRNRQVLPCPDDCPAWVYALMIE-CWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCcccchHHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 6554321 2345555555 99999999999888764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=394.72 Aligned_cols=233 Identities=16% Similarity=0.334 Sum_probs=188.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.+++++.++||+|+||+||+|++. ..||||+++.. ..+.+.+|+.+|+++ +|||||++++++.+ ..++
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~---~~~~ 107 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK---DNLA 107 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSCE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC---CeEE
Confidence 467889999999999999999853 35899998632 236689999999999 99999999998854 3579
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~- 282 (427)
+|||||.+|+|..++ ..+++.++..++.||+.||+|||+++||||||||+||||+.++ .+||+|||+|+.....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC-----
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCceecccCC
Confidence 999999999998765 3589999999999999999999999999999999999999777 8999999999865432
Q ss_pred --CcceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-hC----------
Q 014307 283 --KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LG---------- 347 (427)
Q Consensus 283 --~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~-~~---------- 347 (427)
......+||+.|||||++.+ ...|+.++|||||||+||||+||+.|| .+.++.+.+..+... ..
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf-~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY-SHINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT-TTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC-CCCChHHHHHHHHhcCCCCCCccccccc
Confidence 22345689999999999864 246999999999999999999999999 555666665544432 11
Q ss_pred -ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 -TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 -~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+.+++.+ |+..||..||++.+++.
T Consensus 266 ~~~~l~~li~~-cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 266 CPKAMKRLVAD-CVKKVKEERPLFPQILS 293 (307)
T ss_dssp SCHHHHHHHHH-HTCSSSTTSCCHHHHHH
T ss_pred chHHHHHHHHH-HcCCCHhHCcCHHHHHH
Confidence 1344555555 99999999999888765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=399.09 Aligned_cols=241 Identities=19% Similarity=0.311 Sum_probs=198.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCC-----eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|+++++||+|+||+||+|.+..++ +.||||+++.. ..+.+.+|+.+|.++.+|||||+++|+|..+
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 4578999999999999999999986543 68999999653 2356889999999996669999999998653
Q ss_pred CCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~ 263 (427)
...+++|||||.+|+|..++. .+++.++..++.||+.||+|||+++||||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 456899999999999987752 2788999999999999999999999999999999999998
Q ss_pred CCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014307 264 EQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQL 339 (427)
Q Consensus 264 ~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l 339 (427)
++ .+||+|||+|+........ ...+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.......+..
T Consensus 221 ~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~ 298 (353)
T 4ase_A 221 KN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 298 (353)
T ss_dssp GG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred CC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 77 8999999999876544332 34578999999999987 789999999999999999998 899994433344444
Q ss_pred HHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 340 VKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 340 ~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
..+.+... ++.+.+++.. ||..||..||++.+++.+
T Consensus 299 ~~i~~g~~~~~p~~~~~~~~~li~~-c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 299 RRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHH-HcCcChhHCcCHHHHHHH
Confidence 44444321 3456666666 999999999999888764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-51 Score=422.08 Aligned_cols=243 Identities=21% Similarity=0.397 Sum_probs=214.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
++|+++++||+|+||.||+|+++.+|+.||+|+++... .+.+.+|+.+|+.| +|||||+++++|.+ ...+++||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 68999999999999999999999999999999986533 45688999999999 99999999999986 56789999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC-CCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~ikl~DFGla~~~~~~~~~ 285 (427)
|||.||+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.+ .+.+||+|||+|+.+......
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999999997765 258999999999999999999999999999999999999854 248999999999998877777
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYL 355 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l 355 (427)
...+||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..|.+... ++....++
T Consensus 314 ~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 391 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 391 (573)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred eeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCC-CCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 88899999999999987 78999999999999999999999999 56666777777765421 23455666
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
.+ ||..||..|+++.++|+||||...
T Consensus 392 ~~-~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 392 RK-LLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp HT-TSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred HH-HccCChhHCcCHHHHhcCcCcCCC
Confidence 66 999999999999999999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=418.94 Aligned_cols=246 Identities=23% Similarity=0.352 Sum_probs=202.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHH---HHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREI---KILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~---~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+|. .+++.+ +|||||+++++|.+ .
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~--~ 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--P 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--S
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEE--C
Confidence 478999999999999999999999999999999996422 23344554 444455 89999999999987 5
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..+|+|||||.||+|..++ ..+++..++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.+.
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS 343 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeecC
Confidence 6799999999999998776 4699999999999999999999999999999999999999887 89999999998775
Q ss_pred CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CCHHHHH-HHHHHh------CChHHH
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DNYDQLV-KIAKVL------GTDELN 352 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-~~~~~l~-~i~~~~------~~~~~~ 352 (427)
.. .....+||+.|||||++.+...|+.++|||||||+||||++|+.||.... .+...+. .+.... -+++..
T Consensus 344 ~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~ 422 (689)
T 3v5w_A 344 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 422 (689)
T ss_dssp SC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHHH
Confidence 43 34567999999999998754679999999999999999999999995322 2222222 222211 134566
Q ss_pred HHHHhccCCCChhHHHH-----HhHHhcCCchhhHHH
Q 014307 353 AYLNKYHIELDPHLAAL-----VGRLVILSYFFQFVI 384 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~-----~~~ll~~~~~~~~~~ 384 (427)
.++.+ |+..||..|++ +++++.||||+...+
T Consensus 423 dLI~~-lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 423 SLLEG-LLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp HHHHH-HTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred HHHHH-HccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 66666 99999999998 799999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=389.77 Aligned_cols=284 Identities=24% Similarity=0.408 Sum_probs=223.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---- 202 (427)
..++|++++.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+|+.+ +||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcccc
Confidence 357899999999999999999999999999999999642 246678999999999 9999999999997532
Q ss_pred CCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
...+++||||+.++.+..+...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 217 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC-----C
T ss_pred CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCCC
Confidence 245799999999988777777899999999999999999999999999999999999999877 8999999999877666
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCC
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~ 362 (427)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+... ++. ..
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p~~~-~~~----~~ 290 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPE-FMK----KL 290 (464)
T ss_dssp CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHH-HHT----TS
T ss_pred cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHH-HHH----Hc
Confidence 66677899999999999987 68999999999999999999999999 7788899999999999876432 221 22
Q ss_pred ChhHHHHHhHHhcCCchhhHHHhh-------hhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 363 DPHLAALVGRLVILSYFFQFVIYY-------YYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 363 dp~~r~~~~~ll~~~~~~~~~~~~-------~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
.+..+..+.......-..-...+. ........+.+.|+|++||. .||++|+|+..+++|||=
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~-~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV-IDPAKRISVDDALQHPYI 359 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC-SSTTTSCCHHHHHTSTTT
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcC-CChhhCCCHHHHhcChhh
Confidence 344444333221111000000000 00111235679999999995 999999999999999983
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=372.29 Aligned_cols=237 Identities=17% Similarity=0.203 Sum_probs=183.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHH--HHHHhcCCCCeeeeeeEEEcCCC--CCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIK--ILQNLCGGPNIVKLLDIVRDQQS--KTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~--il~~l~~h~niv~l~~~~~~~~~--~~~~lv 209 (427)
.+|.+.++||+|+||+||+|++ +|+.||||+++....+.+.+|.+ .+.++ +|||||++++++.+.+. ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence 3689999999999999999987 68999999998766665555544 45567 99999999999986543 257999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC--------CceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
||||++|+|..++. .+++..+..++.|++.||+|||++ +||||||||+|||++.++ .+||+|||+|+..
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCccc
Confidence 99999999988763 689999999999999999999987 999999999999999877 8999999999877
Q ss_pred cCCCcc-----eeeccCccccccccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCC-------------CCCH
Q 014307 280 HPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFRKEPFFYG-------------HDNY 336 (427)
Q Consensus 280 ~~~~~~-----~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGvll~elltg~~pf~~~-------------~~~~ 336 (427)
...... ...+||+.|||||++.+.. .|+.++|||||||+||||+||..||... ....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 554322 2358999999999986521 3678999999999999999997765211 1122
Q ss_pred HHHHHHHHHhC--C------------hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 337 DQLVKIAKVLG--T------------DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 337 ~~l~~i~~~~~--~------------~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+......-+ + +.+.+++ ..||..||..||++.++++
T Consensus 239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li-~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIM-RECWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHH-HTTCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcccCCCCCCccccchHHHHHHHHHH-HHHcccCHhHCcCHHHHHH
Confidence 33332221100 0 1233444 4499999999999888765
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=376.99 Aligned_cols=285 Identities=26% Similarity=0.482 Sum_probs=217.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||.||+|.+..+++.||||++.. .....+.+|+.+|+.+.+||||+++++++...+...++
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 3689999999999999999999999999999999853 23356789999999995699999999999876667899
Q ss_pred EEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC----
Q 014307 208 LIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP---- 281 (427)
Q Consensus 208 lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~---- 281 (427)
+||||+.+ +|...+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 88 lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCCC
T ss_pred EEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCcccccccccccc
Confidence 99999995 555444 3689999999999999999999999999999999999999777 899999999986532
Q ss_pred ------------------CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH
Q 014307 282 ------------------GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 343 (427)
Q Consensus 282 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~ 343 (427)
.......+||+.|+|||++.+...|+.++|||||||++|||++|+.|| .+.+..+++..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERII 244 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHH
Confidence 112344689999999999987678999999999999999999999998 7788899999999
Q ss_pred HHhCChHHHHHHHhccCCCChhHHHHHhHHhcCC---------chhhHHH--hhhhhhhhhhhhhHHHHHHhhhhcCchh
Q 014307 344 KVLGTDELNAYLNKYHIELDPHLAALVGRLVILS---------YFFQFVI--YYYYYYYFCLKTCNFLLRNFLVQAQPET 412 (427)
Q Consensus 344 ~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~---------~~~~~~~--~~~~~~~~~~~~~~dllr~~l~~~~P~~ 412 (427)
..++.+....+ .. ...|..+..+..+.... .|..... ........+.+.+.|+|++||. .||++
T Consensus 245 ~~~~~p~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~-~dP~~ 319 (388)
T 3oz6_A 245 GVIDFPSNEDV-ES---IQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ-FNPNK 319 (388)
T ss_dssp HHHCCCCHHHH-HT---SCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC-SSGGG
T ss_pred HhcCCCCHHHH-Hh---ccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc-cCccc
Confidence 88887655432 11 12233333333332221 1111000 0001112356789999999995 99999
Q ss_pred hhhhccccCCCCC
Q 014307 413 MVKVHYCGESAFG 425 (427)
Q Consensus 413 r~~~~~~~~~~~~ 425 (427)
|+|+..+++|||=
T Consensus 320 R~t~~e~l~Hp~~ 332 (388)
T 3oz6_A 320 RISANDALKHPFV 332 (388)
T ss_dssp SCCHHHHTTSTTT
T ss_pred CCCHHHHhCCHHH
Confidence 9999999999983
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=369.33 Aligned_cols=244 Identities=22% Similarity=0.439 Sum_probs=209.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||.||+|++..+|+.||||++... ..+.+.+|+.+|+.+ +||||+++++++.. ...++
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~~ 90 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIET--EKTLY 90 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEE
Confidence 36899999999999999999999999999999998643 235678999999999 89999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.++++..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSSCG
T ss_pred EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCCCc
Confidence 999999999987765 5699999999999999999999999999999999999999777 899999999987766666
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~~ 358 (427)
....+||+.|+|||++.+....+.++|||||||++|+|++|+.|| .+.+..+....+.... -+++...++.+
T Consensus 170 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 247 (328)
T 3fe3_A 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF-DGQNLKELRERVLRGKYRIPFYMSTDCENLLKR- 247 (328)
T ss_dssp GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH-
T ss_pred cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 677789999999999987444458999999999999999999999 4555455555554432 13556666666
Q ss_pred cCCCChhHHHHHhHHhcCCchhhH
Q 014307 359 HIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
|+..||..||+++++++||||...
T Consensus 248 ~L~~dP~~R~t~~eil~h~~~~~~ 271 (328)
T 3fe3_A 248 FLVLNPIKRGTLEQIMKDRWINAG 271 (328)
T ss_dssp HCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred HCCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999999763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=360.67 Aligned_cols=245 Identities=31% Similarity=0.572 Sum_probs=211.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|+++++||+|+||+||+|++..+++.||||+++... ...+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEe--CCEEEE
Confidence 57999999999999999999999999999999986422 36688999999999 99999999999986 567899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Cc
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~ 284 (427)
||||+.++.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCSC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcccc
Confidence 99999987665543 4699999999999999999999999999999999999999777 8999999999876433 33
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------- 348 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~---------------- 348 (427)
.....+|+.|+|||++.+...++.++|||||||++|+|++|..||+.+.+..+++..+.+..+.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 4556889999999999875568999999999999999999999988888888888888776543
Q ss_pred -------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 -------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 -------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+...+++.+ |+..||..||+++++++||||.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 238 PYPMYPATTSLVNVVPKLNATGRDLLQN-LLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccccccCCcchhhcccccChHHHHHHHH-HhccChhhCCCHHHHhcCcccccCC
Confidence 233455555 9999999999999999999998743
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=369.71 Aligned_cols=243 Identities=23% Similarity=0.416 Sum_probs=210.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++++.||+|+||.||+|+++.+|+.||+|+++.. ..+.+.+|+.+|+++ +||||+++++++.+ .
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~ 87 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN--R 87 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--S
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe--C
Confidence 46799999999999999999999999999999998643 246789999999999 89999999999976 5
Q ss_pred CCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC---eEEEEeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE 277 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~ikl~DFGla~ 277 (427)
..+++||||+.+++|..++. .+++.++..++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 67899999999999987763 5899999999999999999999999999999999999986653 69999999999
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+.+...
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (361)
T 2yab_A 168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANITAVSYDFDEEFFSQT 245 (361)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred EcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCCCCCchhccCC
Confidence 8776666667789999999999876 68999999999999999999999999 45555555555544321
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
++.+.+++.+ |+..||..||++.+++.||||..
T Consensus 246 s~~~~~li~~-~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 246 SELAKDFIRK-LLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp CHHHHHHHHH-HSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CHHHHHHHHH-HCCCChhHCcCHHHHhcCcCcCC
Confidence 2345555555 99999999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=369.37 Aligned_cols=245 Identities=22% Similarity=0.371 Sum_probs=205.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+|..+|+.+.+||||+++++++.+ ...+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 47899999999999999999999999999999999743 235578899999998789999999999976 5578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-C
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~ 282 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC--
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeecccCC
Confidence 9999999999987765 4699999999999999999999999999999999999999877 899999999975432 2
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (427)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+....+.+.. -.+....++.
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPF-EAENEDDLFEAILNDEVVYPTWLHEDATGILK 256 (353)
T ss_dssp -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 33456689999999999876 67999999999999999999999999 5556666666665532 1345556566
Q ss_pred hccCCCChhHHHHH------hHHhcCCchhhHH
Q 014307 357 KYHIELDPHLAALV------GRLVILSYFFQFV 383 (427)
Q Consensus 357 ~~~l~~dp~~r~~~------~~ll~~~~~~~~~ 383 (427)
+ |+..||..|+++ ++++.||||....
T Consensus 257 ~-lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 257 S-FMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp H-HTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred H-HhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 6 999999999998 8999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=360.71 Aligned_cols=245 Identities=20% Similarity=0.374 Sum_probs=211.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEec--CCEEEEEE
Confidence 47899999999999999999999999999999998643 345688999999999 99999999999977 55789999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC-CCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.+++|...+. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 9999999877663 48999999999999999999999999999999999999862 348999999999988777667
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYL 355 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l 355 (427)
....|++.|+|||++.+ ..++.++|||||||++|+|++|..|| .+....+.+..+.+... ++.+.+++
T Consensus 161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred ccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCC-cCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHH
Confidence 77889999999999876 67899999999999999999999999 44555555555554321 33455555
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+ |+..||..||++.+++.||||.+..
T Consensus 239 ~~-~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 239 DR-LLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HT-TSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HH-HcCCChhHCcCHHHHhcChhhccCc
Confidence 55 9999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=359.07 Aligned_cols=244 Identities=32% Similarity=0.605 Sum_probs=204.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..++|+++++||+|+||+||+|++ .+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ...+
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 94 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHS--ERCL 94 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECC--SSCE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEcc--CCEE
Confidence 458899999999999999999998 468999999986432 35688999999999 99999999999975 5678
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-
Q 014307 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~- 282 (427)
++||||+.++.+..+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPV 173 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCC
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCc
Confidence 99999999754443332 489999999999999999999999999999999999999777 8999999999876433
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC--------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------------- 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~-------------- 348 (427)
.......+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+..+.+.+..+...++.
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHCCCChHHhhhhhccch
Confidence 33455688999999999877567999999999999999999999999 566667777777665543
Q ss_pred ----------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 ----------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ----------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+++.+++.+ |+..||..||++.++++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSN-MLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHH-HSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHH-HcCCChhHCCCHHHHhcCcccccC
Confidence 234455555 999999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=361.03 Aligned_cols=244 Identities=22% Similarity=0.390 Sum_probs=207.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||+||+|+++.+++.||+|+++.. ....+.+|+.+|+.+ +||||+++++++.+ ...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEe--CCEE
Confidence 36899999999999999999999999999999999642 345688999999999 99999999999976 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-CC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~~ 282 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCC
Confidence 9999999999987665 3689999999999999999999999999999999999999877 89999999998643 23
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (427)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+....+.... -++.+..++.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 237 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILMEEIRFPRTLSPEAKSLLA 237 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCC-CCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 34556789999999999876 689999999999999999999999994 444444444443321 1345566666
Q ss_pred hccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 357 KYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 357 ~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
+ |+..||..|+ ++++++.|+||....
T Consensus 238 ~-lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 238 G-LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp H-HTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred H-HhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 6 9999999998 899999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=355.26 Aligned_cols=244 Identities=23% Similarity=0.407 Sum_probs=208.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.++|++++.||+|+||+||+|++..+++.||||++.. ...+.+.+|+.+++.+ +||||+++++++.. ....++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999999853 3356788999999999 99999999999986 4568999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cce
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~ 286 (427)
|||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ...
T Consensus 96 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred EECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCcccccC
Confidence 99999999987764 589999999999999999999999999999999999999777 89999999998765443 334
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHHh
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNK 357 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~ 357 (427)
...|++.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+..... ++.+.+++.+
T Consensus 175 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 252 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (297)
T ss_dssp CCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHH
T ss_pred CccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHH
Confidence 5689999999999887 68999999999999999999999999 44555555555444322 2345566666
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..||..||++.+++.|+||+...
T Consensus 253 -~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 253 -CLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp -HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred -HccCChhHCcCHHHHhhChhhcccC
Confidence 9999999999999999999998643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=355.15 Aligned_cols=245 Identities=24% Similarity=0.489 Sum_probs=202.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------------------------HHHHHHHHHHHH
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQ 183 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------------------~~~~~~E~~il~ 183 (427)
.++|++.+.||+|+||.||+|++..+++.||||++.... .+.+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 368999999999999999999999999999999986432 245789999999
Q ss_pred HhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE
Q 014307 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (427)
Q Consensus 184 ~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 261 (427)
++ +||||+++++++.+.....+++||||+.++++..+.. .+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99 9999999999998766778999999999999877653 58999999999999999999999999999999999999
Q ss_pred cCCCCeEEEEeeeeeeeecCCCc-ceeeccCccccccccccCCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014307 262 DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338 (427)
Q Consensus 262 ~~~~~~ikl~DFGla~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~ 338 (427)
+.++ .+||+|||+++....... .....|++.|+|||++.+... ++.++|||||||++|+|++|+.||. +......
T Consensus 171 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~ 248 (298)
T 2zv2_A 171 GEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-DERIMCL 248 (298)
T ss_dssp CTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHH
T ss_pred CCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC-CccHHHH
Confidence 9777 899999999987654332 345689999999999876322 4788999999999999999999994 3333333
Q ss_pred HHHHHHHh--------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 339 LVKIAKVL--------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 339 l~~i~~~~--------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
...+.... -++.+.+++.+ |+..||..||++.+++.||||.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 249 HSKIKSQALEFPDQPDIAEDLKDLITR-MLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHCCCCCCSSSCCCHHHHHHHHH-HTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHhcccCCCCCccccCHHHHHHHHH-HhhcChhhCCCHHHHhcCccccC
Confidence 33333221 12455566666 99999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=373.69 Aligned_cols=246 Identities=32% Similarity=0.540 Sum_probs=208.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC----CCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~----~~~~~~lv 209 (427)
.+|++++.||+|+||.||+|++..+++.||||++.... ....+|+++|+.+ +||||+++++++... +..++++|
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEEee
Confidence 46999999999999999999999999999999986432 3345799999999 999999999998642 23357899
Q ss_pred EeecCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 210 FEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 210 ~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
|||+.++.+... ...+++..++.++.||+.||.|||++||+||||||+|||++.++..+||+|||+++.+....
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~ 211 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC
Confidence 999998644322 24689999999999999999999999999999999999999766589999999999876665
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC---------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------------- 348 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~--------------- 348 (427)
.....++|+.|+|||++.+...|+.++|||||||++|||++|+.|| .+.+..+++.++.+.++.
T Consensus 212 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~ 290 (420)
T 1j1b_A 212 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290 (420)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence 5666789999999999877567999999999999999999999998 667778888888776542
Q ss_pred --------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 --------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 --------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+...+++.+ |+..||..|+++.+++.|+||.+..
T Consensus 291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~~-~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSR-LLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp CCCCCCCCCCHHHHSCTTSCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hccCccCCCCHHHhcCCCCCHHHHHHHHH-hccCChhHCCCHHHHhCCHhhcccc
Confidence 344455555 9999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=357.95 Aligned_cols=244 Identities=30% Similarity=0.601 Sum_probs=194.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|++++.||+|+||.||+|+++.+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.. ...+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEEE
Confidence 46799999999999999999999999999999998643 236788999999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 209 IFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 209 v~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
||||+.+ +|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAF 158 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEET
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccceec
Confidence 9999996 554443 2488999999999999999999999999999999999999777 8999999999876
Q ss_pred cCC-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----------
Q 014307 280 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------- 348 (427)
Q Consensus 280 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~---------- 348 (427)
... .......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+..+.
T Consensus 159 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 433 23445688999999999876567999999999999999999999999 566667777777665432
Q ss_pred ------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 ------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.+ |+..||..||++.+++.||||.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHG-LLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHH-HSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHH-HCCCCcccCCCHHHHhCChhhhccc
Confidence 244555556 9999999999999999999999743
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=360.48 Aligned_cols=245 Identities=22% Similarity=0.354 Sum_probs=209.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|+++.+++.||||+++.. ....+..|..++..+.+||||+++++++.+ ...+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~~ 93 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 93 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCEE
Confidence 47899999999999999999999999999999999643 335678899999987799999999999976 5578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-C
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~ 282 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGD 172 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhcccCC
Confidence 9999999999998776 4699999999999999999999999999999999999999877 899999999986433 2
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (427)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.... -++....++.
T Consensus 173 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (345)
T 1xjd_A 173 AKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV 250 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHhCCCCCCcccCHHHHHHHH
Confidence 33456789999999999987 68999999999999999999999999 4555555555554321 1345556666
Q ss_pred hccCCCChhHHHHHh-HHhcCCchhhHH
Q 014307 357 KYHIELDPHLAALVG-RLVILSYFFQFV 383 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~-~ll~~~~~~~~~ 383 (427)
+ |+..||..|+++. +++.||||....
T Consensus 251 ~-lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 251 K-LFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp H-HSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred H-HhcCCHhHcCCChHHHHcCccccCCC
Confidence 6 9999999999998 999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=375.55 Aligned_cols=279 Identities=29% Similarity=0.488 Sum_probs=198.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC---C
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---S 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---~ 203 (427)
..++|++++.||+|+||+||+|+++.+++.||||++... ..+.+.+|+.+|+.+ +||||+++++++.... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccC
Confidence 357899999999999999999999999999999998642 236688999999999 9999999999986432 3
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..+|+||||+.+ +|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 130 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 130 DELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVD 207 (458)
T ss_dssp CCEEEEECCCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTT
T ss_pred ceEEEEEecccc-chhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhcc
Confidence 578999999865 554443 2489999999999999999999999999999999999999877 89999999998654
Q ss_pred CCC----------------------------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh--------
Q 014307 281 PGK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-------- 324 (427)
Q Consensus 281 ~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-------- 324 (427)
... .....+||+.|+|||++.....|+.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 221 23455889999999987655789999999999999999998
Q ss_pred ---CCCCCCCCCC--------------------CHHHHHHHHHHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 325 ---RKEPFFYGHD--------------------NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 325 ---g~~pf~~~~~--------------------~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
|+.+| ++.+ ..+++..+.+.+|.+....+ .. ......+..+..+......
T Consensus 288 ~~~~~p~f-~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~-~~---~~~~~~~~~~~~~~~~~~~-- 360 (458)
T 3rp9_A 288 HADRGPLF-PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI-EA---LEKEDAKRYIRIFPKREGT-- 360 (458)
T ss_dssp GGGCCCSC-C--------------------CHHHHHHHHHHHHHHCCCCHHHH-HT---SSCHHHHHHHTTSCCCCCC--
T ss_pred cccccccC-CCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHH-hh---cCCHHHHHHHHhcCCCCCC--
Confidence 55444 5443 25777788888877654322 11 1112222222211111100
Q ss_pred HHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 382 FVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 382 ~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
.....+......+.|+|++||. .||++|+|+..+++|||
T Consensus 361 ---~~~~~~~~~s~~~~dLl~~mL~-~dP~~R~t~~e~L~Hp~ 399 (458)
T 3rp9_A 361 ---DLAERFPASSADAIHLLKRMLV-FNPNKRITINECLAHPF 399 (458)
T ss_dssp ---CGGGGSTTSCHHHHHHHHHHSC-SSTTTSCCHHHHHHSGG
T ss_pred ---CHHHHCCCCCHHHHHHHHHHhc-cCccccCCHHHHhcCHh
Confidence 0011122346778889999995 99999999999888887
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=355.75 Aligned_cols=246 Identities=28% Similarity=0.543 Sum_probs=205.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhc--CCCCeeeeeeEEEcCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~--~h~niv~l~~~~~~~~ 202 (427)
.++|+++++||+|+||+||+|++..+++.||||+++... ...+.+|+.+++.+. +||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 578999999999999999999999999999999986422 356778888888773 4999999999998643
Q ss_pred CC---CcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeee
Q 014307 203 SK---TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (427)
Q Consensus 203 ~~---~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFG 274 (427)
.. .++++|||+.+ +|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg 165 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFG 165 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSCS
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeCc
Confidence 22 57899999986 6555442 289999999999999999999999999999999999999777 89999999
Q ss_pred eeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC------
Q 014307 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------ 348 (427)
Q Consensus 275 la~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~------ 348 (427)
+++............||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+.
T Consensus 166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~ 243 (308)
T 3g33_A 166 LARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDW 243 (308)
T ss_dssp CTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChhhc
Confidence 9987765556667789999999999987 67999999999999999999999998 666777777777776542
Q ss_pred ---------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 ---------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ---------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.+ |+..||..||++.++++|+||.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 244 PRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLE-MLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHH-HTCSSTTTSCCHHHHHTSTTC----
T ss_pred cchhhccccccCCCCCCcHHHhCccccHHHHHHHHH-HhcCCCccCCCHHHHhcCccccCCC
Confidence 334455555 9999999999999999999998743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=368.96 Aligned_cols=280 Identities=26% Similarity=0.470 Sum_probs=216.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC---
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~--- 203 (427)
..++|++++.||+|+||.||+|++..+++.||||+++.. ..+.+.+|+.+|+++ +||||+++++++.....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcC
Confidence 357899999999999999999999999999999999642 236788999999999 89999999999876432
Q ss_pred CCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..+++||||+++ +|...+. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTIN 180 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC-
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCccccc
Confidence 568999999886 6655543 489999999999999999999999999999999999999777 89999999998764
Q ss_pred CCC-----------------------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhC----------CC
Q 014307 281 PGK-----------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR----------KE 327 (427)
Q Consensus 281 ~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg----------~~ 327 (427)
... .....+||+.|+|||++.....|+.++|||||||++|||++| +.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 332 235678999999999976657899999999999999999974 44
Q ss_pred CCCCCCC-----------------CHHHHHHHHHHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhh
Q 014307 328 PFFYGHD-----------------NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYY 390 (427)
Q Consensus 328 pf~~~~~-----------------~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~ 390 (427)
|++.+.+ ..+++..+.+.+|.+....+- . ...+..+..+..+.......- ...+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~-----~~~~ 331 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK-N---INKPEVIKYIKLFPHRKPINL-----KQKY 331 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHH-T---CCCHHHHHHHHTSCCCCCCCH-----HHHS
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHH-h---ccCHHHHHHHHhCCCCCCCCH-----HHHC
Confidence 4445543 367888888888877554321 1 123444444333222211110 0112
Q ss_pred hhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 391 YFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 391 ~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
....+.+.++|++||. .||++|+|+..+++|||
T Consensus 332 ~~~s~~~~dLl~~mL~-~dP~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 332 PSISDDGINLLESMLK-FNPNKRITIDQALDHPY 364 (432)
T ss_dssp TTSCHHHHHHHHHHSC-SSTTTSCCHHHHHTCGG
T ss_pred CCCCHHHHHHHHHHhc-CCcccCCCHHHHhcChh
Confidence 2356788899999995 99999999999999997
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=356.20 Aligned_cols=245 Identities=21% Similarity=0.398 Sum_probs=209.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+.+|+.+ +||||+++++++.+ .
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~ 86 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 86 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--C
Confidence 36799999999999999999999999999999998642 246789999999999 99999999999976 5
Q ss_pred CCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC---eEEEEeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE 277 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~ikl~DFGla~ 277 (427)
...++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 57899999999999987764 4899999999999999999999999999999999999986552 69999999998
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
............||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+..+.....
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNT 244 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred ECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCC-CCCCHHHHHHHHHhcCCCcCccccccC
Confidence 8766666667789999999999876 68999999999999999999999999 44455555555543211
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+.+++.+ |+..||..||++.+++.||||....
T Consensus 245 ~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 245 SALAKDFIRR-LLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CHHHHHHHHH-HSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred CHHHHHHHHH-HccCChhhCCCHHHHhcCCCccCCc
Confidence 2344455555 9999999999999999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=351.19 Aligned_cols=240 Identities=32% Similarity=0.642 Sum_probs=199.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|++++.||+|+||+||+|++ .+++.||+|+++... .+.+.+|+.+++.+ +||||+++++++.. ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEcc--CCeEEE
Confidence 5799999999999999999998 678999999986432 36788999999999 99999999999976 457899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-C
Q 014307 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~ 283 (427)
||||+.+ ++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccc
Confidence 9999997 554443 3589999999999999999999999999999999999999777 8999999999765432 2
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC---------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------------- 348 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~--------------- 348 (427)
......+|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+.+..+.+..+.
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 3345678999999999877567999999999999999999999998 566667777777665432
Q ss_pred --------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 349 --------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 349 --------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+.+.+++.+ |+..||..||++.+++.||||++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSK-MLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHH-HTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHH-HcCCCcccCCCHHHHhcCcchhh
Confidence 233455555 99999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=362.20 Aligned_cols=243 Identities=25% Similarity=0.454 Sum_probs=207.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|++.+.||+|+||.||+|.++.+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEEE
Confidence 5799999999999999999999999999999999642 235688999999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~~~~~ 283 (427)
||||+.+++|...+. .+++.++..++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++.......
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~ 185 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE 185 (362)
T ss_dssp EECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence 999999999876653 489999999999999999999999999999999999998643 369999999998776655
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~ 353 (427)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+..... ++.+.+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 263 (362)
T 2bdw_A 186 AWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 263 (362)
T ss_dssp SCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHH
T ss_pred ccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence 5566789999999999876 68999999999999999999999999 44454555555544321 345556
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++.+ |+..||..||++.+++.|||+...
T Consensus 264 li~~-~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 264 LIDS-MLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHH-HSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHH-HcCCChhhCcCHHHHhcCcccCCC
Confidence 6666 999999999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=362.04 Aligned_cols=246 Identities=31% Similarity=0.560 Sum_probs=204.7
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC--
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS-- 203 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~-- 203 (427)
...++|++++.||+|+||.||+|.+..+|+.||||++... ..+.+.+|+.+|+.+ +||||+++++++.....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccc
Confidence 3457899999999999999999999999999999998532 235678999999999 89999999999976422
Q ss_pred --CCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 --KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 --~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
..+++||||+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQA 178 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeeccccc
Confidence 4569999999 67776665 4689999999999999999999999999999999999999777 8999999999875
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-----------
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----------- 348 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~----------- 348 (427)
. ......++|+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+..+.
T Consensus 179 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 179 D--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp C--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred c--cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 4 33455688999999999887668999999999999999999999999 677778888888776553
Q ss_pred --------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 --------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 --------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+...+++.+ |+..||..|+++.+++.||||....
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~-mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK-MLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH-HccCChhHCCCHHHHhcChHHHhhc
Confidence 234445555 9999999999999999999998743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=363.52 Aligned_cols=246 Identities=23% Similarity=0.403 Sum_probs=205.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||+||+|+++.+++.||+|++++.. .+.+.+|..+|.++.+||||+++++++.+ ...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 128 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 128 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCEE
Confidence 468999999999999999999999999999999997532 23478899999988789999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee-cCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~-~~~ 282 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.. ...
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecccCC
Confidence 9999999999987665 4699999999999999999999999999999999999999887 8999999999863 334
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------CCHHHHHHHHHHh-------CC
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------DNYDQLVKIAKVL-------GT 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-------~~~~~l~~i~~~~-------~~ 348 (427)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.... ...+.+.+..... -+
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 286 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 286 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTSC
T ss_pred CccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcCC
Confidence 45566789999999999987 789999999999999999999999994221 1222232222211 13
Q ss_pred hHHHHHHHhccCCCChhHHHH------HhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAAL------VGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~------~~~ll~~~~~~~~~ 383 (427)
+....++.+ |+..||..|++ +.+++.||||....
T Consensus 287 ~~~~~li~~-lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 287 VKAASVLKS-FLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp HHHHHHHHH-HTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred HHHHHHHHH-HhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 455565666 99999999987 58999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=369.58 Aligned_cols=246 Identities=23% Similarity=0.371 Sum_probs=207.8
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|+++++||+|+||+||+|+++.+++.||+|++++.. ...+.+|+.++..+ +||||+++++++.+ ...
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~~ 148 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQD--DNN 148 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--CCE
Confidence 4578999999999999999999999999999999996422 12378899999998 99999999999986 567
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
+++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhccc
Confidence 89999999999998776 3589999999999999999999999999999999999999877 899999999987654
Q ss_pred CCcc--eeeccCcccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------
Q 014307 282 GKEY--NVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------- 346 (427)
Q Consensus 282 ~~~~--~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------- 346 (427)
.... ...+||+.|+|||++. +...|+.++|||||||++|||++|+.|| .+.+..+....+.+..
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~~~~~p~~~ 306 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAESLVETYGKIMNHKERFQFPTQV 306 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCC-CCCChhHHHHhhhhccccccCCccc
Confidence 4332 3468999999999986 2357899999999999999999999999 5556666666665321
Q ss_pred --CChHHHHHHHhccCCCChhH--HHHHhHHhcCCchhhHH
Q 014307 347 --GTDELNAYLNKYHIELDPHL--AALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 --~~~~~~~~l~~~~l~~dp~~--r~~~~~ll~~~~~~~~~ 383 (427)
-++....++.+ |+..+|.- |+++++++.||||....
T Consensus 307 ~~~s~~~~dLi~~-lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 307 TDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp CCSCHHHHHHHHT-TSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ccCCHHHHHHHHH-HhcccccccCCCCHHHHhCCCccCCCC
Confidence 13455566666 77777777 89999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=365.45 Aligned_cols=246 Identities=29% Similarity=0.538 Sum_probs=209.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC-----------
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----------- 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~----------- 201 (427)
.++|++++.||+|+||.||+|++..+++.||||++... .....+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTC-CCTTBCCEEEEEEEC-----------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHc-CCCCccchhheeeecCcccccccccc
Confidence 57899999999999999999999999999999998643 23345799999999 999999999998642
Q ss_pred -------------------------CCCCcEEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 014307 202 -------------------------QSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGI 249 (427)
Q Consensus 202 -------------------------~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~i 249 (427)
...++++||||+.++ |...+ ..+++..++.++.||+.||.|||++||
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 162 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT-LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI 162 (383)
T ss_dssp --------------------------CCEEEEEECCCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCCcc-HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 234588999999964 33222 459999999999999999999999999
Q ss_pred eeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 014307 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329 (427)
Q Consensus 250 iHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf 329 (427)
+||||||+|||++.++..+||+|||+|+............+++.|+|||++.+...++.++|||||||++|||++|+.||
T Consensus 163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 242 (383)
T 3eb0_A 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242 (383)
T ss_dssp ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence 99999999999985444899999999998776666677789999999999887567999999999999999999999998
Q ss_pred CCCCCCHHHHHHHHHHhCCh-----------------------------------HHHHHHHhccCCCChhHHHHHhHHh
Q 014307 330 FYGHDNYDQLVKIAKVLGTD-----------------------------------ELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 330 ~~~~~~~~~l~~i~~~~~~~-----------------------------------~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
.+.+..+++..+.+.++.+ .+.+++.+ |+..||..|+++.+++
T Consensus 243 -~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l 320 (383)
T 3eb0_A 243 -SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ-ILRYEPDLRINPYEAM 320 (383)
T ss_dssp -CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH-HCCSSGGGSCCHHHHH
T ss_pred -CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH-HccCChhhCCCHHHHh
Confidence 6778888888888766542 24455555 9999999999999999
Q ss_pred cCCchhhHH
Q 014307 375 ILSYFFQFV 383 (427)
Q Consensus 375 ~~~~~~~~~ 383 (427)
.||||++..
T Consensus 321 ~hp~f~~~~ 329 (383)
T 3eb0_A 321 AHPFFDHLR 329 (383)
T ss_dssp TSGGGHHHH
T ss_pred cCHHHHHHH
Confidence 999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=363.73 Aligned_cols=245 Identities=26% Similarity=0.467 Sum_probs=197.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----C
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----~ 203 (427)
.++|++++.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence 47899999999999999999999999999999998642 235678999999999 9999999999997543 2
Q ss_pred CCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 204 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
...++||||+.++.+..+...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 103 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF 181 (371)
T ss_dssp CEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC--------
T ss_pred cceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeeccccccccc
Confidence 36799999999866655556799999999999999999999999999999999999999777 89999999998765554
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC---------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------------- 348 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~--------------- 348 (427)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+++..+.+.++.
T Consensus 182 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp --------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred ccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 4566789999999999987 68999999999999999999999999 566666666666554332
Q ss_pred ---------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 ---------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ---------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+.+++.+ |+..||..||++.+++.||||...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSK-MLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHH-HSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHH-HCcCChhhCCCHHHHhCCcchhhh
Confidence 233445555 999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=362.36 Aligned_cols=244 Identities=22% Similarity=0.414 Sum_probs=210.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.++|++++.||+|+||.||+|.++.+++.||+|++... ....+.+|+.+|+.+ +||||+++++++.+ ...+++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEe--CCEEEEE
Confidence 46899999999999999999999999999999998753 345688999999999 99999999999976 5678999
Q ss_pred EeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC-CCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.+++|...+. .+++.+++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||+++.......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999987763 58999999999999999999999999999999999999743 34799999999998776666
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHHH
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNAY 354 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~~ 354 (427)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+.. -++.+.++
T Consensus 207 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 284 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284 (387)
T ss_dssp EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHH
T ss_pred eeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCccccccCCHHHHHH
Confidence 667789999999999876 68999999999999999999999999 4555556666655431 13455566
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+ |+..||..||++.+++.|+||...
T Consensus 285 i~~-~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 285 IKN-LLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp HHT-TSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred HHH-HcCCChhHCcCHHHHhhCccccCC
Confidence 666 999999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=353.85 Aligned_cols=242 Identities=21% Similarity=0.402 Sum_probs=207.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||+||+|+++.+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEe--CCEE
Confidence 36799999999999999999999999999999999643 335678899999998 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC--
Confidence 9999999999988776 3589999999999999999999999999999999999999777 899999999986543
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (427)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.+.. -++.+..++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 236 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 3345689999999999876 68999999999999999999999999 4445555555555431 13456666666
Q ss_pred ccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
|+..||..|+ ++++++.||||....
T Consensus 237 -lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 237 -LITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp -HTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred -HhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 9999999999 899999999998754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=368.69 Aligned_cols=247 Identities=25% Similarity=0.378 Sum_probs=208.1
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
...++|++++.||+|+||+||+|+++.+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~ 142 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--DR 142 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CC
Confidence 34578999999999999999999999999999999996422 23478999999999 99999999999976 56
Q ss_pred CcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 205 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
.+++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeeccC
Confidence 7899999999999987763 589999999999999999999999999999999999999877 8999999999876544
Q ss_pred Cc--ceeeccCccccccccccCCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH---hC-------
Q 014307 283 KE--YNVRVASRYFKGPELLVDLQ---DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---LG------- 347 (427)
Q Consensus 283 ~~--~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~---~~------- 347 (427)
.. ....+||+.|+|||++.+.. .|+.++|||||||++|||++|+.|| .+.+..+....+.+. +.
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~~~~~~~p~~~~~ 300 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKIMNHKNSLTFPDDNDI 300 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTHHHHCCCCTTCCC
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC-CCCChhhHHHHHHhccccccCCCcccc
Confidence 32 23568999999999987632 1789999999999999999999999 455666666666543 11
Q ss_pred ChHHHHHHHhccCCCChhH--HHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHL--AALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~--r~~~~~ll~~~~~~~~~ 383 (427)
++....++.+ |+..+|.. |+++++++.||||+...
T Consensus 301 s~~~~~li~~-lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 301 SKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp CHHHHHHHHH-HSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred cHHHHHHHHH-HccChhhhCCCCCHHHHhcCccccCCC
Confidence 2455566666 78878877 89999999999998743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=358.23 Aligned_cols=245 Identities=21% Similarity=0.312 Sum_probs=208.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||+||+|+++.+++.||||+++.. ..+.+.+|..+|..+.+||||+++++++.+ ...+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 96 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDRL 96 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCEE
Confidence 47899999999999999999999999999999999643 235678899999887789999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-CC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~~ 282 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 97 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccCC
Confidence 9999999999998775 4699999999999999999999999999999999999999877 89999999998643 23
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLN 356 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~ 356 (427)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.+.. -++....++.
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 253 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCC-CCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 34456789999999999876 68999999999999999999999999 4555555555555431 1345556666
Q ss_pred hccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 357 KYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 357 ~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
+ |+..||..|+ .+++++.|+||....
T Consensus 254 ~-lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 254 G-LMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp H-HTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred H-HhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 6 9999999999 689999999998654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=359.08 Aligned_cols=241 Identities=24% Similarity=0.480 Sum_probs=203.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhc----CCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~----~h~niv~l~~~~~~~~~~~ 205 (427)
..++|+++++||+|+||+||+|++..+++.||||+++.. ....+..|+.+++.+. .||||+++++++.. ...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~--~~~ 110 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY--YDH 110 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE--TTE
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE--CCe
Confidence 468999999999999999999999999999999999743 2456788999999994 39999999999987 457
Q ss_pred cEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC-----------------
Q 014307 206 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----------------- 263 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~----------------- 263 (427)
.++||||+ +++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 89999999 777766542 4899999999999999999999999999999999999974
Q ss_pred -------CCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH
Q 014307 264 -------EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336 (427)
Q Consensus 264 -------~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~ 336 (427)
+...+||+|||+|..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~ 265 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLF-RTHEHM 265 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHH
T ss_pred cccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCC-CCCcHH
Confidence 234799999999986432 3345688999999999987 68999999999999999999999999 556666
Q ss_pred HHHHHHHHHhCC----------------------------------------------------hHHHHHHHhccCCCCh
Q 014307 337 DQLVKIAKVLGT----------------------------------------------------DELNAYLNKYHIELDP 364 (427)
Q Consensus 337 ~~l~~i~~~~~~----------------------------------------------------~~~~~~l~~~~l~~dp 364 (427)
+.+..+....+. +.+.+++.+ |+..||
T Consensus 266 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP 344 (360)
T 3llt_A 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS-ILQIDP 344 (360)
T ss_dssp HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH-HCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH-HhcCCh
Confidence 777666665442 223355555 999999
Q ss_pred hHHHHHhHHhcCCchh
Q 014307 365 HLAALVGRLVILSYFF 380 (427)
Q Consensus 365 ~~r~~~~~ll~~~~~~ 380 (427)
..||++.++|.||||+
T Consensus 345 ~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 345 TLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGSCCHHHHTTSGGGC
T ss_pred hhCCCHHHHhcCcccC
Confidence 9999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.81 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=203.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|++++.||+|+||+||+|++..+++.||||+++... .+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CCeEEE
Confidence 478999999999999999999999999999999986432 25588999999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-- 283 (427)
||||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCcc
Confidence 999999999987765 489999999999999999999999999999999999999777 89999999998654332
Q ss_pred -cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------CChHHHHH
Q 014307 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAY 354 (427)
Q Consensus 284 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~~~~~~~~ 354 (427)
......|++.|+|||++.+...++.++|||||||++|+|++|+.||............+.... -.+.+.++
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence 234568999999999998744458899999999999999999999954443333333322211 12455555
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+ |+..||..||++.++++|+||.+.
T Consensus 242 i~~-~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 242 LHK-ILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp HHH-HSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHH-HccCChhhCcCHHHHhhChhhccc
Confidence 666 999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=361.09 Aligned_cols=246 Identities=23% Similarity=0.397 Sum_probs=192.8
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++|++++.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.+ ...+++|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILT--PTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEee--CCEEEEE
Confidence 357899999999999999999999999999999999743 346788999999999 99999999999986 4578999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC-eEEEEeeeeeeeecCCCcc
Q 014307 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~-~ikl~DFGla~~~~~~~~~ 285 (427)
|||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++........
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~ 174 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCC
Confidence 9999999987765 46999999999999999999999999999999999999986552 4999999999865444455
Q ss_pred eeeccCccccccccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCH---HHHHHHHHHh--------CChHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNY---DQLVKIAKVL--------GTDELNA 353 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~-~~~DvwSlGvll~elltg~~pf~~~~~~~---~~l~~i~~~~--------~~~~~~~ 353 (427)
....||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||....... ..+..+.... -++.+..
T Consensus 175 ~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 253 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH 253 (361)
T ss_dssp ------CTTSCHHHHHC-SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHH
T ss_pred CCCcCCCCcCChhhhcC-CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHH
Confidence 66789999999999987 4554 44999999999999999999995433222 2222222211 1345556
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++.+ |+..||..||++.+++.||||.+.
T Consensus 254 li~~-~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 254 LISR-IFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp HHHH-HSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred HHHH-HccCChhHCcCHHHHHhCcchhcC
Confidence 6666 999999999999999999999653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=356.80 Aligned_cols=243 Identities=28% Similarity=0.572 Sum_probs=199.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHH----HHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~----~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|+++++||+|+||+||+|++..+++.||||+++..... .+.+|+.+|+.+ +||||+++++++.. ....++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEee--CCEEEEE
Confidence 5799999999999999999999999999999999754332 345799999999 89999999999976 5668999
Q ss_pred EeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Cc
Q 014307 210 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~ 284 (427)
|||+.+ ++...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~ 156 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKT 156 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCccc
Confidence 999996 444433 3489999999999999999999999999999999999999777 8999999999765432 23
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------- 348 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~---------------- 348 (427)
.....+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.++.
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 345678999999999877567999999999999999999999999 666777888877776553
Q ss_pred --------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 --------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 --------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.+ |+..||..||++.++++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTK-LLQFEGRNRISAEDAMKHPFFLSLG 289 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHH-HSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHH-HcCcCcccCCCHHHHhcChhhhhcc
Confidence 233455555 9999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=357.01 Aligned_cols=246 Identities=30% Similarity=0.487 Sum_probs=207.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC-----
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----- 202 (427)
.++|+++++||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+ +||||+++++++....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence 47899999999999999999999999999999998532 235678999999999 8999999999998643
Q ss_pred -CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
...+++||||+.++.+..+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEE
T ss_pred CCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhccc
Confidence 34689999999975544433 4689999999999999999999999999999999999999777 899999999987
Q ss_pred ecCC-----CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-----
Q 014307 279 YHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----- 348 (427)
Q Consensus 279 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~----- 348 (427)
+... .......||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhh
Confidence 6422 22345678999999999877567899999999999999999999998 566667777777665442
Q ss_pred ---------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 ---------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ---------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+.+++.+ |+..||..|+++.++++||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK-LLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHH-HhcCChhhCCCHHHHhCCCCcCCC
Confidence 234455555 999999999999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=361.76 Aligned_cols=243 Identities=21% Similarity=0.390 Sum_probs=201.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+ +||||+++++++.. ...+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~~~ 84 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITT--PTDI 84 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEE
Confidence 36899999999999999999999999999999998642 235688999999999 99999999999987 4568
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+. +++...+ ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....+.
T Consensus 85 ~lv~E~~~-g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 85 VMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGN 162 (336)
T ss_dssp EEEECCCC-EEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSB
T ss_pred EEEEECCC-CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCc
Confidence 99999994 5554443 4699999999999999999999999999999999999999777 89999999998776666
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH------hCChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~------~~~~~~~~~l~~ 357 (427)
.....+|++.|+|||++.+....+.++|||||||++|+|++|+.||... ...+....+... .-++.+.+++.+
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~-~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 241 (336)
T 3h4j_B 163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE-FIPNLFKKVNSCVYVMPDFLSPGAQSLIRR 241 (336)
T ss_dssp TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS-SSTTCBCCCCSSCCCCCTTSCHHHHHHHHT
T ss_pred ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHcCCCCCcccCCHHHHHHHHH
Confidence 6677889999999999987433478999999999999999999999432 211111111100 113455555555
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
|+..||..||++.++++||||...
T Consensus 242 -~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 242 -MIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -TSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -HcCCChhHCcCHHHHHhChhhccC
Confidence 999999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=358.86 Aligned_cols=244 Identities=24% Similarity=0.395 Sum_probs=204.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|++.+.||+|+||.||+|+++.+++.||||+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~ 99 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS--DG 99 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence 36799999999999999999999999999999998632 356789999999999 99999999999987 56
Q ss_pred CcEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeee
Q 014307 205 TPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGL 275 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGl 275 (427)
.+++||||+.+++|...+. .+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 7899999999999865431 389999999999999999999999999999999999998654 2499999999
Q ss_pred eeeecCCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------
Q 014307 276 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------- 346 (427)
Q Consensus 276 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------- 346 (427)
+........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ..+....+.+..
T Consensus 180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~~~~~~~~ 256 (351)
T 3c0i_A 180 AIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKYKMNPRQW 256 (351)
T ss_dssp CEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCCCCCHHHH
T ss_pred eeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCCCCCcccc
Confidence 987754433 345689999999999876 67999999999999999999999999532 233333333321
Q ss_pred --CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 347 --GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 --~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
-++.+.+++.+ |+..||..||++.+++.||||....
T Consensus 257 ~~~s~~~~~li~~-~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 257 SHISESAKDLVRR-MLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp TTSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred ccCCHHHHHHHHH-HCCCChhHCcCHHHHhcChhhcCCc
Confidence 13345555555 9999999999999999999998754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=367.62 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=206.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||.||+|.++.+++.+|+|++.... .+.+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~~~~ 86 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISE--EGHHY 86 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEEC--SSEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEE--CCEEE
Confidence 367999999999999999999999999999999986432 35688999999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--CCeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~~~ikl~DFGla~~~~~~ 282 (427)
+||||+.+++|...+ ..+++.++..++.||+.||.|||++||+||||||+|||++.+ +..+||+|||++......
T Consensus 87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999999986655 469999999999999999999999999999999999999842 347999999999776543
Q ss_pred C-cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHH
Q 014307 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDEL 351 (427)
Q Consensus 283 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~ 351 (427)
. ......||+.|+|||++.+ ..|+.++|||||||++|+|++|..|| .+.+..+....+.+... ++.+
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 244 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEA 244 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred CceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHhCCCCCCccccccCCHHH
Confidence 3 2355689999999999876 68999999999999999999999999 45555566666655421 3455
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+++.+ |+..||..||++.++|.|||+....
T Consensus 245 ~~li~~-~L~~dP~~Rpta~e~L~hp~~~~~~ 275 (444)
T 3soa_A 245 KDLINK-MLTINPSKRITAAEALKHPWISHRS 275 (444)
T ss_dssp HHHHHH-HSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred HHHHHH-HcCCChhHCCCHHHHhcCccccCCc
Confidence 666666 9999999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=360.70 Aligned_cols=246 Identities=21% Similarity=0.435 Sum_probs=208.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||.||+|++..+++.||+|++... ....+.+|+.+|+.+ +||||+++++++.+ ...+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~~ 90 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQD--EEDM 90 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence 46899999999999999999999999999999998642 235688999999999 99999999999986 4578
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeeccCCC
Confidence 99999999999987763 589999999999999999999999999999999999999777 89999999999877666
Q ss_pred cceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CCHHHHH-HHHHHhC------ChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DNYDQLV-KIAKVLG------TDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~-~~~~~l~-~i~~~~~------~~~~~~ 353 (427)
.....+||+.|+|||++.+ ...|+.++|||||||++|||++|+.||.... .....+. .+..... ++.+..
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~ 249 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVS 249 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHH
Confidence 6777899999999999864 2458999999999999999999999995322 2333332 2222111 245556
Q ss_pred HHHhccCCCChhHHHH-HhHHhcCCchhhHH
Q 014307 354 YLNKYHIELDPHLAAL-VGRLVILSYFFQFV 383 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~-~~~ll~~~~~~~~~ 383 (427)
++.+ |+..||..|++ +++++.||||....
T Consensus 250 li~~-lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 250 LLKK-LLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp HHHH-HSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred HHHH-HhcCCHhHhcccHHHHHcChhhhcCC
Confidence 6666 99999999998 99999999998754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=348.54 Aligned_cols=244 Identities=31% Similarity=0.559 Sum_probs=203.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|+++++||+|+||+||+|++..+++.||||++.... .+.+.+|+.+++++ +||||+++++++.. ....++
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeec--CCeEEE
Confidence 68999999999999999999999999999999885432 35578899999999 89999999999986 567899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Cc
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~ 284 (427)
||||+.++++..+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++...... ..
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCcccc
Confidence 99999999887664 4589999999999999999999999999999999999999777 8999999999876533 23
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------- 348 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~---------------- 348 (427)
.....++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 455688999999999987677899999999999999999999998 666667777666655432
Q ss_pred ---------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 ---------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ---------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.+ |+..||..||++.+++.||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKG-CLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHH-HCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHH-HccCChhhcCCHHHHhcChHHHhcc
Confidence 234455555 9999999999999999999999744
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=358.01 Aligned_cols=277 Identities=25% Similarity=0.473 Sum_probs=205.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC----C
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----Q 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~----~ 202 (427)
..++|++++.||+|+||.||+|.+..+|+.||||++... ..+.+.+|+.+|+.+ +||||+++++++... .
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcccc
Confidence 347899999999999999999999999999999998642 245678999999999 899999999999753 2
Q ss_pred CCCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 203 SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
....++++|++ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTA 183 (367)
T ss_dssp CCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC--------
T ss_pred CCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeecccccccc
Confidence 35679999999 56766655 3699999999999999999999999999999999999999777 89999999998653
Q ss_pred CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccC
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l 360 (427)
. .....+||+.|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+++..+.+.+|.+.... +..
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~-~~~--- 256 (367)
T 2fst_X 184 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL-LKK--- 256 (367)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHH-HTT---
T ss_pred c--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHH-HHH---
Confidence 2 3455689999999999887568999999999999999999999999 77788899999999888764321 111
Q ss_pred CCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 361 ELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
......+..+..+...+...- ..........+.|+|++||. .||++|+|+..++.|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~dLl~~mL~-~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 257 ISSESARNYIQSLTQMPKMNF-----ANVFIGANPLAVDLLEKMLV-LDSDKRITAAQALAHAY 314 (367)
T ss_dssp CCCHHHHHHHHTSCCCCCCCH-----HHHTTTCCHHHHHHHHHHSC-SSGGGSCCHHHHHTSGG
T ss_pred hhhHHHHHHHhccCCCCCCCH-----HHHCCCCCHHHHHHHHHhCC-CCcccCcCHHHHhcChh
Confidence 123333444333332221110 00112346778899999995 99999999999988887
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=351.74 Aligned_cols=246 Identities=24% Similarity=0.402 Sum_probs=204.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||.||+|+++.+++.||+|+++... .+.+.+|+.+++++.+||||+++++++.+ ...+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~~ 85 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRL 85 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCEE
Confidence 367999999999999999999999999999999997431 34578899999987789999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-CC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~~ 282 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... ..
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCCC
Confidence 9999999999987665 4699999999999999999999999999999999999999777 89999999998533 33
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------CCHHHHH-HHHHHh------CC
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------DNYDQLV-KIAKVL------GT 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-------~~~~~l~-~i~~~~------~~ 348 (427)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.+. .+.... -+
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s 243 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLS 243 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTSC
T ss_pred CcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCCC
Confidence 34556789999999999887 689999999999999999999999995321 1222222 222211 13
Q ss_pred hHHHHHHHhccCCCChhHHHH------HhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAAL------VGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~------~~~ll~~~~~~~~~ 383 (427)
+....++.+ |+..||..|++ +.+++.||||....
T Consensus 244 ~~~~~li~~-lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 244 VKAASVLKS-FLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp HHHHHHHHH-HTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred HHHHHHHHH-HhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 455565555 99999999998 48999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=356.68 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=190.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ..+.+.+|+.+|+++ +||||+++++++.+ ....++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFET--PTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEec--CCeEEEEEE
Confidence 46799999999999999999999999999999999754 345688999999999 99999999999976 456899999
Q ss_pred ecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC--CCCeEEEEeeeeeeeecCCCcce
Q 014307 212 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYN 286 (427)
Q Consensus 212 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~~ikl~DFGla~~~~~~~~~~ 286 (427)
|+.+++|...+. .+++.+++.++.||+.||.|||++||+||||||+|||++. +...+||+|||+++.........
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 999999877653 4899999999999999999999999999999999999974 23389999999998765554455
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHHHHH
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYLN 356 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l~ 356 (427)
...|++.|+|||++.+ ..++.++|||||||++|||++|+.||.........+..+.+... ++.+.+++.
T Consensus 209 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp ----CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred cccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence 6789999999999887 67999999999999999999999999654443334444443211 234555555
Q ss_pred hccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 357 KYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+ |+..||..||++.+++.||||....
T Consensus 288 ~-~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 288 K-LIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp T-TSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred H-HccCChhhCcCHHHHhcCcccCCCc
Confidence 5 9999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=369.37 Aligned_cols=244 Identities=24% Similarity=0.412 Sum_probs=211.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|.+++.||+|+||.||+|++..+|+.||||+++... ...+.+|+.+|+.+ +||||+++++++.. ...+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~--~~~~ 91 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVIST--PSDI 91 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEE
Confidence 368999999999999999999999999999999996432 35688999999999 99999999999976 4578
Q ss_pred EEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCTTC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccccc
Confidence 99999999999987764 589999999999999999999999999999999999999777 89999999999876666
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (427)
.....+|++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+....+.+.. -++.+..++.+
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~ 249 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPTLFKKICDGIFYTPQYLNPSVISLLKH 249 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSS-CCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCC-CCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHH
Confidence 6667789999999999987434578999999999999999999999 4555556666555432 13456666666
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
|+..||..||++.+++.||||.+.
T Consensus 250 -~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 250 -MLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -HTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -HcCCCchhCcCHHHHHhCHHhhhc
Confidence 999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=361.09 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=206.6
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
...++|++++.||+|+||+||+|+++.+++.||||++++.. .+.+.+|..++..+ +||||+++++++.+ ..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~ 134 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQD--EN 134 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SS
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEee--CC
Confidence 34578999999999999999999999999999999996422 23478899999998 99999999999976 56
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
.+++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLR 213 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheecc
Confidence 789999999999998775 3699999999999999999999999999999999999999877 89999999998775
Q ss_pred CCCcc--eeeccCccccccccccC------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH---h---
Q 014307 281 PGKEY--NVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV---L--- 346 (427)
Q Consensus 281 ~~~~~--~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~---~--- 346 (427)
..... ...+||+.|+|||++.. ...|+.++|||||||++|||++|+.|| .+.+..+...++.+. +
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~~~p 292 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF-YADSTAETYGKIVHYKEHLSLP 292 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTHHHHCCCC
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC-CCCCHHHHHHHHHhcccCcCCC
Confidence 54432 34589999999999862 246899999999999999999999999 455555655555432 1
Q ss_pred -----CChHHHHHHHhccCCCChhHH---HHHhHHhcCCchhhHH
Q 014307 347 -----GTDELNAYLNKYHIELDPHLA---ALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 -----~~~~~~~~l~~~~l~~dp~~r---~~~~~ll~~~~~~~~~ 383 (427)
-++....++.+ |+. +|..| +++++++.||||....
T Consensus 293 ~~~~~~s~~~~dli~~-lL~-~p~~Rlgr~~~~ei~~Hpff~~i~ 335 (412)
T 2vd5_A 293 LVDEGVPEEARDFIQR-LLC-PPETRLGRGGAGDFRTHPFFFGLD 335 (412)
T ss_dssp ----CCCHHHHHHHHT-TSS-CGGGCTTTTTHHHHHTSGGGTTCC
T ss_pred ccccCCCHHHHHHHHH-HcC-ChhhcCCCCCHHHHhcCCCcCCCC
Confidence 13455556666 888 99988 5899999999998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=353.88 Aligned_cols=244 Identities=30% Similarity=0.592 Sum_probs=199.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|+++++||+|+||+||+|++..+++.||||+++... .+.+.+|+.+++++ +||||+++++++.+ ...++
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 109 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHH--NHRLH 109 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEE--TTEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEec--CCEEE
Confidence 368999999999999999999999999999999996432 24567899999999 99999999999986 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC----CeEEEEeeeeeeeec
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEFYH 280 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~----~~ikl~DFGla~~~~ 280 (427)
+||||+.+ +|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++...
T Consensus 110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99999996 555444 3589999999999999999999999999999999999995332 269999999997654
Q ss_pred CC-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------------
Q 014307 281 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (427)
Q Consensus 281 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------------ 347 (427)
.. .......++..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+.+..+.+..+
T Consensus 189 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (329)
T 3gbz_A 189 IPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267 (329)
T ss_dssp -----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence 32 33455678999999999987566899999999999999999999998 56677777777766543
Q ss_pred ------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 348 ------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 348 ------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
.+.+.+++.+ |+..||..||++.++++||||...
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTA-MLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHH-HTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhccccHhhhcccccCHHHHHHHHH-HccCChhhCCCHHHHhCCcccCCC
Confidence 2344455656 999999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=362.19 Aligned_cols=246 Identities=30% Similarity=0.533 Sum_probs=206.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----CCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----~~~~~l 208 (427)
..+|++++.||+|+||.||+|++..+++ +|+|.+... .....+|+.+|+.+ +||||+++++++.... ..++++
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~-~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-KRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC-cchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCceEEEE
Confidence 3579999999999999999999876666 777776432 22334799999999 9999999999987532 234789
Q ss_pred EEeecCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 209 IFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 209 v~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
||||+.++.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.+...+||+|||+|+.....
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 9999998765433 2469999999999999999999999999999999999999943448999999999987666
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC--------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------------- 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~-------------- 348 (427)
.......+++.|+|||++.+...|+.++|||||||++|||++|+.|| .+.+..+++..+.+.++.
T Consensus 196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 196 EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 66667789999999999877567999999999999999999999999 677778888888876543
Q ss_pred ---------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 ---------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ---------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.+ |+..||..|+++.+++.||||++..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISR-LLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHH-HCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHH-HhCCChhhCCCHHHHhcChhhhhhc
Confidence 344455556 9999999999999999999998754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=361.32 Aligned_cols=245 Identities=23% Similarity=0.409 Sum_probs=195.0
Q ss_pred CCEEEE-eeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEc--CCCCCcEEEE
Q 014307 134 DDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~--~~~~~~~lv~ 210 (427)
++|.+. +.||+|+||+||+|+++.+++.||||+++. ...+.+|+.++.++.+||||+++++++.. .+...+++||
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~ 138 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEE
Confidence 568776 789999999999999999999999999974 35678899998777699999999999864 2345689999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--CCeEEEEeeeeeeeecCCC
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~~~ikl~DFGla~~~~~~~ 283 (427)
||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||+++......
T Consensus 139 E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp ECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred EeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999999977763 38999999999999999999999999999999999999862 3389999999998776555
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH---HHHHHHHHHh----------CChH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---DQLVKIAKVL----------GTDE 350 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~---~~l~~i~~~~----------~~~~ 350 (427)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... .....+.... -++.
T Consensus 219 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 297 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 297 (400)
T ss_dssp --------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred ccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHH
Confidence 5667789999999999876 789999999999999999999999995432211 1222222211 1234
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+..++.+ |+..||..||++.+++.|+||...
T Consensus 298 ~~~li~~-~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 298 VKMLIRN-LLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HHHHHHT-TSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHH-HCCCChhHCcCHHHHhcCccccCC
Confidence 5555555 999999999999999999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=344.71 Aligned_cols=242 Identities=23% Similarity=0.416 Sum_probs=197.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|.+.++||+|+||.||+|.+..++..+|+|++... ..+.+.+|+++|+++ +||||+++++++.+ ....++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 97 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED--YHNMYI 97 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheec--CCeEEE
Confidence 46799999999999999999999999999999998643 347789999999999 99999999999976 556899
Q ss_pred EEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--CCeEEEEeeeeeeee
Q 014307 209 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFY 279 (427)
Q Consensus 209 v~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~~~ikl~DFGla~~~ 279 (427)
||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+ ...+||+|||++...
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999987665 469999999999999999999999999999999999999532 237999999999877
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChH
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDE 350 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~ 350 (427)
..........+++.|+|||++. ..++.++|||||||++|+|++|+.||. +.+..+....+.... .++.
T Consensus 178 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (285)
T 3is5_A 178 KSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEVQQKATYKEPNYAVECRPLTPQ 254 (285)
T ss_dssp ---------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCC--CCCCHH
T ss_pred CCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCC-CCCHHHHHhhhccCCcccccccCcCCHH
Confidence 6655566678999999999975 478999999999999999999999994 433333333222211 1345
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+.+++.+ |+..||..||++.+++.||||++
T Consensus 255 ~~~li~~-~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 255 AVDLLKQ-MLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHHHH-HTCSCTTTSCCHHHHHTSGGGGC
T ss_pred HHHHHHH-HccCChhhCcCHHHHhcCHHhhc
Confidence 6666666 99999999999999999999985
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=353.44 Aligned_cols=242 Identities=21% Similarity=0.362 Sum_probs=208.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||.||+|+++.+++.||||+++.. ..+.+.+|+.+|+.+ +||||+++++++.+ ...+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 116 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CCEE
Confidence 46899999999999999999999999999999998643 235688999999999 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~-- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS--
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccC--
Confidence 9999999999987775 4699999999999999999999999999999999999999777 899999999987643
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (427)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+....+.+.. -++.+..++.+
T Consensus 194 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 271 (350)
T 1rdq_E 194 RTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp CBCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred CcccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 2345689999999999887 68999999999999999999999999 4445555555555431 13455566666
Q ss_pred ccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
|+..||..|+. +++++.|+||....
T Consensus 272 -lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 272 -LLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp -HSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred -HhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 99999999998 99999999998754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=359.33 Aligned_cols=246 Identities=20% Similarity=0.246 Sum_probs=202.0
Q ss_pred CCCCEEEEeeeeec--CCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..++|+++++||+| +||.||+|+++.+++.||||+++... .+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~ 99 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIA--DN 99 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TT
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEE--CC
Confidence 35789999999999 99999999999999999999996432 35678899999999 99999999999986 56
Q ss_pred CcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
.+++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||.+...
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~~~ 178 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCEEC
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccceee
Confidence 789999999999987765 4589999999999999999999999999999999999999777 8999999998654
Q ss_pred cCCC--------cceeeccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-----
Q 014307 280 HPGK--------EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----- 345 (427)
Q Consensus 280 ~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~----- 345 (427)
.... ......|+..|+|||++.+. ..++.++|||||||++|||++|+.||.. .+..+.+..+...
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~-~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD-MPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT-CCSTTHHHHC--------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhcCCCCcc
Confidence 3221 11234788899999998763 4789999999999999999999999943 3333333221110
Q ss_pred -----------------------------------------------hCChHHHHHHHhccCCCChhHHHHHhHHhcCCc
Q 014307 346 -----------------------------------------------LGTDELNAYLNKYHIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 346 -----------------------------------------------~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~ 378 (427)
.-++.+.+++.+ |+..||..||++.+++.|||
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~-~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ-CLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHH-HTCSCTTTSCCHHHHTTSGG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHH-HhhcCcccCCCHHHHhcCHH
Confidence 012345556666 99999999999999999999
Q ss_pred hhhHH
Q 014307 379 FFQFV 383 (427)
Q Consensus 379 ~~~~~ 383 (427)
|++..
T Consensus 337 f~~~~ 341 (389)
T 3gni_B 337 FKQIK 341 (389)
T ss_dssp GGGC-
T ss_pred HHHHh
Confidence 99754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=357.78 Aligned_cols=242 Identities=20% Similarity=0.388 Sum_probs=202.2
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
+...+.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+|+++ +||||+++++++.+ ...+++||||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~lv~E~ 167 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFES--KNDIVLVMEY 167 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEEEEEC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEEeC
Confidence 34467899999999999999999999999999763 346788999999999 99999999999986 4568999999
Q ss_pred cCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC-CCCeEEEEeeeeeeeecCCCccee
Q 014307 213 VNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGKEYNV 287 (427)
Q Consensus 213 ~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~ikl~DFGla~~~~~~~~~~~ 287 (427)
+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++. +...+||+|||+++..........
T Consensus 168 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~ 247 (373)
T 2x4f_A 168 VDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247 (373)
T ss_dssp CTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence 9999886554 24899999999999999999999999999999999999942 334899999999998876666667
Q ss_pred eccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHHHHHh
Q 014307 288 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYLNK 357 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l~~ 357 (427)
..||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.++.+.+..+.+... ++.+.+++.+
T Consensus 248 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 325 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPF-LGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325 (373)
T ss_dssp CCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred ccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence 789999999999876 68999999999999999999999999 55566666666665321 3455566666
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..||..||++.+++.||||.+..
T Consensus 326 -~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 326 -LLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp -TSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred -HcCCChhhCCCHHHHhcCcCcCCCc
Confidence 9999999999999999999999855
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=348.66 Aligned_cols=244 Identities=25% Similarity=0.412 Sum_probs=198.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
.++|++++.||+|+||.||+|++. .+++.||+|+++.. ....+.+|+.+|+.+ +||||+++++++..
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT-- 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC--
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc--
Confidence 468999999999999999999985 68999999998753 224577899999999 99999999999976
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
...+++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKES 171 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC---
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCccccc
Confidence 56789999999999987765 3589999999999999999999999999999999999999777 8999999999754
Q ss_pred cCC-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHH
Q 014307 280 HPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELN 352 (427)
Q Consensus 280 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~ 352 (427)
... ......+|++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+... .+.+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 172 IHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPF-TGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp -------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred ccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 322 22345679999999999876 68999999999999999999999999 45555555555554321 34555
Q ss_pred HHHHhccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 353 AYLNKYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
+++.+ |+..||..|+ ++.+++.||||....
T Consensus 250 ~li~~-~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 250 DLLKK-LLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp HHHHH-HSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred HHHHH-HHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 66666 9999999999 899999999998644
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=362.07 Aligned_cols=243 Identities=25% Similarity=0.495 Sum_probs=204.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhc-----CCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~-----~h~niv~l~~~~~~~~~~~ 205 (427)
..+|++++.||+|+||+||+|++..+++.||||+++... ...+.+|+.+++.+. +|+||+++++++.. ...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CCe
Confidence 468999999999999999999999999999999997643 356788999999883 56799999999986 467
Q ss_pred cEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC-eEEEEeeeeeeee
Q 014307 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFY 279 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~-~ikl~DFGla~~~ 279 (427)
+++||||+.+ ++..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|...
T Consensus 174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 8999999986 444333 24899999999999999999999999999999999999997762 2999999999764
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-----------
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----------- 348 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~----------- 348 (427)
. ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.++.+++..+.+.++.
T Consensus 253 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p~~~~~~~~~~ 328 (429)
T 3kvw_A 253 H--QRVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMPSQKLLDASKR 328 (429)
T ss_dssp T--CCCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTBTT
T ss_pred C--CcccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHhhhh
Confidence 3 33445689999999999987 68999999999999999999999988 677778888877776543
Q ss_pred ------------------------------------------------------hHHHHHHHhccCCCChhHHHHHhHHh
Q 014307 349 ------------------------------------------------------DELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 349 ------------------------------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
+.+.+++.+ |+..||..||++.++|
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~-~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 329 AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ-CLEWDPAVRMTPGQAL 407 (429)
T ss_dssp HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHH-HTCSSTTTSCCHHHHH
T ss_pred hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHH-HCCCChhhCCCHHHHh
Confidence 223455665 9999999999999999
Q ss_pred cCCchhhHH
Q 014307 375 ILSYFFQFV 383 (427)
Q Consensus 375 ~~~~~~~~~ 383 (427)
+||||++..
T Consensus 408 ~Hpw~~~~~ 416 (429)
T 3kvw_A 408 RHPWLRRRL 416 (429)
T ss_dssp TSTTTC---
T ss_pred CChhhccCC
Confidence 999999854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=355.49 Aligned_cols=249 Identities=30% Similarity=0.557 Sum_probs=205.2
Q ss_pred ccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 129 QWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 129 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.+...++|.+.+.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 37 ~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 37 AWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSS
T ss_pred eecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCC
Confidence 334568999999999999999999999999999999998642 235678999999999 89999999999976432
Q ss_pred C----CcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 K----TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~----~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
. ..++||||+.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 116 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHA 194 (371)
T ss_dssp STTCCCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC---
T ss_pred cccceeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCccccc
Confidence 2 2489999999644444445699999999999999999999999999999999999999777 8999999999865
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------------
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------------ 347 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------------ 347 (427)
. .......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+
T Consensus 195 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 195 D--AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred c--cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 3 23445678999999999887668999999999999999999999999 56666777777665443
Q ss_pred -------------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 -------------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 -------------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+.+.+++.+ |+..||..||++.+++.||||....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK-MLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHH-HSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHH-HCCCChhhcCCHHHHhcCcccccCC
Confidence 2345555655 9999999999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=346.91 Aligned_cols=242 Identities=19% Similarity=0.362 Sum_probs=206.3
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.|+..+.||+|+||.||+|++..+|+.||||+++. ...+.+.+|+.+++.+ +||||+++++++.. ....++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLV--GEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEEe
Confidence 48888999999999999999988999999999864 2346788999999999 99999999999987 456899999
Q ss_pred ecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cceee
Q 014307 212 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR 288 (427)
Q Consensus 212 ~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~~~ 288 (427)
|+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... .....
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCccccccc
Confidence 999999988765 589999999999999999999999999999999999999777 89999999998765432 33456
Q ss_pred ccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHHhcc
Q 014307 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNKYH 359 (427)
Q Consensus 289 ~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~~~ 359 (427)
.||+.|+|||++.+ ..++.++|||||||++|||++|+.||. +.+..+.+..+..... ++.+.+++.+ |
T Consensus 202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~ 278 (321)
T 2c30_A 202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYF-SDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER-M 278 (321)
T ss_dssp CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH-H
T ss_pred cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH-H
Confidence 89999999999876 689999999999999999999999994 4444555554444321 2345566666 9
Q ss_pred CCCChhHHHHHhHHhcCCchhhHH
Q 014307 360 IELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 360 l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+..||..||++.+++.||||.+..
T Consensus 279 l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 279 LVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ccCChhhCcCHHHHhcChhhccCC
Confidence 999999999999999999998743
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=350.45 Aligned_cols=244 Identities=21% Similarity=0.336 Sum_probs=204.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+|+++ +||||+++++++........+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceEE
Confidence 357899999999999999999999999999999998742 346678999999999 899999999999887667889
Q ss_pred EEEeecCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE----cCCCCeEEEEeeeeee
Q 014307 208 LIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGLAE 277 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~~ikl~DFGla~ 277 (427)
+||||+.+++|..++.. +++..++.++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||+++
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~a~ 164 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAAR 164 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECCCTTCE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEccCCCce
Confidence 99999999999877643 8999999999999999999999999999999999998 5444 79999999999
Q ss_pred eecCCCcceeeccCccccccccccC-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---CCHHHHHHHHHHhC
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH---DNYDQLVKIAKVLG 347 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwSlGvll~elltg~~pf~~~~---~~~~~l~~i~~~~~ 347 (427)
............|++.|+|||++.. ...++.++|||||||++|||++|+.||.... ...+.+..+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p 244 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence 8776666667789999999999852 2678999999999999999999999995332 23444555444321
Q ss_pred C-------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCc
Q 014307 348 T-------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 348 ~-------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~ 378 (427)
. +.+..++.+ |+..||..|+++++++.|+-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~-~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN-ILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHH-HSCCCTTTSCCHHHHHHHHH
T ss_pred cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHH-hccCChhhhccHHHhhhccH
Confidence 0 133344444 99999999999999998875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=339.00 Aligned_cols=245 Identities=25% Similarity=0.453 Sum_probs=208.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.. ....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 81 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFHY 81 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEc--CCEEE
Confidence 578999999999999999999999999999999986432 35678999999999 99999999999976 55678
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~~~~ 282 (427)
+||||+.++++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++......
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 999999999886554 4589999999999999999999999999999999999998654 24999999999877666
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELN 352 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~ 352 (427)
.......|++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+..... ++.+.
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 3kk8_A 162 EAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 239 (284)
T ss_dssp CBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred ccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCC-CCCchhHHHHHHHhccccCCchhhcccCHHHH
Confidence 65666789999999999877 67999999999999999999999999 44454555555544321 34555
Q ss_pred HHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 353 AYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+++.. |+..||..||++.++++|+||....
T Consensus 240 ~li~~-~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 240 SLIDS-MLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp HHHHH-HSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred HHHHH-HcccChhhCCCHHHHhcCccccCCh
Confidence 66666 9999999999999999999998743
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=369.18 Aligned_cols=247 Identities=21% Similarity=0.353 Sum_probs=210.1
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
...++|++.+.||+|+||.||+|+++.+|+.||||+++.. ....+.+|+.+|+.+ +||||+++++++.+ ..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEee--CC
Confidence 3467899999999999999999999999999999998642 235578999999999 99999999999976 56
Q ss_pred CcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 205 TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
.+++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~ 336 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHV 336 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceec
Confidence 7899999999999976652 389999999999999999999999999999999999999777 8999999999987
Q ss_pred cCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHHhC-------ChH
Q 014307 280 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLG-------TDE 350 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--~~~~l~~i~~~~~-------~~~ 350 (427)
.........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... ..+.+........ ++.
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 66666667799999999999887 6799999999999999999999999954322 3344433332221 345
Q ss_pred HHHHHHhccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 351 LNAYLNKYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
...++.+ |+..||..|+ ++.+++.||||....
T Consensus 416 ~~dLI~~-lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 416 ARSLCSQ-LLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp HHHHHHH-HTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred HHHHHHH-hccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 5566666 9999999999 999999999998744
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=338.78 Aligned_cols=243 Identities=24% Similarity=0.437 Sum_probs=208.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.++|++.+.||+|+||.||+|.+..++..+|+|++.. ...+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFED--NTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCeEEEE
Confidence 3679999999999999999999999999999999864 3457789999999999 99999999999976 5668999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE---cCCCCeEEEEeeeeeeeecCCC
Q 014307 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~ikl~DFGla~~~~~~~ 283 (427)
|||+.+++|...+ ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++ .+||+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-cEEEEecccceeccCcc
Confidence 9999999986654 458999999999999999999999999999999999999 5444 89999999998877666
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------CChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------GTDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~~~~~~~ 353 (427)
......+++.|+|||++.+ .++.++|||||||++|+|++|+.|| ......+....+.+.. -++.+.+
T Consensus 164 ~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPF-SAPTDSEVMLKIREGTFTFPEKDWLNVSPQAES 240 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHH
T ss_pred chhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHH
Confidence 6677789999999999865 5899999999999999999999999 4455555555554432 1344555
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+ |+..||..||++.+++.|+||++..
T Consensus 241 li~~-~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 241 LIRR-LLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHH-HTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred HHHH-HccCChhhCcCHHHHhcCHHHhccc
Confidence 5555 9999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=349.26 Aligned_cols=246 Identities=30% Similarity=0.546 Sum_probs=204.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..++|++++.||+|+||.||+|++..+++.||||++.... .+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~ 99 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKK--KKRW 99 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeec--CCEE
Confidence 4578999999999999999999999999999999985422 34577899999999 89999999999986 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~- 282 (427)
++||||+.++++..+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC-------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceeecCCc
Confidence 9999999999887663 4689999999999999999999999999999999999999777 8999999999765433
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------------- 347 (427)
.......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.++.+.+..+....+
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 23455678999999999887557899999999999999999999998 55666666666655433
Q ss_pred ----------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+.+++.+ |+..||..||++.++++||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKK-CLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHH-HTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHH-HhccCcccCCCHHHHhcCchhccCC
Confidence 2345555555 9999999999999999999998743
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=362.01 Aligned_cols=246 Identities=22% Similarity=0.377 Sum_probs=195.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
.++|.+.+.||+|+||+||+|.+..+++.||||++.... ...+.+|+.+|+++ +||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec-
Confidence 478999999999999999999999999999999986432 12378999999999 99999999999864
Q ss_pred CCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeee
Q 014307 202 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLA 276 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla 276 (427)
...++||||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||++
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 3478999999999997765 3589999999999999999999999999999999999997543 25999999999
Q ss_pred eeecCCCcceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------
Q 014307 277 EFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------- 346 (427)
Q Consensus 277 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------- 346 (427)
+...........+||+.|+|||++.+ ...++.++|||||||++|+|++|+.||............+....
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 87765555566789999999999853 35788999999999999999999999954333322222222211
Q ss_pred --CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 347 --GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 --~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
-++.+.+++.+ |+..||..||++.+++.||||++..
T Consensus 370 ~~~~~~~~~li~~-~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 370 AEVSEKALDLVKK-LLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp TTSCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred cccCHHHHHHHHH-HccCChhHCcCHHHHhCCcccCChh
Confidence 13455555655 9999999999999999999998755
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=367.75 Aligned_cols=244 Identities=25% Similarity=0.474 Sum_probs=208.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----------------cHHHHHHHHHHHHHhcCCCCeeeeee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------------KKKKIKREIKILQNLCGGPNIVKLLD 196 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----------------~~~~~~~E~~il~~l~~h~niv~l~~ 196 (427)
.++|+++++||+|+||+||+|+++.+++.||||+++.. ..+.+.+|+.+|+++ +||||+++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~ 113 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIKLFD 113 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCCEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCeEEE
Confidence 47899999999999999999999999999999998642 235688999999999 9999999999
Q ss_pred EEEcCCCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC--eEEEE
Q 014307 197 IVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLI 271 (427)
Q Consensus 197 ~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--~ikl~ 271 (427)
++.+ ...+++||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+
T Consensus 114 ~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 114 VFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 9976 56789999999999986655 46999999999999999999999999999999999999987653 69999
Q ss_pred eeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----
Q 014307 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---- 347 (427)
Q Consensus 272 DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---- 347 (427)
|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.|| .+.+..+.+..+.+...
T Consensus 192 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 268 (504)
T 3q5i_A 192 DFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPF-GGQNDQDIIKKVEKGKYYFDF 268 (504)
T ss_dssp CCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCH
T ss_pred ECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCc
Confidence 9999998877666677889999999999764 6999999999999999999999999 55566666666655321
Q ss_pred ------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+.+++.. |+..||..||++.+++.|||+++..
T Consensus 269 ~~~~~~s~~~~~li~~-~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 269 NDWKNISDEAKELIKL-MLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHTTSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred cccCCCCHHHHHHHHH-HcCCChhHCCCHHHHhcCHhhhhch
Confidence 3445555555 9999999999999999999998743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=347.45 Aligned_cols=244 Identities=22% Similarity=0.410 Sum_probs=208.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 87 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN--R 87 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec--C
Confidence 36799999999999999999999999999999998642 256789999999999 89999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC---eEEEEeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE 277 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~ikl~DFGla~ 277 (427)
...++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 67899999999999987763 4889999999999999999999999999999999999986653 69999999998
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------C
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~ 347 (427)
............|++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+..+.+.. -
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (321)
T 2a2a_A 168 EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANITSVSYDFDEEFFSHT 245 (321)
T ss_dssp ECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHhcccccChhhhccc
Confidence 8766655666789999999999876 68999999999999999999999999 4445555555544322 1
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++.+.+++.+ |+..||..||++.+++.||||...
T Consensus 246 ~~~~~~li~~-~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 246 SELAKDFIRK-LLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CHHHHHHHHT-TSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred CHHHHHHHHH-HcCCChhhCcCHHHHhcCccccCC
Confidence 2344455555 999999999999999999999753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=346.92 Aligned_cols=245 Identities=21% Similarity=0.380 Sum_probs=204.0
Q ss_pred CCCEEEE-eeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|.+. +.||+|+||.||+|++..+++.||+|+++.. ....+.+|+.+++.+.+||||+++++++.+ ...+
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~~~~ 104 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--TSEI 104 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--CCeE
Confidence 3568887 8999999999999999999999999998642 246789999999999778999999999976 5668
Q ss_pred EEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC---CCCeEEEEeeeeeee
Q 014307 207 SLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEF 278 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~---~~~~ikl~DFGla~~ 278 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++. ++ .+||+|||+++.
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~-~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG-DIKIVDFGMSRK 183 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC-CEEECCGGGCEE
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC-cEEEeeCccccc
Confidence 9999999999988776 35899999999999999999999999999999999999986 44 899999999988
Q ss_pred ecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------C
Q 014307 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------T 348 (427)
Q Consensus 279 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~ 348 (427)
...........|++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+.+... .
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 261 (327)
T 3lm5_A 184 IGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPF-VGEDNQETYLNISQVNVDYSEETFSSVS 261 (327)
T ss_dssp C---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred cCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCchHHHHHHHhcccccCchhhcccC
Confidence 765555566789999999999876 68999999999999999999999999 45555555555554321 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.. |+..||..||++.+++.|+||+...
T Consensus 262 ~~~~~li~~-~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 262 QLATDFIQS-LLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp HHHHHHHHH-HSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred HHHHHHHHH-HcCCChhhCcCHHHHhCCHhhcccc
Confidence 345555555 9999999999999999999998744
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=354.91 Aligned_cols=245 Identities=27% Similarity=0.461 Sum_probs=202.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
.++|++.+.||+|+||.||+|+++.+++.||||+++... ....+|++++.++.+||||+++++++.+ ...+++||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEEeC
Confidence 367999999999999999999999999999999997543 2356799999998789999999999976 5678999999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC---eEEEEeeeeeeeecCCC-cc
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGK-EY 285 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~ikl~DFGla~~~~~~~-~~ 285 (427)
+.+++|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||+..+.. .+||+|||+++...... ..
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 177 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence 9999987665 35899999999999999999999999999999999999854432 49999999998765433 34
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-CC-HHHHHHHHHHh----------CChHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DN-YDQLVKIAKVL----------GTDELNA 353 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-~~-~~~l~~i~~~~----------~~~~~~~ 353 (427)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.... +. .+.+..+.... -++.+.+
T Consensus 178 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 256 (342)
T 2qr7_A 178 MTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKD 256 (342)
T ss_dssp CCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHH
T ss_pred eccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHH
Confidence 55688999999999876 568999999999999999999999995432 22 33333443321 1345555
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++.+ |+..||..||++.+++.||||...
T Consensus 257 li~~-~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 257 LVSK-MLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp HHHH-HTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred HHHH-HCCCChhHCcCHHHHhcCCeecCc
Confidence 5555 999999999999999999999763
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=351.41 Aligned_cols=244 Identities=26% Similarity=0.440 Sum_probs=185.5
Q ss_pred CEEEE---eeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 135 DYEVV---RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 135 ~y~~~---~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
+|++. +.||+|+||.||+|+++.+++.||||++.......+.+|+.+++.+.+||||+++++++.+ ....++|||
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv~e 86 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLVME 86 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEEEC
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEEEE
Confidence 46654 7899999999999999999999999999887778899999999999669999999999976 567899999
Q ss_pred ecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC--eEEEEeeeeeeeecCCC-cc
Q 014307 212 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGK-EY 285 (427)
Q Consensus 212 ~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--~ikl~DFGla~~~~~~~-~~ 285 (427)
|+.+++|...+ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+++...... ..
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 166 (325)
T 3kn6_A 87 LLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166 (325)
T ss_dssp CCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence 99999987665 35899999999999999999999999999999999999975442 79999999998664432 34
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------CHHHHHHHHHHh----------CCh
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD------NYDQLVKIAKVL----------GTD 349 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~------~~~~l~~i~~~~----------~~~ 349 (427)
...++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..+.+..+.+.. -++
T Consensus 167 ~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred cccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence 55678999999999876 6899999999999999999999999943221 123333333221 134
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
.+..++.. |+..||..||++.+++.|+||+..
T Consensus 246 ~~~~li~~-~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 246 EAKDLIQG-LLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHH-HHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HHHHHHHH-HCCCChhHCCCHHHHhcChhhccC
Confidence 55555555 999999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=351.86 Aligned_cols=246 Identities=29% Similarity=0.576 Sum_probs=207.8
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC---CC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---~~ 204 (427)
..++|++++.||+|+||.||+|++..+++.||||++.... .+.+.+|+.+|+++ +||||+++++++.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence 3578999999999999999999999999999999996422 35678999999999 9999999999997542 24
Q ss_pred CcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
..++||||+.+ +|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 104 ~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGG
T ss_pred eEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCC
Confidence 68999999996 555443 4699999999999999999999999999999999999999777 8999999999876433
Q ss_pred Cc----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----------
Q 014307 283 KE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------- 348 (427)
Q Consensus 283 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~---------- 348 (427)
.. .....||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+...++.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 260 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCII 260 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 22 244589999999999876567999999999999999999999998 666777777777655443
Q ss_pred ---------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 ---------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ---------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+.+++.+ |+..||..||++.+++.||||.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~R~t~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK-MLTFNPHKRIEVEQALAHPYLEQY 320 (364)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHH-HcCCChhhCCCHHHHhcCcchhhc
Confidence 234455555 999999999999999999999874
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=360.18 Aligned_cols=246 Identities=25% Similarity=0.517 Sum_probs=191.0
Q ss_pred CCEEE-EeeeeecCCeeEEEEEEc--CCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEV-VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~-~~~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
+.|++ .++||+|+||+||+|+++ .+++.||||+++... ...+.+|+.+|+++ +||||+++++++.......+++|
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeEEEE
Confidence 45666 457999999999999976 468899999997533 46788999999999 89999999999987667889999
Q ss_pred EeecCCCchhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE----cCCCCeEEEEeee
Q 014307 210 FEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWG 274 (427)
Q Consensus 210 ~e~~~~~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~~ikl~DFG 274 (427)
|||+.++.+..+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||
T Consensus 99 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kl~Dfg 177 (405)
T 3rgf_A 99 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMG 177 (405)
T ss_dssp EECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT-CEEECCTT
T ss_pred EeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC-cEEEEECC
Confidence 9999875443322 138999999999999999999999999999999999999 4444 89999999
Q ss_pred eeeeecCC----CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------CHHHHHHH
Q 014307 275 LAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQLVKI 342 (427)
Q Consensus 275 la~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--------~~~~l~~i 342 (427)
+|+.+... ......+||+.|+|||++.+...++.++|||||||++|||++|+.||..... ..+++..+
T Consensus 178 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i 257 (405)
T 3rgf_A 178 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 257 (405)
T ss_dssp CCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHH
T ss_pred CceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHH
Confidence 99876432 2234568899999999998756699999999999999999999999953322 24777777
Q ss_pred HHHhCC--------------------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCc
Q 014307 343 AKVLGT--------------------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSY 378 (427)
Q Consensus 343 ~~~~~~--------------------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~ 378 (427)
.+.++. +.+..++.+ |+..||..|+++.++|.|||
T Consensus 258 ~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~-~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 258 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK-LLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHH-HSCSSGGGSCCHHHHHTSGG
T ss_pred HHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHH-HccCCcccCCCHHHHhcChh
Confidence 776653 233455555 99999999999999999999
Q ss_pred hhhH
Q 014307 379 FFQF 382 (427)
Q Consensus 379 ~~~~ 382 (427)
|.+.
T Consensus 337 f~~~ 340 (405)
T 3rgf_A 337 FLED 340 (405)
T ss_dssp GTSS
T ss_pred hccC
Confidence 9873
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=365.73 Aligned_cols=244 Identities=23% Similarity=0.389 Sum_probs=198.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||.||+|++..+++.||||+++.. ....+.+|+.+|+.+ +||||+++++++.. ...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~--~~~~ 223 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDRL 223 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEE--TTEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEee--CCEE
Confidence 46899999999999999999999999999999998642 124567899999998 89999999999987 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~- 281 (427)
++||||+.+++|...+ ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|+....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC-
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccCC
Confidence 9999999999987665 468999999999999999999998 9999999999999999877 899999999975332
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHH
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYL 355 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l 355 (427)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||. +.+..+....+.... -.+.+..++
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 233456789999999999887 789999999999999999999999994 444444444443321 134566666
Q ss_pred HhccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
.+ |+..||..|+ ++.+++.||||....
T Consensus 381 ~~-~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 381 SG-LLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp HH-HTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred HH-HcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 66 9999999999 999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=346.30 Aligned_cols=237 Identities=24% Similarity=0.313 Sum_probs=191.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|+++++||+|+||+||+|++..+++.||||++... .......|+..+.++.+||||+++++++.+ ...+++
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 6799999999999999999999999999999998542 223455677777776699999999999976 567899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
||||+.+ ++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 135 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 135 QTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEECCCC-BHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC----
T ss_pred EEeccCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeecccCCC
Confidence 9999955 544433 3599999999999999999999999999999999999999777 899999999987765555
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------CChHHHHHHH
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAYLN 356 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~~~~~~~~l~ 356 (427)
.....||+.|+|||++.+ .++.++|||||||++|||++|..||+.. +....+.+.. -++.+.+++.
T Consensus 213 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~ 286 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYLPPEFTAGLSSELRSVLV 286 (311)
T ss_dssp --CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCCCHHHHTTSCHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCCCcccccCCCHHHHHHHH
Confidence 566789999999999875 6999999999999999999998777432 2222222111 1345556666
Q ss_pred hccCCCChhHHHHHhHHhcCCchhh
Q 014307 357 KYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+ |+..||..||++.+++.||||++
T Consensus 287 ~-~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 287 M-MLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp H-HSCSSTTTSCCHHHHHTSGGGSC
T ss_pred H-HcCCChhhCcCHHHHHhCccccC
Confidence 6 99999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=351.22 Aligned_cols=246 Identities=28% Similarity=0.494 Sum_probs=197.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--------------HHHHHHHHHHHHHhcCCCCeeeeeeE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKLLDI 197 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------------~~~~~~E~~il~~l~~h~niv~l~~~ 197 (427)
..++|++++.||+|+||.||+|.+. +++.||||++.... .+.+.+|+.+++++ +||||++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 97 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDI 97 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEE
T ss_pred hccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccceeee
Confidence 4578999999999999999999984 59999999985321 26789999999999 89999999999
Q ss_pred EEcC---CCCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEE
Q 014307 198 VRDQ---QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (427)
Q Consensus 198 ~~~~---~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~ 271 (427)
+... ....+++||||+.++.+..+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEEC
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEE
Confidence 8652 3346799999999655444433 489999999999999999999999999999999999999777 89999
Q ss_pred eeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC---
Q 014307 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--- 348 (427)
Q Consensus 272 DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~--- 348 (427)
|||++.............+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+....+.+..+.+..+.
T Consensus 177 Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 177 DFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCh
Confidence 9999986655555566789999999999877667999999999999999999999999 566667777777665443
Q ss_pred -----------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 -----------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 -----------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+..++.+ |+..||..||++.+++.||||+..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK-MLEFNPQRRISTEQALRHPYFESL 323 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHH-HhcCChhhCCCHHHHHcCchhhhc
Confidence 234455555 999999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=351.06 Aligned_cols=248 Identities=26% Similarity=0.449 Sum_probs=197.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC-----CCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-----SKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~-----~~~ 205 (427)
.++|++.+.||+|+||.||+|++..+++.||||++... ......+|++.+..+ +||||+++++++.... ..+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 100 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDRRDIY 100 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCTTCEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhcccccccccee
Confidence 36899999999999999999999999999999988542 234567788888888 9999999999987532 223
Q ss_pred cEEEEeecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHH--HCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 206 PSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
+++||||+.++.+..+. ..+++..++.++.||+.||.||| ++||+||||||+|||++..+..+||+|||+++
T Consensus 101 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~ 180 (360)
T 3e3p_A 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180 (360)
T ss_dssp EEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCB
T ss_pred EEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCce
Confidence 78999999987543322 35889999999999999999999 99999999999999999634499999999998
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC---------
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------- 348 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~--------- 348 (427)
............|++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.++.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 8766666666788999999999877566999999999999999999999999 566677777777665443
Q ss_pred -----------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 -----------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 -----------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.+ |+..||..||++.+++.||||.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA-LLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHH-HTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHH-HhccCccccCCHHHHhcCccccccC
Confidence 234455555 9999999999999999999999854
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=351.19 Aligned_cols=243 Identities=24% Similarity=0.452 Sum_probs=206.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
++|++.+.||+|+||.||+|+++.+|+.||||+++... .+.+.+|+.+++++.+||||+++++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 57999999999999999999998899999999986532 35678999999998789999999999976
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
....++||||+.+++|..++ ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++..+
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHL 250 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCccccc
Confidence 56789999999999987775 3689999999999999999999999999999999999999777 8999999999887
Q ss_pred cCCCcceeeccCccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 280 HPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
..........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||. +....+.+..+.....
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW-HRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCCCCccc
Confidence 76666677789999999999853 2358899999999999999999999994 4444455544444321
Q ss_pred ---ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 348 ---TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 348 ---~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
++.+..++.+ |+..||..||++.+++.||||++
T Consensus 330 ~~~~~~~~~li~~-~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 330 DDRSSTVKDLISR-LLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSSCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ccCCHHHHHHHHH-HcCCChhHCcCHHHHhcCcccCC
Confidence 2235555555 99999999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=367.33 Aligned_cols=244 Identities=25% Similarity=0.485 Sum_probs=210.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|+++.+++.||||++.. .....+.+|+.+++++ +||||+++++++.+ ....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~ 101 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KGYF 101 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CCEE
Confidence 3679999999999999999999999999999999853 2357789999999999 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC--CCCeEEEEeeeeeeeecC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~~ikl~DFGla~~~~~ 281 (427)
++||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++. +...+||+|||+++.+..
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 9999999999987655 46899999999999999999999999999999999999952 233899999999987776
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHH
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDEL 351 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~ 351 (427)
.......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.|| .+.+..+.+..+.+... ++.+
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 258 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPF-NGANEYDILKKVEKGKYTFELPQWKKVSESA 258 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred ccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence 666667789999999999875 6999999999999999999999999 56666666666665421 2345
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..++.+ |+..||..||++.+++.||||....
T Consensus 259 ~~li~~-~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 259 KDLIRK-MLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp HHHHHH-HTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred HHHHHH-HCCCChhHCcCHHHHhhChhhcccc
Confidence 555666 9999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=354.61 Aligned_cols=244 Identities=22% Similarity=0.382 Sum_probs=198.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHH-HHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il-~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++++.||+|+||+||+|+++.+++.||||++++.. ...+.+|..++ +.+ +||||+++++++.+ ...
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~--~~~ 113 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--ADK 113 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEEC--SSE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEe--CCE
Confidence 467999999999999999999999999999999996432 23456677664 445 99999999999976 567
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-C
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~ 281 (427)
+++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++... .
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBCC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCccccccccC
Confidence 89999999999987765 3589999999999999999999999999999999999999877 89999999997533 2
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHH
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYL 355 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l 355 (427)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+....+.+.. -++....++
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTT-CCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 334556789999999999887 68999999999999999999999999 4455555555555431 124555555
Q ss_pred HhccCCCChhHHHHH----hHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALV----GRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~----~~ll~~~~~~~~~ 383 (427)
.+ |+..||..|+.+ .+++.|+||....
T Consensus 271 ~~-lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 271 EG-LLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp HH-HTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred HH-HcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 55 999999999986 6899999998754
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=350.87 Aligned_cols=243 Identities=30% Similarity=0.594 Sum_probs=201.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|++++.||+|+||.||+|++..+++.||||+++... ...+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 85 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KS 85 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TT
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee--CC
Confidence 478999999999999999999999999999999986422 13577999999999 99999999999975 56
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++||||+.+ ++...+. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG 163 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceecc
Confidence 78999999998 4444432 488999999999999999999999999999999999999777 89999999998654
Q ss_pred CC-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-----------
Q 014307 281 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----------- 348 (427)
Q Consensus 281 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~----------- 348 (427)
.. .......+|+.|+|||++.+...++.++|||||||++|||++|..|| .+.++.+++..+.+..+.
T Consensus 164 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (346)
T 1ua2_A 164 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCS 242 (346)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred CCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHcCCCChhhhhhhcc
Confidence 32 23455688999999999876567899999999999999999998877 667777888877776442
Q ss_pred -----------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 -----------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 -----------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+.+++.+ |+..||..||++.+++.|+||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG-LFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHH-HHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred CcccccccccCCCChHHhhccCCHHHHHHHHH-HhccChhhCCCHHHHhcChhhhcC
Confidence 344555555 999999999999999999999863
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=349.54 Aligned_cols=241 Identities=19% Similarity=0.358 Sum_probs=194.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC------
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 203 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~------ 203 (427)
++|++++.||+|+||.||+|+++.+++.||||+++. ...+.+.+|+.+|+++ +||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhhhh
Confidence 579999999999999999999999999999999863 2346789999999999 99999999999865422
Q ss_pred -------------------------------------------------CCcEEEEeecCCCchhhhcCC------CCHH
Q 014307 204 -------------------------------------------------KTPSLIFEHVNNTDFKVLYPT------LSDY 228 (427)
Q Consensus 204 -------------------------------------------------~~~~lv~e~~~~~~l~~~~~~------~~~~ 228 (427)
.++++||||+.+++|..++.. ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 237999999999999877642 4566
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-------------cceeeccCcccc
Q 014307 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-------------EYNVRVASRYFK 295 (427)
Q Consensus 229 ~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-------------~~~~~~~~~~y~ 295 (427)
.++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...... ......||+.|+
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 6899999999999999999999999999999999777 89999999998765442 123357899999
Q ss_pred ccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHHhccCCCChhHHH
Q 014307 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAA 368 (427)
Q Consensus 296 aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dp~~r~ 368 (427)
|||++.+ ..++.++|||||||++|||++|..|+. +..+....+.... ..+.+..++.+ |+..||..||
T Consensus 244 aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rp 318 (332)
T 3qd2_B 244 SPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM---ERVRIITDVRNLKFPLLFTQKYPQEHMMVQD-MLSPSPTERP 318 (332)
T ss_dssp CHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH---HHHHHHHHHHTTCCCHHHHHHCHHHHHHHHH-HHCSSGGGSC
T ss_pred ChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh---HHHHHHHHhhccCCCcccccCChhHHHHHHH-HccCCCCcCC
Confidence 9999887 689999999999999999999876651 1111222221111 12344455555 9999999999
Q ss_pred HHhHHhcCCchhh
Q 014307 369 LVGRLVILSYFFQ 381 (427)
Q Consensus 369 ~~~~ll~~~~~~~ 381 (427)
++.++++||||+.
T Consensus 319 s~~~~l~~~~f~~ 331 (332)
T 3qd2_B 319 EATDIIENAIFEN 331 (332)
T ss_dssp CHHHHHHSTTCCC
T ss_pred CHHHHhhchhhhc
Confidence 9999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=365.10 Aligned_cols=243 Identities=24% Similarity=0.520 Sum_probs=207.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||+||+|++..+++.||||++.. .....+.+|+.+|+++ +||||+++++++.+ ...++
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 97 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY 97 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc--CCEEE
Confidence 3679999999999999999999999999999999853 3356789999999999 99999999999976 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--CCeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~~~ikl~DFGla~~~~~~ 282 (427)
+||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||+++.+...
T Consensus 98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 999999999986654 469999999999999999999999999999999999999643 237999999999877666
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELN 352 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~ 352 (427)
......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.|| .+.+..+.+..+..... ++.+.
T Consensus 178 ~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 254 (486)
T 3mwu_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (486)
T ss_dssp ----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred CccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence 66667789999999999875 5999999999999999999999999 55666666666665421 24455
Q ss_pred HHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 353 AYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
.++.+ |+..||..||++.+++.|||+++.
T Consensus 255 ~li~~-~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 255 DLIRK-MLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp HHHHH-HTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred HHHHH-HcCCChhhCcCHHHHhcCHhhccC
Confidence 66666 999999999999999999999874
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=349.77 Aligned_cols=246 Identities=22% Similarity=0.406 Sum_probs=203.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|++++.||+|+||.||+|++..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~ 101 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED--EQ 101 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc--CC
Confidence 46799999999999999999999999999999998642 236788999999999 89999999999976 56
Q ss_pred CcEEEEeecCCCchhhhcC-------------------------------------------CCCHHHHHHHHHHHHHHH
Q 014307 205 TPSLIFEHVNNTDFKVLYP-------------------------------------------TLSDYDVRYYIYELLKAL 241 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-------------------------------------------~~~~~~~~~i~~qi~~~L 241 (427)
..++||||+.+++|..++. .+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 7899999999999987763 135677888999999999
Q ss_pred HHHHHCCceeeccCCCceEEcCCCC-eEEEEeeeeeeeecCCC-----cceeeccCccccccccccCC-CCCCchhhHHH
Q 014307 242 DYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLDLWS 314 (427)
Q Consensus 242 ~~LH~~~iiHrDlkp~NILl~~~~~-~ikl~DFGla~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwS 314 (427)
+|||++||+||||||+|||++.++. .+||+|||++..+.... ......|++.|+|||++.+. ..++.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 9999999999999999999985542 79999999998654321 23456789999999998642 57899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 315 LGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 315 lGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|||++|||++|+.|| .+....+.+..+.+... ++.+.+++.+ |+..||..||++.+++.||||.+..
T Consensus 262 lG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 262 AGVLLHLLLMGAVPF-PGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSN-LLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHH-HSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHCCCCC-CCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHH-HcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999 55555666665554321 3455566666 9999999999999999999998744
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=365.84 Aligned_cols=243 Identities=24% Similarity=0.466 Sum_probs=206.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|+++++||+|+||+||+|+++.++..||+|+++.. ....+.+|+.+|+.+ +||||+++++++.+ ....++
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~l 113 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFED--KRNYYL 113 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEEE
Confidence 5799999999999999999999999999999998642 346788999999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~~~~~ 283 (427)
||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++.......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~ 193 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence 99999999986654 4689999999999999999999999999999999999997543 359999999999887666
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~ 353 (427)
.....+||+.|+|||++. ..|+.++|||||||++|+|++|+.|| .+....+.+..+.+... ++.+..
T Consensus 194 ~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 270 (494)
T 3lij_A 194 KMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPF-GGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270 (494)
T ss_dssp CBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred cccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence 667788999999999976 46999999999999999999999999 55566666666655421 234555
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+ |+..||..||++.+++.||||.+..
T Consensus 271 li~~-~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 271 LIKQ-MLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HHHH-HTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HHHH-HCCCChhhCccHHHHhcCcccccCc
Confidence 5555 9999999999999999999998864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=338.57 Aligned_cols=245 Identities=19% Similarity=0.366 Sum_probs=187.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHH-HHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~-il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||+||+|++..+++.||||+++... ......|.. .++.+ +||||+++++++.+ ....+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~--~~~~~ 82 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFR--EGDVW 82 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSSEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeec--cCCEE
Confidence 478999999999999999999999999999999986432 122333443 45555 99999999999986 55789
Q ss_pred EEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
+||||+.+ ++..++ ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYL 160 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcccc
Confidence 99999986 443332 3699999999999999999999998 999999999999999777 8999999999877
Q ss_pred cCCCcceeeccCccccccccc---cCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------C
Q 014307 280 HPGKEYNVRVASRYFKGPELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------T 348 (427)
Q Consensus 280 ~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~ 348 (427)
..........|++.|+|||++ .....++.++|||||||++|+|++|+.||.........+........ +
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFS 240 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSC
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCC
Confidence 655555566899999999997 23367899999999999999999999999654555555555444321 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.. |+..||..||++.+++.||||....
T Consensus 241 ~~~~~li~~-~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 241 AEFVDFTSQ-CLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp HHHHHHHHH-HTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHHHHHH-HhhcChhhCcCHHHHHhCcccccCc
Confidence 455566666 9999999999999999999999755
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=335.84 Aligned_cols=243 Identities=23% Similarity=0.419 Sum_probs=202.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 84 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATRV 84 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEec--CCEE
Confidence 46899999999999999999999999999999998542 235688999999999 89999999999976 4568
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.++++...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..... .
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~-~ 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS-S 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCc-c
Confidence 9999999999987665 4689999999999999999999999999999999999999777 899999999865432 2
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~~ 357 (427)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.|| ...+..+....+..... .+.+.+++.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 240 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARDLISR 240 (279)
T ss_dssp -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCC-CCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence 3345688999999999876 68899999999999999999999999 44444455555544321 2455566666
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..||..||++.++++||||....
T Consensus 241 -~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 241 -LLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp -HCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred -HhccChhhCCCHHHHhhCccccCCc
Confidence 9999999999999999999998744
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=334.98 Aligned_cols=244 Identities=24% Similarity=0.458 Sum_probs=202.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
++|++.+.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~ 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFEN--KT 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecC--CC
Confidence 5799999999999999999999999999999998642 257789999999999 89999999999976 45
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC---eEEEEeeeeeee
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEF 278 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~ikl~DFGla~~ 278 (427)
..++||||+.+++|..++ ..+++..+..++.||+.||.|||++||+||||||+||+++.++. .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 689999999999998776 35899999999999999999999999999999999999986542 699999999987
Q ss_pred ecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------C-C
Q 014307 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------G-T 348 (427)
Q Consensus 279 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~-~ 348 (427)
...........+++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.+..+.... . +
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF-LGETKQETLTNISAVNYDFDEEYFSNTS 239 (283)
T ss_dssp CC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred ccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCC-CCcchHHHHHHhHhcccCCcchhcccCC
Confidence 765555566689999999999876 68999999999999999999999999 4444444444443221 1 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.+ |+..||..||++.+++.|+||+...
T Consensus 240 ~~~~~li~~-~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 240 ELAKDFIRR-LLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp HHHHHHHHT-TSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred HHHHHHHHH-HccCCHhHCcCHHHHHhCHHHHHHH
Confidence 344555555 9999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=334.97 Aligned_cols=246 Identities=23% Similarity=0.433 Sum_probs=208.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHHHhcCCCCeeeeeeEEEc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~il~~l~~h~niv~l~~~~~~ 200 (427)
.++|++.+.||+|+||.||+|.++.+++.||||+++... .+.+.+|+.+++++.+||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 578999999999999999999999999999999986432 35578999999999669999999999976
Q ss_pred CCCCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 201 QQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
....++||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 96 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~ 172 (298)
T 1phk_A 96 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 172 (298)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred --CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchh
Confidence 567899999999999887753 689999999999999999999999999999999999999777 89999999998
Q ss_pred eecCCCcceeeccCcccccccccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------ 346 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------ 346 (427)
............++..|+|||++. ....++.++|||||||++|+|++|+.||. ..+..+....+.+..
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~ 251 (298)
T 1phk_A 173 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQFGSP 251 (298)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCTT
T ss_pred hcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCc-CccHHHHHHHHhcCCcccCcc
Confidence 876666666678999999999985 23568899999999999999999999994 444444444444421
Q ss_pred ----CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 347 ----GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 ----~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
-++.+.+++.+ |+..||..||++.+++.|+||.+..
T Consensus 252 ~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 252 EWDDYSDTVKDLVSR-FLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TGGGSCHHHHHHHHH-HCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccccCHHHHHHHHH-HccCCcccCCCHHHHHhChHhhhcc
Confidence 12345555555 9999999999999999999998744
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=352.13 Aligned_cols=245 Identities=24% Similarity=0.413 Sum_probs=203.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhc-------CCCCeeeeeeEEEcC-
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-------GGPNIVKLLDIVRDQ- 201 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~-------~h~niv~l~~~~~~~- 201 (427)
..++|+++++||+|+||+||+|++..+++.||||+++... .+.+.+|+.+|+.+. +|+||+++++++...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 3578999999999999999999999999999999997533 466889999999984 278899999998732
Q ss_pred -CCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCC----------
Q 014307 202 -QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQ---------- 265 (427)
Q Consensus 202 -~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~---------- 265 (427)
....+++||||+.++.+..+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhh
Confidence 355789999999777666554 3489999999999999999999998 999999999999998654
Q ss_pred --------------------------------------CeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCC
Q 014307 266 --------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307 (427)
Q Consensus 266 --------------------------------------~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 307 (427)
..+||+|||++..... ......||+.|+|||++.+ ..++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~ 271 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIG-SGYN 271 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHT-SCCC
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcC-CCCC
Confidence 2699999999987543 3455689999999999987 6799
Q ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCC-----CHHHHHHHHHHhCCh---------------------------------
Q 014307 308 YSLDLWSLGCMFAGMIFRKEPFFYGHD-----NYDQLVKIAKVLGTD--------------------------------- 349 (427)
Q Consensus 308 ~~~DvwSlGvll~elltg~~pf~~~~~-----~~~~l~~i~~~~~~~--------------------------------- 349 (427)
.++|||||||++|||++|+.||..... ..+++..+.+.++..
T Consensus 272 ~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 351 (397)
T 1wak_A 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351 (397)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHH
T ss_pred cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchh
Confidence 999999999999999999999954322 345566666655532
Q ss_pred ---------------HHHHHHHhccCCCChhHHHHHhHHhcCCchh
Q 014307 350 ---------------ELNAYLNKYHIELDPHLAALVGRLVILSYFF 380 (427)
Q Consensus 350 ---------------~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~ 380 (427)
.+..++.+ |+..||..||++.++++||||.
T Consensus 352 ~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 352 EVLVEKYEWSQEEAAGFTDFLLP-MLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHGG-GGCSSGGGSCCHHHHHTSGGGG
T ss_pred HhhhhhcccchhhHHHHHHHHHH-HhccChhhcCCHHHHhhCcccc
Confidence 23344555 9999999999999999999986
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=356.29 Aligned_cols=245 Identities=25% Similarity=0.437 Sum_probs=202.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
.++|++++.||+|+||.||+|++..+++.||||+++... ...+.+|+.+|+++ +||||+++++++.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC-
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee-
Confidence 367999999999999999999999999999999987532 23567899999999 99999999999976
Q ss_pred CCCCcEEEEeecCCC-chhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 202 QSKTPSLIFEHVNNT-DFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~-~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
....++||||+.++ ++..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 101 -~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~ 178 (335)
T 3dls_A 101 -QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAA 178 (335)
T ss_dssp -SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred -CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccce
Confidence 56789999999776 776665 3589999999999999999999999999999999999999776 89999999999
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHh
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~ 357 (427)
............||+.|+|||++.+...++.++|||||||++|+|++|+.||........... .....-++.+.+++.+
T Consensus 179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~~~~~~~~l~~li~~ 257 (335)
T 3dls_A 179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAI-HPPYLVSKELMSLVSG 257 (335)
T ss_dssp ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCC-CCSSCCCHHHHHHHHH
T ss_pred ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhcc-CCCcccCHHHHHHHHH
Confidence 877666667778999999999998743448899999999999999999999943111000000 0000113456666666
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..||..||++.+++.||||.+..
T Consensus 258 -~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 258 -LLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp -HTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred -HccCChhhCcCHHHHhcCccccCCc
Confidence 9999999999999999999998743
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.19 Aligned_cols=245 Identities=22% Similarity=0.380 Sum_probs=201.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+|+.+|+++ +||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEESS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcCC-
Confidence 67999999999999999999999999999999986432 13478999999999 999999999998753
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC--eEEEEeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAE 277 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--~ikl~DFGla~ 277 (427)
..++||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 88 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 88 --DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp --SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred --ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 378999999999987665 35899999999999999999999999999999999999986542 49999999998
Q ss_pred eecCCCcceeeccCcccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------- 346 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------- 346 (427)
............|++.|+|||++. +...++.++|||||||++|+|++|+.||............+....
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence 775544445567899999999974 235789999999999999999999999954433322222222211
Q ss_pred -CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 347 -GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 -~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
-++.+.+++.+ |+..||..||++.+++.|+||....
T Consensus 246 ~~~~~~~~li~~-~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 246 EVSEKALDLVKK-LLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp TSCHHHHHHHHH-HSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred hcCHHHHHHHHH-HcccCHhhCCCHHHHhhCcCcCCHH
Confidence 13455555665 9999999999999999999998755
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=338.78 Aligned_cols=246 Identities=26% Similarity=0.503 Sum_probs=198.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--------
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ-------- 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~-------- 201 (427)
.++|++++.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++++ +||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccccc
Confidence 578999999999999999999999999999999986543 35678999999999 999999999998532
Q ss_pred ----CCCCcEEEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 202 ----QSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 202 ----~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
.....++||||+.+ +|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp --CCSCSEEEEEEECCSE-EHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred ccccccCceeEEeeccCC-CHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 23567999999985 7766654 5899999999999999999999999999999999999986555899999999
Q ss_pred eeeecCC----CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-----
Q 014307 276 AEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----- 346 (427)
Q Consensus 276 a~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----- 346 (427)
++..... .......++..|+|||++.+...++.++|||||||++|||++|+.|| .+.+..+.+..+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF-AGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp CBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHSCCCCH
T ss_pred ccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCch
Confidence 9865432 12234567889999999876568999999999999999999999999 4555556655554432
Q ss_pred -------------------------------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 347 -------------------------------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 347 -------------------------------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
-++.+.+++.+ |+..||..||++.+++.||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ-ILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHT-TSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHH-HcCCCccccCCHHHHhCCcccccc
Confidence 13445555555 999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=341.47 Aligned_cols=245 Identities=21% Similarity=0.392 Sum_probs=207.4
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
...++|.+.+.||+|+||.||+|++..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 114 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--ND 114 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SS
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CC
Confidence 3457899999999999999999999999999999998642 346688999999999 99999999999986 56
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
..++||||+.+++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEY 193 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred eEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceeccc
Confidence 789999999999987765 4589999999999999999999999999999999999999777 899999999987653
Q ss_pred C-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHH
Q 014307 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAY 354 (427)
Q Consensus 282 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~ 354 (427)
. .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.|| ......+....+.+... .+.+..+
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 271 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEYSIPKHINPVAASL 271 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred CcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCC-CCCCHHHHHHHHhcCCCCCCccCCHHHHHH
Confidence 3 33445678999999999887 67899999999999999999999999 44444444444443211 2445555
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+ |+..||..||++.+++.|+||...
T Consensus 272 i~~-~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 272 IQK-MLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp HHH-HTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred HHH-HccCChhHCcCHHHHhcCccccCC
Confidence 555 999999999999999999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=332.63 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=196.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++.+ +||||+++++++.. ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 86 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVIST--PTDF 86 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCeE
Confidence 478999999999999999999999899999999986432 35688999999999 89999999999976 4578
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|..++ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCCCc
Confidence 9999999999987765 3689999999999999999999999999999999999999777 89999999998765554
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (427)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||. .....+....+.... -.+.+..++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 244 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD-DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMH 244 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhhcCcccCchhcCHHHHHHHHH
Confidence 45566889999999998874334689999999999999999999994 333333344443321 13455565666
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
|+..||..||++.+++.|+||++.
T Consensus 245 -~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 245 -MLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -HTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -HccCChhhCCCHHHHHhChhhccC
Confidence 999999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=343.71 Aligned_cols=240 Identities=24% Similarity=0.402 Sum_probs=200.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+|+++ +||||+++++++.. ....+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 130 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTAW 130 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCeEE
Confidence 5699999999999999999999999999999998642 125688999999999 99999999999986 45789
Q ss_pred EEEeecCCCchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.++.+..+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~--- 206 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP--- 206 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCC---
Confidence 99999986443322 24689999999999999999999999999999999999999777 899999999976543
Q ss_pred ceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChHHHHH
Q 014307 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAY 354 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~~~~~ 354 (427)
.....|++.|+|||++.+ ...++.++|||||||++|||++|+.||. +.+..+.+..+.+... ++.+.++
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 285 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPALQSGHWSEYFRNF 285 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCCCCCCTTSCHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 235689999999999852 3578999999999999999999999994 4455555555544321 2345555
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.. |+..||..||++.+++.|+|+.+.
T Consensus 286 i~~-~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 286 VDS-CLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp HHH-HTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHH-HcccChhhCcCHHHHhhChhhhcc
Confidence 555 999999999999999999999764
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=362.80 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=205.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+|+++ +||||+++++++.+ ...
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~~ 259 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFET--KTD 259 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEee--CCE
Confidence 457899999999999999999999999999999999642 235678999999999 99999999999976 567
Q ss_pred cEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 206 PSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
+++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~ 338 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVE 338 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeee
Confidence 899999999999976642 489999999999999999999999999999999999999877 899999999987
Q ss_pred ecCCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CHH-HHHHHHHHh------CC
Q 014307 279 YHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYD-QLVKIAKVL------GT 348 (427)
Q Consensus 279 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--~~~-~l~~i~~~~------~~ 348 (427)
+..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... ... ....+.... -+
T Consensus 339 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 339 LKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp CCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred ccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 765443 334589999999999987 6899999999999999999999999954322 223 333333221 13
Q ss_pred hHHHHHHHhccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
+....++.+ |+..||..|++ +++++.||||....
T Consensus 418 ~~~~~li~~-lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 418 PASKDFCEA-LLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp HHHHHHHHH-HSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred HHHHHHHHH-hccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 455555555 99999999995 58999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=344.21 Aligned_cols=244 Identities=30% Similarity=0.569 Sum_probs=202.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC----
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~---- 203 (427)
.++|.+.+.||+|+||.||+|++..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccc
Confidence 47899999999999999999999999999999998642 235678999999999 89999999999976432
Q ss_pred CCcEEEEeecCCCchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 204 KTPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
...++||||+.+ ++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~-- 177 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHAD-- 177 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC----
T ss_pred eeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCC--
Confidence 245899999995 555444 4699999999999999999999999999999999999999777 89999999997643
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------------
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------------- 347 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------------- 347 (427)
.......+++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+
T Consensus 178 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 256 (353)
T 3coi_A 178 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS-BSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred CCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence 23345678999999999877568999999999999999999999999 55566666766665433
Q ss_pred ----------------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 ----------------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ----------------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+.+++.+ |+..||..||++.+++.||||....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEK-MLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHH-HSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHH-HcCCCcccCCCHHHHhcCcchhhcc
Confidence 2344555555 9999999999999999999998643
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=375.16 Aligned_cols=246 Identities=21% Similarity=0.315 Sum_probs=210.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|++++.||+|+||+||+|+++.+++.||||+++.. ..+.+..|..+|..+.+||+|+++++++.+ ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 357899999999999999999999999999999998742 235678899999988789999999999975 567
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec-C
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~-~ 281 (427)
+++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+... .
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeeccccC
Confidence 89999999999998776 4699999999999999999999999999999999999999887 89999999998643 3
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHH
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYL 355 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l 355 (427)
.......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..|.+.. -++....++
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 573 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPF-EGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 573 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHSSCCCCCTTSCHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCC-CCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 344556789999999999876 78999999999999999999999999 5556666666665432 134566666
Q ss_pred HhccCCCChhHHHHH-----hHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALV-----GRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~-----~~ll~~~~~~~~~ 383 (427)
.+ |+..||..|+.+ ++++.|+||....
T Consensus 574 ~~-lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 574 KG-LMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp HH-HSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred HH-HccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 66 999999999987 9999999998755
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=333.88 Aligned_cols=244 Identities=21% Similarity=0.400 Sum_probs=205.7
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
...++|++.+.||+|+||.||+|.+..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~ 88 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--ND 88 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SS
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeecc--CC
Confidence 3457899999999999999999999999999999998642 246688999999999 99999999999976 55
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
..++||||+.+++|..+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEY 167 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceeccc
Confidence 789999999999987765 4689999999999999999999999999999999999999777 899999999987653
Q ss_pred C-CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHH
Q 014307 282 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAY 354 (427)
Q Consensus 282 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~ 354 (427)
. .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.|| ......+....+.+... .+.+.++
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPF-ETSCLKETYLRIKKNEYSIPKHINPVAASL 245 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTTCCCCCTTSCHHHHHH
T ss_pred CccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHhhccCCCccccCHHHHHH
Confidence 3 23445678999999999876 67899999999999999999999999 44444444444433211 2345555
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+.+ |+..||..||++.+++.|+||..
T Consensus 246 i~~-~l~~~p~~Rps~~~ll~~~~~~~ 271 (294)
T 2rku_A 246 IQK-MLQTDPTARPTINELLNDEFFTS 271 (294)
T ss_dssp HHH-HTCSSGGGSCCGGGGGGSHHHHT
T ss_pred HHH-HcccChhhCcCHHHHhhChheec
Confidence 555 99999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=332.06 Aligned_cols=245 Identities=23% Similarity=0.366 Sum_probs=204.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++|++++.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEc--CCEEEEE
Confidence 5799999999999999999999999999999998643 246788999999999 99999999999976 5678899
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC---
Q 014307 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~--- 283 (427)
|||+.+++|...+. .+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEEC
T ss_pred EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcchh
Confidence 99999999987765 489999999999999999999999999999999999999777 89999999997654322
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------CChHHHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAYL 355 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~~~~~~~~l 355 (427)
......|+..|+|||++.+...++.++|||||||++|+|++|+.||............+.... -++.+.+++
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 234457899999999987644457899999999999999999999965444333333333211 134555555
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.. |+..||..||++.+++.|+||++..
T Consensus 243 ~~-~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 243 HK-ILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HH-HSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HH-HCCCCchhCCCHHHHhcCccccChh
Confidence 55 9999999999999999999998743
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=332.60 Aligned_cols=243 Identities=21% Similarity=0.354 Sum_probs=201.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--CCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~--~~~~ 205 (427)
...|++.+.||+|+||.||+|.+..++..||+|++... ..+.+.+|+.+++.+ +||||+++++++... ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCce
Confidence 35689999999999999999999999999999998642 235688999999999 999999999998753 3456
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
+++||||+.+++|..++ ..+++..++.++.||+.||.|||++| |+||||||+|||++.+...+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 89999999999998776 46899999999999999999999999 99999999999998444489999999997543
Q ss_pred CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHhC--------ChHH
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLG--------TDEL 351 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~-~i~~~~~--------~~~~ 351 (427)
........|++.|+|||++.+ .++.++|||||||++|+|++|+.||.. ..+...+. .+..... .+.+
T Consensus 184 -~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l 259 (290)
T 1t4h_A 184 -ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVKPASFDKVAIPEV 259 (290)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT-CSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred -ccccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCC-cCcHHHHHHHHhccCCccccCCCCCHHH
Confidence 333455679999999998764 699999999999999999999999944 34444433 3332211 2455
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
..++.. |+..||..||++.+++.||||++
T Consensus 260 ~~li~~-~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 260 KEIIEG-CIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHH-HSCSSGGGSCCHHHHHTSGGGC-
T ss_pred HHHHHH-HccCChhhCCCHHHHhhCccccc
Confidence 666666 99999999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=340.27 Aligned_cols=247 Identities=28% Similarity=0.526 Sum_probs=203.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC---CCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ---QSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~---~~~ 204 (427)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ...+.+|+.+++++ +||||+++++++... ...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCccc
Confidence 4578999999999999999999999999999999996432 34577999999999 999999999987643 236
Q ss_pred CcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
..++||||+.+ +|...+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 88 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 88 EVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDES 165 (353)
T ss_dssp CEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred eEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEecccccccccc
Confidence 78999999985 555544 4699999999999999999999999999999999999999777 8999999999876432
Q ss_pred Cc-----------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC---
Q 014307 283 KE-----------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--- 348 (427)
Q Consensus 283 ~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~--- 348 (427)
.. .....|++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIGTPHS 244 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCS
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCch
Confidence 21 123478999999999876568999999999999999999999998 555555555555443332
Q ss_pred -----------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 -----------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 -----------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.+ |+..||..||++.+++.||||....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR-MLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHH-hcCcCcccCCCHHHHhcCccccccC
Confidence 233455555 9999999999999999999998743
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=347.72 Aligned_cols=278 Identities=23% Similarity=0.375 Sum_probs=217.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCCC-----eeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPN-----IVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~n-----iv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+|+.+++.+.+|++ |+++++++.. ...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~~ 130 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF--RNH 130 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE--TTE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc--CCc
Confidence 578999999999999999999999999999999997543 3567789999998855664 9999999987 467
Q ss_pred cEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCceeeccCCCceEEcC-CCCeEEEEeeeeee
Q 014307 206 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAE 277 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH--~~~iiHrDlkp~NILl~~-~~~~ikl~DFGla~ 277 (427)
+++||||+.+ +|..++ ..+++..++.++.||+.||.||| +.||+||||||+|||++. +...+||+|||+++
T Consensus 131 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 8999999986 554443 34899999999999999999999 579999999999999953 23379999999998
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHh
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 357 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~ 357 (427)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+++..+.+..+.+....
T Consensus 210 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~---- 281 (382)
T 2vx3_A 210 QLGQ--RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIPPAHI---- 281 (382)
T ss_dssp ETTC--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHH----
T ss_pred eccc--ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHH----
Confidence 7642 3445688999999999987 67999999999999999999999999 66777888888888887654321
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhH---------------HHhh---------------hhhhhhhhhhhHHHHHHhhhh
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQF---------------VIYY---------------YYYYYFCLKTCNFLLRNFLVQ 407 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~---------------~~~~---------------~~~~~~~~~~~~dllr~~l~~ 407 (427)
+...|..+..+..+....|-... .... ........+.+.++|++||.
T Consensus 282 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~- 358 (382)
T 2vx3_A 282 --LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLD- 358 (382)
T ss_dssp --HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTC-
T ss_pred --HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcC-
Confidence 12335555555544443331100 0000 00001123578999999995
Q ss_pred cCchhhhhhccccCCCC
Q 014307 408 AQPETMVKVHYCGESAF 424 (427)
Q Consensus 408 ~~P~~r~~~~~~~~~~~ 424 (427)
.||++|+|+..++.|||
T Consensus 359 ~dP~~Rpta~e~L~hp~ 375 (382)
T 2vx3_A 359 YDPKTRIQPYYALQHSF 375 (382)
T ss_dssp SCTTTSCCHHHHTTSGG
T ss_pred CChhhCCCHHHHhcCcc
Confidence 99999999999999998
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=337.88 Aligned_cols=242 Identities=22% Similarity=0.466 Sum_probs=200.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEE-cCCCeEEEEEEecccc--HHHHHHHHHHHHHhcCCC------CeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVH-CTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGP------NIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~-~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~~h~------niv~l~~~~~~~~~ 203 (427)
.++|++++.||+|+||.||+|.+ ..+++.||||+++... .+.+.+|+.+++.+ +|+ +++++++++.. .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~i~~~~~~~~~--~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHL-NTTDPNSTFRCVQMLEWFEH--H 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHH-HHHCTTCTTCBCCEEEEEEE--T
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHh-hhcCCCCceeeEeeeccccc--C
Confidence 47899999999999999999998 5688999999997533 36688999999988 444 59999999976 5
Q ss_pred CCcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--------------
Q 014307 204 KTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-------------- 264 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-------------- 264 (427)
..+++||||+ ++++..++. .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 6789999999 556554432 47899999999999999999999999999999999999863
Q ss_pred ----CCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014307 265 ----QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340 (427)
Q Consensus 265 ----~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~ 340 (427)
...+||+|||++.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|| ...+..+.+.
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~ 244 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDD--EHHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVF-PTHDSKEHLA 244 (339)
T ss_dssp EEESCCCEEECCCSSCEETT--SCCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC-CCSCHHHHHH
T ss_pred ccccCCCceEeeCcccccCc--cccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCChHHHHH
Confidence 2369999999998643 23345688999999999887 68999999999999999999999999 5556666666
Q ss_pred HHHHHhCC--------------------------------------------------hHHHHHHHhccCCCChhHHHHH
Q 014307 341 KIAKVLGT--------------------------------------------------DELNAYLNKYHIELDPHLAALV 370 (427)
Q Consensus 341 ~i~~~~~~--------------------------------------------------~~~~~~l~~~~l~~dp~~r~~~ 370 (427)
.+.+..+. +.+.+++.+ |+..||..||++
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rpt~ 323 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQK-MLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH-HTCSSTTTSCCH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHH-HhCcCcccccCH
Confidence 66555442 223455555 999999999999
Q ss_pred hHHhcCCchhhHH
Q 014307 371 GRLVILSYFFQFV 383 (427)
Q Consensus 371 ~~ll~~~~~~~~~ 383 (427)
.+++.||||++..
T Consensus 324 ~ell~hp~f~~~~ 336 (339)
T 1z57_A 324 REALKHPFFDLLK 336 (339)
T ss_dssp HHHTTSGGGGGGG
T ss_pred HHHhcCHHHHHHh
Confidence 9999999998743
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=337.24 Aligned_cols=250 Identities=22% Similarity=0.389 Sum_probs=202.0
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC----CC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SK 204 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----~~ 204 (427)
...++|++++.||+|+||.||+|++..+++.||||++.. ...+.+.+|+.+++++.+||||+++++++.... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 346889999999999999999999999999999999864 345778999999999978999999999998643 45
Q ss_pred CcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 205 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
.+++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTTTC--
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcCceec
Confidence 789999999999987775 3589999999999999999999999999999999999999777 8999999999765
Q ss_pred cCC-CcceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 280 HPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 280 ~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
... .......|+..|+|||++.+ ...++.++|||||||++|+|++|+.|| .+....+.+..+.+...
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 2x7f_A 180 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-CDMHPMRALFLIPRNPAPRLKSKK 258 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSCCCCCSCSC
T ss_pred CcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCC-CCCcHHHHHHHhhcCccccCCccc
Confidence 432 22345578999999999862 256899999999999999999999999 44444455544443221
Q ss_pred -ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 -TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 -~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+..++.. |+..||..||++.+++.||||.+..
T Consensus 259 ~~~~l~~li~~-~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 259 WSKKFQSFIES-CLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp SCHHHHHHHHH-HCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cCHHHHHHHHH-HhccChhhCCCHHHHhhChHHhhCc
Confidence 2455666666 9999999999999999999998744
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=333.03 Aligned_cols=244 Identities=23% Similarity=0.417 Sum_probs=207.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.+.|++++.||+|+||.||+|++..+++.||||+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEec--CCeEEE
Confidence 46799999999999999999999999999999998642 347789999999999 99999999999986 457899
Q ss_pred EEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cc
Q 014307 209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (427)
Q Consensus 209 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~ 285 (427)
||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... ..
T Consensus 98 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBCCB
T ss_pred EEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCcccccc
Confidence 999999999987764 589999999999999999999999999999999999999777 89999999998765433 23
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhc
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKY 358 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~ 358 (427)
....|+..|+|||++.+ ..++.++|||||||++|+|++|+.|| ......+....+.+... ++.+..++..
T Consensus 177 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 253 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPH-SELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA- 253 (303)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH-
T ss_pred CccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCC-CCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH-
Confidence 45678999999999876 68899999999999999999999999 44444444444433211 2345565656
Q ss_pred cCCCChhHHHHHhHHhcCCchhhHH
Q 014307 359 HIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..||..||++.+++.|+||.+..
T Consensus 254 ~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 254 CLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HcCCChhhCcCHHHHhhChhhhcCC
Confidence 9999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=330.55 Aligned_cols=243 Identities=21% Similarity=0.389 Sum_probs=205.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 89 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHD--RKRI 89 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEc--CCEE
Confidence 46899999999999999999999999999999998542 236688999999999 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|...+ ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++..... .
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~-~ 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPS-L 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSS-S
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCcc-c
Confidence 9999999999987665 3589999999999999999999999999999999999999777 899999999976543 2
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (427)
......|+..|+|||++.+ ..++.++|||||||++|+|++|+.|| ...+..+....+.... -++.+.+++..
T Consensus 168 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 245 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPF-DSPSHTETHRRIVNVDLKFPPFLSDGSKDLISK 245 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCC-CCCCHhHHHHHHhccccCCCCcCCHHHHHHHHH
Confidence 3345678999999999887 67899999999999999999999999 4444444444443321 13455555555
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..||..||++.+++.||||+...
T Consensus 246 -~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 246 -LLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -HSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -HhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 9999999999999999999998743
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=340.84 Aligned_cols=244 Identities=22% Similarity=0.350 Sum_probs=195.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC--
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK-- 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~-- 204 (427)
.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+|+.+++++ +||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCCCc
Confidence 478999999999999999999999999999999996431 24678999999999 999999999998764332
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
..++||||+.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++..+..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC-----
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCcccccc
Confidence 458999999999998775 3589999999999999999999999999999999999999777 899999999986643
Q ss_pred CCc----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------C
Q 014307 282 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (427)
Q Consensus 282 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~ 347 (427)
... .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+....+.... -
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPSARHEGL 246 (311)
T ss_dssp -------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred cccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHhcCCCCCcccccCCC
Confidence 321 233568999999999987 68999999999999999999999999 4444444444433321 1
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
++.+..++.+ |+..||..||+..+++.++|+..
T Consensus 247 ~~~l~~li~~-~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 247 SADLDAVVLK-ALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHHHHHHHH-HTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CHHHHHHHHH-HHhcCHhhChhhHHHHHHHHHHH
Confidence 2345555655 99999999999999999888765
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=350.41 Aligned_cols=242 Identities=24% Similarity=0.422 Sum_probs=193.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcC-CCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~-h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||.||+|.+. +++.||||++... ..+.+.+|+.+|+++.+ ||||+++++++.. ...+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 356999999999999999999985 4899999998642 23668899999999953 6999999999976 4568
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||| +.+++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+++.+....
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-CEEECCCSSSCCC----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-eEEEEecCccccccCCC
Confidence 99999 5667776654 3588999999999999999999999999999999999996 44 79999999998765432
Q ss_pred c---ceeeccCccccccccccCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---
Q 014307 284 E---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--- 347 (427)
Q Consensus 284 ~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--- 347 (427)
. ....+||+.|+|||++.+. ..++.++|||||||++|||++|+.||....+....+..+.....
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 288 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 288 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence 2 2456799999999998641 36899999999999999999999999544343444444432211
Q ss_pred -----ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 348 -----TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 348 -----~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
.+.+..++.. |+..||..||++.+++.||||..
T Consensus 289 ~~~~~~~~~~~li~~-~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 289 FPDIPEKDLQDVLKC-CLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp CCCCSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CCccchHHHHHHHHH-HcccChhhCCCHHHHhhCcCccc
Confidence 2345555555 99999999999999999999975
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=333.80 Aligned_cols=244 Identities=20% Similarity=0.406 Sum_probs=180.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|++..+++.||||++.... .+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFED--SNYV 86 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEEC--SSEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEcc--CCeE
Confidence 367999999999999999999999999999999996432 36688999999999 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC--
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCC
Confidence 9999999999987765 3489999999999999999999999999999999999999777 8999999999876433
Q ss_pred C-cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH------hCChHHHHHH
Q 014307 283 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELNAYL 355 (427)
Q Consensus 283 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~------~~~~~~~~~l 355 (427)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||... ...+.+..+... .-++.+.+++
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li 243 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTD-TVKNTLNKVVLADYEMPSFLSIEAKDLI 243 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCC-SCC-----CCSSCCCCCTTSCHHHHHHH
T ss_pred CCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCh-hHHHHHHHHhhcccCCccccCHHHHHHH
Confidence 2 2334578999999999876 67899999999999999999999999433 222222221110 1134555556
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+ |+..||..||++.+++.||||.+..
T Consensus 244 ~~-~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 244 HQ-LLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HH-HSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HH-HcccCHhhCCCHHHHhcCccccCCC
Confidence 66 9999999999999999999998744
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=338.00 Aligned_cols=246 Identities=29% Similarity=0.567 Sum_probs=204.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc-CCCeEEEEEEecccc-----HHHHHHHHHHHHHhc--CCCCeeeeeeEEEc---C
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRD---Q 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~--~h~niv~l~~~~~~---~ 201 (427)
.++|++++.||+|+||.||+|++. .+++.||+|+++... ...+.+|+.+++.+. +||||+++++++.. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 478999999999999999999995 678999999986432 235678888887764 79999999999872 2
Q ss_pred CCCCcEEEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
.....++||||+.+ +|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~~ 167 (326)
T 1blx_A 90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLA 167 (326)
T ss_dssp SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSC
T ss_pred CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCccc
Confidence 34578999999995 6655432 389999999999999999999999999999999999999777 8999999999
Q ss_pred eeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC--------
Q 014307 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-------- 348 (427)
Q Consensus 277 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~-------- 348 (427)
.............++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+..+.
T Consensus 168 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (326)
T 1blx_A 168 RIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPR 245 (326)
T ss_dssp CCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCT
T ss_pred ccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCcccCcc
Confidence 87654444556788999999999877 67999999999999999999999998 566667777777665432
Q ss_pred -------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 -------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 -------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+..++.+ |+..||..||++.+++.||||....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 246 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK-CLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp TCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHH-HSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhcccCcchhhhccccCCHHHHHHHHH-HcCCCcccCCCHHHHhcCccccccc
Confidence 223445555 9999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=334.59 Aligned_cols=251 Identities=23% Similarity=0.395 Sum_probs=203.5
Q ss_pred ccccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 127 TVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 127 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.......++|++++.||+|+||.||+|++..+++.||+|++... ..+.+.+|+.+++.+ +||||+++++++.. .
T Consensus 12 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~ 88 (302)
T 2j7t_A 12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYH--D 88 (302)
T ss_dssp BSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--C
T ss_pred ccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeee--C
Confidence 33445568899999999999999999999999999999998643 346788999999999 99999999999986 4
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
...++||||+.++++..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKN 167 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCccc
Confidence 5789999999999987664 4599999999999999999999999999999999999999777 8999999997532
Q ss_pred cCC-CcceeeccCcccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 280 HPG-KEYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 280 ~~~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
... .......|+..|+|||++. ....++.++|||||||++|+|++|+.|| ...+..+.+..+.+...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T 2j7t_A 168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAKSDPPTLLTPS 246 (302)
T ss_dssp HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSCCCCCSSGG
T ss_pred cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHHHHHhccCCcccCCcc
Confidence 211 1223457899999999984 2367899999999999999999999999 44444555544443321
Q ss_pred --ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 --TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 --~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+..++.. |+..||..||++.+++.||||....
T Consensus 247 ~~~~~l~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 247 KWSVEFRDFLKI-ALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp GSCHHHHHHHHH-HSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ccCHHHHHHHHH-HcccChhhCCCHHHHhcChHHhhhc
Confidence 2345555555 9999999999999999999999755
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=335.10 Aligned_cols=242 Identities=22% Similarity=0.391 Sum_probs=203.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYES--TTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhccc--CCEEEEE
Confidence 36799999999999999999999999999999999753 335688999999999 99999999999976 5578999
Q ss_pred EeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE---cCCCCeEEEEeeeeeeeecCCC
Q 014307 210 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~ikl~DFGla~~~~~~~ 283 (427)
|||+.+++|...+ ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||++..... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~-~ 162 (304)
T 2jam_A 85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-KIMITDFGLSKMEQN-G 162 (304)
T ss_dssp ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTCCCCC-B
T ss_pred EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-CEEEccCCcceecCC-C
Confidence 9999999987664 468999999999999999999999999999999999999 4444 899999999975432 2
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~ 353 (427)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+....+.+... ++.+.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 240 (304)
T 2jam_A 163 IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPF-YEETESKLFEKIKEGYYEFESPFWDDISESAKD 240 (304)
T ss_dssp TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHH
T ss_pred ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCC-CCCCHHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 3345578999999999876 68999999999999999999999999 44444555555544321 245555
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++.+ |+..||..||++.+++.|+||...
T Consensus 241 li~~-~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 241 FICH-LLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp HHHH-HHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred HHHH-HcCCChhHCcCHHHHhcCccccCC
Confidence 5666 999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=339.21 Aligned_cols=242 Identities=25% Similarity=0.488 Sum_probs=201.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCC-eEEEEEEeccc--cHHHHHHHHHHHHHhcCCCC------eeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV--KKKKIKREIKILQNLCGGPN------IVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vavK~~~~~--~~~~~~~E~~il~~l~~h~n------iv~l~~~~~~~~~ 203 (427)
.++|++++.||+|+||+||+|++..++ +.||+|+++.. ..+.+.+|+.+++.+ .|++ ++.+++++.. .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~~~~--~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDWFNF--H 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEEEEE--T
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeeeeee--C
Confidence 578999999999999999999998776 79999999753 346688899999998 5544 8999999876 5
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE------------------
Q 014307 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI------------------ 261 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl------------------ 261 (427)
...++||||+.++.+..+. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 5789999999776655443 258999999999999999999999999999999999999
Q ss_pred -cCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014307 262 -DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340 (427)
Q Consensus 262 -~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~ 340 (427)
+.++ .+||+|||+++... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+.
T Consensus 175 ~~~~~-~~kl~Dfg~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~ 249 (355)
T 2eu9_A 175 SVKNT-SIRVADFGSATFDH--EHHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLF-QTHENREHLV 249 (355)
T ss_dssp EESCC-CEEECCCTTCEETT--SCCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHH
T ss_pred ccCCC-cEEEeecCcccccc--ccccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHH
Confidence 3344 89999999998643 33345689999999999887 68999999999999999999999999 5556666666
Q ss_pred HHHHHhCCh--------------------------------------------------HHHHHHHhccCCCChhHHHHH
Q 014307 341 KIAKVLGTD--------------------------------------------------ELNAYLNKYHIELDPHLAALV 370 (427)
Q Consensus 341 ~i~~~~~~~--------------------------------------------------~~~~~l~~~~l~~dp~~r~~~ 370 (427)
.+.+..+.. .+.+++.+ |+..||..||++
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR-MLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHH-HTCSSTTTSCCH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHH-HhcCChhhCcCH
Confidence 666655431 33355555 999999999999
Q ss_pred hHHhcCCchhhHH
Q 014307 371 GRLVILSYFFQFV 383 (427)
Q Consensus 371 ~~ll~~~~~~~~~ 383 (427)
.+++.||||....
T Consensus 329 ~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 329 AEALLHPFFAGLT 341 (355)
T ss_dssp HHHTTSGGGGGCC
T ss_pred HHHhcChhhcCCC
Confidence 9999999999743
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=336.95 Aligned_cols=248 Identities=19% Similarity=0.346 Sum_probs=195.3
Q ss_pred CCCEEEE-eeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|++. +.||+|+||.||+|.+..+++.||||+++.. ....+.+|+.++.++.+||||+++++++.+ ....++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEE
Confidence 4679885 7899999999999999999999999999643 357789999999997689999999999987 567899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC--eEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--~ikl~DFGla~~~~~~~ 283 (427)
||||+.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||++.......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~ 168 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168 (316)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence 99999999987766 46899999999999999999999999999999999999987652 39999999987653221
Q ss_pred --------cceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-------------HH-
Q 014307 284 --------EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-------------YD- 337 (427)
Q Consensus 284 --------~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~-------------~~- 337 (427)
......|++.|+|||++.+ ...++.++|||||||++|||++|+.||...... ..
T Consensus 169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 248 (316)
T 2ac3_A 169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248 (316)
T ss_dssp -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence 1234468999999999863 135788999999999999999999999543221 11
Q ss_pred HHHHHHHHh----------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 338 QLVKIAKVL----------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 338 ~l~~i~~~~----------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
....+.+.. -++.+.+++.+ |+..||..||++.+++.||||....
T Consensus 249 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 249 LFESIQEGKYEFPDKDWAHISCAAKDLISK-LLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHH-HSCSSTTTSCCHHHHHHSTTCC---
T ss_pred HHHHHhccCcccCchhcccCCHHHHHHHHH-HhhCChhhCCCHHHHhcChhhcCCC
Confidence 222222211 12345555555 9999999999999999999998743
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=339.84 Aligned_cols=243 Identities=20% Similarity=0.355 Sum_probs=205.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH--------------------HHHHHHHHHHHHhcCCCCee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNIV 192 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--------------------~~~~~E~~il~~l~~h~niv 192 (427)
.++|++++.||+|+||.||+|.+ +++.||||++..... +.+.+|+.+++++ +||||+
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~ 106 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYCL 106 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTBC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCcc
Confidence 47899999999999999999998 899999999864221 7889999999999 899999
Q ss_pred eeeeEEEcCCCCCcEEEEeecCCCchhhh------c-----CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceE
Q 014307 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVL------Y-----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVM 260 (427)
Q Consensus 193 ~l~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NIL 260 (427)
++++++.+ ....++||||+.+++|..+ + ..+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 107 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 107 TCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp CCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred eEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999987 4578999999999998876 3 358999999999999999999999 99999999999999
Q ss_pred EcCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH
Q 014307 261 IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 339 (427)
Q Consensus 261 l~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwSlGvll~elltg~~pf~~~~~~~~~l 339 (427)
++.++ .+||+|||++...... ......++..|+|||++.+...++. ++|||||||++|+|++|+.||.......+..
T Consensus 185 ~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 185 MDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp ECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred EcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99777 8999999999876443 4455678999999999887436666 9999999999999999999995444435555
Q ss_pred HHHHHH-------------------------hCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 340 VKIAKV-------------------------LGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 340 ~~i~~~-------------------------~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..+... .-++.+.+++.. |+..||..||++.+++.||||....
T Consensus 263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKL-FLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHH-HCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHH-HccCChhhCCCHHHHhcCccccCCC
Confidence 554322 123455566666 9999999999999999999998744
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=331.96 Aligned_cols=246 Identities=26% Similarity=0.429 Sum_probs=204.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+......+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 36899999999999999999999999999999998642 245688999999999 999999999998766667889
Q ss_pred EEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-----ceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 208 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
+||||+.+++|..++. .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg~ 162 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGL 162 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCCCH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecCch
Confidence 9999999999877763 3899999999999999999999999 99999999999999777 899999999
Q ss_pred eeeecCCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 276 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 276 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
+........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.|| ...+..+....+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~ 240 (279)
T 2w5a_A 163 ARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRY 240 (279)
T ss_dssp HHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred heeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCC-cccCHHHHHHHHhhcccccCCccc
Confidence 976543322 234578999999999887 67999999999999999999999998 44444444444444321
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+.+++.+ |+..||..||++.+++.++|+.+..
T Consensus 241 ~~~l~~li~~-~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 241 SDELNEIITR-MLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp CHHHHHHHHH-HTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred CHHHHHHHHH-HcCCCcccCCCHHHHHhChhhhhhc
Confidence 3455566666 9999999999999999999988743
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=342.81 Aligned_cols=247 Identities=19% Similarity=0.360 Sum_probs=199.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
.++|++++.||+|+||.||+|++. .+++.||||+++.. ..+.+.+|+.+|+++.+||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee--
Confidence 368999999999999999999984 48899999998642 235577899999999779999999999976
Q ss_pred CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 203 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
....++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.+
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEF 209 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEEC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCeec
Confidence 45789999999999987765 4689999999999999999999999999999999999999777 8999999999876
Q ss_pred cCCC--cceeeccCccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CHHHHH-HHHHHhC------
Q 014307 280 HPGK--EYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLV-KIAKVLG------ 347 (427)
Q Consensus 280 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--~~~~l~-~i~~~~~------ 347 (427)
.... .....+||+.|+|||++.+ ...++.++|||||||++|||++|+.||..... ....+. .+.....
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 4322 2234579999999999875 23578999999999999999999999953322 222222 2221111
Q ss_pred ChHHHHHHHhccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
++.+..++.+ |+..||..|| ++++++.|+||....
T Consensus 290 ~~~~~~li~~-~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 290 SALAKDLIQR-LLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp CHHHHHHHHH-HTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHH-HhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 2344555555 9999999999 999999999998744
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=329.26 Aligned_cols=240 Identities=19% Similarity=0.223 Sum_probs=196.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||.||+|++..+++.||||+++.. ....+.+|+.++..+.+||||+++++++.+ ....+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 36799999999999999999999999999999998742 346678899999998789999999999976 55789
Q ss_pred EEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC---------------
Q 014307 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--------------- 265 (427)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--------------- 265 (427)
+||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999998776 3489999999999999999999999999999999999998432
Q ss_pred ---CeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH
Q 014307 266 ---RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342 (427)
Q Consensus 266 ---~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i 342 (427)
..+||+|||++...... ....|++.|+|||++.+...++.++|||||||++|+|++|..++... +....+
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~~~ 240 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----DQWHEI 240 (289)
T ss_dssp --CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----HHHHHH
T ss_pred CCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----hHHHHH
Confidence 26999999999876433 23468999999999887446778999999999999999998776322 223333
Q ss_pred HHHh-------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 343 AKVL-------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 343 ~~~~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
.+.. -++.+.+++.+ |+..||..||++.++++||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 241 RQGRLPRIPQVLSQEFTELLKV-MIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HTTCCCCCSSCCCHHHHHHHHH-HTCSSGGGSCCHHHHHTCTTC---
T ss_pred HcCCCCCCCcccCHHHHHHHHH-HhCCCcccCCCHHHHhhChHhhhh
Confidence 2221 13455566666 999999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=333.49 Aligned_cols=245 Identities=21% Similarity=0.387 Sum_probs=201.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
..++|++++.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.. ....++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFK--NTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCEEEEEe
Confidence 357899999999999999999999999999999998753 347789999999999 99999999999976 55689999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cc
Q 014307 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (427)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~ 285 (427)
||+.+++|..++ ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....... ..
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~ 182 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTMAKR 182 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTTBSCB
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhhcccc
Confidence 999999988765 3689999999999999999999999999999999999999777 89999999998765432 23
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLN 356 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~ 356 (427)
....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||. ..+..+....+..... ++.+.+++.
T Consensus 183 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 260 (314)
T 3com_A 183 NTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYA-DIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVK 260 (314)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHH
T ss_pred CccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhcCCCcccCCcccCCHHHHHHHH
Confidence 45578999999999876 679999999999999999999999994 4444444443333211 345556566
Q ss_pred hccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 357 KYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
. |+..||..||++.+++.|+||....
T Consensus 261 ~-~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 261 Q-CLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp H-HTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred H-HccCChhhCcCHHHHHhCHHHhcCC
Confidence 6 9999999999999999999998754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=356.20 Aligned_cols=244 Identities=16% Similarity=0.185 Sum_probs=190.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhc--CCCCeeeee-------eE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLC--GGPNIVKLL-------DI 197 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~--~h~niv~l~-------~~ 197 (427)
.++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++.+. +||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 47899999999999999999999889999999998632 2467889995555443 899999998 77
Q ss_pred EEcCCC----------C-----CcEEEEeecCCCchhhhcC---CCCH-------HHHHHHHHHHHHHHHHHHHCCceee
Q 014307 198 VRDQQS----------K-----TPSLIFEHVNNTDFKVLYP---TLSD-------YDVRYYIYELLKALDYCHSQGIMHR 252 (427)
Q Consensus 198 ~~~~~~----------~-----~~~lv~e~~~~~~l~~~~~---~~~~-------~~~~~i~~qi~~~L~~LH~~~iiHr 252 (427)
+.+.+. . ..+++|||+ +|+|..++. .+++ ..+..++.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 665321 1 378999999 568776654 3444 7778899999999999999999999
Q ss_pred ccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCC----------CCCCchhhHHHHHHHHHHH
Q 014307 253 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGM 322 (427)
Q Consensus 253 Dlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwSlGvll~el 322 (427)
||||+|||++.++ .+||+|||+|+.. +.......| +.|+|||++.+. ..++.++|||||||++|||
T Consensus 231 Dikp~NIll~~~~-~~kL~DFG~a~~~--~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRG-GVFLTGFEHLVRD--GARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTC-CEEECCGGGCEET--TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC-CEEEEechhheec--CCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999777 8999999999853 334455677 999999998862 1799999999999999999
Q ss_pred HhCCCCCCCCCCCHHHHHHHHHH--hCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 323 IFRKEPFFYGHDNYDQLVKIAKV--LGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 323 ltg~~pf~~~~~~~~~l~~i~~~--~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++|+.||. +....+....+... .-++.+.+++.+ |+..||..||++.+++.||||.+..
T Consensus 307 ltg~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 307 WCADLPIT-KDAALGGSEWIFRSCKNIPQPVRALLEG-FLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHSSCCC-------CCSGGGGSSCCCCCHHHHHHHHH-HTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHCCCCCc-ccccccchhhhhhhccCCCHHHHHHHHH-HcCCCchhCCCHHHHhhChHHHHHH
Confidence 99999994 33322222222221 113456666666 9999999999999999999999754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=340.70 Aligned_cols=243 Identities=24% Similarity=0.417 Sum_probs=192.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCC-CCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h-~niv~l~~~~~~~~~~~ 205 (427)
..++|++++.||+|+||.||+|.+ .+++.||||+++.. ..+.+.+|+.+|+++.+| +||+++++++.. ...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCE
Confidence 357899999999999999999987 56899999998632 235688999999999433 999999999976 567
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+++||| +.+++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+++.....
T Consensus 84 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 84 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCCC---
T ss_pred EEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEEEeecccccccCcc
Confidence 899999 5566776654 4689999999999999999999999999999999999997 45 7999999999876543
Q ss_pred Cc---ceeeccCccccccccccC----------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--
Q 014307 283 KE---YNVRVASRYFKGPELLVD----------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-- 347 (427)
Q Consensus 283 ~~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-- 347 (427)
.. .....||+.|+|||++.+ ...++.++|||||||++|||++|+.||....+....+..+.....
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 32 235679999999999853 256899999999999999999999999544443344443332111
Q ss_pred ------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 348 ------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 348 ------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
.+.+..++.. |+..||..||++.+++.||||..
T Consensus 241 ~~~~~~~~~l~~li~~-~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 241 EFPDIPEKDLQDVLKC-CLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp CCCCCSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHS
T ss_pred CCcccCCHHHHHHHHH-HcCCChhHCCCHHHHHhCccccc
Confidence 1345566665 99999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=352.25 Aligned_cols=196 Identities=18% Similarity=0.278 Sum_probs=170.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEE-----EEcCCCeEEEEEEeccccHHHHHHHHHHHHHhc--CCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~-----~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~--~h~niv~l~~~~~~~~~~ 204 (427)
..++|++.+.||+|+||+||+| .+..+++.||||+++......+.+|+.+++.+. .|+||+++++++.. ..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~--~~ 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF--QN 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC--SS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeec--CC
Confidence 4578999999999999999999 467789999999999888888999999999982 28999999999986 45
Q ss_pred CcEEEEeecCCCchhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC-----------CC
Q 014307 205 TPSLIFEHVNNTDFKVLYP--------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-----------EQ 265 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-----------~~ 265 (427)
..++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++. ++
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 6789999999999987762 4899999999999999999999999999999999999986 45
Q ss_pred CeEEEEeeeeeeeec---CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 014307 266 RKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 331 (427)
Q Consensus 266 ~~ikl~DFGla~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~ 331 (427)
.+||+|||+|+.+. ........+||..|+|||++.+ ..|+.++|||||||++|||++|+.||..
T Consensus 221 -~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 221 -GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp -TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred -CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 89999999997653 2333455689999999999987 6799999999999999999999999954
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=342.83 Aligned_cols=237 Identities=19% Similarity=0.310 Sum_probs=192.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc-------CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
.++|++++.||+|+||.||+|++. .++..||||+++.. ..+.+.+|+.+|+.+.+||||+++++++.+
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ- 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence 478999999999999999999875 34568999999753 235688999999999789999999999976
Q ss_pred CCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEc
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 262 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~ 262 (427)
...+++||||+.+++|..++. .+++.++..++.||+.||+|||++||+||||||+|||++
T Consensus 159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 159 -DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT 237 (370)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred -CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence 567899999999999977652 378889999999999999999999999999999999999
Q ss_pred CCCCeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014307 263 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (427)
Q Consensus 263 ~~~~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~ 338 (427)
.++ .+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|||++ |+.|| .+....+.
T Consensus 238 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~-~~~~~~~~ 314 (370)
T 2psq_A 238 ENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEEL 314 (370)
T ss_dssp TTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGH
T ss_pred CCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCC-CCCCHHHH
Confidence 777 899999999987654322 223456778999999887 689999999999999999999 99888 44444444
Q ss_pred HHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 339 LVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 339 l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...+..... .+.+.+++.. |+..||..||++.+++.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 315 FKLLKEGHRMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 444433221 2345555555 88999999998887765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=328.55 Aligned_cols=244 Identities=24% Similarity=0.518 Sum_probs=206.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||.||+|++..+++.||||++.. ...+.+.+|+.+++++ +||||+++++++.+ ....+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 97 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSSFY 97 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeC--CCeEE
Confidence 3679999999999999999999998999999999854 2356789999999999 99999999999976 55789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~~~~ 282 (427)
+||||+.+++|...+ ..+++..++.++.||+.||.|||++||+||||||+||+++.++ ..+||+|||++......
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999886654 4689999999999999999999999999999999999997543 26999999999876655
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHH
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELN 352 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~ 352 (427)
.......+++.|+|||++.+ .++.++|||||||++|+|++|+.|| .+.+..+.+..+.+... ++.+.
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (287)
T 2wei_A 178 TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPF-YGKNEYDILKRVETGKYAFDLPQWRTISDDAK 254 (287)
T ss_dssp SSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred CccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence 55556678999999999865 5899999999999999999999999 44454555555544311 23455
Q ss_pred HHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 353 AYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+++.+ |+..||..||++.+++.||||.+..
T Consensus 255 ~li~~-~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 255 DLIRK-MLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp HHHHH-HTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred HHHHH-HcccChhhCcCHHHHhcCHHHhccc
Confidence 55555 9999999999999999999998743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=331.39 Aligned_cols=234 Identities=19% Similarity=0.332 Sum_probs=182.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++.+.||+|+||+||+|++ +++.||||++.... .+.+.+|+.+++++ +||||+++++++.. ....+
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 110 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ--PPNLS 110 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--TTCCE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCceE
Confidence 46899999999999999999986 68899999986432 35688999999999 89999999999976 45689
Q ss_pred EEEeecCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 208 LIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
+||||+.+++|..++.. +++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCCCccc
Confidence 99999999999877642 889999999999999999999999 99999999999999777 8999999999755
Q ss_pred cCCC-cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChH
Q 014307 280 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDE 350 (427)
Q Consensus 280 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~ 350 (427)
.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+....+..... ++.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPW-GNLNPAQVVAAVGFKCKRLEIPRNLNPQ 267 (309)
T ss_dssp ------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTT-TTSCHHHHHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhcCCCCCCCccCCHH
Confidence 4332 2345688999999999887 67899999999999999999999999 44444444443322111 234
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+++.. |+..||..||++.+++.
T Consensus 268 l~~li~~-~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 268 VAAIIEG-CWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HccCChhhCcCHHHHHH
Confidence 5555555 88888888888777654
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=343.19 Aligned_cols=243 Identities=23% Similarity=0.370 Sum_probs=201.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..++|++++.||+|+||.||+|.+..+++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 107 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 107 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE--TTEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEE--CCEEE
Confidence 457899999999999999999999999999999998643 235688999999999 99999999999986 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+||||+.+++|..++ ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++..... .
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~-~ 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID-S 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHH-H
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCccccc-c
Confidence 999999999998776 3689999999999999999999996 999999999999999777 899999999965432 2
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHH---------------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI--------------------- 342 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i--------------------- 342 (427)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||... + .+.+..+
T Consensus 186 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPP-D-AKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCC-C-HHHHHHHHC-------------------
T ss_pred cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-C-HHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2344588999999999887 68999999999999999999999999432 2 2221111
Q ss_pred ----------------------HHHh--------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 343 ----------------------AKVL--------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 343 ----------------------~~~~--------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.... -++.+.+++.+ |+..||..||++.+++.||||++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK-CLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHH-HHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHH-HhhcChhhCCCHHHHhhChHhhcch
Confidence 1100 12345566666 9999999999999999999999865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=332.76 Aligned_cols=238 Identities=19% Similarity=0.315 Sum_probs=194.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~l 84 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYK--DKRLNF 84 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEec--CCeeEE
Confidence 357899999999999999999999999999999988543 346688999999999 89999999999986 567899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
||||+.+++|..++ ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceecccccc
Confidence 99999999998775 3589999999999999999999999999999999999999777 899999999987643322
Q ss_pred c---------------eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHH----HHHHHHHH
Q 014307 285 Y---------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD----QLVKIAKV 345 (427)
Q Consensus 285 ~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~----~l~~i~~~ 345 (427)
. ....||+.|+|||++.+ ..++.++|||||||++|||++|..||........ ........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~ 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence 1 14578999999999887 7899999999999999999999999853222110 11111111
Q ss_pred h----CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 346 L----GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 346 ~----~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
. -++.+.+++.. |+..||..||++.+++.
T Consensus 243 ~~~~~~~~~l~~li~~-~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 243 YCPPNCPPSFFPITVR-CCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TCCTTCCTTHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCHHHHHHHHH-HccCChhhCcCHHHHHH
Confidence 1 13456666666 99999999999999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.37 Aligned_cols=200 Identities=25% Similarity=0.412 Sum_probs=168.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||.||+|++..+++.||+|++.. ...+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 86 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE--DDCY 86 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC--SSEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee--CCeE
Confidence 4789999999999999999999999999999999843 1235688999999999 99999999999976 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETS 165 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCcccccccc
Confidence 9999999999998775 3589999999999999999999999999999999999999777 89999999997654332
Q ss_pred --cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014307 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338 (427)
Q Consensus 284 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~ 338 (427)
......|++.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+....+.
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf-~~~~~~~~ 220 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPF-NGETAVSI 220 (294)
T ss_dssp ---------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CSSCHHHH
T ss_pred ccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCChHHH
Confidence 2234578999999999987 67899999999999999999999999 44443333
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=348.30 Aligned_cols=241 Identities=22% Similarity=0.345 Sum_probs=199.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++++ +||||+++++++........+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCeeE
Confidence 357899999999999999999999999999999999742 346678999999999 999999999999887666889
Q ss_pred EEEeecCCCchhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE----cCCCCeEEEEeeeeee
Q 014307 208 LIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGLAE 277 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~~ikl~DFGla~ 277 (427)
+||||+.+++|..++.. +++..++.++.||+.||+|||++||+||||||+|||+ +.++ .+||+|||+++
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~a~ 164 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGAAR 164 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECCGGGCE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEecCCCce
Confidence 99999999999888753 8999999999999999999999999999999999998 5444 79999999999
Q ss_pred eecCCCcceeeccCccccccccccCC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCC---CCCHHHHHHHHHHhC
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAGMIFRKEPFFYG---HDNYDQLVKIAKVLG 347 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwSlGvll~elltg~~pf~~~---~~~~~~l~~i~~~~~ 347 (427)
............|++.|+|||++.+. ..++.++|||||||++|||++|+.||... ....+.+..+.....
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p 244 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence 87666666667899999999997531 45788999999999999999999999533 233445544443211
Q ss_pred C-------------------------------hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 T-------------------------------DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 ~-------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
. +.+..++.. |+..||..|+++.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~-~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN-ILEADQEKCWGFDQFFA 302 (396)
T ss_dssp TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHH-HSCCCTTTSCCHHHHHH
T ss_pred cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHH-hhccChhhhccHHHHHH
Confidence 0 133344444 99999999999888644
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.94 Aligned_cols=241 Identities=19% Similarity=0.305 Sum_probs=194.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEE-----EcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++++.||+|+||.||+|+ +..+++.||||+++... .+.+.+|+.+++++.+||||+++++++.+.
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~- 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC-
Confidence 45789999999999999999998 45567999999997532 356889999999998899999999998764
Q ss_pred CCCcEEEEeecCCCchhhhcCC----------------------------------------------------------
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPT---------------------------------------------------------- 224 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~---------------------------------------------------------- 224 (427)
...+++||||+.+++|..++..
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4458999999999998766521
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc---ceeecc
Q 014307 225 -----------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVA 290 (427)
Q Consensus 225 -----------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~---~~~~~~ 290 (427)
+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....... .....+
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccCC
Confidence 78889999999999999999999999999999999999777 899999999986543322 234567
Q ss_pred CccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHHHhccCCC
Q 014307 291 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYLNKYHIEL 362 (427)
Q Consensus 291 ~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~ 362 (427)
|..|+|||++.+ ..++.++|||||||++|||++ |+.||............+.... -.+.+.+++.. |+..
T Consensus 258 t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~ 335 (359)
T 3vhe_A 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLD-CWHG 335 (359)
T ss_dssp CGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHH-HTCS
T ss_pred CceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHH-HccC
Confidence 888999999876 789999999999999999998 9999944333433333333321 12456666665 8899
Q ss_pred ChhHHHHHhHHhcC
Q 014307 363 DPHLAALVGRLVIL 376 (427)
Q Consensus 363 dp~~r~~~~~ll~~ 376 (427)
||..||++.+++.+
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999988887653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=336.14 Aligned_cols=237 Identities=22% Similarity=0.282 Sum_probs=191.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|++.+.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+++.+.+||||+++++++.. ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEEE
Confidence 47899999999999999999999999999999998643 345688999999999899999999999987 567899999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCe-----EEEEeeeeeeeecCC
Q 014307 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-----LRLIDWGLAEFYHPG 282 (427)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~-----ikl~DFGla~~~~~~ 282 (427)
|+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ . +||+|||+++.+...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEESBCT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccceeeecC
Confidence 99 88877664 3699999999999999999999999999999999999998766 4 999999999876543
Q ss_pred Cc--------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHHH-------
Q 014307 283 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKV------- 345 (427)
Q Consensus 283 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~--~~~~~l~~i~~~------- 345 (427)
.. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... +..+.+..+...
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 32 245689999999999887 789999999999999999999999995432 122223333221
Q ss_pred ---hCChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 346 ---LGTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 346 ---~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+.+..++.. |+..||..||+++++..
T Consensus 243 ~~~~~~p~~~~li~~-~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 243 VLCENFPEMATYLRY-VRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHTTTCHHHHHHHHH-HHHCCTTCCCCHHHHHH
T ss_pred HHhccChHHHHHHHH-HHhCCCCCCCCHHHHHH
Confidence 113344444444 77777877777666554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=334.69 Aligned_cols=237 Identities=18% Similarity=0.314 Sum_probs=190.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCC---eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..++|++.+.||+|+||.||+|++..++ ..||||+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~ 123 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTR--GR 123 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECG--GG
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence 3578999999999999999999997555 45999999753 235688999999999 99999999999976 45
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++||||+.+++|..++ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLE 202 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCcccccc
Confidence 688999999999998776 3689999999999999999999999999999999999999777 89999999998765
Q ss_pred CCCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 014307 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (427)
Q Consensus 281 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~ 348 (427)
..... ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+....+..... +
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPY-WNMTNRDVISSVEEGYRLPAPMGCP 280 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTTCCCCCCTTCC
T ss_pred cCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCc-ccCCHHHHHHHHHcCCCCCCCCCcC
Confidence 43221 22345667999999876 679999999999999999999 99998 44555555555544322 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+.+++.. |+..||..||++.+++.
T Consensus 281 ~~l~~li~~-~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 281 HALHQLMLD-CWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHH-HccCChhhCcCHHHHHH
Confidence 344455555 88888888887766554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=339.09 Aligned_cols=246 Identities=28% Similarity=0.498 Sum_probs=199.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhc----------CCCCeeeeeeEEEc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLC----------GGPNIVKLLDIVRD 200 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~----------~h~niv~l~~~~~~ 200 (427)
.++|++++.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++++. +|+||+++++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 47899999999999999999999999999999999753 2466889999999883 27999999999875
Q ss_pred CC--CCCcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCC-----Ce
Q 014307 201 QQ--SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQ-----RK 267 (427)
Q Consensus 201 ~~--~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~-----~~ 267 (427)
.. ...++++||++ +++|..++ ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ ..
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~ 176 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcce
Confidence 32 33789999999 77776554 2489999999999999999999998 999999999999995322 27
Q ss_pred EEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHH
Q 014307 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-----DNYDQLVKI 342 (427)
Q Consensus 268 ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-----~~~~~l~~i 342 (427)
+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .+.+.+..+
T Consensus 177 ~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (373)
T 1q8y_A 177 IKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253 (373)
T ss_dssp EEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred EEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence 99999999986543 3445688999999999987 679999999999999999999999995332 133445555
Q ss_pred HHHhCC------------------------------------------------hHHHHHHHhccCCCChhHHHHHhHHh
Q 014307 343 AKVLGT------------------------------------------------DELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 343 ~~~~~~------------------------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
.+.++. +.+.+++. .|+..||..||++.+++
T Consensus 254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~-~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS-PMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG-GGGCSSTTTCBCHHHHH
T ss_pred HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH-HHhccCccccCCHHHHh
Confidence 554442 12334444 49999999999999999
Q ss_pred cCCchhhHH
Q 014307 375 ILSYFFQFV 383 (427)
Q Consensus 375 ~~~~~~~~~ 383 (427)
.||||.+..
T Consensus 333 ~hp~f~~~~ 341 (373)
T 1q8y_A 333 NHPWLKDTL 341 (373)
T ss_dssp TCGGGTTCT
T ss_pred hChhhhccc
Confidence 999999743
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=330.64 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=200.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.......
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCCe
Confidence 36799999999999999999999999999999999643 236688999999999 8999999999997665678
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.++||||+.++....+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCT
T ss_pred EEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCc
Confidence 89999999988433221 3589999999999999999999999999999999999999777 899999999987643
Q ss_pred C---CcceeeccCccccccccccCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHH
Q 014307 282 G---KEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDEL 351 (427)
Q Consensus 282 ~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~ 351 (427)
. .......|+..|+|||++.+.. .++.++|||||||++|+|++|+.|| .+.+..+....+.+.. -.+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF-EGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC-CCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 2 2233457899999999987522 2478999999999999999999999 4444444444444321 13455
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+++.+ |+..||..||++.+++.|+||.+..
T Consensus 241 ~~li~~-~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 241 SDLLKG-MLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp HHHHHH-HTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred HHHHHH-HccCChhhCCCHHHHhcCcccccCC
Confidence 566666 9999999999999999999998743
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=331.42 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=192.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC---------
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ--------- 202 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~--------- 202 (427)
++|++++.||+|+||.||+|++..+++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhccc
Confidence 5799999999999999999999999999999998643 235688999999999 9999999999886532
Q ss_pred --CCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 203 --SKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 203 --~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
....++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~ 163 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGLA 163 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCCC
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCcch
Confidence 356799999999999987763 467889999999999999999999999999999999999777 8999999999
Q ss_pred eeecCC---------------CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 014307 277 EFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (427)
Q Consensus 277 ~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~ 341 (427)
...... .......|+..|+|||++.+...++.++|||||||++|+|++ ||..+.+..+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~ 240 (303)
T 1zy4_A 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKK 240 (303)
T ss_dssp SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHH
T ss_pred hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHh
Confidence 765321 123445788999999998865579999999999999999998 66433232333333
Q ss_pred HHHHhC----------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 342 IAKVLG----------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 342 i~~~~~----------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+..... .+.+.+++.. |+..||..||++.+++.||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 241 LRSVSIEFPPDFDDNKMKVEKKIIRL-LIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHSTTCCCCTTCCTTTSHHHHHHHHH-HTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred ccccccccCccccccchHHHHHHHHH-HHhcCcccCcCHHHHhCCCCcCCCC
Confidence 322111 1224455555 9999999999999999999997643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.16 Aligned_cols=244 Identities=16% Similarity=0.270 Sum_probs=196.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEE-----EcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++++.||+|+||.||+|+ +..+++.||||+++.. ....+.+|+.+++++ +||||+++++++..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-- 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ-- 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEec--
Confidence 35789999999999999999999 4457789999998642 234688999999999 99999999999975
Q ss_pred CCCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEE
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRL 270 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl 270 (427)
....++||||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 556789999999999887752 388999999999999999999999999999999999998543 25999
Q ss_pred EeeeeeeeecCC---CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 014307 271 IDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 346 (427)
Q Consensus 271 ~DFGla~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~ 346 (427)
+|||+++..... .......+|+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+.+..+....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf-~~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHTTC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC
Confidence 999999754221 22234567889999999876 689999999999999999998 88888 5555555555554432
Q ss_pred C-------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 347 G-------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 347 ~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
. ++.+.+++.. |+..||..||++.+++.+.++..
T Consensus 304 ~~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 RMDPPKNCPGPVYRIMTQ-CWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHH-HcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 2345555555 99999999999999998766443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=329.86 Aligned_cols=240 Identities=22% Similarity=0.325 Sum_probs=192.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeeeeEEEcC--CCCCcEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQ--QSKTPSL 208 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~~h~niv~l~~~~~~~--~~~~~~l 208 (427)
..++|++++.||+|+||+||+|++ +++.||||++.......+.+|.+++... .+||||+++++++... ....+++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 357899999999999999999987 7899999999887778888888888873 2899999999987643 2346789
Q ss_pred EEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHH--------HCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 209 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH--------~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
||||+.+++|..++. .+++..+..++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+++.
T Consensus 84 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~ 162 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVM 162 (301)
T ss_dssp EECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred ehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeCCCeee
Confidence 999999999988775 5899999999999999999999 99999999999999999777 899999999987
Q ss_pred ecCCCcc-----eeeccCccccccccccCCC-----CCCchhhHHHHHHHHHHHHhC----------CCCCCCCCC---C
Q 014307 279 YHPGKEY-----NVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFR----------KEPFFYGHD---N 335 (427)
Q Consensus 279 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGvll~elltg----------~~pf~~~~~---~ 335 (427)
....... ....||+.|+|||++.+.. .++.++|||||||++|||++| +.||..... .
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~ 242 (301)
T 3q4u_A 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242 (301)
T ss_dssp EETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred cccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcc
Confidence 6544332 2347899999999987632 345799999999999999999 888854322 2
Q ss_pred HHHHHHHHHHhC--------------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 336 YDQLVKIAKVLG--------------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 336 ~~~l~~i~~~~~--------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+.......+ .+.+.+++.. |+..||..||++.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE-CWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHH-HCCSSGGGSCCHHHHHH
T ss_pred hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHH-HhhcChhhCCCHHHHHH
Confidence 333333221111 0234455555 99999999999888765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=335.27 Aligned_cols=245 Identities=20% Similarity=0.365 Sum_probs=180.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++++ +||||+++++++.. ....++
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 90 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVV--KDELWL 90 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEES--SSCEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEee--cCCcEE
Confidence 57899999999999999999999889999999998643 235678899999999 99999999999987 446889
Q ss_pred EEeecCCCchhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 209 IFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 209 v~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~ 169 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSA 169 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEeccchh
Confidence 999999999876653 389999999999999999999999999999999999999777 89999999987
Q ss_pred eecCCC------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-----
Q 014307 278 FYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----- 346 (427)
Q Consensus 278 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----- 346 (427)
...... ......|++.|+|||++.+...++.++|||||||++|+|++|+.||.. ....+.........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~~~~~~~ 248 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK-YPPMKVLMLTLQNDPPSLE 248 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT-SCGGGHHHHHHTSSCCCTT
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc-CchhhHHHHHhccCCCccc
Confidence 654322 123457899999999986545789999999999999999999999943 33333332222110
Q ss_pred -----------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 347 -----------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 -----------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
-.+.+.+++.. |+..||..||++.+++.|+||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 249 TGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp C-----CCCCCCCHHHHHHHHH-HCCSSGGGSCCHHHHHTSTTC----
T ss_pred cccccchhhhhhhHHHHHHHHH-HccCChhhCcCHHHHhhChhhhcCC
Confidence 01345555555 9999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=328.21 Aligned_cols=196 Identities=21% Similarity=0.407 Sum_probs=167.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEE----EcCCCeEEEEEEeccccH---HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~~~---~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..++|+++++||+|+||+||+|+ +..+++.||||+++.... +.+.+|+.+++++ +||||+++++++...+..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHHT
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCC
Confidence 35789999999999999999998 566899999999975433 5688999999999 899999999999766566
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
.+++||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLP 165 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC---
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCccccccc
Confidence 7899999999999987763 389999999999999999999999999999999999999777 89999999998765
Q ss_pred CCCc----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 014307 281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330 (427)
Q Consensus 281 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 330 (427)
.... .....++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred CCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccC
Confidence 4322 223356677999999886 689999999999999999999999883
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=345.53 Aligned_cols=245 Identities=16% Similarity=0.158 Sum_probs=182.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhc-CCCCeeeee-------eEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC-GGPNIVKLL-------DIVR 199 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~-~h~niv~l~-------~~~~ 199 (427)
.+|++.+.||+|+||.||+|++..+++.||||+++... .+.+.+|+.+++.+. +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45999999999999999999999999999999997632 355778888777774 499987755 5555
Q ss_pred cCCC---------------CCcEEEEeecCCCchhhhcC----CCCHHHH------HHHHHHHHHHHHHHHHCCceeecc
Q 014307 200 DQQS---------------KTPSLIFEHVNNTDFKVLYP----TLSDYDV------RYYIYELLKALDYCHSQGIMHRDV 254 (427)
Q Consensus 200 ~~~~---------------~~~~lv~e~~~~~~l~~~~~----~~~~~~~------~~i~~qi~~~L~~LH~~~iiHrDl 254 (427)
.... ..+++||||+. ++|..++. .+.+..+ ..++.||+.||+|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 4322 33799999999 78877664 2444444 577799999999999999999999
Q ss_pred CCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 014307 255 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 333 (427)
Q Consensus 255 kp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~ 333 (427)
||+|||++.++ .+||+|||+|+... .......+++.|+|||++.+ ...++.++|||||||++|||++|+.||....
T Consensus 221 kp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 297 (371)
T 3q60_A 221 TPDNLFIMPDG-RLMLGDVSALWKVG--TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297 (371)
T ss_dssp SGGGEEECTTS-CEEECCGGGEEETT--CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred CHHHEEECCCC-CEEEEecceeeecC--CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence 99999999777 89999999998653 22224567799999999864 2468999999999999999999999995432
Q ss_pred CCHHH-HHH------------HHHH-hCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 334 DNYDQ-LVK------------IAKV-LGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 334 ~~~~~-l~~------------i~~~-~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
..... ... .... .-++.+.+++.+ |+..||..||++.+++.||||.+..
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR-FLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHH-HTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred cccccchhhhhhhhccccccchhhccCCCHHHHHHHHH-HcCCChhhCCCHHHHhcCHHHHHHH
Confidence 11000 000 0000 113455555555 9999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=322.60 Aligned_cols=236 Identities=17% Similarity=0.335 Sum_probs=195.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++++.||+|+||.||+|++. +++.||+|++... ..+.+.+|+.+++++ +||||+++++++.+ ....++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCceEEEE
Confidence 478999999999999999999985 6788999999753 457799999999999 89999999999976 55689999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--c
Q 014307 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~--~ 284 (427)
||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||++....... .
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHS
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEecccccccccccccccc
Confidence 9999999887763 389999999999999999999999999999999999998776 89999999997654322 1
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| .+....+....+..... ++.+.+++.
T Consensus 164 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCC-CCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 223355678999999876 689999999999999999999 88888 45555555555544321 345555555
Q ss_pred hccCCCChhHHHHHhHHhcC
Q 014307 357 KYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~ 376 (427)
. |+..||..||++.+++++
T Consensus 242 ~-~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 242 H-CWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp H-HTCSSGGGSCCHHHHHHH
T ss_pred H-HccCCcccCcCHHHHHHH
Confidence 5 899999999998887763
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=331.14 Aligned_cols=248 Identities=18% Similarity=0.326 Sum_probs=182.6
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCe---EEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
...++|++++.||+|+||.||+|++..++. .||||+++.. ..+.+.+|+.+++++ +||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccc
Confidence 346789999999999999999999877665 8999998642 346788999999999 9999999999997643
Q ss_pred CC----CcEEEEeecCCCchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEE
Q 014307 203 SK----TPSLIFEHVNNTDFKVLYP---------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (427)
Q Consensus 203 ~~----~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ik 269 (427)
.. ..++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~k 177 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVC 177 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEE
Confidence 22 2389999999999877652 489999999999999999999999999999999999999776 899
Q ss_pred EEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014307 270 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 345 (427)
Q Consensus 270 l~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~ 345 (427)
|+|||+++........ ....+++.|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPY-AGIENAEIYNYLIGG 255 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCc-cccChHHHHHHHhcC
Confidence 9999999876443322 23456678999999877 689999999999999999999 88888 555555555544433
Q ss_pred hC-------ChHHHHHHHhccCCCChhHHHH-------HhHHhcCCchhhHH
Q 014307 346 LG-------TDELNAYLNKYHIELDPHLAAL-------VGRLVILSYFFQFV 383 (427)
Q Consensus 346 ~~-------~~~~~~~l~~~~l~~dp~~r~~-------~~~ll~~~~~~~~~ 383 (427)
.. .+.+.+++.+ |+..||..||+ +++++.++|+....
T Consensus 256 ~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 256 NRLKQPPECMEEVYDLMYQ-CWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp CCCCCCTTCCHHHHHHHHH-TTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CCCCCCCccCHHHHHHHHH-HccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 21 2455565666 99999999999 78888888877633
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=327.79 Aligned_cols=259 Identities=19% Similarity=0.324 Sum_probs=189.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH----HHHHHH-HHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKRE-IKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E-~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||.||+|++..+++.||||++..... .....| ..+++.+ +||||+++++++.. ...++
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~--~~~~~ 100 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFIT--NTDVF 100 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEEC--SSEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEec--CCcEE
Confidence 4689999999999999999999999999999999965321 223334 4456666 99999999999986 45789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+||||+ ++.+..+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhccCC
Confidence 999999 44444332 4689999999999999999999995 999999999999999777 8999999999876555
Q ss_pred CcceeeccCcccccccccc----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------Ch
Q 014307 283 KEYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TD 349 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~ 349 (427)
.......+++.|+|||++. ....++.++|||||||++|+|++|+.||.......+.+..+..... ++
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 2dyl_A 179 KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSG 258 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCH
T ss_pred ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCH
Confidence 5555668999999999985 2356899999999999999999999999654555555555554321 24
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhh
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFL 405 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l 405 (427)
.+..++.. |+..||..||++.+++.|+||.+... ...+..++++..+
T Consensus 259 ~l~~li~~-~l~~dp~~Rps~~~ll~h~~~~~~~~--------~~~~~~~~~~~~~ 305 (318)
T 2dyl_A 259 DFQSFVKD-CLTKDHRKRPKYNKLLEHSFIKRYET--------LEVDVASWFKDVM 305 (318)
T ss_dssp HHHHHHHH-HTCSCTTTSCCHHHHTTSHHHHHHHH--------SCCCHHHHHHHHH
T ss_pred HHHHHHHH-HccCChhHCcCHHHHhhCHHHHhccc--------ccchhHHHhhccc
Confidence 55565555 99999999999999999999998552 3334445555544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.39 Aligned_cols=237 Identities=15% Similarity=0.288 Sum_probs=195.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++|++++.||+|+||.||+|.+. ++..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSK--EYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCceEEE
Confidence 3578999999999999999999874 6778999999753 457789999999999 89999999999965 5678999
Q ss_pred EeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 210 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
|||+.+++|..++. .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCEE
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchhhhh
Confidence 99999999877653 489999999999999999999999999999999999999777 8999999999876544322
Q ss_pred --eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-------CChHHHHHH
Q 014307 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTDELNAYL 355 (427)
Q Consensus 286 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-------~~~~~~~~l 355 (427)
....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| ......+....+.... .++.+.+++
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPY-DLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM 238 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred cccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCc-cccChHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence 22344567999999876 678999999999999999999 99998 4445445444444332 134555555
Q ss_pred HhccCCCChhHHHHHhHHhcC
Q 014307 356 NKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.. |+..||..||++.+++.+
T Consensus 239 ~~-~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 239 YS-CWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HH-TTCSSGGGSCCHHHHHHH
T ss_pred HH-HcCCChhhCcCHHHHHHH
Confidence 55 999999999998888764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.71 Aligned_cols=238 Identities=20% Similarity=0.317 Sum_probs=193.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCC-------CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~ 200 (427)
..++|++.++||+|+||.||+|++..+ +..||||+++... ...+.+|+++++.+.+||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 357899999999999999999997543 3689999997532 25688999999999889999999999976
Q ss_pred CCCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE
Q 014307 201 QQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (427)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 261 (427)
....++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 147 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 147 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 556899999999999987752 38999999999999999999999999999999999999
Q ss_pred cCCCCeEEEEeeeeeeeecCCC---cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014307 262 DHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYD 337 (427)
Q Consensus 262 ~~~~~~ikl~DFGla~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~ 337 (427)
+.++ .+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+
T Consensus 225 ~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~-~~~~~~~ 301 (382)
T 3tt0_A 225 TEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVPVEE 301 (382)
T ss_dssp CTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHH
T ss_pred cCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCC-CCCCHHH
Confidence 9777 89999999998664432 2233456788999999987 789999999999999999999 99888 4444444
Q ss_pred HHHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 338 QLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 338 ~l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
....+.+... .+.+.+++.. |+..||..||++.+++.
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~ell~ 345 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVE 345 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 4444433211 2455555555 88999999998877765
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=325.04 Aligned_cols=237 Identities=14% Similarity=0.239 Sum_probs=191.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCC-------eEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
..++|++.+.||+|+||.||+|++..++ ..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~- 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCVC- 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC-
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe-
Confidence 3578999999999999999999988776 57999998643 346789999999999 89999999999976
Q ss_pred CCCCcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCe-------EEE
Q 014307 202 QSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-------LRL 270 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~-------ikl 270 (427)
....++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++.. +||
T Consensus 84 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 84 -GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp -TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred -CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 456789999999999987763 38999999999999999999999999999999999999877621 999
Q ss_pred EeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----
Q 014307 271 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---- 346 (427)
Q Consensus 271 ~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---- 346 (427)
+|||++.... ......++..|+|||++.+...++.++|||||||++|||++|..|++...+............
T Consensus 163 ~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (289)
T 4fvq_A 163 SDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239 (289)
T ss_dssp CCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred ccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC
Confidence 9999986432 223456788999999988656799999999999999999997777755544433333222211
Q ss_pred -CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 -GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 -~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
..+.+.+++.. |+..||..||++.+++.
T Consensus 240 ~~~~~l~~li~~-~l~~dp~~Rps~~~ll~ 268 (289)
T 4fvq_A 240 PKAAELANLINN-CMDYEPDHRPSFRAIIR 268 (289)
T ss_dssp CSSCTTHHHHHH-HSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 12345555555 88888888888777654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=335.62 Aligned_cols=202 Identities=17% Similarity=0.266 Sum_probs=164.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCC-----CeEEEEEEeccccHHHHHHHHHHHHHhc--------------CCCCee
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVKKKKIKREIKILQNLC--------------GGPNIV 192 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~E~~il~~l~--------------~h~niv 192 (427)
..++|++++.||+|+||.||+|.+..+ ++.||||++.... ..+.+|+.+++++. +||||+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 457899999999999999999998765 5889999986543 23444555444432 599999
Q ss_pred eeeeEEEcCCC--CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEc--CC
Q 014307 193 KLLDIVRDQQS--KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HE 264 (427)
Q Consensus 193 ~l~~~~~~~~~--~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~--~~ 264 (427)
++++++..... .+.++||||+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 99999876422 5689999999 88887765 4689999999999999999999999999999999999998 55
Q ss_pred CCeEEEEeeeeeeeecCCCc--------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH
Q 014307 265 QRKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 336 (427)
Q Consensus 265 ~~~ikl~DFGla~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~ 336 (427)
+ .+||+|||+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....+.
T Consensus 191 ~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 191 D-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp T-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred C-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 5 899999999987643321 133459999999999887 679999999999999999999999995434443
Q ss_pred H
Q 014307 337 D 337 (427)
Q Consensus 337 ~ 337 (427)
.
T Consensus 269 ~ 269 (364)
T 3op5_A 269 K 269 (364)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=340.02 Aligned_cols=237 Identities=21% Similarity=0.350 Sum_probs=192.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+|+.+|+++ +||||+++++++.. ...++
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 188 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIY 188 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECS--SSSCE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEec--CCCcE
Confidence 3578999999999999999999998899999999987532 24577899999999 99999999999965 45689
Q ss_pred EEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+||||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGV 267 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECTTSE
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCceecCCCc
Confidence 9999999999877653 489999999999999999999999999999999999999777 89999999998654321
Q ss_pred cc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHH
Q 014307 284 EY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELN 352 (427)
Q Consensus 284 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~ 352 (427)
.. ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+....+.+... ++.+.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 345 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPY-PNLSNQQTREFVEKGGRLPCPELCPDAVF 345 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSS-TTSCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred eeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 11 11234567999999876 679999999999999999998 88888 44444444444433211 23455
Q ss_pred HHHHhccCCCChhHHHHHhHHhc
Q 014307 353 AYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+++.. |+..||..||++.+++.
T Consensus 346 ~li~~-cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 346 RLMEQ-CWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHH-HcCCCchhCcCHHHHHH
Confidence 55555 99999999999888754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.90 Aligned_cols=237 Identities=19% Similarity=0.300 Sum_probs=189.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|++.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.+.+|+|++++++++.+ ....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEEEE
Confidence 47899999999999999999999999999999998643 345688999999999889999999999876 567899999
Q ss_pred ecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC----eEEEEeeeeeeeecCCC
Q 014307 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR----KLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~----~ikl~DFGla~~~~~~~ 283 (427)
|+ +++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++......
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 99 888877653 5899999999999999999999999999999999999986552 39999999998765432
Q ss_pred c--------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHHHh-------
Q 014307 284 E--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKVL------- 346 (427)
Q Consensus 284 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~--~~~~~l~~i~~~~------- 346 (427)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...+.+..+....
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 244 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence 2 244578999999999877 679999999999999999999999995432 2223333332221
Q ss_pred ---C-ChHHHHHHHhccCCCChhHHHHHhHHh
Q 014307 347 ---G-TDELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 347 ---~-~~~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
+ ++.+.+++.. |+..||..||++.+++
T Consensus 245 ~~~~~~~~l~~li~~-~l~~dp~~RP~~~~l~ 275 (298)
T 1csn_A 245 LCAGFPEEFYKYMHY-ARNLAFDATPDYDYLQ 275 (298)
T ss_dssp HTTTSCHHHHHHHHH-HHHCCTTCCCCHHHHH
T ss_pred HHhhCcHHHHHHHHH-HhcCCcccCCCHHHHH
Confidence 1 2233344444 6666777666655543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=332.21 Aligned_cols=238 Identities=18% Similarity=0.246 Sum_probs=188.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeeeeEEEcCC--CCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQ--SKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~~h~niv~l~~~~~~~~--~~~~~l 208 (427)
.++|+++++||+|+||+||+|++ .++.||||+++.... ....+|+.+++++ +||||+++++++.... ...+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCceEEE
Confidence 47899999999999999999987 489999999975443 3456688889998 9999999999998643 234689
Q ss_pred EEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC----------CceeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 209 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 209 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~----------~iiHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
||||+.+++|..++. .+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++
T Consensus 100 v~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a 178 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLA 178 (322)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred EEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEccCCcc
Confidence 999999999987763 589999999999999999999999 999999999999999776 8999999999
Q ss_pred eeecCCCc---ceeeccCccccccccccCC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------------C
Q 014307 277 EFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------------N 335 (427)
Q Consensus 277 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwSlGvll~elltg~~pf~~~~~--------------~ 335 (427)
+....... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||....+ .
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 87754432 2335789999999998762 3456788999999999999999999953221 1
Q ss_pred HHHHHHHHHHhCC--------------hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 336 YDQLVKIAKVLGT--------------DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 336 ~~~l~~i~~~~~~--------------~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+......... +.+.+++.+ |+..||..||++.+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE-CWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred hhhhhhhhhcccCCCCccccccccchHHHHHHHHHH-HccCChhhCcCHHHHHH
Confidence 2222221111110 124455555 89999999999888765
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=332.77 Aligned_cols=245 Identities=23% Similarity=0.419 Sum_probs=175.9
Q ss_pred CCCEEEEe-eeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--CCCCcEEE
Q 014307 133 QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~--~~~~~~lv 209 (427)
.++|++.+ .||+|+||.||+|+++.+++.||||++... ....+|+..+.++.+||||+++++++... ....+++|
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 104 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLII 104 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEE
Confidence 47899965 599999999999999999999999999753 33445555544444999999999998752 23457899
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeeecCC
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~~~~ 282 (427)
|||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||++.....
T Consensus 105 ~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~- 183 (336)
T 3fhr_A 105 MECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ- 183 (336)
T ss_dssp EECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-
Confidence 99999999877753 489999999999999999999999999999999999997543 3599999999986543
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH----HHHHHH----------hCC
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL----VKIAKV----------LGT 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l----~~i~~~----------~~~ 348 (427)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..... ..+... .-+
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3fhr_A 184 NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNT-GQAISPGMKRRIRLGQYGFPNPEWSEVS 261 (336)
T ss_dssp ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCTTTSTTCC
T ss_pred cccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCcc-chhhhhhHHHhhhccccccCchhhccCC
Confidence 33445678999999999866 678999999999999999999999994332 22111 111111 013
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+.+++.+ |+..||..||++.+++.||||.+..
T Consensus 262 ~~~~~li~~-~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 262 EDAKQLIRL-LLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp HHHHHHHHH-HSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred HHHHHHHHH-HCCCChhHCcCHHHHhcCccccccc
Confidence 455565655 9999999999999999999998744
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=331.33 Aligned_cols=237 Identities=20% Similarity=0.325 Sum_probs=191.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++++.||+|+||.||+|++. .+++.||||+++... .+.+.+|+.+++++ +||||+++++++.+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 121 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV-- 121 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc--
Confidence 3578999999999999999999987 345899999997532 35688999999999 99999999999976
Q ss_pred CCCcEEEEeecCCCchhhhc---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccC
Q 014307 203 SKTPSLIFEHVNNTDFKVLY---------------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~---------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk 255 (427)
....++||||+.+++|..++ ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 56789999999999987765 358889999999999999999999999999999
Q ss_pred CCceEEcCCCCeEEEEeeeeeeeecCCC---cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 014307 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFY 331 (427)
Q Consensus 256 p~NILl~~~~~~ikl~DFGla~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~ 331 (427)
|+|||++.++ .+||+|||+++...... ......++..|+|||++.+ ..++.++|||||||++|||++ |..|| .
T Consensus 202 p~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~-~ 278 (343)
T 1luf_A 202 TRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY-Y 278 (343)
T ss_dssp GGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-T
T ss_pred cceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcC-C
Confidence 9999999777 89999999997653322 1234467888999999876 679999999999999999999 99998 4
Q ss_pred CCCCHHHHHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 332 GHDNYDQLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 332 ~~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+....+....+.+... ++.+.+++.. |+..||..||++.+++.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRL-CWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHH-HcccCcccCCCHHHHHH
Confidence 4444444444433211 2344455544 88888888888777653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.82 Aligned_cols=240 Identities=21% Similarity=0.326 Sum_probs=193.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.+.||+|+||.||+|.+. .++..||||+++.. ..+.+.+|+.+++++.+||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 4578999999999999999999973 45678999998643 236688999999999789999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcCC--------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPT--------------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~--------------------------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp 256 (427)
....++||||+.+++|..++.. +++..++.++.||+.||.|||++||+||||||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 200 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 5568999999999998776532 68889999999999999999999999999999
Q ss_pred CceEEcCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 014307 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYG 332 (427)
Q Consensus 257 ~NILl~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~ 332 (427)
+|||++.++ .+||+|||++......... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...
T Consensus 201 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 201 RNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp GGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred hhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 999999777 8999999999866443322 23456778999999876 689999999999999999998 99999544
Q ss_pred CCCHHHHHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 333 HDNYDQLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 333 ~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.........+..... ++.+..++.. |+..||..||++.+++.+
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQS-CWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH-HcCCCchhCcCHHHHHHH
Confidence 333333333322211 3455555555 899999999998887763
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.66 Aligned_cols=244 Identities=22% Similarity=0.412 Sum_probs=198.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhc-CCCCeeeeeeEEEcC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQ 201 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~-~h~niv~l~~~~~~~ 201 (427)
..++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+|+.+++++. .|+||+++++++..
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~- 119 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 119 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec-
Confidence 4578999999999999999999999999999999986432 244678999999994 36999999999986
Q ss_pred CCCCcEEEEeecCC-Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 202 QSKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 202 ~~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
....++|||++.+ ++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+...+||+|||++.
T Consensus 120 -~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 120 -PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp -SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred -CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 4568899999986 7777665 4689999999999999999999999999999999999998444489999999998
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHH---HHhCChHHHHH
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA---KVLGTDELNAY 354 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~---~~~~~~~~~~~ 354 (427)
.... .......|++.|+|||++.+...++.++|||||||++|||++|+.||... +....-. ...-++.+.++
T Consensus 199 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~~~~~~~~~~~~~~l 273 (320)
T 3a99_A 199 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIRGQVFFRQRVSSECQHL 273 (320)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHHHCCCCCSSCCCHHHHHH
T ss_pred cccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----hhhhcccccccccCCHHHHHH
Confidence 7653 33445678999999999876444578999999999999999999999321 1111000 00113455565
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+ |+..||..||++.+++.|+||.+..
T Consensus 274 i~~-~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 274 IRW-CLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHH-HTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHH-HccCChhhCcCHHHHhcCHhhcCcc
Confidence 655 9999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.79 Aligned_cols=236 Identities=17% Similarity=0.285 Sum_probs=192.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++++.||+|+||.||+|.+. ++..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEec--CCCeEEEE
Confidence 478999999999999999999874 7788999999753 457789999999999 89999999999965 56789999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc--
Q 014307 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (427)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-- 284 (427)
||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 99 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBCCHHHHS
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEcccccccccccccccc
Confidence 999999987775 3599999999999999999999999999999999999999777 899999999976543211
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| ...+..+....+.+... .+.+.+++.
T Consensus 178 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 255 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 255 (283)
T ss_dssp TTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTT-TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCc-cccChhHHHHHHhcccCCCCCCcCCHHHHHHHH
Confidence 123345677999999886 679999999999999999998 99998 44455555555554321 344555555
Q ss_pred hccCCCChhHHHHHhHHhcC
Q 014307 357 KYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~ 376 (427)
. |+..+|..||++.+++.+
T Consensus 256 ~-~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 256 S-CWHEKADERPTFKILLSN 274 (283)
T ss_dssp H-TTCSSGGGSCCHHHHHHH
T ss_pred H-HccCChhHCcCHHHHHHH
Confidence 5 999999999998887764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=330.25 Aligned_cols=247 Identities=19% Similarity=0.309 Sum_probs=175.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|++++.||+|+||.||+|.+..+++.||||+++... ...+..|+..+.+..+||||+++++++.. ....++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceEE
Confidence 478999999999999999999999999999999996532 23456666644443499999999999986 457889
Q ss_pred EEeecCCCchhhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 209 IFEHVNNTDFKVL-------YPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 209 v~e~~~~~~l~~~-------~~~~~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
||||+.++....+ ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++ .+||+|||+++...
T Consensus 99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQLV 177 (327)
T ss_dssp EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC--
T ss_pred EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCceecc
Confidence 9999997432221 24589999999999999999999999 999999999999999777 89999999998765
Q ss_pred CCCcceeeccCcccccccccc---CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-----------
Q 014307 281 PGKEYNVRVASRYFKGPELLV---DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------- 346 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------- 346 (427)
.........|+..|+|||++. ....++.++|||||||++|+|++|+.||.......+.+..+.+..
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE 257 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence 554445558999999999983 225689999999999999999999999954333333332221110
Q ss_pred CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 347 GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 ~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
-.+.+.+++.. |+..||..||++.+++.||||....
T Consensus 258 ~~~~l~~li~~-~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 258 FSPSFINFVNL-CLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCHHHHHHHHH-HTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCHHHHHHHHH-HhhCChhhCcCHHHHHhChHHHHhH
Confidence 12345555555 9999999999999999999998755
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=323.19 Aligned_cols=239 Identities=20% Similarity=0.325 Sum_probs=193.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEE-----cCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ..+.+.+|+.+++++.+||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-- 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec--
Confidence 357899999999999999999985 356789999999753 246688999999999889999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 261 (427)
....++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 456889999999999877652 38899999999999999999999999999999999999
Q ss_pred cCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014307 262 DHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYD 337 (427)
Q Consensus 262 ~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~ 337 (427)
+.++ .+||+|||++......... ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||........
T Consensus 179 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 179 THGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp ETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 9776 8999999999866544332 23356778999999876 689999999999999999999 9999854433333
Q ss_pred HHHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 338 QLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 338 ~l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
....+..... ++.+.+++.. |+..||..||++.+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 257 FYKMIKEGFRMLSPEHAPAEMYDIMKT-CWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHhccCCCCCCcccCCHHHHHHHHH-HcCCCchhCcCHHHHHH
Confidence 3333332211 2345555555 88899999988877765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=316.77 Aligned_cols=236 Identities=19% Similarity=0.310 Sum_probs=191.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 201 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~ 201 (427)
..++|++.+.||+|+||.||+|++..+++.||+|++.... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNP 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCC
Confidence 4578999999999999999999999999999999985321 16788999999999 999999999998542
Q ss_pred CCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCC----eEEEE
Q 014307 202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQR----KLRLI 271 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~----~ikl~ 271 (427)
.++||||+.+++|...+ ..+++..++.++.|++.||+|||++| |+||||||+|||++.++. .+||+
T Consensus 96 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 96 ----PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp ----TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred ----CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 36999999999886554 35899999999999999999999999 999999999999986652 39999
Q ss_pred eeeeeeeecCCCcceeeccCccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---
Q 014307 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--- 347 (427)
Q Consensus 272 DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--- 347 (427)
|||+++... .......|++.|+|||++.+ ...++.++|||||||++|+|++|+.||.................+
T Consensus 172 Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 249 (287)
T 4f0f_A 172 DFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249 (287)
T ss_dssp CCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred CCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence 999997533 34455689999999999842 246789999999999999999999999554444333332222221
Q ss_pred ------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 ------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 ------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+.+++.. |+..||..||++.++++
T Consensus 250 ~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 TIPEDCPPRLRNVIEL-CWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCCcccCHHHHHHHHH-HhcCChhhCcCHHHHHH
Confidence 2345555555 89999999999888764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.55 Aligned_cols=237 Identities=16% Similarity=0.323 Sum_probs=191.6
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.+.||+|+||.||+|.+. .+++.||||+++... .+.+.+|+.+++.+ +||||+++++++.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQ-- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEec--
Confidence 3578999999999999999999973 455899999996532 35688999999999 99999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk 255 (427)
....++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 556899999999999877753 27888999999999999999999999999999
Q ss_pred CCceEEcCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 014307 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFY 331 (427)
Q Consensus 256 p~NILl~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~ 331 (427)
|+|||++.++ .+||+|||++......... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .
T Consensus 178 p~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~-~ 254 (314)
T 2ivs_A 178 ARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY-P 254 (314)
T ss_dssp GGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-T
T ss_pred hheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCC-C
Confidence 9999999776 8999999999876544322 23356778999999876 678999999999999999999 99998 4
Q ss_pred CCCCHHHHHHHHHHh-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 332 GHDNYDQLVKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 332 ~~~~~~~l~~i~~~~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+....+....+.... -++.+.+++.. |+..||..||++.+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQ-CWKQEPDKRPVFADISK 304 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHH-HccCChhhCcCHHHHHH
Confidence 444434333333321 12445555555 88888888888777665
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.47 Aligned_cols=241 Identities=20% Similarity=0.333 Sum_probs=199.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEc------------
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD------------ 200 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~------------ 200 (427)
.++|++++.||+|+||.||+|++..+++.||+|+++... +.+.+|+.+++++ +||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~~~~ 87 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSSKNS 87 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC--------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCcccccccc
Confidence 367999999999999999999998899999999997543 4678999999999 99999999998864
Q ss_pred --CCCCCcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEee
Q 014307 201 --QQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 273 (427)
Q Consensus 201 --~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DF 273 (427)
.....+++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Df 166 (284)
T 2a19_B 88 SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDF 166 (284)
T ss_dssp -CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCC
T ss_pred cccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECcc
Confidence 1234578999999999998776 3589999999999999999999999999999999999999777 8999999
Q ss_pred eeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH----hCCh
Q 014307 274 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV----LGTD 349 (427)
Q Consensus 274 Gla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~----~~~~ 349 (427)
|++.............+++.|+|||++.+ ..++.++|||||||++|+|++|..|+... .+....+... .-.+
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 242 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFET---SKFFTDLRDGIISDIFDK 242 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHH---HHHHHHHHTTCCCTTSCH
T ss_pred hhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhH---HHHHHHhhcccccccCCH
Confidence 99988766655566789999999999887 68999999999999999999999887321 1112222111 1134
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
.+.+++.. |+..||..||++.+++.+.+..+
T Consensus 243 ~~~~li~~-~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 243 KEKTLLQK-LLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHHHH-HTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHHHHHH-HccCChhhCcCHHHHHHHHHHHh
Confidence 55555555 99999999999999988766544
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=328.30 Aligned_cols=237 Identities=19% Similarity=0.331 Sum_probs=187.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeE----EEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|++++.||+|+||+||+|++..+++. ||+|.++. ...+.+.+|+.+++++ +||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESS--
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--
Confidence 357899999999999999999998877765 47777743 2346789999999999 999999999999863
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
..++++||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 167 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHHHH
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcceeEc
Confidence 377999999999987765 3589999999999999999999999999999999999999777 8999999999876
Q ss_pred cCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 014307 280 HPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (427)
Q Consensus 280 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~ 348 (427)
...... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+....+....+..... .
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKGERLPQPPICT 245 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred cCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCc-cCCCHHHHHHHHHcCCCCCCCccCC
Confidence 543322 23355778999999887 789999999999999999999 99998 44443333333332221 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
+.+..++.+ |+..||..||++.+++.+
T Consensus 246 ~~~~~li~~-~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 246 IDVYMIMVK-CWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHH-HTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHH-HcCCChhhCCCHHHHHHH
Confidence 345555555 999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=327.11 Aligned_cols=238 Identities=19% Similarity=0.310 Sum_probs=191.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-------CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~ 200 (427)
..++|++.+.||+|+||.||+|++. .++..||||+++... .+.+.+|+.+++++.+||||+++++++..
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999975 356789999997532 35688999999999889999999999976
Q ss_pred CCCCCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE
Q 014307 201 QQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (427)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 261 (427)
....++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 113 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 113 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp --SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 557899999999999987753 27889999999999999999999999999999999999
Q ss_pred cCCCCeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014307 262 DHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYD 337 (427)
Q Consensus 262 ~~~~~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~ 337 (427)
+.++ .+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.|| .+....+
T Consensus 191 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~ 267 (334)
T 2pvf_A 191 TENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVEE 267 (334)
T ss_dssp CTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHH
T ss_pred cCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCc-CcCCHHH
Confidence 9777 899999999987654432 223356778999999876 678999999999999999999 99998 4444444
Q ss_pred HHHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 338 QLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 338 ~l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
....+.+... ++.+.+++.. |+..||..||++.+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 268 LFKLLKEGHRMDKPANCTNELYMMMRD-CWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHH-HccCChhhCcCHHHHHH
Confidence 4444443321 2345555555 88999999998887765
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=319.82 Aligned_cols=235 Identities=22% Similarity=0.379 Sum_probs=181.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC---CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||.||+|++..+ +..||+|+++.. ..+.+.+|+.+++++ +||||+++++++. ...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~---~~~ 89 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT---ENP 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC---SSS
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc---cCc
Confidence 57899999999999999999998653 467999998642 235688999999999 9999999999984 345
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED 168 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccccccCc
Confidence 789999999999887753 589999999999999999999999999999999999999777 899999999987654
Q ss_pred CCc--ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHH
Q 014307 282 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (427)
Q Consensus 282 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (427)
... .....+++.|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+.+... ++.+
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~l 246 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTL 246 (281)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCC-CcCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 332 223356678999999876 689999999999999999997 88888 44455555555543321 2345
Q ss_pred HHHHHhccCCCChhHHHHHhHHhc
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+++.. |+..||..||++.+++.
T Consensus 247 ~~li~~-~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 247 YSLMTK-CWAYDPSRRPRFTELKA 269 (281)
T ss_dssp HHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHH-HccCChhhCcCHHHHHH
Confidence 555555 88899999988877664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=322.02 Aligned_cols=243 Identities=23% Similarity=0.377 Sum_probs=194.1
Q ss_pred EEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec
Q 014307 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 137 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
.....||+|+||.||+|.+..+++.||||++.... .+.+.+|+.+++.+ +||||+++++++.. ....++||||+
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~ 101 (295)
T 2clq_A 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSE--NGFIKIFMEQV 101 (295)
T ss_dssp SSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEEECC
T ss_pred CCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEe--CCcEEEEEEeC
Confidence 33457999999999999999999999999986532 46688999999999 99999999999976 45789999999
Q ss_pred CCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cce
Q 014307 214 NNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (427)
Q Consensus 214 ~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~ 286 (427)
.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.....+||+|||++....... ...
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 181 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE 181 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence 9999877653 356888999999999999999999999999999999998734489999999998764332 234
Q ss_pred eeccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------CChHHHHHHHh
Q 014307 287 VRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAYLNK 357 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~~~~~~~~l~~ 357 (427)
...|+..|+|||++.+. ..++.++|||||||++|+|++|+.||................. -++.+..++.+
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILK 261 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHH
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHH
Confidence 45789999999998652 2488999999999999999999999954333322222221111 13455555655
Q ss_pred ccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
|+..||..||++.+++.|+||....
T Consensus 262 -~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 262 -CFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp -TTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred -HccCChhhCCCHHHHhcChhhhhcc
Confidence 9999999999999999999998643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=323.43 Aligned_cols=241 Identities=19% Similarity=0.316 Sum_probs=195.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.+.||+|+||.||+|++. .+++.||||+++... ...+.+|+.+++++.+||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 3578999999999999999999853 467899999987532 356889999999997799999999998754
Q ss_pred CCCcEEEEeecCCCchhhhcCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYPT-------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 263 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~ 263 (427)
...+++||||+.+++|..++.. +++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 4568999999999999877632 788899999999999999999999999999999999997
Q ss_pred CCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHH
Q 014307 264 EQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQL 339 (427)
Q Consensus 264 ~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l 339 (427)
++ .+||+|||+++........ ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||..........
T Consensus 184 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 184 KN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CC-CEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 77 8999999999866443322 23467788999999876 689999999999999999998 999985444444444
Q ss_pred HHHHHHh-------CChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 340 VKIAKVL-------GTDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 340 ~~i~~~~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
..+.... -++.+.+++.. |+..||..||++.+++.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHhccCccCCCCCCCCHHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 4443321 13455565655 889999999988887763
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=340.55 Aligned_cols=235 Identities=16% Similarity=0.305 Sum_probs=194.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++|++.++||+|+||+||+|.+. ++..||||+++. ...+.+.+|+.+|+++ +||||+++++++. ...+++|
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~---~~~~~lv 260 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT---KEPIYII 260 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSSCEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe---CCccEEE
Confidence 4578999999999999999999984 578899999975 3467899999999999 9999999999985 3468999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEY 339 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGBCCHHH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceEcCCCce
Confidence 99999999987764 588899999999999999999999999999999999999777 899999999986543211
Q ss_pred --ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 285 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 285 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
.....++..|+|||++.. ..++.++|||||||++|||++ |+.|| .+.+..+.+..+.+... ++.+.++
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred eccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 122345677999999876 689999999999999999999 99998 55566666666655432 2345555
Q ss_pred HHhccCCCChhHHHHHhHHhc
Q 014307 355 LNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.. |+..||..||++.+++.
T Consensus 418 i~~-cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 418 MMR-CWKNRPEERPTFEYIQS 437 (454)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HccCChhHCcCHHHHHH
Confidence 555 89999999998777653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=325.80 Aligned_cols=196 Identities=21% Similarity=0.385 Sum_probs=172.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEE----EcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..++|++++.||+|+||.||+|+ +..+++.||||++.... .+.+.+|+.+++++ +||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSC
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCc
Confidence 35789999999999999999998 46789999999997543 35588999999999 999999999999876677
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEECC
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceecc
Confidence 8999999999999887753 489999999999999999999999999999999999999777 89999999998765
Q ss_pred CCCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 014307 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330 (427)
Q Consensus 281 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 330 (427)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 44322 23457778999999876 678999999999999999999999984
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=313.59 Aligned_cols=235 Identities=18% Similarity=0.354 Sum_probs=183.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..++|++.+.||+|+||.||+|.+ +++.||||+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 79 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLK--EP 79 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECC--C-
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEec--CC
Confidence 357899999999999999999997 4899999998642 235688999999999 99999999999976 55
Q ss_pred CcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeeccCCCceEEcCC-------CCeEEEEe
Q 014307 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------QRKLRLID 272 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~-------~~~ikl~D 272 (427)
..++||||+.+++|..++ ..+++..++.++.|++.||.|||++| |+||||||+|||++.+ ...+||+|
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp -CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred ceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 689999999999998776 46899999999999999999999999 9999999999999852 33799999
Q ss_pred eeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------
Q 014307 273 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------ 346 (427)
Q Consensus 273 FGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------ 346 (427)
||++....... .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+.......+....
T Consensus 160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~ 236 (271)
T 3dtc_A 160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAYGVAMNKLALPIP 236 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHHHTSCCCCCCC
T ss_pred CCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHhhhcCCCCCCCC
Confidence 99998654332 335578999999999876 679999999999999999999999994 444433333332211
Q ss_pred --CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 --GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 --~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
-++.+.+++.+ |+..||..||++.++++
T Consensus 237 ~~~~~~~~~li~~-~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 237 STCPEPFAKLMED-CWNPDPHSRPSFTNILD 266 (271)
T ss_dssp TTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHH-HhcCCcccCcCHHHHHH
Confidence 12345555555 89999999999888775
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=338.13 Aligned_cols=234 Identities=16% Similarity=0.307 Sum_probs=192.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
..++|++.+.||+|+||.||+|.+ .++.||||+++.. ..+.+.+|+.+|+++ +||||+++++++... ...+++||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~~iv~ 266 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVT 266 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECT-TSCEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcC-CCceEEEE
Confidence 457899999999999999999987 4789999999753 357789999999999 999999999998764 34689999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~--~ 343 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--Q 343 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC-----
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCccccccc--c
Confidence 9999999987763 278999999999999999999999999999999999999777 8999999999854322 2
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHh
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNK 357 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~ 357 (427)
....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+....+....+.+... ++.+.+++..
T Consensus 344 ~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 421 (450)
T 1k9a_A 344 DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKN 421 (450)
T ss_dssp ---CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSS-TTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred cCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence 23466788999999987 789999999999999999998 99998 45455555555544321 2455555555
Q ss_pred ccCCCChhHHHHHhHHhc
Q 014307 358 YHIELDPHLAALVGRLVI 375 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~ 375 (427)
|+..||..||++.+++.
T Consensus 422 -cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 422 -CWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -HTCSSGGGSCCHHHHHH
T ss_pred -HcCCChhHCcCHHHHHH
Confidence 99999999999887764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=344.75 Aligned_cols=237 Identities=18% Similarity=0.331 Sum_probs=196.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++|++.++||+|+||.||+|+++.++..||||+++.. ..+.+.+|+.+|+++ +||||+++++++.. ...+++|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~--~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEec--CCcEEEE
Confidence 457899999999999999999999988999999999753 457899999999999 99999999999976 4568999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEECCTTCCE
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccceeccCCce
Confidence 99999999887763 488999999999999999999999999999999999999777 899999999987643321
Q ss_pred c--eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 285 Y--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 285 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
. ....++..|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+.+... ++.+.++
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1 12244567999999876 679999999999999999999 88888 55454444444443321 2455555
Q ss_pred HHhccCCCChhHHHHHhHHhc
Q 014307 355 LNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.. |+..||..||++.+++.
T Consensus 452 i~~-cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 452 MRA-CWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HcCcChhHCcCHHHHHH
Confidence 555 99999999999988864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.17 Aligned_cols=238 Identities=26% Similarity=0.483 Sum_probs=182.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
..++|++.+.||+|+||.||+|.+..+++.||||+++. .....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~ 106 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIE--DNE 106 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCc
Confidence 34689999999999999999999999999999999864 2235688999999999 99999999999986 457
Q ss_pred cEEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 206 PSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
.++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRF 185 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC-----
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceee
Confidence 899999999999877653 489999999999999999999999999999999999999777 899999999976
Q ss_pred ecCCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------C
Q 014307 279 YHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------T 348 (427)
Q Consensus 279 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~ 348 (427)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+........ +
T Consensus 186 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 186 FSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp -------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred ecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence 543322 234578999999999876 68999999999999999999999999654444444333222211 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+.+++.. |+..||..||++.+++.
T Consensus 265 ~~l~~li~~-~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 265 EELRQLVNM-CINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHH-HcCCChhhCCCHHHHHH
Confidence 345555555 88999999998877664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.82 Aligned_cols=240 Identities=16% Similarity=0.190 Sum_probs=181.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcC---CCeEEEEEEecccc--------------HHHHHHHHHHHHHhcCCCCeeee
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKL 194 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~~~--------------~~~~~~E~~il~~l~~h~niv~l 194 (427)
..++|++.+.||+|+||.||+|++.. ++..+|||++.... ...+.+|+.+++.+ +||||+++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~ 113 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLF 113 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCccee
Confidence 35789999999999999999999987 78899999986432 12355677888888 99999999
Q ss_pred eeEEEcC--CCCCcEEEEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC-CeE
Q 014307 195 LDIVRDQ--QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKL 268 (427)
Q Consensus 195 ~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~i 268 (427)
++++... +....++||||+ +++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 9998762 356789999999 889888775 589999999999999999999999999999999999998654 279
Q ss_pred EEEeeeeeeeecCCCc--------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014307 269 RLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340 (427)
Q Consensus 269 kl~DFGla~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~ 340 (427)
||+|||+++.+..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.........+.
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999987643221 244578999999999887 6899999999999999999999999954434444333
Q ss_pred HHHHHh---------------C-ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 341 KIAKVL---------------G-TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 341 ~i~~~~---------------~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...... . ++.+.+++.. |+..||..||++.+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVC-AHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHH-HHTCCTTCCCCHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHH-HhhcCcccCCCHHHHHH
Confidence 222211 1 1233444444 66777777776665543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=319.53 Aligned_cols=239 Identities=24% Similarity=0.363 Sum_probs=189.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEE----EcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|+++++||+|+||.||+|+ +..+++.||||+++.. ..+.+.+|+.+++.+ +||||+++++++......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCc
Confidence 4679999999999999999998 5678999999998743 236788999999999 999999999999886667
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
.+++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIE 177 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECC
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECccccccccc
Confidence 789999999999998776 3589999999999999999999999999999999999999777 89999999998775
Q ss_pred CCCc----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------------CCCHHHHHHHH
Q 014307 281 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG-------------HDNYDQLVKIA 343 (427)
Q Consensus 281 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~-------------~~~~~~l~~i~ 343 (427)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++|..|+... ......+....
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred CCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 5432 223467778999999876 67889999999999999999999876211 01111111111
Q ss_pred HH-h-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 344 KV-L-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 344 ~~-~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.. . -++.+.+++.+ |+..||..||++.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRK-CWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHH-TTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHH-HcCCCCCCCCCHHHHHH
Confidence 11 0 12345555555 88888888888877664
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=319.43 Aligned_cols=237 Identities=19% Similarity=0.334 Sum_probs=196.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++|++.+.||+|+||.||+|.+..++..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCEEEE
Confidence 457899999999999999999999999999999998753 346788999999999 89999999999965 5668999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++........
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGTSCSSSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccceeccCCcc
Confidence 99999999887763 389999999999999999999999999999999999999777 899999999986543322
Q ss_pred --ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 285 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 285 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.+... ++.+.++
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKDYRMERPEGCPEKVYEL 244 (288)
T ss_dssp EEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 223356778999999876 689999999999999999999 88888 44444444444433321 2445555
Q ss_pred HHhccCCCChhHHHHHhHHhc
Q 014307 355 LNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.. |+..||..||++.+++.
T Consensus 245 i~~-~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 245 MRA-CWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HhCCChhhCcCHHHHHH
Confidence 555 89999999999888865
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=323.10 Aligned_cols=238 Identities=21% Similarity=0.330 Sum_probs=194.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCe-----EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.+.||+|+||.||+|.+..+++ .||+|+++.. ..+.+.+|+.+++.+.+||||+++++++..
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 45889999999999999999999876654 7999999753 345688999999999789999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 265 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~ 265 (427)
....++||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 557899999999999877652 378999999999999999999999999999999999999777
Q ss_pred CeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHH
Q 014307 266 RKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 341 (427)
Q Consensus 266 ~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~ 341 (427)
.+||+|||++......... ....++..|+|||++.+ ..++.++|||||||++|||++ |..||. +....+.+..
T Consensus 202 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-~~~~~~~~~~ 278 (333)
T 2i1m_A 202 -VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYP-GILVNSKFYK 278 (333)
T ss_dssp -EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST-TCCSSHHHHH
T ss_pred -eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCc-ccchhHHHHH
Confidence 8999999999865433221 23456778999999876 689999999999999999998 888884 4333333333
Q ss_pred HHHH-h-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 342 IAKV-L-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 342 i~~~-~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+... . .++.+..++.. |+..||..||++.+++.
T Consensus 279 ~~~~~~~~~~~~~~~~~l~~li~~-~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGYQMAQPAFAPKNIYSIMQA-CWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHH-HhccChhhCcCHHHHHH
Confidence 3332 1 12445555555 99999999999888876
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=336.28 Aligned_cols=242 Identities=19% Similarity=0.299 Sum_probs=186.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++.....+.+.+|+.+|+++.+||||+++++++.+ ...+++||||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv~E~ 90 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIALEL 90 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEECC
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEEEec
Confidence 4667888999999999998764 468999999999877677889999999987689999999999876 5678999999
Q ss_pred cCCCchhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC------------CCeEEE
Q 014307 213 VNNTDFKVLYPT----------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------QRKLRL 270 (427)
Q Consensus 213 ~~~~~l~~~~~~----------~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~------------~~~ikl 270 (427)
+. ++|..++.. ..+..++.++.||+.||+|||++||+||||||+|||++.+ ...+||
T Consensus 91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 97 477766532 1233457799999999999999999999999999999743 237999
Q ss_pred EeeeeeeeecCCCc-----ceeeccCccccccccccC------CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHH
Q 014307 271 IDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 338 (427)
Q Consensus 271 ~DFGla~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~ 338 (427)
+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|||++ |+.||... ...+
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~-~~~~- 247 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK-YSRE- 247 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST-TTHH-
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc-hhhH-
Confidence 99999987754322 234579999999999864 2568999999999999999999 89998432 2222
Q ss_pred HHHHHHHh-C------------ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 339 LVKIAKVL-G------------TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 339 l~~i~~~~-~------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
..+.+.. . .+.+.+++.. |+..||..||++.+++.||||+..
T Consensus 248 -~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~-~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 248 -SNIIRGIFSLDEMKCLHDRSLIAEATDLISQ-MIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp -HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHH-HTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred -HHHhcCCCCcccccccccccchHHHHHHHHH-HhhCChhhCCCHHHHHhCCccCCc
Confidence 2222211 1 1234455555 999999999999999999999754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=320.83 Aligned_cols=239 Identities=18% Similarity=0.317 Sum_probs=183.8
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcC---CCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|++.+.||+|+||.||+|.+.. ++..||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+...
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence 45789999999999999999998765 4568999998642 235688999999999 89999999999986443
Q ss_pred C---CcEEEEeecCCCchhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEE
Q 014307 204 K---TPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (427)
Q Consensus 204 ~---~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~ 271 (427)
. ..++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~ 189 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVA 189 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEEC
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEe
Confidence 2 458999999999987765 3589999999999999999999999999999999999999777 89999
Q ss_pred eeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC
Q 014307 272 DWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG 347 (427)
Q Consensus 272 DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~ 347 (427)
|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..|| .+....+....+.....
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~ 267 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPY-PGVQNHEMYDYLLHGHR 267 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTTCC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHHHHHHcCCC
Confidence 9999986644321 233456778999999887 789999999999999999999 77787 45455444444443321
Q ss_pred -------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 -------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 -------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+.+++.. |+..||..||++.+++.
T Consensus 268 ~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~ 301 (313)
T 3brb_A 268 LKQPEDCLDELYEIMYS-CWRTDPLDRPTFSVLRL 301 (313)
T ss_dssp CCCBTTCCHHHHHHHHH-TTCSSGGGSCCHHHHHH
T ss_pred CCCCccccHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 2445555555 88999999988777664
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=328.01 Aligned_cols=237 Identities=17% Similarity=0.290 Sum_probs=190.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeE----EEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|++++.||+|+||+||+|++..+++. ||+|.+... ....+.+|+.+++.+ +||||+++++++..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG--- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---
Confidence 357899999999999999999999888765 777776432 224567899999999 99999999999853
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
...++||||+.+++|..++ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLL 165 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGS
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCccccc
Confidence 4588999999999987665 2588999999999999999999999999999999999999777 8999999999876
Q ss_pred cCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 014307 280 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (427)
Q Consensus 280 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~ 348 (427)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| .+....+....+.+... .
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPY-AGLRLAEVPDLLEKGERLAQPQICT 243 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCTTHHHHHHHTTCBCCCCTTBC
T ss_pred CcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCc-cccCHHHHHHHHHcCCCCCCCCcCc
Confidence 44332 234567778999999876 679999999999999999999 99999 44444444444433211 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
+.+..++.+ |+..||..||++.+++.+
T Consensus 244 ~~~~~li~~-~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 244 IDVYMVMVK-CWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTTTHHHHH-HTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 345555655 999999999998887764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=312.38 Aligned_cols=234 Identities=17% Similarity=0.326 Sum_probs=192.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++++.||+|+||.||+|.+ .++..||||+++.. ..+.+.+|+++++.+ +||||+++++++.. ...++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC---CCcEEEE
Confidence 57899999999999999999997 46788999998753 457789999999999 99999999999863 3478999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCcccccccCcccc
Confidence 9999999988875 589999999999999999999999999999999999999776 8999999999876543221
Q ss_pred --eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHH
Q 014307 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYL 355 (427)
Q Consensus 286 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l 355 (427)
....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+....+.+..+.+... ++.+.+++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 243 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPY-PGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred cccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCC-cccCHHHHHHHHhcccCCCCcccccHHHHHHH
Confidence 22345678999999876 678999999999999999999 88888 45455555554443321 23455555
Q ss_pred HhccCCCChhHHHHHhHHhc
Q 014307 356 NKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~ 375 (427)
.. |+..||..||++.+++.
T Consensus 244 ~~-~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 244 RL-CWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HH-HTCSSGGGSCCHHHHHH
T ss_pred HH-HhccChhhCCCHHHHHH
Confidence 55 88899999988777654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=316.44 Aligned_cols=237 Identities=20% Similarity=0.302 Sum_probs=185.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|++.+.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+++.+ .|++++..+..+... ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccCC-CCceEEEEE
Confidence 57899999999999999999999999999999998643 345688999999999 666666556655432 567899999
Q ss_pred ecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEc---CCCCeEEEEeeeeeeeecCCCc
Q 014307 212 HVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 212 ~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|+ +++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+|||++........
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDART 163 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCccccccccc
Confidence 99 778776653 699999999999999999999999999999999999994 444 899999999987654432
Q ss_pred --------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCHHHHHHHHHH---------
Q 014307 285 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLVKIAKV--------- 345 (427)
Q Consensus 285 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~--~~~~~l~~i~~~--------- 345 (427)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... +..+.+..+...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred ccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 245578999999999887 679999999999999999999999995322 222222222221
Q ss_pred -hC-ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 346 -LG-TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 346 -~~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+ ++.+.+++.. |+..||..||++.+++.
T Consensus 243 ~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 243 CKGYPSEFATYLNF-CRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp TTTSCHHHHHHHHH-HHTSCTTCCCCHHHHHH
T ss_pred HhhCCHHHHHHHHH-HHhcCcCcCCCHHHHHH
Confidence 01 2344444444 77888888877666554
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=337.81 Aligned_cols=244 Identities=20% Similarity=0.294 Sum_probs=186.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
..+|++.+.||+|+||+|+.. ...+++.||||++.......+.+|+.+|+.+.+||||+++++++.+ ....++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEEC
Confidence 457999999999999997643 3468999999999765555577899999998789999999999876 5678999999
Q ss_pred cCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC----CCeEEEEeeeeeeeecCCC-
Q 014307 213 VNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 213 ~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~----~~~ikl~DFGla~~~~~~~- 283 (427)
+.+ +|..++. ...+.++..++.||+.||.|||++||+||||||+|||++.+ ...+||+|||+|+......
T Consensus 100 ~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 100 CAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp CSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 985 6655542 35566778999999999999999999999999999999532 2258899999998765432
Q ss_pred ---cceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhCC---------
Q 014307 284 ---EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGT--------- 348 (427)
Q Consensus 284 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~~--------- 348 (427)
......||+.|+|||++.+ ...++.++|||||||++|||++ |..||. ... ..+...+......
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~-~~~-~~~~~~~~~~~~~~~~~~~~~~ 256 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG-KSL-QRQANILLGACSLDCLHPEKHE 256 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB-STT-THHHHHHTTCCCCTTSCTTCHH
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc-hhh-HHHHHHHhccCCccccCccccc
Confidence 2344679999999999874 2567889999999999999999 888883 222 2222222211111
Q ss_pred -hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 -DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 -~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+...+++.+ |+..||..||++.+++.||||+...
T Consensus 257 ~~~~~~li~~-~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 257 DVIARELIEK-MIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp HHHHHHHHHH-HSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred cHHHHHHHHH-HHhCCHhhCCCHHHHHhCccccChH
Confidence 123344555 9999999999999999999998755
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=312.49 Aligned_cols=235 Identities=17% Similarity=0.326 Sum_probs=193.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.+.||+|+||.||+|.+. +++.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 82 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLVT 82 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SSSCEEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCCeEEEE
Confidence 468999999999999999999985 6789999999753 457789999999999 99999999999976 45689999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--c
Q 014307 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 284 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~--~ 284 (427)
||+.+++|..++. .+++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++....... .
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCCHHHHS
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEcccccccccccccccc
Confidence 9999999877653 489999999999999999999999999999999999999777 89999999997653321 1
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| .+.+..+....+..... ++.+.+++.
T Consensus 162 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPY-ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp TTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCC-CCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 123356678999999876 678999999999999999999 88888 44454455544443321 344555555
Q ss_pred hccCCCChhHHHHHhHHhc
Q 014307 357 KYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~ 375 (427)
. |+..||..||++.+++.
T Consensus 240 ~-~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 240 H-CWRERPEDRPAFSRLLR 257 (267)
T ss_dssp H-HTCSSGGGSCCHHHHHH
T ss_pred H-HccCChhhCcCHHHHHH
Confidence 5 89999999998888765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=332.86 Aligned_cols=236 Identities=19% Similarity=0.324 Sum_probs=182.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||.||+|++. .++..||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~ 120 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK--SKP 120 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCc
Confidence 467999999999999999999876 46778999998643 235688999999999 99999999999975 567
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.++||||+.+++|..++. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLED 199 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCcccccccc
Confidence 899999999999987763 589999999999999999999999999999999999999777 899999999987654
Q ss_pred CCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 014307 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (427)
Q Consensus 282 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~ 349 (427)
.... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.||. +....+....+.+... ++
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~-~~~~~~~~~~i~~~~~~~~~~~~~~ 277 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYW-EMSNQDVIKAVDEGYRLPPPMDCPA 277 (373)
T ss_dssp --------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTT-TCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred CCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCCCCCCccccH
Confidence 3221 12234667999999876 689999999999999999998 999984 4444444444443321 23
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+++.. |+..||..||++.+++.
T Consensus 278 ~l~~li~~-cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 278 ALYQLMLD-CWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHH-HhCcChhhCcCHHHHHH
Confidence 45555555 99999999999888765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=326.06 Aligned_cols=237 Identities=18% Similarity=0.299 Sum_probs=190.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEE--EEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKC--IIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v--avK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|++..++..+ |+|.++.. ..+.+.+|+.+++++.+||||+++++++.+ ....
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCce
Confidence 368999999999999999999998888865 99988642 235588999999998789999999999976 5678
Q ss_pred EEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCe
Q 014307 207 SLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 267 (427)
++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~ 180 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-V 180 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-C
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC-e
Confidence 99999999999877652 488999999999999999999999999999999999999777 8
Q ss_pred EEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 014307 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 346 (427)
Q Consensus 268 ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~ 346 (427)
+||+|||+++............++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+....
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf-~~~~~~~~~~~~~~~~ 258 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPY-CGMTCAELYEKLPQGY 258 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHGGGTC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCC-CCCcHHHHHHHhhcCC
Confidence 99999999975433333344566788999999876 678999999999999999998 99998 4444444444443321
Q ss_pred C-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 G-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 ~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
. ++.+.+++.. |+..||..||++.+++.
T Consensus 259 ~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~ 293 (327)
T 1fvr_A 259 RLEKPLNCDDEVYDLMRQ-CWREKPYERPSFAQILV 293 (327)
T ss_dssp CCCCCTTBCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHH-HccCChhhCcCHHHHHH
Confidence 1 2445555555 88999999998888765
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=319.31 Aligned_cols=244 Identities=24% Similarity=0.416 Sum_probs=191.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcC-CCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~-h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++++.||+|+||.||+|.+. +++.||||++... ..+.+.+|+.+++++.+ |+||+++++++.. ....
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCEE
Confidence 467999999999999999999984 5889999998532 23668899999999943 6999999999976 4568
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||| +.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++.......
T Consensus 104 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~-~~kL~Dfg~~~~~~~~~ 180 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQMQPDT 180 (313)
T ss_dssp EEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCC-----
T ss_pred EEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CC-eEEEeeccccccccCcc
Confidence 99999 5666776654 4589999999999999999999999999999999999997 44 89999999998664332
Q ss_pred c---ceeeccCccccccccccCC----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---
Q 014307 284 E---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--- 347 (427)
Q Consensus 284 ~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--- 347 (427)
. .....|++.|+|||++.+. ..++.++|||||||++|+|++|+.||.........+..+.....
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 260 (313)
T 3cek_A 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence 2 2345789999999998641 36889999999999999999999999544444444433332111
Q ss_pred -----ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 -----TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 -----~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+.+.+++.. |+..||..||++.+++.|+||....
T Consensus 261 ~~~~~~~~l~~li~~-~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 261 FPDIPEKDLQDVLKC-CLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCCCSCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred CcccchHHHHHHHHH-HccCCcccCcCHHHHhcCccccCCC
Confidence 2345565655 9999999999999999999998743
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=318.20 Aligned_cols=234 Identities=21% Similarity=0.368 Sum_probs=177.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|++..+++.||||+++... .+.+.+|+.+++++ +||||+++++++.. ....
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 109 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEI--DGQL 109 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEee--CCeE
Confidence 368999999999999999999999999999999986432 26688999999999 99999999999987 5678
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDEK 188 (309)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC--------
T ss_pred EEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCccccccc
Confidence 9999999999998776 3589999999999999999999999999999999999999777 89999999997654332
Q ss_pred --cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHH
Q 014307 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDEL 351 (427)
Q Consensus 284 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~ 351 (427)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+ ...+........ ++.+
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQ-GDQ-LSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp --------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSC-SCH-HHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred cccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCC-Cch-HHHHHHHhccCCCCccccCCCCCHHH
Confidence 2234578999999999876 688999999999999999999999994 322 223332222111 1233
Q ss_pred HHHHHhccCCCChhHHH-HHhHHh
Q 014307 352 NAYLNKYHIELDPHLAA-LVGRLV 374 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~-~~~~ll 374 (427)
.+++.+ |+..||..|| ++++++
T Consensus 266 ~~li~~-~l~~dP~~Rp~s~~~l~ 288 (309)
T 2h34_A 266 DAVIAR-GMAKNPEDRYVTCGDLS 288 (309)
T ss_dssp HHHHHH-HTCSSGGGSCSSHHHHH
T ss_pred HHHHHH-hccCCHHHHHHhHHHHH
Confidence 344444 6777777776 555444
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=315.54 Aligned_cols=233 Identities=20% Similarity=0.318 Sum_probs=183.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
..++|++.+.||+|+||.||+|.+ .++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+ ..++||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~lv~ 78 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACLN----PVCLVM 78 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCTT----TTEEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC----CcEEEE
Confidence 346899999999999999999987 4789999999653 346789999999999 99999999998753 478999
Q ss_pred eecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 211 EHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 211 e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
||+.+++|..++. .++...+..++.||+.||.|||+ +||+||||||+|||++.++..+||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999987763 36788999999999999999999 89999999999999997775689999999975532
Q ss_pred CCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HHHHHh-------CChHHHH
Q 014307 282 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVL-------GTDELNA 353 (427)
Q Consensus 282 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~-~i~~~~-------~~~~~~~ 353 (427)
......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.........+. .+.... -++.+.+
T Consensus 159 --~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 159 --HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235 (307)
T ss_dssp --------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHH
T ss_pred --ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHH
Confidence 2334578999999999876 6899999999999999999999999954433333222 222111 1234555
Q ss_pred HHHhccCCCChhHHHHHhHHhc
Q 014307 354 YLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+ |+..||..||++.+++.
T Consensus 236 li~~-~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 236 LMTR-CWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp HHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHH-HhcCChhhCcCHHHHHH
Confidence 5555 89999999998888765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=314.20 Aligned_cols=234 Identities=15% Similarity=0.340 Sum_probs=179.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..++|++.++||+|+||+||+|++ +..||+|+++.. ..+.+.+|+.+++++ +||||++++++.. ....
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~---~~~~ 94 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST---APQL 94 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC---SSSC
T ss_pred CccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeecc---CCcc
Confidence 457899999999999999999985 335999998632 235688999999999 9999999999753 3457
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-
Q 014307 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~- 281 (427)
++||||+.+++|...+. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRW 173 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC--------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceeccccccc
Confidence 89999999999877663 489999999999999999999999999999999999999777 899999999975543
Q ss_pred --CCcceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 282 --GKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 282 --~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
........|++.|+|||++.. ...++.++|||||||++|+|++|+.|| .+..+.+.+..+.....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY-SNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT-SSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc-cccchHHHHHHHhcccccCcchhhccc
Confidence 222344578999999999852 257889999999999999999999999 44455555554443321
Q ss_pred --ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 --TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 --~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+..++.. |+..+|..||++.+++.
T Consensus 253 ~~~~~l~~li~~-~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 253 NCPKRMKRLMAE-CLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHH-HccCChhhCCCHHHHHH
Confidence 1344455555 88888888888777654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=318.62 Aligned_cols=238 Identities=20% Similarity=0.300 Sum_probs=183.0
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
..++|++.+.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+ .|++++..++.+... ....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~~-~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGAE-GDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEEE-TTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecCC-CCceEEEE
Confidence 357899999999999999999999999999999987542 335688999999999 666666666655432 56779999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE---cCCCCeEEEEeeeeeeeecCCC
Q 014307 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~ikl~DFGla~~~~~~~ 283 (427)
||+ +++|..++ ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECBCTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecCccceeccCcc
Confidence 999 77877664 368999999999999999999999999999999999999 5555 89999999998765432
Q ss_pred c--------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHH---h----
Q 014307 284 E--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKV---L---- 346 (427)
Q Consensus 284 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--~~~~l~~i~~~---~---- 346 (427)
. .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..+.+..+... .
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhh
Confidence 2 234578999999999887 6799999999999999999999999953221 11222222211 0
Q ss_pred ---C-ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 ---G-TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 ---~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+ ++.+.+++.. |+..||..||++.+++.
T Consensus 242 ~~~~~~~~l~~li~~-~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 242 LCKGYPSEFATYLNF-CRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HTTTSCHHHHHHHHH-HHTSCTTCCCCHHHHHH
T ss_pred hhccCCHHHHHHHHH-HHhcCCCCCCCHHHHHH
Confidence 1 3445455555 78888888888777654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=328.30 Aligned_cols=244 Identities=22% Similarity=0.399 Sum_probs=191.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhc---CCCCeeeeeeEEEc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC---GGPNIVKLLDIVRD 200 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~---~h~niv~l~~~~~~ 200 (427)
.++|++.+.||+|+||.||+|++..+++.||||+++... ...+.+|+.++.++. +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 478999999999999999999999999999999996432 123557999999885 79999999999876
Q ss_pred CCCCCcEEEEee-cCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 201 QQSKTPSLIFEH-VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 201 ~~~~~~~lv~e~-~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
....++|||+ +.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.+++.+||+|||++
T Consensus 110 --~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 --QEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred --CCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 4567899999 78888877653 58999999999999999999999999999999999999843448999999999
Q ss_pred eeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH--HhCChHHHHH
Q 014307 277 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK--VLGTDELNAY 354 (427)
Q Consensus 277 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~--~~~~~~~~~~ 354 (427)
..... .......|+..|+|||++.+....+.++|||||||++|+|++|+.||... .+....... ..-.+.+.++
T Consensus 188 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~l 263 (312)
T 2iwi_A 188 ALLHD-EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD---QEILEAELHFPAHVSPDCCAL 263 (312)
T ss_dssp EECCS-SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---HHHHHTCCCCCTTSCHHHHHH
T ss_pred hhccc-CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---HHHhhhccCCcccCCHHHHHH
Confidence 87653 33455678999999999876344456899999999999999999999321 111110000 0113455566
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+ |+..||..||++.+++.|+||....
T Consensus 264 i~~-~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 264 IRR-CLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp HHH-HTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred HHH-HccCChhhCcCHHHHhcChhhcCch
Confidence 666 9999999999999999999998744
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.96 Aligned_cols=235 Identities=17% Similarity=0.314 Sum_probs=188.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++|++.++||+|+||.||+|.+. .+..||||+++.. ..+.+.+|+.+|+++ +||||+++++++.+ ..+++|
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~---~~~~iv 256 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 256 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---CceEEE
Confidence 4578999999999999999999985 4577999999753 457799999999999 99999999999864 457899
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|||+.+++|..++. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 257 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEY 335 (452)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC-------
T ss_pred ehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccceecCCCce
Confidence 99999999987764 389999999999999999999999999999999999999776 899999999986643321
Q ss_pred --ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 285 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 285 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
.....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+....+.+..+.+... ++.+.++
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp -------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred ecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 123345678999999876 689999999999999999999 89888 55555566655554322 2344555
Q ss_pred HHhccCCCChhHHHHHhHHhc
Q 014307 355 LNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.. |+..||..||++++++.
T Consensus 414 i~~-cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 414 MCQ-CWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HccCChhhCcCHHHHHH
Confidence 555 88999999988776654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=313.12 Aligned_cols=237 Identities=18% Similarity=0.295 Sum_probs=193.1
Q ss_pred CCCCEEEEe-eeeecCCeeEEEEEEc--CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVR-KVGRGKYSEVFEGVHC--TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~-~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..++|.+.+ .||+|+||.||+|.+. .++..||||+++.. ..+.+.+|+.+++++ +||||+++++++.. .
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~ 82 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 82 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---C
Confidence 346788877 9999999999999864 46889999999753 345688999999999 99999999999943 4
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++||||+.+++|..++ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALG 161 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECT
T ss_pred CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeeec
Confidence 589999999999998776 3489999999999999999999999999999999999999776 89999999998765
Q ss_pred CCCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh------C-C
Q 014307 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL------G-T 348 (427)
Q Consensus 281 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~------~-~ 348 (427)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| ......+....+.+.. . +
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQGKRMECPPECP 239 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred cCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHHHHHHHHhcCCcCCCCCCcC
Confidence 43322 22345788999999876 678999999999999999998 99998 4555555555554431 1 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
+.+.+++.. |+..||..||++.+++.+
T Consensus 240 ~~l~~li~~-~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 240 PELYALMSD-CWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp HHHHHHHHH-TTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHH-HcCCChhhCcCHHHHHHH
Confidence 455555555 899999999988887764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.42 Aligned_cols=237 Identities=20% Similarity=0.318 Sum_probs=189.4
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCC---CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.+|++.+.||+|+||.||+|.+..+ ...+|+|.++.. ..+.+.+|+.+++++ +||||+++++++... ....
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcC-CCce
Confidence 4699999999999999999996543 346899998642 235688999999999 999999999987653 4567
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSCG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECccccccccccc
Confidence 89999999999987763 488999999999999999999999999999999999999776 8999999999865433
Q ss_pred Cc-----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChH
Q 014307 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDE 350 (427)
Q Consensus 283 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~ 350 (427)
.. .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..|++.+.+..+....+.+... ++.
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 260 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred chhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence 21 233456778999999876 68999999999999999999966666566666565555544322 344
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+++.. |+..||..||++.+++.
T Consensus 261 l~~li~~-~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 261 LYEVMLK-CWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HcCCChhhCcCHHHHHH
Confidence 5555555 88899998888777665
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=313.49 Aligned_cols=236 Identities=24% Similarity=0.371 Sum_probs=188.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC---CeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||.||+|++..+ +..||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~ 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEE---EP 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECS---SS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CC
Confidence 57899999999999999999987543 456999998753 346788999999999 99999999999864 34
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.++||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIED 165 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC--
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCccccc
Confidence 689999999999877763 489999999999999999999999999999999999999777 899999999976543
Q ss_pred CCc--ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHH
Q 014307 282 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (427)
Q Consensus 282 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (427)
... .....++..|+|||++.+ ..++.++|||||||++|+|++ |+.||. .....+....+..... ++.+
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFF-WLENKDVIGVLEKGDRLPKPDLCPPVL 243 (281)
T ss_dssp -------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-TSCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred ccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcc-cCChHHHHHHHhcCCCCCCCCCCCHHH
Confidence 322 233456778999999876 689999999999999999998 999994 3344444444433221 2345
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcC
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
..++.. |+..||..||++.+++.+
T Consensus 244 ~~li~~-~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 244 YTLMTR-CWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHHH-HccCCchhCcCHHHHHHH
Confidence 555555 899999999998887753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=322.21 Aligned_cols=236 Identities=19% Similarity=0.341 Sum_probs=186.1
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEE----EEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC----IIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v----avK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|++++.||+|+||.||+|++..+++.+ |+|.++. ...+.+.+|+.+++.+ +||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESS--
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecC--
Confidence 3578999999999999999999998887754 6666642 3457789999999999 999999999999863
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
..++++||+.++++..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 167 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC----
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeEc
Confidence 378999999999987765 3589999999999999999999999999999999999999777 8999999999876
Q ss_pred cCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 014307 280 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (427)
Q Consensus 280 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~ 348 (427)
..... .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+....+....+.+... .
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKGERLPQPPICT 245 (327)
T ss_dssp ------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred cCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcCCCCCCCccCC
Confidence 43322 223355778999999887 789999999999999999999 99998 44444444443333221 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+..++.. |+..||..||++.+++.
T Consensus 246 ~~l~~li~~-~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 246 IDVYMIMRK-CWMIDADSRPKFRELII 271 (327)
T ss_dssp HHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 355555555 99999999999888876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=325.90 Aligned_cols=237 Identities=18% Similarity=0.287 Sum_probs=189.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
..++|++.+.||+|+||.||+|++ .+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.. ....++
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 112 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE--RNEMIL 112 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC--TTCCEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEEE
Confidence 457899999999999999999996 57899999998643 346788999999999 99999999999865 567889
Q ss_pred EEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 209 IFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 209 v~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
||||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGTE 191 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence 999999999987763 388999999999999999999999999999999999999777 899999999986543
Q ss_pred CC---cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--HHHHHHHHHHh--C-------
Q 014307 282 GK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVL--G------- 347 (427)
Q Consensus 282 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~--~~~l~~i~~~~--~------- 347 (427)
.. ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... .+......... +
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 22 2234568999999999876 67999999999999999999999999533211 01111000000 0
Q ss_pred -----------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 -----------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 -----------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
...+..++.+ |+..||..||++.+++.
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~ell~ 308 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVK-CLALSSEDRPSMGDVLW 308 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 0123344444 89999999999888775
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.63 Aligned_cols=240 Identities=19% Similarity=0.264 Sum_probs=190.9
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~----~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
...++|++.+.||+|+||.||+|++ .+++.||||+++.... ..+.+|+.+++.+ +||||+++++++.. ....
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~ 102 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMT--PTER 102 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECC--SSCC
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEec--CCce
Confidence 4568899999999999999999985 5789999999875332 3688999999999 89999999999976 4567
Q ss_pred EEEEeecCCCchhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CceeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 207 SLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
++||||+.+++|..++. .+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~ 181 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA 181 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence 89999999999887653 288999999999999999999999 999999999999999776 8999999999
Q ss_pred eeecCCCc--ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC----CCCCHHHHHHHHHHhC---
Q 014307 277 EFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY----GHDNYDQLVKIAKVLG--- 347 (427)
Q Consensus 277 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~----~~~~~~~l~~i~~~~~--- 347 (427)
........ .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.. ..........+.....
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred cccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 87653322 334468999999999876 6789999999999999999999999941 1111111111110000
Q ss_pred -----------------ChHHHHHHHhccCCCChhHHHHHhHHhcCC
Q 014307 348 -----------------TDELNAYLNKYHIELDPHLAALVGRLVILS 377 (427)
Q Consensus 348 -----------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~ 377 (427)
.+.+.+++.. |+..||..||++.+++.+-
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALL-CTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHH-HTCSCGGGSCCHHHHHHHH
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHH-HhCcCCccCCCHHHHHHHh
Confidence 0234455555 9999999999999988753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=320.09 Aligned_cols=238 Identities=18% Similarity=0.313 Sum_probs=192.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++.+.||+|+||.||+|++. .+++.||||++... ....+.+|+.+++.+ +||||+++++++.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-- 99 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 99 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc--
Confidence 3578999999999999999999876 35789999998643 234588999999999 99999999999965
Q ss_pred CCCcEEEEeecCCCchhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEE
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 269 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ik 269 (427)
....++||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~-~~k 178 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVK 178 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC-eEE
Confidence 557889999999999877652 468899999999999999999999999999999999999777 899
Q ss_pred EEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHH
Q 014307 270 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 345 (427)
Q Consensus 270 l~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~ 345 (427)
|+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..|| .+.+..+....+.+.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~ 256 (322)
T 1p4o_A 179 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQVLRFVMEG 256 (322)
T ss_dssp ECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTT-TTSCHHHHHHHHHTT
T ss_pred ECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCcc-ccCCHHHHHHHHHcC
Confidence 999999975543221 123356788999999876 679999999999999999999 78887 444444444444332
Q ss_pred h-------CChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 346 L-------GTDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 346 ~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
. -++.+.+++.. |+..||..||++.+++.+
T Consensus 257 ~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 257 GLLDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCCCCCHHHHHHHHH-HcCCCcccCcCHHHHHHH
Confidence 1 12345555555 999999999999988764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=311.59 Aligned_cols=233 Identities=17% Similarity=0.279 Sum_probs=190.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++.+.||+|+||.||+|++ +++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+......+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeE
Confidence 46899999999999999999997 4899999998743 235688999999999 999999999999876567889
Q ss_pred EEEeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 208 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
+||||+.+++|..++. .+++..++.++.||+.||.|||++| |+||||||+|||++.++ .++|+|||++....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFSFQ 164 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSCCTTS
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccceeeec
Confidence 9999999999987763 3799999999999999999999999 99999999999999776 79999999875432
Q ss_pred CCCcceeeccCccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------CChH
Q 014307 281 PGKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDE 350 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~~~~ 350 (427)
.....+|+.|+|||++.+. ..++.++|||||||++|||++|+.|| .+....+....+.... -++.
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF-ADLSNMEIGMKVALEGLRPTIPPGISPH 239 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTT-TTSCHHHHHHHHHHSCCCCCCCTTCCHH
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCc-cccChHHHHHHHHhcCCCCCCCCCCCHH
Confidence 2345788999999998762 22344899999999999999999999 4444444444443321 1245
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+++.. |+..||..||++.+++.
T Consensus 240 ~~~li~~-~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 240 VSKLMKI-CMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HcCCChhhCcCHHHHHH
Confidence 5555555 88999999998887764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=327.15 Aligned_cols=236 Identities=19% Similarity=0.234 Sum_probs=186.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC--------CCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeee-----------
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK----------- 193 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~----------- 193 (427)
.++|++.+.||+|+||.||+|++.. .++.||||++... +.+.+|+.+++++ +||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhhhccCCcc
Confidence 4789999999999999999999977 4889999999754 5688999999999 8998887
Q ss_pred ----eeeEEEcCCCCCcEEEEeecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC
Q 014307 194 ----LLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (427)
Q Consensus 194 ----l~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~ 264 (427)
+++++... ....++||||+ +++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 118 ~i~~~~~~~~~~-~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~ 195 (352)
T 2jii_A 118 AIPTCMGFGVHQ-DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPE 195 (352)
T ss_dssp SCCCCCEEEEET-TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETT
T ss_pred CccchhhccccC-CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCC
Confidence 56666652 56789999999 88887775 358999999999999999999999999999999999999965
Q ss_pred C-CeEEEEeeeeeeeecCCCc--------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 014307 265 Q-RKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335 (427)
Q Consensus 265 ~-~~ikl~DFGla~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~ 335 (427)
+ ..+||+|||+++.+..... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 4 2799999999976543221 133478999999999887 68999999999999999999999999654435
Q ss_pred HHHHHHHHHHhC----------------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 336 YDQLVKIAKVLG----------------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 336 ~~~l~~i~~~~~----------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+........ ++.+.+++.. |+..||..||++.+++.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKV-VMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHH-HHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHH-HHhCChhhCCCHHHHHH
Confidence 555444333210 2344444444 77777777777666544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=314.40 Aligned_cols=237 Identities=21% Similarity=0.331 Sum_probs=191.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCe---EEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
-.|++.+.||+|+||+||+|.+..+++ .||+|+++... .+.+.+|+.+++.+ +||||+++++++.+. ....
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPP-EGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS-SSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecC-CCCc
Confidence 357888999999999999999765544 79999986432 35678999999999 999999999999764 3445
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
+++|||+.+++|..++. .+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDR 177 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCC
Confidence 89999999999887763 488999999999999999999999999999999999999777 8999999999755332
Q ss_pred C-----cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChH
Q 014307 283 K-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDE 350 (427)
Q Consensus 283 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~ 350 (427)
. ......++..|+|||.+.+ ..++.++|||||||++|+|++|..|++...+..+....+..... ++.
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDS 256 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHH
Confidence 1 2233467788999999876 68999999999999999999987787676666655555544322 234
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+++.. |+..||..||++.+++.
T Consensus 257 l~~li~~-~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 257 LYQVMQQ-CWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HccCChhhCcCHHHHHH
Confidence 5555555 88888888888777654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=322.08 Aligned_cols=244 Identities=16% Similarity=0.265 Sum_probs=191.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEE-----EcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|++++.||+|+||.||+|+ +..+++.||||++... ....+.+|+.+++++ +||||+++++++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC--
Confidence 34789999999999999999998 5567889999998532 235688999999999 99999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEE
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRL 270 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl 270 (427)
....++||||+.+++|..++. .+++.+++.++.||+.||.|||++||+||||||+|||++.++ ..+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 456789999999999887752 388899999999999999999999999999999999998432 36999
Q ss_pred EeeeeeeeecCCC---cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh
Q 014307 271 IDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 346 (427)
Q Consensus 271 ~DFGla~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~ 346 (427)
+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| .+....+....+....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~-~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVLEFVTSGG 262 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHTTC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCC-CCcCHHHHHHHHhcCC
Confidence 9999997543322 1233467888999999876 689999999999999999998 88888 4444444444443321
Q ss_pred -------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 347 -------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 347 -------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
-++.+.+++.. |+..||..||++.+++.+.|+..
T Consensus 263 ~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQ-CWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHH-HhcCChhhCcCHHHHHHHHHHHh
Confidence 12445555555 99999999999999998876543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=323.15 Aligned_cols=240 Identities=20% Similarity=0.335 Sum_probs=173.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEc------CCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRD------QQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~------~~~ 203 (427)
..+|++.+.||+|+||.||+|++..+++.||||++.... ...+.+|+.+++++.+||||+++++++.. ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999999999999999885433 35678999999999569999999999853 224
Q ss_pred CCcEEEEeecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
...+++|||+.+ +|..++ ..+++..++.++.||+.||.|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 107 ~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~ 184 (337)
T 3ll6_A 107 AEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGS 184 (337)
T ss_dssp EEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred ceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence 457899999985 544433 24999999999999999999999999 99999999999999777 899999999
Q ss_pred eeeecCCCcc-------------eeeccCcccccccccc--CCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH
Q 014307 276 AEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340 (427)
Q Consensus 276 a~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~ 340 (427)
++........ ....+++.|+|||++. ....++.++|||||||++|+|++|+.||.. ....+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~ 263 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED-GAKLRIVN 263 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc-hhHHHhhc
Confidence 9866433221 1456899999999983 225789999999999999999999999943 22222221
Q ss_pred HHHHH----hCChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 341 KIAKV----LGTDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 341 ~i~~~----~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
..... ...+.+..++.. |+..||..||++.+++.+
T Consensus 264 ~~~~~~~~~~~~~~~~~li~~-~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 264 GKYSIPPHDTQYTVFHSLIRA-MLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp --CCCCTTCCSSGGGHHHHHH-HSCSSGGGSCCHHHHHHH
T ss_pred CcccCCcccccchHHHHHHHH-HccCChhhCcCHHHHHHH
Confidence 11100 012345555555 999999999999998875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=326.07 Aligned_cols=238 Identities=17% Similarity=0.274 Sum_probs=184.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHH--HhcCCCCeeeeeeEEEc---CCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ--NLCGGPNIVKLLDIVRD---QQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~--~l~~h~niv~l~~~~~~---~~~~~~~ 207 (427)
.++|++++.||+|+||.||+|++ +++.||||+++......+..|.+++. .+ +||||+++++.+.. ......+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCceEE
Confidence 47899999999999999999976 78999999998777676666666654 35 99999999986643 2234568
Q ss_pred EEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---------CceeeccCCCceEEcCCCCeEEEEeeeee
Q 014307 208 LIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276 (427)
Q Consensus 208 lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---------~iiHrDlkp~NILl~~~~~~ikl~DFGla 276 (427)
+||||+.+++|..++ ...++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 89 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~DFG~a 167 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLS 167 (336)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEeeccce
Confidence 999999999998876 3578889999999999999999999 999999999999999777 8999999999
Q ss_pred eeecCCC---------cceeeccCccccccccccCC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCH-----
Q 014307 277 EFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY----- 336 (427)
Q Consensus 277 ~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~----- 336 (427)
+.+.... ......||+.|+|||++.+. ..++.++|||||||++|||++|..||+.+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~ 247 (336)
T 3g2f_A 168 MRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMA 247 (336)
T ss_dssp EECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCT
T ss_pred eecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHh
Confidence 8764322 12244789999999998752 346678999999999999999988886654321
Q ss_pred -----------HHHHHHHHHhCC---------------hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 337 -----------DQLVKIAKVLGT---------------DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 337 -----------~~l~~i~~~~~~---------------~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+......... +.+.+++.. |+..||..||++.+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 248 FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED-CWDQDAEARLTAQXAEE 311 (336)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHH-HSCSSGGGSCCHHHHHH
T ss_pred hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHH-HhcCChhhCcchHHHHH
Confidence 111111111000 135555555 88999999998887754
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=318.31 Aligned_cols=237 Identities=16% Similarity=0.294 Sum_probs=186.7
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCC----eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..++|++.+.||+|+||.||+|.+..++ ..||||+++.. ....+.+|+.+++++ +||||+++++++.. .
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 118 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y 118 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec--C
Confidence 3578999999999999999999986553 46999998743 235688999999999 99999999999965 5
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
...++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL 197 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC----
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcchhh
Confidence 6789999999999998775 3589999999999999999999999999999999999999776 8999999999876
Q ss_pred cCCCc----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 280 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 280 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
..... .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+....+.+..+.+...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~ 275 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPY-WELSNHEVMKAINDGFRLPTPMDC 275 (333)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred ccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCc-ccCCHHHHHHHHHCCCcCCCcccC
Confidence 44322 122345678999999876 689999999999999999999 99998 44444555555443321
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+.+++.. |+..+|..||++.+++.
T Consensus 276 ~~~l~~li~~-~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 276 PSAIYQLMMQ-CWQQERARRPKFADIVS 302 (333)
T ss_dssp BHHHHHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 2345555555 99999999999888775
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=320.32 Aligned_cols=238 Identities=21% Similarity=0.314 Sum_probs=186.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeeeeEEEcCCC--CCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~~h~niv~l~~~~~~~~~--~~~~lv 209 (427)
.++|++++.||+|+||.||+|++ +++.||||++.........+|.+++..+ .+||||+++++++..... ..+++|
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 113 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI 113 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence 46799999999999999999987 4899999999877667777777776654 389999999999886432 578999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC--------CceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~--------~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
|||+.+++|..++. .+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++..+
T Consensus 114 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~ 192 (337)
T 3mdy_A 114 TDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKF 192 (337)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCCCceee
Confidence 99999999987763 689999999999999999999999 999999999999999777 8999999999766
Q ss_pred cCCCcc-----eeeccCccccccccccCCCCCCc------hhhHHHHHHHHHHHHhC----------CCCCCCCC---CC
Q 014307 280 HPGKEY-----NVRVASRYFKGPELLVDLQDYDY------SLDLWSLGCMFAGMIFR----------KEPFFYGH---DN 335 (427)
Q Consensus 280 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~------~~DvwSlGvll~elltg----------~~pf~~~~---~~ 335 (427)
...... ....||+.|+|||++.+ ..++. ++|||||||++|||++| +.||.... ..
T Consensus 193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 271 (337)
T 3mdy_A 193 ISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271 (337)
T ss_dssp C---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc
Confidence 443222 24578999999999876 34444 49999999999999999 77774322 23
Q ss_pred HHHHHHHHHHhC--------------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 336 YDQLVKIAKVLG--------------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 336 ~~~l~~i~~~~~--------------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+........ .+.+.+++.. |+..||..||++.+++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-~l~~dP~~Rps~~ell~ 324 (337)
T 3mdy_A 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE-CWAHNPASRLTALRVKK 324 (337)
T ss_dssp HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHH-HSCSSGGGSCCHHHHHH
T ss_pred hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHH-hhhhChhhCCCHHHHHH
Confidence 333333322111 0124445555 99999999999888765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=312.74 Aligned_cols=235 Identities=17% Similarity=0.299 Sum_probs=187.2
Q ss_pred CCCEEEEe-eeeecCCeeEEEEEE--cCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVR-KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~-~LG~G~fg~V~~~~~--~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|++.+ .||+|+||.||+|.+ ..+++.||||+++... .+.+.+|+.+++.+ +||||+++++++. ..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~---~~ 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE---AE 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE---SS
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEC---CC
Confidence 46899998 999999999999954 5567899999987432 46788999999999 9999999999984 34
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
..++||||+.+++|..++ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRA 169 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCT
T ss_pred CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceeecc
Confidence 678999999999988775 3589999999999999999999999999999999999999777 899999999987654
Q ss_pred CCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh-------CCh
Q 014307 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------GTD 349 (427)
Q Consensus 282 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-------~~~ 349 (427)
.... ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| .+.+..+....+.... -++
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKGERMGCPAGCPR 247 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred CCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 4332 22345678999999876 678999999999999999999 99998 4444444333333321 123
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+++.. |+..||..||++.+++.
T Consensus 248 ~l~~li~~-~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 248 EMYDLMNL-CWTYDVENRPGFAAVEL 272 (291)
T ss_dssp HHHHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 45555555 88888888888777654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=317.41 Aligned_cols=192 Identities=23% Similarity=0.394 Sum_probs=166.7
Q ss_pred EEEEeeeeecCCeeEEEEEE----cCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 136 YEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~----~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
|+++++||+|+||+||+|.. ..+++.||||+++... .+.+.+|+.+|+++ +||||+++++++.+.....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCCceEE
Confidence 59999999999999988754 3578999999997532 45688999999999 899999999999987667889
Q ss_pred EEEeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-
Q 014307 208 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~- 284 (427)
+||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++........
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~ 190 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEY 190 (318)
T ss_dssp EEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCTTCSE
T ss_pred EEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCccccccccccccc
Confidence 9999999999988774 489999999999999999999999999999999999999776 899999999987755432
Q ss_pred ---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 014307 285 ---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330 (427)
Q Consensus 285 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 330 (427)
.....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 191 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 191 YRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp EEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 233467788999999876 678899999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=321.29 Aligned_cols=241 Identities=22% Similarity=0.353 Sum_probs=186.8
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--CCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~--~~~~~ 206 (427)
..++|++.+.||+|+||.||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++... .....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCcee
Confidence 457899999999999999999999999999999998543 346688999999999 999999999998742 23467
Q ss_pred EEEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 207 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
++||||+.+++|..++ ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~ 184 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCEES
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcchhc
Confidence 8999999999987655 3489999999999999999999999999999999999999777 8999999998754
Q ss_pred cCCCc----------ceeeccCccccccccccCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCC---CCCHHHHHHH-H
Q 014307 280 HPGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYG---HDNYDQLVKI-A 343 (427)
Q Consensus 280 ~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwSlGvll~elltg~~pf~~~---~~~~~~l~~i-~ 343 (427)
..... .....|++.|+|||++.+.. .++.++|||||||++|+|++|+.||... .......... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 32111 12345789999999986522 3789999999999999999999998321 1111111100 0
Q ss_pred HH----hCChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 344 KV----LGTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 344 ~~----~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.. .-++.+.+++.. |+..||..||++.+++.
T Consensus 265 ~~~~~~~~~~~l~~li~~-~l~~dp~~Rps~~~ll~ 299 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNS-MMTVDPHQRPHIPLLLS 299 (317)
T ss_dssp -CCCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCCccccCCHHHHHHHHH-HhhcChhhCCCHHHHHH
Confidence 00 012345555555 88999999998877765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=311.35 Aligned_cols=233 Identities=16% Similarity=0.314 Sum_probs=183.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|++.+.||+|+||.||+|.+ +++.||||+++.. ..+.+.+|+.+++++ +||||+++++++... ....++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-CCceEEEEe
Confidence 47899999999999999999987 5899999999754 446789999999999 999999999987653 446899999
Q ss_pred ecCCCchhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce
Q 014307 212 HVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (427)
Q Consensus 212 ~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~ 286 (427)
|+.+++|..++.. +++..+..++.|++.||.|||++||+||||||+||+++.++ .+||+|||++...... ..
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~--~~ 172 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST--QD 172 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeecccccccccc--cc
Confidence 9999999877642 78999999999999999999999999999999999999777 8999999999754332 23
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhc
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKY 358 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~ 358 (427)
...++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| ......+....+.+... ++.+.+++..
T Consensus 173 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~- 249 (278)
T 1byg_A 173 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN- 249 (278)
T ss_dssp ---CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSC-TTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH-
T ss_pred CCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH-
Confidence 3467888999999876 689999999999999999998 99998 44343344443333211 2445555555
Q ss_pred cCCCChhHHHHHhHHhc
Q 014307 359 HIELDPHLAALVGRLVI 375 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~ 375 (427)
|+..||..||++.+++.
T Consensus 250 ~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 250 CWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HhcCChhhCCCHHHHHH
Confidence 88999999998887765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=340.52 Aligned_cols=235 Identities=17% Similarity=0.317 Sum_probs=192.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
..++|++.++||+|+||.||+|.+. .+..||||+++.. ..+.+.+|+.+|+++ +||||+++++++.+ ..+++|
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~---~~~~lv 339 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIV 339 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEE
T ss_pred chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---ccceEe
Confidence 4578999999999999999999985 4577999999753 457899999999999 99999999999864 458999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
|||+.+++|..++. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++......
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEY 418 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCCCHHH
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccceecCCCce
Confidence 99999999987764 389999999999999999999999999999999999999776 89999999997654221
Q ss_pred -cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 284 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
......++..|+|||++.+ ..++.++|||||||+||||++ |+.|| .+....+.+..+.+... .+.+.++
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1122345678999999876 689999999999999999999 89888 55555566655554322 2345555
Q ss_pred HHhccCCCChhHHHHHhHHhc
Q 014307 355 LNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.. |+..||..||++.+++.
T Consensus 497 i~~-cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 497 MCQ-CWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHH-HTCSSGGGSCCHHHHHH
T ss_pred HHH-HcCCChhHCcCHHHHHH
Confidence 555 88999999988776653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=325.60 Aligned_cols=237 Identities=19% Similarity=0.306 Sum_probs=179.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCC---eEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..|++.+.||+|+||.||+|.+..++ ..||+|.++. ...+.+.+|+.+++++ +||||+++++++... ....
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~-~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCC-SSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcC-CCCe
Confidence 45889999999999999999875443 4689999864 2346788999999999 999999999987643 4567
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++||||+.+++|..++. .+++.++..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecccccccccc
Confidence 89999999999988763 478899999999999999999999999999999999999777 8999999999865433
Q ss_pred Cc-----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChH
Q 014307 283 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDE 350 (427)
Q Consensus 283 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~ 350 (427)
.. .....++..|+|||++.+ ..++.++|||||||++|||++|..|++.+.+..+....+.+... ++.
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 324 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP 324 (373)
T ss_dssp ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHH
T ss_pred ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 21 123456778999999876 68999999999999999999954444455555454444433211 234
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+++.. |+..||..||++.+++.
T Consensus 325 l~~li~~-cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 325 LYEVMLK-CWHPKAEMRPSFSELVS 348 (373)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HcCCChhhCcCHHHHHH
Confidence 5555555 88999999988777664
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=315.94 Aligned_cols=240 Identities=18% Similarity=0.241 Sum_probs=192.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHh-cCCCCeeeeeeEEEcCCC--CCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l-~~h~niv~l~~~~~~~~~--~~~~lv 209 (427)
.++|++.+.||+|+||.||+|.+ +++.||||+++......+.+|++++..+ .+||||+++++++..... ..+++|
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv 118 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 118 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEE
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEE
Confidence 36799999999999999999987 5899999999887778889999999883 289999999999986532 378999
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHH--------HCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH--------~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
|||+.+++|..++. .+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||++...
T Consensus 119 ~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~ 197 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 197 (342)
T ss_dssp ECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCTTCEEE
T ss_pred EeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECCCceec
Confidence 99999999987764 5899999999999999999999 89999999999999999777 8999999999877
Q ss_pred cCCCc-----ceeeccCccccccccccCCCC-----CCchhhHHHHHHHHHHHHhC----------CCCCCCCCC---CH
Q 014307 280 HPGKE-----YNVRVASRYFKGPELLVDLQD-----YDYSLDLWSLGCMFAGMIFR----------KEPFFYGHD---NY 336 (427)
Q Consensus 280 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~-----~~~~~DvwSlGvll~elltg----------~~pf~~~~~---~~ 336 (427)
..... .....|++.|+|||++.+... ++.++|||||||++|||++| ..||..... ..
T Consensus 198 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 277 (342)
T 1b6c_B 198 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277 (342)
T ss_dssp ETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence 55432 234578999999999876322 33689999999999999999 788854322 23
Q ss_pred HHHHHHHHHh--CC------------hHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 337 DQLVKIAKVL--GT------------DELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 337 ~~l~~i~~~~--~~------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
+.+....... .. +.+.+++. .|+..||..||++.+++.+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~-~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR-ECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHH-HHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHH-HHhccChhhCCCHHHHHHH
Confidence 3333222110 00 12334444 4999999999998887753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=332.88 Aligned_cols=237 Identities=21% Similarity=0.316 Sum_probs=187.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|+++++||+|+||.||+|++..+++.||||+++.. ....+.+|+++++.+.++++++.+..++.. ....++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEEEE
Confidence 47899999999999999999999999999999998642 335688999999999555666666665544 567799999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE---cCCCCeEEEEeeeeeeeecCCCc
Q 014307 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
|+ +++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||| +.++ .+||+|||+++.+.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTTT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC-eEEEEeCCcceeccCCcc
Confidence 99 77777665 369999999999999999999999999999999999999 4444 899999999987754432
Q ss_pred --------ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--CHHHHHHHHHH---------
Q 014307 285 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKV--------- 345 (427)
Q Consensus 285 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~--~~~~l~~i~~~--------- 345 (427)
.....|+..|+|||++.+ ..++.++|||||||+||||++|+.||..... ..+.+..+...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 125679999999999887 6899999999999999999999999954322 12222222211
Q ss_pred -hC-ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 346 -LG-TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 346 -~~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+ .+.+.+++.. |+..+|..||++.+++.
T Consensus 241 ~~~~p~~l~~li~~-cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 241 CRGYPTEFASYFHY-CRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HTTSCHHHHHHHHH-HHTCCTTCCCCHHHHHH
T ss_pred hcCCcHHHHHHHHH-HhcCChhhCcCHHHHHH
Confidence 12 2345555555 89999999998777654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.13 Aligned_cols=236 Identities=17% Similarity=0.293 Sum_probs=190.1
Q ss_pred CCCCEEEEe-eeeecCCeeEEEEEEc--CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVR-KVGRGKYSEVFEGVHC--TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~-~LG~G~fg~V~~~~~~--~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..+++.+.+ +||+|+||.||+|.++ .++..||||+++.. ..+.+.+|+++|+++ +||||+++++++.. .
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~ 408 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 408 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---S
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---C
Confidence 456677776 8999999999999875 35677999999752 457799999999999 99999999999975 3
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
.+++||||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCccccc
Confidence 4899999999999987753 489999999999999999999999999999999999999777 89999999998654
Q ss_pred CCCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 014307 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (427)
Q Consensus 281 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~ 348 (427)
..... ....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+.+..+.+... +
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~ 565 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQGKRMECPPECP 565 (613)
T ss_dssp --------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCSHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 33221 12244578999999876 689999999999999999998 99998 56666676666654321 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+.+++.. |+..+|..||++.+++.
T Consensus 566 ~~l~~li~~-cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 566 PELYALMSD-CWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHHHHHH-TTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 455555555 99999999998777653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=313.11 Aligned_cols=239 Identities=19% Similarity=0.359 Sum_probs=188.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEE----cCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~----~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++++.||+|+||.||+|++ ..+++.||||+++... .+.+.+|+.+++++ +||||+++++++.......
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC----C
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCCCc
Confidence 46799999999999999999984 5689999999987533 35688999999999 9999999999987765667
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
+++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQ 197 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCS
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhccc
Confidence 899999999999887753 489999999999999999999999999999999999999777 899999999987654
Q ss_pred CCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC----------C-HHHHHHHHHHh
Q 014307 282 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD----------N-YDQLVKIAKVL 346 (427)
Q Consensus 282 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~----------~-~~~l~~i~~~~ 346 (427)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|..||..... . ......+.+.+
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 4321 23356677999999876 6789999999999999999999998842110 0 11111111111
Q ss_pred ----------C-ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 ----------G-TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 ----------~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
. ++.+.+++.. |+..||..||++.+++.
T Consensus 277 ~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 277 KNNGRLPRPDGCPDEIYMIMTE-CWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHH-HSCSSGGGSCCHHHHHH
T ss_pred hcCCCCCCCCcccHHHHHHHHH-HcCCChhhCcCHHHHHH
Confidence 1 2344455544 88888888888877764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=340.71 Aligned_cols=233 Identities=17% Similarity=0.286 Sum_probs=186.5
Q ss_pred CEEEE-eeeeecCCeeEEEEEE--cCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 135 DYEVV-RKVGRGKYSEVFEGVH--CTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 135 ~y~~~-~~LG~G~fg~V~~~~~--~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.+.+. ++||+|+||.||+|.+ +.+++.||||+++.. ..+.+.+|+.+|+++ +|||||++++++.. ...
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~---~~~ 444 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESW 444 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES---SSE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---CCE
Confidence 34443 5899999999999965 456789999999753 246799999999999 89999999999964 347
Q ss_pred EEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 207 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.+....
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC--
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCc
Confidence 8999999999998776 3589999999999999999999999999999999999999777 89999999998664432
Q ss_pred c----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHH
Q 014307 284 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (427)
Q Consensus 284 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (427)
. .....++..|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+... ++.+
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~~~l 601 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKGERMGCPAGCPREM 601 (635)
T ss_dssp -----------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 2 223355678999999876 689999999999999999998 99998 55555555555544321 2355
Q ss_pred HHHHHhccCCCChhHHHHHhHHhc
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+++.. |+..||..||++.+++.
T Consensus 602 ~~li~~-cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 602 YDLMNL-CWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred HHHHHH-HcCCCHhHCcCHHHHHH
Confidence 555555 99999999999888764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=308.75 Aligned_cols=235 Identities=19% Similarity=0.288 Sum_probs=181.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-CC--eEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-DN--EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~--~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++++.||+|+||.||+|++.. ++ ..||||+++.. ..+.+.+|+.+++++ +||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTP-- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccC--
Confidence 4689999999999999999998643 33 36899998642 236688999999999 999999999999753
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
..++||||+.+++|...+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRAL 171 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred -CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccccccc
Confidence 378999999999987665 3489999999999999999999999999999999999999777 8999999999876
Q ss_pred cCCCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHh--------
Q 014307 280 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL-------- 346 (427)
Q Consensus 280 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~-------- 346 (427)
...... ....++..|+|||++.+ ..++.++|||||||++|+|++ |+.|| .+.+..+.+..+.+..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~ 249 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPED 249 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred cccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-ccCCHHHHHHHHHccCCCCCCCcC
Confidence 544321 23456778999999876 678999999999999999999 99998 4444444444443321
Q ss_pred CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 347 GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 347 ~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
-++.+.+++.. |+..||..||++.+++.
T Consensus 250 ~~~~l~~li~~-~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 250 CPQDIYNVMVQ-CWAHKPEDRPTFVALRD 277 (291)
T ss_dssp CCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred cCHHHHHHHHH-HccCCcccCcCHHHHHH
Confidence 12345555555 88899999988888765
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=311.54 Aligned_cols=225 Identities=22% Similarity=0.400 Sum_probs=181.1
Q ss_pred CCCEEEE-eeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEc--CCCCCcEEE
Q 014307 133 QDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~--~~~~~~~lv 209 (427)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++. ...+.+|+.++.++.+||||+++++++.. .....+++|
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv 93 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 93 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence 3678887 779999999999999999999999999974 45678999999666699999999999875 334568999
Q ss_pred EeecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC--CCeEEEEeeeeeeeecCC
Q 014307 210 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 210 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~--~~~ikl~DFGla~~~~~~ 282 (427)
|||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.+ ...+||+|||++....
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-- 171 (299)
T 3m2w_A 94 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-- 171 (299)
T ss_dssp ECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT--
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc--
Confidence 99999999877652 48999999999999999999999999999999999999973 3389999999986432
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHH--------------HhCC
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK--------------VLGT 348 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~--------------~~~~ 348 (427)
+ ..++.++|||||||++|||++|+.||... ...+....+.. ..-+
T Consensus 172 -------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (299)
T 3m2w_A 172 -------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSN-HGLAISPGMKTRIRMGQYEFPNPEWSEVS 230 (299)
T ss_dssp -------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCSCCSSCTTCCSSCHHHHTTSC
T ss_pred -------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCC-cchhhhHHHHHHHhhccccCCchhcccCC
Confidence 1 35778999999999999999999999432 22111100000 0123
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+..++.+ |+..||..||++.+++.||||.+..
T Consensus 231 ~~~~~li~~-~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 231 EEVKMLIRN-LLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHHHHHH-HcccChhhCCCHHHHhcChhhcccc
Confidence 455566666 9999999999999999999998754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=312.60 Aligned_cols=230 Identities=18% Similarity=0.267 Sum_probs=182.4
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
|...+.||+|+||.||+|.+ +++.||||++... ..+.+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 107 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSD--GDDLCL 107 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEec--CCceEE
Confidence 44558899999999999985 6889999998642 246788999999999 99999999999976 457899
Q ss_pred EEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 209 IFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 209 v~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKF 186 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSC
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeecccccccccc
Confidence 999999999876653 489999999999999999999999999999999999999776 8999999999876443
Q ss_pred Cc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH-----------hC-
Q 014307 283 KE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-----------LG- 347 (427)
Q Consensus 283 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~-----------~~- 347 (427)
.. .....|++.|+|||++.+ .++.++|||||||++|+|++|+.||...... +.+..+.+. +.
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 263 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDK 263 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHTTSCCHHHHSCS
T ss_pred cccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhhhhhhhhhhccc
Confidence 22 223478999999999865 5899999999999999999999999543221 111111111 10
Q ss_pred ---------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 ---------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 ---------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.+.+.+++.. |+..||..||++.+++.
T Consensus 264 ~~~~~~~~~~~~l~~li~~-cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 264 KMNDADSTSVEAMYSVASQ-CLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp SCSCCCHHHHHHHHHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred cccccchHHHHHHHHHHHH-HcCCCcccCcCHHHHHH
Confidence 0223344444 88899999998887764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=347.23 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=197.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEc----CCCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD----QQSKT 205 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~----~~~~~ 205 (427)
++|++.+.||+|+||.||+|.+..+++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.. .....
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCCe
Confidence 6799999999999999999999999999999998642 245688999999999 99999999998754 22566
Q ss_pred cEEEEeecCCCchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC--eEEEEeeeeee
Q 014307 206 PSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAE 277 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--~ikl~DFGla~ 277 (427)
.++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 789999999999987763 4889999999999999999999999999999999999986552 48999999998
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH-HH----HH--------
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KI----AK-------- 344 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~-~i----~~-------- 344 (427)
............|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .... .+ ..
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-~~~~~~i~~~~~~~~~~~~~l 250 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-VQWHGKVREKSNEHIVVYDDL 250 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-HHSSTTCC------CCSCCCC
T ss_pred ccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccch-hhhhhhhhcccchhhhhhhhh
Confidence 7766655666789999999999876 78999999999999999999999999543111 1100 00 00
Q ss_pred --------H------h---CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHH
Q 014307 345 --------V------L---GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVI 384 (427)
Q Consensus 345 --------~------~---~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~ 384 (427)
. + -.+.+..++.. |+..||..||++.+++.|+||.....
T Consensus 251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~-mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQC-MLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp SSSCCCCSSSCCSCCCCGGGHHHHHHHHHH-HSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred ccccccccccCCchhhchhhhHHHHHHHHH-HccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 0 0 01344555555 99999999999999999999998663
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=336.15 Aligned_cols=236 Identities=22% Similarity=0.401 Sum_probs=190.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCC---CeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..++|++.+.||+|+||.||+|.+..+ +..||||+++... .+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---C
Confidence 457899999999999999999998643 4679999986422 36688999999999 99999999999843 4
Q ss_pred CcEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++||||+.+++|..++. .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYME 542 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecC
Confidence 5789999999999987763 488999999999999999999999999999999999999777 89999999998764
Q ss_pred CCCcc--eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChH
Q 014307 281 PGKEY--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDE 350 (427)
Q Consensus 281 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~ 350 (427)
..... ....+++.|+|||++.+ ..++.++|||||||++|||++ |..|| .+....+.+..+.+... ++.
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 620 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPT 620 (656)
T ss_dssp C----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHHTCCCCCCTTCCHH
T ss_pred CCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHcCCCCCCCccccHH
Confidence 43322 23356678999999876 689999999999999999997 88888 55555666666554321 245
Q ss_pred HHHHHHhccCCCChhHHHHHhHHhc
Q 014307 351 LNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 351 ~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+..++.+ |+..||..||++.+++.
T Consensus 621 l~~li~~-~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 621 LYSLMTK-CWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHH-HcCCChhHCcCHHHHHH
Confidence 5555555 89999999998888764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=328.07 Aligned_cols=243 Identities=14% Similarity=0.155 Sum_probs=179.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCC-CCe---------ee---
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG-PNI---------VK--- 193 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h-~ni---------v~--- 193 (427)
..+|.+.+.||+|+||.||+|++..+|+.||||+++.. ..+.+.+|+.+++.+ .| +|. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCBCCCCE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhcccccchh
Confidence 45589999999999999999999999999999998732 246688999999988 54 221 11
Q ss_pred ---------eeeEEEcCC---CCCcEEEEeecCCCchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 014307 194 ---------LLDIVRDQQ---SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMH 251 (427)
Q Consensus 194 ---------l~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~iiH 251 (427)
+..++.... ....+++|+.+ +++|..++. .+++..+..++.||+.||+|||++||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111111111 22345566654 456655541 2667788889999999999999999999
Q ss_pred eccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCcccccccccc---------CCCCCCchhhHHHHHHHHHHH
Q 014307 252 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDLWSLGCMFAGM 322 (427)
Q Consensus 252 rDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DvwSlGvll~el 322 (427)
|||||+|||++.++ .+||+|||+++... ......+| +.|+|||++. ....++.++|||||||++|||
T Consensus 235 rDiKp~NILl~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 235 TYLRPVDIVLDQRG-GVFLTGFEHLVRDG--ASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp SCCCGGGEEECTTC-CEEECCGGGCEETT--EEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCC-eEEEEeccceeecC--CccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 99999999999887 79999999997643 23455677 9999999983 235688999999999999999
Q ss_pred HhCCCCCCCCCCCHHHHHHHHHH-hC-ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 323 IFRKEPFFYGHDNYDQLVKIAKV-LG-TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 323 ltg~~pf~~~~~~~~~l~~i~~~-~~-~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++|+.||.. .+..+....+... .. ++.+.+++.+ |+..||..||++.+++.|+||.+..
T Consensus 311 ltg~~Pf~~-~~~~~~~~~~~~~~~~~~~~~~~li~~-~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 311 WCADLPNTD-DAALGGSEWIFRSCKNIPQPVRALLEG-FLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp HHSSCCCCT-TGGGSCSGGGGSSCCCCCHHHHHHHHH-HTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHCCCCCCC-cchhhhHHHHHhhcccCCHHHHHHHHH-HccCChhhCcCHHHHHhCHHHHHHH
Confidence 999999943 2222222222110 11 3455555555 9999999999999999999999855
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=314.61 Aligned_cols=234 Identities=18% Similarity=0.195 Sum_probs=180.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhc--------CCCCeee
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNIVK 193 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~--------~h~niv~ 193 (427)
.++|++++.||+|+||+||+|++ +++.||||+++... .+.+.+|+.+|+.+. .||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35788999999999999999997 78999999997532 277899999999984 4888888
Q ss_pred eeeEEEcC----------------------------CCCCcEEEEeecCCCch-hhhc-CCCCHHHHHHHHHHHHHHHHH
Q 014307 194 LLDIVRDQ----------------------------QSKTPSLIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKALDY 243 (427)
Q Consensus 194 l~~~~~~~----------------------------~~~~~~lv~e~~~~~~l-~~~~-~~~~~~~~~~i~~qi~~~L~~ 243 (427)
+.+++... ....+++||||+.++++ ..+. ..+++..++.++.||+.||+|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 87765421 25678999999999854 4443 358999999999999999999
Q ss_pred HH-HCCceeeccCCCceEEcCCC-------------------CeEEEEeeeeeeeecCCCcceeeccCccccccccccCC
Q 014307 244 CH-SQGIMHRDVKPHNVMIDHEQ-------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303 (427)
Q Consensus 244 LH-~~~iiHrDlkp~NILl~~~~-------------------~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~ 303 (427)
|| ++||+||||||+|||++.++ ..+||+|||+|+..... ..+||+.|+|||++.+.
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCC
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCC
Confidence 99 99999999999999998664 27999999999876543 45899999999999863
Q ss_pred CCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCCHHHHHHHHHHh-------------CChHHHHHHHhccCCCChhHHHH
Q 014307 304 QDYDYSLDLWSLGCM-FAGMIFRKEPFFYGHDNYDQLVKIAKVL-------------GTDELNAYLNKYHIELDPHLAAL 369 (427)
Q Consensus 304 ~~~~~~~DvwSlGvl-l~elltg~~pf~~~~~~~~~l~~i~~~~-------------~~~~~~~~l~~~~l~~dp~~r~~ 369 (427)
. +.++||||||++ .+++++|..||............+.+.. -++.+.+++.+ |+..| +
T Consensus 253 -~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~-~L~~d-----s 324 (336)
T 2vuw_A 253 -G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRT-MLNFS-----S 324 (336)
T ss_dssp -S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHH-GGGSS-----S
T ss_pred -C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHH-HhccC-----C
Confidence 3 889999998777 7778889888821000001111222110 02345555655 88877 8
Q ss_pred HhHHh-cCCchh
Q 014307 370 VGRLV-ILSYFF 380 (427)
Q Consensus 370 ~~~ll-~~~~~~ 380 (427)
+.++| .||||+
T Consensus 325 a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 ATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHCGGGC
T ss_pred HHHHHhcCCCcC
Confidence 89999 999984
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=308.71 Aligned_cols=234 Identities=18% Similarity=0.310 Sum_probs=182.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..++|++.+.||+|+||.||+|.+.. .+|+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~ 104 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMS--PPHL 104 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEEC--SSCE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CCce
Confidence 35789999999999999999998743 4899998642 234577899999999 99999999999986 4568
Q ss_pred EEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-
Q 014307 207 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 281 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~- 281 (427)
++||||+.+++|..++. .+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||++.....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSISGVL 182 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC-----
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCccccccc
Confidence 99999999999988774 489999999999999999999999999999999999998 45 799999999865432
Q ss_pred -----CCcceeeccCccccccccccC--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-
Q 014307 282 -----GKEYNVRVASRYFKGPELLVD--------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG- 347 (427)
Q Consensus 282 -----~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~- 347 (427)
........|+..|+|||++.+ ...++.++|||||||++|||++|+.|| ......+....+.....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~-~~~~~~~~~~~~~~~~~~ 261 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-KTQPAEAIIWQMGTGMKP 261 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSS-SSCCHHHHHHHHHTTCCC
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHhccCCCC
Confidence 122334568899999999864 245889999999999999999999999 44444444444433211
Q ss_pred -------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 -------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 -------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+.+++.. |+..||..||++.+++.
T Consensus 262 ~~~~~~~~~~l~~li~~-~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 262 NLSQIGMGKEISDILLF-CWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CCCCSSCCTTHHHHHHH-HHCSSTTTSCCHHHHHH
T ss_pred CCCcCCCCHHHHHHHHH-HhcCChhhCcCHHHHHH
Confidence 2344455544 78888888887777654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.09 Aligned_cols=239 Identities=20% Similarity=0.266 Sum_probs=190.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC---
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK--- 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~--- 204 (427)
.++|++.+.||+|+||.||+|++.. +++.||||++... ....+.+|+.+++++ +||||+++++++...+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCCCc
Confidence 4789999999999999999999976 7899999998642 234678999999999 999999999999864321
Q ss_pred CcEEEEeecCCCchhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 205 TPSLIFEHVNNTDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
..++||||+.+++|..... .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~~- 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF- 234 (681)
T ss_dssp EEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTCC-
T ss_pred eeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhcccC-
Confidence 2689999999999977654 69999999999999999999999999999999999999864 7999999999876433
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCC
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~d 363 (427)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ............+.+..++.+ |+..|
T Consensus 235 --~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~-~l~~d 308 (681)
T 2pzi_A 235 --GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-GLPEDDPVLKTYDSYGRLLRR-AIDPD 308 (681)
T ss_dssp --SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS-SCCTTCHHHHHCHHHHHHHHH-HTCSS
T ss_pred --CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc-cccccccccccCHHHHHHHhh-hccCC
Confidence 45679999999999865 4589999999999999999998887421100 000000000113455566666 99999
Q ss_pred hhHHHHHhHHhcCCchhh
Q 014307 364 PHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 364 p~~r~~~~~ll~~~~~~~ 381 (427)
|..|++..+.+.++|+..
T Consensus 309 P~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 309 PRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp GGGSCSSHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHHH
Confidence 999998888888777653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=292.30 Aligned_cols=209 Identities=13% Similarity=0.151 Sum_probs=166.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
.++|++.+.||+|+||.||+|++..+++.||||+++... .+.+.+|+.++.++ +||||+++++++.+ ....
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~~~~ 106 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHT--RAGG 106 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEE--CCcE
Confidence 468999999999999999999999999999999997532 26688999999999 99999999999987 4668
Q ss_pred EEEEeecCCCchhhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 207 SLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~~-~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
++||||+.+++|..++.. ....++..++.||+.||+|||++||+||||||+|||++.++ .+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~----------- 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA----------- 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC-----------
T ss_pred EEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc-----------
Confidence 999999999999887753 56678899999999999999999999999999999999777 78887443
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH-------H----HHHHH--hCChHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL-------V----KIAKV--LGTDELN 352 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l-------~----~i~~~--~~~~~~~ 352 (427)
|++ .++.++|||||||++|||++|+.||... +..+.+ . ..... --++.+.
T Consensus 175 --------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 175 --------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp --------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCC-SBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred --------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcC-CcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 222 3788999999999999999999999533 221111 0 00000 1123444
Q ss_pred HHHHhccCCCChhHHHHHhHHhc
Q 014307 353 AYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+++.+ |+..||..| ++.+++.
T Consensus 238 ~li~~-~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 238 AVAAR-SVQGDGGIR-SASTLLN 258 (286)
T ss_dssp HHHHH-HHCTTSSCC-CHHHHHH
T ss_pred HHHHH-HcccCCccC-CHHHHHH
Confidence 55555 777888877 7766655
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-33 Score=292.82 Aligned_cols=182 Identities=20% Similarity=0.154 Sum_probs=129.4
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc-------------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-------------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..++.|++|.+..++....|+.+|+|++... +.+++.+|+++|+++..|+||+++++++++ +..+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed--~~~~ 317 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN--AQSG 317 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC--SSEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE--CCEE
Confidence 4567888888888888788999999998532 235689999999999889999999999987 5678
Q ss_pred EEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-Ccc
Q 014307 207 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 285 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~~~ 285 (427)
||||||++|++|.+.+..........|+.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... ...
T Consensus 318 yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 318 WLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC---CCS
T ss_pred EEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCCccc
Confidence 99999999999998875433333456899999999999999999999999999999887 8999999999876543 334
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCC
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRK 326 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~ 326 (427)
...+||+.|+|||++.+ .+..++|+||+|+++++|.++.
T Consensus 397 ~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp HHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred cCceechhhccHHHhCC--CCCCcccccccccchhhhcccc
Confidence 56789999999999875 5778899999999987765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=251.68 Aligned_cols=180 Identities=17% Similarity=0.213 Sum_probs=140.1
Q ss_pred EEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 137 ~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
...+.||+|+||+||+|. ..++.+++|...... .+.+.+|+++|+++ +||||+++..++.. ...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~--~~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVD--LDN 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEE--TTT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEe--CCc
Confidence 446789999999999994 467888998763211 24478999999999 99999954444443 345
Q ss_pred cEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-
Q 014307 206 PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~- 284 (427)
.++||||+++++|..++.. +..++.||+.||+|||++||+||||||+|||++. .+||+|||+|+.......
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence 6899999999999988876 6789999999999999999999999999999996 799999999998754322
Q ss_pred -------ceeeccCccccccccccC-CCCCCchhhHHHHHHHHHHHHhCCCCC
Q 014307 285 -------YNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPF 329 (427)
Q Consensus 285 -------~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwSlGvll~elltg~~pf 329 (427)
.....||+.|+|||++.+ ...|+..+|+|+..+-..+.+.++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 135689999999999864 135778899999999888888887766
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=212.55 Aligned_cols=143 Identities=18% Similarity=0.239 Sum_probs=118.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------------------cHHHHHHHHHHHHHhcCCCCe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNI 191 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------------------~~~~~~~E~~il~~l~~h~ni 191 (427)
...|++.+.||+|+||.||+|.+ .+|+.||||+++.. ....+.+|+.+|+++ + |
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l-~--~- 163 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-Q--G- 163 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-T--T-
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc-c--C-
Confidence 45577889999999999999999 88999999999632 235588999999999 4 4
Q ss_pred eeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEE
Q 014307 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 271 (427)
Q Consensus 192 v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~ 271 (427)
+++.+++.. ...++||||+++++|.. + ...+...++.||+.||.|||++||+||||||+|||++ ++ .+||+
T Consensus 164 ~~v~~~~~~---~~~~lvmE~~~g~~L~~-l---~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~ 234 (282)
T 1zar_A 164 LAVPKVYAW---EGNAVLMELIDAKELYR-V---RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWII 234 (282)
T ss_dssp SSSCCEEEE---ETTEEEEECCCCEEGGG-C---CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEEC
T ss_pred CCcCeEEec---cceEEEEEecCCCcHHH-c---chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEE
Confidence 666666543 34689999999999987 3 2244567999999999999999999999999999999 66 89999
Q ss_pred eeeeeeeecCCCcceeeccCcccccccccc
Q 014307 272 DWGLAEFYHPGKEYNVRVASRYFKGPELLV 301 (427)
Q Consensus 272 DFGla~~~~~~~~~~~~~~~~~y~aPE~~~ 301 (427)
|||+|+.. ..++|||.+.
T Consensus 235 DFG~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 235 DFPQSVEV------------GEEGWREILE 252 (282)
T ss_dssp CCTTCEET------------TSTTHHHHHH
T ss_pred ECCCCeEC------------CCCCHHHHHH
Confidence 99999642 3467899864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.6e-22 Score=188.56 Aligned_cols=135 Identities=18% Similarity=0.199 Sum_probs=107.9
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeE--EEEEEecccc---------------------------HHHHHHHHHHHHHh
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPVK---------------------------KKKIKREIKILQNL 185 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~--vavK~~~~~~---------------------------~~~~~~E~~il~~l 185 (427)
-|++.+.||+|+||.||+|.+..+|+. ||||+++... ...+.+|+.+|.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778999 9999875321 12578999999999
Q ss_pred cCCCC--eeeeeeEEEcCCCCCcEEEEeecCC-C----chhhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeeccCCC
Q 014307 186 CGGPN--IVKLLDIVRDQQSKTPSLIFEHVNN-T----DFKVLYPTLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPH 257 (427)
Q Consensus 186 ~~h~n--iv~l~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~iiHrDlkp~ 257 (427)
.|++ ++.+++. ...++||||+.+ | .|.......++.++..++.||+.||.||| ++||+||||||+
T Consensus 128 -~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 -KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp -HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred -HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 6664 3444442 246899999943 3 55554444456678899999999999999 999999999999
Q ss_pred ceEEcCCCCeEEEEeeeeeeee
Q 014307 258 NVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 258 NILl~~~~~~ikl~DFGla~~~ 279 (427)
|||++. .++|+|||+|...
T Consensus 201 NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEESS---SEEECCCTTCEET
T ss_pred HEEEcC---cEEEEECcccccC
Confidence 999986 6999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2.7e-18 Score=167.24 Aligned_cols=134 Identities=15% Similarity=0.219 Sum_probs=101.1
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----------------H--------HHHHHHHHHHHHhcCCC
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------K--------KKIKREIKILQNLCGGP 189 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----------------~--------~~~~~E~~il~~l~~h~ 189 (427)
=|++.+.||.|+||.||+|.+ .+|+.||||+++... . -...+|...|.++ .+.
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~ 173 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEE 173 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hhc
Confidence 489999999999999999997 579999999975310 0 0124577788877 433
Q ss_pred Ce--eeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC-
Q 014307 190 NI--VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR- 266 (427)
Q Consensus 190 ni--v~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~- 266 (427)
++ ...++.. ..+|||||++|..+..+.. ..++..++.||+.+|.+||++|||||||||.|||++.++.
T Consensus 174 gv~vp~p~~~~------~~~LVME~i~G~~L~~l~~---~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 174 GFPVPEPIAQS------RHTIVMSLVDALPMRQVSS---VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp TCSCCCEEEEE------TTEEEEECCSCEEGGGCCC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCCeeeecc------CceEEEEecCCccHhhhcc---cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 33 2223221 2379999999998876542 2345678899999999999999999999999999986652
Q ss_pred --------eEEEEeeeeeeee
Q 014307 267 --------KLRLIDWGLAEFY 279 (427)
Q Consensus 267 --------~ikl~DFGla~~~ 279 (427)
.+.|+||+-+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3789999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=2.6e-13 Score=125.98 Aligned_cols=137 Identities=18% Similarity=0.247 Sum_probs=110.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
+.|++...+|.|+.+.||++.. .++.+++|+... .....+.+|+.+|+.+.++..++++++++.. ....++||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEE
Confidence 4588889999999999999974 468999999864 3345689999999999667788899998875 45678999
Q ss_pred eecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 014307 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS-------------------------------------------- 246 (427)
Q Consensus 211 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-------------------------------------------- 246 (427)
|+++|.++...... ......++.+++.+|..||+
T Consensus 90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 99999998765422 23345788899999999998
Q ss_pred ---------------CCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 247 ---------------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 247 ---------------~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
..++|+|++|.|||++.++ .+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence 4589999999999998533 56799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=2.6e-12 Score=118.63 Aligned_cols=135 Identities=17% Similarity=0.174 Sum_probs=99.9
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCC-CeeeeeeEEEcCCCCCcEEEEeec
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSLIFEHV 213 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~ 213 (427)
.+.+....+.|..+.||++.. .+|..+++|+........+.+|+.+++.+..+. .+++++++... ....++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~--~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC--CCCCEEEEEec
Confidence 455544444666799999964 567789999987654456789999999995552 25678887765 34578999999
Q ss_pred CCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------------
Q 014307 214 NNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG--------------------------------------------- 248 (427)
Q Consensus 214 ~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------------- 248 (427)
+|..+. ..... ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (264)
T 1nd4_A 98 PGQDLL--SSHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 172 (264)
T ss_dssp SSEETT--TSCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred CCcccC--cCcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHH
Confidence 999884 22222 2356778888888888753
Q ss_pred -------------ceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 249 -------------IMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 249 -------------iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
++|+|++|.|||++.++ .+.|+|||.+..
T Consensus 173 ~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~ 214 (264)
T 1nd4_A 173 RLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV 214 (264)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred HHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence 99999999999998543 567999999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.26 E-value=3.4e-11 Score=117.10 Aligned_cols=140 Identities=20% Similarity=0.341 Sum_probs=107.9
Q ss_pred EEeeeeecCCeeEEEEEEcCCCeEEEEEEec--ccc----HHHHHHHHHHHHHhcC-CCCeeeeeeEEEcCCC-CCcEEE
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVK----KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQS-KTPSLI 209 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~--~~~----~~~~~~E~~il~~l~~-h~niv~l~~~~~~~~~-~~~~lv 209 (427)
.++.|+.|.++.||++.. .+..+++|+.. ... ...+.+|+.+++.|.. +..+++++.++.+... +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 357789999999999875 35678888876 322 3468899999999943 3457888888765321 457899
Q ss_pred EeecCCCchh-hhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 014307 210 FEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS------------------------------------------ 246 (427)
Q Consensus 210 ~e~~~~~~l~-~~~~~~~~~~~~~i~~qi~~~L~~LH~------------------------------------------ 246 (427)
|||++|..+. .....++..+...++.+++..|..||+
T Consensus 120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9999998874 345567888889999999999999997
Q ss_pred ----------------CCceeeccCCCceEEcCCCC-eEEEEeeeeeeee
Q 014307 247 ----------------QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFY 279 (427)
Q Consensus 247 ----------------~~iiHrDlkp~NILl~~~~~-~ikl~DFGla~~~ 279 (427)
.+++|+|+++.|||++.++. .+.|+||+.+..-
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999987652 4689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=4.8e-11 Score=113.30 Aligned_cols=185 Identities=17% Similarity=0.242 Sum_probs=123.5
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCC--eeeeeeEEEcCC-CCCcEEEEeecCC
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN--IVKLLDIVRDQQ-SKTPSLIFEHVNN 215 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~n--iv~l~~~~~~~~-~~~~~lv~e~~~~ 215 (427)
+.++.|....||++. ..+++|+.... ....+.+|+.+|+.+..+.. +++++....... ....++||++++|
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458999999999863 45888986543 34678899999999844432 344444432221 1245789999999
Q ss_pred Cchhh-hcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------------
Q 014307 216 TDFKV-LYPTLSDYDVRYYIYELLKALDYCHS------------------------------------------------ 246 (427)
Q Consensus 216 ~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~------------------------------------------------ 246 (427)
..+.. ....++..+...++.|++..|..||+
T Consensus 101 ~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 180 (304)
T 3sg8_A 101 VPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDI 180 (304)
T ss_dssp EECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHH
T ss_pred eECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHH
Confidence 98764 44567888888899999999999986
Q ss_pred ----------CCceeeccCCCceEEcCC-CCeEEEEeeeeeeeecCCCcceeeccCccccccccc----cCCCC------
Q 014307 247 ----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL----VDLQD------ 305 (427)
Q Consensus 247 ----------~~iiHrDlkp~NILl~~~-~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~------ 305 (427)
..++|+|++|.||+++.+ +..+.|+||+.+....+............-..|+.. ..++.
T Consensus 181 l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~ 260 (304)
T 3sg8_A 181 LENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTV 260 (304)
T ss_dssp HTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHH
T ss_pred HhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHH
Confidence 136999999999999964 446889999998764332111110000000122211 11111
Q ss_pred ---CCchhhHHHHHHHHHHHHhCCCCC
Q 014307 306 ---YDYSLDLWSLGCMFAGMIFRKEPF 329 (427)
Q Consensus 306 ---~~~~~DvwSlGvll~elltg~~pf 329 (427)
.....+.|++|.++|.+.+|..+|
T Consensus 261 ~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 261 LEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 122368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=9.3e-08 Score=90.66 Aligned_cols=134 Identities=18% Similarity=0.252 Sum_probs=97.1
Q ss_pred eeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCC--CeeeeeeEEEcCCCCCcEEEEeecCCC
Q 014307 140 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGP--NIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~--niv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (427)
+.++.|....||+. +..+++|+-... ....+.+|..+|+.|..+- .+++.+.+... .....+++||+++|.
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCCe
Confidence 55788999999987 466888886432 3467889999999995431 35666666653 245678999999998
Q ss_pred chhh-hcCCCCHHHHHHHHHHHHHHHHHHHHC------------------------------------------------
Q 014307 217 DFKV-LYPTLSDYDVRYYIYELLKALDYCHSQ------------------------------------------------ 247 (427)
Q Consensus 217 ~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~------------------------------------------------ 247 (427)
.+.. ....++..+...++.++...|..||+.
T Consensus 99 ~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 99 ILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp ECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred ECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 8765 334556666666677777777666642
Q ss_pred ------------CceeeccCCCceEEcC---CCCeEEEEeeeeeeee
Q 014307 248 ------------GIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFY 279 (427)
Q Consensus 248 ------------~iiHrDlkp~NILl~~---~~~~ikl~DFGla~~~ 279 (427)
.++|+|+++.|||++. ++..+.|+||+.+..-
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3499999999999986 3434589999988753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=1.3e-07 Score=87.75 Aligned_cols=133 Identities=14% Similarity=0.101 Sum_probs=95.7
Q ss_pred eeecCCe-eEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhh
Q 014307 142 VGRGKYS-EVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 220 (427)
Q Consensus 142 LG~G~fg-~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~ 220 (427)
+..|..| .||+.....++..+++|+-.......+.+|..+|+.|..+--+.++++++.+. ...++|||++.|..+..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCccccc
Confidence 4445554 69988776677889999987766678899999999996655577888888763 56789999999987655
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------------
Q 014307 221 LYPTLSDYDVRYYIYELLKALDYCHSQ----------------------------------------------------- 247 (427)
Q Consensus 221 ~~~~~~~~~~~~i~~qi~~~L~~LH~~----------------------------------------------------- 247 (427)
.... .......+..++...|.-||..
T Consensus 110 ~~~~-~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 188 (272)
T 4gkh_A 110 VLEE-YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLP 188 (272)
T ss_dssp HHHH-CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCC
T ss_pred cccC-CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccc
Confidence 4322 1222334555555555555521
Q ss_pred -----CceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 248 -----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 248 -----~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
.++|+|+.+.|||++.++ .+-|+||+.+..
T Consensus 189 ~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~ 223 (272)
T 4gkh_A 189 FSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI 223 (272)
T ss_dssp CCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred ccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence 168999999999998544 566999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.44 E-value=6.3e-07 Score=86.59 Aligned_cols=83 Identities=12% Similarity=0.104 Sum_probs=58.4
Q ss_pred EEEeee-eecCCeeEEEEEEc--C----CCeEEEEEEecccc------HHHHHHHHHHHHHhcCC--CCeeeeeeEEEcC
Q 014307 137 EVVRKV-GRGKYSEVFEGVHC--T----DNEKCIIKILKPVK------KKKIKREIKILQNLCGG--PNIVKLLDIVRDQ 201 (427)
Q Consensus 137 ~~~~~L-G~G~fg~V~~~~~~--~----~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h--~niv~l~~~~~~~ 201 (427)
...+.| +.|..+.+|+.... . ++..+++|+..... ...+.+|+.+|+.|..+ -.+++++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 345778 88989999988652 0 26788999875432 24678999999988554 3577888876543
Q ss_pred C-CCCcEEEEeecCCCchh
Q 014307 202 Q-SKTPSLIFEHVNNTDFK 219 (427)
Q Consensus 202 ~-~~~~~lv~e~~~~~~l~ 219 (427)
. ....++|||+++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 2 13467999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=2.5e-06 Score=83.72 Aligned_cols=74 Identities=16% Similarity=0.225 Sum_probs=49.6
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----------cHHHHHHHHHHHHHhcCC-C-CeeeeeeEEEcCCCCCc
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----------~~~~~~~E~~il~~l~~h-~-niv~l~~~~~~~~~~~~ 206 (427)
.+.||.|..+.||++....+++.++||...+. ..+.+..|.++|+.+... + .+++++.+. ....
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d----~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc----CCcc
Confidence 46799999999999976556788999976432 124567899999988443 3 344565432 2335
Q ss_pred EEEEeecCCC
Q 014307 207 SLIFEHVNNT 216 (427)
Q Consensus 207 ~lv~e~~~~~ 216 (427)
++|||++.+.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 7999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=2.1e-05 Score=74.98 Aligned_cols=133 Identities=14% Similarity=0.176 Sum_probs=78.5
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC-CCeeeeeeE------EEcCCCCCcEEEEe
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDI------VRDQQSKTPSLIFE 211 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h-~niv~l~~~------~~~~~~~~~~lv~e 211 (427)
++.|+.|..+.||++.. .+..+++|+... ....+..|..+++.|..+ -.+++++.. ... ....+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~--~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKH--GSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEE--TTEEEEEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEE--CCEEEEEEE
Confidence 34567778899999875 344589999875 335566677777776321 134444431 111 345689999
Q ss_pred ecCCCchh---------------hhc---CCC--C-----------HHH-------------------------------
Q 014307 212 HVNNTDFK---------------VLY---PTL--S-----------DYD------------------------------- 229 (427)
Q Consensus 212 ~~~~~~l~---------------~~~---~~~--~-----------~~~------------------------------- 229 (427)
|++|..+. .+. ..+ + +..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986432 110 111 1 000
Q ss_pred HHHHHHHHHHHHHHHHH-------------CCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 230 VRYYIYELLKALDYCHS-------------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 230 ~~~i~~qi~~~L~~LH~-------------~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
+..+..++..++++|+. .+++|+|+++.|||++.++ .+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENE-QIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence 01111223445666652 5799999999999997555 78999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.97 E-value=6.4e-05 Score=71.14 Aligned_cols=77 Identities=17% Similarity=0.180 Sum_probs=60.7
Q ss_pred EEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC--CCeeeeeeEEEcCCCCCcEEEEeecCC
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSLIFEHVNN 215 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h--~niv~l~~~~~~~~~~~~~lv~e~~~~ 215 (427)
-.+.|+.|....+|+... ++..+++|+........+..|...|+.|... ..+++++.+... ....++|||++++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~--~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS--QGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC--SSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec--CCceEEEEEeccC
Confidence 357799999999999874 5778889988766667789999999988543 567888887765 3567899999998
Q ss_pred Cch
Q 014307 216 TDF 218 (427)
Q Consensus 216 ~~l 218 (427)
...
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=5.2e-05 Score=74.88 Aligned_cols=78 Identities=13% Similarity=0.131 Sum_probs=46.1
Q ss_pred HCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeecc--CccccccccccCCC--CCCchhhHHHHHHHHHH
Q 014307 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAG 321 (427)
Q Consensus 246 ~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~--~~~y~aPE~~~~~~--~~~~~~DvwSlGvll~e 321 (427)
...++|+|+++.|||++.++ ++|+||+.+..-.+......... ...|.+|+...... .-....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45799999999999998654 89999999975432211111111 12355555442110 11123455577777777
Q ss_pred HHhC
Q 014307 322 MIFR 325 (427)
Q Consensus 322 lltg 325 (427)
.+.+
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=8.3e-05 Score=69.84 Aligned_cols=70 Identities=10% Similarity=0.039 Sum_probs=44.9
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHH--HHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeec-CC
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV-NN 215 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~--~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~-~~ 215 (427)
++.|+.|....+|++ ..+++|+....... ...+|+.+++.+..+.-..+++++.. ..-++++||+ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~~----~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVDP----ATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEECT----TTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEEC----CCCEEEEeecCCC
Confidence 467899999999998 45788887542211 23578888888744433356665432 1235899999 66
Q ss_pred Cch
Q 014307 216 TDF 218 (427)
Q Consensus 216 ~~l 218 (427)
..+
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.70 E-value=7.2e-05 Score=70.81 Aligned_cols=139 Identities=17% Similarity=0.209 Sum_probs=80.0
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCC-CeeeeeeEEEc----CCCCCcEEE
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGP-NIVKLLDIVRD----QQSKTPSLI 209 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~h~-niv~l~~~~~~----~~~~~~~lv 209 (427)
..-++.|+.|....||++.. . +..+++|+... .....+..|+.+++.|..+. .+++++..... ......+++
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~-~-~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHT-T-KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEEEECC---EEEEEEEE-S-SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred ceEeeccCCCcccceEEEEe-C-CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 34457788899899999875 2 33688998876 24456778999988884431 13344321000 012345789
Q ss_pred EeecCCCchhh---------------hc---CCC--------CHHHHHH---------------HHHHHHHHHHHHHH--
Q 014307 210 FEHVNNTDFKV---------------LY---PTL--------SDYDVRY---------------YIYELLKALDYCHS-- 246 (427)
Q Consensus 210 ~e~~~~~~l~~---------------~~---~~~--------~~~~~~~---------------i~~qi~~~L~~LH~-- 246 (427)
+++++|..+.. +. ..+ ....... +...+...++.+..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 99999864311 00 111 0000000 00123445556653
Q ss_pred -----CCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 247 -----QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 247 -----~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
.+++|+|+++.|||++.++ .+.|+||+.+.
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~ 216 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFAC 216 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCE
T ss_pred cccCCcccCCCCCCccCEEEeCCc-eEEEecchhcc
Confidence 3699999999999998543 45799999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00015 Score=71.91 Aligned_cols=73 Identities=14% Similarity=0.138 Sum_probs=52.5
Q ss_pred EeeeeecCCeeEEEEEEcC-------CCeEEEEEEeccccH-HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 139 VRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~~~~-~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
++.|+.|....||++.... ++..+++|+...... ..+.+|..+++.|..+.-.+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~------g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC------CEEE
Confidence 4678889899999998642 257899998854222 5667899999998555444677776532 2899
Q ss_pred eecCCCc
Q 014307 211 EHVNNTD 217 (427)
Q Consensus 211 e~~~~~~ 217 (427)
||++|..
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998744
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.0006 Score=63.43 Aligned_cols=76 Identities=14% Similarity=0.121 Sum_probs=55.4
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCC--CCeeeeeeEEEcCCCCCcEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h--~niv~l~~~~~~~~~~~~~lv 209 (427)
...-++.+|.|..+.||+... .+|+.|.+|+-... ....+..|+..|+.|... --+++++++. . -++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~--~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----D--RTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----T--TEEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----C--ceEE
Confidence 455678899999999999986 67889999986432 235688999999998433 2345555542 1 3689
Q ss_pred EeecCCCc
Q 014307 210 FEHVNNTD 217 (427)
Q Consensus 210 ~e~~~~~~ 217 (427)
|||+.+..
T Consensus 89 ~e~l~~~~ 96 (288)
T 3f7w_A 89 MEWVDERP 96 (288)
T ss_dssp EECCCCCC
T ss_pred EEeecccC
Confidence 99988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00012 Score=69.64 Aligned_cols=135 Identities=13% Similarity=0.121 Sum_probs=71.4
Q ss_pred eeeeecCCee-EEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCC-CeeeeeeEEEcCCCCCcEEEEeecCCCc
Q 014307 140 RKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSLIFEHVNNTD 217 (427)
Q Consensus 140 ~~LG~G~fg~-V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~-niv~l~~~~~~~~~~~~~lv~e~~~~~~ 217 (427)
+.|+.|.... +|+... .++..+++|...+.....+..|+.+++.+..+. .+++++.+. ...+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCcc
Confidence 3455554444 666642 236677787654432245667888888874432 355666653 2222 68999987754
Q ss_pred hhhhcC--------------------------CCC---HHHHH-------H-HH------------HHHHHHHHHHH---
Q 014307 218 FKVLYP--------------------------TLS---DYDVR-------Y-YI------------YELLKALDYCH--- 245 (427)
Q Consensus 218 l~~~~~--------------------------~~~---~~~~~-------~-i~------------~qi~~~L~~LH--- 245 (427)
+...+. .++ ..... . +. ..+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 421110 011 11100 0 00 01112223331
Q ss_pred ---HCCceeeccCCCceEEcCC---CCeEEEEeeeeeeee
Q 014307 246 ---SQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFY 279 (427)
Q Consensus 246 ---~~~iiHrDlkp~NILl~~~---~~~ikl~DFGla~~~ 279 (427)
...++|+|+.+.|||++.+ ...+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 2469999999999999864 136899999998753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00029 Score=68.46 Aligned_cols=133 Identities=11% Similarity=0.169 Sum_probs=81.5
Q ss_pred eeeeecCCeeEEEEEEcC-------CCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 140 RKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 140 ~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
+.|..|-...+|++.... +++.+++|+.-.. ....+.+|..+++.|..+.-.+++++.+.+ .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE------GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------ccEE
Confidence 457778888899987532 3578999986331 345667999999988655555777776632 2899
Q ss_pred eecCCCchhhh--c----------------C---C----CC--HHHHHHHHHHHHH-------------------HHHHH
Q 014307 211 EHVNNTDFKVL--Y----------------P---T----LS--DYDVRYYIYELLK-------------------ALDYC 244 (427)
Q Consensus 211 e~~~~~~l~~~--~----------------~---~----~~--~~~~~~i~~qi~~-------------------~L~~L 244 (427)
||++|..+... . . . .. ...+..+..++.. .++.|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99998654311 0 0 0 11 2334444433321 23333
Q ss_pred HH--------CCceeeccCCCceEEcCC---CCeEEEEeeeeeee
Q 014307 245 HS--------QGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEF 278 (427)
Q Consensus 245 H~--------~~iiHrDlkp~NILl~~~---~~~ikl~DFGla~~ 278 (427)
.+ ..++|+|+.+.|||++.+ ...+.|+||..|..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 248999999999999865 23789999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0011 Score=66.11 Aligned_cols=74 Identities=16% Similarity=0.163 Sum_probs=49.8
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHH--HHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCC
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK--IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 216 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~--~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~ 216 (427)
++.|+.|-...+|++....++..+++|+........ ..+|..+++.|..+.-.+++++.+. + .+||||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~---~---G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT---N---GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET---T---EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC---C---eEEEEeeCCc
Confidence 467888999999999864435889999875322111 2589999999955544467887762 1 2699999885
Q ss_pred ch
Q 014307 217 DF 218 (427)
Q Consensus 217 ~l 218 (427)
.+
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00061 Score=64.47 Aligned_cols=74 Identities=14% Similarity=0.221 Sum_probs=48.4
Q ss_pred eeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCC-CeeeeeeEEEcC----CCCCcEEEEeec
Q 014307 141 KVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQ----QSKTPSLIFEHV 213 (427)
Q Consensus 141 ~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~-niv~l~~~~~~~----~~~~~~lv~e~~ 213 (427)
.|+ |....||++.. .+|+.+++|+..+. ....+..|..+++.|..+. .+++++.. ... ..+..+++|+++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEec
Confidence 456 88889998754 34667999998743 4567888999998884331 24445443 100 123457899999
Q ss_pred CCCc
Q 014307 214 NNTD 217 (427)
Q Consensus 214 ~~~~ 217 (427)
+|..
T Consensus 110 ~G~~ 113 (328)
T 1zyl_A 110 GGRQ 113 (328)
T ss_dssp CCEE
T ss_pred CCCC
Confidence 8854
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00083 Score=64.86 Aligned_cols=74 Identities=14% Similarity=0.148 Sum_probs=46.1
Q ss_pred EeeeeecCCeeEEEEEEcC--------CCeEEEEEEeccccHH--HHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 139 VRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~--------~~~~vavK~~~~~~~~--~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++.|+.|....||++.... .+..+++|+....... ....|..+++.+..+.-.+++++.+ . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----CcE
Confidence 4668888889999987632 1368899987542221 2367899998885443355776654 1 258
Q ss_pred EEeecCCCch
Q 014307 209 IFEHVNNTDF 218 (427)
Q Consensus 209 v~e~~~~~~l 218 (427)
||||++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999988543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.01 Score=56.47 Aligned_cols=71 Identities=10% Similarity=0.144 Sum_probs=44.0
Q ss_pred eecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC--CCeeeeeeEEEc----CCCCCcEEEEeecCCC
Q 014307 143 GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRD----QQSKTPSLIFEHVNNT 216 (427)
Q Consensus 143 G~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h--~niv~l~~~~~~----~~~~~~~lv~e~~~~~ 216 (427)
|.|....||++.. .+| .+++|+..... ...|+.+++.|..+ +++++.+..... ......+++|+|++|.
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~---~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH---DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS---CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc---chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 4444689999874 344 89999876543 25677777777432 224555432100 1135568999999987
Q ss_pred ch
Q 014307 217 DF 218 (427)
Q Consensus 217 ~l 218 (427)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 54
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.12 E-value=0.013 Score=57.60 Aligned_cols=74 Identities=12% Similarity=0.154 Sum_probs=50.3
Q ss_pred EeeeeecCCeeEEEEEEcCC-------CeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 139 VRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~-------~~~vavK~~~~~~~--~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
++.|..|-...+|++..... +..+++|+...... -...+|..+++.+..+.-.+++++.+. -++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~------~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP------EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET------TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC------CCEE
Confidence 46677788889999886421 57899998643221 123579999988855544567776441 2589
Q ss_pred EeecCCCch
Q 014307 210 FEHVNNTDF 218 (427)
Q Consensus 210 ~e~~~~~~l 218 (427)
|||++|..+
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.64 E-value=0.042 Score=53.50 Aligned_cols=30 Identities=30% Similarity=0.596 Sum_probs=24.6
Q ss_pred ceeeccCCCceEEcC-----CCCeEEEEeeeeeee
Q 014307 249 IMHRDVKPHNVMIDH-----EQRKLRLIDWGLAEF 278 (427)
Q Consensus 249 iiHrDlkp~NILl~~-----~~~~ikl~DFGla~~ 278 (427)
++|+|+.+.|||+.. ++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999932 344799999999864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=93.44 E-value=0.42 Score=42.07 Aligned_cols=92 Identities=10% Similarity=-0.020 Sum_probs=57.6
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcceeeccCcccccccccc
Q 014307 223 PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301 (427)
Q Consensus 223 ~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~ 301 (427)
.++++++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+| .|.+.+ +.+. .....+.|||...
T Consensus 44 ~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------~~~~~~~~pe~~~ 110 (229)
T 2yle_A 44 QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------AGEPPPVAGKLGY 110 (229)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C-----------------------CCSS
T ss_pred CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------ccccCCCChhhcc
Confidence 579999999999999999877622 1212333456888888887 554442 1110 1122356888753
Q ss_pred CCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 014307 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 329 (427)
Q Consensus 302 ~~~~~~~~~DvwSlGvll~elltg~~pf 329 (427)
...+.+.=|||||++||.-+--..|-
T Consensus 111 --~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 111 --SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp --SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred --ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 35678899999999999988655553
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=89.76 E-value=0.083 Score=50.68 Aligned_cols=33 Identities=21% Similarity=0.400 Sum_probs=28.0
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++..+++.+ |+..||..|++++++|+||||++.
T Consensus 327 ~~a~DLl~~-lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDK-LLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHH-HTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHH-HCcCChhHCcCHHHHhcCcccCCC
Confidence 455566666 999999999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.58 E-value=0.1 Score=50.72 Aligned_cols=32 Identities=16% Similarity=0.110 Sum_probs=29.2
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
..+.+.|+|++||. .||++|+|+..++.|||=
T Consensus 317 ~s~~~~dLl~~mL~-~dP~~R~ta~e~L~Hp~f 348 (398)
T 4b99_A 317 ADRQALSLLGRMLR-FEPSARISAAAALRHPFL 348 (398)
T ss_dssp CCHHHHHHHHHHSC-SSTTTSCCHHHHTTSGGG
T ss_pred CCHHHHHHHHHHCc-CChhHCcCHHHHhcCHhh
Confidence 46789999999995 999999999999999983
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=87.07 E-value=0.2 Score=46.74 Aligned_cols=35 Identities=20% Similarity=0.329 Sum_probs=29.1
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+.+++.+ |+..||..||++.++++||||+...
T Consensus 293 ~~~~~~li~~-~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 293 SPEALDFLDK-LLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CHHHHHHHHT-TSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHH-HhcCCcccCCCHHHHhcCccHhhhc
Confidence 3555666666 9999999999999999999998743
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=85.60 E-value=0.18 Score=48.45 Aligned_cols=32 Identities=13% Similarity=0.194 Sum_probs=26.7
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
.+.+++.+ |+..||..||++.++|.||||.+.
T Consensus 348 ~~~dli~~-mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 348 KFKDLILR-MLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHHH-HTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHHHHH-hcCCChhhCCCHHHHhcCcccccC
Confidence 44555666 999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=85.27 E-value=0.24 Score=45.43 Aligned_cols=32 Identities=16% Similarity=0.315 Sum_probs=28.9
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.++|++||. .||++|+|+..+++|||
T Consensus 234 ~~s~~~~~li~~~L~-~dP~~R~s~~eil~hpw 265 (275)
T 3hyh_A 234 FLSPGAAGLIKRMLI-VNPLNRISIHEIMQDDW 265 (275)
T ss_dssp TSCHHHHHHHHHHSC-SSGGGSCCHHHHHHCHH
T ss_pred CCCHHHHHHHHHHcc-CChhHCcCHHHHHcCcc
Confidence 356789999999995 99999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=84.68 E-value=0.25 Score=47.00 Aligned_cols=32 Identities=16% Similarity=0.110 Sum_probs=29.4
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.|+|++||. .||++|+|+..++.|||
T Consensus 295 ~~s~~~~dli~~~L~-~dP~~R~ta~e~l~Hp~ 326 (346)
T 4fih_A 295 KVSPSLKGFLDRLLV-RDPAQRATAAELLKHPF 326 (346)
T ss_dssp GSCHHHHHHHHHHSC-SSTTTSCCHHHHTTCGG
T ss_pred cCCHHHHHHHHHHcC-CChhHCcCHHHHhcCHh
Confidence 356889999999995 99999999999999998
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=83.66 E-value=0.6 Score=43.75 Aligned_cols=32 Identities=22% Similarity=0.288 Sum_probs=29.2
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
....+.++|++||. .||++|+|+..+++|||-
T Consensus 237 ~s~~~~~li~~~L~-~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 237 MSTDCENLLKRFLV-LNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp SCHHHHHHHHHHCC-SSTTTSCCHHHHTTCTTT
T ss_pred CCHHHHHHHHHHCC-CChhHCcCHHHHhcCHhh
Confidence 56789999999995 999999999999999984
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=83.26 E-value=0.29 Score=45.25 Aligned_cols=31 Identities=6% Similarity=0.118 Sum_probs=28.4
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+.+.++|+++|. .||++|+|+..+++|||
T Consensus 255 ~~~~~~~li~~~L~-~dP~~R~s~~e~l~Hp~ 285 (290)
T 3fpq_A 255 AIPEVKEIIEGCIR-QNKDERYSIKDLLNHAF 285 (290)
T ss_dssp CCHHHHHHHHHHSC-SSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHcc-CChhHCcCHHHHhcCcc
Confidence 45678999999995 99999999999999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=83.16 E-value=0.53 Score=47.99 Aligned_cols=33 Identities=21% Similarity=0.263 Sum_probs=29.8
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
...+.+.|+|++||. .||++|+++..+++|||=
T Consensus 382 ~~s~~~~dli~~~L~-~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 382 GISEDGKDFIRKLLL-ADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp TSCHHHHHHHHTTSC-SSGGGSCCHHHHHHSTTT
T ss_pred CCCHHHHHHHHHHcc-CChhHCcCHHHHhcCcCc
Confidence 357889999999995 999999999999999983
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=82.01 E-value=0.33 Score=45.03 Aligned_cols=32 Identities=16% Similarity=0.122 Sum_probs=28.4
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
..+.+.++|++||. .||++|+|+..+++|||=
T Consensus 273 ~~~~~~~li~~~L~-~dP~~Rpt~~ell~hp~f 304 (311)
T 3niz_A 273 FCQEGIDLLSNMLC-FDPNKRISARDAMNHPYF 304 (311)
T ss_dssp CCHHHHHHHHHHSC-SCTTTSCCHHHHHTSGGG
T ss_pred cCHHHHHHHHHHcC-CChhHCCCHHHHhcCccc
Confidence 34678899999995 999999999999999983
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=81.91 E-value=0.31 Score=44.55 Aligned_cols=32 Identities=19% Similarity=0.137 Sum_probs=28.8
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
..+.+.++|++||. .||++|+|+..+++|||=
T Consensus 255 ~~~~~~~li~~~L~-~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 255 LNATGRDLLQNLLK-CNPVQRISAEEALQHPYF 286 (292)
T ss_dssp CCHHHHHHHHHHSC-SSGGGSCCHHHHHTSGGG
T ss_pred cChHHHHHHHHHhc-cChhhCCCHHHHhcCccc
Confidence 45678899999995 999999999999999984
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=81.84 E-value=0.39 Score=46.06 Aligned_cols=35 Identities=14% Similarity=0.234 Sum_probs=28.9
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++...+++.+ |+..||..|+++.++++||||..+.
T Consensus 302 ~~~~~dll~~-~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 302 NEEALDLLDK-LLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp CHHHHHHHHH-HCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred CHHHHHHHHH-hhccCcccCCCHHHHhCCHHHHHhc
Confidence 3455666666 9999999999999999999987644
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=81.19 E-value=0.41 Score=44.71 Aligned_cols=32 Identities=16% Similarity=0.035 Sum_probs=28.9
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
..+.+.++|++||. .||++|+++..+++|||=
T Consensus 291 ~~~~~~~li~~~L~-~dP~~R~t~~e~l~hp~f 322 (329)
T 3gbz_A 291 LDDEGLDLLTAMLE-MDPVKRISAKNALEHPYF 322 (329)
T ss_dssp SCHHHHHHHHHHTC-SSGGGSCCHHHHHTSGGG
T ss_pred cCHHHHHHHHHHcc-CChhhCCCHHHHhCCccc
Confidence 45778999999995 999999999999999983
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=81.00 E-value=0.38 Score=47.32 Aligned_cols=35 Identities=9% Similarity=0.239 Sum_probs=29.5
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+....++.+ |+..||..|++++++|.||||....
T Consensus 370 s~~~~dLl~~-mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 370 SADAIHLLKR-MLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CHHHHHHHHH-HhccCccccCCHHHHhcCHhhhhcC
Confidence 3555666666 9999999999999999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=80.95 E-value=0.34 Score=44.24 Aligned_cols=31 Identities=19% Similarity=0.175 Sum_probs=28.4
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+.+.++|++||. .||++|+++..+++|||
T Consensus 253 ~~~~~~~li~~~L~-~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 253 LDESGIDLLSKMLK-LDPNQRITAKQALEHAY 283 (288)
T ss_dssp CCHHHHHHHHHHTC-SSTTTSCCHHHHHTSGG
T ss_pred cCHHHHHHHHHHcC-CCcccCCCHHHHhcCcc
Confidence 46778899999995 99999999999999998
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=80.90 E-value=0.47 Score=46.36 Aligned_cols=31 Identities=10% Similarity=-0.080 Sum_probs=28.2
Q ss_pred hhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 394 LKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 394 ~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
.+.+.|+|++||. +||++|+|+..+++|||=
T Consensus 382 ~~~~~dli~~~L~-~dP~~Rpta~e~L~Hpw~ 412 (429)
T 3kvw_A 382 DPLFLDFLKQCLE-WDPAVRMTPGQALRHPWL 412 (429)
T ss_dssp CHHHHHHHHHHTC-SSTTTSCCHHHHHTSTTT
T ss_pred hHHHHHHHHHHCC-CChhhCCCHHHHhCChhh
Confidence 5678999999995 999999999999999983
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=80.62 E-value=0.43 Score=46.67 Aligned_cols=35 Identities=11% Similarity=0.219 Sum_probs=29.4
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++...+++.+ |+..||..|++++++|.||||....
T Consensus 335 s~~~~dLl~~-mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 335 SDDGINLLES-MLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp CHHHHHHHHH-HSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred CHHHHHHHHH-HhcCCcccCCCHHHHhcChhhhhcc
Confidence 4555666666 9999999999999999999998754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.55 E-value=0.42 Score=44.54 Aligned_cols=31 Identities=13% Similarity=0.046 Sum_probs=28.3
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+.+.++|++||. .||++|+|+..+++|||
T Consensus 254 ~~~~~~~li~~~L~-~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 254 LDSDGADLLTKLLQ-FEGRNRISAEDAMKHPF 284 (324)
T ss_dssp SCHHHHHHHHHHSC-SSGGGSCCHHHHTTSGG
T ss_pred CCHHHHHHHHHHcC-cCcccCCCHHHHhcChh
Confidence 45678999999995 99999999999999998
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.31 E-value=0.41 Score=46.21 Aligned_cols=30 Identities=13% Similarity=0.211 Sum_probs=27.8
Q ss_pred hhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 394 LKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 394 ~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
.+.+.++|++||. .||++|+|+..++.|||
T Consensus 307 ~~~~~~Ll~~~L~-~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 307 DSKAFHLLQKLLT-MDPIKRITSEQAMQDPY 336 (405)
T ss_dssp TSHHHHHHHHHSC-SSGGGSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHcc-CCcccCCCHHHHhcChh
Confidence 5678899999995 99999999999999998
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.13 E-value=0.52 Score=43.34 Aligned_cols=32 Identities=13% Similarity=0.127 Sum_probs=28.8
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
..+.+.++|++||. .||++|+|+..++.|||=
T Consensus 269 ~~~~~~~li~~~L~-~dP~~R~t~~e~l~h~~~ 300 (308)
T 3g33_A 269 MEESGAQLLLEMLT-FNPHKRISAFRALQHSYL 300 (308)
T ss_dssp CCHHHHHHHHHHTC-SSTTTSCCHHHHHTSTTC
T ss_pred ccHHHHHHHHHHhc-CCCccCCCHHHHhcCccc
Confidence 45778999999995 999999999999999983
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=80.11 E-value=0.47 Score=45.22 Aligned_cols=34 Identities=15% Similarity=0.034 Sum_probs=29.8
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFGS 426 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~~ 426 (427)
...+.+.++|++||. .||++|+|+..+++|||=.
T Consensus 363 ~~~~~~~~li~~~L~-~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 363 EEAAGFTDFLLPMLE-LIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHHHHHHGGGGC-SSGGGSCCHHHHHTSGGGG
T ss_pred hhHHHHHHHHHHHhc-cChhhcCCHHHHhhCcccc
Confidence 345678999999995 9999999999999999843
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 427 | ||||
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-89 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-45 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-44 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-42 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-41 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-40 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-40 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-39 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-39 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-36 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-36 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-36 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-33 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-32 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-32 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-32 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-31 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-29 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-29 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-27 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 9e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-25 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-25 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-25 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-24 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 271 bits (693), Expect = 6e-89
Identities = 209/270 (77%), Positives = 243/270 (90%)
Query: 103 PSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC 162
PS+ARVY+D+N RPREYWDYES V+WG QDDY++VRK+GRGKYSEVFE ++ T+NEK
Sbjct: 4 PSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKV 63
Query: 163 IIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY 222
++KILKPVKKKKIKREIKIL+NL GGPNI+ L DIV+D S+TP+L+FEHVNNTDFK LY
Sbjct: 64 VVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123
Query: 223 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282
TL+DYD+R+Y+YE+LKALDYCHS GIMHRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG
Sbjct: 124 QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183
Query: 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
+EYNVRVASRYFKGPELLVD Q YDYSLD+WSLGCM A MIFRKEPFF+GHDNYDQLV+I
Sbjct: 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
Query: 343 AKVLGTDELNAYLNKYHIELDPHLAALVGR 372
AKVLGT++L Y++KY+IELDP ++GR
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGR 273
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-46
Identities = 75/227 (33%), Positives = 119/227 (52%), Gaps = 13/227 (5%)
Query: 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 191
++ Y + +G G + V++ C E IK + K+ RE++I++ L NI
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75
Query: 192 VKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKAL 241
V+L K L+ ++V T ++V TL V+ Y+Y+L ++L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 301
Y HS GI HRD+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
DY S+D+WS GC+ A ++ + P F G DQLV+I KVLGT
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGT 241
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (397), Expect = 9e-45
Identities = 55/248 (22%), Positives = 109/248 (43%), Gaps = 18/248 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKKIKREIKILQNLCGGPN 190
D Y+++ ++G G + V V + K + P+ K +K EI I+ L P
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 246
++ L D D+ LI E ++ + +S+ +V Y+ + + L + H
Sbjct: 88 LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 247 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
I+H D+KP N+M + ++ +++ID+GLA +P + V A+ F PE++ D +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
+ D+W++G + ++ P F G D+ + L + + + + P
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWE-----FDEDAFSSVSPE 258
Query: 366 LAALVGRL 373
+ L
Sbjct: 259 AKDFIKNL 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-44
Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 14/223 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 189
DD+E + ++G G VF+ H K++ P + +I RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 246
IV S+ EH++ + + + + ++K L Y
Sbjct: 65 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 247 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+ IMHRDVKP N++++ ++L D+G++ N V +R + PE L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y D+WS+G M + P +L+ +V G
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 3e-44
Identities = 55/234 (23%), Positives = 112/234 (47%), Gaps = 17/234 (7%)
Query: 123 YESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REI 179
YE +T +D +E++ ++G G + +V++ + + K++ +++++ EI
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 180 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIY 235
IL + PNIVKLLD + + ++ E + L++ ++
Sbjct: 61 DILASCDH-PNIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCK 117
Query: 236 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 294
+ L AL+Y H I+HRD+K N++ + ++L D+G++ + + + + + Y+
Sbjct: 118 QTLDALNYLHDNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYW 176
Query: 295 KGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE+++ + YDY D+WSLG M + P + + L+KIAK
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAK 229
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-43
Identities = 55/221 (24%), Positives = 102/221 (46%), Gaps = 16/221 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D+E+ R +G+GK+ V+ +K+L + + +++RE++I +L
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
PNI++L D LI E+ + YI EL AL YC
Sbjct: 66 -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
HS+ ++HRD+KP N+++ L++ D+G + + P + + PE++ +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
+D +DLWSLG + + K P F + + +I++V
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV 219
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 153 bits (387), Expect = 2e-43
Identities = 49/248 (19%), Positives = 100/248 (40%), Gaps = 18/248 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPN 190
D Y++ ++G G + V K + K+ +++EI+ + L P
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84
Query: 191 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 246
+V L D D +I+E ++ + + +S+ + Y+ ++ K L + H
Sbjct: 85 LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 247 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 305
+H D+KP N+M ++ +L+LID+GL P + V + F PE+ +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 365
Y D+WS+G + ++ P F G ++ + L + + +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDWN-----MDDSAFSGISED 255
Query: 366 LAALVGRL 373
+ +L
Sbjct: 256 GKDFIRKL 263
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 149 bits (378), Expect = 6e-43
Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 24/232 (10%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIK 180
++YE +GRG S V +H ++ +KI+ ++ +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 181 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 237
IL+ + G PNI++L D L+F+ + + F L TLS+ + R + L
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 238 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 297
L+ + H I+HRD+KP N+++D + ++L D+G + PG++ + + P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 298 ELL-----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
E++ + Y +D+WS G + ++ P F+ L I
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMIMS 229
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-42
Identities = 53/247 (21%), Positives = 106/247 (42%), Gaps = 17/247 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ Y + +GRG++ V V + + + K +K + +K+EI IL NI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 247
+ L + + +IFE ++ D F+ + L++ ++ Y++++ +AL + HS
Sbjct: 64 LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 248 GIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 366
+ D+WSLG + ++ P F N + I T + + E+
Sbjct: 181 STATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEYT-----FDEEAFKEISIEA 234
Query: 367 AALVGRL 373
V RL
Sbjct: 235 MDFVDRL 241
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-42
Identities = 58/250 (23%), Positives = 111/250 (44%), Gaps = 15/250 (6%)
Query: 134 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 192
DDY+V +V G G +V + + EK +K+L+ K +RE+++ P+IV
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68
Query: 193 KLLDIVRDQQS--KTPSLIFEHVNNTD-FKVLY----PTLSDYDVRYYIYELLKALDYCH 245
+++D+ + + K ++ E ++ + F + ++ + + + +A+ Y H
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 246 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
S I HRDVKP N++ L+L D+G A+ + Y+ PE+L
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
+ YD S D+WSLG + ++ P FY + + + + + N E+
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPP-FYSNHGLAISPGMKTRIRMGQYE-FPNPEWSEVS 245
Query: 364 PHLAALVGRL 373
+ L+ L
Sbjct: 246 EEVKMLIRNL 255
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-42
Identities = 68/227 (29%), Positives = 120/227 (52%), Gaps = 15/227 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 189
Y + +G G Y V + + IK + P + ++ REIKIL
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66
Query: 190 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCH 245
NI+ + DI+R +Q K L+ + +K+L LS+ + Y++Y++L+ L Y H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 301
S ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++ PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+ + Y S+D+WS+GC+ A M+ + P F G DQL I +LG+
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGS 231
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-41
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 15/221 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 189
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYCHS 246
N+VK R + L E+ + + F + P + + D + + ++L+ + Y H
Sbjct: 64 NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 303
GI HRD+KP N+++D L++ D+GLA + N + + PELL
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + +D+WS G + M+ + + + Q K
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWK 220
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-41
Identities = 62/258 (24%), Positives = 109/258 (42%), Gaps = 30/258 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
+DYEV+ +G G Y + +D + + K L +K+ + E+ +L+ L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY------PTLSDYDVRYYIYELLKAL 241
PNIV+ D + D+ + T ++ E+ D V+ L + V + +L AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 242 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 295
CH + ++HRD+KP NV +D +Q ++L D+GLA + + V + Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 296 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 355
PE + Y+ D+WSLGC+ + P F + KI
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKI--------REGKF 231
Query: 356 NKYHIELDPHLAALVGRL 373
+ L ++ R+
Sbjct: 232 RRIPYRYSDELNEIITRM 249
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 7e-41
Identities = 70/224 (31%), Positives = 121/224 (54%), Gaps = 13/224 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
YE + K+G G Y VF+ + +E +K ++ + REI +L+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 245
NIV+L D++ + +L+FE + F L V+ ++++LLK L +CH
Sbjct: 61 KNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
S+ ++HRD+KP N++I+ +L ++GLA F P + Y+ V + +++ P++L +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
Y S+D+WS GC+FA + P F G+D DQL +I ++LGT
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT 221
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-40
Identities = 49/218 (22%), Positives = 96/218 (44%), Gaps = 12/218 (5%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGP 189
+ Y K+G+G V+ + ++ I+ + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77
Query: 190 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 247
NIV LD ++ E++ + + + + E L+AL++ HS
Sbjct: 78 NIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
++HRD+K N+++ + ++L D+G + + + V + Y+ PE++ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+D+WSLG M MI + P + + L IA
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT 230
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (364), Expect = 2e-40
Identities = 54/222 (24%), Positives = 100/222 (45%), Gaps = 19/222 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCG 187
+ +R++G G + V+ ++E IK + K + I +E++ LQ L
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 244
PN ++ + T L+ E+ + +V L + ++ + L+ L Y
Sbjct: 75 -PNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 304
HS ++HRDVK N+++ ++L D+G A P + V + Y+ PE+++ +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187
Query: 305 D--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ YD +D+WSLG + RK P F + L IA+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ 228
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-40
Identities = 70/235 (29%), Positives = 126/235 (53%), Gaps = 11/235 (4%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
++++ V K+G G Y V++ + E +K ++ + + REI +L+ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYCHS 246
PNIVKLLD++ + F H + F + ++ Y+++LL+ L +CHS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 305
++HRD+KP N++I+ E ++L D+GLA + P + Y V + +++ PE+L+ +
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
Y ++D+WSLGC+FA M+ R+ F G DQL +I + LGT + + +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 3e-40
Identities = 68/239 (28%), Positives = 124/239 (51%), Gaps = 15/239 (6%)
Query: 120 YWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKK 174
++ E W + Y ++ VG G Y V V K IK L + K+
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 175 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL-YPTLSDYD 229
RE+++L+++ N++ LLD+ ++ L+ + K++ + L +
Sbjct: 64 AYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDR 122
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
+++ +Y++LK L Y H+ GI+HRD+KP N+ ++ + +++D+GLA E V
Sbjct: 123 IQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYV 179
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+R+++ PE++++ Y ++D+WS+GC+ A MI K F G D+ DQL +I KV GT
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL-FKGSDHLDQLKEIMKVTGT 237
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-39
Identities = 77/270 (28%), Positives = 128/270 (47%), Gaps = 22/270 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 188
YE + K+G+G + EVF+ H +K +K + +K+ REIKILQ L
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KH 68
Query: 189 PNIVKLLDIVRDQQSK------TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLK 239
N+V L++I R + S + L+F+ + +L + +++ + LL
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 240 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNVRVASRYF 294
L Y H I+HRD+K NV+I + L+L D+GLA + K Y RV + ++
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 295 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 354
+ PELL+ +DY +DLW GC+ A M R P G+ QL I+++ G+ +
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 355 LNKYHIELDPHLAALVGRLVILSYFFQFVI 384
N + EL L + G+ + + +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYV 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-39
Identities = 71/236 (30%), Positives = 124/236 (52%), Gaps = 17/236 (7%)
Query: 137 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGG 188
E + +G G+++ V++ N+ IK +K + + REIK+LQ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCH 245
PNI+ LLD + SL+F+ + ++ L+ ++ Y+ L+ L+Y H
Sbjct: 60 PNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 304
I+HRD+KP+N+++D E L+L D+GLA F P + Y +V +R+++ PELL +
Sbjct: 118 QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
Y +D+W++GC+ A ++ R PF G + DQL +I + LGT + + +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-39
Identities = 67/243 (27%), Positives = 126/243 (51%), Gaps = 16/243 (6%)
Query: 116 RPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PV 170
RP ++ E W + Y+ + VG G Y V + +K L +
Sbjct: 1 RP-TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII 59
Query: 171 KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTPSLIFEHVNNTDFKVLY--PTL 225
K+ RE+++L+++ N++ LLD+ +S + H+ D + L
Sbjct: 60 HAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+D V++ IY++L+ L Y HS I+HRD+KP N+ ++ + +++D+GLA H E
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEM 175
Query: 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 345
VA+R+++ PE++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I ++
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL-FPGTDHIDQLKLILRL 234
Query: 346 LGT 348
+GT
Sbjct: 235 VGT 237
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-39
Identities = 69/230 (30%), Positives = 116/230 (50%), Gaps = 18/230 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLCG 187
YE V ++G G Y +VF+ +K ++ RE+ +L++L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 188 G--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELL 238
PN+V+L D+ ++ + L+FEHV+ L P + ++ +++LL
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 239 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
+ LD+ HS ++HRD+KP N+++ + +L D+GLA Y V + +++ PE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYRAPE 185
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+L+ Y +DLWS+GC+FA M RK P F G + DQL KI V+G
Sbjct: 186 VLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGL 233
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (353), Expect = 3e-39
Identities = 70/236 (29%), Positives = 127/236 (53%), Gaps = 15/236 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 188
+ Y + K+G G Y V++ + E +K ++ K REI IL+ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
NIVKL D++ ++ L+FEH++ K+L L + ++ +LL + YCH
Sbjct: 60 SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 246 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 304
+ ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++ P++L+ +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360
Y ++D+WS+GC+FA M+ P F G DQL++I ++LGT + N +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 4e-39
Identities = 57/223 (25%), Positives = 103/223 (46%), Gaps = 18/223 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCG 187
+D++ + +G G +S V + + IKIL+ K + RE ++ L
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYC 244
P VKL +D + + N + + + + R+Y E++ AL+Y
Sbjct: 68 -PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLV 301
H +GI+HRD+KP N++++ + +++ D+G A+ P + N V + + PELL
Sbjct: 125 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + S DLW+LGC+ ++ P F + Y KI K
Sbjct: 184 E-KSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIK 224
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 6e-39
Identities = 60/250 (24%), Positives = 109/250 (43%), Gaps = 19/250 (7%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGG 188
+D Y+ +G G +SEV + IK + K+ ++ EI +L +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCH 245
PNIV L DI LI + V+ + F + ++ D I+++L A+ Y H
Sbjct: 67 PNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 246 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
GI+HRD+KP N++ E K+ + D+GL++ PG + + + PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
+ Y ++D WS+G + ++ P FY ++ +I K + + Y ++
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP-FYDENDAKLFEQILKAEYE-----FDSPYWDDIS 237
Query: 364 PHLAALVGRL 373
+ L
Sbjct: 238 DSAKDFIRHL 247
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-38
Identities = 50/209 (23%), Positives = 96/209 (45%), Gaps = 13/209 (6%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQ 183
+ Y+V +G G + V+ G+ +DN IK ++ + ++ E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 184 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKA 240
+ G +++LLD S L F + L + R + +++L+A
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 300
+ +CH+ G++HRD+K N++ID + +L+LID+G Y +R + PE +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWI 181
Query: 301 VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 329
+ + S +WSLG + M+ PF
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (332), Expect = 3e-36
Identities = 54/255 (21%), Positives = 97/255 (38%), Gaps = 22/255 (8%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 186
D YE+ +G G SEV + +K+L+ P + +RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64
Query: 187 GGPNIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 241
P IV + D + P ++ E+V+ + + ++ I + +AL
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
++ H GI+HRDVKP N+MI I +A+ + + + + + PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
D D++SLGC+ ++ + P F G + + +
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHVREDPI-----PPSAR 237
Query: 359 HIELDPHLAALVGRL 373
H L L A+V +
Sbjct: 238 HEGLSADLDAVVLKA 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 134 bits (337), Expect = 4e-36
Identities = 61/251 (24%), Positives = 106/251 (42%), Gaps = 22/251 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D+ V R +GRG + EV+ + +K L + + E +L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 188 G--PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 242
G P IV + S I + +N D + S+ D+R+Y E++ L+
Sbjct: 64 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
+ H++ +++RD+KP N+++D E +R+ D GLA + K + + + PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179
Query: 303 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362
YD S D +SLGCM ++ P F H D+ L +
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRMTLTMAV------ELPDSF 232
Query: 363 DPHLAALVGRL 373
P L +L+ L
Sbjct: 233 SPELRSLLEGL 243
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-36
Identities = 55/255 (21%), Positives = 114/255 (44%), Gaps = 25/255 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQN 184
D Y+ ++G G+++ V + + + K +K + ++ I+RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 241
+ PN++ L ++ ++ LI E V DF +L++ + ++ ++L +
Sbjct: 70 IQ-HPNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 242 DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 298
Y HS I H D+KP N+M+ + ++++ID+GLA G E+ + F PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 299 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358
++ + + D+WS+G + ++ P F G + L ++ V + ++Y
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASP-FLGDTKQETLANVSAVNYE-----FEDEY 239
Query: 359 HIELDPHLAALVGRL 373
+ RL
Sbjct: 240 FSNTSALAKDFIRRL 254
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-36
Identities = 43/255 (16%), Positives = 105/255 (41%), Gaps = 26/255 (10%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 188
V +++G G + V++G + +K+L P + + K E+ +L+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63
Query: 189 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIYELLKALDYC 244
NI+ + Q +++ + + + L+ + + + +DY
Sbjct: 64 VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLV 301
H++ I+HRD+K +N+ + + +++ D+GLA + S + PE++
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 302 DLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
Y + D+++ G + ++ + P + +N DQ++ + +G L+ L+K
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFM---VGRGYLSPDLSKVR 235
Query: 360 IELDPHLAALVGRLV 374
+ L+ +
Sbjct: 236 SNCPKAMKRLMAECL 250
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-36
Identities = 48/251 (19%), Positives = 101/251 (40%), Gaps = 23/251 (9%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPN 190
+ ++GRG + V++G+ + L+ K +++ K E ++L+ L PN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69
Query: 191 IVKLLDIVRD--QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 245
IV+ D + K L+ E + + K + + +R + ++LK L + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 246 SQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 303
++ I+HRD+K N+ I +++ D GLA V + + F PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363
+ YD S+D+++ G M + P+ + ++ +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-------GVKPASFDKVAI 239
Query: 364 PHLAALVGRLV 374
P + ++ +
Sbjct: 240 PEVKEIIEGCI 250
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 5e-36
Identities = 59/239 (24%), Positives = 115/239 (48%), Gaps = 13/239 (5%)
Query: 119 EYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKK 173
+++ E + Y+ ++ +G G V + IK L K
Sbjct: 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK 61
Query: 174 KIKREIKILQNLCGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYD 229
+ RE+ +++ + NI+ LL++ Q++ + L+ E ++ +V+ L
Sbjct: 62 RAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 120
Query: 230 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 289
+ Y +Y++L + + HS GI+HRD+KP N+++ + +++D+GLA V
Sbjct: 121 MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYV 179
Query: 290 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 348
+RY++ PE+++ Y ++D+WS+GC+ M+ K F G D DQ K+ + LGT
Sbjct: 180 VTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGT 236
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-35
Identities = 48/219 (21%), Positives = 98/219 (44%), Gaps = 15/219 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D+ + + +G+G + +VF N+ IK LK + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 244
P + + + +++ + E++N D +Y E++ L +
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 245 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 303
HS+GI++RD+K N+++D + ++ D+G+ E + N + + PE+L+
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 342
Q Y++S+D WS G + M+ + P F+G D + I
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI 215
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 6e-35
Identities = 35/217 (16%), Positives = 91/217 (41%), Gaps = 14/217 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIV 192
+ ++++ +G+G++ +V G + K +K +K + E ++ L N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLV 63
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
+LL ++ +++ ++ E++ L L + + ++ +A++Y
Sbjct: 64 QLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 307
+HRD+ NV++ + ++ D+GL + + + + PE L + + +
Sbjct: 123 NFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFS 178
Query: 308 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
D+WS G + + + D + ++ K
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 215
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-34
Identities = 49/249 (19%), Positives = 94/249 (37%), Gaps = 42/249 (16%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILK----PVKKKKIKREIKILQN 184
++ E + +G G + +V ++ + +K+LK +++ + E+K++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--------------------- 222
L NIV LL S LIFE+ D L
Sbjct: 97 LGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 223 ----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278
L+ D+ + Y++ K +++ + +HRD+ NV++ H + +++ D+GLA
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKICDFGLARD 213
Query: 279 YHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 335
Y VR + PE L + Y D+WS G + + + G
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 336 YDQLVKIAK 344
K+ +
Sbjct: 273 DANFYKLIQ 281
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-33
Identities = 35/219 (15%), Positives = 88/219 (40%), Gaps = 14/219 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ ++V ++G G++ EV+ G + + K +K LK + E +++ L +
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRL 70
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
V+L +V + +I E++ N L+ + ++ + + +
Sbjct: 71 VRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PELLVDLQD 305
+ +HRD++ N+++ + ++ D+GLA + A K ++
Sbjct: 128 RNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + ++ + G N + + + +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-33
Identities = 39/227 (17%), Positives = 81/227 (35%), Gaps = 21/227 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVK------KKKIKREIKILQN 184
D ++ K+G G + V G + K + +K LKP RE+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 240
L N+++L +V K ++ E + Y ++ +
Sbjct: 68 LDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGP 297
+ Y S+ +HRD+ N+++ +++ D+GL ++ V +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + + ++ D W G M + + G + L KI K
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 124 bits (312), Expect = 3e-33
Identities = 39/231 (16%), Positives = 90/231 (38%), Gaps = 20/231 (8%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKKKKIKREIKILQNLCGGPNIVKL 194
Y+V R++G G + +FEG + +N++ IK + +++ E + + L G I +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMH 251
++ L+ + + + +L S V ++L + H + +++
Sbjct: 67 YYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 252 RDVKPHNVMID----HEQRKLRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 299
RD+KP N +I + ++D+G+ +FY +E + +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 350
+ ++ DL +LG +F + + G K ++ +
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYERIGEKKQ 233
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 9e-33
Identities = 49/254 (19%), Positives = 111/254 (43%), Gaps = 21/254 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-------KKKIKREIKILQ 183
+++E+++ +G G Y +VF + + +K+LK + + E ++L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALD 242
++ P +V L + + L + + + ++++V+ Y+ E++ AL+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 299
+ H GI++RD+K N+++D + L D+GL++ + + Y+ Y +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 359
+D ++D WSLG + ++ P F + +I++ + E Y
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILKSEP-----PYP 256
Query: 360 IELDPHLAALVGRL 373
E+ L+ RL
Sbjct: 257 QEMSALAKDLIQRL 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-32
Identities = 35/219 (15%), Positives = 87/219 (39%), Gaps = 14/219 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ V+++G G++ V G + +K IK ++ + ++ E +++ L P +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKL 62
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTD----FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 247
V+L + +Q L+FE + + + + + ++ + + Y
Sbjct: 63 VQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDLQD 305
++HRD+ N ++ Q +++ D+G+ F + + + PE+
Sbjct: 121 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR 178
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Y D+WS G + + + + N + + I+
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (307), Expect = 3e-32
Identities = 46/218 (21%), Positives = 94/218 (43%), Gaps = 13/218 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
D++++R +G G + V + +K+LK + + E +L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 188 GPNIVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
P I+++ +D Q + + E + ++Y E+ AL+Y HS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+ I++RD+KP N+++D + +++ D+G A++ + + PE++ + Y
Sbjct: 123 KDIIYRDLKPENILLD-KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-KPY 178
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ S+D WS G + M+ P FY + KI
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILN 215
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 3e-32
Identities = 37/220 (16%), Positives = 87/220 (39%), Gaps = 16/220 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
+ + K+G+G + EV+ G + IK LKP + + +E ++++ L +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKL 74
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 246
V+L +V ++ ++ E+++ L + ++ + Y
Sbjct: 75 VQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPELLVDLQ 304
+HRD++ N+++ E ++ D+GLA + + PE +
Sbjct: 132 MNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-G 189
Query: 305 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + + + + G N + L ++ +
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (308), Expect = 4e-32
Identities = 48/218 (22%), Positives = 93/218 (42%), Gaps = 13/218 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 187
D ++ ++ +G G + V H +KIL K K+K E +ILQ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCHS 246
P +VKL +D + + + + S+ R+Y +++ +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+++RD+KP N++ID + +++ D+G A+ + PE+++ + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ ++D W+LG + M P F+ KI
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPP-FFADQPIQIYEKIVS 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-32
Identities = 42/218 (19%), Positives = 85/218 (38%), Gaps = 10/218 (4%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 187
+D++ ++ +G+G + +V +KIL+ E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 188 GPNIVKLLDIVRDQQSK-TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 246
P + L + ++ R+Y E++ AL+Y HS
Sbjct: 65 -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 247 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 306
+ +++RD+K N+M+D + +++ D+GL + +++ DY
Sbjct: 124 RDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
++D W LG + M+ + P FY D+ I
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELILM 219
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 7e-32
Identities = 38/221 (17%), Positives = 91/221 (41%), Gaps = 14/221 (6%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 191
D ++++G G++ V G IK++K + + + E K++ NL +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKL 61
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
V+L + Q + +I E++ N + ++ +A++Y S+
Sbjct: 62 VQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDLQD 305
+HRD+ N +++ + +++ D+GL+ + + + + PE+L+
Sbjct: 120 QFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SK 177
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 346
+ D+W+ G + + + + N + IA+ L
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 1e-31
Identities = 43/225 (19%), Positives = 86/225 (38%), Gaps = 18/225 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 192
+ Y + RK+G G + +++ G E+ IK+ K ++ E KI + + GG I
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 249
+ + ++ E + + F S V +++ ++Y HS+
Sbjct: 67 TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 250 MHRDVKPHNVMIDHEQRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 299
+HRDVKP N ++ ++ + ID+GLA+ Y + + + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 300 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + DL SLG + + G + K +
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGS-LPWQGLKAATKRQKYER 227
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-31
Identities = 38/236 (16%), Positives = 84/236 (35%), Gaps = 29/236 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 187
+D + +G G + +V + D + I + + E+++L L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 188 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------------------FKVLYPTLSDY 228
PNI+ LL + L E+ + + TLS
Sbjct: 70 HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 229 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 288
+ ++ ++ + +DY + +HRD+ N+++ E ++ D+GL+ + +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ E L Y + D+WS G + ++ + G + K+ +
Sbjct: 187 RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 241
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-31
Identities = 43/223 (19%), Positives = 91/223 (40%), Gaps = 17/223 (7%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLC 186
+ E+ R +G G++ +V +G++ + + +K K +K +E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF- 65
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALD 242
P+IVKL+ ++ + +I E + + +L + Y Y+L AL
Sbjct: 66 DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYFKGPELLV 301
Y S+ +HRD+ NV++ ++L D+GL+ + Y + +
Sbjct: 123 YLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 302 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + + + D+W G ++ F G N D + +I
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 224
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 119 bits (298), Expect = 4e-31
Identities = 37/227 (16%), Positives = 82/227 (36%), Gaps = 20/227 (8%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLC 186
++ + +G G++ EV G ++ I +K +K + E I+
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 187 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALD 242
PN++ L +V S +I E + N + + + + +
Sbjct: 86 H-PNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 243 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 302
Y +HRD+ N++++ ++ D+GL+ F ++ K P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 303 -----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + + D+WS G + ++ E ++ N D + I +
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (294), Expect = 8e-31
Identities = 39/218 (17%), Positives = 86/218 (39%), Gaps = 11/218 (5%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNI 191
D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + PN+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNL 75
Query: 192 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 247
V+LL + + F L +S + Y ++ A++Y +
Sbjct: 76 VQLLGVCTREPPFYIITEF-MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 248 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQDY 306
+HRD+ N ++ E +++ D+GL+ + + +
Sbjct: 135 NFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 307 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
D+W+ G + + + G D Q+ ++ +
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE 230
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-30
Identities = 45/243 (18%), Positives = 86/243 (35%), Gaps = 35/243 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVK----KKKIKREIKILQN 184
+ + +G G + +V E + +K+LKP ++ + E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD---------------------FKVLYP 223
L NIV LL +I E+ D +
Sbjct: 83 LGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
L D+ + Y++ K + + S+ +HRD+ N+++ H + ++ D+GLA
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDS 199
Query: 284 EYNVRVASRYFKG--PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
Y V+ +R + Y + D+WS G + + G + K
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 342 IAK 344
+ K
Sbjct: 260 MIK 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-29
Identities = 38/227 (16%), Positives = 91/227 (40%), Gaps = 21/227 (9%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKK----IKREIKILQN 184
+ +++ ++ +G G + V++G+ + E IK L+ K I E ++ +
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 240
+ P++ +LL I T LI + + + + + ++ K
Sbjct: 68 VDN-PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 297
++Y + ++HRD+ NV++ Q +++ D+GLA+ ++ +
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
E ++ + Y + D+WS G ++ + G + + K
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-29
Identities = 41/228 (17%), Positives = 92/228 (40%), Gaps = 21/228 (9%)
Query: 132 EQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCI--IKILKPVKKKK----IKREIKILQN 184
++D+ + ++G G + V +GV+ ++ IK+LK +K + RE +I+
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIYELLKA 240
L P IV+L+ + + + L+ E K L + +V ++++
Sbjct: 66 L-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMG 121
Query: 241 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKG 296
+ Y + +HRD+ NV++ + ++ D+GL++ Y +
Sbjct: 122 MKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 297 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
PE + + + D+WS G + + + + + I +
Sbjct: 181 PECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (285), Expect = 2e-29
Identities = 44/250 (17%), Positives = 86/250 (34%), Gaps = 42/250 (16%)
Query: 133 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQ 183
+++ E VR +G G + VF+ +K+LK + +RE ++
Sbjct: 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71
Query: 184 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------------------------ 219
PNIVKLL + + L+FE++ D
Sbjct: 72 EFDN-PNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 220 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 276
P LS + ++ + Y + +HRD+ N ++ E +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLS 187
Query: 277 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
+ Y A P + Y D+W+ G + + +YG
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 335 NYDQLVKIAK 344
+ + + +
Sbjct: 248 HEEVIYYVRD 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-28
Identities = 43/221 (19%), Positives = 94/221 (42%), Gaps = 20/221 (9%)
Query: 140 RKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKK----KKIKREIKILQNLCGGPNIV 192
+GRG + V+ G ++ K I +K L + + E I+++ PN++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-PNVL 91
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG 248
LL I + P ++ ++ + D + + D+ + ++ K + + S+
Sbjct: 92 SLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK 150
Query: 249 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-----FKGPELLVDL 303
+HRD+ N M+D + +++ D+GLA + + +V + + E L
Sbjct: 151 FVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT- 208
Query: 304 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
Q + D+WS G + ++ R P + + +D V + +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 4e-28
Identities = 39/219 (17%), Positives = 86/219 (39%), Gaps = 20/219 (9%)
Query: 140 RKVGRGKYSEVFEGVHC--TDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 192
+++G G + V +G + + +KILK P K ++ E ++Q L P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71
Query: 193 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGI 249
+++ I ++++ L+ E + D ++ ++++ + Y
Sbjct: 72 RMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 250 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 305
+HRD+ NV++ Q ++ D+GL++ + Y + PE +
Sbjct: 129 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186
Query: 306 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ D+WS G + + + G + + K
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 2e-27
Identities = 39/227 (17%), Positives = 86/227 (37%), Gaps = 21/227 (9%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNL 185
+ +G G++ EV++G+ T + K IK LK ++ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 186 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKAL 241
NI++L ++ + +I E++ N S + + + +
Sbjct: 67 SH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGP 297
Y + +HRD+ N++++ ++ D+GL+ E + + P
Sbjct: 124 KYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 298 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
E + + S D+WS G + ++ E ++ N++ + I
Sbjct: 183 EAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 9e-26
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 28/240 (11%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNL-------- 185
Y +VRK+G G +S V+ +N +KI++ V + + EIK+LQ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 186 --CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF------KVLYPTLSDYDVRYYIYEL 237
G +I+KLLD + ++ + K + + V+ +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 238 LKALDYC-HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 293
L LDY GI+H D+KP NV+++ LI +A+ + S R
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 294 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF-----FYGHDNYDQLVKIAKVLGT 348
++ PE+L+ + D+WS C+ +I F + D + +I ++LG
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 3e-25
Identities = 42/236 (17%), Positives = 87/236 (36%), Gaps = 30/236 (12%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQN 184
+ + R++G+G + V+EGV + IK + + + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------YPTLSDYDVR 231
++V+LL +V Q + +I E + D K S +
Sbjct: 80 F-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136
Query: 232 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR 288
E+ + Y ++ +HRD+ N M+ + +++ D+G+ + Y
Sbjct: 137 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKG 195
Query: 289 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 344
+ + PE L D + D+WS G + + E + G N L + +
Sbjct: 196 LLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-25
Identities = 43/244 (17%), Positives = 91/244 (37%), Gaps = 37/244 (15%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVKKKK----IKREIKIL 182
D + + +G G + +V ++ K +K+LK +K + E++++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 183 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------------YP 223
+ + NI+ LL +I E+ + + +
Sbjct: 73 KMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 224 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283
LS D+ Y++ + ++Y S+ +HRD+ NV++ + ++ D+GLA H
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHID 189
Query: 284 EY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 340
Y + PE L D + Y + D+WS G + + + G +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 341 KIAK 344
+ +
Sbjct: 249 LLKE 252
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-25
Identities = 41/224 (18%), Positives = 84/224 (37%), Gaps = 26/224 (11%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIV 192
+ +G+G++ EV+ G E+ +KI +++ RE +I Q + NI+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 193 KLLDIVRDQQSKTPS--LIFEHVNNTD-FKVLY-PTLSDYDVRYYIYELLKALDYCHSQ- 247
+ L+ ++ + F L T++ + L + H +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 248 -------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 295
I HRD+K N+++ + D GLA + + N RV ++ +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 296 GPELL-----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 334
PE+L + + D++++G +F + R D
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 7e-24
Identities = 41/243 (16%), Positives = 93/243 (38%), Gaps = 36/243 (14%)
Query: 134 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKP----VKKKKIKREIKILQN 184
D ++ + +GRG + +V E +K+LK + + + E+KIL +
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 185 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------------VLYPTL 225
+ N+V LL +I E + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 226 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285
+ + Y +++ K +++ S+ +HRD+ N+++ E+ +++ D+GLA + +Y
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDY 190
Query: 286 ----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341
+ R+ ++ + + Y D+WS G + + + G ++ +
Sbjct: 191 VRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 342 IAK 344
K
Sbjct: 249 RLK 251
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 4e-20
Identities = 32/203 (15%), Positives = 68/203 (33%), Gaps = 34/203 (16%)
Query: 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------------VKKKKIKREIKILQ 183
+ + +G GK S VF +C++K K + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 184 NLCGGPNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 241
+ KL + + + +++ E ++ + + + + +L+ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116
Query: 242 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 296
+ +GI+H D+ +NV++ E +ID+ + E G +VR YF
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEGIW--IIDFPQSVEVGEEGWREILERDVRNIITYFS- 173
Query: 297 PELLVDLQDYDYSLDLWSLGCMF 319
+ Y D+ S
Sbjct: 174 -------RTYRTEKDINSAIDRI 189
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 427 | |||
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.51 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.15 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.98 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.34 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.72 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 91.16 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 90.66 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 90.42 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 90.25 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 89.81 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 89.81 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 89.5 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 89.4 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 88.87 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 88.81 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 88.32 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 88.18 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 87.93 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 87.48 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 87.39 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 87.25 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 86.83 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 86.21 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 86.1 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 86.03 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 85.79 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 85.4 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 85.39 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 84.76 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 84.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 82.54 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 81.91 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 81.27 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 80.61 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 80.32 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-58 Score=446.32 Aligned_cols=319 Identities=66% Similarity=1.122 Sum_probs=278.8
Q ss_pred CCCCcccccCCCcCCCCCcccccccccccCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHH
Q 014307 102 APSKARVYSDINVVRPREYWDYESLTVQWGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI 181 (427)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~i 181 (427)
.|++++++.+++...+.++|+++...+.+...++|+++++||+|+||+||+|+++.+|+.||||+++....+.+.+|+.+
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~i 82 (328)
T d3bqca1 3 VPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI 82 (328)
T ss_dssp CCCCCSSSTTTTTTSCHHHHCGGGCCCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHH
T ss_pred CCCcceeeccccccCCCccchhhhcccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHH
Confidence 46777888888888899999999999988899999999999999999999999999999999999998888899999999
Q ss_pred HHHhcCCCCeeeeeeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE
Q 014307 182 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (427)
Q Consensus 182 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 261 (427)
|+++.+||||++++++|.......+++||||+.+++|....+.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi 162 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence 99996799999999999877778899999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCeEEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 014307 262 DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (427)
Q Consensus 262 ~~~~~~ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~ 341 (427)
+.++..+||+|||+|+...........++|+.|+|||.+.+...++.++||||+||++|||++|+.||..+.+..++...
T Consensus 163 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~ 242 (328)
T d3bqca1 163 DHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 242 (328)
T ss_dssp ETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred cCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH
Confidence 97776899999999998877777778899999999999887667899999999999999999999999888888889999
Q ss_pred HHHHhCChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccC
Q 014307 342 IAKVLGTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGE 421 (427)
Q Consensus 342 i~~~~~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~ 421 (427)
+.+.++.+....+........++.............|..-.. ........+++.|+|++||. .||++|+|+..+++
T Consensus 243 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~s~~~~dli~~mL~-~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 243 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVH---SENQHLVSPEALDFLDKLLR-YDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCC---TTTGGGCCHHHHHHHHHHSC-SSGGGSCCHHHHHT
T ss_pred HHHHHCCchhhhhhhhcccccCcccchhcccccccchhhccc---ccccccCCHHHHHHHHHHcc-CChhHCcCHHHHhc
Confidence 999999888888877766666666544433333333322111 11223356789999999995 99999999999999
Q ss_pred CCC
Q 014307 422 SAF 424 (427)
Q Consensus 422 ~~~ 424 (427)
|||
T Consensus 319 Hp~ 321 (328)
T d3bqca1 319 HPY 321 (328)
T ss_dssp SGG
T ss_pred Ccc
Confidence 997
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-56 Score=414.09 Aligned_cols=245 Identities=23% Similarity=0.369 Sum_probs=204.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+++ +|||||++++++.+ ...+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~--~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeecc--CceeEE
Confidence 367999999999999999999999999999999986432 34588999999999 99999999999987 567899
Q ss_pred EEeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC--
Q 014307 209 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-- 283 (427)
||||+.+++|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEE
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCcc
Confidence 999999999987764 489999999999999999999999999999999999999777 89999999998765332
Q ss_pred -cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh--------CChHHHHH
Q 014307 284 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL--------GTDELNAY 354 (427)
Q Consensus 284 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~--------~~~~~~~~ 354 (427)
.....+||+.|+|||++.+...++.++|||||||++|||++|+.||....+.......+.... -++...++
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 234568999999999998743457889999999999999999999954443333333332211 13455566
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+.+ |+..||..||+++++++||||++.
T Consensus 240 i~~-~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 240 LHK-ILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp HHH-HSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred HHH-HcCCChhHCcCHHHHhcCHhhCcC
Confidence 655 999999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=408.76 Aligned_cols=240 Identities=23% Similarity=0.432 Sum_probs=208.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|+++.+++.||+|++.+ ...+.+.+|+.+|+++ +|||||++++++.+ ...++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~ 82 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--ATRVY 82 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEE--CCEEE
Confidence 579999999999999999999999999999999863 2346688999999999 99999999999986 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.+|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ..
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~-~~ 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS-SR 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCC-CC
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCC-Cc
Confidence 999999999997765 4699999999999999999999999999999999999999777 899999999986543 34
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~~~ 358 (427)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+... ++.+.+++.+
T Consensus 161 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 237 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYKRISRVEFTFPDFVTEGARDLISR- 237 (263)
T ss_dssp CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH-
T ss_pred ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH-
Confidence 456789999999999987 68999999999999999999999999 55555566665554321 3456666666
Q ss_pred cCCCChhHHHHHhHHhcCCchhh
Q 014307 359 HIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
|+..||..||+++++++||||..
T Consensus 238 ~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 238 LLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-55 Score=412.80 Aligned_cols=242 Identities=22% Similarity=0.414 Sum_probs=211.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc---ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.++|+++++||+|+||+||+|+++.+|+.||||+++. ...+.+.+|+.+|+++ +|||||++++++.+ ...+++|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEE--CCEEEEE
Confidence 4579999999999999999999999999999999864 3456789999999999 99999999999987 5578999
Q ss_pred EeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cce
Q 014307 210 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 286 (427)
Q Consensus 210 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~~ 286 (427)
|||+.+++|..+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.... ...
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeecccccccc
Confidence 9999999998775 3699999999999999999999999999999999999999777 89999999998775443 345
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC---------ChHHHHHHHh
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------TDELNAYLNK 357 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------~~~~~~~l~~ 357 (427)
..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+..+..... ++.+..++.+
T Consensus 175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 252 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPY-LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252 (293)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCC-CCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence 6689999999999987 78999999999999999999999999 55566666666655421 2345555666
Q ss_pred ccCCCChhHHHHHhHHhcCCchhh
Q 014307 358 YHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
|+..||..||++.+++.||||+.
T Consensus 253 -~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 253 -CLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp -HTCSSTTTSCCHHHHTTCGGGGG
T ss_pred -HccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-55 Score=419.09 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=204.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
..++|+++++||+|+||+||+|+++.+|+.||+|+++. ...+.+.+|+.+|+++ +|||||+++++|.+ ...++
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEEC--SSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEE
Confidence 35789999999999999999999999999999999864 2246788999999999 99999999999987 45789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~ 283 (427)
+||||+.+++|..++ ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~-~ 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID-S 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHH-H
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCC-C
Confidence 999999999998776 369999999999999999999997 4999999999999999877 899999999986543 2
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-----------------
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------------- 346 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------------- 346 (427)
.....+||+.|+|||++.+ ..|+.++||||+||++|||++|+.||........+...+....
T Consensus 159 ~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 3346799999999999988 7899999999999999999999999965544333222111110
Q ss_pred --------------------------------CChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 347 --------------------------------GTDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 347 --------------------------------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.++++.+++.+ |+..||..||+++++|+||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~-~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK-CLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHH-HTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHH-HcCCChhHCcCHHHHhhCHhhCcCC
Confidence 12345555666 9999999999999999999999754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=406.53 Aligned_cols=242 Identities=27% Similarity=0.432 Sum_probs=195.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+++|+++ +|||||++++++.+.....++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 367999999999999999999999999999999986432 35588999999999 999999999999876677889
Q ss_pred EEEeecCCCchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeeccCCCceEEcCCCCeEEEEeeee
Q 014307 208 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGL 275 (427)
Q Consensus 208 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~-----iiHrDlkp~NILl~~~~~~ikl~DFGl 275 (427)
+||||+.+|+|..++ ..+++..++.++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccc
Confidence 999999999998765 35999999999999999999999976 99999999999999877 899999999
Q ss_pred eeeecCCCc-ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 276 AEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 276 a~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
|+.+..... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+....+.+..-
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCC-CCCCHHHHHHHHHcCCCCCCCccc
Confidence 987654433 345789999999999876 78999999999999999999999999 45555555555554321
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCch
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYF 379 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~ 379 (427)
++.+.+++.+ |+..||..||+++++++|||.
T Consensus 239 s~~l~~li~~-~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITR-MLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHH-HTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHH-HcCCChhHCcCHHHHHhCCcC
Confidence 3456666666 999999999999999999994
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=409.73 Aligned_cols=245 Identities=23% Similarity=0.394 Sum_probs=209.0
Q ss_pred CCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 131 GEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 131 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
...+.|+++++||+|+||+||+|+++.+++.||||+++.. ..+.+.+|+++|+++ +|||||++++++.+ ...++
T Consensus 9 ~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~~ 85 (288)
T d2jfla1 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENNLW 85 (288)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred CcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCeEE
Confidence 3456799999999999999999999999999999998643 335688999999999 99999999999987 56789
Q ss_pred EEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-
Q 014307 208 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 282 (427)
Q Consensus 208 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~- 282 (427)
+||||+.+++|..++ ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 86 lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHH
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCc
Confidence 999999999987664 3599999999999999999999999999999999999999877 8999999999765432
Q ss_pred CcceeeccCccccccccccC----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CCh
Q 014307 283 KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTD 349 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~ 349 (427)
......+||+.|+|||++.+ ...|+.++|||||||++|||++|+.|| .+.+..+.+..+.+.. -++
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~s~ 243 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH-HELNPMRVLLKIAKSEPPTLAQPSRWSS 243 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTT-TTSCGGGHHHHHHHSCCCCCSSGGGSCH
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCC-CCCCHHHHHHHHHcCCCCCCCccccCCH
Confidence 22345689999999999842 356899999999999999999999999 5556666666666542 134
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
++.+++.+ |+..||..||++.++++||||..
T Consensus 244 ~~~~li~~-~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 244 NFKDFLKK-CLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp HHHHHHHH-HSCSSTTTSCCHHHHTTSGGGCC
T ss_pred HHHHHHHH-HccCChhHCcCHHHHhcCcccCC
Confidence 55666666 99999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=399.80 Aligned_cols=241 Identities=21% Similarity=0.373 Sum_probs=201.1
Q ss_pred CCE-EEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC--CCCC
Q 014307 134 DDY-EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 205 (427)
Q Consensus 134 ~~y-~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~--~~~~ 205 (427)
++| ++.++||+|+||+||+|+++.+++.||+|+++.. ..+.+.+|+++|+++ +|||||++++++.+. ....
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCE
Confidence 445 7788999999999999999999999999998642 235688999999999 899999999998753 3456
Q ss_pred cEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 206 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
+++||||+.+++|..++ ..+++.+++.++.||+.||+|||++| |+||||||+|||++.+...+||+|||+|+...
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 89999999999998775 36999999999999999999999998 99999999999997544489999999998543
Q ss_pred CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHH-HHHHHHh--------CChHH
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL-VKIAKVL--------GTDEL 351 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l-~~i~~~~--------~~~~~ 351 (427)
.......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||. +..+.+.+ ..+.+.. ..+++
T Consensus 167 -~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 242 (270)
T d1t4ha_ 167 -ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGVKPASFDKVAIPEV 242 (270)
T ss_dssp -TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTT-TCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred -CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCC-CcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence 334456789999999999865 69999999999999999999999994 44444444 3333222 13456
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcCCchh
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVILSYFF 380 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~~~~~ 380 (427)
.+++.+ |+..||+.||+++++++||||+
T Consensus 243 ~~li~~-~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 243 KEIIEG-CIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHH-HSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHH-HccCCHhHCcCHHHHhCCcccC
Confidence 666666 9999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=403.31 Aligned_cols=242 Identities=25% Similarity=0.434 Sum_probs=204.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|+++.+++.||||+++. ...+.+.+|+++|+++ +||||+++++++.+ ...++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEEC--SSEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEE--CCEEE
Confidence 679999999999999999999999999999999863 2335689999999999 99999999999986 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~- 283 (427)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCCc
Confidence 999999999987664 4699999999999999999999999999999999999999777 89999999998775332
Q ss_pred --cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHH
Q 014307 284 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYL 355 (427)
Q Consensus 284 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l 355 (427)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+.++.+.- -++++.+++
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 241 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKIIKLEYDFPEKFFPKARDLV 241 (288)
T ss_dssp ------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred ccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCC-CCcCHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 2345689999999999987 68999999999999999999999999 5556666666665432 134555566
Q ss_pred HhccCCCChhHHHHHhHH------hcCCchhhH
Q 014307 356 NKYHIELDPHLAALVGRL------VILSYFFQF 382 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~l------l~~~~~~~~ 382 (427)
.+ |+..||..|++++++ +.||||+..
T Consensus 242 ~~-~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 242 EK-LLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HT-TSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HH-HccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 66 999999999999884 677887764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.3e-53 Score=412.14 Aligned_cols=244 Identities=21% Similarity=0.392 Sum_probs=213.6
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
++|++++.||+|+||.||+|+++.+|+.||||++.... .+.+.+|+.+|+++ +|||||++++++.+ ...+++||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEE
Confidence 58999999999999999999999999999999986533 35688999999999 99999999999987 56789999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC-CCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~-~~~ikl~DFGla~~~~~~~~~ 285 (427)
|||.+|+|..++ ..+++.+++.++.||+.||+|||++|||||||||+|||++.+ .+.+||+|||+|+.+......
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999999987665 248999999999999999999999999999999999999643 348999999999988777777
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYL 355 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l 355 (427)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+..... ++.+..++
T Consensus 183 ~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 260 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI 260 (350)
T ss_dssp EEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHH
T ss_pred ceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 78899999999999987 78999999999999999999999999 56666677777665421 24555666
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+ |+..||..||++.++|.||||.+..
T Consensus 261 ~~-~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 261 RK-LLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HH-HCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HH-HccCChhHCcCHHHHhcCcccCCCC
Confidence 66 9999999999999999999998643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-53 Score=412.88 Aligned_cols=242 Identities=22% Similarity=0.421 Sum_probs=212.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
++|++++.||+|+||+||+|+++.+|+.||||+++... ...+.+|+.+|+++ +|||||+++++|.+ ...+++||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEE
Confidence 57999999999999999999999999999999986533 45678999999999 99999999999986 56789999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC-CCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~-~~~~ikl~DFGla~~~~~~~~~ 285 (427)
|||.+++|...+. ++++.+++.++.||+.||+|||++||+||||||+|||++. +.+.+||+|||+|+.+......
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCce
Confidence 9999999976542 4899999999999999999999999999999999999973 2348999999999988877777
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYL 355 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l 355 (427)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+... ++.+.+++
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 263 (352)
T d1koba_ 186 KVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI 263 (352)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred eeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence 78899999999999887 78999999999999999999999999 66667777777766421 24555666
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhh
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
.+ |+..||..|+++.++|.||||+.
T Consensus 264 ~~-~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 264 KN-LLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp HT-TSCSSGGGSCCHHHHHTSTTTSS
T ss_pred HH-HccCChhHCcCHHHHhcCHhhCC
Confidence 66 99999999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-54 Score=408.98 Aligned_cols=243 Identities=25% Similarity=0.432 Sum_probs=192.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
.+.|++++.||+|+||+||+|+++.+++.||||++... ..+.+.+|+.+|+++ +|||||++++++.+ ...+++
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~l 84 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYES--GGHLYL 84 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEE
Confidence 46799999999999999999999999999999998643 234577999999999 99999999999976 567899
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC--CCCeEEEEeeeeeeeecCCC
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~~ikl~DFGla~~~~~~~ 283 (427)
||||+.+++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||+.. +++.+||+|||+|+......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999997765 35999999999999999999999999999999999999953 23489999999999876666
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHH
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNA 353 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~ 353 (427)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+....+....+.+... ++++.+
T Consensus 165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 242 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEYEFDSPYWDDISDSAKD 242 (307)
T ss_dssp --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence 6677899999999999987 68999999999999999999999999 45555555555554321 245556
Q ss_pred HHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 354 YLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 354 ~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
++.+ |+..||..||++.+++.||||..
T Consensus 243 li~~-~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 243 FIRH-LMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp HHHH-HSCSSGGGSCCHHHHHHSTTTTS
T ss_pred HHHH-HccCCHhHCcCHHHHhcCHhhCC
Confidence 6666 99999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-53 Score=401.83 Aligned_cols=245 Identities=21% Similarity=0.397 Sum_probs=211.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc---------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~---------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|+++ +|||||++++++.+ .
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~ 85 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN--K 85 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--C
Confidence 46799999999999999999999999999999998532 246789999999999 99999999999987 5
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCC---eEEEEeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE 277 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---~ikl~DFGla~ 277 (427)
..+++|||||.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++. .+||+|||+|+
T Consensus 86 ~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 86 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 6789999999999998765 46999999999999999999999999999999999999986653 59999999999
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.|| .+.+..+.+..+.+...
T Consensus 166 ~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (293)
T d1jksa_ 166 KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNYEFEDEYFSNT 243 (293)
T ss_dssp ECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred hcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCC-CCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence 8877766777899999999999987 68999999999999999999999999 55566666665554321
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++.+.+++.+ |+..||..||++++++.||||+...
T Consensus 244 s~~~~~li~~-~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 244 SALAKDFIRR-LLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp CHHHHHHHHT-TSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CHHHHHHHHH-HccCChhHCcCHHHHhcCcccCCCC
Confidence 2344455555 9999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-53 Score=405.84 Aligned_cols=239 Identities=23% Similarity=0.400 Sum_probs=204.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
+.|+++++||+|+||+||+|+++.+++.||||+++... .+.+.+|+.+|+++ +|||||++++++.+ ...++
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLR--EHTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEE--CCEEE
Confidence 45999999999999999999999999999999986422 24588999999999 99999999999987 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+|||||.++++..+. ..+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP--- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC---
Confidence 999999999886543 4699999999999999999999999999999999999999777 899999999986543
Q ss_pred ceeeccCccccccccccC--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC--------ChHHHHH
Q 014307 285 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--------TDELNAY 354 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~--------~~~~~~~ 354 (427)
.....||+.|+|||++.+ ...|+.++|||||||++|||++|+.|| .+....+.+..+.+... ++.+..+
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT-TTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 345689999999999864 246899999999999999999999999 45555666666554321 2455566
Q ss_pred HHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 355 LNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+.+ |+..||..||++++++.|||+.+
T Consensus 247 i~~-~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 247 VDS-CLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHH-HTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHH-HCcCChhHCcCHHHHHhCHHhcC
Confidence 666 99999999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=405.29 Aligned_cols=243 Identities=22% Similarity=0.397 Sum_probs=209.0
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|+++.+|+.||||++++. ..+.+.+|+.+|+++ +||||+++++++.+ ...++
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~~~ 81 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRLC 81 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecc--ccccc
Confidence 6799999999999999999999999999999999642 346688999999999 99999999999987 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC-CC
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GK 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~-~~ 283 (427)
+||||+.+|+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTTC
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCCc
Confidence 999999999997665 4699999999999999999999999999999999999999887 899999999987544 34
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (427)
.....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+....+.... -++....++.+
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCC-CCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 4566799999999999987 78999999999999999999999999 4545444444444321 23566666666
Q ss_pred ccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 358 YHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 358 ~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
|+..||..|+. ++++++||||....
T Consensus 239 -~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 239 -LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -HTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -hccCCchhhcccccccHHHHHcCcccccCC
Confidence 99999999994 89999999998643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-52 Score=391.00 Aligned_cols=245 Identities=23% Similarity=0.421 Sum_probs=211.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHHHhcCCCCeeeeeeEEEc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------------~~~~~~E~~il~~l~~h~niv~l~~~~~~ 200 (427)
.++|++++.||+|+||+||+|+++.+++.||||+++... .+.+.+|+.+|+++..||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999999999999999999986421 24578999999999559999999999986
Q ss_pred CCCCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 201 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
...+++||||+++++|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~ 158 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 158 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchhee
Confidence 56789999999999998776 4699999999999999999999999999999999999999777 89999999999
Q ss_pred eecCCCcceeeccCccccccccccC-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-----
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----- 347 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----- 347 (427)
.+..........||+.|+|||.+.+ ...++.++||||+||++|||++|+.|| .+.+..+.+..+.+.-.
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHTCCCCCTT
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC-CCCCHHHHHHHHHhCCCCCCCc
Confidence 8877666677889999999999853 245789999999999999999999999 55555666655554321
Q ss_pred -----ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 348 -----TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 348 -----~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++++.+++.+ |+..||..|++++++++||||+++
T Consensus 238 ~~~~~s~~~~~li~~-~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 EWDDYSDTVKDLVSR-FLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp TGGGSCHHHHHHHHH-HCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ccccCCHHHHHHHHH-HccCChhHCcCHHHHHcCHHHHHh
Confidence 2455666666 999999999999999999999874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-52 Score=400.32 Aligned_cols=241 Identities=21% Similarity=0.407 Sum_probs=208.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|+++++||+|+||+||+|+++.+|+.||||+++. ...+.+.+|+.+|+.+ +|||||++++++.+ ...++
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~ 80 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQIF 80 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEee--CCeee
Confidence 579999999999999999999999999999999863 2346788999999999 99999999999986 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.++++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.... .
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~--~ 157 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD--V 157 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--C
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEecc--c
Confidence 999999999987665 4589999999999999999999999999999999999999877 899999999987643 3
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~~~ 358 (427)
....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+... ++++..++.+
T Consensus 158 ~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 234 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR- 234 (316)
T ss_dssp BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH-
T ss_pred cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCC-CCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence 445789999999999887 68999999999999999999999999 55566666666655321 3455666666
Q ss_pred cCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 359 HIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
|+..||..|+ +++++++||||+...
T Consensus 235 ~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 235 LITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp HTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred HhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 9999999985 999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-53 Score=400.39 Aligned_cols=239 Identities=29% Similarity=0.559 Sum_probs=205.5
Q ss_pred EEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEE
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 209 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--------~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv 209 (427)
.++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+++ +|||||++++++.+ ...+++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~--~~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH--KSNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC--TTCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeecc--CCceeeh
Confidence 4688999999999999999999999999986422 23578999999999 99999999999976 5678999
Q ss_pred EeecCCCchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-cc
Q 014307 210 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 285 (427)
Q Consensus 210 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~~ 285 (427)
|||+.++++..+.. .+++.+++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...... ..
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCcccc
Confidence 99999998776653 589999999999999999999999999999999999999777 89999999997664432 34
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-----------------
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----------------- 348 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~----------------- 348 (427)
...+||+.|+|||++.+...|+.++|||||||++|||++|+.|| .+.++.+++..+.+.++.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 45689999999999877567899999999999999999999887 777888888888876543
Q ss_pred -----------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 -----------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 -----------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+++.+++.+ |+..||..|++++++|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~-~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQG-LFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHH-HHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHH-HccCChhhCcCHHHHhCCHhhCCC
Confidence 344555666 999999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=399.53 Aligned_cols=245 Identities=20% Similarity=0.372 Sum_probs=213.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccH--HHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~--~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++++.||+|+||+||+|+++.+++.||||+++.... ..+.+|+.+|+.+ +|||||+++++|.+ ...+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 4789999999999999999999999999999999975443 4578999999999 99999999999987 56789999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC-CeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~~ikl~DFGla~~~~~~~~~ 285 (427)
|||.+++|...+. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+++........
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 9999999987653 489999999999999999999999999999999999997543 37999999999988776667
Q ss_pred eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------ChHHHHHH
Q 014307 286 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG----------TDELNAYL 355 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~----------~~~~~~~l 355 (427)
....+++.|+|||.+.+ ..|+.++|||||||++|+|++|+.|| .+.+..+.+..+.+... ++++.+++
T Consensus 161 ~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 238 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTT-CCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHH
Confidence 77899999999999876 68999999999999999999999999 55566666666655321 24455566
Q ss_pred HhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 356 NKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 356 ~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
.+ |+..||..|+++++++.||||.+..
T Consensus 239 ~~-~L~~dp~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 239 DR-LLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HT-TSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred HH-HccCChhHCcCHHHHhcCHhhccCc
Confidence 66 9999999999999999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-53 Score=400.83 Aligned_cols=274 Identities=28% Similarity=0.509 Sum_probs=217.5
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+++|+++ +|||||++++++.+ ...+++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~--~~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEecccccc--ccceeE
Confidence 6899999999999999999999999999999998642 246788999999999 99999999999987 567899
Q ss_pred EEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-C
Q 014307 209 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (427)
Q Consensus 209 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~ 283 (427)
||||+.++.+.... ..+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+..... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSB
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCcc
Confidence 99999987655432 3599999999999999999999999999999999999999777 8999999999876543 3
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCC
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 363 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~d 363 (427)
......||+.|+|||++.....++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+.+....+... ...
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~---~~~ 233 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGV---TSM 233 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTG---GGS
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCCchhhcccc---ccc
Confidence 4456689999999999877566789999999999999999999999 667778888888887776432211100 011
Q ss_pred hhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 364 PHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 364 p~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
+............++.. ......+.+.|+|++||. .||++|+|+..++.|||
T Consensus 234 ~~~~~~~~~~~~~~~~~--------~~~~~s~~~~dll~~mL~-~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSK--------VVPPLDEDGRSLLSQMLH-YDPNKRISAKAALAHPF 285 (298)
T ss_dssp TTCCTTSCCCCCCCHHH--------HSTTCCHHHHHHHHHHTC-SSTTTSCCHHHHHTSGG
T ss_pred cccccccccccccchhh--------hccCCCHHHHHHHHHHcc-CChhHCcCHHHHhCCHh
Confidence 11111111111111111 122356788999999995 99999999999999998
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-52 Score=401.58 Aligned_cols=241 Identities=22% Similarity=0.371 Sum_probs=209.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|+.+ +|||||++++++.+ ...++
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~ 117 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSNLY 117 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccc--ccccc
Confidence 6899999999999999999999999999999998632 235688999999999 99999999999986 56788
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+.++++...+ ..+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+.... .
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~--~ 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG--R 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS--C
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeeccc--c
Confidence 999999999987665 4699999999999999999999999999999999999999877 899999999987653 3
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC------ChHHHHHHHhc
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAYLNKY 358 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~------~~~~~~~l~~~ 358 (427)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.+... ++++..++.+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf-~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~- 271 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN- 271 (350)
T ss_dssp BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH-
T ss_pred cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCC-CCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH-
Confidence 445789999999999987 78999999999999999999999999 55566666666655421 3566666666
Q ss_pred cCCCChhHH-----HHHhHHhcCCchhhHH
Q 014307 359 HIELDPHLA-----ALVGRLVILSYFFQFV 383 (427)
Q Consensus 359 ~l~~dp~~r-----~~~~~ll~~~~~~~~~ 383 (427)
|+..||..| ++++++++||||....
T Consensus 272 ~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp HSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred HhhhCHHhccccccccHHHHHcCccccCCC
Confidence 999999888 4999999999998744
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=403.96 Aligned_cols=244 Identities=22% Similarity=0.404 Sum_probs=203.5
Q ss_pred CCEEEEe-eeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEc--CCCCCcEEEE
Q 014307 134 DDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~-~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~--~~~~~~~lv~ 210 (427)
++|++++ .||+|+||+||+|+++.+++.||||+++. ...+.+|+.++.++.+|||||+++++|.+ ....++|+||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEE
Confidence 6799876 59999999999999999999999999974 46678999998777689999999999975 3346789999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCC--CeEEEEeeeeeeeecCCC
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~--~~ikl~DFGla~~~~~~~ 283 (427)
|||.||+|..++. .+++.+++.++.||+.||+|||++||+||||||+|||++.++ ..+||+|||+|+......
T Consensus 89 Ey~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp ECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred ECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC
Confidence 9999999987752 489999999999999999999999999999999999998532 369999999999887777
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH--------------hCCh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV--------------LGTD 349 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~--------------~~~~ 349 (427)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||. +.+..+....+... .-++
T Consensus 169 ~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~-~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 246 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFY-SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCE-ETTCC--------CCCSCSSSCCTTHHHHSCH
T ss_pred ccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCC-CCCHHHHHHHHHHHHhcCCCCCCCcccccCCH
Confidence 7777899999999999876 689999999999999999999999994 43333333222211 1134
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++.+++.+ |+..||..||++.+++.||||.+.
T Consensus 247 ~~~~li~~-~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 247 EVKMLIRN-LLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp HHHHHHHH-HSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHH-HccCChhHCcCHHHHHcCHHhhCC
Confidence 56666666 999999999999999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=401.25 Aligned_cols=245 Identities=32% Similarity=0.546 Sum_probs=211.8
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC----CCCCcEEEE
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTPSLIF 210 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~----~~~~~~lv~ 210 (427)
+|+.+++||+|+||+||+|+++.+|+.||||+++... ....+|+.+|+++ +||||++++++|... +..++++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 6999999999999999999999999999999996533 3345899999999 999999999998642 345689999
Q ss_pred eecCCCchhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 211 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 211 e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
||+.++++..+. ..+++.+++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+++.......
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 999987544332 35999999999999999999999999999999999999998776899999999998877777
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------- 348 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~---------------- 348 (427)
....+|++.|+|||++.+...|+.++|||||||++|||++|+.|| ...+..+++..+.+.+|.
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~ 257 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 257 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence 777899999999999887678999999999999999999999998 666778888888776543
Q ss_pred -------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 -------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 -------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
++..+++.+ |+..||..|+++.++|.||||++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~-mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 258 KFPQIKAHPWTKVFRPRTPPEAIALCSR-LLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCCCCCGGGTSCTTSCHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cccccccCchhhhcccCCCHHHHHHHHH-HccCChhHCcCHHHHhcCHhhcccc
Confidence 344455555 9999999999999999999998754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=392.49 Aligned_cols=243 Identities=22% Similarity=0.372 Sum_probs=206.8
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc------ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~------~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
++|++++.||+|+||+||+|+++.+++.||||++++ ...+.+..|..++.+..+|||||++++++.+ ...+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCcee
Confidence 679999999999999999999999999999999963 2234567788877653499999999999987 56789
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC-C
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 283 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~-~ 283 (427)
+||||+.+|+|..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhcccccc
Confidence 999999999998776 4699999999999999999999999999999999999999777 8999999999866543 3
Q ss_pred cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh------CChHHHHHHHh
Q 014307 284 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL------GTDELNAYLNK 357 (427)
Q Consensus 284 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~------~~~~~~~~l~~ 357 (427)
......||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.+..+.+..+.... -++.+..++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF-~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 236 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 236 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 3455689999999999987 78999999999999999999999999 5555555555554331 13566666666
Q ss_pred ccCCCChhHHHHHh-HHhcCCchhhH
Q 014307 358 YHIELDPHLAALVG-RLVILSYFFQF 382 (427)
Q Consensus 358 ~~l~~dp~~r~~~~-~ll~~~~~~~~ 382 (427)
|+..||..|+++. +++.||||++.
T Consensus 237 -~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 237 -LFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp -HSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred -hcccCCCCCcCHHHHHHhCchhccC
Confidence 9999999999996 79999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=391.82 Aligned_cols=246 Identities=30% Similarity=0.565 Sum_probs=208.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC-CeEEEEEEecccc-----HHHHHHHHHHHHHhc--CCCCeeeeeeEEEcC---
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQ--- 201 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vavK~~~~~~-----~~~~~~E~~il~~l~--~h~niv~l~~~~~~~--- 201 (427)
.++|+++++||+|+||+||+|++..+ ++.||||+++... ...+.+|+.+|+.|. +||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999999655 6789999986422 234678888887763 799999999998642
Q ss_pred CCCCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 202 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
....++++|||+.++.+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~~~ 164 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR 164 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhhhh
Confidence 345789999999998765332 3589999999999999999999999999999999999999777 89999999998
Q ss_pred eecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC---------
Q 014307 278 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------- 348 (427)
Q Consensus 278 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~--------- 348 (427)
............||+.|+|||++.+ ..|+.++|||||||++|||++|+.|| .+.++.+++..+.+..+.
T Consensus 165 ~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 242 (305)
T d1blxa_ 165 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD 242 (305)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSCTT
T ss_pred hhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCchhccccc
Confidence 7666666677899999999999887 78999999999999999999999999 667778888888776542
Q ss_pred ------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 ------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+...+++.+ |+..||..||++.++|.||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~-mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK-CLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp CSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHH-HSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccchhhhhccccccchhhccccCCHHHHHHHHH-HCcCChhHCcCHHHHhcChhhcCc
Confidence 233445555 999999999999999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.1e-51 Score=398.45 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=200.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc------HHHHHHH---HHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKRE---IKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E---~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
-++|++++.||+|+||.||+|+++.+|+.||||++.+.. ...+.+| +.+++.+ +|||||++++++.+ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~--~ 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT--P 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC--S
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEE--C
Confidence 368999999999999999999999999999999986422 2334555 4455555 79999999999987 4
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..+|+||||+.+++|..++ ..+++.+++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+.
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS 158 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecC
Confidence 6689999999999998775 3589999999999999999999999999999999999999777 89999999998765
Q ss_pred CCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh---------CChHH
Q 014307 281 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL---------GTDEL 351 (427)
Q Consensus 281 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~---------~~~~~ 351 (427)
.. .....+||+.|+|||++.+...|+.++|||||||++|||++|+.||... ...+......... -++.+
T Consensus 159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (364)
T d1omwa3 159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH-KTKDKHEIDRMTLTMAVELPDSFSPEL 236 (364)
T ss_dssp SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS-CSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence 43 3456689999999999876467999999999999999999999999533 2222211111111 13566
Q ss_pred HHHHHhccCCCChhHHHH-----HhHHhcCCchhhHH
Q 014307 352 NAYLNKYHIELDPHLAAL-----VGRLVILSYFFQFV 383 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~-----~~~ll~~~~~~~~~ 383 (427)
.+++.+ |+..||..|++ +++++.||||+...
T Consensus 237 ~~li~~-~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 237 RSLLEG-LLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp HHHHHH-HTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred HHHHHH-HcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 666666 99999999999 79999999998743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=389.09 Aligned_cols=239 Identities=23% Similarity=0.416 Sum_probs=198.6
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---------HHHHHHHHHHHHHhc-CCCCeeeeeeEEEcCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------~~~~~~E~~il~~l~-~h~niv~l~~~~~~~~ 202 (427)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ...+.+|+.+|+++. .|||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-- 80 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 80 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee--
Confidence 468999999999999999999999999999999986421 133678999999993 38999999999987
Q ss_pred CCCcEEEEeecCC-Cchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 203 SKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 203 ~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
....++||||+.+ +++..++ ..+++.+++.++.||+.||+|||++||+||||||+|||++.++..+||+|||+|+.
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 4568999999986 4554443 46999999999999999999999999999999999999986655899999999986
Q ss_pred ecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHH------hCChHHH
Q 014307 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV------LGTDELN 352 (427)
Q Consensus 279 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~------~~~~~~~ 352 (427)
.. ........||+.|+|||++.+...++.++|||||||++|||++|+.||.. .+. +.+. .-++++.
T Consensus 161 ~~-~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~~---i~~~~~~~~~~~s~~~~ 232 (273)
T d1xwsa_ 161 LK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEE---IIRGQVFFRQRVSSECQ 232 (273)
T ss_dssp CC-SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS----HHH---HHHCCCCCSSCCCHHHH
T ss_pred cc-cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC----chH---HhhcccCCCCCCCHHHH
Confidence 54 34456678999999999987744567889999999999999999999942 111 1111 1145666
Q ss_pred HHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 353 AYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+++.+ |+..||..||+++++++||||++.
T Consensus 233 ~li~~-~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 233 HLIRW-CLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHH-HTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHHHH-HccCCHhHCcCHHHHhcCHhhCCC
Confidence 66666 999999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-51 Score=395.03 Aligned_cols=279 Identities=28% Similarity=0.489 Sum_probs=206.1
Q ss_pred cCCCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC--
Q 014307 130 WGEQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-- 202 (427)
Q Consensus 130 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~-- 202 (427)
+...++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|+.+ +|||||+++++|...+
T Consensus 14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETL 92 (346)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSST
T ss_pred eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccc
Confidence 34568999999999999999999999999999999998642 235678999999999 9999999999997643
Q ss_pred --CCCcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 203 --SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 203 --~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
...+++||||+ +.++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ 170 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred cccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceec
Confidence 23679999999 44555443 4799999999999999999999999999999999999999877 899999999987
Q ss_pred ecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhc
Q 014307 279 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 358 (427)
Q Consensus 279 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~ 358 (427)
.. ...+...||+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+..+.+... ++...
T Consensus 171 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 246 (346)
T d1cm8a_ 171 AD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAE-FVQRL 246 (346)
T ss_dssp CC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHH-HHHTC
T ss_pred cC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCCCcHH-HHhhh
Confidence 53 34566789999999999987667899999999999999999999999 5667778888777777654332 11111
Q ss_pred cCCCChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 359 HIELDPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
.............+.-..+|.. ......+.+.|+|++||. .||++|+|+..++.|||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~s~~~~dli~~mL~-~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFAS--------ILTNASPLAVNLLEKMLV-LDAEQRVTAGEALAHPY 303 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGG--------TCTTCCHHHHHHHHHHSC-SSTTTSCCHHHHHHSGG
T ss_pred cchhhhhhhccCCcccccchHH--------hccCCCHHHHHHHHHHCc-CChhHCcCHHHHhcChh
Confidence 0000001111111111111111 112244566777777774 77777777777777776
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-51 Score=384.57 Aligned_cols=237 Identities=18% Similarity=0.318 Sum_probs=199.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.++||+|+||+||+|+++.+++.||||+++. ...+.+.+|+.+|+++ +|||||++++++.+ ...+++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEee--CCeeEEEe
Confidence 4689999999999999999999999999999999864 3457799999999999 99999999999976 56788999
Q ss_pred eecCCCchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcc
Q 014307 211 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 285 (427)
Q Consensus 211 e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~ 285 (427)
||+.+|++..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+........
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCSSSSE
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEccccceeecCCCCce
Confidence 999999987665 3589999999999999999999999999999999999999877 8999999999876543322
Q ss_pred --eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 286 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 286 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
....|+..|+|||++.+ ..|+.++|||||||++|||++|+.||+.+.+..+....+.+... ++.+.+++.
T Consensus 172 ~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 250 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 250 (287)
T ss_dssp EETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHH
Confidence 23457888999999887 78999999999999999999988888665554443333333321 345666666
Q ss_pred hccCCCChhHHHHHhHHhc
Q 014307 357 KYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~ 375 (427)
+ |+..||..||++.+++.
T Consensus 251 ~-cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 251 A-CWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp H-HTCSSGGGSCCHHHHHH
T ss_pred H-HcCCCHhHCcCHHHHHH
Confidence 6 99999999999998854
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-50 Score=383.17 Aligned_cols=241 Identities=31% Similarity=0.611 Sum_probs=204.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|+++++||+|+||+||+|+++ +|+.||||+++... .+.+.+|+.+|+++ +||||+++++++.+ ....++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHT--KKRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEEC--SSCEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeeccc--CCceeE
Confidence 68999999999999999999984 78999999986422 46789999999999 99999999999987 566889
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-c
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~ 284 (427)
+||++.++++..+. ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|....... .
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCccc
Confidence 99999998876664 3599999999999999999999999999999999999999877 89999999998765432 3
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------- 348 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~---------------- 348 (427)
.....+++.|+|||.+.+...++.++|||||||++|||++|+.|| .+.++.+++.++.+..+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence 345578999999999987677899999999999999999999999 566777888877765543
Q ss_pred -------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 349 -------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 349 -------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+.+.+++.+ |+..||..|+++++++.||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~-~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 236 PNFTVYEPLPWESFLKGLDESGIDLLSK-MLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHH-HTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccCcchhhhcccCCHHHHHHHHH-HccCChhHCcCHHHHhcCcccCc
Confidence 233455555 99999999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=378.92 Aligned_cols=239 Identities=17% Similarity=0.321 Sum_probs=200.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|+++++||+|+||+||+|++ .+++.||||+++. ...+.+.+|+.+|+++ +|||||++++++.+ ..+++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~---~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ---EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc---CCeEEEE
Confidence 46899999999999999999997 4678999999964 3457799999999999 99999999998754 3578999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~- 284 (427)
||+.+|+|..++. ++++..+..++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|+.......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceEEccCCccc
Confidence 9999999977653 489999999999999999999999999999999999999777 899999999997754432
Q ss_pred -ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.....|+..|+|||++.+ ..++.++|||||||++|||+||..|++...+..+.+..+.+... ++.+.+++.
T Consensus 166 ~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 244 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMR 244 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHH
Confidence 234568889999999876 67999999999999999999987777677666666666655422 245556555
Q ss_pred hccCCCChhHHHHHhHHhc--CCch
Q 014307 357 KYHIELDPHLAALVGRLVI--LSYF 379 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~--~~~~ 379 (427)
+ |+..||..||+++++++ ++||
T Consensus 245 ~-cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 245 L-CWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp H-HTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HcCCCHhHCcCHHHHHHHhhhhh
Confidence 5 99999999999999876 4554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=376.56 Aligned_cols=237 Identities=16% Similarity=0.319 Sum_probs=190.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|+++++||+|+||+||+|+++ +++.||||+++. ...+.+.+|+++++++ +|||||+++|++.. ....++||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~--~~~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--QAPICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceecc--CCceEEEE
Confidence 468999999999999999999985 678899999974 3457799999999999 99999999999976 45688999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc--
Q 014307 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (427)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-- 284 (427)
||+.+|+|..++ ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|+.......
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCcee
Confidence 999999988764 2478999999999999999999999999999999999999877 899999999987654432
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHh
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNK 357 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~ 357 (427)
.....||..|+|||++.+ ..|+.++|||||||++|||+|+..|++...+..+.+..+..... ++.+.+++..
T Consensus 159 ~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 234578899999999887 68999999999999999999976676566666566666655422 3455555555
Q ss_pred ccCCCChhHHHHHhHHhcC
Q 014307 358 YHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 358 ~~l~~dp~~r~~~~~ll~~ 376 (427)
|+..||..||++++++++
T Consensus 238 -cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 -CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -HTCSSGGGSCCHHHHHHH
T ss_pred -HccCCHhHCcCHHHHHHH
Confidence 999999999999998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-50 Score=382.50 Aligned_cols=245 Identities=30% Similarity=0.499 Sum_probs=205.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC-----
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 202 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~----- 202 (427)
-++|+++++||+|+||+||+|+++.+|+.||||++... ....+.+|+.+|+++ +||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 47899999999999999999999999999999998532 236688999999999 9999999999986532
Q ss_pred -CCCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeee
Q 014307 203 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 278 (427)
Q Consensus 203 -~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~ 278 (427)
...+++||||+.++++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~ 166 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARA 166 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecceeee
Confidence 34689999999988876554 3689999999999999999999999999999999999999877 899999999987
Q ss_pred ecCCC-----cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC-----
Q 014307 279 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----- 348 (427)
Q Consensus 279 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~----- 348 (427)
+.... .....+||+.|+|||++.+...|+.++|||||||++|||++|+.|| .+.++.+.+..+.+..+.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCCCChhh
Confidence 65322 2234579999999999987668999999999999999999999998 566777777777666542
Q ss_pred ---------------------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 349 ---------------------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 349 ---------------------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+...+++.+ |+..||+.|++++++|.||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~-mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK-LLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGSS
T ss_pred ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHH-HCcCChhHCcCHHHHHcChhhcc
Confidence 233345555 99999999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=386.49 Aligned_cols=281 Identities=24% Similarity=0.414 Sum_probs=212.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcC----CCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSK 204 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~----~~~ 204 (427)
++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+|+++ +||||++++++|... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence 6899999999999999999999999999999998632 235688999999999 999999999999754 346
Q ss_pred CcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 205 TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
.+|+||||+.++++......+++..++.+++||+.||+|||++||+||||||+|||++.++ .+|++|||+++.......
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~~ 174 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFM 174 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC---------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhhccccccc
Confidence 8899999999999988888999999999999999999999999999999999999999877 799999999987776666
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCCCh
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 364 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~dp 364 (427)
....++|+.|+|||++.+ ..++.++||||+||++|+|++|+.|| .+.++..++.++....+.+... ++. ...+
T Consensus 175 ~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~~~~~-~~~----~~~~ 247 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPE-FMK----KLQP 247 (355)
T ss_dssp ------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHH-HHT----TSCH
T ss_pred cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccCCCHH-HHH----Hhhh
Confidence 677789999999999987 68999999999999999999999998 6777788888888777654322 111 1223
Q ss_pred hHHHHHhHHhcCCchhhHHH-------hhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 365 HLAALVGRLVILSYFFQFVI-------YYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 365 ~~r~~~~~ll~~~~~~~~~~-------~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+................. ..........+.+.|+|++||. .||++|+|+..++.|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~-~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV-IDPAKRISVDDALQHPY 313 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC-SSTTTSCCHHHHHTSTT
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCc-CChhHCcCHHHHhcCcc
Confidence 33322222111110000000 0001122346778999999995 99999999999999998
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-50 Score=383.71 Aligned_cols=239 Identities=21% Similarity=0.350 Sum_probs=196.4
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCe-----EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|+++++||+|+||+||+|++..+++ .||+|.+... ....+.+|+.+|.++.+|||||++++++.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 35789999999999999999999876543 7999998542 235688999999998789999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC--------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP--------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 256 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~--------------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp 256 (427)
...+++||||+++|+|..++. .+++.+++.++.||+.||+|||++|||||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 556899999999999987652 378899999999999999999999999999999
Q ss_pred CceEEcCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 014307 257 HNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYG 332 (427)
Q Consensus 257 ~NILl~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~ 332 (427)
+|||++.++ .+||+|||+|+........ ....||+.|||||++.+ ..|+.++|||||||++|||++ |+.|| .+
T Consensus 193 ~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~~Pf-~~ 269 (325)
T d1rjba_ 193 RNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPY-PG 269 (325)
T ss_dssp GGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSS-TT
T ss_pred hccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCCCCC-CC
Confidence 999999777 8999999999876544332 24567899999999886 789999999999999999998 89898 45
Q ss_pred CCCHHHHHHHHHHh-C-------ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 333 HDNYDQLVKIAKVL-G-------TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 333 ~~~~~~l~~i~~~~-~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.+..+.+.++.+.- . ++.+.+++.+ |+..||..||++++++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~-cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQS-CWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH-HcCCChhHCcCHHHHHHH
Confidence 45545555544431 1 2445555555 999999999999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=375.15 Aligned_cols=244 Identities=31% Similarity=0.566 Sum_probs=211.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 208 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~l 208 (427)
++|+++++||+|+||+||+|+++.+++.||||+++.. ....+.+|+.+|+.+ +||||+++++++.+ ....++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~--~~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeecccccc--ccceeE
Confidence 5899999999999999999999999999999998642 246788999999999 99999999999987 456789
Q ss_pred EEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCC-c
Q 014307 209 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 284 (427)
Q Consensus 209 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~-~ 284 (427)
++|++.++++..+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++ .+||+|||.|+...... .
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCSC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCcc
Confidence 99999999876654 4689999999999999999999999999999999999999777 89999999998775443 3
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCC----------------
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---------------- 348 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~---------------- 348 (427)
.....+++.|+|||++.+...++.++|||||||++|||++|+.||+.+.+..+++..+....+.
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 3445677889999998875668999999999999999999999998888888888877766543
Q ss_pred -------------------hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 -------------------DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 -------------------~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+...+++.+ |+..||..|++++++|.||||+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~-mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQN-LLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHH-HSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccchhhhccccCCHHHHHHHHH-HccCChhHCcCHHHHhcChhhcCC
Confidence 234455655 999999999999999999999863
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=376.05 Aligned_cols=235 Identities=15% Similarity=0.320 Sum_probs=189.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
..++|++.++||+|+||+||+|++ +..||||+++. ...+.+.+|+.+|+++ +|||||++++++.+ ..+
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~---~~~ 78 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA---PQL 78 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS---SSC
T ss_pred ccccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec---cEE
Confidence 357899999999999999999975 34599999863 2346788999999999 99999999998753 457
Q ss_pred EEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 207 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
++||||+++|+|..++ ..+++..+..++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.....
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeecccc
Confidence 8999999999998765 3489999999999999999999999999999999999999777 8999999999766432
Q ss_pred C---cceeeccCccccccccccCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh-C---------
Q 014307 283 K---EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL-G--------- 347 (427)
Q Consensus 283 ~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~-~--------- 347 (427)
. ......||+.|||||++.+. ..|+.++|||||||++|||+||+.|| .+.++.+++....... .
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf-~~~~~~~~~~~~~~~~~~~p~~~~~~~ 236 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY-SNINNRDQIIFMVGRGYLSPDLSKVRS 236 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT-TTCCCHHHHHHHHHHTSCCCCGGGSCT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC-CCCChHHHHHHHHhcCCCCCcchhccc
Confidence 2 23456899999999998642 35899999999999999999999999 5556666655444331 1
Q ss_pred --ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 348 --TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 348 --~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
++.+.+++.+ |+..||..||++.+++.+
T Consensus 237 ~~~~~l~~li~~-cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 237 NCPKAMKRLMAE-CLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred cchHHHHHHHHH-HcCCCHhHCcCHHHHHHH
Confidence 2345555555 999999999998888763
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-49 Score=377.98 Aligned_cols=236 Identities=18% Similarity=0.317 Sum_probs=182.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCe---EEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++.+.||+|+||+||+|+++.+++ .||||.+... ..+.+.+|+.+|+++ +|||||+++|++.+ ...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~--~~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTK--STP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SSS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--CCE
Confidence 4679999999999999999999876654 6889987542 235689999999999 99999999999966 456
Q ss_pred cEEEEeecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
+++||||+.+|+|..++. .+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLED 180 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEccC
Confidence 899999999999977542 489999999999999999999999999999999999999777 899999999987654
Q ss_pred CCcc------eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 282 GKEY------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 282 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
.... ....||+.|+|||++.+ ..|+.++|||||||++|||+| |+.|| .+....+.+..+.+...
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~ 258 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPY-WDMTNQDVINAIEQDYRLPPPMDC 258 (299)
T ss_dssp ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCccc
Confidence 3322 12357888999999887 789999999999999999998 88888 55555566665554332
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+.+++.. |+..||..||++.+++.
T Consensus 259 ~~~l~~li~~-cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 259 PSALHQLMLD-CWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp CHHHHHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred hHHHHHHHHH-HcCCCHhHCcCHHHHHH
Confidence 2344454544 89999999998777654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=369.32 Aligned_cols=236 Identities=17% Similarity=0.295 Sum_probs=199.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc--ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|+++++||+|+||+||+|++ .+++.||||+++. ...+.+.+|+.+++++ +||||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~--~~~~~iv~ 78 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK--QRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECC--SSSEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEee--CCceEEEE
Confidence 36788999999999999999998 5788999999874 3457899999999999 99999999999976 46689999
Q ss_pred eecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc--
Q 014307 211 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (427)
Q Consensus 211 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-- 284 (427)
||+.+|++..+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCcee
Confidence 999999987663 3589999999999999999999999999999999999999777 899999999986654432
Q ss_pred ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 285 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 285 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.....+|..|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+....+.+... ++.+..++.
T Consensus 158 ~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence 234578899999999886 789999999999999999998 78888 55555666656655422 245656666
Q ss_pred hccCCCChhHHHHHhHHhcC
Q 014307 357 KYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~~ 376 (427)
+ |+..||..||++++++++
T Consensus 236 ~-cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 236 S-CWHEKADERPTFKILLSN 254 (258)
T ss_dssp H-TTCSSGGGSCCHHHHHHH
T ss_pred H-HccCCHhHCcCHHHHHHH
Confidence 6 999999999999998875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=372.51 Aligned_cols=235 Identities=18% Similarity=0.302 Sum_probs=193.7
Q ss_pred CCCCEEEEe-eeeecCCeeEEEEEEcC--CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 132 EQDDYEVVR-KVGRGKYSEVFEGVHCT--DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 132 ~~~~y~~~~-~LG~G~fg~V~~~~~~~--~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
..++|.+.+ +||+|+||+||+|.++. ++..||||+++.. ..+.+.+|+++|+++ +|||||++++++.. .
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~ 81 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---E 81 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---S
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc---C
Confidence 356788888 59999999999998754 4568999998642 235688999999999 99999999999864 3
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
.+++||||+++|+|..++ ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhccc
Confidence 478999999999998764 2489999999999999999999999999999999999999777 89999999998875
Q ss_pred CCCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------C
Q 014307 281 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------T 348 (427)
Q Consensus 281 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~ 348 (427)
..... ....||+.|+|||++.+ ..++.++|||||||++|||+| |+.|| .+....+.+..+.+... +
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~ 238 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPY-KKMKGPEVMAFIEQGKRMECPPECP 238 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTT-TTCCTHHHHHHHHTTCCCCCCTTCC
T ss_pred ccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCCCCCCCcCC
Confidence 54332 23467889999999876 689999999999999999998 89998 55566666666655322 2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHh
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
+.+.+++.+ |+..||..||++.++.
T Consensus 239 ~~l~~li~~-cl~~~p~~RPs~~~i~ 263 (285)
T d1u59a_ 239 PELYALMSD-CWIYKWEDRPDFLTVE 263 (285)
T ss_dssp HHHHHHHHH-TTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHH-HcCCCHhHCcCHHHHH
Confidence 455555555 9999999999877764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-49 Score=383.41 Aligned_cols=276 Identities=26% Similarity=0.476 Sum_probs=203.9
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC--CCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--KTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~--~~~ 206 (427)
.++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|+++ +||||+++++++..... ...
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccce
Confidence 468999999999999999999999999999999997432 34678999999999 99999999999975432 123
Q ss_pred EEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 207 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
++++|++.+++|..++ ..+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCc
Confidence 4556677788887775 4799999999999999999999999999999999999999777 899999999987644322
Q ss_pred ----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccC
Q 014307 285 ----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 360 (427)
Q Consensus 285 ----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l 360 (427)
....+|++.|+|||++.....++.++||||+||++|||++|+.|| .+.+..++...+...+..+...... .
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~----~ 239 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLN----C 239 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHH----T
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhccCCChhhhh----h
Confidence 345679999999999866577899999999999999999999999 5666677777666665544322111 1
Q ss_pred CCChhHHHHHhHHhcC---CchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 361 ELDPHLAALVGRLVIL---SYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 361 ~~dp~~r~~~~~ll~~---~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
......+.....+... +|-. ........+.++|++||. .||+.|+|+..++.|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~s~~~~~li~~~L~-~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNR--------LFPNADSKALDLLDKMLT-FNPHKRIEVEQALAHPY 297 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHH--------HCTTSCHHHHHHHHHHSC-SSTTTSCCHHHHHTSGG
T ss_pred hhhhhhhcccccCCccCCCCHHH--------hCCCCCHHHHHHHHHHcc-CChhHCcCHHHHhcCHh
Confidence 1111111111111110 1100 011233456677777774 77777777777777776
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.6e-49 Score=369.42 Aligned_cols=236 Identities=22% Similarity=0.371 Sum_probs=187.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC--C
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--K 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~--~ 204 (427)
.++|++.+.||+|+||+||+|++..+|+.||||+++.. ....+.+|+.+|+.+ +||||+++++++...+. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCCc
Confidence 47899999999999999999999999999999998642 234688999999999 99999999999986433 3
Q ss_pred CcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 205 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
.+|+||||+.+++|.... ..+++.+++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.+.....
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC-
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhhcc
Confidence 578999999999987665 3699999999999999999999999999999999999999777 799999999876543
Q ss_pred CC----cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC----------
Q 014307 282 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---------- 347 (427)
Q Consensus 282 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~---------- 347 (427)
.. .....+||+.|+|||++.+ ..|+.++|||||||++|||+||+.|| .+.+..+.+.++.+.-.
T Consensus 164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 164 SGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ---------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred ccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCC-CCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 32 2345689999999999887 68999999999999999999999999 55566666655554321
Q ss_pred ChHHHHHHHhccCCCChhHHH-HHhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAA-LVGRL 373 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~-~~~~l 373 (427)
++.+.+++.+ |+..||..|| +++++
T Consensus 242 s~~l~~li~~-~L~~dp~~R~~sa~~l 267 (277)
T d1o6ya_ 242 SADLDAVVLK-ALAKNPENRYQTAAEM 267 (277)
T ss_dssp CHHHHHHHHH-HTCSSGGGSCSSHHHH
T ss_pred CHHHHHHHHH-HccCCHhHCHhHHHHH
Confidence 2344555555 7777777777 44444
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-49 Score=368.95 Aligned_cols=235 Identities=17% Similarity=0.297 Sum_probs=192.4
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
.++|++.++||+|+||+||+|+++. ++.||||+++.. ..+.+.+|+.+++++ +|||||++++++.+ ..+++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~---~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---SSCEEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEec---CCeEEEE
Confidence 4689999999999999999999854 467999999643 357799999999999 99999999999853 3478999
Q ss_pred eecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc-
Q 014307 211 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 284 (427)
Q Consensus 211 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~- 284 (427)
||+.+|++...+. .+++.++..++.||+.||+|||++||+||||||+||||+.++ .+||+|||+|+.......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhhccCCCce
Confidence 9999998876653 589999999999999999999999999999999999999777 899999999987644332
Q ss_pred -ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHH
Q 014307 285 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLN 356 (427)
Q Consensus 285 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~ 356 (427)
.....||+.|+|||++.+ +.++.++|||||||++|||++|+.||+.+....+.+..+.+... ++.+.+++.
T Consensus 170 ~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 248 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC 248 (285)
T ss_dssp ------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred eeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHH
Confidence 334578999999999986 78999999999999999999988888777666666666654432 245556555
Q ss_pred hccCCCChhHHHHHhHHhc
Q 014307 357 KYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 357 ~~~l~~dp~~r~~~~~ll~ 375 (427)
+ |+..||+.||++++++.
T Consensus 249 ~-cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 249 Q-CWRKEPEERPTFEYLQA 266 (285)
T ss_dssp H-HTCSSGGGSCCHHHHHH
T ss_pred H-HcccCHhHCcCHHHHHH
Confidence 5 99999999999998765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=378.89 Aligned_cols=277 Identities=25% Similarity=0.471 Sum_probs=211.7
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC---CC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~---~~ 204 (427)
.++|+++++||+|+||+||+|+++.+|+.||||+++.. ..+.+.+|+.+|+++ +|||||++++++.... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccC
Confidence 57899999999999999999999999999999998642 235678999999999 9999999999986432 23
Q ss_pred CcEEEEeecCCCchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCC
Q 014307 205 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 282 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~ 282 (427)
..++++||+.+++|..++ +++++.+++.++.||+.||+|||++||+||||||+|||++.++ .+|++|||+|... .
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~--~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHT--D 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----CC--T
T ss_pred ceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhccc--C
Confidence 446677888899998776 4699999999999999999999999999999999999999887 8999999999754 3
Q ss_pred CcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhCChHHHHHHHhccCCC
Q 014307 283 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 362 (427)
Q Consensus 283 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~~~~~~~~l~~~~l~~ 362 (427)
.......|++.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+.......+.+..+.+..... ....
T Consensus 173 ~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~----~~~~ 247 (348)
T d2gfsa1 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELL----KKIS 247 (348)
T ss_dssp GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHH----TTCC
T ss_pred cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChHHh----hhcc
Confidence 44556788999999999887667899999999999999999999998 677777888888777665432211 1112
Q ss_pred ChhHHHHHhHHhcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 363 DPHLAALVGRLVILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 363 dp~~r~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
....+.....+...+...-. ..+....+.+.|+|++||. .||++|+|+..++.|||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~s~~~~dli~~mL~-~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFA-----NVFIGANPLAVDLLEKMLV-LDSDKRITAAQALAHAY 303 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHH-----HHSTTCCHHHHHHHHHHSC-SSGGGSCCHHHHHTSGG
T ss_pred chhhhhhhhhcccCCCcchh-----hhcCCCCHHHHHHHHHHCc-CChhhCcCHHHHhcCHh
Confidence 22223332222222111100 0112345677788888884 88888888888888886
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=367.12 Aligned_cols=238 Identities=16% Similarity=0.276 Sum_probs=186.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCC----eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
..+.|++.+.||+|+||+||+|.++.++ ..||||+++.. ....+.+|+.+|+++ +|||||+++|++.+ .
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~--~ 81 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--Y 81 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEec--C
Confidence 3467999999999999999999987655 47999998642 234688999999999 99999999999976 4
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
..+++||||+.++++.... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++ .+||+|||+|+..
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL 160 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhcc
Confidence 5688999999999876654 4689999999999999999999999999999999999999877 8999999999876
Q ss_pred cCCCc----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------C
Q 014307 280 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------T 348 (427)
Q Consensus 280 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~ 348 (427)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|..||+......+.+..+.+... +
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239 (283)
T ss_dssp -------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred cCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence 54322 223467889999999887 78999999999999999999988887666655555555544322 1
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+.+++.. |+..||..||++.+++.
T Consensus 240 ~~l~~li~~-cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 240 SAIYQLMMQ-CWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHHH-HTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHH-HCcCCHhHCcCHHHHHH
Confidence 334444444 99999999998877654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=367.19 Aligned_cols=231 Identities=18% Similarity=0.304 Sum_probs=187.1
Q ss_pred EEEE-eeeeecCCeeEEEEEEcC--CCeEEEEEEeccc-----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcE
Q 014307 136 YEVV-RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 207 (427)
Q Consensus 136 y~~~-~~LG~G~fg~V~~~~~~~--~~~~vavK~~~~~-----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~ 207 (427)
+.+. ++||+|+||+||+|.+.. +++.||||+++.. ..+.+.+|+++|+++ +|||||++++++.. ...+
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~---~~~~ 83 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA---ESWM 83 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEES---SSEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEecc---CCEE
Confidence 3443 479999999999998653 4578999998642 235689999999999 99999999999864 3468
Q ss_pred EEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc
Q 014307 208 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 284 (427)
Q Consensus 208 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~ 284 (427)
+||||+++|+|..++ ..+++.++..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.......
T Consensus 84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCS
T ss_pred EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhcccccc
Confidence 999999999998765 3599999999999999999999999999999999999999777 899999999987654432
Q ss_pred c----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHH
Q 014307 285 Y----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELN 352 (427)
Q Consensus 285 ~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~ 352 (427)
. ....||+.|+|||++.+ ..++.++|||||||++|||++ |+.|| .+.+..+....+.+... ++.+.
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf-~~~~~~~~~~~i~~~~~~~~p~~~~~~~~ 240 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPY-RGMKGSEVTAMLEKGERMGCPAGCPREMY 240 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCC-CCCCHHHHHHHHHcCCCCCCCcccCHHHH
Confidence 2 23468889999999876 679999999999999999998 89998 55555555555544321 24555
Q ss_pred HHHHhccCCCChhHHHHHhHHh
Q 014307 353 AYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 353 ~~l~~~~l~~dp~~r~~~~~ll 374 (427)
+++.. |+..||..||++.+++
T Consensus 241 ~li~~-cl~~dp~~RPs~~~i~ 261 (277)
T d1xbba_ 241 DLMNL-CWTYDVENRPGFAAVE 261 (277)
T ss_dssp HHHHH-HTCSSTTTSCCHHHHH
T ss_pred HHHHH-HcCCCHhHCcCHHHHH
Confidence 55555 9999999999998874
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=367.75 Aligned_cols=240 Identities=19% Similarity=0.306 Sum_probs=188.5
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|+++++||+|+||+||+|++.. +++.||||+++.. ..+.+.+|..++.++.+|+||+.+++++... .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-G 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-T
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-C
Confidence 4789999999999999999999754 3478999998642 2356778899999987899999999988654 4
Q ss_pred CCcEEEEeecCCCchhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC
Q 014307 204 KTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 264 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~ 264 (427)
..+++||||+++|+|..++. .+++.++..++.||+.||.|||++|||||||||+|||++.+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~ 170 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 170 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence 56899999999999987752 37889999999999999999999999999999999999977
Q ss_pred CCeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHH
Q 014307 265 QRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 341 (427)
Q Consensus 265 ~~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~ 341 (427)
+ .+||+|||+|+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|++.+....+.+..
T Consensus 171 ~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 171 N-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp G-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred C-cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 7 899999999986644332 234578999999999987 78999999999999999999976544455554454444
Q ss_pred HHHH-h-------CChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 342 IAKV-L-------GTDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 342 i~~~-~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
+.+. . -++.+.+++.+ |+..||..||++.++++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~-cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLD-CWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHH-HcCCChhHCcCHHHHHHH
Confidence 4332 1 13456666666 999999999999988764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=361.29 Aligned_cols=236 Identities=22% Similarity=0.376 Sum_probs=184.3
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCC---eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 205 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~ 205 (427)
.++|++++.||+|+||+||+|++..++ ..||||.++.. ..+.+.+|+.+|+++ +|||||++++++.+ ..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---NP 81 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS---SS
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec---Ce
Confidence 478999999999999999999986543 57899988642 235688999999999 99999999999853 46
Q ss_pred cEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecC
Q 014307 206 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 281 (427)
Q Consensus 206 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~ 281 (427)
+++||||+.++++..+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMED 160 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC---------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheeccC
Confidence 89999999999987653 3589999999999999999999999999999999999999777 899999999987654
Q ss_pred CCc--ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHH
Q 014307 282 GKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDEL 351 (427)
Q Consensus 282 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~ 351 (427)
... .....||+.|+|||++.+ ..|+.++|||||||++|||++ |..|| .+....+.+..+.+... ++.+
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 238 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGERLPMPPNCPPTL 238 (273)
T ss_dssp ----------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred CcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 332 234567889999999886 789999999999999999998 77777 55566666666554322 2455
Q ss_pred HHHHHhccCCCChhHHHHHhHHhcC
Q 014307 352 NAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 352 ~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.+++.+ |+..||..||++.+++.+
T Consensus 239 ~~li~~-cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 239 YSLMTK-CWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHHH-HcCCCHhHCcCHHHHHHH
Confidence 555555 999999999999988764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=366.31 Aligned_cols=236 Identities=19% Similarity=0.326 Sum_probs=190.2
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCe----EEEEEEecc----ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 204 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~----~vavK~~~~----~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~ 204 (427)
.++|++++.||+|+||+||+|++..+|+ +||+|.++. ...+.+.+|+.+|+++ +|||||++++++.+.
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS---
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC---
Confidence 4679999999999999999999987776 588888753 2346789999999999 999999999999753
Q ss_pred CcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 205 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 205 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++++|++.++++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceecc
Confidence 467889999998876543 3589999999999999999999999999999999999999777 89999999998765
Q ss_pred CCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------Ch
Q 014307 281 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TD 349 (427)
Q Consensus 281 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~ 349 (427)
.... .....||+.|+|||++.+ +.|+.++|||||||++|||+| |..|| .+.+..+....+.+... ++
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~-~~~~~~~~~~~i~~~~~~~~p~~~~~ 240 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKGERLPQPPICTI 240 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCGGGHHHHHHHTCCCCCCTTBCH
T ss_pred cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 4332 233468899999999887 689999999999999999999 66666 55555554444544322 23
Q ss_pred HHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 350 ELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 350 ~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
.+..++.+ |+..||..||++.+++.+
T Consensus 241 ~~~~li~~-cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 241 DVYMIMVK-CWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHH-hCCCChhhCcCHHHHHHH
Confidence 45555555 999999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=367.93 Aligned_cols=245 Identities=19% Similarity=0.364 Sum_probs=200.3
Q ss_pred CCEEEEeeeeecCCeeEEEEEEc---CCCeEEEEEEeccc-------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vavK~~~~~-------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
++|+++++||+|+||+||+|++. .+|+.||||+++.. ..+.+.+|+++|+++.+||||+++++++.+ .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--~ 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--E 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--T
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--C
Confidence 67999999999999999999873 46899999998642 235678999999999666999999999987 4
Q ss_pred CCcEEEEeecCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeec
Q 014307 204 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 280 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~ 280 (427)
..++++|||+.+++|...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFV 180 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECC
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhhhc
Confidence 5789999999999997765 4688999999999999999999999999999999999999877 89999999998764
Q ss_pred CCC--cceeeccCccccccccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHh----------C
Q 014307 281 PGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL----------G 347 (427)
Q Consensus 281 ~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~----------~ 347 (427)
... ......|++.|+|||.+.+. ..++.++|||||||+||||++|+.||.. ....+....+.+.. .
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~-~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRILKSEPPYPQEM 259 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC-TTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHHhcccCCCCCcccC
Confidence 332 23456899999999998653 2578899999999999999999999943 33333333232221 2
Q ss_pred ChHHHHHHHhccCCCChhHHH-----HHhHHhcCCchhhHH
Q 014307 348 TDELNAYLNKYHIELDPHLAA-----LVGRLVILSYFFQFV 383 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~-----~~~~ll~~~~~~~~~ 383 (427)
++.+..++.+ |+..||..|+ +++++++||||++..
T Consensus 260 s~~~~~li~~-~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 260 SALAKDLIQR-LLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp CHHHHHHHHH-HTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CHHHHHHHHH-HcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 3456666666 9999999998 589999999998744
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-47 Score=364.77 Aligned_cols=238 Identities=19% Similarity=0.284 Sum_probs=197.2
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|+++++||+|+||+||+|+++. +++.||||+++... .+.+.+|+.+|+++ +||||+++++++..
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~-- 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV-- 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceeeecc--
Confidence 45789999999999999999999753 46789999986432 45689999999999 99999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccC
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 255 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk 255 (427)
....+++|||+.+++|..++. .+++..+..++.||+.||+|||++||||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 567889999999999877652 37888999999999999999999999999999
Q ss_pred CCceEEcCCCCeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 014307 256 PHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 332 (427)
Q Consensus 256 p~NILl~~~~~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~ 332 (427)
|+|||++.++ .+||+|||+|+....... .....+++.|+|||.+.+ ..|+.++|||||||++|||++|..|++.+
T Consensus 168 p~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 168 TRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp GGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 9999999877 899999999976543322 234578889999999987 78999999999999999999997665577
Q ss_pred CCCHHHHHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 333 HDNYDQLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 333 ~~~~~~l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
.++.+.+..+.+... ++++.+++.. |+..+|..||++.+++.
T Consensus 246 ~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~-cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 246 MAHEEVIYYVRDGNILACPENCPLELYNLMRL-CWSKLPADRPSFCSIHR 294 (301)
T ss_dssp SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCCccchHHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 777777766654422 2455555555 99999999999888743
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=367.46 Aligned_cols=239 Identities=18% Similarity=0.279 Sum_probs=197.0
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeE--EEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCc
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~--vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~ 206 (427)
-++|++.++||+|+||+||+|+++.++.. ||||.++.. ..+.+.+|+++|.++.+|||||++++++.+ ...+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--CCee
Confidence 36899999999999999999999888874 677777532 234689999999998679999999999986 5678
Q ss_pred EEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCe
Q 014307 207 SLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 267 (427)
Q Consensus 207 ~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ 267 (427)
++||||+.+|+|..++ ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~-~ 165 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-V 165 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-C
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-c
Confidence 9999999999998775 3589999999999999999999999999999999999999877 8
Q ss_pred EEEEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC
Q 014307 268 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347 (427)
Q Consensus 268 ikl~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~ 347 (427)
+||+|||+|+............||..|+|||.+.+ ..|+.++|||||||++|||++|..|++.+.+..+.+..+.+...
T Consensus 166 ~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~ 244 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244 (309)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred eEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC
Confidence 99999999986654444455678999999999976 78999999999999999999987766566666665555544321
Q ss_pred -------ChHHHHHHHhccCCCChhHHHHHhHHhcC
Q 014307 348 -------TDELNAYLNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 348 -------~~~~~~~l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
++.+..++.+ |+..||+.||++.+++.+
T Consensus 245 ~~~~~~~~~~~~~li~~-cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 245 LEKPLNCDDEVYDLMRQ-CWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCTTBCHHHHHHHHH-HTCSSGGGSCCHHHHHHH
T ss_pred CCCCccCCHHHHHHHHH-HcCCChhHCcCHHHHHHH
Confidence 2456666666 999999999999998864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=357.30 Aligned_cols=239 Identities=21% Similarity=0.341 Sum_probs=198.9
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEc-----CCCeEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCC
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 202 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~ 202 (427)
..++|+++++||+|+||.||+|++. .+++.||||+++.. ....+.+|+.+++++.+|||||++++++.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 3478999999999999999999864 45679999999753 235688999999999779999999999976
Q ss_pred CCCcEEEEeecCCCchhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE
Q 014307 203 SKTPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (427)
Q Consensus 203 ~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 261 (427)
...+++||||+.++++..++. .+++.++..++.||+.||+|||++|||||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 456899999999999877652 48899999999999999999999999999999999999
Q ss_pred cCCCCeEEEEeeeeeeeecCCCcc---eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHH
Q 014307 262 DHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 338 (427)
Q Consensus 262 ~~~~~~ikl~DFGla~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~ 338 (427)
+.++ .+||+|||+++........ ....||+.|+|||++.+ ..++.++|||||||++|||+|++.||+.+....+.
T Consensus 179 ~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 179 THGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp ETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9777 8999999999876544332 33578999999999886 78999999999999999999966676677666666
Q ss_pred HHHHHHH-h-------CChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 339 LVKIAKV-L-------GTDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 339 l~~i~~~-~-------~~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.++.+. . -++.+..++.+ |+..||..||++.+++.
T Consensus 257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~-cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 257 FYKMIKEGFRMLSPEHAPAEMYDIMKT-CWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHTCCCCCCTTSCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCCCCCCcccccHHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 6655543 1 12455566655 99999999999988875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=355.58 Aligned_cols=234 Identities=19% Similarity=0.294 Sum_probs=185.1
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCC-C--eEEEEEEeccc------cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTD-N--EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~-~--~~vavK~~~~~------~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|++.+.||+|+||+||+|++... + ..||||++++. ..+.+.+|+.+|+++ +||||+++++++.+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~--- 82 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT--- 82 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee---
Confidence 46799999999999999999986533 2 47899998642 235689999999999 99999999999964
Q ss_pred CCcEEEEeecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 204 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
..+++||||+.++++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRAL 161 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhc
Confidence 3578999999999876554 3599999999999999999999999999999999999999877 8999999999877
Q ss_pred cCCCcc----eeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------
Q 014307 280 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG------- 347 (427)
Q Consensus 280 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~------- 347 (427)
...... ....++..|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+.+..+.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~ 239 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPED 239 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTSCCCCCCCTT
T ss_pred ccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHHhCCCCCCCccc
Confidence 544332 23357778999999987 789999999999999999998 89888 66666666666654311
Q ss_pred -ChHHHHHHHhccCCCChhHHHHHhHHh
Q 014307 348 -TDELNAYLNKYHIELDPHLAALVGRLV 374 (427)
Q Consensus 348 -~~~~~~~l~~~~l~~dp~~r~~~~~ll 374 (427)
++.+.+++.+ |+..||..||++.+++
T Consensus 240 ~~~~l~~li~~-cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 240 CPQDIYNVMVQ-CWAHKPEDRPTFVALR 266 (273)
T ss_dssp CCHHHHHHHHH-HTCSSGGGSCCHHHHH
T ss_pred ccHHHHHHHHH-HcCCChhHCcCHHHHH
Confidence 2455555555 9999999999988875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=355.98 Aligned_cols=238 Identities=20% Similarity=0.318 Sum_probs=189.5
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCC-------eEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEc
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 200 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~ 200 (427)
..++|++++.||+|+||.||+|++..++ ..||||+++... ...+.+|...+.++.+|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 3478999999999999999999976554 479999986432 35678899999998789999999999976
Q ss_pred CCCCCcEEEEeecCCCchhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEE
Q 014307 201 QQSKTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 261 (427)
Q Consensus 201 ~~~~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl 261 (427)
...+++||||+.+|++..++ ..+++.+++.++.||+.||+|||++|||||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 56789999999999998776 247999999999999999999999999999999999999
Q ss_pred cCCCCeEEEEeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHH
Q 014307 262 DHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYD 337 (427)
Q Consensus 262 ~~~~~~ikl~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~ 337 (427)
+.++ .+||+|||+++....... .....+++.|+|||++.+ +.|+.++|||||||++|||++ |..|| .+.+..+
T Consensus 169 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~-~~~~~~~ 245 (299)
T d1fgka_ 169 TEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY-PGVPVEE 245 (299)
T ss_dssp CTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHH
T ss_pred cCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCC-CCCCHHH
Confidence 9877 899999999987654432 234578889999999987 789999999999999999998 56665 5544444
Q ss_pred HHHHHHHHhC-------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 338 QLVKIAKVLG-------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 338 ~l~~i~~~~~-------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
....+.+... ++.+.+++.+ |+..||..||++.+++.
T Consensus 246 ~~~~i~~~~~~~~p~~~~~~l~~li~~-cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 246 LFKLLKEGHRMDKPSNCTNELYMMMRD-CWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCCCCCCccchHHHHHHHHH-HccCCHhHCcCHHHHHH
Confidence 4444433221 2455665555 99999999999888866
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=350.57 Aligned_cols=233 Identities=16% Similarity=0.312 Sum_probs=185.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~-~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|+++++||+|+||.||+|++ .|+.||||+++... .+.+.+|+++++++ +||||++++|++.+. ...+++|||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~e 81 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE 81 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---CCEEEEC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEec-CCcEEEEEe
Confidence 46799999999999999999997 57899999997543 46799999999999 999999999998653 345799999
Q ss_pred ecCCCchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCcce
Q 014307 212 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 286 (427)
Q Consensus 212 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~~~ 286 (427)
|+.+|+|..++. .+++..++.++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+++.... ...
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~--~~~ 158 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASS--TQD 158 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------
T ss_pred ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecCC--CCc
Confidence 999999987753 389999999999999999999999999999999999999877 899999999986543 234
Q ss_pred eeccCccccccccccCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHHHHhc
Q 014307 287 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG-------TDELNAYLNKY 358 (427)
Q Consensus 287 ~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~ellt-g~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~l~~~ 358 (427)
...++..|+|||++.+ ..++.++|||||||++|||+| |+.|| ...+..+....+.+... ++.+.+++.+
T Consensus 159 ~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~- 235 (262)
T d1byga_ 159 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN- 235 (262)
T ss_dssp ---CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSC-TTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH-
T ss_pred cccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH-
Confidence 4577889999999887 689999999999999999998 56665 55555555555543211 2455555555
Q ss_pred cCCCChhHHHHHhHHhc
Q 014307 359 HIELDPHLAALVGRLVI 375 (427)
Q Consensus 359 ~l~~dp~~r~~~~~ll~ 375 (427)
|+..||..||++.++++
T Consensus 236 cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 236 CWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HcccCHhHCcCHHHHHH
Confidence 99999999999888765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-46 Score=354.29 Aligned_cols=237 Identities=18% Similarity=0.294 Sum_probs=196.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcC-----CCeEEEEEEecccc----HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCC
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 203 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vavK~~~~~~----~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~ 203 (427)
.++|+++++||+|+||+||+|.++. +++.||||+++... ...+.+|+.+++++ +||||+++++++.. .
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~--~ 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ--G 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS--S
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEec--C
Confidence 4789999999999999999998753 35789999997422 24578999999999 89999999999965 4
Q ss_pred CCcEEEEeecCCCchhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEE
Q 014307 204 KTPSLIFEHVNNTDFKVLY-------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 270 (427)
Q Consensus 204 ~~~~lv~e~~~~~~l~~~~-------------~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl 270 (427)
...++||||+.+|++..++ ..+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~-~~Kl 174 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKI 174 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc-eEEE
Confidence 5689999999999987764 2368888999999999999999999999999999999999776 8999
Q ss_pred EeeeeeeeecCCCc---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC
Q 014307 271 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 347 (427)
Q Consensus 271 ~DFGla~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~ 347 (427)
+|||+|+....... .....+++.|+|||.+.+ ..++.++|||||||++|||+||..|++.+.+..+.+..+.+...
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~ 253 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 253 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999986543322 233468899999999887 78999999999999999999997555577776666666655322
Q ss_pred -------ChHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 348 -------TDELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 348 -------~~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
++.+.+++.+ |+..+|..||++.+++.
T Consensus 254 ~~~p~~~~~~l~~li~~-cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 254 LDKPDNCPDMLFELMRM-CWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCCCTTCCHHHHHHHHH-HTCSSGGGSCCHHHHHH
T ss_pred CCCcccchHHHHHHHHH-HcCCChhHCcCHHHHHH
Confidence 2456666666 99999999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=351.74 Aligned_cols=234 Identities=20% Similarity=0.328 Sum_probs=187.3
Q ss_pred EEeeeeecCCeeEEEEEEcCCC---eEEEEEEeccc----cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 138 VVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 138 ~~~~LG~G~fg~V~~~~~~~~~---~~vavK~~~~~----~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
..++||+|+||+||+|++..++ ..||||.++.. ..+.+.+|+++|+++ +||||++++|++... ....++||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~-~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRS-EGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEET-TTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEec-CCceEEEE
Confidence 3578999999999999986543 36899998642 236689999999999 999999999998653 45688999
Q ss_pred eecCCCchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeeeeeeeecCCCc--
Q 014307 211 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 284 (427)
Q Consensus 211 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~~~~~~-- 284 (427)
||+.++++..+.. ..++..+..++.|++.||.|||+.+|+||||||+|||++.++ .+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTTCCC
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhcccccccc
Confidence 9999999987653 467888999999999999999999999999999999999766 899999999987644322
Q ss_pred ---ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHhC-------ChHHHHH
Q 014307 285 ---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------TDELNAY 354 (427)
Q Consensus 285 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~~i~~~~~-------~~~~~~~ 354 (427)
.....||..|+|||++.+ ..++.++|||||||++|||++|+.||+...+..+....+.+... ++.+.++
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 223467889999999876 68999999999999999999999998766555555555443321 2456666
Q ss_pred HHhccCCCChhHHHHHhHHhcC
Q 014307 355 LNKYHIELDPHLAALVGRLVIL 376 (427)
Q Consensus 355 l~~~~l~~dp~~r~~~~~ll~~ 376 (427)
+.. |+..||..||++.+++++
T Consensus 267 i~~-cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLK-CWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHH-HTCSSGGGSCCHHHHHHH
T ss_pred HHH-HcCCCHhHCcCHHHHHHH
Confidence 666 999999999999998864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-45 Score=347.98 Aligned_cols=234 Identities=21% Similarity=0.286 Sum_probs=179.2
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEee
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 212 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e~ 212 (427)
++|++++.||+|+||+||+|++..+|+.||||++... ..+.+.+|+++++.+.+|++|+.+.+++.+ ....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~--~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE--TTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec--CCEEEEEEEE
Confidence 6799999999999999999999999999999998643 335688999999999444445555555544 5567899999
Q ss_pred cCCCchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcC--CCCeEEEEeeeeeeeecCCCc---
Q 014307 213 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKE--- 284 (427)
Q Consensus 213 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~--~~~~ikl~DFGla~~~~~~~~--- 284 (427)
+.++...... ..+++..+..++.|++.||+|||++||+||||||+|||++. .+..+||+|||+|+.+.....
T Consensus 85 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~ 164 (299)
T d1ckia_ 85 LGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH 164 (299)
T ss_dssp CCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred cCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence 9776654433 46999999999999999999999999999999999999864 233799999999998754332
Q ss_pred -----ceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCHHHHH---HHHHH----------h
Q 014307 285 -----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV---KIAKV----------L 346 (427)
Q Consensus 285 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~~~~~~l~---~i~~~----------~ 346 (427)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ...+... +.... .
T Consensus 165 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ckia_ 165 IPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGL-KAATKRQKYERISEKKMSTPIEVLCK 242 (299)
T ss_dssp CCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCC-C-------HHHHHHHHHHSCHHHHTT
T ss_pred eeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCccccc-chHHHHHHHHHhhcccCCCChhHhcc
Confidence 234579999999999887 68999999999999999999999999533 2222211 11111 0
Q ss_pred C-ChHHHHHHHhccCCCChhHHHHHhH
Q 014307 347 G-TDELNAYLNKYHIELDPHLAALVGR 372 (427)
Q Consensus 347 ~-~~~~~~~l~~~~l~~dp~~r~~~~~ 372 (427)
+ ++.+.+++.. |+..+|+.||+..+
T Consensus 243 ~~p~~~~~li~~-cl~~~p~~RP~~~~ 268 (299)
T d1ckia_ 243 GYPSEFATYLNF-CRSLRFDDKPDYSY 268 (299)
T ss_dssp TSCHHHHHHHHH-HHHSCTTCCCCHHH
T ss_pred CCCHHHHHHHHH-HccCChhHCcCHHH
Confidence 1 2344455544 88888888876554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.3e-44 Score=337.88 Aligned_cols=194 Identities=20% Similarity=0.347 Sum_probs=166.8
Q ss_pred CCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEEe
Q 014307 133 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 211 (427)
Q Consensus 133 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~e 211 (427)
.++|+++++||+|+||+||+|+++.+|+.||||+++. .....+.+|+++++.+.+|+|++.+++++.. ....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEE
Confidence 3689999999999999999999999999999999854 3345678999999999777999999999876 567889999
Q ss_pred ecCCCchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCC----CCeEEEEeeeeeeeecCCC
Q 014307 212 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGK 283 (427)
Q Consensus 212 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~----~~~ikl~DFGla~~~~~~~ 283 (427)
|+. ++|.... ..++...+..++.|++.||+|||++||+||||||+|||++.+ ...+||+|||+|+.+....
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 82 LLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 995 4544443 358999999999999999999999999999999999999742 3379999999998765432
Q ss_pred --------cceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 014307 284 --------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 330 (427)
Q Consensus 284 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~ 330 (427)
.....+||+.|||||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 2234579999999999987 789999999999999999999999994
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=342.42 Aligned_cols=237 Identities=17% Similarity=0.209 Sum_probs=184.1
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHH--HHhcCCCCeeeeeeEEEcCCC--CCcEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKIL--QNLCGGPNIVKLLDIVRDQQS--KTPSLI 209 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il--~~l~~h~niv~l~~~~~~~~~--~~~~lv 209 (427)
.+|.+.++||+|+||+||+|++ +|+.||||+++........+|.+++ ..+ +||||+++++++.+.+. ..+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEEE
Confidence 4688999999999999999986 6899999999876666666665554 456 89999999999986533 357899
Q ss_pred EeecCCCchhhhcC--CCCHHHHHHHHHHHHHHHHHHHH--------CCceeeccCCCceEEcCCCCeEEEEeeeeeeee
Q 014307 210 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 279 (427)
Q Consensus 210 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~--------~~iiHrDlkp~NILl~~~~~~ikl~DFGla~~~ 279 (427)
|||+.+++|..++. .+++..+..++.|++.||.|||+ +||+||||||+||||+.++ .+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCccccc
Confidence 99999999988775 68899999999999999999996 5999999999999999777 8999999999877
Q ss_pred cCCCc-----ceeeccCccccccccccCCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCC-------------CCH
Q 014307 280 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFRKEPFFYGH-------------DNY 336 (427)
Q Consensus 280 ~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwSlGvll~elltg~~pf~~~~-------------~~~ 336 (427)
..... .....||+.|+|||++.+.. .++.++|||||||+||||+||..||.... ...
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 55432 23468999999999986522 25778999999999999999987763211 122
Q ss_pred HHHHHHHHHhCC--------------hHHHHHHHhccCCCChhHHHHHhHHhc
Q 014307 337 DQLVKIAKVLGT--------------DELNAYLNKYHIELDPHLAALVGRLVI 375 (427)
Q Consensus 337 ~~l~~i~~~~~~--------------~~~~~~l~~~~l~~dp~~r~~~~~ll~ 375 (427)
+.+......-+. ..+.+++.+ |+..||..||++.+++.
T Consensus 239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~-cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE-CWYANGAARLTALRIKK 290 (303)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHT-TCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHH-HcccCHhHCcCHHHHHH
Confidence 222222211010 124444444 99999999999888765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-43 Score=345.39 Aligned_cols=281 Identities=22% Similarity=0.345 Sum_probs=207.7
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHHHhc----------CCCCeeeeeeEEEcC
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----------GGPNIVKLLDIVRDQ 201 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~il~~l~----------~h~niv~l~~~~~~~ 201 (427)
++|+++++||+|+||+||+|+++.+|+.||||+++... .+.+.+|+++|+.+. .|+||+++++++...
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 56999999999999999999999999999999997543 366788999998872 358999999998876
Q ss_pred CCCCcEEEEeecCCCchhhh------cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeeccCCCceEEcCCCC-----eEE
Q 014307 202 QSKTPSLIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR-----KLR 269 (427)
Q Consensus 202 ~~~~~~lv~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~-----~ik 269 (427)
.....+++++++........ ...+++..++.++.||+.||+|||+ .||+||||||+|||++.++. .+|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence 56667777777766543211 2468999999999999999999998 89999999999999986552 489
Q ss_pred EEeeeeeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CCHHHHHHHHH
Q 014307 270 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-----DNYDQLVKIAK 344 (427)
Q Consensus 270 l~DFGla~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvll~elltg~~pf~~~~-----~~~~~l~~i~~ 344 (427)
++|||.|.... ......+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||.... ...+.+..+..
T Consensus 173 l~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 173 IADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp ECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred Eeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 99999998653 33456789999999999887 789999999999999999999999995322 22345566666
Q ss_pred HhCChHHHHHHHhccCCCChhHHHHHhH--H------hcCCchhhHHHhhhhhhhhhhhhhHHHHHHhhhhcCchhhhhh
Q 014307 345 VLGTDELNAYLNKYHIELDPHLAALVGR--L------VILSYFFQFVIYYYYYYYFCLKTCNFLLRNFLVQAQPETMVKV 416 (427)
Q Consensus 345 ~~~~~~~~~~l~~~~l~~dp~~r~~~~~--l------l~~~~~~~~~~~~~~~~~~~~~~~~dllr~~l~~~~P~~r~~~ 416 (427)
.+|..+.... ... ......... . .....+.......+.+.....+.+.|+|++||. +||++|+|+
T Consensus 250 ~lg~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~-~dP~~Rpta 322 (362)
T d1q8ya_ 250 LLGELPSYLL-RNG-----KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ-LDPRKRADA 322 (362)
T ss_dssp HHCSCCHHHH-HHC-----TTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC-SSTTTCBCH
T ss_pred HhCCCCHHHh-hcc-----cccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC-CChhHCcCH
Confidence 6665332211 110 000000000 0 000111111111222334467889999999995 999999999
Q ss_pred ccccCCCC
Q 014307 417 HYCGESAF 424 (427)
Q Consensus 417 ~~~~~~~~ 424 (427)
..++.|||
T Consensus 323 ~e~L~Hp~ 330 (362)
T d1q8ya_ 323 GGLVNHPW 330 (362)
T ss_dssp HHHHTCGG
T ss_pred HHHhcCcc
Confidence 99999997
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.2e-26 Score=202.87 Aligned_cols=166 Identities=17% Similarity=0.209 Sum_probs=121.5
Q ss_pred EEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---------------------HHHHHHHHHHHHHhcCCCCeeee
Q 014307 136 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNIVKL 194 (427)
Q Consensus 136 y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---------------------~~~~~~E~~il~~l~~h~niv~l 194 (427)
+.+.++||+|+||+||+|++ .+|+.||||+++... .....+|..++.++ .|.+++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 35789999999999999998 578999999875311 12345688899998 88999988
Q ss_pred eeEEEcCCCCCcEEEEeecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeeccCCCceEEcCCCCeEEEEeee
Q 014307 195 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 274 (427)
Q Consensus 195 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~~ikl~DFG 274 (427)
+++. . .+++|||+++..+.. ++...+..++.|++.+|.|||++||+||||||+|||++.+ .++|+|||
T Consensus 80 ~~~~----~--~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG 147 (191)
T d1zara2 80 YAWE----G--NAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP 147 (191)
T ss_dssp EEEE----T--TEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred EEec----C--CEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence 8753 1 369999999877654 4556677899999999999999999999999999999954 58999999
Q ss_pred eeeeecCCCcceeeccCccccccccccCCCCCCchhhHHHHHHH
Q 014307 275 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCM 318 (427)
Q Consensus 275 la~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwSlGvl 318 (427)
+|................. ...+.+. +.|+.++|+||+.--
T Consensus 148 ~a~~~~~~~~~~~l~rd~~-~~~~~f~--r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 148 QSVEVGEEGWREILERDVR-NIITYFS--RTYRTEKDINSAIDR 188 (191)
T ss_dssp TCEETTSTTHHHHHHHHHH-HHHHHHH--HHHCCCCCHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHHH-HHHHHHc--CCCCCcccHHHHHHH
Confidence 9976543221110000000 0011111 468889999997643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.51 E-value=4.1e-07 Score=81.52 Aligned_cols=137 Identities=18% Similarity=0.241 Sum_probs=91.9
Q ss_pred CCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 134 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 134 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
..|++++..+.++.+.||+.. .+++.+++|+..... ...+.+|..++..+..+--+.+++.+... ....++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~--~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec--CCceEEEE
Confidence 356666766666667999875 567778889875432 34578899999988655556788887765 45678999
Q ss_pred eecCCCchhhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 014307 211 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS-------------------------------------------- 246 (427)
Q Consensus 211 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-------------------------------------------- 246 (427)
+++.|..+....... .....++.++...|..||+
T Consensus 90 ~~l~G~~~~~~~~~~--~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T d1j7la_ 90 SEADGVLCSEEYEDE--QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHTTTC--SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSH
T ss_pred Eeccccccccccccc--ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHH
Confidence 999998875443221 1112233333333343431
Q ss_pred ---------C------CceeeccCCCceEEcCCCCeEEEEeeeeee
Q 014307 247 ---------Q------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 277 (427)
Q Consensus 247 ---------~------~iiHrDlkp~NILl~~~~~~ikl~DFGla~ 277 (427)
. .++|+|+.|.|||++.++ .+-|+||+.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDwe~a~ 212 (263)
T d1j7la_ 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCE
T ss_pred HHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc-eEEEeechhcc
Confidence 1 268999999999998543 45699999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.15 E-value=6.9e-06 Score=72.82 Aligned_cols=75 Identities=17% Similarity=0.134 Sum_probs=53.9
Q ss_pred eeecC-CeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCC-CCeeeeeeEEEcCCCCCcEEEEeecCCCchh
Q 014307 142 VGRGK-YSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 219 (427)
Q Consensus 142 LG~G~-fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h-~niv~l~~~~~~~~~~~~~lv~e~~~~~~l~ 219 (427)
+..|. -+.||+... .++..+++|.........+..|...|+.+..+ -.+++++.+..+ ....++||++++|..+.
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~--~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE--AGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC--SSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc--ccceEEEEEeeeccccc
Confidence 44444 367898875 55677899988776666788999999888443 235677777655 45678999999987654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.98 E-value=1.8e-05 Score=75.13 Aligned_cols=75 Identities=15% Similarity=0.198 Sum_probs=49.5
Q ss_pred EeeeeecCCeeEEEEEEcCCCeEEEEEEecc----------ccHHHHHHHHHHHHHhcCC--CCeeeeeeEEEcCCCCCc
Q 014307 139 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP 206 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~----------~~~~~~~~E~~il~~l~~h--~niv~l~~~~~~~~~~~~ 206 (427)
.+.||.|....||++....+++.++||.-.+ ...++...|..+|+.+..+ ..+++++.+. ...-
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d----~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD----TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE----TTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc----CCCC
Confidence 4578999999999998777788899996432 1124466788888877443 3456666543 2335
Q ss_pred EEEEeecCCCc
Q 014307 207 SLIFEHVNNTD 217 (427)
Q Consensus 207 ~lv~e~~~~~~ 217 (427)
++|||++.+..
T Consensus 107 ~lvmE~L~~~~ 117 (392)
T d2pula1 107 VTVMEDLSHLK 117 (392)
T ss_dssp EEEECCCTTSE
T ss_pred EEEEeccCCcc
Confidence 68999998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.34 E-value=0.00036 Score=65.87 Aligned_cols=74 Identities=14% Similarity=0.144 Sum_probs=53.1
Q ss_pred EeeeeecCCeeEEEEEEcC-------CCeEEEEEEecc-ccHHHHHHHHHHHHHhcCCCCeeeeeeEEEcCCCCCcEEEE
Q 014307 139 VRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 210 (427)
Q Consensus 139 ~~~LG~G~fg~V~~~~~~~-------~~~~vavK~~~~-~~~~~~~~E~~il~~l~~h~niv~l~~~~~~~~~~~~~lv~ 210 (427)
++.|+.|---.+|++.... ..+.|.+++.-. .......+|..+++.+..+.-.+++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~------g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG------GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT------EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC------ceEE
Confidence 3678889999999998643 245678887642 2334466899999998666556788888732 4899
Q ss_pred eecCCCch
Q 014307 211 EHVNNTDF 218 (427)
Q Consensus 211 e~~~~~~l 218 (427)
||++|..+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99988544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.34 E-value=0.00013 Score=67.08 Aligned_cols=68 Identities=13% Similarity=0.245 Sum_probs=44.5
Q ss_pred CeeEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHHHhcCCC-Ceeeeee-----EEEcCCCCCcEEEEeecCCCc
Q 014307 147 YSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLLD-----IVRDQQSKTPSLIFEHVNNTD 217 (427)
Q Consensus 147 fg~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~il~~l~~h~-niv~l~~-----~~~~~~~~~~~lv~e~~~~~~ 217 (427)
--.||++.. .+|+.+++|+.++. ..+++..|...+..|..+. -++..+. .+. .....+.+++++.|..
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~--~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN--HQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE--ETTEEEEEEECCCCEE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeee--eeeEEEEEEeecCCcC
Confidence 358999975 57888999999864 4577889999998884321 1111111 111 1445678889888754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.72 E-value=0.00085 Score=60.92 Aligned_cols=50 Identities=12% Similarity=0.193 Sum_probs=33.1
Q ss_pred CEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccc-cHHHHHHHHHHHHHhc
Q 014307 135 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLC 186 (427)
Q Consensus 135 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~il~~l~ 186 (427)
...-.+.|..|---+.|+... ++..+++|+.... ..+.+..|+.++..|.
T Consensus 19 ~~~~~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 19 SLTSYKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp CEEEEEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred CceEeecCCCCcccCeEEEEE--CCCcEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence 445556677888889999875 3445899998653 4566778888888883
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=91.16 E-value=0.028 Score=50.73 Aligned_cols=32 Identities=19% Similarity=0.308 Sum_probs=27.7
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
++..+++.+ |+..||..|++++++|+||||+.
T Consensus 293 ~~~~dli~~-mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 293 PEALDFLDK-LLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp HHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHHH-HccCChhHCcCHHHHhcCcccCC
Confidence 455566666 99999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.66 E-value=0.027 Score=50.12 Aligned_cols=33 Identities=6% Similarity=-0.014 Sum_probs=29.6
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
...+++.|+|++||. .||++|+|+..++.|||=
T Consensus 251 ~~s~~~~dll~~~L~-~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 251 AAGDDLLDLIQGLFL-FNPCARITATQALKMKYF 283 (299)
T ss_dssp TCCHHHHHHHHHHHC-SSTTTSCCHHHHHTSGGG
T ss_pred cCCHHHHHHHHHHcc-CChhhCcCHHHHhCCHhh
Confidence 356789999999995 999999999999999983
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=90.42 E-value=0.029 Score=51.18 Aligned_cols=34 Identities=26% Similarity=0.440 Sum_probs=28.0
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+...+++.+ |+..||..||+++++|.||||++..
T Consensus 302 ~~~~dll~~-mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 302 KEISDFLSP-MLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHHHHGG-GGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHHHHHHH-HCCCChhHCcCHHHHhcCcccCCCC
Confidence 344555666 9999999999999999999999643
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.25 E-value=0.034 Score=50.87 Aligned_cols=32 Identities=19% Similarity=0.231 Sum_probs=27.5
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhh
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQ 381 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~ 381 (427)
+++.+++.+ |+..||+.||+++++|+||||++
T Consensus 285 ~~~~dll~~-mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 285 SQARDLLSK-MLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHHHHH-HSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHHHHH-HCcCChhHCcCHHHHhcCcccCC
Confidence 345566666 99999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=89.81 E-value=0.031 Score=49.36 Aligned_cols=32 Identities=19% Similarity=0.116 Sum_probs=29.1
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.|+|++||. .||++|+|+..++.|||
T Consensus 252 ~~s~~~~dli~~~L~-~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 252 GLDESGIDLLSKMLK-LDPNQRITAKQALEHAY 283 (286)
T ss_dssp SCCHHHHHHHHHHTC-SSTTTSCCHHHHHTSGG
T ss_pred cCCHHHHHHHHHHcc-CChhHCcCHHHHhcCcc
Confidence 456788999999995 99999999999999998
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.81 E-value=0.029 Score=49.92 Aligned_cols=32 Identities=13% Similarity=-0.003 Sum_probs=29.0
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.|+|++||. .||++|+|+..++.|||
T Consensus 264 ~~s~~~~dli~~mL~-~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 264 DIDELGKDLLLKCLT-FNPAKRISAYSALSHPY 295 (305)
T ss_dssp SCCHHHHHHHHHHSC-SSTTTSCCHHHHHTSGG
T ss_pred cCCHHHHHHHHHHCc-CChhHCcCHHHHhcChh
Confidence 346788999999995 99999999999999998
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.50 E-value=0.042 Score=48.42 Aligned_cols=32 Identities=19% Similarity=0.137 Sum_probs=28.6
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
..+.+.|+|++||. .||++|+|+..++.|||=
T Consensus 255 ~s~~~~dll~~mL~-~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 255 LNATGRDLLQNLLK-CNPVQRISAEEALQHPYF 286 (292)
T ss_dssp CCHHHHHHHHHHSC-SSGGGSCCHHHHTTSGGG
T ss_pred CCHHHHHHHHHHcc-CChhHCcCHHHHhcChhh
Confidence 35678999999995 999999999999999983
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.40 E-value=0.033 Score=49.96 Aligned_cols=30 Identities=17% Similarity=0.141 Sum_probs=27.7
Q ss_pred hhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 394 LKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 394 ~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
.+.+.|+|++||. .||++|+|+..+++|||
T Consensus 278 ~~~~~dLl~~mL~-~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 278 DPYALDLIDKLLV-LDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CHHHHHHHHHHSC-SSTTTSCCHHHHHHSGG
T ss_pred CHHHHHHHHHHCc-CChhHCcCHHHHHcChh
Confidence 5678899999995 99999999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.87 E-value=0.055 Score=49.02 Aligned_cols=34 Identities=21% Similarity=0.267 Sum_probs=28.5
Q ss_pred ChHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 348 TDELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 348 ~~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
++...+++.+ |+..||..|+++.++|+||||.+.
T Consensus 274 s~~~~dli~~-mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 274 NPLAVDLLEK-MLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHHHHHH-HSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CHHHHHHHHH-HCcCChhhCcCHHHHhcCHhhCCC
Confidence 3455566666 999999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.81 E-value=0.049 Score=48.33 Aligned_cols=33 Identities=12% Similarity=0.262 Sum_probs=28.2
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+++.+++.+ |+..||..||++++++.||||++.
T Consensus 257 ~~~~dll~~-mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 257 EDGRSLLSQ-MLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHHHHH-HTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHH-HccCChhHCcCHHHHhCCHhhccC
Confidence 455666666 999999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.32 E-value=0.08 Score=46.09 Aligned_cols=31 Identities=13% Similarity=0.128 Sum_probs=28.8
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+.+.++|++||. .||++|+|+..+++|||
T Consensus 227 ~s~~~~~li~~~L~-~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 227 VTEGARDLISRLLK-HNPSQRPMLREVLEHPW 257 (263)
T ss_dssp SCHHHHHHHHHHTC-SSGGGSCCHHHHHTCHH
T ss_pred CCHHHHHHHHHHcc-CCHhHCcCHHHHHcCcC
Confidence 56789999999995 99999999999999998
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.18 E-value=0.054 Score=49.17 Aligned_cols=33 Identities=21% Similarity=0.254 Sum_probs=27.9
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQF 382 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~ 382 (427)
+...+++.+ |+..||..||++.++|.||||+..
T Consensus 275 ~~~~dli~~-mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 275 PLAVNLLEK-MLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHHHHHH-HSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHHHHH-HCcCChhHCcCHHHHhcChhhCcC
Confidence 455566666 999999999999999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.93 E-value=0.12 Score=45.01 Aligned_cols=31 Identities=13% Similarity=0.012 Sum_probs=28.8
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+.+.++|++||. .||+.|+++..+++|||
T Consensus 238 ~s~~l~~li~~~L~-~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 238 YSDELNEIITRMLN-LKDYHRPSVEEILENPL 268 (269)
T ss_dssp SCHHHHHHHHHHTC-SSGGGSCCHHHHHTSTT
T ss_pred cCHHHHHHHHHHcC-CChhHCcCHHHHHhCCc
Confidence 56789999999995 99999999999999998
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=87.48 E-value=0.14 Score=46.61 Aligned_cols=33 Identities=21% Similarity=0.263 Sum_probs=29.6
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
...+.+.++|++||. .||++|+|+..+++|||=
T Consensus 251 ~~s~~~~~li~~~L~-~dP~~R~t~~eil~hp~~ 283 (350)
T d1koaa2 251 GISEDGKDFIRKLLL-ADPNTRMTIHQALEHPWL 283 (350)
T ss_dssp GCCHHHHHHHHHHCC-SSGGGSCCHHHHHHSTTT
T ss_pred CCCHHHHHHHHHHcc-CChhHCcCHHHHhcCccc
Confidence 356789999999995 999999999999999983
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.39 E-value=0.059 Score=49.05 Aligned_cols=31 Identities=13% Similarity=0.053 Sum_probs=28.5
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+++.|+|++||. .||++|+|+..++.|||
T Consensus 275 ~s~~~~dLl~~mL~-~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 275 TPPEAIALCSRLLE-YTPTARLTPLEACAHSF 305 (350)
T ss_dssp SCHHHHHHHHHHSC-SSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHcc-CChhHCcCHHHHhcCHh
Confidence 46679999999995 99999999999999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.25 E-value=0.092 Score=45.92 Aligned_cols=32 Identities=16% Similarity=0.148 Sum_probs=29.0
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.++|++||. .||++|+|+..+++|||
T Consensus 231 ~~s~~~~~li~~~L~-~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 231 KIDSAPLALLHKILV-ENPSARITIPDIKKDRW 262 (271)
T ss_dssp GSCHHHHHHHHHHSC-SSTTTSCCHHHHTTCTT
T ss_pred cCCHHHHHHHHHHcC-CChhHCcCHHHHhcCHh
Confidence 356788999999995 99999999999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.83 E-value=0.052 Score=48.85 Aligned_cols=31 Identities=13% Similarity=0.122 Sum_probs=28.2
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
....+.|+|++||. .||++|+|+..++.|||
T Consensus 270 ~s~~~~dli~~~L~-~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 270 FSLEFQDFVNKCLI-KNPAERADLKQLMVHAF 300 (322)
T ss_dssp BCHHHHHHHHHHTC-SSTTTSCCHHHHHTSHH
T ss_pred CCHHHHHHHHHHcC-CChhHCcCHHHHhhCHh
Confidence 35678999999995 99999999999999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.21 E-value=0.085 Score=46.11 Aligned_cols=32 Identities=6% Similarity=0.116 Sum_probs=28.8
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.++|++||. .||++|+|+..+++|||
T Consensus 237 ~~~~~~~~li~~~l~-~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIR-QNKDERYSIKDLLNHAF 268 (270)
T ss_dssp CCCHHHHHHHHHHSC-SSGGGSCCHHHHHTSGG
T ss_pred cCCHHHHHHHHHHcc-CCHhHCcCHHHHhCCcc
Confidence 356678999999995 99999999999999998
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.10 E-value=0.068 Score=46.76 Aligned_cols=32 Identities=16% Similarity=0.241 Sum_probs=29.4
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.++|++||. .||++|+|+..++.|||
T Consensus 226 ~~s~~~~~li~~~L~-~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 226 RVSSECQHLIRWCLA-LRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp CCCHHHHHHHHHHTC-SSGGGSCCHHHHHTSGG
T ss_pred CCCHHHHHHHHHHcc-CCHhHCcCHHHHhcCHh
Confidence 457889999999995 99999999999999997
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.03 E-value=0.11 Score=46.54 Aligned_cols=32 Identities=6% Similarity=-0.003 Sum_probs=28.8
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.|+|++||. .||++|+|+..+++|||
T Consensus 229 ~~s~~~~~li~~~L~-~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 229 EISIEAMDFVDRLLV-KERKSRMTASEALQHPW 260 (321)
T ss_dssp TSCHHHHHHHHTTSC-SSGGGSCCHHHHHHSHH
T ss_pred CCCHHHHHHHHHHcc-CChhHCcCHHHHhcCHh
Confidence 356789999999995 99999999999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.79 E-value=0.21 Score=43.95 Aligned_cols=33 Identities=12% Similarity=0.165 Sum_probs=29.4
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
...+.+.++|++||. .||++|+|+..++.|||=
T Consensus 242 ~~s~~~~~li~~~L~-~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 242 NTSALAKDFIRRLLV-KDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp TSCHHHHHHHHTTSC-SSGGGSCCHHHHHHSTTT
T ss_pred CCCHHHHHHHHHHcc-CChhHCcCHHHHhcCccc
Confidence 356788999999995 999999999999999983
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.40 E-value=0.1 Score=47.28 Aligned_cols=34 Identities=21% Similarity=0.340 Sum_probs=28.4
Q ss_pred hHHHHHHHhccCCCChhHHHHHhHHhcCCchhhHH
Q 014307 349 DELNAYLNKYHIELDPHLAALVGRLVILSYFFQFV 383 (427)
Q Consensus 349 ~~~~~~l~~~~l~~dp~~r~~~~~ll~~~~~~~~~ 383 (427)
+.+..++.+ |+..||..||+++++|.||||.+..
T Consensus 269 ~~~~~li~~-~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 269 SKALDLLDK-MLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHHHHH-HSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHH-HccCChhHCcCHHHHhcCHhhccCC
Confidence 455666666 9999999999999999999998643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=85.39 E-value=0.2 Score=44.45 Aligned_cols=33 Identities=9% Similarity=0.110 Sum_probs=29.7
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
...+.+.++|++||. .||++|+|+..+++|||=
T Consensus 235 ~~s~~~~~li~~~L~-~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 235 DISDSAKDFIRHLME-KDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp TSCHHHHHHHHHHSC-SSGGGSCCHHHHHHSTTT
T ss_pred CCCHHHHHHHHHHcc-CCHhHCcCHHHHhcCHhh
Confidence 356789999999995 999999999999999984
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.76 E-value=0.11 Score=45.76 Aligned_cols=32 Identities=9% Similarity=-0.007 Sum_probs=29.2
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAFG 425 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~~ 425 (427)
..+.+.++|++||. .||++|+|+..+++|||=
T Consensus 241 ~s~~~~~li~~~L~-~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 241 WSSNFKDFLKKCLE-KNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp SCHHHHHHHHHHSC-SSTTTSCCHHHHTTSGGG
T ss_pred CCHHHHHHHHHHcc-CChhHCcCHHHHhcCccc
Confidence 56789999999995 999999999999999983
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.00 E-value=0.13 Score=45.36 Aligned_cols=31 Identities=13% Similarity=-0.052 Sum_probs=28.8
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+.+.++|++||. .||++|+++..+++|||
T Consensus 242 ~s~~~~~li~~~L~-~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 242 LSAIFRDFLNRCLD-MDVEKRGSAKELLQHQF 272 (293)
T ss_dssp SCHHHHHHHHHHTC-SSTTTSCCHHHHTTCGG
T ss_pred CCHHHHHHHHHHcc-CChhHCcCHHHHhcCHh
Confidence 56789999999995 99999999999999998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=82.54 E-value=0.17 Score=44.17 Aligned_cols=32 Identities=25% Similarity=0.241 Sum_probs=29.5
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.++|++||. .+|++|+++..+++|||
T Consensus 241 ~~s~~~~~li~~~L~-~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 241 DYSDTVKDLVSRFLV-VQPQKRYTAEEALAHPF 272 (277)
T ss_dssp GSCHHHHHHHHHHCC-SSGGGSCCHHHHTTSGG
T ss_pred cCCHHHHHHHHHHcc-CChhHCcCHHHHHcCHH
Confidence 467889999999995 99999999999999998
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=81.91 E-value=5.4 Score=34.69 Aligned_cols=141 Identities=16% Similarity=0.224 Sum_probs=76.3
Q ss_pred CCCCEEEEeeeeecCCeeEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHHHhcCCCCeeeeee---------------
Q 014307 132 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD--------------- 196 (427)
Q Consensus 132 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~il~~l~~h~niv~l~~--------------- 196 (427)
..++++.++.=-.|+-|..|. . .++..++||.-.....+.+-.|+...-.+ .-|...-+.-
T Consensus 67 ~l~~~K~i~~s~~Gs~Gv~FV-~--~e~gaiVlK~s~tta~E~y~~eLAr~LGv-pvPqmRvI~~~~~E~~~~~~~~l~~ 142 (342)
T d1cjaa_ 67 NLQQFKGIERSEKGTEGLFFV-E--TESGVFIVKRSTNIESETFCSLLCMRLGL-HAPKVRVVSSNSEEGTNMLECLAAI 142 (342)
T ss_dssp CGGGEEEEEECCSTTSCEEEE-E--ESSCEEEEECCTTHHHHHHHHHHHHHHTC-CCCCEEEEESSSHHHHHHHHHHHHH
T ss_pred hHHhhhceEEeecCCceEEEE-E--cCCceEEEecCCchHHHHHHHHHHHHhCC-CCCceEEecCCCHHHHHHHHHHhcC
Confidence 345676666655666665554 2 45677888976544444444454444444 4555444320
Q ss_pred -----EEEcCCCCCcEEEEeecCCCchhhhcCC-CCHHHHHHHHHHH--HHHHH-HHHHC---Cceeecc-CCCceEEcC
Q 014307 197 -----IVRDQQSKTPSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYEL--LKALD-YCHSQ---GIMHRDV-KPHNVMIDH 263 (427)
Q Consensus 197 -----~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~i~~qi--~~~L~-~LH~~---~iiHrDl-kp~NILl~~ 263 (427)
.....-.....++|||..|..+...... .+.......+.++ +-+++ +++.. .+++|+- .+.||+++.
T Consensus 143 ~e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~ 222 (342)
T d1cjaa_ 143 DKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSE 222 (342)
T ss_dssp CSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEES
T ss_pred CChhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhhhHHHHHHHHcCCccccccccCCCCccceEEec
Confidence 0001112345789999998887655432 1111112223332 23333 34432 3555532 899999998
Q ss_pred CCCeEEEEeeeee
Q 014307 264 EQRKLRLIDWGLA 276 (427)
Q Consensus 264 ~~~~ikl~DFGla 276 (427)
++..+..+|=|..
T Consensus 223 n~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 223 RGATVVPIDSKII 235 (342)
T ss_dssp BTTCEEECSCCCC
T ss_pred CCcEEEEecCCcc
Confidence 8877777775544
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=81.27 E-value=0.18 Score=45.74 Aligned_cols=32 Identities=19% Similarity=0.279 Sum_probs=29.1
Q ss_pred hhhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 392 FCLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 392 ~~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
...+.+.|+|++||. .||++|+|+..+++|||
T Consensus 254 ~~s~~~~~li~~~L~-~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQ-KEPRKRLTVHDALEHPW 285 (352)
T ss_dssp TSCHHHHHHHHTTSC-SSGGGSCCHHHHHTSTT
T ss_pred CCCHHHHHHHHHHcc-CChhHCcCHHHHhcCHh
Confidence 356788999999995 99999999999999998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.61 E-value=0.47 Score=42.18 Aligned_cols=31 Identities=23% Similarity=0.261 Sum_probs=27.9
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhc-cccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVH-YCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~-~~~~~~~ 424 (427)
..+.+.++|++||. .||+.|+++. .++.|||
T Consensus 226 ~s~~~~dli~~~L~-~dP~~R~s~~~~l~~hpf 257 (320)
T d1xjda_ 226 LEKEAKDLLVKLFV-REPEKRLGVRGDIRQHPL 257 (320)
T ss_dssp SCHHHHHHHHHHSC-SSGGGSBTTBSCGGGSGG
T ss_pred CCHHHHHHHHHhcc-cCCCCCcCHHHHHHhCch
Confidence 56789999999995 9999999995 7999998
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=80.32 E-value=0.16 Score=45.17 Aligned_cols=31 Identities=10% Similarity=0.025 Sum_probs=28.5
Q ss_pred hhhhhHHHHHHhhhhcCchhhhhhccccCCCC
Q 014307 393 CLKTCNFLLRNFLVQAQPETMVKVHYCGESAF 424 (427)
Q Consensus 393 ~~~~~~dllr~~l~~~~P~~r~~~~~~~~~~~ 424 (427)
..+.+.++|++||. .||+.|+|+..++.|||
T Consensus 239 ~s~~~~~li~~~L~-~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 239 WSEYFRNFVDSCLQ-KIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp SCHHHHHHHHHHTC-SSGGGSCCHHHHTTCHH
T ss_pred CCHHHHHHHHHHCc-CChhHCcCHHHHHhCHH
Confidence 46789999999995 99999999999999987
|